data_2hsy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hsy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.791 0.329 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 47.7 t -112.12 131.31 63.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.814 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -110.93 159.46 17.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.437 0.637 . . . . 0.0 111.833 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -121.76 116.32 24.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.569 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 54' ' ' TYR . 67.2 mt -89.05 104.36 16.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.013 0.435 . . . . 0.0 111.306 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -99.52 -35.2 9.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.427 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -117.73 141.09 48.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.944 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.36 -25.98 38.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.427 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -58.63 -40.26 82.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.011 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -63.85 -27.05 68.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.408 ' CZ ' HD12 ' A' ' 15' ' ' LEU . 49.3 t80 -90.0 -46.92 8.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -57.95 -60.74 3.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.072 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.4 p -55.86 -23.09 28.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.294 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.84 -28.22 60.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.46 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.419 HD21 ' CD2' ' A' ' 79' ' ' TYR . 86.1 mt -89.94 -17.96 26.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.364 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.33 -86.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.328 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.1 p -90.47 29.33 1.3 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.08 87.86 1.44 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.77 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -80.07 -37.32 34.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 110.588 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -57.95 -168.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.607 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.423 HD21 HG21 ' A' ' 23' ' ' VAL . 2.7 tt -91.1 119.88 31.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.962 0.411 . . . . 0.0 110.689 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.486 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 59.6 t -113.05 107.95 24.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.532 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.423 HG21 HD21 ' A' ' 21' ' ' LEU . 43.3 t -99.92 144.81 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.507 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.407 HG12 ' CZ ' ' A' ' 26' ' ' PHE . 48.4 t -126.43 147.89 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.447 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 37.7 t70 -137.13 113.16 9.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.961 0.41 . . . . 0.0 111.211 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.512 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 70.4 m-85 -110.34 107.2 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 1.7 p90 -150.69 121.85 7.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.783 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.18 18.17 4.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.638 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.0 p 49.61 62.86 2.42 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.14 0.495 . . . . 0.0 111.119 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.507 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.8 m-90 -77.72 -61.19 2.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.149 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 41.8 t 165.11 109.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.562 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.04 -146.38 18.42 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.027 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . 84.2 Cg_exo -46.28 -36.49 17.32 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.834 2.356 . . . . 0.0 112.88 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 24.4 p -51.76 -26.04 8.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -113.77 -28.7 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.2 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.7 ttm -77.35 -29.85 53.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.292 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 33' ' ' PRO . 54.1 mt -89.94 -6.16 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.706 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.466 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -51.08 -55.35 28.84 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.536 0.208 . . . . 0.0 111.408 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.466 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 37.9 Cg_exo -61.58 -39.04 57.69 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.55 2.167 . . . . 0.0 112.285 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 60.7 mtt -53.08 -75.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.58 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.6 pt -51.69 -43.16 32.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.35 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.86 -33.65 76.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.753 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.3 ttpt -76.2 -41.25 50.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.288 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.434 ' CG ' HD12 ' A' ' 96' ' ' ILE . 6.1 m-85 -64.26 -23.96 67.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.716 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -54.85 -29.14 54.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.06 0.457 . . . . 0.0 110.473 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -84.54 -1.83 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.944 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -90.17 -46.5 8.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.048 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.434 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 17.6 m-85 -73.89 168.05 20.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.186 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -111.6 -22.69 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.269 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -146.0 66.45 1.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.034 0.445 . . . . 0.0 111.199 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.55 117.64 24.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.018 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.69 104.12 16.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.631 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.512 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 3.6 m-85 -89.85 106.89 18.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.928 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.486 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 12.8 m-30 -96.86 109.1 21.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 110.953 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -89.89 129.56 36.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.083 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.432 HD12 ' CE1' ' A' ' 26' ' ' PHE . 96.2 mt -148.35 136.84 21.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.642 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -107.29 -96.73 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.065 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.4 t -156.2 -69.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.849 0.357 . . . . 0.0 111.076 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -79.76 -33.47 40.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.13 -29.41 57.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.041 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.461 ' O ' ' HB3' ' A' ' 62' ' ' SER . 30.5 t -112.98 -67.13 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.842 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 33.2 t 75.28 -7.82 1.7 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.14 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -90.36 -64.32 1.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.924 0.393 . . . . 0.0 110.865 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.3 t -62.92 -59.98 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.137 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.22 -31.15 2.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.445 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -63.62 -58.59 6.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.738 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -74.31 -55.67 5.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.759 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.4 82.99 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.5 128.02 34.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.109 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.6 t -89.55 132.88 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -136.97 50.85 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.16 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.3 t -170.33 -163.69 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.635 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.465 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.3 ptm -170.1 90.92 0.52 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.431 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.88 -162.53 2.93 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.88 -1.3 . . . . 0.0 112.27 -0.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 88.0 m -137.12 105.02 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.602 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 3.8 mp -114.05 140.69 48.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.958 0.409 . . . . 0.0 111.217 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.1 pt -138.59 156.79 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.804 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 1.4 m-85 -124.1 125.52 44.64 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.959 0.409 . . . . 0.0 111.507 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 65.4 m-85 -110.93 124.43 52.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.925 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -116.57 -38.26 3.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.44 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.55 45.03 1.22 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.055 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.85 27.03 58.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.908 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -152.92 124.66 7.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.774 0.321 . . . . 0.0 110.832 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.67 111.05 0.73 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.381 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.91 -46.89 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 77.0 p -113.46 77.8 1.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 110.997 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -81.69 160.05 23.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.044 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.1 t -150.95 83.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.854 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.1 m -109.38 99.38 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.216 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.8 -111.05 0.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.208 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -179.72 91.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 0.0 111.109 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -178.16 123.37 0.26 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.865 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.516 ' O ' HG12 ' A' ' 96' ' ' ILE . 12.3 Cg_endo -57.57 -59.43 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.426 2.084 . . . . 0.0 112.498 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -42.1 -30.44 0.29 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.955 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -20.26 60.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.662 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 93' ' ' PRO . 8.9 pt -78.84 -42.96 24.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.872 0.367 . . . . 0.0 111.025 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.422 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -62.59 -64.38 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.578 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -54.64 -25.78 28.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.253 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.41 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -83.4 -63.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.047 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.434 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 63.1 mt -59.89 -44.92 95.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.6 -16.43 60.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.747 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.4 t -85.76 -56.71 3.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.796 0.331 . . . . 0.0 111.237 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -70.33 -23.87 62.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.138 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.555 -179.399 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.917 0.389 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t 63.72 125.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.685 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 m -106.71 166.99 10.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -106.2 90.28 3.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.064 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 54' ' ' TYR . 74.6 mt -89.03 132.7 34.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.187 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -133.52 -58.3 0.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.792 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 t -91.88 149.94 21.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.053 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.55 -28.25 67.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.208 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -55.67 -30.9 61.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -72.63 -39.26 67.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.432 ' CE1' HD22 ' A' ' 15' ' ' LEU . 52.1 t80 -61.95 -71.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.981 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -47.57 -30.08 3.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.532 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 t -66.01 -23.3 66.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.194 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.08 -36.03 15.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.26 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 2.2 mm? -82.12 -0.3 44.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.446 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.92 -82.12 0.27 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 111.061 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -90.54 30.42 1.15 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.185 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.63 168.04 41.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.645 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -159.57 -45.67 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.644 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -59.43 -170.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.731 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.414 ' CD2' HG21 ' A' ' 100' ' ' ILE . 44.4 tp -75.38 107.36 7.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.209 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.16 97.63 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.563 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -105.74 137.97 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.593 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG13 ' CE2' ' A' ' 26' ' ' PHE . 48.1 t -116.59 139.08 44.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.329 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -117.93 98.18 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.508 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.429 ' CE2' HG13 ' A' ' 24' ' ' VAL . 61.3 m-85 -96.02 96.98 9.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.916 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.2 p90 -136.54 122.16 19.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.65 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.25 112.16 23.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.479 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.7 p -74.54 105.36 5.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.471 . . . . 0.0 111.629 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.531 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.2 m-90 -105.32 -60.38 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.471 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 44.7 t 159.07 90.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.418 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.3 -82.54 0.21 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.759 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.755 ' O ' ' N ' ' A' ' 35' ' ' LYS . 87.3 Cg_endo -79.79 -155.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.496 2.13 . . . . 0.0 110.852 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 4.6 p 42.04 -68.81 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.755 ' N ' ' O ' ' A' ' 33' ' ' PRO . 86.9 tttt -55.27 -39.84 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.382 . . . . 0.0 111.306 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -62.68 1.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.473 ' H ' ' CD1' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -90.16 34.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.936 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.484 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -90.06 -59.65 0.24 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.621 0.248 . . . . 0.0 110.914 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.484 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 59.6 Cg_exo -52.54 -41.15 69.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.353 2.035 . . . . 0.0 112.35 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.414 ' CE ' ' CB ' ' A' ' 93' ' ' PRO . 70.0 mtp -50.07 -71.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 110.788 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 pt -55.38 -45.57 78.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.258 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.9 -35.29 74.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.844 0.354 . . . . 0.0 110.727 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.429 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 11.6 tmtt? -69.9 -49.28 53.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.412 ' CG ' ' OE1' ' A' ' 47' ' ' GLN . 6.0 m-85 -47.54 -28.85 2.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.271 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.13 -29.29 57.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.837 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.61 -32.98 25.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.404 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.412 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 84.5 mt-30 -60.52 -26.39 66.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.455 ' CZ ' HG22 ' A' ' 100' ' ' ILE . 42.1 m-85 -90.1 176.82 6.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.779 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.3 m -114.05 -27.83 7.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.258 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -138.9 68.96 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 111.424 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.74 115.18 20.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.99 101.3 14.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.394 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -93.72 132.11 38.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.444 ' HB3' ' CD1' ' A' ' 5' ' ' LEU . 15.3 m-30 -121.62 106.42 11.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.806 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.91 130.11 36.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.984 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.6 mt -155.47 140.96 17.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.829 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -101.42 -128.38 0.21 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.475 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.3 t -126.58 -70.13 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.084 0 CA-C-O 120.777 0.322 . . . . 0.0 111.015 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -72.61 -39.72 67.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.739 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -58.17 -29.51 65.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.7 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.25 70.53 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.2 t -76.86 -2.03 31.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.541 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -84.83 -38.07 19.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.816 0.341 . . . . 0.0 111.089 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.2 t -90.2 -56.31 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.251 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.19 -32.55 16.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.65 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -58.25 -48.28 80.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.89 -51.59 66.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.01 77.33 6.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.091 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.05 115.06 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.2 m -138.56 143.02 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.188 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -116.77 174.88 5.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.828 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 81.8 p 50.69 95.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.522 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 21.6 mmt -91.24 150.76 42.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.78 -178.98 22.88 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 123.723 -1.366 . . . . 0.0 112.7 0.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -149.85 130.69 14.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.56 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.0 mp -123.98 131.98 53.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.0 111.335 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 pt -130.47 139.58 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.502 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.443 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 2.7 m-85 -114.23 125.64 54.15 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.044 0.449 . . . . 0.0 111.572 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 69.7 m-85 -109.61 162.14 14.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.718 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -153.41 67.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.74 20.74 18.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.415 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.77 64.51 1.2 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.565 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -178.18 115.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.954 0.407 . . . . 0.0 111.157 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 44.3 tt0 -79.31 98.43 6.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.575 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.91 -32.43 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.412 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 92.2 m -113.88 102.8 10.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.889 0.376 . . . . 0.0 110.468 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -110.0 144.31 38.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.003 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.415 HG23 ' CE1' ' A' ' 78' ' ' PHE . 50.2 t -137.57 82.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.704 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.65 106.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.325 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.03 -108.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.371 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -179.93 68.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.991 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -142.51 96.4 6.29 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.052 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.427 ' O ' HG13 ' A' ' 96' ' ' ILE . 32.0 Cg_exo -58.6 -17.1 33.32 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.589 2.192 . . . . 0.0 112.503 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.27 -29.73 17.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.853 0.358 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.52 -25.32 62.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.173 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 93' ' ' PRO . 2.1 pp -56.59 -31.9 35.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 34.5 ttpt -62.93 -65.11 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.16 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -39.01 -33.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.655 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.47 -46.87 12.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.455 HG22 ' CZ ' ' A' ' 48' ' ' TYR . 73.4 mt -74.07 -5.68 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.541 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.22 -32.9 16.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.727 0.299 . . . . 0.0 111.379 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.7 p -89.67 -58.55 2.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 111.387 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.401 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 47.2 m-80 -60.08 -17.99 43.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.591 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 11.3 p . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.769 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.409 ' HG3' ' N ' ' A' ' 2' ' ' VAL . 23.0 ptp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.889 0.376 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 45.4 t -147.93 102.19 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.701 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -101.53 152.44 20.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.423 0.63 . . . . 0.0 111.851 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -113.01 118.84 35.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.402 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 4.7 mp -89.15 117.68 28.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.977 0.418 . . . . 0.0 111.616 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -107.79 -37.0 6.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.172 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.2 t -115.95 143.81 44.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.831 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.48 -23.79 41.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.302 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 m -60.12 -45.01 94.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -59.9 -27.4 66.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.35 . . . . 0.0 110.895 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.462 ' CZ ' ' CD1' ' A' ' 15' ' ' LEU . 48.6 t80 -90.03 -48.81 6.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.175 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -57.79 -61.81 2.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.1 p -54.56 -24.33 20.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.349 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.06 -66.06 0.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.362 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 11' ' ' TYR . 82.2 mt -54.85 -24.11 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.4 -79.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.205 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -90.2 17.24 7.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.04 105.88 3.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -109.47 -22.0 12.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 111.065 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -54.92 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.092 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.416 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 4.4 tt -177.83 107.99 0.06 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.455 ' CG1' ' CD2' ' A' ' 54' ' ' TYR . 58.3 t -102.79 124.72 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.723 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.19 122.57 69.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.43 ' CG1' ' CE2' ' A' ' 26' ' ' PHE . 51.8 t -104.0 112.55 37.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.756 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -108.68 98.44 7.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.451 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 61.0 m-85 -86.3 115.55 23.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.88 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 2.3 p90 -135.81 117.12 14.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.661 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . . . -86.79 4.52 40.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.771 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.8 p 49.18 70.83 0.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 111.178 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.478 ' CZ2' ' HG2' ' A' ' 73' ' ' MET . 3.0 m-90 -89.12 -57.84 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.148 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.8 t -139.57 -104.35 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.384 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.616 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -136.05 25.76 3.17 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.9 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 85.7 Cg_endo -82.44 -41.32 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 121.982 1.788 . . . . 0.0 112.114 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.9 p -98.39 -41.93 7.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.247 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -52.18 -42.12 63.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.382 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.7 ttt -67.72 -25.79 65.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.117 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.0 mm -86.97 -10.72 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.693 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.459 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -59.91 -63.37 4.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 82.5 Cg_exo -45.76 -40.68 19.44 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.333 2.022 . . . . 0.0 112.801 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.6 mtt -54.17 -79.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.644 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -57.55 -29.71 34.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.778 0.323 . . . . 0.0 110.969 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 88.4 tt0 -70.35 -26.92 63.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.704 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 13.4 tmtt? -87.09 -45.92 10.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.241 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -54.82 -27.47 42.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.703 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.82 -30.56 23.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.087 0.47 . . . . 0.0 110.495 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -83.15 -26.53 30.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.59 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -72.64 -26.1 61.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.302 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.421 ' CE2' HD13 ' A' ' 100' ' ' ILE . 49.1 m-85 -83.18 167.67 17.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.374 . . . . 0.0 111.039 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -97.28 -33.48 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.821 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -153.01 98.57 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.823 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.63 121.24 10.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.629 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.94 109.28 20.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 10.4 m-85 -97.96 116.05 29.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.525 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.455 ' CD2' ' CG1' ' A' ' 22' ' ' VAL . 17.7 m-30 -112.26 99.77 8.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.864 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -90.04 127.63 36.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.427 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 90.0 mt -130.87 162.77 28.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.216 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.426 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 38.8 t70 -106.33 -109.5 0.29 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.515 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' A' ' 57' ' ' ASP . 16.1 m -160.51 -48.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.742 0.306 . . . . 0.0 111.399 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -110.75 -33.63 6.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.5 -27.32 56.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.695 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.508 ' O ' ' OG ' ' A' ' 62' ' ' SER . 46.8 t -106.74 -68.78 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.508 ' OG ' ' O ' ' A' ' 61' ' ' VAL . 86.1 p 64.59 5.75 2.86 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.015 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.49 -38.64 13.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.974 0.416 . . . . 0.0 110.656 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.408 ' HB ' HD12 ' A' ' 56' ' ' LEU . 27.0 t -90.05 -47.21 14.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.248 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.0 -30.31 1.0 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.653 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -73.79 -37.03 65.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -88.91 -57.49 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.754 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.06 81.24 8.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.067 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.67 117.81 5.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.01 174.53 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -175.98 91.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.16 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.6 t -178.22 -171.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.478 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 52.8 mtt -156.83 93.73 2.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.02 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -89.39 -162.66 1.93 Allowed 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.297 -1.126 . . . . 0.0 112.502 0.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 95.4 m -141.55 105.65 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.676 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 3.9 mp -118.91 119.75 35.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.227 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.435 HG23 HD11 ' A' ' 77' ' ' ILE . 29.8 pt -121.31 166.99 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.51 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.9 m-85 -130.87 128.55 40.83 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.054 0.454 . . . . 0.0 111.338 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 60.2 m-85 -109.76 131.78 54.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.062 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -132.91 60.05 1.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.085 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.65 38.65 0.65 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.026 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.49 29.12 72.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.006 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -142.72 115.43 8.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 111.06 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.3 tt0 -69.98 104.13 2.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.596 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.42 -37.72 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.462 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 88.5 m -106.82 107.32 18.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 110.397 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -110.77 152.59 26.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.339 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' A' ' 78' ' ' PHE . 44.8 t -149.44 82.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.683 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.59 98.5 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.199 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.1 -107.26 0.2 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.436 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 173.62 92.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -153.37 116.66 2.74 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.03 -11.99 32.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.507 2.138 . . . . 0.0 112.652 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.57 -38.25 10.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.68 0.276 . . . . 0.0 111.287 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.71 -35.2 21.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 111.021 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -53.06 -43.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.524 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.44 -72.2 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.318 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -51.47 -26.24 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.761 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . . . -72.47 -62.57 1.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.752 0.311 . . . . 0.0 111.071 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.443 HD12 HG22 ' A' ' 100' ' ' ILE . 62.3 mt -73.83 -7.39 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.411 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.04 -27.3 26.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.689 0.28 . . . . 0.0 111.329 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.6 m -90.06 -56.09 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.294 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -55.35 -45.49 76.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.453 -179.524 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.852 0.358 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.46 123.78 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.926 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 -178.2 4.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 0.0 110.597 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -124.0 90.13 3.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.19 178.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.43 HD12 ' CD1' ' A' ' 54' ' ' TYR . 5.0 mp -89.07 141.12 28.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -133.68 -69.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.2 t -79.32 162.18 25.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.056 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.27 -30.34 67.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.062 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -59.02 -33.83 71.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -69.7 -30.72 68.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.826 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.424 ' CZ ' HD12 ' A' ' 15' ' ' LEU . 45.8 t80 -75.75 -45.99 33.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.905 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.29 -56.29 19.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -59.1 -28.0 66.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.052 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.66 -66.4 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.136 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.453 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 81.4 mt -58.06 -26.72 62.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.037 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.78 -68.0 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -78.21 -28.46 48.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.19 119.07 12.84 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -114.37 -31.08 6.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 0.0 111.195 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.92 -108.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 tt -139.49 121.65 15.82 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.784 0.326 . . . . 0.0 110.439 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.421 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 60.3 t -111.92 122.81 66.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.009 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.32 124.7 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -110.67 115.56 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.058 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -102.43 120.24 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.419 ' CE1' HD12 ' A' ' 56' ' ' LEU . 54.6 m-85 -108.26 119.52 39.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.16 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.424 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 2.5 p90 -155.15 113.3 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.644 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.06 23.2 6.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.403 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p 46.81 70.14 0.42 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.96 0.409 . . . . 0.0 110.769 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CZ3' ' HB2' ' A' ' 73' ' ' MET . 2.5 m-90 -83.05 -57.86 3.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.868 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.4 t -118.89 -37.1 3.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.894 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 142.14 -38.38 1.48 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.504 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 58.7 Cg_exo -40.7 -46.96 4.71 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.622 2.214 . . . . 0.0 112.927 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.8 p -53.56 -31.75 47.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.004 0.43 . . . . 0.0 110.737 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -83.64 -25.93 30.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.9 ttm -70.18 -33.21 71.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.687 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.4 HD13 HG23 ' A' ' 37' ' ' ILE . 56.4 mt -90.15 -1.36 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.46 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -59.09 -63.72 3.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 121.206 -0.197 . . . . 0.0 111.279 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.46 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 86.1 Cg_exo -44.07 -34.55 6.69 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.379 2.053 . . . . 0.0 112.512 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.7 mtt -56.11 -74.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.644 HD11 ' HG3' ' A' ' 42' ' ' GLU . 2.4 pp -63.8 -25.28 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.199 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.644 ' HG3' HD11 ' A' ' 41' ' ' ILE . 93.4 mt-10 -72.41 -30.96 65.11 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.001 0.429 . . . . 0.0 109.997 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.433 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -77.23 -44.51 29.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.828 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.6 m-85 -55.65 -23.05 25.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.647 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -56.94 -28.15 61.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 110.536 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -89.14 -7.78 55.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.872 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -90.06 -51.06 5.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.583 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.47 ' CE2' HG13 ' A' ' 100' ' ' ILE . 51.8 m-85 -68.0 143.63 55.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.904 0.383 . . . . 0.0 111.336 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.3 m -76.73 -34.03 58.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 1.5 p30 -150.11 100.32 2.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.297 0.57 . . . . 0.0 111.395 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . . . -146.54 125.07 12.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.28 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.52 107.39 19.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.552 ' CZ ' ' HA ' ' A' ' 45' ' ' ALA . 14.6 m-85 -101.75 124.95 48.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.915 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.43 ' CD1' HD12 ' A' ' 5' ' ' LEU . 17.6 m-30 -112.36 123.43 50.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -102.75 119.83 39.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' A' ' 26' ' ' PHE . 81.2 mt -130.87 155.38 46.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.801 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -120.04 -83.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.119 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.6 p 178.32 -45.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.33 . . . . 0.0 111.085 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -85.96 -58.12 2.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.776 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -59.55 -30.47 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.21 54.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.041 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.5 t -70.16 -27.32 64.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.63 -40.9 69.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.42 -48.98 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.942 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.52 -45.54 9.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.514 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -59.36 -58.8 7.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.77 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -60.88 -68.72 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.47 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.94 75.43 2.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.778 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -48.57 137.77 11.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.231 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.1 t -124.31 158.64 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.08 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -164.56 70.49 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.415 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 41.5 t -177.74 -163.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.646 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.9 ptm -175.03 100.2 0.27 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.426 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 6.0 Cg_exo -79.76 -155.35 1.14 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.464 -1.057 . . . . 0.0 112.216 -0.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.415 ' OG1' ' HB3' ' A' ' 72' ' ' SER . 87.3 m -159.14 111.06 2.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.2 mp -123.95 127.3 47.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.259 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.4 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 24.2 pt -117.03 156.32 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.733 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.582 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -127.04 123.46 37.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.01 0.433 . . . . 0.0 111.427 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.453 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 66.7 m-85 -109.83 176.79 4.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.573 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -153.0 -46.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.628 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.0 29.27 1.69 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.191 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.09 44.14 3.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.272 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -162.25 123.57 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.023 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.431 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 22.1 pt-20 -82.3 101.72 10.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.45 . . . . 0.0 110.672 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.54 -34.18 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.446 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 63.7 m -107.96 110.36 22.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.417 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -111.56 158.91 18.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.267 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.6 t -155.22 80.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.773 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.82 63.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.13 0.49 . . . . 0.0 111.27 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -133.57 -158.2 8.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.305 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.03 76.18 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.31 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -154.75 138.32 10.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.555 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.87 -1.03 10.63 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.62 2.213 . . . . 0.0 113.261 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.57 -40.76 9.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.683 0.278 . . . . 0.0 111.241 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.3 -31.52 6.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.7 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -69.76 -36.22 68.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.309 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -61.66 -73.33 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.607 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -55.64 -41.74 73.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.986 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.446 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -54.27 -55.85 24.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.317 . . . . 0.0 111.324 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.47 HG13 ' CE2' ' A' ' 48' ' ' TYR . 32.8 mm -62.22 -51.01 77.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.747 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -23.68 66.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.227 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -54.8 -62.91 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.55 . . . . 0.0 110.826 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -127.71 46.54 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.078 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.099 179.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.835 0.35 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.417 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 15.8 m -56.96 154.14 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.034 0.445 . . . . 0.0 111.629 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.9 m -101.11 163.9 12.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -98.65 90.7 4.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 54' ' ' TYR . 5.2 mp -88.84 127.46 35.63 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.956 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -129.71 -58.21 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.196 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.9 t -90.24 139.82 30.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.13 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.02 66.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.163 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.4 p -55.88 -37.68 69.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.813 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.18 -32.95 74.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -65.09 -62.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.155 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.93 -54.61 42.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.8 p -56.69 -22.55 35.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.22 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.32 -60.55 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.322 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.461 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 78.5 mt -55.7 -23.0 26.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.165 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.89 -61.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 111.249 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -75.16 -48.35 24.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.066 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.79 108.24 0.68 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.773 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -109.85 -25.17 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 0.0 110.916 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -53.49 -79.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.448 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 4.3 tt -169.02 116.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 110.554 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.449 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 50.1 t -105.76 137.99 33.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.506 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.31 108.94 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 0.0 111.319 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.44 HG21 HG12 ' A' ' 77' ' ' ILE . 34.7 m -102.38 122.92 55.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.87 103.92 13.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CE1' ' CD1' ' A' ' 56' ' ' LEU . 63.4 m-85 -91.99 101.7 14.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.173 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.425 ' HA ' ' CH2' ' A' ' 30' ' ' TRP . 2.4 p90 -134.53 122.21 22.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.519 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.25 23.65 4.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.868 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.2 p 46.52 80.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.985 0.421 . . . . 0.0 111.355 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.45 ' CZ2' ' HG2' ' A' ' 73' ' ' MET . 3.6 m-90 -86.63 -58.87 2.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.322 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.5 t -143.44 -77.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.502 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.579 ' N ' ' HD3' ' A' ' 33' ' ' PRO . . . -168.69 52.59 0.22 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.923 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 32' ' ' GLY . 37.5 Cg_endo -94.3 -68.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.051 2.501 . . . . 0.0 112.204 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.0 p -68.63 -34.87 76.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.813 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 38' ' ' ALA . 9.4 tmtt? -52.93 -55.5 22.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.66 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.8 ttt -51.22 -42.69 61.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.2 pt -90.2 10.7 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.134 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.51 ' HB2' ' HD3' ' A' ' 39' ' ' PRO . . . -62.94 -51.04 74.01 Favored Pre-proline 0 C--N 1.331 -0.203 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.301 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 50.4 Cg_exo -55.53 -32.44 82.72 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.277 1.985 . . . . 0.0 112.09 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 63.3 mtt -55.1 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.456 ' CD1' ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -55.5 -28.78 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 111.132 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.456 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 8.7 tm-20 -71.38 -27.09 63.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.368 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -86.01 -50.75 6.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.413 ' O ' ' CD2' ' A' ' 48' ' ' TYR . 9.8 m-85 -54.19 -30.25 48.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.406 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.426 ' HB1' ' CD2' ' A' ' 53' ' ' PHE . . . -51.91 -27.83 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.239 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -90.1 -33.61 16.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.76 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -61.81 -24.56 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.105 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 100' ' ' ILE . 39.2 m-85 -82.28 159.07 23.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.991 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -81.28 -38.96 26.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 1.6 p30 -150.0 104.75 3.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.118 0.485 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.09 123.23 11.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.092 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.0 100.26 13.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.426 ' CD2' ' HB1' ' A' ' 45' ' ' ALA . 9.4 m-85 -94.87 127.34 40.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.496 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.449 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 18.8 m-30 -118.23 126.44 52.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.004 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -107.32 99.13 8.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.603 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.444 ' CD1' ' CE1' ' A' ' 26' ' ' PHE . 98.1 mt -98.77 164.28 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.236 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -144.2 162.89 35.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.439 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.7 t -86.83 0.53 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.794 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -113.22 -75.93 0.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.644 0.259 . . . . 0.0 111.211 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.57 -23.02 57.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.197 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 64' ' ' VAL . 39.8 t -127.98 47.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.5 t -62.69 -26.24 68.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.016 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -60.75 -55.14 36.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.993 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.402 ' CG2' ' CG1' ' A' ' 61' ' ' VAL . 55.7 t -58.8 -48.92 84.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.025 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.08 -26.5 6.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.311 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -58.48 -64.54 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.727 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -59.65 -57.95 10.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.801 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.24 83.51 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -56.57 111.77 1.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.027 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.9 t -92.15 127.36 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.8 t -153.47 39.45 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.177 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.0 m -128.03 -53.87 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.704 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.45 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 55.1 mtm 65.16 83.62 0.19 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.303 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 85.9 Cg_endo -89.18 -166.11 2.98 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.881 -1.3 . . . . 0.0 112.477 -0.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.8 m -144.88 103.0 3.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.719 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.0 mp -109.67 119.16 38.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.609 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -127.15 152.41 35.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.054 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.547 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.9 m-85 -117.87 134.84 54.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.374 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.461 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 76.4 m-85 -109.47 147.49 32.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.66 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -145.67 76.91 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.659 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.13 51.62 1.33 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.12 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.76 27.39 59.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.873 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -144.32 147.45 33.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.965 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -102.21 135.01 44.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.673 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.79 -39.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.876 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 83.1 m -101.1 118.94 37.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.849 0.357 . . . . 0.0 110.262 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -118.13 170.66 8.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.017 0.437 . . . . 0.0 111.614 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -155.81 83.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.704 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.3 88.79 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.29 -34.52 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.973 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 77.53 83.28 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.926 0.393 . . . . 0.0 111.121 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -145.41 129.81 8.86 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.625 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.401 ' O ' ' CG2' ' A' ' 96' ' ' ILE . 30.1 Cg_endo -64.11 -8.64 16.86 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.668 2.245 . . . . 0.0 113.326 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.1 -34.69 10.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.697 0.285 . . . . 0.0 111.173 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.66 -33.87 68.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.128 0.49 . . . . 0.0 110.171 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.401 ' CG2' ' O ' ' A' ' 93' ' ' PRO . 4.2 tp -56.01 -50.41 69.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.297 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.427 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 11.0 tmtt? -59.01 -57.35 13.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.718 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -68.71 -11.76 60.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.61 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.45 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -81.19 -60.03 2.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.778 0.323 . . . . 0.0 111.38 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 48' ' ' TYR . 2.0 mp -75.66 -57.14 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.068 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -46.09 -27.05 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.671 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.9 t -77.96 -57.78 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.429 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -109.97 40.91 1.82 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 111.391 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.992 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.829 0.347 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.1 t -53.39 133.61 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.8 m -107.2 165.02 11.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.08 0.467 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -96.21 79.07 3.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.48 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.6 tp -89.16 95.75 10.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.495 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -106.02 -36.93 6.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.348 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -105.21 145.43 30.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.622 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.34 75.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.056 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -51.83 -28.95 17.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.72 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -80.8 -30.49 35.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.567 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -78.79 -45.27 21.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -57.16 -52.24 66.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -62.46 -27.73 69.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.79 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.19 -53.14 60.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 83.7 mt -59.47 -30.96 68.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.881 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.22 -67.91 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -90.39 24.9 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.366 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.66 -97.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.628 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.4 t0 68.75 -62.16 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.647 0.261 . . . . 0.0 111.167 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -46.62 -82.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.15 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 103' ' ' ASN . 34.7 tp -178.47 111.85 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.752 0.31 . . . . 0.0 110.977 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.404 HG13 ' CE2' ' A' ' 54' ' ' TYR . 47.7 t -105.13 141.02 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.616 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.2 t -144.03 111.03 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 111.373 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.418 HG13 ' CE2' ' A' ' 26' ' ' PHE . 62.1 t -99.96 116.85 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.732 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 27' ' ' PHE . 10.0 t0 -106.07 103.73 13.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.936 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.487 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 64.8 m-85 -92.07 108.53 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.986 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CD1' ' OD1' ' A' ' 25' ' ' ASP . 1.7 p90 -153.23 120.37 5.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.79 27.01 2.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.2 p 49.72 51.86 15.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.08 0.467 . . . . 0.0 110.999 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.526 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.1 m-90 -66.73 -62.71 1.31 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.009 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.8 t 161.86 144.75 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.758 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.07 -112.43 3.65 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.676 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HA ' HD11 ' A' ' 37' ' ' ILE . 91.1 Cg_exo -43.66 -71.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.953 2.435 . . . . 0.0 113.413 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.8 p -48.78 -24.19 1.33 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -84.15 -73.07 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.784 0.326 . . . . 0.0 111.863 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 83.6 mtp -66.28 -34.07 77.16 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.552 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.4 mp -90.52 24.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.186 0.517 . . . . 0.0 111.207 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.413 ' N ' ' CD ' ' A' ' 39' ' ' PRO . . . -90.15 -52.35 0.33 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.85 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 43' ' ' LYS . 34.0 Cg_exo -62.47 -32.18 80.45 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.649 2.233 . . . . 0.0 113.009 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.496 ' HE2' ' HA ' ' A' ' 37' ' ' ILE . 42.4 mtm -57.56 -77.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.918 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 42' ' ' GLU . 2.6 pp -56.0 -27.41 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.758 0.313 . . . . 0.0 111.044 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.447 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 89.1 tt0 -75.2 -28.13 59.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.029 0.443 . . . . 0.0 110.512 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' PRO . 22.9 ttpp -83.37 -48.6 10.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.427 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -50.52 -27.12 6.07 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.845 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . . . -55.59 -28.67 56.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.957 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.92 -14.77 33.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.108 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -85.4 10.08 13.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.571 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.42 153.26 40.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.755 0.312 . . . . 0.0 110.823 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -80.91 -40.34 24.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.968 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -134.52 95.79 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.068 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -143.4 121.75 12.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.2 98.39 9.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.371 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 10.6 m-85 -91.64 129.11 37.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.31 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 22' ' ' VAL . 17.6 m-30 -114.09 107.13 15.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.89 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -89.77 125.43 35.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.437 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.444 HD12 ' CE1' ' A' ' 26' ' ' PHE . 86.7 mt -130.62 156.74 44.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.067 0.46 . . . . 0.0 111.53 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.54 117.96 15.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.238 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.74 74.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.074 0.464 . . . . 0.0 111.2 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 t70 179.89 -69.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.135 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -78.63 -31.03 46.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.886 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.415 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 25.1 t -113.47 30.69 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.878 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.1 p -49.03 -26.89 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.345 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -44.62 -55.36 5.26 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.523 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -59.58 -46.4 93.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.001 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.91 -34.21 58.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.431 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -54.95 -69.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.08 -47.54 85.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.5 80.38 9.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.37 111.23 1.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.423 HG22 ' CD2' ' A' ' 26' ' ' PHE . 48.7 t -119.08 145.63 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -144.5 70.15 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.031 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.4 m -165.46 -175.61 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.697 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.465 ' CB ' ' CZ3' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -170.02 106.66 0.44 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.672 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -74.66 -155.64 1.06 Allowed 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 124.1 -1.208 . . . . 0.0 111.99 -0.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 86.9 m -164.22 108.23 0.96 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.8 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 3.9 mp -123.56 119.3 29.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.423 HD13 ' CZ ' ' A' ' 79' ' ' TYR . 26.3 pt -110.37 152.8 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.017 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -127.03 122.84 35.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.051 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.445 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 68.7 m-85 -109.68 136.99 48.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.21 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -118.11 -36.45 3.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.311 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.98 49.57 0.8 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.906 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.54 28.0 66.9 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.777 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -145.94 114.28 6.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.751 0.31 . . . . 0.0 110.962 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 11.9 pt-20 -58.08 123.94 17.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.662 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.4 m -136.04 -44.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.494 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 94.3 m -103.33 105.36 15.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 110.619 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -103.49 147.86 26.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.455 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 48.4 t -138.28 82.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.798 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.4 t -109.54 62.78 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.11 127.05 1.42 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.259 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.25 124.68 17.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.774 0.321 . . . . 0.0 111.049 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -176.15 103.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.612 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.439 ' O ' ' CG2' ' A' ' 96' ' ' ILE . 11.2 Cg_endo -56.2 -13.98 10.9 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.652 2.235 . . . . 0.0 113.23 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -96.91 -44.56 6.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.69 -31.18 15.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 110.625 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 93' ' ' PRO . 4.2 tp -58.03 -44.84 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.05 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -61.32 -75.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.934 0.397 . . . . 0.0 111.2 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -44.66 -32.92 1.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.542 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -68.98 -41.74 77.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.405 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.96 -44.34 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.338 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.57 -13.48 59.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.6 p -90.14 -26.32 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 49.8 m-80 -114.72 -19.43 11.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.658 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.614 -179.176 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.835 0.35 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.412 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 59.4 t -48.23 121.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.61 170.51 7.89 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.249 0.547 . . . . 0.0 110.974 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -111.71 98.17 7.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.001 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.432 HD22 ' CG ' ' A' ' 54' ' ' TYR . 5.4 mp -88.98 119.61 29.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.845 0.355 . . . . 0.0 111.168 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -107.86 -69.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.906 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.6 t -84.56 162.86 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.13 -29.45 60.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.3 p -59.67 -33.39 71.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.05 -31.58 70.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.417 ' CE1' HD22 ' A' ' 15' ' ' LEU . 45.4 t80 -90.14 -36.37 14.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.61 -54.64 44.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -67.81 -20.12 65.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.279 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.59 -53.27 19.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.215 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD22 ' CE1' ' A' ' 11' ' ' TYR . 85.1 mt -58.63 -28.85 66.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.11 -58.87 2.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.356 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -55.96 -72.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.98 129.37 47.36 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.646 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -125.23 22.9 7.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.655 0.264 . . . . 0.0 111.17 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -96.54 -75.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.811 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 104' ' ' VAL . 20.3 tp -159.09 107.33 1.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.965 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t -103.57 112.91 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.623 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.9 114.68 43.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.584 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 54.8 t -100.28 145.1 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.399 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 38.3 t70 -127.07 92.76 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 0.0 111.595 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.416 ' CE1' HD21 ' A' ' 56' ' ' LEU . 72.6 m-85 -88.84 94.87 10.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.832 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 5.3 p90 -129.69 122.24 28.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.421 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -93.24 79.45 4.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.363 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.7 t -48.1 94.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.983 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.54 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.8 m-90 -92.06 -48.65 6.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 44.7 t 150.02 58.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.935 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.19 -121.9 0.58 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.655 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.416 ' O ' HG12 ' A' ' 37' ' ' ILE . 32.0 Cg_exo -57.13 -73.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.392 2.061 . . . . 0.0 112.192 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 6.0 p -41.54 -32.06 0.32 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -65.18 -47.36 77.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.039 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.2 mtp -84.81 -23.2 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.395 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 33' ' ' PRO . 49.0 mm -75.53 -7.55 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.425 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.503 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -63.77 -63.98 3.37 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.503 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 72.3 Cg_exo -48.64 -38.49 36.6 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.323 2.015 . . . . 0.0 112.905 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 64.1 mtt -52.5 -82.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.15 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.432 HD11 ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -56.38 -26.98 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.16 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' N ' HD11 ' A' ' 41' ' ' ILE . 89.4 tt0 -72.24 -25.85 61.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.399 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -85.89 -48.25 8.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.017 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -54.06 -27.46 32.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' HB1' ' CG ' ' A' ' 53' ' ' PHE . . . -56.8 -27.35 59.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.811 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -89.96 -10.78 43.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.095 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -90.08 16.85 7.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.668 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 100' ' ' ILE . 37.3 m-85 -131.88 158.37 41.54 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.9 m -95.63 -33.78 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -136.39 77.76 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.76 116.63 18.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.85 94.79 9.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.957 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.412 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 9.8 m-85 -90.03 128.55 36.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.638 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CG ' HD22 ' A' ' 5' ' ' LEU . 18.6 m-30 -114.91 96.12 5.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.982 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -89.79 120.88 31.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.333 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 3.6 mp -129.79 -175.94 3.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.471 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -137.12 -82.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p 177.83 -37.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.744 0.307 . . . . 0.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -98.22 -31.46 12.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.45 -38.01 82.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.831 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.3 t -103.81 -50.82 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.845 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.1 t 68.24 -63.92 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.46 -67.4 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.471 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.4 t -57.41 -61.03 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.029 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.89 -28.9 2.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.387 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -76.02 -62.23 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.739 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -60.35 -29.44 68.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.492 ' N ' ' HD3' ' A' ' 67' ' ' LYS . . . -88.25 80.79 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.895 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -53.75 95.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -86.94 157.77 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.273 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.6 p -149.6 128.52 12.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.73 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.4 m 62.43 82.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.933 0.397 . . . . 0.0 110.553 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.455 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 38.2 mtp -84.3 152.32 61.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.617 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.07 173.28 53.0 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 123.63 -1.404 . . . . 0.0 112.71 0.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.0 m -147.86 132.25 17.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.607 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.444 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.1 mp -124.59 142.31 51.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.207 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -139.36 147.47 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.833 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.481 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.6 m-85 -117.87 121.3 40.37 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.051 0.453 . . . . 0.0 111.435 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 61.2 m-85 -109.65 130.4 55.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.002 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.61 53.53 1.83 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.219 0.533 . . . . 0.0 109.924 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.21 41.4 0.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.146 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.34 37.03 86.26 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.078 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -151.09 107.76 3.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.69 0.281 . . . . 0.0 111.242 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.466 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 44.4 tt0 -58.77 126.82 29.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.169 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.3 m -138.67 -46.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 71.5 p -113.4 77.88 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.126 0.489 . . . . 0.0 111.045 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -80.7 158.84 25.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.147 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 60.0 t -141.52 85.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.697 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 89' ' ' VAL . 35.1 m -109.26 78.06 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.139 0.495 . . . . 0.0 111.294 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.99 148.05 16.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.325 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.26 76.38 7.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.872 0.367 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -156.48 125.6 3.08 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.58 -6.89 20.1 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.49 2.127 . . . . 0.0 112.79 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.51 -36.32 12.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.0 110.94 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.14 -28.08 6.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.159 0.504 . . . . 0.0 110.204 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.455 HD13 HG23 ' A' ' 96' ' ' ILE . 6.1 tt -80.92 -33.03 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.729 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.43 -61.05 2.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -75.69 -5.92 47.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.641 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -89.7 -43.94 10.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.797 0.332 . . . . 0.0 111.244 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.418 HD12 ' CE2' ' A' ' 48' ' ' TYR . 63.0 mt -74.13 -53.81 16.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.782 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.28 -20.94 31.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.652 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.9 p -82.95 -75.52 0.31 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.664 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -52.72 -37.82 59.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.118 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 14.8 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.485 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.861 0.363 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.495 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 59.6 t -57.57 145.18 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 m -107.84 158.62 17.17 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.638 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -96.71 92.6 6.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.423 ' CD2' ' HB3' ' A' ' 54' ' ' TYR . 4.8 mp -88.9 109.94 20.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.704 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -104.53 -55.65 2.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.34 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.0 t -101.49 151.68 21.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.55 67.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.5 p -55.87 -31.31 62.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -69.23 -36.73 77.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.757 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -60.66 -40.94 93.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.85 -65.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -57.8 -24.6 58.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.019 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.95 -54.8 42.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.449 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 80.8 mt -82.92 1.39 39.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.332 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.06 -74.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.786 0.327 . . . . 0.0 111.245 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.1 p -71.83 -34.42 69.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.08 119.08 7.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.573 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.78 26.69 5.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.02 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -93.96 -70.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.687 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.436 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 4.2 tt -174.86 105.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.368 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 49.3 t -99.82 132.62 44.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.82 115.48 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.142 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.418 HG11 ' CE2' ' A' ' 26' ' ' PHE . 47.2 t -99.96 117.79 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.711 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -106.94 99.44 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.442 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 53.8 m-85 -90.41 111.24 22.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.999 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.41 ' CE1' ' O ' ' A' ' 56' ' ' LEU . 1.7 p90 -144.56 120.02 10.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.615 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.415 ' CB ' ' NE1' ' A' ' 30' ' ' TRP . . . -85.57 10.33 13.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.538 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.8 p 49.65 51.01 17.29 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.017 0.437 . . . . 0.0 111.204 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.529 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.3 m-90 -67.12 -62.31 1.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.971 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.4 t 160.48 127.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.461 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.25 -118.78 4.08 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.314 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.33 -43.57 27.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.601 2.201 . . . . 0.0 112.81 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 26.3 p -69.96 63.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 0.0 111.268 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 35' ' ' LYS . 7.2 ttpm? 176.1 -53.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.486 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.0 tpt -84.09 -30.05 26.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.6 mt -86.87 -30.43 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.984 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.37 -52.63 41.37 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.55 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.24 -43.5 37.07 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.039 1.826 . . . . 0.0 111.495 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.822 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 71.0 mtp -60.33 -22.04 62.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.994 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.3 mt -91.62 -55.78 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.151 0.5 . . . . 0.0 110.085 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 3.9 tm-20 -54.94 -57.06 13.18 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.72 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.513 ' HB3' ' NZ ' ' A' ' 43' ' ' LYS . 5.4 ttpm? -49.62 -47.97 49.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.075 0.464 . . . . 0.0 110.465 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.822 ' CD1' ' O ' ' A' ' 40' ' ' MET . 7.1 m-85 -54.59 -23.93 18.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.192 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -58.46 -28.14 65.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.031 0.444 . . . . 0.0 110.678 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -89.7 -11.25 42.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.068 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.03 15.57 9.86 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.608 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.428 ' CD1' HG22 ' A' ' 100' ' ' ILE . 42.3 m-85 -125.68 145.45 50.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.839 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.8 p -66.54 -47.06 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -143.7 99.26 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.988 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.14 122.7 16.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.03 97.66 11.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 8.6 m-85 -89.89 126.2 35.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.883 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 19.3 m-30 -119.37 104.18 10.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.54 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.79 123.5 33.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.091 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.41 ' O ' ' CE1' ' A' ' 27' ' ' PHE . 86.4 mt -128.72 158.93 37.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.855 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -145.69 -176.58 5.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -90.54 158.85 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.067 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 t70 67.22 -70.0 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -55.6 -30.37 60.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.98 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.2 t -137.72 53.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.967 0.413 . . . . 0.0 110.936 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.6 t -71.44 -28.68 64.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -58.36 -40.25 81.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.055 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.4 t -75.8 -52.85 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.83 -39.41 58.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.21 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -60.87 -31.78 71.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.815 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -81.55 -47.4 13.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.789 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.86 77.66 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.121 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.6 118.12 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.818 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.73 150.75 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.221 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.7 m -133.78 57.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.98 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 m -141.84 -169.38 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.548 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.435 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.1 ptp -166.11 91.59 0.83 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.447 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.66 -163.79 3.09 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 124.063 -1.224 . . . . 0.0 112.393 -0.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 89.8 m -133.48 118.04 17.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.586 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.2 mp -123.74 137.23 54.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.847 0.356 . . . . 0.0 111.278 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.7 pt -133.72 162.72 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.834 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.461 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.0 m-85 -132.41 128.64 37.97 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 111.242 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 71.2 m-85 -109.89 158.82 17.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.742 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -156.6 73.46 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.794 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.28 -18.65 23.12 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.505 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.01 48.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.26 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -169.96 127.64 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.995 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.66 98.69 5.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.3 m -110.75 -28.32 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.364 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 99.7 m -114.84 103.3 10.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.918 0.389 . . . . 0.0 110.269 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -107.36 157.67 17.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.266 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -155.27 81.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.717 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.64 106.14 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.333 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.06 -113.43 0.29 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.426 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -178.19 77.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 111.035 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -151.86 129.35 5.74 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.438 ' CB ' ' CE ' ' A' ' 40' ' ' MET . 87.0 Cg_endo -82.39 9.59 3.94 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.635 2.223 . . . . 0.0 113.021 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.91 -50.78 3.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.732 0.301 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.96 -27.93 14.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 110.614 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.4 tp -54.14 -43.47 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.194 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -71.92 -71.51 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.031 0.443 . . . . 0.0 111.129 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -44.2 -32.19 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.583 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.24 -51.39 15.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.181 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.428 HG22 ' CD1' ' A' ' 48' ' ' TYR . 66.4 mt -76.26 -5.14 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.496 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.55 -24.61 21.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 0.0 111.38 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -89.98 -59.38 2.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.31 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -54.62 -43.1 71.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.101 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.373 -179.396 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.858 0.361 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.63 137.44 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.672 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.5 m -89.94 168.05 12.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 110.871 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -108.51 94.8 5.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.886 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.439 HD22 ' CD2' ' A' ' 54' ' ' TYR . 4.9 mp -88.96 132.05 34.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.205 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.61 -62.85 0.95 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 t -86.19 152.98 22.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.17 -28.84 64.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.327 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.5 p -57.42 -30.41 64.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.058 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -74.34 -37.64 63.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.47 -52.43 65.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.22 -56.03 27.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.057 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -57.8 -28.72 64.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.028 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.42 76.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.135 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.47 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 78.3 mt -67.96 -40.34 83.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.044 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.0 -46.45 62.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.204 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.5 m -75.78 -53.43 8.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.057 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.06 115.26 7.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.599 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -113.14 -31.89 6.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.71 0.29 . . . . 0.0 111.039 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.91 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.997 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.425 ' CD1' ' HB2' ' A' ' 103' ' ' ASN . 41.5 tp -159.65 115.98 2.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.457 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 54.2 t -111.72 106.34 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.832 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.8 t -102.92 144.12 14.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.31 146.54 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -135.84 111.8 9.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.944 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -105.44 113.56 27.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.198 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.41 ' HB2' ' CB ' ' A' ' 34' ' ' CYS . 2.1 p90 -147.92 120.72 8.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.721 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.84 9.92 8.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.686 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.2 p 50.57 55.51 9.4 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.059 0.457 . . . . 0.0 111.058 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.534 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.2 m-90 -71.81 -61.88 1.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.014 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 39.6 t 158.85 101.77 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.467 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.84 -126.69 2.51 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.279 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 35' ' ' LYS . 92.4 Cg_exo -42.73 -60.61 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.962 2.441 . . . . 0.0 113.234 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 26.9 p -65.85 66.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.357 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 56.6 tptt 176.14 -35.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.3 mtt -81.84 -65.89 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.684 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.16 18.69 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.415 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -63.42 -53.37 53.0 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.648 0.261 . . . . 0.0 110.663 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 43' ' ' LYS . 52.3 Cg_exo -55.58 -33.07 85.58 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.64 2.227 . . . . 0.0 112.21 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.44 ' CE ' ' HB3' ' A' ' 93' ' ' PRO . 67.3 mtp -54.82 -71.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 110.468 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.6 pt -52.44 -39.25 28.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.094 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.28 -27.52 65.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.64 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -79.72 -45.84 18.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -53.62 -25.04 15.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.546 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -55.79 -29.97 60.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.732 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -87.63 -3.12 58.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.877 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -90.27 -35.24 15.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.542 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.425 ' CD2' HG21 ' A' ' 100' ' ' ILE . 45.7 m-85 -76.49 157.29 32.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.798 0.332 . . . . 0.0 111.183 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.4 p -79.98 -38.36 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -155.38 104.07 2.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.133 0.492 . . . . 0.0 111.403 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 53' ' ' PHE . . . -150.13 125.69 10.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.104 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.32 107.46 19.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 110.771 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 45' ' ' ALA . 9.3 m-85 -99.96 130.79 46.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.004 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.457 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 20.5 m-30 -113.9 119.73 38.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -104.11 115.02 29.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.883 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.408 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 89.7 mt -134.68 170.7 15.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.237 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.28 153.59 46.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.644 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.09 55.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.986 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -177.46 -65.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.054 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.53 -30.65 61.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.036 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.2 t -102.13 -58.84 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.814 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.9 t 67.35 -64.64 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.393 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -40.6 -68.39 0.18 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.828 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.13 -44.21 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.163 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.31 56.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -57.15 -68.24 0.25 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.988 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.94 -25.37 57.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.72 74.49 7.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.311 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.0 mp0 -69.89 105.97 3.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.762 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.2 m -132.95 -178.58 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.8 p -164.48 72.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.819 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -157.54 -170.17 3.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.609 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.8 ptt? -165.81 98.56 0.76 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.192 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.76 -155.43 1.06 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.261 -1.141 . . . . 0.0 112.129 0.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.7 m -155.65 100.66 2.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.587 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 3.9 mp -113.85 162.79 15.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.917 0.389 . . . . 0.0 111.256 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.1 pt -156.89 160.18 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.82 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 1.3 m-85 -128.68 123.05 32.16 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.984 0.421 . . . . 0.0 111.368 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.47 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 69.8 m-85 -109.91 101.79 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.831 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.97 -70.53 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 110.732 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.39 27.32 7.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.368 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.08 49.82 1.69 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.364 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -169.82 114.96 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.334 . . . . 0.0 110.882 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -55.62 99.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.38 -28.99 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.799 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.43 ' O ' ' CD1' ' A' ' 78' ' ' PHE . 89.1 m -122.44 74.99 1.21 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 110.649 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -82.37 159.6 23.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.2 0.524 . . . . 0.0 111.643 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -156.72 86.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.085 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 m -108.61 87.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.37 0.605 . . . . 0.0 111.28 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.36 -152.06 7.09 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.968 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.42 92.75 2.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.795 0.331 . . . . 0.0 110.998 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -144.53 101.21 4.7 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.071 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.44 ' HB3' ' CE ' ' A' ' 40' ' ' MET . 32.1 Cg_exo -58.52 -15.14 23.76 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.553 2.169 . . . . 0.0 112.431 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.62 -31.49 13.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 110.83 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.86 -31.33 64.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.797 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.406 ' CG2' ' O ' ' A' ' 93' ' ' PRO . 3.8 tp -53.76 -33.87 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.072 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -68.29 -67.7 0.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.118 0.485 . . . . 0.0 110.832 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -53.72 -49.48 68.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.492 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.25 -65.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.625 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.425 HG21 ' CD2' ' A' ' 48' ' ' TYR . 41.2 mm -52.33 -48.57 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.41 -21.8 17.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.856 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.5 m -57.55 -50.09 74.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.491 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.425 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 21.1 m-80 -122.84 5.56 9.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.621 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.623 -179.212 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.801 0.334 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 43.9 t -55.94 132.27 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.945 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -107.13 168.71 9.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 110.803 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -108.41 98.99 8.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.156 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 54' ' ' TYR . 63.2 mt -88.81 96.05 10.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.252 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -89.88 -57.06 2.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.882 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.4 t -95.38 158.43 15.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.32 -29.33 62.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.083 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.4 p -57.75 -31.34 66.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -71.19 -31.32 67.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -76.21 -42.64 45.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -70.13 -50.17 43.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -58.97 -28.64 66.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -64.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.203 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.444 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 81.9 mt -57.44 -21.87 39.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.17 -79.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.446 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.7 m -83.43 -29.62 27.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.197 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.1 104.3 0.23 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.673 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -86.99 -27.38 23.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 0.0 110.705 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -53.62 -176.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.973 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 100' ' ' ILE . 4.8 tt -86.11 115.84 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.698 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.447 ' CG1' ' CD2' ' A' ' 54' ' ' TYR . 56.5 t -102.99 127.2 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.644 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.401 ' CG2' ' CD2' ' A' ' 21' ' ' LEU . 46.3 t -120.12 119.61 60.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.368 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.9 t -104.77 124.84 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.482 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -117.21 103.77 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.919 0.39 . . . . 0.0 111.612 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.454 ' CE1' HD11 ' A' ' 56' ' ' LEU . 75.1 m-85 -93.88 115.28 27.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.948 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.467 ' CD2' ' CG2' ' A' ' 29' ' ' THR . 1.1 p90 -150.19 117.96 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 111.212 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.36 -9.53 58.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.893 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.467 ' CG2' ' CD2' ' A' ' 27' ' ' PHE . 69.4 p 52.73 74.08 0.31 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.361 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.542 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.0 m-90 -80.92 -62.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 43.6 t 158.86 69.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.459 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.4 -121.11 0.78 Allowed Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.927 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.16 -52.1 6.02 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.702 2.268 . . . . 0.0 112.562 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.5 p -79.77 60.87 3.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.727 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -162.99 -47.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.392 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.2 tpt -83.56 -26.79 29.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.53 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 HG22 HD13 ' A' ' 37' ' ' ILE . 63.1 mt -79.96 -15.69 13.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.204 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.433 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -52.48 -60.08 7.21 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.403 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 86.2 Cg_exo -46.93 -36.03 19.44 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.369 2.046 . . . . 0.0 112.605 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.403 ' HB3' ' HB3' ' A' ' 93' ' ' PRO . 55.1 mtt -57.5 -76.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.577 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.408 ' CD1' ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -60.23 -24.39 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.908 0.385 . . . . 0.0 110.861 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.408 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 89.4 tt0 -75.53 -26.58 58.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.489 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.47 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 6.6 tmtm? -85.7 -48.3 8.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.177 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CG ' HD12 ' A' ' 96' ' ' ILE . 7.4 m-85 -46.33 -29.8 1.81 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.214 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.9 -26.32 14.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -90.06 -30.34 17.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.993 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -62.07 -35.68 79.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.326 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.412 ' CE2' HG23 ' A' ' 100' ' ' ILE . 46.7 m-85 -97.13 155.59 16.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 110.761 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -106.61 -21.77 12.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.309 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -125.52 35.32 4.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.764 0.316 . . . . 0.0 111.454 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.8 118.16 36.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.282 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.67 95.84 10.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.437 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 13.5 m-85 -89.69 123.34 33.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.607 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CD2' ' CG1' ' A' ' 22' ' ' VAL . 14.7 m-30 -115.82 102.81 10.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.806 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -89.83 124.11 34.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.571 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 26' ' ' PHE . 86.2 mt -119.36 146.86 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.293 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -134.39 161.42 35.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.548 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.1 m -77.67 156.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.198 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.1 t0 66.03 -72.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.222 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.44 -30.85 61.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.109 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -139.95 55.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.4 m -80.48 -22.08 41.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -47.21 -29.76 2.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.292 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.43 -54.85 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.993 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.43 -35.56 19.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.421 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -58.45 -45.24 88.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.765 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -89.51 -65.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.62 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.66 77.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.822 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -50.86 93.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.18 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.0 t -148.83 136.28 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.814 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.3 p -105.21 150.13 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.534 ' O ' ' HB2' ' A' ' 73' ' ' MET . 60.4 p -61.01 -173.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.904 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.607 ' H ' ' HA ' ' A' ' 74' ' ' PRO . 60.3 ttp 167.52 -38.11 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.607 ' HA ' ' H ' ' A' ' 73' ' ' MET . 94.0 Cg_endo -76.57 175.26 48.97 Favored 'Cis proline' 0 C--N 1.36 1.157 0 CA-C-N 120.67 1.275 . . . . 0.0 113.812 0.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.3 m -127.89 135.82 50.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.764 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.1 mp -129.93 146.18 51.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.906 0.384 . . . . 0.0 111.231 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 pt -143.15 159.86 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.812 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.3 m-85 -129.57 126.87 39.51 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 111.505 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.444 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 67.5 m-85 -109.69 153.62 24.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.752 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -114.89 -38.78 3.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.975 0.417 . . . . 0.0 110.454 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.77 28.44 0.31 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.067 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.1 42.28 2.1 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.278 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -165.31 109.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.674 0.273 . . . . 0.0 111.13 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.04 115.49 3.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.443 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 m -126.34 -43.2 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 64.5 p -112.31 83.41 1.8 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.151 0.5 . . . . 0.0 110.795 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -83.09 166.17 18.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.592 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.424 HG22 ' CE1' ' A' ' 78' ' ' PHE . 45.8 t -156.72 87.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.967 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.3 m -108.76 107.7 23.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.16 0.505 . . . . 0.0 111.337 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.77 -118.95 0.47 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.19 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 177.77 56.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.796 0.331 . . . . 0.0 111.133 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -146.28 134.27 10.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.122 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.531 ' O ' HG12 ' A' ' 96' ' ' ILE . 57.1 Cg_endo -73.67 -19.32 21.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.413 2.075 . . . . 0.0 112.158 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.04 62.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.801 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.11 -39.85 12.62 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.511 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 93' ' ' PRO . 21.2 pt -59.74 -35.38 59.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.888 0.375 . . . . 0.0 110.822 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -55.23 -70.41 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.948 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -59.94 -29.87 68.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -64.45 -42.81 95.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.064 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.417 ' HA ' HD13 ' A' ' 21' ' ' LEU . 75.5 mt -82.34 -31.84 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.63 -27.55 65.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.028 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.7 p -58.28 -58.22 9.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.081 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -128.06 54.54 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.035 179.865 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.867 0.365 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.6 t -83.63 136.84 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.8 p -105.01 172.17 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.476 0.655 . . . . 0.0 111.764 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -127.16 107.99 10.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.626 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' A' ' 54' ' ' TYR . 80.6 mt -89.16 88.37 7.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.007 0.432 . . . . 0.0 111.362 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.96 -43.55 10.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.198 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.4 t -105.58 137.41 43.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.783 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.15 -25.86 24.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.416 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -59.17 -28.75 66.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.037 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.92 -26.28 48.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -78.54 -54.3 6.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.127 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -57.32 -59.86 4.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -57.18 -25.52 59.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.279 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.58 -61.91 1.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.792 0.33 . . . . 0.0 111.373 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.424 HD22 ' CD2' ' A' ' 79' ' ' TYR . 87.9 mt -53.64 -24.59 14.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.233 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.07 -68.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.309 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.9 m -60.06 -63.51 1.27 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.42 121.9 24.39 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.732 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -124.01 -1.04 8.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -69.29 -76.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.716 0.293 . . . . 0.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.422 ' CD2' ' CG2' ' A' ' 23' ' ' VAL . 3.7 tt -167.5 110.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 60.2 t -102.34 132.6 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' CG2' ' CD2' ' A' ' 21' ' ' LEU . 47.8 t -134.37 118.29 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.277 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.461 ' CG1' ' CE2' ' A' ' 26' ' ' PHE . 43.5 t -99.98 123.09 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.452 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -110.86 87.81 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.591 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.461 ' CE2' ' CG1' ' A' ' 24' ' ' VAL . 60.6 m-85 -82.14 112.22 18.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.809 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -133.32 117.06 16.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.952 0.406 . . . . 0.0 111.324 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.448 ' O ' ' CD2' ' A' ' 30' ' ' TRP . . . -94.43 107.22 19.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.583 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.8 p -53.7 114.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.1 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.448 ' CD2' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -179.56 42.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -176.54 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.156 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 152.37 -44.51 0.63 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.219 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 82.7 Cg_exo -45.56 -63.62 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.572 2.181 . . . . 0.0 112.746 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.7 p -49.48 -45.53 46.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -58.5 -36.99 74.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.123 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.2 tpt -73.36 -26.51 61.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 40.9 mm -90.37 27.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.361 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.431 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -86.82 -54.98 0.37 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.084 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 43' ' ' LYS . 40.9 Cg_exo -57.31 -33.12 95.58 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.423 2.082 . . . . 0.0 112.298 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.402 ' CE ' ' HG3' ' A' ' 93' ' ' PRO . 57.4 mtt -60.56 -75.56 0.06 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 0.0 110.485 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.445 HG23 HD12 ' A' ' 41' ' ' ILE . 12.9 pt -51.57 -30.18 10.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.188 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -78.82 -30.71 45.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.463 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 39' ' ' PRO . 87.9 tttt -84.31 -38.26 20.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -48.24 -25.35 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.773 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 53' ' ' PHE . . . -55.27 -32.35 62.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.15 0.5 . . . . 0.0 110.587 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -85.28 -5.1 59.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -90.14 -51.62 5.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.299 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.439 ' CE2' HG13 ' A' ' 100' ' ' ILE . 50.5 m-85 -79.74 172.41 13.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.174 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.2 p -105.56 -29.68 10.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.241 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -148.72 80.17 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.435 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.447 ' CB ' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.44 124.54 36.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.208 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.45 106.79 18.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.041 0.448 . . . . 0.0 110.688 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.589 ' CE2' ' HA ' ' A' ' 45' ' ' ALA . 21.6 m-85 -99.9 119.44 38.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.232 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.463 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 15.1 m-30 -111.24 96.56 6.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.048 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -89.83 110.55 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.448 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 3.8 mp -118.78 157.87 26.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 0.0 111.485 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -129.78 162.31 28.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.353 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.94 -32.47 58.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.432 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -97.82 -62.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.147 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -52.44 -26.06 11.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.15 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.0 t -133.77 60.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.3 t -81.11 0.66 35.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.415 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -90.04 -49.1 6.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 111.041 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -59.58 -51.53 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.18 -29.52 1.6 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.639 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -63.95 -71.32 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.001 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -65.48 -42.6 92.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.04 76.78 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -58.42 100.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.88 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.6 t -141.79 157.38 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.151 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -86.91 -173.99 4.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.84 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.454 ' C ' ' HA ' ' A' ' 74' ' ' PRO . 81.1 p -167.18 79.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.011 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.647 ' N ' ' CA ' ' A' ' 74' ' ' PRO . 23.2 ptp -115.85 8.05 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.647 ' CA ' ' N ' ' A' ' 73' ' ' MET . 73.0 Cg_endo -83.04 -167.33 5.51 Favored 'Cis proline' 0 C--N 1.361 1.225 0 CA-C-N 121.442 1.551 . . . . 0.0 112.62 -0.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 96.4 m -140.98 133.93 29.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.977 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.1 mp -124.96 115.51 20.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.842 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.458 HG22 HD13 ' A' ' 77' ' ' ILE . 29.4 pt -109.88 158.68 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.762 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.592 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -131.15 131.4 44.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.397 . . . . 0.0 111.217 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 83.9 m-85 -109.36 141.57 41.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.674 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -122.17 68.01 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 0.0 110.77 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.85 26.75 13.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.207 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.6 53.43 2.27 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.364 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -176.54 122.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.43 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 52.1 mt-10 -65.76 138.47 57.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.647 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 m -157.19 -39.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.527 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 88.0 m -105.73 106.93 17.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.951 0.405 . . . . 0.0 110.116 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -104.23 149.52 25.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.584 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.6 t -154.55 81.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.534 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.64 111.12 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.21 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -117.57 0.42 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.29 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -178.23 71.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 0.0 111.049 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 49.8 t30 -150.93 139.31 12.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.661 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 92' ' ' ASN . 18.9 Cg_exo -65.01 -24.86 59.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.414 2.076 . . . . 0.0 112.275 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.53 -27.19 27.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.925 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.39 -27.61 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.093 0.473 . . . . 0.0 110.213 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 93' ' ' PRO . 5.8 tt -90.06 -38.23 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.771 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -61.81 -57.68 10.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.718 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.44 -13.68 61.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.625 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . . . -84.72 -60.61 2.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.787 0.327 . . . . 0.0 111.535 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.439 HG13 ' CE2' ' A' ' 48' ' ' TYR . 46.3 mm -47.48 -41.85 7.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.139 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.07 -23.4 46.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.218 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -55.72 -65.43 0.6 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -131.87 65.66 1.57 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.09 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.052 179.839 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.548 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 8.7 p -63.77 156.92 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.066 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.6 174.29 6.35 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 111.119 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -125.79 105.96 9.34 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.926 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 54' ' ' TYR . 63.0 mt -88.89 127.47 35.64 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.103 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.682 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 8.8 mmpt? -118.15 -50.42 2.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.759 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.2 t -102.57 159.92 15.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.192 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.73 -29.93 65.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.9 p -56.02 -30.77 62.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.867 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -70.41 -30.62 67.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.766 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.441 ' CZ ' ' CD1' ' A' ' 15' ' ' LEU . 45.6 t80 -75.37 -46.6 32.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.001 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.26 -50.55 45.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -56.65 -23.26 40.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.488 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.423 ' HB3' ' CE2' ' A' ' 54' ' ' TYR . . . -84.09 -60.24 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.518 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.441 ' CD1' ' CZ ' ' A' ' 11' ' ' TYR . 86.0 mt -52.06 -25.52 8.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.162 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.64 -55.73 4.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.2 m -90.39 23.3 3.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.396 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.63 149.59 22.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.438 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -156.3 -46.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -58.55 -75.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 103' ' ' ASN . 28.5 tp -167.47 120.69 0.94 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.808 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 61.8 t -111.56 124.52 68.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.2 t -128.32 126.22 65.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 57.5 t -112.09 114.0 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.804 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.417 ' OD1' ' HG ' ' A' ' 76' ' ' LEU . 24.3 m-20 -111.42 102.78 11.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.237 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.418 ' CE1' HD12 ' A' ' 56' ' ' LEU . 49.6 m-85 -91.7 107.99 19.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.997 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -149.01 121.27 8.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.623 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.26 20.12 4.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.586 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p 49.7 55.84 8.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 111.112 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.499 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.5 m-90 -71.24 -61.74 1.66 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.214 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 43.1 t 164.38 129.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.521 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.81 -122.54 5.38 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.031 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.37 -47.45 5.9 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.56 2.173 . . . . 0.0 112.721 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.5 p -52.25 -23.88 6.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.6 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -107.76 -37.56 6.1 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.423 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.3 tpt -76.27 -40.38 51.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 111.351 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.436 HD11 HG21 ' A' ' 37' ' ' ILE . 59.9 mt -79.0 -1.06 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.661 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.504 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -51.44 -63.3 2.1 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 74.7 Cg_exo -50.28 -35.37 43.5 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.213 1.942 . . . . 0.0 113.237 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' A' ' 93' ' ' PRO . 60.7 mtp -65.49 -69.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.621 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.652 HD12 ' HG2' ' A' ' 42' ' ' GLU . 2.4 pp -56.35 -20.28 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.217 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.652 ' HG2' HD12 ' A' ' 41' ' ' ILE . 3.7 mm-40 -86.95 -32.95 19.84 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.1 ttpt -78.27 -44.32 25.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.158 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.19 -32.04 71.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.584 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -54.06 -27.76 34.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.016 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.01 -34.61 16.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.739 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -58.87 -27.83 65.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.073 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CE2' HD11 ' A' ' 100' ' ' ILE . 44.6 m-85 -81.78 155.76 25.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.893 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.5 m -89.24 -32.08 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -151.92 96.87 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.09 112.42 4.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.82 106.93 18.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.172 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.548 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 2.1 m-85 -89.91 124.6 34.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.463 ' HB3' ' CD1' ' A' ' 5' ' ' LEU . 17.8 m-30 -112.43 90.52 3.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.486 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -89.84 156.51 18.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.225 0.536 . . . . 0.0 111.791 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.418 HD12 ' CE1' ' A' ' 26' ' ' PHE . 93.6 mt -151.43 -177.7 6.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.636 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -149.15 133.3 17.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.754 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -74.76 60.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.077 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.7 t70 178.82 -63.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.621 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -59.37 -30.13 68.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.78 -58.29 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.048 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 t 68.0 -62.44 0.35 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.423 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -43.71 -61.57 1.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.765 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.11 -57.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.808 0.337 . . . . 0.0 111.212 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.99 -31.62 0.95 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.787 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -60.26 -58.64 7.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.876 0.37 . . . . 0.0 110.674 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.42 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.503 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.71 79.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.76 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.25 122.86 9.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.243 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.08 127.92 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.9 m -134.96 45.14 2.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.6 t -146.36 -163.48 1.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.687 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.472 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.9 ptm -171.35 92.67 0.43 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.405 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 69.4 Cg_endo -86.11 -163.52 2.78 Favored 'Cis proline' 0 C--N 1.349 0.6 0 C-N-CA 124.132 -1.195 . . . . 0.0 112.427 0.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 91.9 m -138.98 106.72 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.437 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 2.4 mp -118.84 128.58 54.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.302 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.44 HD11 ' CE2' ' A' ' 79' ' ' TYR . 2.4 pp -128.57 173.0 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.886 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.602 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 8.2 m-85 -135.0 120.44 19.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.746 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 47.2 m-85 -109.8 137.9 46.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.522 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -106.04 -59.74 1.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 0.0 110.753 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.42 29.52 3.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.141 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.54 35.65 3.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.229 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -151.88 124.2 8.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 111.142 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.4 tt0 -78.94 98.6 6.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.549 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.75 -37.49 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.684 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 74.7 m -109.79 110.79 21.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.221 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -122.6 145.07 48.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.593 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 30.5 m -139.86 83.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.714 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.8 m -109.44 66.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.294 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -144.9 17.2 1.97 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.523 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.13 56.45 5.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.349 . . . . 0.0 111.127 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.49 101.19 34.36 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.198 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.408 ' HG3' ' CD1' ' A' ' 37' ' ' ILE . 8.3 Cg_exo -71.28 -17.41 30.98 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.726 2.284 . . . . 0.0 112.195 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.77 -43.44 5.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.51 -28.42 8.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.228 0.537 . . . . 0.0 110.186 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.6 tt -60.79 -29.34 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.778 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 97' ' ' LYS . 5.2 tmtm? -55.69 -58.33 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.434 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -72.61 -36.07 68.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.06 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.84 81.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.221 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.417 HD11 ' CE2' ' A' ' 48' ' ' TYR . 63.5 mt -75.04 -37.68 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.133 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.07 -19.17 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.891 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 64.0 m -90.04 -38.55 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 111.581 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.41 ' HB3' HD11 ' A' ' 21' ' ' LEU . 26.8 t-20 -83.66 -39.42 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.428 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.402 ' N ' HD11 ' A' ' 21' ' ' LEU . 11.9 p . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.339 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.8 tpp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.896 0.379 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.9 t -149.43 110.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.817 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 p -89.72 170.75 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.497 0.665 . . . . 0.0 111.658 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.524 ' NE2' ' N ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -127.97 120.18 27.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.592 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.437 HD12 ' CD2' ' A' ' 54' ' ' TYR . 72.5 mt -88.96 96.21 10.63 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.194 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -89.93 -47.04 8.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.507 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.5 t -104.04 142.33 34.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.79 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.46 -24.69 21.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.299 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.6 p -59.58 -43.9 93.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -62.87 -25.68 68.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.873 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.423 ' CZ ' HD12 ' A' ' 15' ' ' LEU . 50.9 t80 -90.05 -46.92 8.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.069 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -60.33 -62.94 1.5 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.034 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -55.41 -26.32 41.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.97 -61.3 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.433 HD23 ' CD2' ' A' ' 79' ' ' TYR . 85.2 mt -54.03 -24.7 18.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.155 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.66 -74.74 0.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.231 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -64.77 -48.12 75.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.054 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.68 102.52 0.17 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.601 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -112.21 -22.69 10.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.616 0.246 . . . . 0.0 111.188 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -54.2 -72.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.131 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 103' ' ' ASN . 52.4 tp -171.38 106.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.939 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 59.4 t -105.09 127.97 59.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.045 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.67 133.8 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.868 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 47.5 t -114.83 122.17 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.209 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -114.5 121.62 44.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.59 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.445 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 69.5 m-85 -107.83 127.88 54.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.247 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CZ ' ' HE3' ' A' ' 55' ' ' LYS . 2.2 p90 -146.44 114.77 6.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.548 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.428 ' CB ' ' NE1' ' A' ' 30' ' ' TRP . . . -89.4 16.95 6.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.578 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p 49.97 52.94 13.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.94 0.4 . . . . 0.0 111.471 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.543 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.1 m-90 -73.74 -60.94 2.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.981 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.5 t 154.0 134.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.672 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.93 -105.15 3.16 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.681 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -43.12 -62.9 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.883 2.389 . . . . 0.0 113.112 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.4 p -70.9 62.99 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.769 0.318 . . . . 0.0 111.062 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.4 tptt 177.89 -56.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.8 ttt -55.37 -71.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.235 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.511 HG21 HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -90.26 40.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.237 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.441 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -80.6 -57.07 0.63 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.875 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.441 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 53.2 Cg_exo -55.13 -26.2 49.57 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.222 1.948 . . . . 0.0 112.053 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 63.6 mtt -60.29 -73.39 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.728 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -57.42 -26.52 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.989 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.441 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 4.2 tm-20 -77.32 -30.33 54.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.202 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -82.39 -43.01 17.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.05 -29.34 43.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.197 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.89 -26.72 26.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.034 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -90.02 -29.31 18.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.797 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -66.05 -14.74 62.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.543 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -92.27 161.96 14.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.772 0.32 . . . . 0.0 111.029 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -78.38 -43.67 26.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -155.69 106.28 2.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.118 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.18 127.56 16.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.856 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.69 102.27 14.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.489 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 7.0 m-85 -92.61 116.13 28.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.037 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.462 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 12.3 m-30 -106.55 90.94 3.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.172 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.448 ' HE3' ' CZ ' ' A' ' 27' ' ' PHE . 63.5 tttp -89.79 106.69 18.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.161 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 4.1 mp -110.34 141.03 43.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.803 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -80.7 -80.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 p 178.31 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.962 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -103.77 -33.63 8.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.773 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.11 -30.03 67.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.82 -65.83 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.03 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.1 t 68.42 -64.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.236 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -46.91 -61.0 2.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.411 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.5 t -55.75 -56.29 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.172 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.87 -31.45 28.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.315 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -70.9 -28.74 64.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -86.26 -78.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.402 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.92 81.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.267 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.28 143.72 57.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.809 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -156.31 144.79 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.4 p -124.24 68.23 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.984 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.7 m -144.23 176.36 9.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.477 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 67.9 mtm -157.18 96.97 2.06 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.89 -161.88 2.81 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.947 -1.272 . . . . 0.0 112.273 -0.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 91.3 m -140.32 112.88 7.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.652 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.0 mp -120.09 142.85 48.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.0 pt -139.24 162.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.431 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 2.3 m-85 -132.28 127.52 35.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.95 0.405 . . . . 0.0 111.329 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.433 ' CD2' HD23 ' A' ' 15' ' ' LEU . 60.1 m-85 -109.93 140.03 44.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.696 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -110.5 -31.96 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.837 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.97 27.75 0.35 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.2 33.96 6.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.373 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.555 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -154.32 102.04 2.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.328 . . . . 0.0 110.781 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 39.5 tt0 -53.64 97.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.078 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.77 -31.21 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.322 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 94.6 m -116.29 101.02 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.234 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -108.68 146.91 32.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.057 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.3 t -136.55 80.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.757 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.0 m -109.95 103.88 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.232 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.02 -109.45 0.22 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.395 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.16 81.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.31 . . . . 0.0 110.904 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -160.09 112.72 1.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.746 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.4 ' O ' ' CG2' ' A' ' 96' ' ' ILE . 63.9 Cg_exo -52.26 -22.72 16.2 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.629 2.219 . . . . 0.0 112.734 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.56 -30.46 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.98 -27.28 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.019 0.438 . . . . 0.0 110.402 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 96' ' ' ILE . 6.1 tt -82.65 -35.13 12.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.832 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -69.43 -62.81 1.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.003 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -59.32 -20.3 53.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.349 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -90.11 -40.68 12.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.57 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.404 HG12 ' HB ' ' A' ' 104' ' ' VAL . 12.0 tt -75.61 -28.05 19.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.743 0.306 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.05 89.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.384 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.8 m -73.22 -24.05 60.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.289 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 21' ' ' LEU . 5.6 m120 -92.58 -61.78 1.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.404 ' HB ' HG12 ' A' ' 100' ' ' ILE . 11.2 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.886 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.895 0.378 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.425 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 55.4 t -63.86 106.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 p -98.96 177.17 5.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.54 0.686 . . . . 0.0 111.73 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -130.52 107.46 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.674 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 3.6 mp -89.18 101.21 13.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.078 0.466 . . . . 0.0 111.462 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -89.91 -37.6 14.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.871 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.6 t -111.77 141.09 45.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.06 -23.7 14.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.403 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.5 p -59.74 -45.22 92.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.115 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -61.67 -26.02 67.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -90.07 -49.47 6.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -57.1 -67.06 0.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 t -56.09 -24.35 39.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.099 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.21 -57.22 11.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.226 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.6 mt -56.2 -26.98 52.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.98 -29.94 18.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.252 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -87.36 -60.51 1.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.038 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.99 114.42 4.54 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.653 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -112.32 -30.18 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.738 0.304 . . . . 0.0 110.924 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -59.17 -76.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.942 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 103' ' ' ASN . 25.9 tp -156.28 116.66 3.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.983 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 59.2 t -107.93 135.37 46.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.56 143.99 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.006 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.03 112.45 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.91 129.82 48.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.456 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 58.2 m-85 -114.64 134.6 54.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.356 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.466 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 1.8 p90 -150.72 113.36 4.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.549 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.97 23.31 2.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.566 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 79.9 p 49.65 49.33 20.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.852 0.358 . . . . 0.0 111.428 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.457 ' CZ2' ' HG2' ' A' ' 73' ' ' MET . 2.5 m-90 -67.96 -60.46 2.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.6 t -163.87 -104.97 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.685 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -101.1 -34.64 4.49 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.619 -0.8 . . . . 0.0 114.69 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 76.1 Cg_exo -41.95 -32.13 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.311 2.007 . . . . 0.0 113.27 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.411 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 26.1 p -97.19 -42.15 7.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.389 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -81.67 0.39 38.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 32' ' ' GLY . 16.2 tpt -90.24 -55.34 3.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.858 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.9 pt -90.28 36.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.511 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.423 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -75.98 -54.85 2.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.906 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 41.9 Cg_exo -56.7 -29.46 80.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.328 2.019 . . . . 0.0 111.993 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 59.2 mtt -59.42 -75.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.67 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -62.19 -23.42 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.126 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' N ' HD11 ' A' ' 41' ' ' ILE . 5.4 tp10 -77.95 -27.69 49.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.595 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -87.69 -42.42 12.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -48.03 -27.57 2.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.467 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.36 -30.01 17.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.603 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -89.97 -31.34 17.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.082 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -63.01 -31.5 72.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.43 ' CE2' HG13 ' A' ' 100' ' ' ILE . 42.7 m-85 -100.58 146.67 26.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.094 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.2 m -85.94 -32.12 21.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.7 p-10 -134.16 85.17 2.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.82 118.43 16.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.749 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.87 105.25 17.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.275 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.425 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 7.4 m-85 -102.25 128.62 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.557 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -113.37 112.26 23.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.442 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.466 ' HE3' ' CE1' ' A' ' 27' ' ' PHE . 52.9 tptt -89.78 112.1 23.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.471 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.443 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 90.4 mt -123.46 150.45 43.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 111.655 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -132.75 150.16 52.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.177 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.68 81.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.574 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -179.97 -92.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.728 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -27.28 62.97 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.784 0.326 . . . . 0.0 110.666 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 32.5 t -112.8 35.04 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 t -51.39 -24.97 5.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -50.87 -55.28 17.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.312 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.2 t -66.77 -59.31 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.07 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.97 -28.25 2.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.514 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -58.44 -55.48 34.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -73.96 -33.64 63.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.52 64.62 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.02 112.68 4.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.45 -178.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.6 m -157.41 80.61 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.6 p -173.22 179.0 2.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.457 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 58.9 mtm -152.51 102.29 2.74 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.686 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.86 -158.38 1.67 Allowed 'Cis proline' 0 C--N 1.348 0.534 0 C-N-CA 124.405 -1.081 . . . . 0.0 112.361 0.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 88.8 m -145.85 96.86 2.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.418 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.1 mp -109.66 140.57 43.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.004 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.425 HD13 ' CZ ' ' A' ' 79' ' ' TYR . 22.6 pt -133.87 162.08 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.412 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.3 m-85 -127.16 125.2 40.74 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.111 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 63.3 m-85 -109.49 164.49 12.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.938 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -168.69 60.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.071 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.72 40.59 0.71 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.026 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.0 34.45 83.49 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.872 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -148.76 117.15 6.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.827 0.346 . . . . 0.0 111.118 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.44 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.3 tt0 -73.73 144.67 45.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.679 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.7 m -151.7 -46.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.701 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 96.5 m -104.4 116.44 32.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.11 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -123.98 127.9 48.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.311 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 32.2 m -118.98 84.69 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.163 0.506 . . . . 0.0 110.495 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 89' ' ' VAL . 34.8 m -109.14 99.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.394 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.1 -109.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.529 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 178.48 78.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.327 . . . . 0.0 111.176 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -155.02 128.43 4.39 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.71 -13.53 24.52 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.509 2.139 . . . . 0.0 112.753 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.09 -48.59 4.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.181 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.5 -30.29 3.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.234 0.54 . . . . 0.0 110.188 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.0 tt -66.63 -50.58 65.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.177 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HD2' ' O ' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -53.35 -54.16 40.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.369 . . . . 0.0 110.684 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.405 ' NE2' ' CE ' ' A' ' 97' ' ' LYS . 99.2 mm-40 -49.22 -26.53 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.523 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.57 -27.51 22.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.597 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.43 HG13 ' CE2' ' A' ' 48' ' ' TYR . 48.1 mm -68.23 -59.28 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.373 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.86 -14.99 38.82 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.3 m -81.26 -29.5 34.37 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.44 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 36.8 m-80 -122.25 -9.42 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 100' ' ' ILE . 10.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.467 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.83 0.348 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 47.2 t -57.69 137.17 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 m -111.28 151.21 28.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.932 0.396 . . . . 0.0 110.955 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -91.55 97.99 11.39 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD21 ' CG ' ' A' ' 54' ' ' TYR . 4.9 mp -88.93 134.89 33.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.0 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -126.1 -64.78 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.5 t -91.44 148.47 22.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.065 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.74 69.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 m -56.88 -33.47 66.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.73 -25.17 58.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -82.29 -61.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.391 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -55.57 -58.58 7.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.46 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.0 t -56.79 -28.32 61.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.332 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.58 76.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 0.0 111.338 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.06 -44.14 97.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.083 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.1 -28.95 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.509 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 t -56.64 -78.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.212 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.96 136.16 13.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.627 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -85.9 -6.8 59.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.675 0.274 . . . . 0.0 111.252 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -54.7 -175.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.807 0.337 . . . . 0.0 110.962 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 27.1 tp -79.25 107.56 12.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.817 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -99.79 127.97 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.698 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 78' ' ' PHE . 48.9 t -137.02 133.75 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.552 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.426 ' HB ' HG12 ' A' ' 77' ' ' ILE . 40.6 t -103.24 160.4 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.255 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.424 ' OD2' ' CE1' ' A' ' 27' ' ' PHE . 38.3 t70 -137.53 89.57 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.417 ' CZ ' HG13 ' A' ' 24' ' ' VAL . 61.2 m-85 -96.36 111.17 23.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.607 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 0.5 OUTLIER -138.64 -44.99 0.49 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.412 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . 61.87 87.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 110.867 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.9 p -57.69 115.1 2.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.824 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.569 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.1 m-90 -101.61 -59.3 1.72 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 52.4 t 160.3 46.11 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.97 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.59 -118.08 0.42 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.783 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 35' ' ' LYS . 75.4 Cg_exo -49.73 -69.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.495 2.13 . . . . 0.0 112.336 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 10.2 p -61.26 75.85 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.375 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 33' ' ' PRO . 17.3 tppt? 175.72 -42.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.851 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.8 ttm -67.77 -49.01 64.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.224 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.41 ' CD1' ' C ' ' A' ' 37' ' ' ILE . 2.0 pp -90.22 25.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.001 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.41 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -78.44 -54.18 1.21 Allowed Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.627 0.251 . . . . 0.0 111.036 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 51.7 Cg_exo -55.12 -36.69 93.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.529 2.153 . . . . 0.0 112.226 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 60.6 mtt -54.16 -75.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.545 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 pt -51.15 -43.62 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.307 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -64.05 -33.18 75.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.772 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -77.05 -45.91 25.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.572 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.443 ' CG ' HD11 ' A' ' 96' ' ' ILE . 6.9 m-85 -56.03 -32.24 63.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.039 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' CG ' ' A' ' 53' ' ' PHE . . . -50.29 -27.8 6.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.329 0.585 . . . . 0.0 109.723 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -77.93 -38.78 44.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.746 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -58.02 -38.04 75.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.519 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CE2' HG23 ' A' ' 100' ' ' ILE . 32.4 m-85 -75.58 170.53 15.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.37 . . . . 0.0 110.925 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.8 m -116.55 -19.77 9.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.495 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -145.24 47.71 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.802 0.334 . . . . 0.0 111.465 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.6 119.16 38.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.553 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.73 96.46 10.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 110.881 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.492 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 6.5 m-85 -90.37 126.15 35.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.882 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.426 ' CG ' HD21 ' A' ' 5' ' ' LEU . 18.8 m-30 -121.78 107.6 12.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.376 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.456 ' NZ ' ' HB2' ' A' ' 55' ' ' LYS . 4.9 ttmp? -89.78 120.02 30.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.935 0.398 . . . . 0.0 111.173 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.4 mt -138.01 135.68 36.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.812 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -112.64 -178.06 3.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.662 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.26 65.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 111.099 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -178.35 -60.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.357 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -75.76 -23.6 55.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.81 40.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.791 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 t -53.76 -26.21 22.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.267 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.95 -50.83 72.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.027 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.7 t -72.24 -55.33 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.147 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.83 -28.88 2.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.444 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -60.83 -46.73 89.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.846 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -81.77 -47.29 13.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.771 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.11 79.45 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.58 114.86 5.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.934 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -135.63 125.26 41.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.2 t -112.32 92.98 4.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.986 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -177.76 -74.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.705 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 61.7 mtt 57.67 102.45 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.734 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.48 167.77 31.68 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.833 0.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 26' ' ' PHE . 71.6 m -154.87 132.41 11.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.355 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.1 mp -131.16 136.55 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 111.667 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.426 HG12 ' HB ' ' A' ' 24' ' ' VAL . 28.2 pt -133.13 150.68 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.977 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.51 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.1 m-85 -125.94 132.47 52.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.093 0.473 . . . . 0.0 111.267 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.441 ' CE1' ' HG2' ' A' ' 84' ' ' GLU . 84.1 m-85 -109.51 114.35 27.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.151 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -72.18 -75.26 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.799 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.59 33.68 3.87 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.023 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.52 27.42 4.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.176 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -158.24 150.29 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 91.5 mt-10 -82.39 97.02 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.14 -27.09 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.291 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 97.7 m -117.21 103.4 10.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.942 0.401 . . . . 0.0 110.069 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -103.29 155.24 18.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.363 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t -155.5 80.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.614 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -109.55 112.38 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.994 0.426 . . . . 0.0 111.279 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.59 -116.42 0.37 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.36 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -176.51 40.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.81 0.338 . . . . 0.0 111.074 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -130.43 134.08 25.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.526 ' O ' HG12 ' A' ' 96' ' ' ILE . 34.0 Cg_endo -66.62 -56.24 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.361 2.04 . . . . 0.0 112.655 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -40.65 -31.97 0.19 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.21 -22.86 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.591 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 93' ' ' PRO . 9.2 pt -76.35 -35.35 27.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.922 0.391 . . . . 0.0 110.929 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -56.1 -68.79 0.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.359 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.49 -34.57 77.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.624 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.98 -43.12 68.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.818 0.342 . . . . 0.0 111.454 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.417 HG23 ' CE2' ' A' ' 48' ' ' TYR . 74.2 mt -84.76 -18.82 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.21 -23.37 21.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.752 0.31 . . . . 0.0 111.569 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.4 m -89.99 -65.75 0.99 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.83 0.348 . . . . 0.0 111.482 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.64 -29.18 16.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.456 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.287 -179.786 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtm . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.775 0.322 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.489 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 13.7 p -54.42 144.1 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -124.14 159.23 30.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.063 0.459 . . . . 0.0 110.933 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -102.0 100.0 10.22 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.438 HD23 ' CD2' ' A' ' 54' ' ' TYR . 5.5 mp -88.83 109.36 20.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.806 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -96.25 -66.37 0.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -85.04 150.92 24.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.301 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.74 -28.68 70.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.095 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.1 t -55.88 -35.84 66.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.36 -40.9 94.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.516 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -67.76 -55.76 11.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.929 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.58 -56.3 23.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.9 t -57.03 -29.1 63.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.92 -61.05 2.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.215 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.465 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 79.6 mt -59.51 -26.72 65.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.004 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.03 -70.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.225 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -74.78 -27.25 60.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.87 169.66 1.66 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.691 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -177.36 -37.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 111.075 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -51.84 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.418 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 4.9 tt -172.73 108.24 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.753 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 60.6 t -100.79 132.06 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.688 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.404 ' CG2' ' CD2' ' A' ' 21' ' ' LEU . 46.6 t -125.6 122.24 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.384 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.421 HG12 ' CE2' ' A' ' 26' ' ' PHE . 49.4 t -105.19 129.92 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.53 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -116.74 106.67 13.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.022 0.439 . . . . 0.0 111.488 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.483 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 77.4 m-85 -99.24 101.29 12.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.226 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.446 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 4.5 p90 -127.22 105.96 8.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.499 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -96.14 73.67 2.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.444 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.452 ' C ' ' O ' ' A' ' 28' ' ' ALA . 68.3 p -23.91 105.72 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.502 ' CZ3' ' HB2' ' A' ' 73' ' ' MET . 3.2 m-90 -113.63 -54.75 2.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.2 m -123.15 -2.15 8.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.109 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.651 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 88.4 23.33 37.41 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.769 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 62.3 Cg_endo -75.53 -50.62 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.87 1.713 . . . . 0.0 111.941 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.8 m -63.82 -37.37 87.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -64.19 -26.96 68.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.19 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 57.4 ttp -58.47 -62.0 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.0 110.988 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.3 pt -90.35 31.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.707 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.464 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -78.93 -59.38 0.64 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.122 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 65.0 Cg_exo -52.07 -35.15 60.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.335 2.023 . . . . 0.0 112.298 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.44 ' CE ' ' HB2' ' A' ' 93' ' ' PRO . 66.0 mtp -57.27 -74.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.668 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 pt -48.52 -42.07 12.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.76 0.314 . . . . 0.0 111.211 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -67.07 -33.75 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.487 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -73.83 -44.75 54.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.111 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -55.77 -27.48 51.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.777 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.55 -29.37 50.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.75 -30.46 23.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.589 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -64.69 -25.81 68.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.24 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -79.6 176.28 9.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.861 0.363 . . . . 0.0 110.941 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.8 m -97.89 -36.67 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.788 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -149.84 90.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.61 129.31 34.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.837 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.53 93.27 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.228 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 7.4 m-85 -90.08 131.26 36.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.31 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CD2' HD23 ' A' ' 5' ' ' LEU . 20.0 m-30 -119.37 129.83 55.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.856 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 87.3 tttt -103.5 145.28 30.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.68 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.475 ' CD1' ' CE1' ' A' ' 26' ' ' PHE . 88.1 mt -143.73 140.0 29.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.37 -175.72 3.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.94 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.7 t -82.93 151.73 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 7.4 t70 63.36 132.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 39.2 tt0 73.63 -54.77 0.68 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.151 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 36.6 t -95.03 2.29 9.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.536 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.1 m -63.81 -30.23 71.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.782 0.325 . . . . 0.0 111.005 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -51.41 -25.85 6.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.4 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.4 ' CG1' HD12 ' A' ' 56' ' ' LEU . 36.2 t -68.7 -54.61 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.047 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.99 70.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.21 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -56.45 -67.65 0.28 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.986 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -57.59 -37.72 73.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.01 78.04 6.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.822 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -53.5 102.2 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.426 ' CG1' ' CG2' ' A' ' 75' ' ' THR . 44.5 t -138.94 152.51 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.996 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.3 p -143.82 116.14 8.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.54 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.477 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 41.2 t 179.32 -163.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.222 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.502 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 18.3 ptm 178.41 93.76 0.15 Allowed Pre-proline 0 N--CA 1.463 0.187 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.85 -161.61 2.61 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.354 -0.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 19.1 m -146.66 115.82 6.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.05 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.43 ' HB2' ' CG2' ' A' ' 88' ' ' VAL . 5.2 mp -126.58 115.7 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.935 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.416 HD13 ' CE2' ' A' ' 79' ' ' TYR . 28.6 pt -116.03 164.98 11.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.438 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.0 m-85 -133.86 131.03 38.71 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.038 0.447 . . . . 0.0 111.403 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.465 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 75.0 m-85 -109.89 152.33 25.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.625 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -116.15 -38.08 3.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.811 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.71 31.87 0.22 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.282 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.99 37.45 2.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.281 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -161.48 118.7 2.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -73.64 110.57 8.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.312 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.9 -37.46 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.452 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 72.3 m -107.14 111.67 24.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.798 0.332 . . . . 0.0 110.322 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -125.42 152.21 45.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.186 0.517 . . . . 0.0 111.556 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 28.5 m -138.67 88.29 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.219 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 31.1 m -109.25 94.45 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.333 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.87 -112.77 0.62 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.206 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.09 55.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.861 0.362 . . . . 0.0 111.125 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -144.85 126.37 7.83 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.195 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.44 ' HB2' ' CE ' ' A' ' 40' ' ' MET . 81.4 Cg_endo -79.21 2.62 8.16 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.663 2.242 . . . . 0.0 112.64 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.32 -39.48 10.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.008 0.432 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.14 -30.33 70.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.681 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.438 ' CD1' ' N ' ' A' ' 97' ' ' LYS . 2.2 pp -57.43 -32.91 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.438 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 50.0 tttm -54.27 -69.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.731 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -62.55 -21.64 65.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . . . -59.66 -54.03 51.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.47 HD13 ' N ' ' A' ' 100' ' ' ILE . 2.0 mp -75.51 -35.62 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.576 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.26 68.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.308 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.8 m -57.02 -74.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.12 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -105.15 62.03 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.993 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.007 179.831 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.518 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 10.8 mmt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.8 0.333 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.7 t -50.49 111.09 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.926 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.1 m -103.47 160.38 14.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 111.241 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -104.65 94.45 5.31 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.418 HD23 ' CG ' ' A' ' 54' ' ' TYR . 5.2 mp -88.96 132.32 34.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -130.13 -64.15 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -77.71 143.08 38.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.105 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.75 -29.26 70.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.8 p -55.51 -30.64 61.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -77.41 -38.26 50.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.606 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -72.21 -42.44 65.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.032 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -58.22 -68.17 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.061 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.5 p -55.66 -26.08 42.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.04 -53.07 62.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.243 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.442 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 84.7 mt -69.35 -30.83 68.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.7 -54.55 15.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.212 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -90.36 24.64 2.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.457 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.12 142.45 16.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.449 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -151.48 -46.6 0.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.635 0.255 . . . . 0.0 110.832 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -57.05 -76.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.803 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.432 ' CD1' ' HB3' ' A' ' 103' ' ' ASN . 41.7 tp -177.23 109.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.136 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 54' ' ' TYR . 48.1 t -103.86 117.23 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.744 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.47 122.94 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 61.1 t -109.05 126.24 66.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -122.54 107.0 11.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.526 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 52.6 m-85 -93.34 98.86 11.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.355 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.3 p90 -134.24 121.86 21.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.245 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.16 21.95 3.01 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.7 p 46.88 73.25 0.19 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.856 0.36 . . . . 0.0 110.986 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.517 ' CH2' ' HB2' ' A' ' 73' ' ' MET . 0.0 OUTLIER -146.96 62.26 1.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.153 0.501 . . . . 0.0 112.334 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.1 t 60.29 155.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.508 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.71 178.57 20.12 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.636 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HG2' ' HD3' ' A' ' 74' ' ' PRO . 6.1 Cg_endo -49.63 -22.6 6.85 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.866 2.377 . . . . 0.0 112.548 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.5 p -51.86 -39.99 59.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.877 0.37 . . . . 0.0 111.077 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -87.28 -32.07 19.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.033 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.25 -41.16 70.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.018 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 48.8 mt -90.43 21.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.481 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.482 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -73.1 -58.21 2.6 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 121.239 -0.184 . . . . 0.0 111.106 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.482 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 36.3 Cg_exo -58.28 -35.74 98.4 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.343 2.029 . . . . 0.0 112.002 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 62.5 mtt -54.4 -76.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.4 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.433 HG22 HD13 ' A' ' 41' ' ' ILE . 12.6 pt -49.9 -43.34 19.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.286 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.409 ' N ' HG13 ' A' ' 41' ' ' ILE . 39.6 tt0 -63.9 -31.78 73.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.771 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HB3' ' NZ ' ' A' ' 43' ' ' LYS . 6.2 ttpm? -84.55 -55.21 4.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.636 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.423 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 11.5 m-85 -49.92 -28.11 6.23 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.851 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.25 -28.15 39.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.037 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -89.7 -33.61 16.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.983 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.27 -27.05 68.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.271 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.447 ' CE1' HG23 ' A' ' 100' ' ' ILE . 44.4 m-85 -82.95 157.05 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 111.014 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -82.12 -37.22 26.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -154.5 101.86 2.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.974 0.416 . . . . 0.0 111.149 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.48 124.1 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.973 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.98 106.22 18.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.289 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -92.52 112.17 24.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.224 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.418 ' CG ' HD23 ' A' ' 5' ' ' LEU . 16.7 m-30 -114.73 102.48 10.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.824 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -89.87 130.55 36.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 HD11 ' CE1' ' A' ' 26' ' ' PHE . 90.2 mt -130.63 149.58 52.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.861 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -120.75 159.29 25.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.99 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.406 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 48.5 t -104.61 160.09 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 58' ' ' VAL . 8.1 t0 69.23 -63.07 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -60.96 -29.7 69.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.626 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.3 t -98.97 -57.23 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.767 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.4 t 68.18 -62.77 0.35 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.481 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.96 -47.54 8.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.643 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.01 -61.88 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.32 -30.35 0.81 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.375 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -57.3 -55.27 36.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.725 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -65.86 -63.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.55 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.407 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . . . -75.49 76.79 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -49.65 119.1 3.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.255 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.7 t -90.33 137.35 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.0 t -143.16 48.58 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 111.359 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.1 p -179.31 178.2 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.584 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.517 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 20.7 ptt? -150.09 100.25 3.23 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.582 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HD3' ' HG2' ' A' ' 33' ' ' PRO . 95.5 Cg_endo -78.24 -163.58 3.47 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.931 -1.279 . . . . 0.0 112.388 -0.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 32.5 m -143.47 97.17 3.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.988 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 2.4 mp -109.87 135.66 50.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.006 0.431 . . . . 0.0 111.656 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.403 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 25.5 pt -132.35 166.18 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.478 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.3 m-85 -131.52 125.93 33.63 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 111.679 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.442 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 60.8 m-85 -111.56 153.64 25.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.366 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -127.83 -58.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.704 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.75 -14.16 8.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.476 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.97 41.58 0.12 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.261 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -162.29 127.71 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.965 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.407 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 88.7 tt0 -69.63 95.96 0.9 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.746 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.88 -32.92 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 98.9 m -113.02 103.39 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 110.091 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -106.43 159.66 15.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.574 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.1 t -155.57 83.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.389 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -109.22 77.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.199 0.523 . . . . 0.0 111.264 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.73 -112.15 0.83 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.067 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 171.57 93.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.629 0.252 . . . . 0.0 110.86 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -173.5 131.59 0.57 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.968 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.99 -20.29 22.64 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.634 2.223 . . . . 0.0 112.812 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.55 -35.32 19.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.57 0.224 . . . . 0.0 111.228 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.07 -28.86 4.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.157 0.504 . . . . 0.0 110.049 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.3 tt -90.03 -37.97 10.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.427 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.0 -71.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.975 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -56.68 -22.95 38.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.041 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.412 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -77.21 -67.3 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.123 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.447 HG23 ' CE1' ' A' ' 48' ' ' TYR . 37.1 mm -51.99 -35.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.18 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.7 -71.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 111.683 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.3 m -61.22 -24.75 66.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.602 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 21' ' ' LEU . 5.7 m120 -80.63 -62.47 1.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' A' ' 100' ' ' ILE . 13.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.763 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.6 mtp . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.794 0.33 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.5 t 60.05 116.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.048 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 m -93.81 169.25 10.44 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.146 0.498 . . . . 0.0 110.84 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -110.12 91.45 3.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.186 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.434 HD22 ' CG ' ' A' ' 54' ' ' TYR . 6.6 mp -88.97 136.21 33.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.024 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -130.32 -58.22 1.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.5 t -96.74 142.5 28.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.053 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.83 -27.35 65.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.181 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 t -56.61 -38.07 71.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.31 -36.04 80.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.401 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 49.1 t80 -66.8 -47.68 71.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.972 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -58.45 -60.17 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -57.23 -24.63 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.93 -40.56 72.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.284 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 79' ' ' TYR . 83.9 mt -90.17 15.04 11.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.576 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.11 -90.57 0.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.752 -0.203 . . . . 0.0 111.038 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.8 p -90.4 19.14 5.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.625 0.25 . . . . 0.0 111.374 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 19' ' ' ASP . . . -70.2 -74.45 0.67 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.716 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 1.4 m-20 79.77 -41.81 0.24 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.589 0.355 . . . . 0.0 111.365 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -54.03 -174.48 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.454 HD22 HG22 ' A' ' 23' ' ' VAL . 7.5 tt -77.39 99.06 5.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.979 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.457 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 60.8 t -105.58 111.94 36.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.101 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.476 HG23 ' CD2' ' A' ' 78' ' ' PHE . 46.8 t -119.32 139.58 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.808 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -113.51 128.96 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.497 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 36.5 t70 -112.29 101.51 9.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.962 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.449 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 64.4 m-85 -92.52 107.95 19.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 1.4 p90 -153.01 121.38 6.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.356 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.06 17.41 2.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.663 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.1 p 49.66 55.13 9.85 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.049 0.452 . . . . 0.0 110.945 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.517 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.7 m-90 -69.41 -62.21 1.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.192 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 40.4 t 164.29 140.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.85 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.47 -120.73 6.35 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.537 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.418 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 89.1 Cg_exo -43.07 -70.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.822 2.348 . . . . 0.0 112.863 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.9 p -48.29 -26.64 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 111.423 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -85.66 -72.37 0.49 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.791 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.0 mtt -59.51 -22.24 61.34 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 33' ' ' PRO . 55.8 mt -89.97 -11.03 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.511 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -54.1 -65.23 1.33 Allowed Pre-proline 0 C--N 1.331 -0.215 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.32 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 78.0 Cg_exo -50.29 -36.29 46.67 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.133 1.888 . . . . 0.0 112.616 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.408 ' SD ' ' CB ' ' A' ' 93' ' ' PRO . 56.2 mtt -59.11 -78.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.071 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.696 HD12 ' HG3' ' A' ' 42' ' ' GLU . 2.4 pp -56.34 -24.76 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.131 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.696 ' HG3' HD12 ' A' ' 41' ' ' ILE . 43.3 mt-10 -77.35 -30.5 53.9 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.004 0.431 . . . . 0.0 109.902 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -79.48 -45.21 19.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.145 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.429 ' CG ' HD11 ' A' ' 96' ' ' ILE . 10.1 m-85 -60.32 -29.53 68.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.635 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.36 -31.01 53.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.916 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -84.57 -32.14 23.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.507 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.2 -28.47 69.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.017 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.465 ' CZ ' ' HB ' ' A' ' 100' ' ' ILE . 39.0 m-85 -78.78 148.69 32.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.953 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -80.02 -34.72 38.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -146.27 92.91 2.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.07 123.04 19.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.968 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.65 93.98 7.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.164 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.96 127.93 36.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.124 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.457 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 14.9 m-30 -113.5 108.25 16.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.858 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -89.9 120.85 31.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.729 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.42 HD12 ' CE1' ' A' ' 26' ' ' PHE . 90.3 mt -131.31 145.57 51.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.263 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -106.99 161.21 14.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.57 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.11 -27.42 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.229 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.67 -60.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.168 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.49 -40.12 77.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.185 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -112.87 48.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.012 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.4 t -62.08 -31.33 71.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -49.15 -45.67 44.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.204 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.414 HG12 ' CZ ' ' A' ' 26' ' ' PHE . 47.2 t -73.51 -56.27 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.966 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.34 -52.87 15.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.721 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -50.25 -59.1 4.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -54.65 -73.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.037 0.446 . . . . 0.0 110.706 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.69 68.16 7.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.522 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -44.27 135.66 4.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.551 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.87 159.28 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.923 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.7 p -146.21 80.17 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.116 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -178.56 -161.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.613 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 20.3 ptt? -177.28 94.16 0.24 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.404 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 69.3 Cg_endo -88.26 -160.21 1.51 Allowed 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.239 -1.15 . . . . 0.0 112.32 -0.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 51.5 m -139.9 115.73 10.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.834 0.349 . . . . 0.0 110.954 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 3.9 mp -120.93 115.24 22.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.977 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.4 pt -109.92 157.52 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.668 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.492 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 3.0 m-85 -130.83 125.53 33.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 111.774 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.421 ' CE2' HD11 ' A' ' 15' ' ' LEU . 71.5 m-85 -110.13 150.59 28.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.898 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.04 -22.17 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.136 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.62 31.31 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.27 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.81 44.58 5.11 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.368 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -164.45 107.48 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.382 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -56.93 115.33 2.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.496 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 m -128.02 -48.56 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.492 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 46.4 p -105.2 82.78 1.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.207 0.527 . . . . 0.0 111.0 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.408 ' NH2' HG21 ' A' ' 89' ' ' VAL . 7.2 ptm180 -97.53 142.27 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.633 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 32.8 m -139.75 88.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.542 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.408 HG21 ' NH2' ' A' ' 87' ' ' ARG . 26.0 m -108.98 109.71 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.524 . . . . 0.0 111.128 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.2 -96.2 0.1 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.302 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 176.44 70.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 110.979 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -137.29 88.14 17.51 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.408 ' CB ' ' SD ' ' A' ' 40' ' ' MET . 24.3 Cg_exo -63.55 -14.44 42.53 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.773 2.315 . . . . 0.0 112.487 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.46 -31.3 14.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 110.96 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.1 -23.82 67.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.206 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.429 HD11 ' CG ' ' A' ' 44' ' ' PHE . 21.9 pt -56.34 -38.81 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.933 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.427 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -49.46 -55.91 11.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.605 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -68.59 -25.9 65.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.812 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.429 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -70.5 -57.41 4.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.144 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.465 ' HB ' ' CZ ' ' A' ' 48' ' ' TYR . 3.1 mp -75.54 -5.7 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.237 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.96 -28.75 18.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.702 0.287 . . . . 0.0 111.377 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 m -90.05 -67.0 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 111.408 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -46.86 -32.6 3.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.545 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.417 -179.438 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.432 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 46.0 t -74.86 129.4 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.965 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 m -120.89 149.74 42.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.994 0.426 . . . . 0.0 110.966 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -89.9 109.72 20.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 54' ' ' TYR . 70.3 mt -88.83 104.77 17.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 110.868 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 11.1 mmpt? -89.94 -47.46 7.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.028 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.3 t -104.89 147.41 27.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.245 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.44 -27.73 68.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.01 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.3 p -54.86 -31.27 59.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -71.09 -35.1 71.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.58 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -69.4 -43.87 72.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.026 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -53.16 -60.42 3.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.1 p -64.83 -21.17 66.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.212 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.91 71.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.376 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 82.0 mt -57.4 -36.12 70.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.966 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.03 50.72 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.045 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.7 p -81.97 148.44 28.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 19' ' ' ASP . . . -80.3 83.06 1.43 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.615 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 8.8 t70 80.41 -40.6 0.18 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.702 0.401 . . . . 0.0 111.68 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -45.28 129.17 8.06 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.829 0.347 . . . . 0.0 111.231 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 4.8 tt -80.33 110.88 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.437 ' CG2' ' CE2' ' A' ' 54' ' ' TYR . 10.6 p -100.84 116.06 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.41 ' CG2' ' CD2' ' A' ' 21' ' ' LEU . 47.4 t -104.88 146.76 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.044 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.41 HG13 ' CZ ' ' A' ' 26' ' ' PHE . 48.5 t -126.1 113.8 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.806 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -101.48 120.56 40.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.942 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.442 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 61.2 m-85 -109.45 106.48 16.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.036 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 5.0 p90 -127.35 121.41 30.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.221 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.16 18.54 3.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p 49.3 78.04 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 111.437 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.614 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 0.7 OUTLIER -100.89 -56.05 2.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.946 179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.614 ' CB ' ' O ' ' A' ' 30' ' ' TRP . 42.0 t 132.73 104.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.562 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.03 -92.85 0.25 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.412 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.46 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 11.4 Cg_endo -55.55 -57.79 1.43 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.835 2.357 . . . . 0.0 112.862 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.415 ' SG ' ' CE3' ' A' ' 30' ' ' TRP . 31.1 p -81.12 58.26 3.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 110.975 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -172.19 -46.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.6 ttt -65.68 -54.18 30.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.833 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.425 HG21 HD13 ' A' ' 37' ' ' ILE . 33.0 pt -90.28 21.54 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.52 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.502 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -71.03 -62.74 1.75 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.179 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.502 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 74.9 Cg_exo -50.14 -29.62 22.92 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.167 1.911 . . . . 0.0 112.685 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.462 ' CE ' ' HB3' ' A' ' 93' ' ' PRO . 37.7 mtp -62.56 -73.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.098 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.444 HD11 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -55.8 -23.46 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' N ' HD11 ' A' ' 41' ' ' ILE . 39.6 tt0 -81.17 -31.33 34.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.991 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -76.64 -42.06 43.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.377 179.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -55.19 -23.45 21.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -55.76 -28.27 55.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.128 0.49 . . . . 0.0 110.513 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.69 -0.49 50.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.807 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -90.15 -60.57 1.89 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.172 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.446 ' CE2' ' CG2' ' A' ' 100' ' ' ILE . 17.2 m-85 -70.67 165.16 23.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.041 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.6 m -113.69 -18.39 11.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.756 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -134.79 53.7 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.971 0.415 . . . . 0.0 111.398 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . . . -119.28 113.0 20.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.305 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.44 100.5 13.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.127 0.489 . . . . 0.0 110.84 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 45' ' ' ALA . 12.9 m-85 -92.12 134.22 35.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.186 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.437 ' CE2' ' CG2' ' A' ' 22' ' ' VAL . 19.0 m-30 -122.91 116.73 24.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.792 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -102.33 91.47 4.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.979 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 26' ' ' PHE . 85.0 mt -95.94 132.62 41.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -80.1 -9.26 59.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.663 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 39.1 t 64.74 25.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.111 0.481 . . . . 0.0 110.83 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.1 -47.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.49 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.21 -32.34 73.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.457 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.461 ' O ' ' OG ' ' A' ' 62' ' ' SER . 44.2 t -96.16 -44.37 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.743 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 61' ' ' VAL . 95.5 p 61.33 -65.85 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.749 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 61' ' ' VAL . 7.5 t70 -36.79 -58.22 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.535 0.334 . . . . 0.0 111.851 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.0 -54.12 36.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.045 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.63 -46.3 63.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.34 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -58.91 -40.36 84.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -72.1 -62.34 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.738 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.4 85.08 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -58.32 112.35 1.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.091 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -155.46 110.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.6 m -105.71 50.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -119.24 -170.73 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.647 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.492 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 18.1 ptp -166.7 98.8 0.68 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.378 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.427 ' HA ' ' HH2' ' A' ' 30' ' ' TRP . 94.4 Cg_endo -89.32 -165.05 2.67 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 124.262 -1.141 . . . . 0.0 112.451 -0.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 87.8 m -144.79 118.44 9.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.2 mp -126.37 127.47 45.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.962 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.432 HD11 ' CE2' ' A' ' 79' ' ' TYR . 17.1 pt -122.11 155.95 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.489 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.2 m-85 -127.5 118.56 24.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.424 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.462 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 61.3 m-85 -109.94 112.43 24.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.698 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.09 -54.26 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.834 0.35 . . . . 0.0 110.791 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.6 28.47 2.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.495 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.1 54.57 0.9 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.325 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -176.9 113.12 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.837 0.351 . . . . 0.0 110.976 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -58.91 96.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -109.89 -41.59 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 60.0 m -108.68 102.29 11.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.918 0.39 . . . . 0.0 110.151 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -102.6 154.57 19.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.377 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.4 t -154.35 81.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.574 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.44 72.68 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.59 -136.35 2.36 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.117 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.91 91.71 1.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.282 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -152.08 112.47 2.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.11 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HB3' ' CE ' ' A' ' 40' ' ' MET . 46.2 Cg_exo -57.16 -16.47 21.79 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.71 2.273 . . . . 0.0 112.593 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.82 -30.21 17.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 111.191 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.04 -30.87 16.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 110.841 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 93' ' ' PRO . 4.6 tp -68.58 -22.59 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.22 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HD2' ' O ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -83.82 -53.08 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.197 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -67.34 -47.59 70.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.027 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.5 -59.3 5.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.402 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.446 ' CG2' ' CE2' ' A' ' 48' ' ' TYR . 32.9 mm -57.43 -40.8 76.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.46 -28.22 66.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.193 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.5 m -57.94 -51.55 69.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.951 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -136.35 61.36 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.979 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.99 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.766 0.317 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.9 t 61.03 112.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.661 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.96 174.17 6.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.214 0.53 . . . . 0.0 111.061 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -118.42 96.28 5.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.056 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.465 HD12 ' CG ' ' A' ' 54' ' ' TYR . 62.7 mt -88.96 153.85 20.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.294 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -150.03 -66.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.952 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.6 t -82.57 161.94 22.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.128 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.95 63.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.158 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.1 p -56.44 -29.35 61.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.011 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -75.82 -32.82 59.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -78.3 -46.09 21.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.005 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -57.48 -64.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.084 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 t -57.76 -26.07 61.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.006 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.94 -63.34 1.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.301 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.9 mt -54.16 -25.09 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.123 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.87 -57.13 7.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.073 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.9 t -90.18 18.11 6.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.5 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.22 76.22 2.28 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -88.7 -40.58 13.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.97 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -58.48 -78.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.414 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 4.5 tt -177.59 113.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.774 0.321 . . . . 0.0 110.412 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.477 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 62.6 t -104.02 144.15 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.657 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.4 ' CG2' ' CD2' ' A' ' 21' ' ' LEU . 40.0 t -146.18 129.38 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.482 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.456 ' CG1' ' CE2' ' A' ' 26' ' ' PHE . 52.0 t -100.4 147.75 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.344 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 36.0 t70 -135.6 85.19 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.722 0.296 . . . . 0.0 111.697 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.456 ' CE2' ' CG1' ' A' ' 24' ' ' VAL . 65.8 m-85 -86.78 77.43 9.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.067 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 12.9 p90 -99.89 -34.59 10.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' O ' ' CD2' ' A' ' 27' ' ' PHE . . . 61.37 -162.64 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.584 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 79.2 p -134.11 65.27 1.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.001 0.429 . . . . 0.0 110.975 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.54 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -83.4 -60.1 2.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.916 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 39.1 t 147.44 110.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.458 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 33' ' ' PRO . . . 136.08 -132.42 6.12 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.37 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 10.7 Cg_endo -54.26 -34.09 78.26 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.71 2.274 . . . . 0.0 112.806 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 29.7 p -71.69 56.19 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.19 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 27.9 tptp 172.62 -42.84 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.75 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.505 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 11.1 mmt -58.04 -73.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.408 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.458 ' HB ' ' HG3' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -86.45 8.53 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.68 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.423 ' N ' ' CD ' ' A' ' 39' ' ' PRO . . . -57.91 -52.7 72.51 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.921 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 38' ' ' ALA . 50.9 Cg_exo -54.69 -31.94 73.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.583 2.189 . . . . 0.0 112.288 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 72.2 mtp -54.41 -73.77 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.928 0.394 . . . . 0.0 110.469 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.6 pt -50.56 -44.05 24.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.258 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -63.64 -33.15 74.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.79 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -76.47 -49.35 16.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.939 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.422 ' CD2' HD13 ' A' ' 96' ' ' ILE . 8.0 m-85 -51.79 -27.76 13.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.01 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . . . -52.89 -28.89 25.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.055 0.455 . . . . 0.0 110.576 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -82.85 -25.21 32.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.602 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -58.44 -56.74 18.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.034 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.405 ' CE2' HG23 ' A' ' 100' ' ' ILE . 16.3 m-85 -62.28 171.03 2.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.156 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 m -97.14 -31.98 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 1.5 p30 -140.54 99.18 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.183 0.516 . . . . 0.0 111.146 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.83 117.62 6.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.79 107.09 18.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.279 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 6.6 m-85 -100.01 129.6 46.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.52 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.477 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 17.2 m-30 -115.4 107.26 14.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.444 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -89.85 122.46 32.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.436 ' CD1' ' CE1' ' A' ' 26' ' ' PHE . 94.0 mt -136.32 172.19 13.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.644 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -130.54 -102.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.927 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.6 m -157.54 -45.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 120.709 0.29 . . . . 0.0 111.25 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -110.67 -35.96 5.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.01 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.61 -31.45 66.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.756 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -97.52 -66.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.745 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.0 t 68.31 -63.07 0.35 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.433 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -38.75 -38.62 0.43 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.731 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.02 -54.35 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.096 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.13 -41.12 7.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.811 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -57.33 -47.74 80.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.106 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -82.45 -55.99 4.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.957 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.36 82.16 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -58.49 98.6 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.418 HG22 ' CD2' ' A' ' 26' ' ' PHE . 53.7 t -108.22 151.62 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.2 p -155.79 85.28 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.076 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.2 t -177.9 177.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.442 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 64.9 mtm -154.64 96.48 2.59 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -85.36 -158.75 1.55 Allowed 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.492 -1.045 . . . . 0.0 112.199 0.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 63.3 m -144.62 114.43 7.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.752 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.2 mp -126.89 111.8 14.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.902 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.432 HD13 ' CZ ' ' A' ' 79' ' ' TYR . 26.3 pt -115.75 163.32 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.639 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.3 m-85 -128.11 125.73 39.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.448 ' CE1' ' HB3' ' A' ' 84' ' ' GLU . 63.2 m-85 -109.49 165.04 11.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.43 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -168.51 63.79 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.714 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.3 23.83 4.36 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.028 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.73 -4.67 73.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.254 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 13.2 mptt -109.7 110.63 21.72 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.735 0.302 . . . . 0.0 111.088 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 24.4 pt-20 -68.24 125.59 26.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.467 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.92 -42.04 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.612 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 72.2 m -103.96 113.66 27.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.949 0.404 . . . . 0.0 110.093 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -112.14 155.09 24.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.33 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.2 t -155.84 79.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.793 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 27.0 m -109.62 91.99 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.313 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -103.38 0.17 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.384 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.5 85.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -151.64 81.88 5.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.859 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HG3' ' HB ' ' A' ' 37' ' ' ILE . 51.9 Cg_exo -54.55 -20.45 21.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.863 2.375 . . . . 0.0 112.698 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.84 -2.41 58.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.588 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.0 -23.94 21.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.71 0.29 . . . . 0.0 111.267 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.422 HD13 ' CD2' ' A' ' 44' ' ' PHE . 24.3 pt -54.79 -34.43 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.135 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.47 -60.37 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.032 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -68.17 -27.65 66.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.4 -64.06 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.288 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.405 HG23 ' CE2' ' A' ' 48' ' ' TYR . 66.6 mt -55.78 -35.01 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.216 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.09 -23.79 64.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.327 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.3 m -54.53 -70.13 0.11 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -106.33 56.34 0.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.948 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.791 0.329 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 47.7 t -112.12 131.31 63.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.814 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -110.93 159.46 17.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.437 0.637 . . . . 0.0 111.833 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -121.76 116.32 24.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.569 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 54' ' ' TYR . 67.2 mt -89.05 104.36 16.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.013 0.435 . . . . 0.0 111.306 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -99.52 -35.2 9.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.427 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -117.73 141.09 48.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.944 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.36 -25.98 38.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.427 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -58.63 -40.26 82.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.011 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -63.85 -27.05 68.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.408 ' CZ ' HD12 ' A' ' 15' ' ' LEU . 49.3 t80 -90.0 -46.92 8.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -57.95 -60.74 3.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.072 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.4 p -55.86 -23.09 28.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.294 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.84 -28.22 60.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.46 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.419 HD21 ' CD2' ' A' ' 79' ' ' TYR . 86.1 mt -89.94 -17.96 26.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.364 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.33 -86.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.328 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.1 p -90.47 29.33 1.3 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.08 87.86 1.44 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.77 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -80.07 -37.32 34.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 110.588 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -57.95 -168.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.607 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.423 HD21 HG21 ' A' ' 23' ' ' VAL . 2.7 tt -91.1 119.88 31.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.962 0.411 . . . . 0.0 110.689 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.486 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 59.6 t -113.05 107.95 24.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.532 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.423 HG21 HD21 ' A' ' 21' ' ' LEU . 43.3 t -99.92 144.81 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.507 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.407 HG12 ' CZ ' ' A' ' 26' ' ' PHE . 48.4 t -126.43 147.89 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.447 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 37.7 t70 -137.13 113.16 9.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.961 0.41 . . . . 0.0 111.211 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.512 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 70.4 m-85 -110.34 107.2 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 1.7 p90 -150.69 121.85 7.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.783 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.18 18.17 4.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.638 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.0 p 49.61 62.86 2.42 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.14 0.495 . . . . 0.0 111.119 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.507 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.8 m-90 -77.72 -61.19 2.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.149 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 41.8 t 165.11 109.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.562 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.04 -146.38 18.42 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.027 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . 84.2 Cg_exo -46.28 -36.49 17.32 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.834 2.356 . . . . 0.0 112.88 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 24.4 p -51.76 -26.04 8.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -113.77 -28.7 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.2 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.7 ttm -77.35 -29.85 53.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.292 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 33' ' ' PRO . 54.1 mt -89.94 -6.16 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.706 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.466 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -51.08 -55.35 28.84 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.536 0.208 . . . . 0.0 111.408 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.466 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 37.9 Cg_exo -61.58 -39.04 57.69 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.55 2.167 . . . . 0.0 112.285 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 60.7 mtt -53.08 -75.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.58 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.6 pt -51.69 -43.16 32.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.35 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.86 -33.65 76.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.753 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.3 ttpt -76.2 -41.25 50.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.288 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.434 ' CG ' HD12 ' A' ' 96' ' ' ILE . 6.1 m-85 -64.26 -23.96 67.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.716 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -54.85 -29.14 54.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.06 0.457 . . . . 0.0 110.473 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -84.54 -1.83 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.944 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -90.17 -46.5 8.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.048 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.434 ' CE2' ' CD1' ' A' ' 100' ' ' ILE . 17.6 m-85 -73.89 168.05 20.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.186 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -111.6 -22.69 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.269 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -146.0 66.45 1.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.034 0.445 . . . . 0.0 111.199 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.55 117.64 24.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.018 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.69 104.12 16.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.631 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.512 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 3.6 m-85 -89.85 106.89 18.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.928 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.486 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 12.8 m-30 -96.86 109.1 21.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 110.953 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -89.89 129.56 36.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.083 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.432 HD12 ' CE1' ' A' ' 26' ' ' PHE . 96.2 mt -148.35 136.84 21.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.642 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -107.29 -96.73 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.065 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.4 t -156.2 -69.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.849 0.357 . . . . 0.0 111.076 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -79.76 -33.47 40.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.13 -29.41 57.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.041 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.461 ' O ' ' HB3' ' A' ' 62' ' ' SER . 30.5 t -112.98 -67.13 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.842 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 33.2 t 75.28 -7.82 1.7 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.14 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -90.36 -64.32 1.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.924 0.393 . . . . 0.0 110.865 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.3 t -62.92 -59.98 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.137 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.22 -31.15 2.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.445 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -63.62 -58.59 6.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.738 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -74.31 -55.67 5.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.759 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.4 82.99 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.5 128.02 34.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.109 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.6 t -89.55 132.88 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -136.97 50.85 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.16 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.3 t -170.33 -163.69 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.635 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.465 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.3 ptm -170.1 90.92 0.52 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.431 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.88 -162.53 2.93 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.88 -1.3 . . . . 0.0 112.27 -0.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 88.0 m -137.12 105.02 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.602 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 3.8 mp -114.05 140.69 48.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.958 0.409 . . . . 0.0 111.217 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.1 pt -138.59 156.79 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.804 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 1.4 m-85 -124.1 125.52 44.64 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.959 0.409 . . . . 0.0 111.507 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 65.4 m-85 -110.93 124.43 52.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.925 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -116.57 -38.26 3.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.44 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.55 45.03 1.22 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.055 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.85 27.03 58.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.908 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -152.92 124.66 7.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.774 0.321 . . . . 0.0 110.832 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.67 111.05 0.73 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.381 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.91 -46.89 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 77.0 p -113.46 77.8 1.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 110.997 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -81.69 160.05 23.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.044 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.1 t -150.95 83.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.854 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.1 m -109.38 99.38 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.216 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.8 -111.05 0.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.208 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -179.72 91.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 0.0 111.109 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -178.16 123.37 0.26 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.865 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.516 ' O ' HG12 ' A' ' 96' ' ' ILE . 12.3 Cg_endo -57.57 -59.43 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.426 2.084 . . . . 0.0 112.498 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -42.1 -30.44 0.29 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.955 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -20.26 60.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.662 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 93' ' ' PRO . 8.9 pt -78.84 -42.96 24.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.872 0.367 . . . . 0.0 111.025 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.422 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -62.59 -64.38 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.578 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -54.64 -25.78 28.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.253 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.41 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -83.4 -63.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.047 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.434 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 63.1 mt -59.89 -44.92 95.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.6 -16.43 60.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.747 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.4 t -85.76 -56.71 3.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.796 0.331 . . . . 0.0 111.237 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -70.33 -23.87 62.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.138 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.555 -179.399 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.917 0.389 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t 63.72 125.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.685 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 m -106.71 166.99 10.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -106.2 90.28 3.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.064 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 54' ' ' TYR . 74.6 mt -89.03 132.7 34.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.187 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -133.52 -58.3 0.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.792 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 t -91.88 149.94 21.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.053 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.55 -28.25 67.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.208 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -55.67 -30.9 61.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -72.63 -39.26 67.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.432 ' CE1' HD22 ' A' ' 15' ' ' LEU . 52.1 t80 -61.95 -71.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.981 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -47.57 -30.08 3.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.532 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 t -66.01 -23.3 66.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.194 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.08 -36.03 15.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.26 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 2.2 mm? -82.12 -0.3 44.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.446 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.92 -82.12 0.27 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 111.061 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -90.54 30.42 1.15 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.185 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.63 168.04 41.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.645 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -159.57 -45.67 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.644 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -59.43 -170.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.731 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.414 ' CD2' HG21 ' A' ' 100' ' ' ILE . 44.4 tp -75.38 107.36 7.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.209 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.16 97.63 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.563 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.3 t -105.74 137.97 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.593 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG13 ' CE2' ' A' ' 26' ' ' PHE . 48.1 t -116.59 139.08 44.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.329 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -117.93 98.18 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.508 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.429 ' CE2' HG13 ' A' ' 24' ' ' VAL . 61.3 m-85 -96.02 96.98 9.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.916 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.2 p90 -136.54 122.16 19.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.65 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.25 112.16 23.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.479 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.7 p -74.54 105.36 5.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.471 . . . . 0.0 111.629 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.531 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.2 m-90 -105.32 -60.38 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.471 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 44.7 t 159.07 90.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.418 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.3 -82.54 0.21 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.759 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.755 ' O ' ' N ' ' A' ' 35' ' ' LYS . 87.3 Cg_endo -79.79 -155.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.496 2.13 . . . . 0.0 110.852 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 4.6 p 42.04 -68.81 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.755 ' N ' ' O ' ' A' ' 33' ' ' PRO . 86.9 tttt -55.27 -39.84 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.382 . . . . 0.0 111.306 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -62.68 1.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.473 ' H ' ' CD1' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -90.16 34.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.936 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.484 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -90.06 -59.65 0.24 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.621 0.248 . . . . 0.0 110.914 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.484 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 59.6 Cg_exo -52.54 -41.15 69.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.353 2.035 . . . . 0.0 112.35 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.414 ' CE ' ' CB ' ' A' ' 93' ' ' PRO . 70.0 mtp -50.07 -71.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 110.788 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 pt -55.38 -45.57 78.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.258 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.9 -35.29 74.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.844 0.354 . . . . 0.0 110.727 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.429 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 11.6 tmtt? -69.9 -49.28 53.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.412 ' CG ' ' OE1' ' A' ' 47' ' ' GLN . 6.0 m-85 -47.54 -28.85 2.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.271 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.13 -29.29 57.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.837 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.61 -32.98 25.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.404 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.412 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 84.5 mt-30 -60.52 -26.39 66.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.455 ' CZ ' HG22 ' A' ' 100' ' ' ILE . 42.1 m-85 -90.1 176.82 6.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.779 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.3 m -114.05 -27.83 7.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.258 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -138.9 68.96 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 111.424 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.74 115.18 20.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.99 101.3 14.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.394 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -93.72 132.11 38.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.444 ' HB3' ' CD1' ' A' ' 5' ' ' LEU . 15.3 m-30 -121.62 106.42 11.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.806 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.91 130.11 36.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.984 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.6 mt -155.47 140.96 17.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.829 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -101.42 -128.38 0.21 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.475 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.3 t -126.58 -70.13 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.084 0 CA-C-O 120.777 0.322 . . . . 0.0 111.015 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -72.61 -39.72 67.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.739 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -58.17 -29.51 65.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.7 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.25 70.53 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.2 t -76.86 -2.03 31.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.541 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -84.83 -38.07 19.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.816 0.341 . . . . 0.0 111.089 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.2 t -90.2 -56.31 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.251 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.19 -32.55 16.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.65 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -58.25 -48.28 80.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.89 -51.59 66.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.01 77.33 6.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.091 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.05 115.06 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.2 m -138.56 143.02 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.188 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -116.77 174.88 5.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.828 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 81.8 p 50.69 95.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.522 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 21.6 mmt -91.24 150.76 42.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.78 -178.98 22.88 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 123.723 -1.366 . . . . 0.0 112.7 0.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -149.85 130.69 14.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.56 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.0 mp -123.98 131.98 53.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.0 111.335 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 pt -130.47 139.58 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.502 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.443 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 2.7 m-85 -114.23 125.64 54.15 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.044 0.449 . . . . 0.0 111.572 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 69.7 m-85 -109.61 162.14 14.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.718 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -153.41 67.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.74 20.74 18.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.415 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.77 64.51 1.2 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.565 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -178.18 115.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.954 0.407 . . . . 0.0 111.157 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 44.3 tt0 -79.31 98.43 6.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.575 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.91 -32.43 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.412 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 92.2 m -113.88 102.8 10.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.889 0.376 . . . . 0.0 110.468 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -110.0 144.31 38.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.003 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.415 HG23 ' CE1' ' A' ' 78' ' ' PHE . 50.2 t -137.57 82.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.704 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.65 106.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.325 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.03 -108.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.371 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -179.93 68.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.991 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -142.51 96.4 6.29 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.052 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.427 ' O ' HG13 ' A' ' 96' ' ' ILE . 32.0 Cg_exo -58.6 -17.1 33.32 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.589 2.192 . . . . 0.0 112.503 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.27 -29.73 17.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.853 0.358 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.52 -25.32 62.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.173 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 93' ' ' PRO . 2.1 pp -56.59 -31.9 35.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 34.5 ttpt -62.93 -65.11 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.16 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -39.01 -33.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.655 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.47 -46.87 12.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.455 HG22 ' CZ ' ' A' ' 48' ' ' TYR . 73.4 mt -74.07 -5.68 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.541 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.22 -32.9 16.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.727 0.299 . . . . 0.0 111.379 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.7 p -89.67 -58.55 2.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 111.387 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.401 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 47.2 m-80 -60.08 -17.99 43.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.591 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 11.3 p . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.769 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' HG3' ' N ' ' A' ' 2' ' ' VAL . 23.0 ptp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.889 0.376 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 45.4 t -147.93 102.19 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.701 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -101.53 152.44 20.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.423 0.63 . . . . 0.0 111.851 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -113.01 118.84 35.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.402 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 4.7 mp -89.15 117.68 28.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.977 0.418 . . . . 0.0 111.616 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -107.79 -37.0 6.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.172 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.2 t -115.95 143.81 44.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.831 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.48 -23.79 41.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.302 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 m -60.12 -45.01 94.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -59.9 -27.4 66.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.35 . . . . 0.0 110.895 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.462 ' CZ ' ' CD1' ' A' ' 15' ' ' LEU . 48.6 t80 -90.03 -48.81 6.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.175 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -57.79 -61.81 2.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.1 p -54.56 -24.33 20.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.349 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.06 -66.06 0.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.362 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 11' ' ' TYR . 82.2 mt -54.85 -24.11 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.4 -79.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.205 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -90.2 17.24 7.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.04 105.88 3.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -109.47 -22.0 12.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 111.065 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -54.92 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.092 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.416 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 4.4 tt -177.83 107.99 0.06 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.455 ' CG1' ' CD2' ' A' ' 54' ' ' TYR . 58.3 t -102.79 124.72 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.723 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.19 122.57 69.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.43 ' CG1' ' CE2' ' A' ' 26' ' ' PHE . 51.8 t -104.0 112.55 37.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.756 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -108.68 98.44 7.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.451 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 61.0 m-85 -86.3 115.55 23.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.88 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 2.3 p90 -135.81 117.12 14.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.661 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . . . -86.79 4.52 40.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.771 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.8 p 49.18 70.83 0.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 111.178 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.478 ' CZ2' ' HG2' ' A' ' 73' ' ' MET . 3.0 m-90 -89.12 -57.84 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.148 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.8 t -139.57 -104.35 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.384 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.616 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -136.05 25.76 3.17 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.9 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 85.7 Cg_endo -82.44 -41.32 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 121.982 1.788 . . . . 0.0 112.114 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.9 p -98.39 -41.93 7.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.247 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -52.18 -42.12 63.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.382 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.7 ttt -67.72 -25.79 65.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.117 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.0 mm -86.97 -10.72 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.693 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.459 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -59.91 -63.37 4.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 82.5 Cg_exo -45.76 -40.68 19.44 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.333 2.022 . . . . 0.0 112.801 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.6 mtt -54.17 -79.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.644 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -57.55 -29.71 34.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.778 0.323 . . . . 0.0 110.969 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 88.4 tt0 -70.35 -26.92 63.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.704 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 13.4 tmtt? -87.09 -45.92 10.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.241 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -54.82 -27.47 42.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.703 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.82 -30.56 23.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.087 0.47 . . . . 0.0 110.495 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -83.15 -26.53 30.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.59 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -72.64 -26.1 61.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.302 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.421 ' CE2' HD13 ' A' ' 100' ' ' ILE . 49.1 m-85 -83.18 167.67 17.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.374 . . . . 0.0 111.039 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -97.28 -33.48 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.821 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -153.01 98.57 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.823 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.63 121.24 10.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.629 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.94 109.28 20.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 10.4 m-85 -97.96 116.05 29.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.525 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.455 ' CD2' ' CG1' ' A' ' 22' ' ' VAL . 17.7 m-30 -112.26 99.77 8.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.864 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -90.04 127.63 36.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.427 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 90.0 mt -130.87 162.77 28.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.216 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.426 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 38.8 t70 -106.33 -109.5 0.29 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.515 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' A' ' 57' ' ' ASP . 16.1 m -160.51 -48.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.742 0.306 . . . . 0.0 111.399 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -110.75 -33.63 6.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 110.742 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.5 -27.32 56.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.695 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.508 ' O ' ' OG ' ' A' ' 62' ' ' SER . 46.8 t -106.74 -68.78 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.508 ' OG ' ' O ' ' A' ' 61' ' ' VAL . 86.1 p 64.59 5.75 2.86 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.015 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.49 -38.64 13.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.974 0.416 . . . . 0.0 110.656 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.408 ' HB ' HD12 ' A' ' 56' ' ' LEU . 27.0 t -90.05 -47.21 14.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.248 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.0 -30.31 1.0 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.653 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -73.79 -37.03 65.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -88.91 -57.49 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.754 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.06 81.24 8.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.067 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.67 117.81 5.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.01 174.53 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -175.98 91.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.16 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.6 t -178.22 -171.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.478 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 52.8 mtt -156.83 93.73 2.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.02 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -89.39 -162.66 1.93 Allowed 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.297 -1.126 . . . . 0.0 112.502 0.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 95.4 m -141.55 105.65 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.676 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 3.9 mp -118.91 119.75 35.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.227 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.435 HG23 HD11 ' A' ' 77' ' ' ILE . 29.8 pt -121.31 166.99 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.51 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.9 m-85 -130.87 128.55 40.83 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.054 0.454 . . . . 0.0 111.338 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 60.2 m-85 -109.76 131.78 54.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.062 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -132.91 60.05 1.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.085 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.65 38.65 0.65 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.026 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.49 29.12 72.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.006 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -142.72 115.43 8.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 111.06 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.3 tt0 -69.98 104.13 2.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.596 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.42 -37.72 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.462 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 88.5 m -106.82 107.32 18.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 110.397 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -110.77 152.59 26.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.339 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' A' ' 78' ' ' PHE . 44.8 t -149.44 82.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.683 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.59 98.5 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.199 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.1 -107.26 0.2 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.436 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 173.62 92.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -153.37 116.66 2.74 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.03 -11.99 32.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.507 2.138 . . . . 0.0 112.652 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.57 -38.25 10.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.68 0.276 . . . . 0.0 111.287 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.71 -35.2 21.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 111.021 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 tp -53.06 -43.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.524 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.44 -72.2 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.318 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -51.47 -26.24 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.761 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . . . -72.47 -62.57 1.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.752 0.311 . . . . 0.0 111.071 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.443 HD12 HG22 ' A' ' 100' ' ' ILE . 62.3 mt -73.83 -7.39 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.411 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.04 -27.3 26.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.689 0.28 . . . . 0.0 111.329 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.6 m -90.06 -56.09 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.294 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -55.35 -45.49 76.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.453 -179.524 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.852 0.358 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.46 123.78 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.926 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 -178.2 4.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 0.0 110.597 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -124.0 90.13 3.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.19 178.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.43 HD12 ' CD1' ' A' ' 54' ' ' TYR . 5.0 mp -89.07 141.12 28.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -133.68 -69.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.2 t -79.32 162.18 25.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.056 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.27 -30.34 67.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.062 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -59.02 -33.83 71.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -69.7 -30.72 68.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.826 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.424 ' CZ ' HD12 ' A' ' 15' ' ' LEU . 45.8 t80 -75.75 -45.99 33.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.905 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.29 -56.29 19.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -59.1 -28.0 66.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.052 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.66 -66.4 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.136 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.453 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 81.4 mt -58.06 -26.72 62.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.037 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.78 -68.0 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -78.21 -28.46 48.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.19 119.07 12.84 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -114.37 -31.08 6.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 0.0 111.195 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.92 -108.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 tt -139.49 121.65 15.82 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.784 0.326 . . . . 0.0 110.439 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.421 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 60.3 t -111.92 122.81 66.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.009 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.32 124.7 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.0 t -110.67 115.56 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.058 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -102.43 120.24 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.419 ' CE1' HD12 ' A' ' 56' ' ' LEU . 54.6 m-85 -108.26 119.52 39.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.16 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.424 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 2.5 p90 -155.15 113.3 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.644 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.06 23.2 6.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.403 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p 46.81 70.14 0.42 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.96 0.409 . . . . 0.0 110.769 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CZ3' ' HB2' ' A' ' 73' ' ' MET . 2.5 m-90 -83.05 -57.86 3.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.868 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.4 t -118.89 -37.1 3.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.894 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 142.14 -38.38 1.48 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.504 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 58.7 Cg_exo -40.7 -46.96 4.71 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.622 2.214 . . . . 0.0 112.927 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.8 p -53.56 -31.75 47.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.004 0.43 . . . . 0.0 110.737 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -83.64 -25.93 30.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.9 ttm -70.18 -33.21 71.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.687 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.4 HD13 HG23 ' A' ' 37' ' ' ILE . 56.4 mt -90.15 -1.36 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.46 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -59.09 -63.72 3.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 121.206 -0.197 . . . . 0.0 111.279 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.46 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 86.1 Cg_exo -44.07 -34.55 6.69 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.379 2.053 . . . . 0.0 112.512 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.7 mtt -56.11 -74.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.644 HD11 ' HG3' ' A' ' 42' ' ' GLU . 2.4 pp -63.8 -25.28 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.199 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.644 ' HG3' HD11 ' A' ' 41' ' ' ILE . 93.4 mt-10 -72.41 -30.96 65.11 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.001 0.429 . . . . 0.0 109.997 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.433 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -77.23 -44.51 29.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.828 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.6 m-85 -55.65 -23.05 25.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.647 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -56.94 -28.15 61.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 110.536 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -89.14 -7.78 55.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.872 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -90.06 -51.06 5.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.583 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.47 ' CE2' HG13 ' A' ' 100' ' ' ILE . 51.8 m-85 -68.0 143.63 55.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.904 0.383 . . . . 0.0 111.336 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.3 m -76.73 -34.03 58.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 1.5 p30 -150.11 100.32 2.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.297 0.57 . . . . 0.0 111.395 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . . . -146.54 125.07 12.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.28 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.52 107.39 19.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.552 ' CZ ' ' HA ' ' A' ' 45' ' ' ALA . 14.6 m-85 -101.75 124.95 48.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.915 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.43 ' CD1' HD12 ' A' ' 5' ' ' LEU . 17.6 m-30 -112.36 123.43 50.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -102.75 119.83 39.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' A' ' 26' ' ' PHE . 81.2 mt -130.87 155.38 46.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.801 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -120.04 -83.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.119 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.6 p 178.32 -45.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.33 . . . . 0.0 111.085 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -85.96 -58.12 2.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.776 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -59.55 -30.47 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.21 54.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.041 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.5 t -70.16 -27.32 64.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.63 -40.9 69.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.42 -48.98 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.942 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.52 -45.54 9.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.514 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -59.36 -58.8 7.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.77 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -60.88 -68.72 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.47 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.94 75.43 2.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.778 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -48.57 137.77 11.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.231 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.1 t -124.31 158.64 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.08 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -164.56 70.49 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.415 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 41.5 t -177.74 -163.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.646 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.9 ptm -175.03 100.2 0.27 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.426 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 6.0 Cg_exo -79.76 -155.35 1.14 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.464 -1.057 . . . . 0.0 112.216 -0.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.415 ' OG1' ' HB3' ' A' ' 72' ' ' SER . 87.3 m -159.14 111.06 2.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.2 mp -123.95 127.3 47.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.259 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.4 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 24.2 pt -117.03 156.32 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.733 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.582 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -127.04 123.46 37.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.01 0.433 . . . . 0.0 111.427 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.453 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 66.7 m-85 -109.83 176.79 4.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.573 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -153.0 -46.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.628 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.0 29.27 1.69 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.191 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.09 44.14 3.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.272 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -162.25 123.57 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.023 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.431 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 22.1 pt-20 -82.3 101.72 10.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.45 . . . . 0.0 110.672 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.54 -34.18 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.446 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 63.7 m -107.96 110.36 22.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.417 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -111.56 158.91 18.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.267 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.6 t -155.22 80.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.773 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.82 63.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.13 0.49 . . . . 0.0 111.27 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -133.57 -158.2 8.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.305 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.03 76.18 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.31 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -154.75 138.32 10.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.555 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.87 -1.03 10.63 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.62 2.213 . . . . 0.0 113.261 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.57 -40.76 9.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.683 0.278 . . . . 0.0 111.241 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.3 -31.52 6.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.7 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 tp -69.76 -36.22 68.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.309 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -61.66 -73.33 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.607 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -55.64 -41.74 73.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.986 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.446 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -54.27 -55.85 24.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.317 . . . . 0.0 111.324 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.47 HG13 ' CE2' ' A' ' 48' ' ' TYR . 32.8 mm -62.22 -51.01 77.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.747 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -23.68 66.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.227 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -54.8 -62.91 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.55 . . . . 0.0 110.826 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -127.71 46.54 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.078 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.099 179.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.835 0.35 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.417 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 15.8 m -56.96 154.14 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.034 0.445 . . . . 0.0 111.629 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.9 m -101.11 163.9 12.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -98.65 90.7 4.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 54' ' ' TYR . 5.2 mp -88.84 127.46 35.63 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.956 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -129.71 -58.21 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.196 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.9 t -90.24 139.82 30.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.13 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.02 66.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.163 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.4 p -55.88 -37.68 69.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.813 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.18 -32.95 74.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -65.09 -62.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.155 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.93 -54.61 42.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.8 p -56.69 -22.55 35.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.22 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.32 -60.55 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.322 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.461 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 78.5 mt -55.7 -23.0 26.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.165 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.89 -61.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 111.249 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -75.16 -48.35 24.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.066 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.79 108.24 0.68 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.773 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -109.85 -25.17 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 0.0 110.916 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -53.49 -79.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.448 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 4.3 tt -169.02 116.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 110.554 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.449 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 50.1 t -105.76 137.99 33.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.506 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.31 108.94 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 0.0 111.319 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.44 HG21 HG12 ' A' ' 77' ' ' ILE . 34.7 m -102.38 122.92 55.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.87 103.92 13.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CE1' ' CD1' ' A' ' 56' ' ' LEU . 63.4 m-85 -91.99 101.7 14.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.173 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.425 ' HA ' ' CH2' ' A' ' 30' ' ' TRP . 2.4 p90 -134.53 122.21 22.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.519 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.25 23.65 4.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.868 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.2 p 46.52 80.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.985 0.421 . . . . 0.0 111.355 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.45 ' CZ2' ' HG2' ' A' ' 73' ' ' MET . 3.6 m-90 -86.63 -58.87 2.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.322 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.5 t -143.44 -77.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.502 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.579 ' N ' ' HD3' ' A' ' 33' ' ' PRO . . . -168.69 52.59 0.22 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.923 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 32' ' ' GLY . 37.5 Cg_endo -94.3 -68.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.051 2.501 . . . . 0.0 112.204 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.0 p -68.63 -34.87 76.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.813 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 38' ' ' ALA . 9.4 tmtt? -52.93 -55.5 22.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.66 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.8 ttt -51.22 -42.69 61.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.2 pt -90.2 10.7 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.134 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.51 ' HB2' ' HD3' ' A' ' 39' ' ' PRO . . . -62.94 -51.04 74.01 Favored Pre-proline 0 C--N 1.331 -0.203 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.301 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 50.4 Cg_exo -55.53 -32.44 82.72 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.277 1.985 . . . . 0.0 112.09 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 63.3 mtt -55.1 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.456 ' CD1' ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -55.5 -28.78 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 111.132 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 8.7 tm-20 -71.38 -27.09 63.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.368 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -86.01 -50.75 6.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.413 ' O ' ' CD2' ' A' ' 48' ' ' TYR . 9.8 m-85 -54.19 -30.25 48.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.406 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' HB1' ' CD2' ' A' ' 53' ' ' PHE . . . -51.91 -27.83 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.239 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -90.1 -33.61 16.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.76 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -61.81 -24.56 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.105 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 100' ' ' ILE . 39.2 m-85 -82.28 159.07 23.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.991 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -81.28 -38.96 26.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 1.6 p30 -150.0 104.75 3.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.118 0.485 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.09 123.23 11.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.092 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.0 100.26 13.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.426 ' CD2' ' HB1' ' A' ' 45' ' ' ALA . 9.4 m-85 -94.87 127.34 40.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.496 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.449 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 18.8 m-30 -118.23 126.44 52.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.004 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -107.32 99.13 8.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.603 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.444 ' CD1' ' CE1' ' A' ' 26' ' ' PHE . 98.1 mt -98.77 164.28 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.236 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -144.2 162.89 35.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.439 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.7 t -86.83 0.53 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.794 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -113.22 -75.93 0.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.644 0.259 . . . . 0.0 111.211 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.57 -23.02 57.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.197 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 64' ' ' VAL . 39.8 t -127.98 47.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.5 t -62.69 -26.24 68.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.016 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -60.75 -55.14 36.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.993 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.402 ' CG2' ' CG1' ' A' ' 61' ' ' VAL . 55.7 t -58.8 -48.92 84.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.025 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.08 -26.5 6.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.311 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -58.48 -64.54 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.727 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -59.65 -57.95 10.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.801 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.24 83.51 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -56.57 111.77 1.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.027 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.9 t -92.15 127.36 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.8 t -153.47 39.45 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.177 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.0 m -128.03 -53.87 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.704 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.45 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 55.1 mtm 65.16 83.62 0.19 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.303 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 85.9 Cg_endo -89.18 -166.11 2.98 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.881 -1.3 . . . . 0.0 112.477 -0.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.8 m -144.88 103.0 3.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.719 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.0 mp -109.67 119.16 38.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.609 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -127.15 152.41 35.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.054 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.547 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.9 m-85 -117.87 134.84 54.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.374 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.461 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 76.4 m-85 -109.47 147.49 32.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.66 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -145.67 76.91 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.659 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.13 51.62 1.33 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.12 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.76 27.39 59.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.873 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -144.32 147.45 33.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.965 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -102.21 135.01 44.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.673 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.79 -39.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.876 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 83.1 m -101.1 118.94 37.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.849 0.357 . . . . 0.0 110.262 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -118.13 170.66 8.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.017 0.437 . . . . 0.0 111.614 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -155.81 83.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.704 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.3 88.79 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.29 -34.52 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.973 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 77.53 83.28 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.926 0.393 . . . . 0.0 111.121 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -145.41 129.81 8.86 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.625 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.401 ' O ' ' CG2' ' A' ' 96' ' ' ILE . 30.1 Cg_endo -64.11 -8.64 16.86 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.668 2.245 . . . . 0.0 113.326 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.1 -34.69 10.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.697 0.285 . . . . 0.0 111.173 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.66 -33.87 68.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.128 0.49 . . . . 0.0 110.171 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.401 ' CG2' ' O ' ' A' ' 93' ' ' PRO . 4.2 tp -56.01 -50.41 69.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.297 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.427 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 11.0 tmtt? -59.01 -57.35 13.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.718 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -68.71 -11.76 60.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.61 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.45 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -81.19 -60.03 2.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.778 0.323 . . . . 0.0 111.38 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 48' ' ' TYR . 2.0 mp -75.66 -57.14 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.068 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -46.09 -27.05 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.671 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.9 t -77.96 -57.78 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.429 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -109.97 40.91 1.82 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 111.391 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.992 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.829 0.347 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.1 t -53.39 133.61 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.8 m -107.2 165.02 11.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.08 0.467 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -96.21 79.07 3.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.48 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.6 tp -89.16 95.75 10.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.495 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -106.02 -36.93 6.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.348 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -105.21 145.43 30.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.622 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.34 75.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.056 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -51.83 -28.95 17.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.72 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -80.8 -30.49 35.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.567 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -78.79 -45.27 21.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -57.16 -52.24 66.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -62.46 -27.73 69.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.79 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.19 -53.14 60.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 83.7 mt -59.47 -30.96 68.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.881 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.22 -67.91 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -90.39 24.9 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.366 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.66 -97.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.628 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.4 t0 68.75 -62.16 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.647 0.261 . . . . 0.0 111.167 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -46.62 -82.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.15 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 103' ' ' ASN . 34.7 tp -178.47 111.85 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.752 0.31 . . . . 0.0 110.977 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.404 HG13 ' CE2' ' A' ' 54' ' ' TYR . 47.7 t -105.13 141.02 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.616 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.2 t -144.03 111.03 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 111.373 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.418 HG13 ' CE2' ' A' ' 26' ' ' PHE . 62.1 t -99.96 116.85 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.732 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 27' ' ' PHE . 10.0 t0 -106.07 103.73 13.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.936 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.487 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 64.8 m-85 -92.07 108.53 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.986 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CD1' ' OD1' ' A' ' 25' ' ' ASP . 1.7 p90 -153.23 120.37 5.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.79 27.01 2.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.2 p 49.72 51.86 15.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.08 0.467 . . . . 0.0 110.999 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.526 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.1 m-90 -66.73 -62.71 1.31 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.009 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.8 t 161.86 144.75 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.758 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.07 -112.43 3.65 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.676 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HA ' HD11 ' A' ' 37' ' ' ILE . 91.1 Cg_exo -43.66 -71.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.953 2.435 . . . . 0.0 113.413 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.8 p -48.78 -24.19 1.33 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -84.15 -73.07 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.784 0.326 . . . . 0.0 111.863 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 83.6 mtp -66.28 -34.07 77.16 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.552 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 1.4 mp -90.52 24.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.186 0.517 . . . . 0.0 111.207 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.413 ' N ' ' CD ' ' A' ' 39' ' ' PRO . . . -90.15 -52.35 0.33 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.85 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 43' ' ' LYS . 34.0 Cg_exo -62.47 -32.18 80.45 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.649 2.233 . . . . 0.0 113.009 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.496 ' HE2' ' HA ' ' A' ' 37' ' ' ILE . 42.4 mtm -57.56 -77.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.918 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 42' ' ' GLU . 2.6 pp -56.0 -27.41 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.758 0.313 . . . . 0.0 111.044 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.447 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 89.1 tt0 -75.2 -28.13 59.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.029 0.443 . . . . 0.0 110.512 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' PRO . 22.9 ttpp -83.37 -48.6 10.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.427 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -50.52 -27.12 6.07 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.845 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . . . -55.59 -28.67 56.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.957 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.92 -14.77 33.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.108 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -85.4 10.08 13.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.571 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.42 153.26 40.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.755 0.312 . . . . 0.0 110.823 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -80.91 -40.34 24.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.968 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -134.52 95.79 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.068 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -143.4 121.75 12.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.2 98.39 9.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.371 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 10.6 m-85 -91.64 129.11 37.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.31 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 22' ' ' VAL . 17.6 m-30 -114.09 107.13 15.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.89 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -89.77 125.43 35.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.437 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.444 HD12 ' CE1' ' A' ' 26' ' ' PHE . 86.7 mt -130.62 156.74 44.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.067 0.46 . . . . 0.0 111.53 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.54 117.96 15.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.238 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.74 74.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.074 0.464 . . . . 0.0 111.2 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 t70 179.89 -69.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.135 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -78.63 -31.03 46.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.886 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.415 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 25.1 t -113.47 30.69 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.878 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.1 p -49.03 -26.89 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.345 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -44.62 -55.36 5.26 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.523 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -59.58 -46.4 93.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.001 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.91 -34.21 58.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.431 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -54.95 -69.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.08 -47.54 85.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.5 80.38 9.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.37 111.23 1.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.423 HG22 ' CD2' ' A' ' 26' ' ' PHE . 48.7 t -119.08 145.63 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -144.5 70.15 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.031 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.4 m -165.46 -175.61 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.697 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.465 ' CB ' ' CZ3' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -170.02 106.66 0.44 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.672 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -74.66 -155.64 1.06 Allowed 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 124.1 -1.208 . . . . 0.0 111.99 -0.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 86.9 m -164.22 108.23 0.96 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.8 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 3.9 mp -123.56 119.3 29.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.423 HD13 ' CZ ' ' A' ' 79' ' ' TYR . 26.3 pt -110.37 152.8 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.017 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -127.03 122.84 35.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.051 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.445 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 68.7 m-85 -109.68 136.99 48.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.21 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -118.11 -36.45 3.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.311 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.98 49.57 0.8 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.906 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.54 28.0 66.9 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.777 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -145.94 114.28 6.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.751 0.31 . . . . 0.0 110.962 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 11.9 pt-20 -58.08 123.94 17.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.662 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.4 m -136.04 -44.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.494 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 94.3 m -103.33 105.36 15.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 110.619 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -103.49 147.86 26.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.455 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 48.4 t -138.28 82.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.798 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.4 t -109.54 62.78 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.11 127.05 1.42 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.259 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.25 124.68 17.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.774 0.321 . . . . 0.0 111.049 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -176.15 103.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.612 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.439 ' O ' ' CG2' ' A' ' 96' ' ' ILE . 11.2 Cg_endo -56.2 -13.98 10.9 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.652 2.235 . . . . 0.0 113.23 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -96.91 -44.56 6.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.69 -31.18 15.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 110.625 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 93' ' ' PRO . 4.2 tp -58.03 -44.84 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.05 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -61.32 -75.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.934 0.397 . . . . 0.0 111.2 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -44.66 -32.92 1.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.542 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -68.98 -41.74 77.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.405 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.96 -44.34 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.338 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.57 -13.48 59.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.6 p -90.14 -26.32 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 49.8 m-80 -114.72 -19.43 11.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.658 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.614 -179.176 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.835 0.35 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 59.4 t -48.23 121.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.61 170.51 7.89 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.249 0.547 . . . . 0.0 110.974 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -111.71 98.17 7.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.001 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.432 HD22 ' CG ' ' A' ' 54' ' ' TYR . 5.4 mp -88.98 119.61 29.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.845 0.355 . . . . 0.0 111.168 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -107.86 -69.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.906 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.6 t -84.56 162.86 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.13 -29.45 60.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.3 p -59.67 -33.39 71.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.05 -31.58 70.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.417 ' CE1' HD22 ' A' ' 15' ' ' LEU . 45.4 t80 -90.14 -36.37 14.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.61 -54.64 44.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -67.81 -20.12 65.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.279 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.59 -53.27 19.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.215 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD22 ' CE1' ' A' ' 11' ' ' TYR . 85.1 mt -58.63 -28.85 66.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.11 -58.87 2.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.356 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -55.96 -72.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.98 129.37 47.36 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.646 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -125.23 22.9 7.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.655 0.264 . . . . 0.0 111.17 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -96.54 -75.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.811 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 104' ' ' VAL . 20.3 tp -159.09 107.33 1.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.965 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t -103.57 112.91 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.623 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.9 114.68 43.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.584 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 54.8 t -100.28 145.1 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.399 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 38.3 t70 -127.07 92.76 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 0.0 111.595 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.416 ' CE1' HD21 ' A' ' 56' ' ' LEU . 72.6 m-85 -88.84 94.87 10.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.832 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 5.3 p90 -129.69 122.24 28.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.421 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -93.24 79.45 4.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.363 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.7 t -48.1 94.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.983 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.54 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.8 m-90 -92.06 -48.65 6.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 44.7 t 150.02 58.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.935 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.19 -121.9 0.58 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.655 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.416 ' O ' HG12 ' A' ' 37' ' ' ILE . 32.0 Cg_exo -57.13 -73.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.392 2.061 . . . . 0.0 112.192 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 6.0 p -41.54 -32.06 0.32 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -65.18 -47.36 77.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.039 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.2 mtp -84.81 -23.2 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.395 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 33' ' ' PRO . 49.0 mm -75.53 -7.55 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.425 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.503 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -63.77 -63.98 3.37 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.503 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 72.3 Cg_exo -48.64 -38.49 36.6 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.323 2.015 . . . . 0.0 112.905 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 64.1 mtt -52.5 -82.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.15 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.432 HD11 ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -56.38 -26.98 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.16 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' N ' HD11 ' A' ' 41' ' ' ILE . 89.4 tt0 -72.24 -25.85 61.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.399 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -85.89 -48.25 8.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.017 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -54.06 -27.46 32.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' HB1' ' CG ' ' A' ' 53' ' ' PHE . . . -56.8 -27.35 59.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.811 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -89.96 -10.78 43.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.095 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -90.08 16.85 7.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.668 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 100' ' ' ILE . 37.3 m-85 -131.88 158.37 41.54 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.9 m -95.63 -33.78 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -136.39 77.76 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.76 116.63 18.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.85 94.79 9.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.957 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.412 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 9.8 m-85 -90.03 128.55 36.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.638 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CG ' HD22 ' A' ' 5' ' ' LEU . 18.6 m-30 -114.91 96.12 5.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.982 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -89.79 120.88 31.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.333 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 3.6 mp -129.79 -175.94 3.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.471 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -137.12 -82.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p 177.83 -37.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.744 0.307 . . . . 0.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -98.22 -31.46 12.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.45 -38.01 82.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.831 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.3 t -103.81 -50.82 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.845 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.1 t 68.24 -63.92 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.46 -67.4 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.471 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.4 t -57.41 -61.03 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.029 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.89 -28.9 2.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.387 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -76.02 -62.23 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.739 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -60.35 -29.44 68.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.492 ' N ' ' HD3' ' A' ' 67' ' ' LYS . . . -88.25 80.79 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.895 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -53.75 95.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -86.94 157.77 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.273 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.6 p -149.6 128.52 12.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.73 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.4 m 62.43 82.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.933 0.397 . . . . 0.0 110.553 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.455 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 38.2 mtp -84.3 152.32 61.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.617 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.07 173.28 53.0 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 123.63 -1.404 . . . . 0.0 112.71 0.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.0 m -147.86 132.25 17.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.607 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.444 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.1 mp -124.59 142.31 51.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.207 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -139.36 147.47 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.833 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.481 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.6 m-85 -117.87 121.3 40.37 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.051 0.453 . . . . 0.0 111.435 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 61.2 m-85 -109.65 130.4 55.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.002 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.61 53.53 1.83 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.219 0.533 . . . . 0.0 109.924 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.21 41.4 0.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.146 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.34 37.03 86.26 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.078 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -151.09 107.76 3.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.69 0.281 . . . . 0.0 111.242 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 44.4 tt0 -58.77 126.82 29.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.169 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.3 m -138.67 -46.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 71.5 p -113.4 77.88 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.126 0.489 . . . . 0.0 111.045 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -80.7 158.84 25.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.147 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 60.0 t -141.52 85.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.697 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 89' ' ' VAL . 35.1 m -109.26 78.06 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.139 0.495 . . . . 0.0 111.294 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.99 148.05 16.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.325 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.26 76.38 7.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.872 0.367 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -156.48 125.6 3.08 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.58 -6.89 20.1 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.49 2.127 . . . . 0.0 112.79 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.51 -36.32 12.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.0 110.94 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.14 -28.08 6.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.159 0.504 . . . . 0.0 110.204 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.455 HD13 HG23 ' A' ' 96' ' ' ILE . 6.1 tt -80.92 -33.03 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.729 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.43 -61.05 2.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -75.69 -5.92 47.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.641 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -89.7 -43.94 10.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.797 0.332 . . . . 0.0 111.244 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.418 HD12 ' CE2' ' A' ' 48' ' ' TYR . 63.0 mt -74.13 -53.81 16.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.782 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.28 -20.94 31.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.652 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.9 p -82.95 -75.52 0.31 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.664 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -52.72 -37.82 59.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.118 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 21' ' ' LEU . 14.8 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.485 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.861 0.363 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.495 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 59.6 t -57.57 145.18 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 m -107.84 158.62 17.17 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.638 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -96.71 92.6 6.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.423 ' CD2' ' HB3' ' A' ' 54' ' ' TYR . 4.8 mp -88.9 109.94 20.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.704 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -104.53 -55.65 2.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.34 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.0 t -101.49 151.68 21.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.55 67.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.5 p -55.87 -31.31 62.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -69.23 -36.73 77.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.757 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -60.66 -40.94 93.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.85 -65.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -57.8 -24.6 58.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.019 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.95 -54.8 42.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.449 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 80.8 mt -82.92 1.39 39.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.332 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.06 -74.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.786 0.327 . . . . 0.0 111.245 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.1 p -71.83 -34.42 69.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.08 119.08 7.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.573 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.78 26.69 5.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.02 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -93.96 -70.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.687 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.436 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 4.2 tt -174.86 105.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.368 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 49.3 t -99.82 132.62 44.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.82 115.48 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.142 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.418 HG11 ' CE2' ' A' ' 26' ' ' PHE . 47.2 t -99.96 117.79 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.711 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -106.94 99.44 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.442 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 53.8 m-85 -90.41 111.24 22.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.999 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.41 ' CE1' ' O ' ' A' ' 56' ' ' LEU . 1.7 p90 -144.56 120.02 10.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.615 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.415 ' CB ' ' NE1' ' A' ' 30' ' ' TRP . . . -85.57 10.33 13.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.538 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.8 p 49.65 51.01 17.29 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.017 0.437 . . . . 0.0 111.204 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.529 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.3 m-90 -67.12 -62.31 1.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.971 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.4 t 160.48 127.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.461 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.25 -118.78 4.08 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.314 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.33 -43.57 27.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.601 2.201 . . . . 0.0 112.81 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 26.3 p -69.96 63.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 0.0 111.268 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 35' ' ' LYS . 7.2 ttpm? 176.1 -53.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.486 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.0 tpt -84.09 -30.05 26.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.6 mt -86.87 -30.43 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.984 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.37 -52.63 41.37 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.55 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.24 -43.5 37.07 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.039 1.826 . . . . 0.0 111.495 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.822 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 71.0 mtp -60.33 -22.04 62.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.994 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.3 mt -91.62 -55.78 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.151 0.5 . . . . 0.0 110.085 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' HG2' ' CG2' ' A' ' 2' ' ' VAL . 3.9 tm-20 -54.94 -57.06 13.18 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.72 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.513 ' HB3' ' NZ ' ' A' ' 43' ' ' LYS . 5.4 ttpm? -49.62 -47.97 49.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.075 0.464 . . . . 0.0 110.465 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.822 ' CD1' ' O ' ' A' ' 40' ' ' MET . 7.1 m-85 -54.59 -23.93 18.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.192 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -58.46 -28.14 65.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.031 0.444 . . . . 0.0 110.678 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -89.7 -11.25 42.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.068 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.03 15.57 9.86 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.608 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.428 ' CD1' HG22 ' A' ' 100' ' ' ILE . 42.3 m-85 -125.68 145.45 50.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.839 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.8 p -66.54 -47.06 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -143.7 99.26 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.988 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.14 122.7 16.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.03 97.66 11.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 8.6 m-85 -89.89 126.2 35.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.883 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 19.3 m-30 -119.37 104.18 10.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.54 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.79 123.5 33.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.091 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.41 ' O ' ' CE1' ' A' ' 27' ' ' PHE . 86.4 mt -128.72 158.93 37.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.855 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -145.69 -176.58 5.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -90.54 158.85 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.067 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 t70 67.22 -70.0 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -55.6 -30.37 60.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.98 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.2 t -137.72 53.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.967 0.413 . . . . 0.0 110.936 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.6 t -71.44 -28.68 64.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -58.36 -40.25 81.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.055 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.4 t -75.8 -52.85 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.83 -39.41 58.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.21 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -60.87 -31.78 71.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.815 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -81.55 -47.4 13.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.789 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.86 77.66 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.121 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.6 118.12 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.818 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.73 150.75 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.221 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.7 m -133.78 57.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.98 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 m -141.84 -169.38 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.548 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.435 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.1 ptp -166.11 91.59 0.83 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.447 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.66 -163.79 3.09 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 124.063 -1.224 . . . . 0.0 112.393 -0.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 89.8 m -133.48 118.04 17.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.586 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.2 mp -123.74 137.23 54.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.847 0.356 . . . . 0.0 111.278 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.7 pt -133.72 162.72 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.834 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.461 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.0 m-85 -132.41 128.64 37.97 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 111.242 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 71.2 m-85 -109.89 158.82 17.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.742 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -156.6 73.46 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.794 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.28 -18.65 23.12 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.505 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.01 48.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.26 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -169.96 127.64 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.995 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.66 98.69 5.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.3 m -110.75 -28.32 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.364 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 99.7 m -114.84 103.3 10.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.918 0.389 . . . . 0.0 110.269 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -107.36 157.67 17.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.266 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -155.27 81.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.717 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.64 106.14 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.333 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.06 -113.43 0.29 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.426 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -178.19 77.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 111.035 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -151.86 129.35 5.74 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.438 ' CB ' ' CE ' ' A' ' 40' ' ' MET . 87.0 Cg_endo -82.39 9.59 3.94 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.635 2.223 . . . . 0.0 113.021 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.91 -50.78 3.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.732 0.301 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.96 -27.93 14.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 110.614 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.4 tp -54.14 -43.47 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.194 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -71.92 -71.51 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.031 0.443 . . . . 0.0 111.129 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -44.2 -32.19 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.583 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.24 -51.39 15.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.181 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.428 HG22 ' CD1' ' A' ' 48' ' ' TYR . 66.4 mt -76.26 -5.14 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.496 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.55 -24.61 21.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 0.0 111.38 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -89.98 -59.38 2.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.31 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -54.62 -43.1 71.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.101 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.373 -179.396 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.858 0.361 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.63 137.44 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.672 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.5 m -89.94 168.05 12.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 110.871 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -108.51 94.8 5.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.886 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.439 HD22 ' CD2' ' A' ' 54' ' ' TYR . 4.9 mp -88.96 132.05 34.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.205 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.61 -62.85 0.95 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 t -86.19 152.98 22.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.17 -28.84 64.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.327 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.5 p -57.42 -30.41 64.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.058 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -74.34 -37.64 63.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.47 -52.43 65.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.22 -56.03 27.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.057 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -57.8 -28.72 64.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.028 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.42 76.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.135 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.47 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 78.3 mt -67.96 -40.34 83.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.044 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.0 -46.45 62.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.204 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.5 m -75.78 -53.43 8.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.057 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.06 115.26 7.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.599 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -113.14 -31.89 6.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.71 0.29 . . . . 0.0 111.039 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.91 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.997 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.425 ' CD1' ' HB2' ' A' ' 103' ' ' ASN . 41.5 tp -159.65 115.98 2.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.457 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 54.2 t -111.72 106.34 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.832 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.8 t -102.92 144.12 14.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.31 146.54 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -135.84 111.8 9.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.944 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -105.44 113.56 27.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.198 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.41 ' HB2' ' CB ' ' A' ' 34' ' ' CYS . 2.1 p90 -147.92 120.72 8.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.721 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.84 9.92 8.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.686 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.2 p 50.57 55.51 9.4 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.059 0.457 . . . . 0.0 111.058 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.534 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.2 m-90 -71.81 -61.88 1.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.014 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 39.6 t 158.85 101.77 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.467 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.84 -126.69 2.51 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.279 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 35' ' ' LYS . 92.4 Cg_exo -42.73 -60.61 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.962 2.441 . . . . 0.0 113.234 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 26.9 p -65.85 66.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.357 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 56.6 tptt 176.14 -35.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.3 mtt -81.84 -65.89 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.684 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.16 18.69 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.415 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -63.42 -53.37 53.0 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.648 0.261 . . . . 0.0 110.663 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 43' ' ' LYS . 52.3 Cg_exo -55.58 -33.07 85.58 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.64 2.227 . . . . 0.0 112.21 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.44 ' CE ' ' HB3' ' A' ' 93' ' ' PRO . 67.3 mtp -54.82 -71.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 110.468 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.6 pt -52.44 -39.25 28.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.094 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.28 -27.52 65.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.64 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -79.72 -45.84 18.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -53.62 -25.04 15.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.546 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -55.79 -29.97 60.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.732 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -87.63 -3.12 58.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.877 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -90.27 -35.24 15.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.542 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.425 ' CD2' HG21 ' A' ' 100' ' ' ILE . 45.7 m-85 -76.49 157.29 32.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.798 0.332 . . . . 0.0 111.183 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.4 p -79.98 -38.36 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -155.38 104.07 2.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.133 0.492 . . . . 0.0 111.403 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 53' ' ' PHE . . . -150.13 125.69 10.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.104 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.32 107.46 19.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 110.771 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 45' ' ' ALA . 9.3 m-85 -99.96 130.79 46.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.004 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.457 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 20.5 m-30 -113.9 119.73 38.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -104.11 115.02 29.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.883 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.408 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 89.7 mt -134.68 170.7 15.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.237 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.28 153.59 46.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.644 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.09 55.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.986 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -177.46 -65.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.054 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.53 -30.65 61.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.036 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 51.2 t -102.13 -58.84 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.814 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.9 t 67.35 -64.64 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.393 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -40.6 -68.39 0.18 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.828 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.13 -44.21 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.163 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.31 56.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -57.15 -68.24 0.25 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.988 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.94 -25.37 57.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.72 74.49 7.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.311 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.0 mp0 -69.89 105.97 3.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.762 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.2 m -132.95 -178.58 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.8 p -164.48 72.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.819 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -157.54 -170.17 3.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.609 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.8 ptt? -165.81 98.56 0.76 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.192 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.76 -155.43 1.06 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.261 -1.141 . . . . 0.0 112.129 0.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.7 m -155.65 100.66 2.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.587 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 3.9 mp -113.85 162.79 15.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.917 0.389 . . . . 0.0 111.256 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.1 pt -156.89 160.18 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.82 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 1.3 m-85 -128.68 123.05 32.16 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.984 0.421 . . . . 0.0 111.368 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.47 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 69.8 m-85 -109.91 101.79 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.831 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.97 -70.53 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 110.732 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.39 27.32 7.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.368 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.08 49.82 1.69 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.364 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -169.82 114.96 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.334 . . . . 0.0 110.882 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -55.62 99.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.6 m -121.38 -28.99 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.799 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.43 ' O ' ' CD1' ' A' ' 78' ' ' PHE . 89.1 m -122.44 74.99 1.21 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 110.649 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -82.37 159.6 23.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.2 0.524 . . . . 0.0 111.643 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -156.72 86.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.085 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 m -108.61 87.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.37 0.605 . . . . 0.0 111.28 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.36 -152.06 7.09 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.968 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.42 92.75 2.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.795 0.331 . . . . 0.0 110.998 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -144.53 101.21 4.7 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.071 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.44 ' HB3' ' CE ' ' A' ' 40' ' ' MET . 32.1 Cg_exo -58.52 -15.14 23.76 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.553 2.169 . . . . 0.0 112.431 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.62 -31.49 13.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 110.83 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.86 -31.33 64.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.797 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.406 ' CG2' ' O ' ' A' ' 93' ' ' PRO . 3.8 tp -53.76 -33.87 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.072 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -68.29 -67.7 0.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.118 0.485 . . . . 0.0 110.832 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -53.72 -49.48 68.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.492 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.25 -65.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.625 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.425 HG21 ' CD2' ' A' ' 48' ' ' TYR . 41.2 mm -52.33 -48.57 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.41 -21.8 17.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.856 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.5 m -57.55 -50.09 74.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.491 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.425 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 21.1 m-80 -122.84 5.56 9.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.621 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.623 -179.212 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.801 0.334 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 43.9 t -55.94 132.27 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.945 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -107.13 168.71 9.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 110.803 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -108.41 98.99 8.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.156 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 54' ' ' TYR . 63.2 mt -88.81 96.05 10.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.252 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -89.88 -57.06 2.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.882 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.4 t -95.38 158.43 15.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.32 -29.33 62.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.083 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.4 p -57.75 -31.34 66.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -71.19 -31.32 67.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -76.21 -42.64 45.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -70.13 -50.17 43.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -58.97 -28.64 66.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -64.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.203 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.444 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 81.9 mt -57.44 -21.87 39.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.17 -79.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.446 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.7 m -83.43 -29.62 27.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.197 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.1 104.3 0.23 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.673 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -86.99 -27.38 23.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 0.0 110.705 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -53.62 -176.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.973 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 100' ' ' ILE . 4.8 tt -86.11 115.84 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.698 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.447 ' CG1' ' CD2' ' A' ' 54' ' ' TYR . 56.5 t -102.99 127.2 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.644 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.401 ' CG2' ' CD2' ' A' ' 21' ' ' LEU . 46.3 t -120.12 119.61 60.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.368 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.9 t -104.77 124.84 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.482 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -117.21 103.77 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.919 0.39 . . . . 0.0 111.612 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.454 ' CE1' HD11 ' A' ' 56' ' ' LEU . 75.1 m-85 -93.88 115.28 27.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.948 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.467 ' CD2' ' CG2' ' A' ' 29' ' ' THR . 1.1 p90 -150.19 117.96 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 111.212 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.36 -9.53 58.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.893 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.467 ' CG2' ' CD2' ' A' ' 27' ' ' PHE . 69.4 p 52.73 74.08 0.31 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.361 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.542 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.0 m-90 -80.92 -62.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 43.6 t 158.86 69.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.459 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.4 -121.11 0.78 Allowed Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.927 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.16 -52.1 6.02 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.702 2.268 . . . . 0.0 112.562 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.5 p -79.77 60.87 3.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.727 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -162.99 -47.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.392 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.2 tpt -83.56 -26.79 29.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.53 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 HG22 HD13 ' A' ' 37' ' ' ILE . 63.1 mt -79.96 -15.69 13.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.204 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.433 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -52.48 -60.08 7.21 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.403 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 86.2 Cg_exo -46.93 -36.03 19.44 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.369 2.046 . . . . 0.0 112.605 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.403 ' HB3' ' HB3' ' A' ' 93' ' ' PRO . 55.1 mtt -57.5 -76.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.577 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.408 ' CD1' ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -60.23 -24.39 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.908 0.385 . . . . 0.0 110.861 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.408 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 89.4 tt0 -75.53 -26.58 58.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.489 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.47 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 6.6 tmtm? -85.7 -48.3 8.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.177 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.424 ' CG ' HD12 ' A' ' 96' ' ' ILE . 7.4 m-85 -46.33 -29.8 1.81 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.214 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.9 -26.32 14.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -90.06 -30.34 17.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.993 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -62.07 -35.68 79.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.326 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.412 ' CE2' HG23 ' A' ' 100' ' ' ILE . 46.7 m-85 -97.13 155.59 16.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 110.761 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -106.61 -21.77 12.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.309 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -125.52 35.32 4.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.764 0.316 . . . . 0.0 111.454 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.8 118.16 36.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.282 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.67 95.84 10.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.437 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 13.5 m-85 -89.69 123.34 33.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.607 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CD2' ' CG1' ' A' ' 22' ' ' VAL . 14.7 m-30 -115.82 102.81 10.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.806 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -89.83 124.11 34.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.571 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 26' ' ' PHE . 86.2 mt -119.36 146.86 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.293 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -134.39 161.42 35.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.548 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.1 m -77.67 156.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.198 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.1 t0 66.03 -72.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.222 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.44 -30.85 61.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.109 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -139.95 55.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.4 m -80.48 -22.08 41.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -47.21 -29.76 2.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.292 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.43 -54.85 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.993 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.43 -35.56 19.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.421 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -58.45 -45.24 88.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.765 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -89.51 -65.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.62 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.66 77.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.822 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -50.86 93.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.18 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.0 t -148.83 136.28 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.814 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.3 p -105.21 150.13 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.534 ' O ' ' HB2' ' A' ' 73' ' ' MET . 60.4 p -61.01 -173.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.904 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.607 ' H ' ' HA ' ' A' ' 74' ' ' PRO . 60.3 ttp 167.52 -38.11 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.607 ' HA ' ' H ' ' A' ' 73' ' ' MET . 94.0 Cg_endo -76.57 175.26 48.97 Favored 'Cis proline' 0 C--N 1.36 1.157 0 CA-C-N 120.67 1.275 . . . . 0.0 113.812 0.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.3 m -127.89 135.82 50.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.764 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.1 mp -129.93 146.18 51.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.906 0.384 . . . . 0.0 111.231 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 pt -143.15 159.86 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.812 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.3 m-85 -129.57 126.87 39.51 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 111.505 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.444 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 67.5 m-85 -109.69 153.62 24.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.752 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -114.89 -38.78 3.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.975 0.417 . . . . 0.0 110.454 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.77 28.44 0.31 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.067 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.1 42.28 2.1 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.278 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -165.31 109.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.674 0.273 . . . . 0.0 111.13 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.04 115.49 3.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.443 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 m -126.34 -43.2 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 64.5 p -112.31 83.41 1.8 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.151 0.5 . . . . 0.0 110.795 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -83.09 166.17 18.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.592 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.424 HG22 ' CE1' ' A' ' 78' ' ' PHE . 45.8 t -156.72 87.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.967 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.3 m -108.76 107.7 23.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.16 0.505 . . . . 0.0 111.337 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.77 -118.95 0.47 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.19 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 177.77 56.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.796 0.331 . . . . 0.0 111.133 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -146.28 134.27 10.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.122 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.531 ' O ' HG12 ' A' ' 96' ' ' ILE . 57.1 Cg_endo -73.67 -19.32 21.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.413 2.075 . . . . 0.0 112.158 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.04 62.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.801 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.11 -39.85 12.62 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.511 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 93' ' ' PRO . 21.2 pt -59.74 -35.38 59.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.888 0.375 . . . . 0.0 110.822 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -55.23 -70.41 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.948 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -59.94 -29.87 68.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -64.45 -42.81 95.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.064 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.417 ' HA ' HD13 ' A' ' 21' ' ' LEU . 75.5 mt -82.34 -31.84 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.63 -27.55 65.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.028 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.7 p -58.28 -58.22 9.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.081 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -128.06 54.54 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.035 179.865 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.867 0.365 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.6 t -83.63 136.84 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.8 p -105.01 172.17 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.476 0.655 . . . . 0.0 111.764 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -127.16 107.99 10.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.626 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' A' ' 54' ' ' TYR . 80.6 mt -89.16 88.37 7.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.007 0.432 . . . . 0.0 111.362 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.96 -43.55 10.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.198 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.4 t -105.58 137.41 43.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.783 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.15 -25.86 24.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.416 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -59.17 -28.75 66.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.037 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.92 -26.28 48.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -78.54 -54.3 6.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.127 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -57.32 -59.86 4.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -57.18 -25.52 59.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.279 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.58 -61.91 1.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.792 0.33 . . . . 0.0 111.373 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.424 HD22 ' CD2' ' A' ' 79' ' ' TYR . 87.9 mt -53.64 -24.59 14.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.233 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.07 -68.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.309 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.9 m -60.06 -63.51 1.27 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.42 121.9 24.39 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.732 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -124.01 -1.04 8.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -69.29 -76.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.716 0.293 . . . . 0.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.422 ' CD2' ' CG2' ' A' ' 23' ' ' VAL . 3.7 tt -167.5 110.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 60.2 t -102.34 132.6 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' CG2' ' CD2' ' A' ' 21' ' ' LEU . 47.8 t -134.37 118.29 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.277 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.461 ' CG1' ' CE2' ' A' ' 26' ' ' PHE . 43.5 t -99.98 123.09 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.452 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -110.86 87.81 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.591 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.461 ' CE2' ' CG1' ' A' ' 24' ' ' VAL . 60.6 m-85 -82.14 112.22 18.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.809 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -133.32 117.06 16.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.952 0.406 . . . . 0.0 111.324 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' O ' ' CD2' ' A' ' 30' ' ' TRP . . . -94.43 107.22 19.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.583 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.8 p -53.7 114.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.1 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.448 ' CD2' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -179.56 42.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -176.54 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.156 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 152.37 -44.51 0.63 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.219 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 82.7 Cg_exo -45.56 -63.62 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.572 2.181 . . . . 0.0 112.746 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.7 p -49.48 -45.53 46.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -58.5 -36.99 74.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.123 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.2 tpt -73.36 -26.51 61.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 40.9 mm -90.37 27.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.361 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.431 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -86.82 -54.98 0.37 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.084 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 43' ' ' LYS . 40.9 Cg_exo -57.31 -33.12 95.58 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.423 2.082 . . . . 0.0 112.298 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.402 ' CE ' ' HG3' ' A' ' 93' ' ' PRO . 57.4 mtt -60.56 -75.56 0.06 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 0.0 110.485 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.445 HG23 HD12 ' A' ' 41' ' ' ILE . 12.9 pt -51.57 -30.18 10.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.188 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -78.82 -30.71 45.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.463 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 39' ' ' PRO . 87.9 tttt -84.31 -38.26 20.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -48.24 -25.35 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.773 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 53' ' ' PHE . . . -55.27 -32.35 62.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.15 0.5 . . . . 0.0 110.587 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -85.28 -5.1 59.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -90.14 -51.62 5.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.299 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.439 ' CE2' HG13 ' A' ' 100' ' ' ILE . 50.5 m-85 -79.74 172.41 13.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.174 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.2 p -105.56 -29.68 10.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.241 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -148.72 80.17 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.435 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.447 ' CB ' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.44 124.54 36.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.208 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.45 106.79 18.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.041 0.448 . . . . 0.0 110.688 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.589 ' CE2' ' HA ' ' A' ' 45' ' ' ALA . 21.6 m-85 -99.9 119.44 38.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.232 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.463 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 15.1 m-30 -111.24 96.56 6.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.048 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -89.83 110.55 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.448 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 3.8 mp -118.78 157.87 26.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 0.0 111.485 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -129.78 162.31 28.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.353 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.94 -32.47 58.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.432 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -97.82 -62.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.147 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -52.44 -26.06 11.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.15 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.0 t -133.77 60.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.3 t -81.11 0.66 35.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.415 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -90.04 -49.1 6.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 111.041 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -59.58 -51.53 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.18 -29.52 1.6 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.639 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -63.95 -71.32 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.001 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -65.48 -42.6 92.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.04 76.78 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -58.42 100.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.88 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.6 t -141.79 157.38 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.151 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -86.91 -173.99 4.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.84 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.454 ' C ' ' HA ' ' A' ' 74' ' ' PRO . 81.1 p -167.18 79.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.011 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.647 ' N ' ' CA ' ' A' ' 74' ' ' PRO . 23.2 ptp -115.85 8.05 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.647 ' CA ' ' N ' ' A' ' 73' ' ' MET . 73.0 Cg_endo -83.04 -167.33 5.51 Favored 'Cis proline' 0 C--N 1.361 1.225 0 CA-C-N 121.442 1.551 . . . . 0.0 112.62 -0.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 96.4 m -140.98 133.93 29.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.977 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.1 mp -124.96 115.51 20.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.842 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.458 HG22 HD13 ' A' ' 77' ' ' ILE . 29.4 pt -109.88 158.68 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.762 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.592 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -131.15 131.4 44.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.397 . . . . 0.0 111.217 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 83.9 m-85 -109.36 141.57 41.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.674 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -122.17 68.01 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 0.0 110.77 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.85 26.75 13.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.207 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.6 53.43 2.27 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.364 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -176.54 122.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.43 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 52.1 mt-10 -65.76 138.47 57.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.647 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 m -157.19 -39.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.527 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 88.0 m -105.73 106.93 17.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.951 0.405 . . . . 0.0 110.116 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -104.23 149.52 25.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.584 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.6 t -154.55 81.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.534 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.64 111.12 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.21 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -117.57 0.42 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.29 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -178.23 71.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 0.0 111.049 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 49.8 t30 -150.93 139.31 12.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.661 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 92' ' ' ASN . 18.9 Cg_exo -65.01 -24.86 59.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.414 2.076 . . . . 0.0 112.275 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.53 -27.19 27.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.925 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.39 -27.61 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.093 0.473 . . . . 0.0 110.213 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 93' ' ' PRO . 5.8 tt -90.06 -38.23 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.771 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -61.81 -57.68 10.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.718 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.44 -13.68 61.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.625 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . . . -84.72 -60.61 2.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.787 0.327 . . . . 0.0 111.535 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.439 HG13 ' CE2' ' A' ' 48' ' ' TYR . 46.3 mm -47.48 -41.85 7.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.139 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.07 -23.4 46.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.218 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -55.72 -65.43 0.6 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -131.87 65.66 1.57 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.09 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.052 179.839 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.548 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 8.7 p -63.77 156.92 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.066 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.6 174.29 6.35 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 111.119 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -125.79 105.96 9.34 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.926 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 54' ' ' TYR . 63.0 mt -88.89 127.47 35.64 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.103 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.682 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 8.8 mmpt? -118.15 -50.42 2.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.759 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.2 t -102.57 159.92 15.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.192 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.73 -29.93 65.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.9 p -56.02 -30.77 62.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.867 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -70.41 -30.62 67.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.766 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.441 ' CZ ' ' CD1' ' A' ' 15' ' ' LEU . 45.6 t80 -75.37 -46.6 32.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.001 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.26 -50.55 45.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -56.65 -23.26 40.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.488 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.423 ' HB3' ' CE2' ' A' ' 54' ' ' TYR . . . -84.09 -60.24 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.518 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.441 ' CD1' ' CZ ' ' A' ' 11' ' ' TYR . 86.0 mt -52.06 -25.52 8.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.162 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.64 -55.73 4.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.2 m -90.39 23.3 3.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.396 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.63 149.59 22.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.438 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -156.3 -46.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -58.55 -75.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 103' ' ' ASN . 28.5 tp -167.47 120.69 0.94 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.808 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 61.8 t -111.56 124.52 68.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.2 t -128.32 126.22 65.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 57.5 t -112.09 114.0 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.804 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.417 ' OD1' ' HG ' ' A' ' 76' ' ' LEU . 24.3 m-20 -111.42 102.78 11.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.237 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.418 ' CE1' HD12 ' A' ' 56' ' ' LEU . 49.6 m-85 -91.7 107.99 19.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.997 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -149.01 121.27 8.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.623 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.26 20.12 4.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.586 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p 49.7 55.84 8.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 111.112 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.499 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.5 m-90 -71.24 -61.74 1.66 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.214 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 43.1 t 164.38 129.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.521 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.81 -122.54 5.38 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.031 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.37 -47.45 5.9 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.56 2.173 . . . . 0.0 112.721 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.5 p -52.25 -23.88 6.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.6 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -107.76 -37.56 6.1 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.423 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.3 tpt -76.27 -40.38 51.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 111.351 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.436 HD11 HG21 ' A' ' 37' ' ' ILE . 59.9 mt -79.0 -1.06 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.661 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.504 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -51.44 -63.3 2.1 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 74.7 Cg_exo -50.28 -35.37 43.5 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.213 1.942 . . . . 0.0 113.237 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' A' ' 93' ' ' PRO . 60.7 mtp -65.49 -69.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.621 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.652 HD12 ' HG2' ' A' ' 42' ' ' GLU . 2.4 pp -56.35 -20.28 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.217 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.652 ' HG2' HD12 ' A' ' 41' ' ' ILE . 3.7 mm-40 -86.95 -32.95 19.84 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.1 ttpt -78.27 -44.32 25.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.158 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.19 -32.04 71.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.584 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -54.06 -27.76 34.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.016 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.01 -34.61 16.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.739 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -58.87 -27.83 65.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.073 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CE2' HD11 ' A' ' 100' ' ' ILE . 44.6 m-85 -81.78 155.76 25.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.893 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.5 m -89.24 -32.08 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -151.92 96.87 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.09 112.42 4.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.82 106.93 18.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.172 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.548 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 2.1 m-85 -89.91 124.6 34.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.463 ' HB3' ' CD1' ' A' ' 5' ' ' LEU . 17.8 m-30 -112.43 90.52 3.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.486 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -89.84 156.51 18.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.225 0.536 . . . . 0.0 111.791 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.418 HD12 ' CE1' ' A' ' 26' ' ' PHE . 93.6 mt -151.43 -177.7 6.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.636 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -149.15 133.3 17.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.754 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -74.76 60.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.077 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.7 t70 178.82 -63.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.621 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -59.37 -30.13 68.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.78 -58.29 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.048 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 t 68.0 -62.44 0.35 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.423 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -43.71 -61.57 1.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.765 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.11 -57.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.808 0.337 . . . . 0.0 111.212 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.99 -31.62 0.95 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.787 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -60.26 -58.64 7.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.876 0.37 . . . . 0.0 110.674 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.42 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.503 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.71 79.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.76 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.25 122.86 9.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.243 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.08 127.92 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.9 m -134.96 45.14 2.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.6 t -146.36 -163.48 1.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.687 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.472 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.9 ptm -171.35 92.67 0.43 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.405 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 69.4 Cg_endo -86.11 -163.52 2.78 Favored 'Cis proline' 0 C--N 1.349 0.6 0 C-N-CA 124.132 -1.195 . . . . 0.0 112.427 0.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 91.9 m -138.98 106.72 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.437 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 2.4 mp -118.84 128.58 54.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.302 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.44 HD11 ' CE2' ' A' ' 79' ' ' TYR . 2.4 pp -128.57 173.0 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.886 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.602 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 8.2 m-85 -135.0 120.44 19.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.746 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 47.2 m-85 -109.8 137.9 46.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.522 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -106.04 -59.74 1.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 0.0 110.753 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.42 29.52 3.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.141 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.54 35.65 3.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.229 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -151.88 124.2 8.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 111.142 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.4 tt0 -78.94 98.6 6.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.549 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.75 -37.49 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.684 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 74.7 m -109.79 110.79 21.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.221 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -122.6 145.07 48.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.593 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 30.5 m -139.86 83.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.714 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 32.8 m -109.44 66.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.294 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -144.9 17.2 1.97 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.523 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.13 56.45 5.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.349 . . . . 0.0 111.127 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.49 101.19 34.36 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.198 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.408 ' HG3' ' CD1' ' A' ' 37' ' ' ILE . 8.3 Cg_exo -71.28 -17.41 30.98 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.726 2.284 . . . . 0.0 112.195 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.77 -43.44 5.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.51 -28.42 8.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.228 0.537 . . . . 0.0 110.186 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.6 tt -60.79 -29.34 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.778 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 97' ' ' LYS . 5.2 tmtm? -55.69 -58.33 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.434 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -72.61 -36.07 68.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.06 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.84 81.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.221 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.417 HD11 ' CE2' ' A' ' 48' ' ' TYR . 63.5 mt -75.04 -37.68 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.133 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.07 -19.17 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.891 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 64.0 m -90.04 -38.55 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 111.581 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.41 ' HB3' HD11 ' A' ' 21' ' ' LEU . 26.8 t-20 -83.66 -39.42 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.428 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.402 ' N ' HD11 ' A' ' 21' ' ' LEU . 11.9 p . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.339 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.8 tpp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.896 0.379 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.9 t -149.43 110.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.817 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 p -89.72 170.75 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.497 0.665 . . . . 0.0 111.658 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.524 ' NE2' ' N ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -127.97 120.18 27.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.592 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.437 HD12 ' CD2' ' A' ' 54' ' ' TYR . 72.5 mt -88.96 96.21 10.63 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.194 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -89.93 -47.04 8.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.507 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.5 t -104.04 142.33 34.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.79 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.46 -24.69 21.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.299 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.6 p -59.58 -43.9 93.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -62.87 -25.68 68.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.873 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.423 ' CZ ' HD12 ' A' ' 15' ' ' LEU . 50.9 t80 -90.05 -46.92 8.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.069 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -60.33 -62.94 1.5 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.034 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -55.41 -26.32 41.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.97 -61.3 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.433 HD23 ' CD2' ' A' ' 79' ' ' TYR . 85.2 mt -54.03 -24.7 18.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.155 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.66 -74.74 0.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.231 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -64.77 -48.12 75.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.054 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.68 102.52 0.17 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.601 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -112.21 -22.69 10.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.616 0.246 . . . . 0.0 111.188 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -54.2 -72.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.131 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 103' ' ' ASN . 52.4 tp -171.38 106.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.939 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 59.4 t -105.09 127.97 59.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.045 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.67 133.8 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.868 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 47.5 t -114.83 122.17 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.209 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -114.5 121.62 44.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.59 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.445 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 69.5 m-85 -107.83 127.88 54.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.247 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CZ ' ' HE3' ' A' ' 55' ' ' LYS . 2.2 p90 -146.44 114.77 6.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.548 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.428 ' CB ' ' NE1' ' A' ' 30' ' ' TRP . . . -89.4 16.95 6.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.578 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p 49.97 52.94 13.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.94 0.4 . . . . 0.0 111.471 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.543 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.1 m-90 -73.74 -60.94 2.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.981 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.5 t 154.0 134.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.672 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.93 -105.15 3.16 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.681 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -43.12 -62.9 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.883 2.389 . . . . 0.0 113.112 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.4 p -70.9 62.99 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.769 0.318 . . . . 0.0 111.062 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.4 tptt 177.89 -56.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.8 ttt -55.37 -71.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.235 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.511 HG21 HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -90.26 40.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.237 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.441 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -80.6 -57.07 0.63 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.875 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.441 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 53.2 Cg_exo -55.13 -26.2 49.57 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.222 1.948 . . . . 0.0 112.053 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 63.6 mtt -60.29 -73.39 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.728 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -57.42 -26.52 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.989 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.441 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 4.2 tm-20 -77.32 -30.33 54.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.202 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -82.39 -43.01 17.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.05 -29.34 43.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.197 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.89 -26.72 26.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.034 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -90.02 -29.31 18.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.797 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -66.05 -14.74 62.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.543 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -92.27 161.96 14.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.772 0.32 . . . . 0.0 111.029 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -78.38 -43.67 26.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -155.69 106.28 2.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.118 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.18 127.56 16.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.856 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.69 102.27 14.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.489 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 7.0 m-85 -92.61 116.13 28.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.037 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.462 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 12.3 m-30 -106.55 90.94 3.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.172 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.448 ' HE3' ' CZ ' ' A' ' 27' ' ' PHE . 63.5 tttp -89.79 106.69 18.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.161 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 4.1 mp -110.34 141.03 43.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.803 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -80.7 -80.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 p 178.31 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.962 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -103.77 -33.63 8.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.773 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.11 -30.03 67.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.82 -65.83 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.03 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.1 t 68.42 -64.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.236 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -46.91 -61.0 2.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.411 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.5 t -55.75 -56.29 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.172 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.87 -31.45 28.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.315 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -70.9 -28.74 64.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -86.26 -78.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.402 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.92 81.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.267 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.28 143.72 57.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.809 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 m -156.31 144.79 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.4 p -124.24 68.23 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.984 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.7 m -144.23 176.36 9.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.477 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 67.9 mtm -157.18 96.97 2.06 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.89 -161.88 2.81 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.947 -1.272 . . . . 0.0 112.273 -0.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 91.3 m -140.32 112.88 7.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.652 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.0 mp -120.09 142.85 48.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.0 pt -139.24 162.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.431 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 2.3 m-85 -132.28 127.52 35.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.95 0.405 . . . . 0.0 111.329 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.433 ' CD2' HD23 ' A' ' 15' ' ' LEU . 60.1 m-85 -109.93 140.03 44.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.696 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -110.5 -31.96 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.837 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.97 27.75 0.35 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.2 33.96 6.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.373 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.555 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -154.32 102.04 2.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.328 . . . . 0.0 110.781 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 39.5 tt0 -53.64 97.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.078 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.77 -31.21 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.322 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 94.6 m -116.29 101.02 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.234 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -108.68 146.91 32.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.057 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.3 t -136.55 80.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.757 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.0 m -109.95 103.88 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.232 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.02 -109.45 0.22 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.395 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.16 81.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.31 . . . . 0.0 110.904 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -160.09 112.72 1.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.746 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' O ' ' CG2' ' A' ' 96' ' ' ILE . 63.9 Cg_exo -52.26 -22.72 16.2 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.629 2.219 . . . . 0.0 112.734 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.56 -30.46 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.98 -27.28 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.019 0.438 . . . . 0.0 110.402 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 96' ' ' ILE . 6.1 tt -82.65 -35.13 12.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.832 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -69.43 -62.81 1.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.003 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -59.32 -20.3 53.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.349 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -90.11 -40.68 12.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.57 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.404 HG12 ' HB ' ' A' ' 104' ' ' VAL . 12.0 tt -75.61 -28.05 19.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.743 0.306 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.05 89.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.384 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.8 m -73.22 -24.05 60.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.289 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 21' ' ' LEU . 5.6 m120 -92.58 -61.78 1.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.404 ' HB ' HG12 ' A' ' 100' ' ' ILE . 11.2 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.886 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.895 0.378 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.425 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 55.4 t -63.86 106.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 p -98.96 177.17 5.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.54 0.686 . . . . 0.0 111.73 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -130.52 107.46 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.674 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 3.6 mp -89.18 101.21 13.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.078 0.466 . . . . 0.0 111.462 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -89.91 -37.6 14.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.871 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.6 t -111.77 141.09 45.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.06 -23.7 14.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.403 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.5 p -59.74 -45.22 92.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.115 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -61.67 -26.02 67.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -90.07 -49.47 6.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -57.1 -67.06 0.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 t -56.09 -24.35 39.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.099 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.21 -57.22 11.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.226 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.6 mt -56.2 -26.98 52.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.98 -29.94 18.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.252 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -87.36 -60.51 1.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.038 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.99 114.42 4.54 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.653 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -112.32 -30.18 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.738 0.304 . . . . 0.0 110.924 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -59.17 -76.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.942 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 103' ' ' ASN . 25.9 tp -156.28 116.66 3.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.983 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 59.2 t -107.93 135.37 46.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.56 143.99 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.006 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.03 112.45 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.91 129.82 48.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.456 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 58.2 m-85 -114.64 134.6 54.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.356 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.466 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 1.8 p90 -150.72 113.36 4.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.549 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.97 23.31 2.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.566 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 79.9 p 49.65 49.33 20.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.852 0.358 . . . . 0.0 111.428 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.457 ' CZ2' ' HG2' ' A' ' 73' ' ' MET . 2.5 m-90 -67.96 -60.46 2.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.6 t -163.87 -104.97 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.685 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -101.1 -34.64 4.49 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.619 -0.8 . . . . 0.0 114.69 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 76.1 Cg_exo -41.95 -32.13 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.311 2.007 . . . . 0.0 113.27 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.411 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 26.1 p -97.19 -42.15 7.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.389 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -81.67 0.39 38.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 32' ' ' GLY . 16.2 tpt -90.24 -55.34 3.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.858 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.9 pt -90.28 36.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.511 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -75.98 -54.85 2.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.906 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 41.9 Cg_exo -56.7 -29.46 80.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.328 2.019 . . . . 0.0 111.993 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 59.2 mtt -59.42 -75.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.67 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -62.19 -23.42 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.126 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' N ' HD11 ' A' ' 41' ' ' ILE . 5.4 tp10 -77.95 -27.69 49.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.595 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -87.69 -42.42 12.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -48.03 -27.57 2.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.467 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.36 -30.01 17.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.603 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -89.97 -31.34 17.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.082 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -63.01 -31.5 72.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.43 ' CE2' HG13 ' A' ' 100' ' ' ILE . 42.7 m-85 -100.58 146.67 26.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.094 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.2 m -85.94 -32.12 21.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.7 p-10 -134.16 85.17 2.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.82 118.43 16.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.749 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.87 105.25 17.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.275 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.425 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 7.4 m-85 -102.25 128.62 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.557 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -113.37 112.26 23.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.442 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.466 ' HE3' ' CE1' ' A' ' 27' ' ' PHE . 52.9 tptt -89.78 112.1 23.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.471 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.443 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 90.4 mt -123.46 150.45 43.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 111.655 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -132.75 150.16 52.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.177 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.68 81.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.574 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -179.97 -92.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.728 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -27.28 62.97 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.784 0.326 . . . . 0.0 110.666 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 32.5 t -112.8 35.04 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 t -51.39 -24.97 5.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -50.87 -55.28 17.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.312 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.2 t -66.77 -59.31 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.07 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.97 -28.25 2.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.514 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -58.44 -55.48 34.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -73.96 -33.64 63.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.52 64.62 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.02 112.68 4.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.45 -178.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.6 m -157.41 80.61 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.6 p -173.22 179.0 2.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.457 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 58.9 mtm -152.51 102.29 2.74 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.686 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.86 -158.38 1.67 Allowed 'Cis proline' 0 C--N 1.348 0.534 0 C-N-CA 124.405 -1.081 . . . . 0.0 112.361 0.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 88.8 m -145.85 96.86 2.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.418 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.1 mp -109.66 140.57 43.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.004 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.425 HD13 ' CZ ' ' A' ' 79' ' ' TYR . 22.6 pt -133.87 162.08 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.412 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.3 m-85 -127.16 125.2 40.74 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.111 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 63.3 m-85 -109.49 164.49 12.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.938 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -168.69 60.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.071 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.72 40.59 0.71 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.026 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.0 34.45 83.49 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.872 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -148.76 117.15 6.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.827 0.346 . . . . 0.0 111.118 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.44 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.3 tt0 -73.73 144.67 45.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.679 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.7 m -151.7 -46.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.701 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 96.5 m -104.4 116.44 32.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.11 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -123.98 127.9 48.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.311 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 32.2 m -118.98 84.69 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.163 0.506 . . . . 0.0 110.495 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 89' ' ' VAL . 34.8 m -109.14 99.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.394 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.1 -109.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.529 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 178.48 78.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.327 . . . . 0.0 111.176 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -155.02 128.43 4.39 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.71 -13.53 24.52 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.509 2.139 . . . . 0.0 112.753 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.09 -48.59 4.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.181 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.5 -30.29 3.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.234 0.54 . . . . 0.0 110.188 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.0 tt -66.63 -50.58 65.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.177 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HD2' ' O ' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -53.35 -54.16 40.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.369 . . . . 0.0 110.684 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.405 ' NE2' ' CE ' ' A' ' 97' ' ' LYS . 99.2 mm-40 -49.22 -26.53 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.523 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.57 -27.51 22.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.597 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.43 HG13 ' CE2' ' A' ' 48' ' ' TYR . 48.1 mm -68.23 -59.28 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.373 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.86 -14.99 38.82 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.3 m -81.26 -29.5 34.37 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.44 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 36.8 m-80 -122.25 -9.42 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 100' ' ' ILE . 10.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.467 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.83 0.348 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 47.2 t -57.69 137.17 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 m -111.28 151.21 28.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.932 0.396 . . . . 0.0 110.955 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -91.55 97.99 11.39 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD21 ' CG ' ' A' ' 54' ' ' TYR . 4.9 mp -88.93 134.89 33.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.0 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -126.1 -64.78 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.5 t -91.44 148.47 22.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.065 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.74 69.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 m -56.88 -33.47 66.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.73 -25.17 58.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -82.29 -61.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.391 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -55.57 -58.58 7.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.46 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.0 t -56.79 -28.32 61.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.332 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.58 76.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 0.0 111.338 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.06 -44.14 97.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.083 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.1 -28.95 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.509 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 t -56.64 -78.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.212 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.96 136.16 13.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.627 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -85.9 -6.8 59.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.675 0.274 . . . . 0.0 111.252 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -54.7 -175.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.807 0.337 . . . . 0.0 110.962 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 27.1 tp -79.25 107.56 12.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.817 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -99.79 127.97 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.698 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 78' ' ' PHE . 48.9 t -137.02 133.75 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.552 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.426 ' HB ' HG12 ' A' ' 77' ' ' ILE . 40.6 t -103.24 160.4 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.255 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.424 ' OD2' ' CE1' ' A' ' 27' ' ' PHE . 38.3 t70 -137.53 89.57 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.417 ' CZ ' HG13 ' A' ' 24' ' ' VAL . 61.2 m-85 -96.36 111.17 23.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.607 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 0.5 OUTLIER -138.64 -44.99 0.49 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.412 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . 61.87 87.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 110.867 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.9 p -57.69 115.1 2.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.824 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.569 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.1 m-90 -101.61 -59.3 1.72 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 52.4 t 160.3 46.11 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.97 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.59 -118.08 0.42 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.783 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 35' ' ' LYS . 75.4 Cg_exo -49.73 -69.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.495 2.13 . . . . 0.0 112.336 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 10.2 p -61.26 75.85 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.375 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 33' ' ' PRO . 17.3 tppt? 175.72 -42.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.851 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.8 ttm -67.77 -49.01 64.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.224 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.41 ' CD1' ' C ' ' A' ' 37' ' ' ILE . 2.0 pp -90.22 25.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.001 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.41 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -78.44 -54.18 1.21 Allowed Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.627 0.251 . . . . 0.0 111.036 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 51.7 Cg_exo -55.12 -36.69 93.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.529 2.153 . . . . 0.0 112.226 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 60.6 mtt -54.16 -75.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.545 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 pt -51.15 -43.62 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.307 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -64.05 -33.18 75.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.772 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -77.05 -45.91 25.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.572 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.443 ' CG ' HD11 ' A' ' 96' ' ' ILE . 6.9 m-85 -56.03 -32.24 63.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.039 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' CG ' ' A' ' 53' ' ' PHE . . . -50.29 -27.8 6.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.329 0.585 . . . . 0.0 109.723 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -77.93 -38.78 44.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.746 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -58.02 -38.04 75.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.519 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CE2' HG23 ' A' ' 100' ' ' ILE . 32.4 m-85 -75.58 170.53 15.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.37 . . . . 0.0 110.925 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.8 m -116.55 -19.77 9.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.495 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -145.24 47.71 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.802 0.334 . . . . 0.0 111.465 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.6 119.16 38.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.553 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.73 96.46 10.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 110.881 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.492 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 6.5 m-85 -90.37 126.15 35.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.882 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.426 ' CG ' HD21 ' A' ' 5' ' ' LEU . 18.8 m-30 -121.78 107.6 12.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.376 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.456 ' NZ ' ' HB2' ' A' ' 55' ' ' LYS . 4.9 ttmp? -89.78 120.02 30.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.935 0.398 . . . . 0.0 111.173 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.4 mt -138.01 135.68 36.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.812 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -112.64 -178.06 3.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.662 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.26 65.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 111.099 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -178.35 -60.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.357 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -75.76 -23.6 55.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.81 40.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.791 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 t -53.76 -26.21 22.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.267 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.95 -50.83 72.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.027 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.7 t -72.24 -55.33 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.147 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.83 -28.88 2.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.444 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -60.83 -46.73 89.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.846 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -81.77 -47.29 13.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.771 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.11 79.45 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.58 114.86 5.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.934 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -135.63 125.26 41.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.2 t -112.32 92.98 4.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.986 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -177.76 -74.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.705 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 61.7 mtt 57.67 102.45 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.734 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.48 167.77 31.68 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.833 0.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 26' ' ' PHE . 71.6 m -154.87 132.41 11.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.355 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.1 mp -131.16 136.55 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 111.667 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.426 HG12 ' HB ' ' A' ' 24' ' ' VAL . 28.2 pt -133.13 150.68 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.977 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.51 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.1 m-85 -125.94 132.47 52.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.093 0.473 . . . . 0.0 111.267 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.441 ' CE1' ' HG2' ' A' ' 84' ' ' GLU . 84.1 m-85 -109.51 114.35 27.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.151 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -72.18 -75.26 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.799 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.59 33.68 3.87 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.023 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.52 27.42 4.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.176 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -158.24 150.29 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 91.5 mt-10 -82.39 97.02 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.14 -27.09 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.291 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 97.7 m -117.21 103.4 10.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.942 0.401 . . . . 0.0 110.069 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -103.29 155.24 18.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.363 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t -155.5 80.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.614 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -109.55 112.38 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.994 0.426 . . . . 0.0 111.279 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.59 -116.42 0.37 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.36 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -176.51 40.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.81 0.338 . . . . 0.0 111.074 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -130.43 134.08 25.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.526 ' O ' HG12 ' A' ' 96' ' ' ILE . 34.0 Cg_endo -66.62 -56.24 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.361 2.04 . . . . 0.0 112.655 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -40.65 -31.97 0.19 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.21 -22.86 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.591 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 93' ' ' PRO . 9.2 pt -76.35 -35.35 27.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.922 0.391 . . . . 0.0 110.929 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -56.1 -68.79 0.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.359 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.49 -34.57 77.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.624 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.98 -43.12 68.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.818 0.342 . . . . 0.0 111.454 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.417 HG23 ' CE2' ' A' ' 48' ' ' TYR . 74.2 mt -84.76 -18.82 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.21 -23.37 21.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.752 0.31 . . . . 0.0 111.569 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.4 m -89.99 -65.75 0.99 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.83 0.348 . . . . 0.0 111.482 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.64 -29.18 16.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.456 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.287 -179.786 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtm . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.775 0.322 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.489 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 13.7 p -54.42 144.1 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -124.14 159.23 30.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.063 0.459 . . . . 0.0 110.933 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -102.0 100.0 10.22 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.438 HD23 ' CD2' ' A' ' 54' ' ' TYR . 5.5 mp -88.83 109.36 20.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.806 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -96.25 -66.37 0.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -85.04 150.92 24.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.301 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.74 -28.68 70.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.095 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.1 t -55.88 -35.84 66.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.36 -40.9 94.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.516 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -67.76 -55.76 11.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.929 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.58 -56.3 23.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.9 t -57.03 -29.1 63.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.92 -61.05 2.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.215 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.465 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 79.6 mt -59.51 -26.72 65.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.004 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.03 -70.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.225 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -74.78 -27.25 60.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.87 169.66 1.66 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.691 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -177.36 -37.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 111.075 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -51.84 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.418 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 4.9 tt -172.73 108.24 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.753 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 60.6 t -100.79 132.06 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.688 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.404 ' CG2' ' CD2' ' A' ' 21' ' ' LEU . 46.6 t -125.6 122.24 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.384 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.421 HG12 ' CE2' ' A' ' 26' ' ' PHE . 49.4 t -105.19 129.92 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.53 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -116.74 106.67 13.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.022 0.439 . . . . 0.0 111.488 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.483 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 77.4 m-85 -99.24 101.29 12.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.226 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.446 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 4.5 p90 -127.22 105.96 8.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.499 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -96.14 73.67 2.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.444 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.452 ' C ' ' O ' ' A' ' 28' ' ' ALA . 68.3 p -23.91 105.72 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.502 ' CZ3' ' HB2' ' A' ' 73' ' ' MET . 3.2 m-90 -113.63 -54.75 2.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.2 m -123.15 -2.15 8.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.109 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.651 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 88.4 23.33 37.41 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.769 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 62.3 Cg_endo -75.53 -50.62 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.87 1.713 . . . . 0.0 111.941 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.8 m -63.82 -37.37 87.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -64.19 -26.96 68.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.19 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 57.4 ttp -58.47 -62.0 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.0 110.988 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.3 pt -90.35 31.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.707 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.464 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -78.93 -59.38 0.64 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.122 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 65.0 Cg_exo -52.07 -35.15 60.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.335 2.023 . . . . 0.0 112.298 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.44 ' CE ' ' HB2' ' A' ' 93' ' ' PRO . 66.0 mtp -57.27 -74.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.668 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 pt -48.52 -42.07 12.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.76 0.314 . . . . 0.0 111.211 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -67.07 -33.75 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.487 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -73.83 -44.75 54.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.111 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -55.77 -27.48 51.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.777 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.55 -29.37 50.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.75 -30.46 23.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.589 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -64.69 -25.81 68.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.24 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -79.6 176.28 9.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.861 0.363 . . . . 0.0 110.941 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.8 m -97.89 -36.67 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.788 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -149.84 90.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.61 129.31 34.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.837 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.53 93.27 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.228 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 7.4 m-85 -90.08 131.26 36.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.31 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CD2' HD23 ' A' ' 5' ' ' LEU . 20.0 m-30 -119.37 129.83 55.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.856 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HB2' ' CG2' ' A' ' 2' ' ' VAL . 87.3 tttt -103.5 145.28 30.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.68 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.475 ' CD1' ' CE1' ' A' ' 26' ' ' PHE . 88.1 mt -143.73 140.0 29.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.37 -175.72 3.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.94 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.7 t -82.93 151.73 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 7.4 t70 63.36 132.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 39.2 tt0 73.63 -54.77 0.68 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.151 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 36.6 t -95.03 2.29 9.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.536 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.1 m -63.81 -30.23 71.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.782 0.325 . . . . 0.0 111.005 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -51.41 -25.85 6.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.4 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.4 ' CG1' HD12 ' A' ' 56' ' ' LEU . 36.2 t -68.7 -54.61 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.047 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.99 70.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.21 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -56.45 -67.65 0.28 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.986 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -57.59 -37.72 73.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.01 78.04 6.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.822 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -53.5 102.2 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.426 ' CG1' ' CG2' ' A' ' 75' ' ' THR . 44.5 t -138.94 152.51 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.996 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.3 p -143.82 116.14 8.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.54 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.477 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 41.2 t 179.32 -163.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.222 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.502 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 18.3 ptm 178.41 93.76 0.15 Allowed Pre-proline 0 N--CA 1.463 0.187 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.85 -161.61 2.61 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.354 -0.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 19.1 m -146.66 115.82 6.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.05 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.43 ' HB2' ' CG2' ' A' ' 88' ' ' VAL . 5.2 mp -126.58 115.7 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.935 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.416 HD13 ' CE2' ' A' ' 79' ' ' TYR . 28.6 pt -116.03 164.98 11.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.438 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.0 m-85 -133.86 131.03 38.71 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.038 0.447 . . . . 0.0 111.403 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.465 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 75.0 m-85 -109.89 152.33 25.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.625 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -116.15 -38.08 3.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.811 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.71 31.87 0.22 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.282 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.99 37.45 2.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.281 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -161.48 118.7 2.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -73.64 110.57 8.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.312 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.9 -37.46 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.452 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 72.3 m -107.14 111.67 24.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.798 0.332 . . . . 0.0 110.322 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -125.42 152.21 45.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.186 0.517 . . . . 0.0 111.556 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 28.5 m -138.67 88.29 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.219 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 31.1 m -109.25 94.45 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.333 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.87 -112.77 0.62 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.206 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.09 55.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.861 0.362 . . . . 0.0 111.125 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -144.85 126.37 7.83 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.195 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.44 ' HB2' ' CE ' ' A' ' 40' ' ' MET . 81.4 Cg_endo -79.21 2.62 8.16 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.663 2.242 . . . . 0.0 112.64 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.32 -39.48 10.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.008 0.432 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.14 -30.33 70.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.681 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.438 ' CD1' ' N ' ' A' ' 97' ' ' LYS . 2.2 pp -57.43 -32.91 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 50.0 tttm -54.27 -69.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.731 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -62.55 -21.64 65.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 78' ' ' PHE . . . -59.66 -54.03 51.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.47 HD13 ' N ' ' A' ' 100' ' ' ILE . 2.0 mp -75.51 -35.62 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.576 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.26 68.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.308 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.8 m -57.02 -74.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.12 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -105.15 62.03 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.993 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.007 179.831 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.518 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 10.8 mmt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.8 0.333 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.7 t -50.49 111.09 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.926 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.1 m -103.47 160.38 14.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 111.241 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -104.65 94.45 5.31 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.418 HD23 ' CG ' ' A' ' 54' ' ' TYR . 5.2 mp -88.96 132.32 34.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -130.13 -64.15 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -77.71 143.08 38.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.105 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.75 -29.26 70.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.8 p -55.51 -30.64 61.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -77.41 -38.26 50.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.606 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -72.21 -42.44 65.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.032 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -58.22 -68.17 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.061 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.5 p -55.66 -26.08 42.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.04 -53.07 62.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.243 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.442 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 84.7 mt -69.35 -30.83 68.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.7 -54.55 15.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.212 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -90.36 24.64 2.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.457 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.12 142.45 16.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.449 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -151.48 -46.6 0.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.635 0.255 . . . . 0.0 110.832 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -57.05 -76.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.803 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.432 ' CD1' ' HB3' ' A' ' 103' ' ' ASN . 41.7 tp -177.23 109.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.136 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 54' ' ' TYR . 48.1 t -103.86 117.23 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.744 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.47 122.94 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 61.1 t -109.05 126.24 66.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -122.54 107.0 11.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.526 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 52.6 m-85 -93.34 98.86 11.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.355 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.3 p90 -134.24 121.86 21.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.245 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.16 21.95 3.01 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.7 p 46.88 73.25 0.19 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.856 0.36 . . . . 0.0 110.986 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.517 ' CH2' ' HB2' ' A' ' 73' ' ' MET . 0.0 OUTLIER -146.96 62.26 1.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.153 0.501 . . . . 0.0 112.334 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.1 t 60.29 155.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.508 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.71 178.57 20.12 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.636 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HG2' ' HD3' ' A' ' 74' ' ' PRO . 6.1 Cg_endo -49.63 -22.6 6.85 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.866 2.377 . . . . 0.0 112.548 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.5 p -51.86 -39.99 59.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.877 0.37 . . . . 0.0 111.077 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -87.28 -32.07 19.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.033 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.25 -41.16 70.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.018 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 48.8 mt -90.43 21.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.481 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.482 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -73.1 -58.21 2.6 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 121.239 -0.184 . . . . 0.0 111.106 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.482 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 36.3 Cg_exo -58.28 -35.74 98.4 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.343 2.029 . . . . 0.0 112.002 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 62.5 mtt -54.4 -76.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.4 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.433 HG22 HD13 ' A' ' 41' ' ' ILE . 12.6 pt -49.9 -43.34 19.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.286 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' N ' HG13 ' A' ' 41' ' ' ILE . 39.6 tt0 -63.9 -31.78 73.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.771 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.491 ' HB3' ' NZ ' ' A' ' 43' ' ' LYS . 6.2 ttpm? -84.55 -55.21 4.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.636 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.423 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 11.5 m-85 -49.92 -28.11 6.23 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.851 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.25 -28.15 39.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.037 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -89.7 -33.61 16.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.983 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.27 -27.05 68.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.271 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.447 ' CE1' HG23 ' A' ' 100' ' ' ILE . 44.4 m-85 -82.95 157.05 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 111.014 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -82.12 -37.22 26.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -154.5 101.86 2.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.974 0.416 . . . . 0.0 111.149 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.48 124.1 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.973 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.98 106.22 18.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.289 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -92.52 112.17 24.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.224 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.418 ' CG ' HD23 ' A' ' 5' ' ' LEU . 16.7 m-30 -114.73 102.48 10.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.824 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -89.87 130.55 36.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 HD11 ' CE1' ' A' ' 26' ' ' PHE . 90.2 mt -130.63 149.58 52.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.861 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -120.75 159.29 25.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.99 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.406 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 48.5 t -104.61 160.09 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 58' ' ' VAL . 8.1 t0 69.23 -63.07 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -60.96 -29.7 69.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.626 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.3 t -98.97 -57.23 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.767 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.4 t 68.18 -62.77 0.35 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.481 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.96 -47.54 8.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.643 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.01 -61.88 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.32 -30.35 0.81 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.375 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -57.3 -55.27 36.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.725 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -65.86 -63.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.55 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.407 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . . . -75.49 76.79 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -49.65 119.1 3.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.255 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.7 t -90.33 137.35 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.0 t -143.16 48.58 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 111.359 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.1 p -179.31 178.2 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.584 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.517 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 20.7 ptt? -150.09 100.25 3.23 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.582 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HD3' ' HG2' ' A' ' 33' ' ' PRO . 95.5 Cg_endo -78.24 -163.58 3.47 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.931 -1.279 . . . . 0.0 112.388 -0.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 32.5 m -143.47 97.17 3.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.988 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 2.4 mp -109.87 135.66 50.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.006 0.431 . . . . 0.0 111.656 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.403 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 25.5 pt -132.35 166.18 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.478 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.3 m-85 -131.52 125.93 33.63 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 111.679 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.442 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 60.8 m-85 -111.56 153.64 25.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.366 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -127.83 -58.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.704 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.75 -14.16 8.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.476 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.97 41.58 0.12 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.261 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -162.29 127.71 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.965 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.407 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 88.7 tt0 -69.63 95.96 0.9 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.746 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.88 -32.92 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.156 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 98.9 m -113.02 103.39 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 110.091 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -106.43 159.66 15.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.574 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.1 t -155.57 83.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.389 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -109.22 77.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.199 0.523 . . . . 0.0 111.264 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.73 -112.15 0.83 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.067 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 171.57 93.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.629 0.252 . . . . 0.0 110.86 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -173.5 131.59 0.57 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.968 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.99 -20.29 22.64 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.634 2.223 . . . . 0.0 112.812 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.55 -35.32 19.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.57 0.224 . . . . 0.0 111.228 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.07 -28.86 4.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.157 0.504 . . . . 0.0 110.049 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.3 tt -90.03 -37.97 10.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.427 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.0 -71.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.975 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -56.68 -22.95 38.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.041 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.412 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -77.21 -67.3 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.123 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.447 HG23 ' CE1' ' A' ' 48' ' ' TYR . 37.1 mm -51.99 -35.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.18 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.7 -71.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 111.683 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.3 m -61.22 -24.75 66.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.602 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 21' ' ' LEU . 5.7 m120 -80.63 -62.47 1.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' A' ' 100' ' ' ILE . 13.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.763 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.6 mtp . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.794 0.33 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.5 t 60.05 116.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.048 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 m -93.81 169.25 10.44 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.146 0.498 . . . . 0.0 110.84 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -110.12 91.45 3.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.186 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.434 HD22 ' CG ' ' A' ' 54' ' ' TYR . 6.6 mp -88.97 136.21 33.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.024 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -130.32 -58.22 1.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.5 t -96.74 142.5 28.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.053 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.83 -27.35 65.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.181 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 t -56.61 -38.07 71.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.31 -36.04 80.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.401 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 49.1 t80 -66.8 -47.68 71.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.972 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -58.45 -60.17 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -57.23 -24.63 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.93 -40.56 72.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.284 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 79' ' ' TYR . 83.9 mt -90.17 15.04 11.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.576 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.11 -90.57 0.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.752 -0.203 . . . . 0.0 111.038 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.8 p -90.4 19.14 5.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.625 0.25 . . . . 0.0 111.374 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 19' ' ' ASP . . . -70.2 -74.45 0.67 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.716 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 1.4 m-20 79.77 -41.81 0.24 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.589 0.355 . . . . 0.0 111.365 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -54.03 -174.48 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.454 HD22 HG22 ' A' ' 23' ' ' VAL . 7.5 tt -77.39 99.06 5.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.979 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.457 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 60.8 t -105.58 111.94 36.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.101 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.476 HG23 ' CD2' ' A' ' 78' ' ' PHE . 46.8 t -119.32 139.58 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.808 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -113.51 128.96 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.497 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 36.5 t70 -112.29 101.51 9.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.962 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.449 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 64.4 m-85 -92.52 107.95 19.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 1.4 p90 -153.01 121.38 6.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.356 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.06 17.41 2.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.663 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.1 p 49.66 55.13 9.85 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.049 0.452 . . . . 0.0 110.945 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.517 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.7 m-90 -69.41 -62.21 1.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.192 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 40.4 t 164.29 140.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.85 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.47 -120.73 6.35 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.537 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.418 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 89.1 Cg_exo -43.07 -70.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.822 2.348 . . . . 0.0 112.863 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.9 p -48.29 -26.64 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 111.423 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -85.66 -72.37 0.49 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.791 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.0 mtt -59.51 -22.24 61.34 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 33' ' ' PRO . 55.8 mt -89.97 -11.03 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.511 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -54.1 -65.23 1.33 Allowed Pre-proline 0 C--N 1.331 -0.215 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.32 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 78.0 Cg_exo -50.29 -36.29 46.67 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.133 1.888 . . . . 0.0 112.616 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.408 ' SD ' ' CB ' ' A' ' 93' ' ' PRO . 56.2 mtt -59.11 -78.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.071 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.696 HD12 ' HG3' ' A' ' 42' ' ' GLU . 2.4 pp -56.34 -24.76 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.131 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.696 ' HG3' HD12 ' A' ' 41' ' ' ILE . 43.3 mt-10 -77.35 -30.5 53.9 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.004 0.431 . . . . 0.0 109.902 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -79.48 -45.21 19.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.145 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.429 ' CG ' HD11 ' A' ' 96' ' ' ILE . 10.1 m-85 -60.32 -29.53 68.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.635 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.36 -31.01 53.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.916 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -84.57 -32.14 23.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.507 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.2 -28.47 69.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.017 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.465 ' CZ ' ' HB ' ' A' ' 100' ' ' ILE . 39.0 m-85 -78.78 148.69 32.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.953 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -80.02 -34.72 38.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -146.27 92.91 2.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.07 123.04 19.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.968 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.65 93.98 7.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.164 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.96 127.93 36.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.124 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.457 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 14.9 m-30 -113.5 108.25 16.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.858 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -89.9 120.85 31.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.729 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.42 HD12 ' CE1' ' A' ' 26' ' ' PHE . 90.3 mt -131.31 145.57 51.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.263 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -106.99 161.21 14.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.57 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.11 -27.42 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.229 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.67 -60.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.168 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.49 -40.12 77.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.185 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -112.87 48.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.012 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.4 t -62.08 -31.33 71.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -49.15 -45.67 44.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.204 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.414 HG12 ' CZ ' ' A' ' 26' ' ' PHE . 47.2 t -73.51 -56.27 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.966 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.34 -52.87 15.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.721 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -50.25 -59.1 4.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -54.65 -73.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.037 0.446 . . . . 0.0 110.706 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.69 68.16 7.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.522 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -44.27 135.66 4.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.551 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.87 159.28 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.923 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.7 p -146.21 80.17 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.116 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -178.56 -161.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.613 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 20.3 ptt? -177.28 94.16 0.24 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.404 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 69.3 Cg_endo -88.26 -160.21 1.51 Allowed 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.239 -1.15 . . . . 0.0 112.32 -0.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 51.5 m -139.9 115.73 10.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.834 0.349 . . . . 0.0 110.954 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 3.9 mp -120.93 115.24 22.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.977 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.4 pt -109.92 157.52 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.668 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.492 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 3.0 m-85 -130.83 125.53 33.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 111.774 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.421 ' CE2' HD11 ' A' ' 15' ' ' LEU . 71.5 m-85 -110.13 150.59 28.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.898 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.04 -22.17 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.136 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.62 31.31 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.27 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.81 44.58 5.11 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.368 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -164.45 107.48 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.382 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -56.93 115.33 2.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.496 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 m -128.02 -48.56 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.492 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 46.4 p -105.2 82.78 1.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.207 0.527 . . . . 0.0 111.0 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.408 ' NH2' HG21 ' A' ' 89' ' ' VAL . 7.2 ptm180 -97.53 142.27 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.633 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 32.8 m -139.75 88.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.542 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.408 HG21 ' NH2' ' A' ' 87' ' ' ARG . 26.0 m -108.98 109.71 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.524 . . . . 0.0 111.128 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.2 -96.2 0.1 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.302 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 176.44 70.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 110.979 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -137.29 88.14 17.51 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.408 ' CB ' ' SD ' ' A' ' 40' ' ' MET . 24.3 Cg_exo -63.55 -14.44 42.53 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.773 2.315 . . . . 0.0 112.487 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.46 -31.3 14.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 110.96 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.1 -23.82 67.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.206 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.429 HD11 ' CG ' ' A' ' 44' ' ' PHE . 21.9 pt -56.34 -38.81 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.933 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.427 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -49.46 -55.91 11.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.605 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -68.59 -25.9 65.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.812 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.429 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -70.5 -57.41 4.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.144 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.465 ' HB ' ' CZ ' ' A' ' 48' ' ' TYR . 3.1 mp -75.54 -5.7 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.237 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.96 -28.75 18.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.702 0.287 . . . . 0.0 111.377 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 m -90.05 -67.0 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 111.408 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -46.86 -32.6 3.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.545 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.417 -179.438 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.432 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 46.0 t -74.86 129.4 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.965 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 m -120.89 149.74 42.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.994 0.426 . . . . 0.0 110.966 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -89.9 109.72 20.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 54' ' ' TYR . 70.3 mt -88.83 104.77 17.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 110.868 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 11.1 mmpt? -89.94 -47.46 7.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.028 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.3 t -104.89 147.41 27.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.245 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.44 -27.73 68.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.01 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.3 p -54.86 -31.27 59.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -71.09 -35.1 71.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.58 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -69.4 -43.87 72.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.026 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -53.16 -60.42 3.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.1 p -64.83 -21.17 66.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.212 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.91 71.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.376 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 82.0 mt -57.4 -36.12 70.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.966 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.03 50.72 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.045 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.7 p -81.97 148.44 28.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 19' ' ' ASP . . . -80.3 83.06 1.43 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.615 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 8.8 t70 80.41 -40.6 0.18 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.702 0.401 . . . . 0.0 111.68 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -45.28 129.17 8.06 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.829 0.347 . . . . 0.0 111.231 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 4.8 tt -80.33 110.88 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.437 ' CG2' ' CE2' ' A' ' 54' ' ' TYR . 10.6 p -100.84 116.06 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.41 ' CG2' ' CD2' ' A' ' 21' ' ' LEU . 47.4 t -104.88 146.76 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.044 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.41 HG13 ' CZ ' ' A' ' 26' ' ' PHE . 48.5 t -126.1 113.8 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.806 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -101.48 120.56 40.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.942 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.442 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 61.2 m-85 -109.45 106.48 16.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.036 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 5.0 p90 -127.35 121.41 30.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.221 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.16 18.54 3.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p 49.3 78.04 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 111.437 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.614 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 0.7 OUTLIER -100.89 -56.05 2.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.946 179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.614 ' CB ' ' O ' ' A' ' 30' ' ' TRP . 42.0 t 132.73 104.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.562 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.03 -92.85 0.25 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.412 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.46 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 11.4 Cg_endo -55.55 -57.79 1.43 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.835 2.357 . . . . 0.0 112.862 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.415 ' SG ' ' CE3' ' A' ' 30' ' ' TRP . 31.1 p -81.12 58.26 3.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 110.975 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -172.19 -46.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.6 ttt -65.68 -54.18 30.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.833 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.425 HG21 HD13 ' A' ' 37' ' ' ILE . 33.0 pt -90.28 21.54 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.52 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.502 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . . . -71.03 -62.74 1.75 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.179 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.502 ' HD3' ' CB ' ' A' ' 38' ' ' ALA . 74.9 Cg_exo -50.14 -29.62 22.92 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.167 1.911 . . . . 0.0 112.685 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.462 ' CE ' ' HB3' ' A' ' 93' ' ' PRO . 37.7 mtp -62.56 -73.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.098 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.444 HD11 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -55.8 -23.46 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' N ' HD11 ' A' ' 41' ' ' ILE . 39.6 tt0 -81.17 -31.33 34.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.991 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -76.64 -42.06 43.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.377 179.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -55.19 -23.45 21.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -55.76 -28.27 55.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.128 0.49 . . . . 0.0 110.513 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.69 -0.49 50.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.807 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -90.15 -60.57 1.89 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.172 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.446 ' CE2' ' CG2' ' A' ' 100' ' ' ILE . 17.2 m-85 -70.67 165.16 23.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.041 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.6 m -113.69 -18.39 11.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.756 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -134.79 53.7 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.971 0.415 . . . . 0.0 111.398 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . . . -119.28 113.0 20.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.305 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.44 100.5 13.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.127 0.489 . . . . 0.0 110.84 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 45' ' ' ALA . 12.9 m-85 -92.12 134.22 35.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.186 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.437 ' CE2' ' CG2' ' A' ' 22' ' ' VAL . 19.0 m-30 -122.91 116.73 24.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.792 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -102.33 91.47 4.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.979 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 26' ' ' PHE . 85.0 mt -95.94 132.62 41.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -80.1 -9.26 59.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.663 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 39.1 t 64.74 25.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.111 0.481 . . . . 0.0 110.83 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.1 -47.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.49 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.21 -32.34 73.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.457 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.461 ' O ' ' OG ' ' A' ' 62' ' ' SER . 44.2 t -96.16 -44.37 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.743 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 61' ' ' VAL . 95.5 p 61.33 -65.85 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.749 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 61' ' ' VAL . 7.5 t70 -36.79 -58.22 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.535 0.334 . . . . 0.0 111.851 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.0 -54.12 36.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.045 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.63 -46.3 63.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.34 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -58.91 -40.36 84.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -72.1 -62.34 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.738 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.4 85.08 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -58.32 112.35 1.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.091 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -155.46 110.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.6 m -105.71 50.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -119.24 -170.73 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.647 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.492 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 18.1 ptp -166.7 98.8 0.68 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.378 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.427 ' HA ' ' HH2' ' A' ' 30' ' ' TRP . 94.4 Cg_endo -89.32 -165.05 2.67 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 124.262 -1.141 . . . . 0.0 112.451 -0.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 87.8 m -144.79 118.44 9.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.2 mp -126.37 127.47 45.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.962 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.432 HD11 ' CE2' ' A' ' 79' ' ' TYR . 17.1 pt -122.11 155.95 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.489 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.2 m-85 -127.5 118.56 24.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.424 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.462 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 61.3 m-85 -109.94 112.43 24.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.698 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.09 -54.26 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.834 0.35 . . . . 0.0 110.791 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.6 28.47 2.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.495 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.1 54.57 0.9 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.325 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -176.9 113.12 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.837 0.351 . . . . 0.0 110.976 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -58.91 96.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -109.89 -41.59 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 60.0 m -108.68 102.29 11.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.918 0.39 . . . . 0.0 110.151 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -102.6 154.57 19.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.377 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.4 t -154.35 81.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.574 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.44 72.68 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.59 -136.35 2.36 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.117 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.91 91.71 1.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.282 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -152.08 112.47 2.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.11 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HB3' ' CE ' ' A' ' 40' ' ' MET . 46.2 Cg_exo -57.16 -16.47 21.79 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.71 2.273 . . . . 0.0 112.593 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.82 -30.21 17.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 111.191 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.04 -30.87 16.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 110.841 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 93' ' ' PRO . 4.6 tp -68.58 -22.59 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.22 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HD2' ' O ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -83.82 -53.08 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.197 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -67.34 -47.59 70.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.027 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.5 -59.3 5.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.402 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.446 ' CG2' ' CE2' ' A' ' 48' ' ' TYR . 32.9 mm -57.43 -40.8 76.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.46 -28.22 66.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.193 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.5 m -57.94 -51.55 69.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.951 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -136.35 61.36 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.979 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.99 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.766 0.317 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.9 t 61.03 112.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.661 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.96 174.17 6.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.214 0.53 . . . . 0.0 111.061 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -118.42 96.28 5.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.056 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.465 HD12 ' CG ' ' A' ' 54' ' ' TYR . 62.7 mt -88.96 153.85 20.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.294 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -150.03 -66.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.952 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.6 t -82.57 161.94 22.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.128 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.95 63.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.158 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.1 p -56.44 -29.35 61.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.011 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -75.82 -32.82 59.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -78.3 -46.09 21.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.005 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -57.48 -64.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.084 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 t -57.76 -26.07 61.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.006 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.94 -63.34 1.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.301 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.9 mt -54.16 -25.09 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.123 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.87 -57.13 7.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.073 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.9 t -90.18 18.11 6.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.5 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.22 76.22 2.28 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -88.7 -40.58 13.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.97 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -58.48 -78.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.414 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 4.5 tt -177.59 113.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.774 0.321 . . . . 0.0 110.412 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.477 ' CG1' ' CE2' ' A' ' 54' ' ' TYR . 62.6 t -104.02 144.15 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.657 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.4 ' CG2' ' CD2' ' A' ' 21' ' ' LEU . 40.0 t -146.18 129.38 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.482 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.456 ' CG1' ' CE2' ' A' ' 26' ' ' PHE . 52.0 t -100.4 147.75 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.344 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 36.0 t70 -135.6 85.19 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.722 0.296 . . . . 0.0 111.697 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.456 ' CE2' ' CG1' ' A' ' 24' ' ' VAL . 65.8 m-85 -86.78 77.43 9.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.067 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 12.9 p90 -99.89 -34.59 10.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' O ' ' CD2' ' A' ' 27' ' ' PHE . . . 61.37 -162.64 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.584 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 79.2 p -134.11 65.27 1.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.001 0.429 . . . . 0.0 110.975 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.54 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -83.4 -60.1 2.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.916 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 39.1 t 147.44 110.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.458 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 33' ' ' PRO . . . 136.08 -132.42 6.12 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.37 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 10.7 Cg_endo -54.26 -34.09 78.26 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.71 2.274 . . . . 0.0 112.806 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 29.7 p -71.69 56.19 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.19 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 27.9 tptp 172.62 -42.84 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.75 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.505 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 11.1 mmt -58.04 -73.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.408 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.458 ' HB ' ' HG3' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -86.45 8.53 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.68 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' N ' ' CD ' ' A' ' 39' ' ' PRO . . . -57.91 -52.7 72.51 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.921 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 38' ' ' ALA . 50.9 Cg_exo -54.69 -31.94 73.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.583 2.189 . . . . 0.0 112.288 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 72.2 mtp -54.41 -73.77 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.928 0.394 . . . . 0.0 110.469 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.6 pt -50.56 -44.05 24.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.258 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -63.64 -33.15 74.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.79 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -76.47 -49.35 16.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.939 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.422 ' CD2' HD13 ' A' ' 96' ' ' ILE . 8.0 m-85 -51.79 -27.76 13.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.01 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . . . -52.89 -28.89 25.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.055 0.455 . . . . 0.0 110.576 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -82.85 -25.21 32.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.602 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -58.44 -56.74 18.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.034 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.405 ' CE2' HG23 ' A' ' 100' ' ' ILE . 16.3 m-85 -62.28 171.03 2.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.156 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 m -97.14 -31.98 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 1.5 p30 -140.54 99.18 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.183 0.516 . . . . 0.0 111.146 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.83 117.62 6.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.79 107.09 18.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.279 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 6.6 m-85 -100.01 129.6 46.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.52 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.477 ' CE2' ' CG1' ' A' ' 22' ' ' VAL . 17.2 m-30 -115.4 107.26 14.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.444 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -89.85 122.46 32.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.436 ' CD1' ' CE1' ' A' ' 26' ' ' PHE . 94.0 mt -136.32 172.19 13.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.644 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -130.54 -102.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.927 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.6 m -157.54 -45.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 120.709 0.29 . . . . 0.0 111.25 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -110.67 -35.96 5.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.01 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.61 -31.45 66.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.756 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -97.52 -66.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.745 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.0 t 68.31 -63.07 0.35 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.433 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -38.75 -38.62 0.43 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.731 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.02 -54.35 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.096 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.13 -41.12 7.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.811 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -57.33 -47.74 80.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.106 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -82.45 -55.99 4.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.957 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.36 82.16 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -58.49 98.6 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.418 HG22 ' CD2' ' A' ' 26' ' ' PHE . 53.7 t -108.22 151.62 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.2 p -155.79 85.28 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.076 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.2 t -177.9 177.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.442 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 64.9 mtm -154.64 96.48 2.59 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -85.36 -158.75 1.55 Allowed 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.492 -1.045 . . . . 0.0 112.199 0.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 63.3 m -144.62 114.43 7.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.752 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 76' ' ' LEU . 4.2 mp -126.89 111.8 14.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.902 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.432 HD13 ' CZ ' ' A' ' 79' ' ' TYR . 26.3 pt -115.75 163.32 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.639 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.3 m-85 -128.11 125.73 39.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.448 ' CE1' ' HB3' ' A' ' 84' ' ' GLU . 63.2 m-85 -109.49 165.04 11.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.43 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -168.51 63.79 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.714 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.3 23.83 4.36 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.028 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.73 -4.67 73.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.254 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 13.2 mptt -109.7 110.63 21.72 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.735 0.302 . . . . 0.0 111.088 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 24.4 pt-20 -68.24 125.59 26.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.467 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.92 -42.04 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.612 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 72.2 m -103.96 113.66 27.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.949 0.404 . . . . 0.0 110.093 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -112.14 155.09 24.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.33 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.2 t -155.84 79.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.793 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 27.0 m -109.62 91.99 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.313 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -103.38 0.17 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.384 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.5 85.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -151.64 81.88 5.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.859 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HG3' ' HB ' ' A' ' 37' ' ' ILE . 51.9 Cg_exo -54.55 -20.45 21.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.863 2.375 . . . . 0.0 112.698 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.84 -2.41 58.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.588 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.0 -23.94 21.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.71 0.29 . . . . 0.0 111.267 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.422 HD13 ' CD2' ' A' ' 44' ' ' PHE . 24.3 pt -54.79 -34.43 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.135 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.47 -60.37 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.032 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -68.17 -27.65 66.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.4 -64.06 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.288 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.405 HG23 ' CE2' ' A' ' 48' ' ' TYR . 66.6 mt -55.78 -35.01 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.216 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.09 -23.79 64.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.327 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.3 m -54.53 -70.13 0.11 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -106.33 56.34 0.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.948 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.791 0.329 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 47.7 t -112.12 131.31 63.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.814 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -110.93 159.46 17.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.437 0.637 . . . . 0.0 111.833 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -121.76 116.32 24.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.569 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.567 ' HB2' HD21 ' A' ' 56' ' ' LEU . 67.2 mt -89.05 104.36 16.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.013 0.435 . . . . 0.0 111.306 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -99.52 -35.2 9.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.427 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -117.73 141.09 48.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.944 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.36 -25.98 38.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.427 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -58.63 -40.26 82.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.011 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -63.85 -27.05 68.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.553 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 49.3 t80 -90.0 -46.92 8.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -57.95 -60.74 3.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.072 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.4 p -55.86 -23.09 28.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.294 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.4 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -74.84 -28.22 60.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.46 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.553 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 86.1 mt -89.94 -17.96 26.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.364 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.33 -86.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.328 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.1 p -90.47 29.33 1.3 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.08 87.86 1.44 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.77 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -80.07 -37.32 34.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 110.588 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -57.95 -168.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.607 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.849 HD13 HG23 ' A' ' 100' ' ' ILE . 2.7 tt -91.1 119.88 31.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.962 0.411 . . . . 0.0 110.689 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.604 ' N ' HD23 ' A' ' 21' ' ' LEU . 59.6 t -113.05 107.95 24.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.532 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.638 HG23 HD22 ' A' ' 21' ' ' LEU . 43.3 t -99.92 144.81 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.507 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.494 HG11 ' CE2' ' A' ' 26' ' ' PHE . 48.4 t -126.43 147.89 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.447 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 37.7 t70 -137.13 113.16 9.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.961 0.41 . . . . 0.0 111.211 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.539 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 70.4 m-85 -110.34 107.2 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 1.7 p90 -150.69 121.85 7.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.783 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.652 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -88.18 18.17 4.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.638 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.0 p 49.61 62.86 2.42 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.14 0.495 . . . . 0.0 111.119 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.652 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.8 m-90 -77.72 -61.19 2.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.149 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 41.8 t 165.11 109.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.562 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.04 -146.38 18.42 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.027 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . 84.2 Cg_exo -46.28 -36.49 17.32 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.834 2.356 . . . . 0.0 112.88 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 24.4 p -51.76 -26.04 8.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -113.77 -28.7 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.2 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.7 ttm -77.35 -29.85 53.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.292 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 37' ' ' ILE . 54.1 mt -89.94 -6.16 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.706 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.836 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -51.08 -55.35 28.84 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.536 0.208 . . . . 0.0 111.408 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.836 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 37.9 Cg_exo -61.58 -39.04 57.69 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.55 2.167 . . . . 0.0 112.285 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 60.7 mtt -53.08 -75.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.58 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.788 HG22 HG21 ' A' ' 96' ' ' ILE . 11.6 pt -51.69 -43.16 32.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.35 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 41' ' ' ILE . 39.4 tt0 -63.86 -33.65 76.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.753 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.3 ttpt -76.2 -41.25 50.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.288 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.772 ' CG ' HD11 ' A' ' 96' ' ' ILE . 6.1 m-85 -64.26 -23.96 67.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.716 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -54.85 -29.14 54.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.06 0.457 . . . . 0.0 110.473 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -84.54 -1.83 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.944 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -90.17 -46.5 8.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.048 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.528 ' CE2' HD12 ' A' ' 100' ' ' ILE . 17.6 m-85 -73.89 168.05 20.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.186 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -111.6 -22.69 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.269 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.529 ' OD1' HG23 ' A' ' 104' ' ' VAL . 52.7 p-10 -146.0 66.45 1.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.034 0.445 . . . . 0.0 111.199 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HB3' ' HE1' ' A' ' 53' ' ' PHE . . . -124.55 117.64 24.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.018 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.69 104.12 16.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.631 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 3.6 m-85 -89.85 106.89 18.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.928 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.516 ' CE2' HG13 ' A' ' 22' ' ' VAL . 12.8 m-30 -96.86 109.1 21.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 110.953 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -89.89 129.56 36.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.083 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.718 HD22 HG21 ' A' ' 61' ' ' VAL . 96.2 mt -148.35 136.84 21.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.642 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -107.29 -96.73 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.065 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.4 t -156.2 -69.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.849 0.357 . . . . 0.0 111.076 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -79.76 -33.47 40.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.13 -29.41 57.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.041 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.718 HG21 HD22 ' A' ' 56' ' ' LEU . 30.5 t -112.98 -67.13 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.842 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.476 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 33.2 t 75.28 -7.82 1.7 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.14 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.698 ' H ' HG12 ' A' ' 61' ' ' VAL . 35.0 m-20 -90.36 -64.32 1.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.924 0.393 . . . . 0.0 110.865 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.3 t -62.92 -59.98 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.137 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.22 -31.15 2.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.445 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -63.62 -58.59 6.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.738 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -74.31 -55.67 5.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.759 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.4 82.99 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.5 128.02 34.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.109 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.6 t -89.55 132.88 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -136.97 50.85 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.16 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.403 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 36.3 t -170.33 -163.69 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.635 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.486 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.3 ptm -170.1 90.92 0.52 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.431 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.88 -162.53 2.93 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.88 -1.3 . . . . 0.0 112.27 -0.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.589 ' C ' HD12 ' A' ' 76' ' ' LEU . 88.0 m -137.12 105.02 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.602 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 76' ' ' LEU . 3.8 mp -114.05 140.69 48.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.958 0.409 . . . . 0.0 111.217 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.591 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 25.1 pt -138.59 156.79 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.804 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.471 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.4 m-85 -124.1 125.52 44.64 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.959 0.409 . . . . 0.0 111.507 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.591 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 65.4 m-85 -110.93 124.43 52.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.925 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -116.57 -38.26 3.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.44 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.55 45.03 1.22 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.055 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.85 27.03 58.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.908 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.46 ' O ' HG13 ' A' ' 85' ' ' VAL . 60.5 mttp -152.92 124.66 7.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.774 0.321 . . . . 0.0 110.832 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.67 111.05 0.73 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.381 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 86' ' ' THR . 19.0 m -120.91 -46.89 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.485 ' N ' HG23 ' A' ' 85' ' ' VAL . 77.0 p -113.46 77.8 1.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 110.997 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -81.69 160.05 23.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.044 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.1 t -150.95 83.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.854 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 89' ' ' VAL . 32.1 m -109.38 99.38 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.216 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.8 -111.05 0.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.208 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -179.72 91.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 0.0 111.109 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -178.16 123.37 0.26 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.865 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 96' ' ' ILE . 12.3 Cg_endo -57.57 -59.43 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.426 2.084 . . . . 0.0 112.498 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -42.1 -30.44 0.29 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.955 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -20.26 60.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.662 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.788 HG21 HG22 ' A' ' 41' ' ' ILE . 8.9 pt -78.84 -42.96 24.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.872 0.367 . . . . 0.0 111.025 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -62.59 -64.38 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.578 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -54.64 -25.78 28.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.253 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.4 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -83.4 -63.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.047 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.849 HG23 HD13 ' A' ' 21' ' ' LEU . 63.1 mt -59.89 -44.92 95.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.6 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -63.6 -16.43 60.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.747 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.4 t -85.76 -56.71 3.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.796 0.331 . . . . 0.0 111.237 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -70.33 -23.87 62.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.138 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 101' ' ' ALA . 10.8 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.555 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.917 0.389 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 46.7 t 63.72 125.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.685 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.9 m -106.71 166.99 10.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.403 ' H ' HG22 ' A' ' 3' ' ' THR . 13.8 mp0 -106.2 90.28 3.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.064 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.537 HD11 ' CG ' ' A' ' 54' ' ' TYR . 74.6 mt -89.03 132.7 34.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.187 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -133.52 -58.3 0.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.792 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 t -91.88 149.94 21.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.053 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . . . -67.55 -28.25 67.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.208 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -55.67 -30.9 61.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -72.63 -39.26 67.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.95 -71.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.981 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -47.57 -30.08 3.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.532 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 t -66.01 -23.3 66.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.194 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.08 -36.03 15.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.26 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.2 mm? -82.12 -0.3 44.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.446 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.92 -82.12 0.27 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 111.061 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -90.54 30.42 1.15 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.185 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.63 168.04 41.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.645 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -159.57 -45.67 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.644 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -59.43 -170.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.731 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 104' ' ' VAL . 44.4 tp -75.38 107.36 7.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.209 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 58.2 t -109.16 97.63 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.563 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' A' ' 21' ' ' LEU . 43.3 t -105.74 137.97 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.593 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.701 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 48.1 t -116.59 139.08 44.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.329 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -117.93 98.18 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.508 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.701 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 61.3 m-85 -96.02 96.98 9.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.916 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 2.2 p90 -136.54 122.16 19.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.65 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.25 112.16 23.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.479 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.7 p -74.54 105.36 5.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.471 . . . . 0.0 111.629 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.557 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.2 m-90 -105.32 -60.38 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.471 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 44.7 t 159.07 90.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.418 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.3 -82.54 0.21 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.759 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.755 ' O ' ' N ' ' A' ' 35' ' ' LYS . 87.3 Cg_endo -79.79 -155.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.496 2.13 . . . . 0.0 110.852 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 4.6 p 42.04 -68.81 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.755 ' N ' ' O ' ' A' ' 33' ' ' PRO . 86.9 tttt -55.27 -39.84 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.382 . . . . 0.0 111.306 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -62.68 1.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.861 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -90.16 34.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.936 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.878 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -90.06 -59.65 0.24 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.621 0.248 . . . . 0.0 110.914 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.878 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 59.6 Cg_exo -52.54 -41.15 69.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.353 2.035 . . . . 0.0 112.35 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.414 ' CE ' ' CB ' ' A' ' 93' ' ' PRO . 70.0 mtp -50.07 -71.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 110.788 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.781 ' CG2' HG21 ' A' ' 96' ' ' ILE . 9.1 pt -55.38 -45.57 78.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.258 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.62 ' OE2' ' HB1' ' A' ' 38' ' ' ALA . 50.9 mt-10 -59.9 -35.29 74.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.844 0.354 . . . . 0.0 110.727 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 11.6 tmtt? -69.9 -49.28 53.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.417 ' CD2' HD11 ' A' ' 96' ' ' ILE . 6.0 m-85 -47.54 -28.85 2.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.271 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.13 -29.29 57.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.837 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.61 -32.98 25.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.404 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.412 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 84.5 mt-30 -60.52 -26.39 66.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.779 ' CE2' HG21 ' A' ' 100' ' ' ILE . 42.1 m-85 -90.1 176.82 6.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.779 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.3 m -114.05 -27.83 7.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.258 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -138.9 68.96 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 111.424 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.518 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -124.74 115.18 20.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.99 101.3 14.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.394 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.518 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 5.9 m-85 -93.72 132.11 38.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.537 ' CG ' HD11 ' A' ' 5' ' ' LEU . 15.3 m-30 -121.62 106.42 11.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.806 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.91 130.11 36.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.984 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.806 HD22 HG11 ' A' ' 61' ' ' VAL . 97.6 mt -155.47 140.96 17.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.829 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -101.42 -128.38 0.21 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.475 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.3 t -126.58 -70.13 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.084 0 CA-C-O 120.777 0.322 . . . . 0.0 111.015 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -72.61 -39.72 67.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.739 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -58.17 -29.51 65.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.7 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.806 HG11 HD22 ' A' ' 56' ' ' LEU . 43.6 t -140.25 70.53 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.2 t -76.86 -2.03 31.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.541 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 57.1 m-20 -84.83 -38.07 19.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.816 0.341 . . . . 0.0 111.089 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.647 HG11 ' CD1' ' A' ' 56' ' ' LEU . 46.2 t -90.2 -56.31 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.251 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.19 -32.55 16.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.65 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -58.25 -48.28 80.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.89 -51.59 66.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.01 77.33 6.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.091 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.05 115.06 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.481 ' HB ' HG21 ' A' ' 75' ' ' THR . 35.2 m -138.56 143.02 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.188 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -116.77 174.88 5.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.828 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 81.8 p 50.69 95.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.524 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 21.6 mmt -91.24 150.76 42.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.78 -178.98 22.88 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 123.723 -1.366 . . . . 0.0 112.7 0.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.934 HG23 HG12 ' A' ' 89' ' ' VAL . 91.8 m -149.85 130.69 14.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.748 HD12 ' C ' ' A' ' 75' ' ' THR . 4.0 mp -123.98 131.98 53.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.0 111.335 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.466 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 27.8 pt -130.47 139.58 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.502 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.7 m-85 -114.23 125.64 54.15 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.044 0.449 . . . . 0.0 111.572 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.594 ' CD2' HD11 ' A' ' 15' ' ' LEU . 69.7 m-85 -109.61 162.14 14.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.718 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -153.41 67.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.74 20.74 18.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.415 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.77 64.51 1.2 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.565 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -178.18 115.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.954 0.407 . . . . 0.0 111.157 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 44.3 tt0 -79.31 98.43 6.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.575 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.91 -32.43 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.412 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.707 HG21 HD21 ' A' ' 103' ' ' ASN . 92.2 m -113.88 102.8 10.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.889 0.376 . . . . 0.0 110.468 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -110.0 144.31 38.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.003 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.2 t -137.57 82.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.704 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.934 HG12 HG23 ' A' ' 75' ' ' THR . 34.8 m -109.65 106.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.325 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.03 -108.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.371 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -179.93 68.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.991 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 5.7 m120 -142.51 96.4 6.29 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.052 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.45 ' O ' HG13 ' A' ' 96' ' ' ILE . 32.0 Cg_exo -58.6 -17.1 33.32 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.589 2.192 . . . . 0.0 112.503 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.27 -29.73 17.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.853 0.358 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 92' ' ' ASN . . . -71.52 -25.32 62.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.173 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.794 HD12 ' N ' ' A' ' 97' ' ' LYS . 2.1 pp -56.59 -31.9 35.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.794 ' N ' HD12 ' A' ' 96' ' ' ILE . 34.5 ttpt -62.93 -65.11 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.16 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -39.01 -33.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.655 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.47 -46.87 12.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.779 HG21 ' CE2' ' A' ' 48' ' ' TYR . 73.4 mt -74.07 -5.68 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.541 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.22 -32.9 16.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.727 0.299 . . . . 0.0 111.379 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.7 p -89.67 -58.55 2.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 111.387 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.707 HD21 HG21 ' A' ' 86' ' ' THR . 47.2 m-80 -60.08 -17.99 43.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.591 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.614 ' HA ' HD22 ' A' ' 21' ' ' LEU . 11.3 p . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.769 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 23.0 ptp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.889 0.376 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.525 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 45.4 t -147.93 102.19 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.701 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -101.53 152.44 20.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.423 0.63 . . . . 0.0 111.851 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -113.01 118.84 35.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.402 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 11' ' ' TYR . 4.7 mp -89.15 117.68 28.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.977 0.418 . . . . 0.0 111.616 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -107.79 -37.0 6.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.172 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.2 t -115.95 143.81 44.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.831 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.48 -23.79 41.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.302 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 m -60.12 -45.01 94.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -59.9 -27.4 66.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.35 . . . . 0.0 110.895 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.869 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 48.6 t80 -90.03 -48.81 6.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.175 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -57.79 -61.81 2.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.1 p -54.56 -24.33 20.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.349 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.06 -66.06 0.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.362 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.869 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 82.2 mt -54.85 -24.11 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.4 -79.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.205 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -90.2 17.24 7.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.04 105.88 3.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -109.47 -22.0 12.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 111.065 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -54.92 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.092 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.758 HD13 HG23 ' A' ' 100' ' ' ILE . 4.4 tt -177.83 107.99 0.06 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.532 HG13 ' CE2' ' A' ' 54' ' ' TYR . 58.3 t -102.79 124.72 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.723 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 ' CD2' ' A' ' 21' ' ' LEU . 40.8 t -116.19 122.57 69.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.469 HG11 ' CE2' ' A' ' 26' ' ' PHE . 51.8 t -104.0 112.55 37.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.756 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -108.68 98.44 7.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.499 ' CE1' HD12 ' A' ' 56' ' ' LEU . 61.0 m-85 -86.3 115.55 23.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.88 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 2.3 p90 -135.81 117.12 14.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.661 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.882 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -86.79 4.52 40.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.771 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.8 p 49.18 70.83 0.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 111.178 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.882 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 3.0 m-90 -89.12 -57.84 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.148 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.8 t -139.57 -104.35 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.384 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.616 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -136.05 25.76 3.17 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.9 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 85.7 Cg_endo -82.44 -41.32 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 121.982 1.788 . . . . 0.0 112.114 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 22.9 p -98.39 -41.93 7.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.247 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -52.18 -42.12 63.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.382 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.7 ttt -67.72 -25.79 65.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.117 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 37' ' ' ILE . 50.0 mm -86.97 -10.72 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.693 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.901 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -59.91 -63.37 4.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.901 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 82.5 Cg_exo -45.76 -40.68 19.44 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.333 2.022 . . . . 0.0 112.801 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.6 mtt -54.17 -79.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.644 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.934 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -57.55 -29.71 34.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.778 0.323 . . . . 0.0 110.969 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.934 ' N ' HD12 ' A' ' 41' ' ' ILE . 88.4 tt0 -70.35 -26.92 63.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.704 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.431 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 13.4 tmtt? -87.09 -45.92 10.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.241 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -54.82 -27.47 42.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.703 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 1' ' ' MET . . . -51.82 -30.56 23.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.087 0.47 . . . . 0.0 110.495 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -83.15 -26.53 30.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.59 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -72.64 -26.1 61.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.302 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -83.18 167.67 17.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.374 . . . . 0.0 111.039 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -97.28 -33.48 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.821 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -153.01 98.57 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.823 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.63 121.24 10.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.629 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.94 109.28 20.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.525 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 10.4 m-85 -97.96 116.05 29.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.525 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.532 ' CE2' HG13 ' A' ' 22' ' ' VAL . 17.7 m-30 -112.26 99.77 8.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.864 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -90.04 127.63 36.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 5' ' ' LEU . 90.0 mt -130.87 162.77 28.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.216 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.55 ' O ' HG13 ' A' ' 58' ' ' VAL . 38.8 t70 -106.33 -109.5 0.29 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.515 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 57' ' ' ASP . 16.1 m -160.51 -48.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.742 0.306 . . . . 0.0 111.399 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 58' ' ' VAL . 1.3 m-20 -110.75 -33.63 6.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 110.742 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.5 -27.32 56.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.695 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.81 HG12 ' H ' ' A' ' 63' ' ' ASP . 46.8 t -106.74 -68.78 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 61' ' ' VAL . 86.1 p 64.59 5.75 2.86 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.015 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.81 ' H ' HG12 ' A' ' 61' ' ' VAL . 1.4 m-20 -90.49 -38.64 13.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.974 0.416 . . . . 0.0 110.656 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 68' ' ' ALA . 27.0 t -90.05 -47.21 14.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.248 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.0 -30.31 1.0 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.653 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -73.79 -37.03 65.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -88.91 -57.49 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.754 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 64' ' ' VAL . . . -82.06 81.24 8.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.067 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.67 117.81 5.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.613 ' HB ' HG21 ' A' ' 75' ' ' THR . 35.4 m -133.01 174.53 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -175.98 91.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.16 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.405 ' CB ' HG21 ' A' ' 89' ' ' VAL . 39.6 t -178.22 -171.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.474 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 52.8 mtt -156.83 93.73 2.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.02 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.461 ' O ' HG23 ' A' ' 89' ' ' VAL . 95.8 Cg_endo -89.39 -162.66 1.93 Allowed 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.297 -1.126 . . . . 0.0 112.502 0.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.671 ' C ' HD12 ' A' ' 76' ' ' LEU . 95.4 m -141.55 105.65 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.676 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.671 HD12 ' C ' ' A' ' 75' ' ' THR . 3.9 mp -118.91 119.75 35.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.227 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.8 pt -121.31 166.99 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.9 m-85 -130.87 128.55 40.83 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.054 0.454 . . . . 0.0 111.338 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 60.2 m-85 -109.76 131.78 54.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.062 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -132.91 60.05 1.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.085 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.65 38.65 0.65 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.026 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.49 29.12 72.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.006 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -142.72 115.43 8.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 111.06 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.3 tt0 -69.98 104.13 2.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.596 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.42 -37.72 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.462 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.568 HG21 HD21 ' A' ' 103' ' ' ASN . 88.5 m -106.82 107.32 18.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 110.397 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -110.77 152.59 26.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.339 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -149.44 82.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.683 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 89' ' ' VAL . 7.4 p -109.59 98.5 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.199 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -170.1 -107.26 0.2 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.436 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 90' ' ' GLY . . . 173.62 92.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -153.37 116.66 2.74 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.513 ' O ' HG22 ' A' ' 96' ' ' ILE . 21.5 Cg_exo -65.03 -11.99 32.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.507 2.138 . . . . 0.0 112.652 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.57 -38.25 10.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.68 0.276 . . . . 0.0 111.287 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.71 -35.2 21.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 111.021 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.816 HD13 HG22 ' A' ' 41' ' ' ILE . 4.2 tp -53.06 -43.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.524 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.44 -72.2 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.318 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -51.47 -26.24 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.761 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.427 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -72.47 -62.57 1.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.752 0.311 . . . . 0.0 111.071 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.758 HG23 HD13 ' A' ' 21' ' ' LEU . 62.3 mt -73.83 -7.39 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.411 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.04 -27.3 26.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.689 0.28 . . . . 0.0 111.329 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.6 m -90.06 -56.09 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.294 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.568 HD21 HG21 ' A' ' 86' ' ' THR . 60.3 m-80 -55.35 -45.49 76.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.453 -179.524 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.852 0.358 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 53' ' ' PHE . 46.2 t -73.46 123.78 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.568 HG22 ' H ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -96.61 -178.2 4.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 0.0 110.597 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.568 ' H ' HG22 ' A' ' 3' ' ' THR . 21.3 mp0 -124.0 90.13 3.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.19 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.638 HD21 ' CD2' ' A' ' 54' ' ' TYR . 5.0 mp -89.07 141.12 28.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -133.68 -69.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.2 t -79.32 162.18 25.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.056 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . . . -70.27 -30.34 67.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.062 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -59.02 -33.83 71.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 53.1 mt-10 -69.7 -30.72 68.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.826 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.463 ' HH ' HD11 ' A' ' 15' ' ' LEU . 45.8 t80 -75.75 -45.99 33.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.905 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.29 -56.29 19.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -59.1 -28.0 66.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.052 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . -63.66 -66.4 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.136 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.548 ' CD2' HG11 ' A' ' 22' ' ' VAL . 81.4 mt -58.06 -26.72 62.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.037 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.78 -68.0 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -78.21 -28.46 48.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.19 119.07 12.84 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -114.37 -31.08 6.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 0.0 111.195 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.92 -108.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.806 HD12 ' HA ' ' A' ' 104' ' ' VAL . 4.5 tt -139.49 121.65 15.82 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.784 0.326 . . . . 0.0 110.439 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.637 ' N ' HD23 ' A' ' 21' ' ' LEU . 60.3 t -111.92 122.81 66.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.009 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.496 HG23 HD22 ' A' ' 21' ' ' LEU . 42.9 t -118.32 124.7 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.461 HG21 ' HE1' ' A' ' 11' ' ' TYR . 47.0 t -110.67 115.56 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.058 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -102.43 120.24 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.416 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 54.6 m-85 -108.26 119.52 39.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.16 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.424 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 2.5 p90 -155.15 113.3 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.644 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.06 23.2 6.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.403 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p 46.81 70.14 0.42 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.96 0.409 . . . . 0.0 110.769 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 73' ' ' MET . 2.5 m-90 -83.05 -57.86 3.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.868 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.4 t -118.89 -37.1 3.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.894 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 142.14 -38.38 1.48 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.504 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 58.7 Cg_exo -40.7 -46.96 4.71 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.622 2.214 . . . . 0.0 112.927 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.8 p -53.56 -31.75 47.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.004 0.43 . . . . 0.0 110.737 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -83.64 -25.93 30.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.9 ttm -70.18 -33.21 71.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.687 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.605 HG23 ' SD ' ' A' ' 40' ' ' MET . 56.4 mt -90.15 -1.36 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.883 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -59.09 -63.72 3.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 121.206 -0.197 . . . . 0.0 111.279 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.883 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 86.1 Cg_exo -44.07 -34.55 6.69 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.379 2.053 . . . . 0.0 112.512 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.605 ' SD ' HG23 ' A' ' 37' ' ' ILE . 65.7 mtt -56.11 -74.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.855 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -63.8 -25.28 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.199 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.855 ' N ' HD12 ' A' ' 41' ' ' ILE . 93.4 mt-10 -72.41 -30.96 65.11 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.001 0.429 . . . . 0.0 109.997 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.451 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -77.23 -44.51 29.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.828 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.437 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.6 m-85 -55.65 -23.05 25.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.647 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -56.94 -28.15 61.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 110.536 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -89.14 -7.78 55.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.872 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -90.06 -51.06 5.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.583 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 100' ' ' ILE . 51.8 m-85 -68.0 143.63 55.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.904 0.383 . . . . 0.0 111.336 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.3 m -76.73 -34.03 58.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 1.5 p30 -150.11 100.32 2.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.297 0.57 . . . . 0.0 111.395 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.71 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -146.54 125.07 12.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.28 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.52 107.39 19.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.71 ' CZ ' ' HB3' ' A' ' 51' ' ' ALA . 14.6 m-85 -101.75 124.95 48.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.915 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.638 ' CD2' HD21 ' A' ' 5' ' ' LEU . 17.6 m-30 -112.36 123.43 50.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' O ' HD23 ' A' ' 56' ' ' LEU . 40.1 ttmt -102.75 119.83 39.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.865 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.034 HD22 HG11 ' A' ' 61' ' ' VAL . 81.2 mt -130.87 155.38 46.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.801 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -120.04 -83.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.119 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 59' ' ' ASP . 8.6 p 178.32 -45.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.33 . . . . 0.0 111.085 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 58' ' ' VAL . 7.5 t0 -85.96 -58.12 2.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.776 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -59.55 -30.47 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.034 HG11 HD22 ' A' ' 56' ' ' LEU . 46.9 t -127.21 54.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.041 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.5 t -70.16 -27.32 64.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 1.5 m-20 -54.63 -40.9 69.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.42 -48.98 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.942 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.52 -45.54 9.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.514 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -59.36 -58.8 7.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.77 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.542 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -60.88 -68.72 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.47 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.94 75.43 2.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.778 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -48.57 137.77 11.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.231 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.649 HG13 HG21 ' A' ' 75' ' ' THR . 56.1 t -124.31 158.64 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.08 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.483 ' N ' HG12 ' A' ' 70' ' ' VAL . 79.9 p -164.56 70.49 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.42 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 41.5 t -177.74 -163.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.646 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.9 ptm -175.03 100.2 0.27 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.426 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.76 -155.35 1.14 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.464 -1.057 . . . . 0.0 112.216 -0.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.75 ' C ' HD12 ' A' ' 76' ' ' LEU . 87.3 m -159.14 111.06 2.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.75 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -123.95 127.3 47.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.259 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.565 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 24.2 pt -117.03 156.32 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.733 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.65 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -127.04 123.46 37.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.01 0.433 . . . . 0.0 111.427 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.565 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 66.7 m-85 -109.83 176.79 4.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.573 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -153.0 -46.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.628 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.0 29.27 1.69 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.191 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.09 44.14 3.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.272 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -162.25 123.57 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.023 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 22.1 pt-20 -82.3 101.72 10.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.45 . . . . 0.0 110.672 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.54 -34.18 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.446 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 63.7 m -107.96 110.36 22.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.417 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -111.56 158.91 18.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.267 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 95' ' ' ALA . 47.6 t -155.22 80.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.773 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 75' ' ' THR . 35.3 m -109.82 63.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.13 0.49 . . . . 0.0 111.27 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -133.57 -158.2 8.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.305 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.03 76.18 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.31 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -154.75 138.32 10.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.555 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.87 -1.03 10.63 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.62 2.213 . . . . 0.0 113.261 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.57 -40.76 9.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.683 0.278 . . . . 0.0 111.241 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' A' ' 88' ' ' VAL . . . -48.3 -31.52 6.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.7 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 41' ' ' ILE . 3.6 tp -69.76 -36.22 68.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.309 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -61.66 -73.33 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.607 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -55.64 -41.74 73.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.986 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.461 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -54.27 -55.85 24.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.317 . . . . 0.0 111.324 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.586 HG21 ' CE2' ' A' ' 48' ' ' TYR . 32.8 mm -62.22 -51.01 77.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.747 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -23.68 66.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.227 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -54.8 -62.91 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.55 . . . . 0.0 110.826 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -127.71 46.54 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.078 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.806 ' HA ' HD12 ' A' ' 21' ' ' LEU . 9.5 p . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.099 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.835 0.35 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.439 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 15.8 m -56.96 154.14 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.034 0.445 . . . . 0.0 111.629 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.513 ' HB ' HD11 ' A' ' 5' ' ' LEU . 6.9 m -101.11 163.9 12.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.867 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.424 ' N ' HG22 ' A' ' 3' ' ' THR . 14.6 mp0 -98.65 90.7 4.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 5' ' ' LEU . 5.2 mp -88.84 127.46 35.63 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.956 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -129.71 -58.21 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.196 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.9 t -90.24 139.82 30.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.13 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.02 66.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.163 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.4 p -55.88 -37.68 69.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.813 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 47.6 mt-10 -67.18 -32.95 74.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.656 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 47.3 t80 -65.09 -62.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.155 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.93 -54.61 42.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.8 p -56.69 -22.55 35.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.22 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.733 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -79.32 -60.55 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.322 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.656 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 78.5 mt -55.7 -23.0 26.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.165 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.89 -61.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 111.249 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -75.16 -48.35 24.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.066 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.79 108.24 0.68 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.773 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -109.85 -25.17 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 0.0 110.916 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -53.49 -79.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.653 HD21 ' CD2' ' A' ' 78' ' ' PHE . 4.3 tt -169.02 116.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 110.554 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.584 HG13 ' CE2' ' A' ' 54' ' ' TYR . 50.1 t -105.76 137.99 33.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.506 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG23 ' CD2' ' A' ' 21' ' ' LEU . 40.6 t -132.31 108.94 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 0.0 111.319 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.732 HG23 HD11 ' A' ' 77' ' ' ILE . 34.7 m -102.38 122.92 55.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.87 103.92 13.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.537 ' HB3' HG21 ' A' ' 70' ' ' VAL . 63.4 m-85 -91.99 101.7 14.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.173 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.435 ' HA ' ' CH2' ' A' ' 30' ' ' TRP . 2.4 p90 -134.53 122.21 22.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.519 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 1.054 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -93.25 23.65 4.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.868 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.2 p 46.52 80.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.985 0.421 . . . . 0.0 111.355 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.45 ' CZ3' ' HG2' ' A' ' 33' ' ' PRO . 3.6 m-90 -86.63 -58.87 2.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.322 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.5 t -143.44 -77.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.502 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.587 ' N ' ' HD3' ' A' ' 33' ' ' PRO . . . -168.69 52.59 0.22 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.923 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 32' ' ' GLY . 37.5 Cg_endo -94.3 -68.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.051 2.501 . . . . 0.0 112.204 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.0 p -68.63 -34.87 76.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.813 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 35' ' ' LYS . 9.4 tmtt? -52.93 -55.5 22.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.66 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.8 ttt -51.22 -42.69 61.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.585 HD13 ' HB1' ' A' ' 91' ' ' ALA . 36.2 pt -90.2 10.7 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.134 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.637 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -62.94 -51.04 74.01 Favored Pre-proline 0 C--N 1.331 -0.203 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.301 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 50.4 Cg_exo -55.53 -32.44 82.72 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.277 1.985 . . . . 0.0 112.09 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 63.3 mtt -55.1 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.977 HG22 HD13 ' A' ' 96' ' ' ILE . 2.5 pp -55.5 -28.78 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 111.132 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.926 ' N ' HD12 ' A' ' 41' ' ' ILE . 8.7 tm-20 -71.38 -27.09 63.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.368 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -86.01 -50.75 6.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.419 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 9.8 m-85 -54.19 -30.25 48.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.406 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -51.91 -27.83 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.239 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -90.1 -33.61 16.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.76 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -61.81 -24.56 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.105 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' CZ ' ' HB ' ' A' ' 100' ' ' ILE . 39.2 m-85 -82.28 159.07 23.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.991 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -81.28 -38.96 26.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 1.6 p30 -150.0 104.75 3.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.118 0.485 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.09 123.23 11.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.092 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -90.0 100.26 13.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 9.4 m-85 -94.87 127.34 40.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.496 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.733 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 18.8 m-30 -118.23 126.44 52.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.004 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -107.32 99.13 8.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.603 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.836 HD22 HG11 ' A' ' 61' ' ' VAL . 98.1 mt -98.77 164.28 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.236 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 38.3 t70 -144.2 162.89 35.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.439 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.054 HG21 ' HB2' ' A' ' 28' ' ' ALA . 45.7 t -86.83 0.53 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.794 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -113.22 -75.93 0.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.644 0.259 . . . . 0.0 111.211 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.813 ' HG3' HG23 ' A' ' 61' ' ' VAL . 12.0 pt-20 -58.57 -23.02 57.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.197 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.836 HG11 HD22 ' A' ' 56' ' ' LEU . 39.8 t -127.98 47.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.5 t -62.69 -26.24 68.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.016 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -60.75 -55.14 36.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.993 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.578 HG11 HD13 ' A' ' 56' ' ' LEU . 55.7 t -58.8 -48.92 84.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.025 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.08 -26.5 6.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.311 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -58.48 -64.54 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.727 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -59.65 -57.95 10.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.801 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.24 83.51 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -56.57 111.77 1.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.027 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 26' ' ' PHE . 45.9 t -92.15 127.36 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.8 t -153.47 39.45 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.177 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.0 m -128.03 -53.87 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.704 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 55.1 mtm 65.16 83.62 0.19 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.303 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 85.9 Cg_endo -89.18 -166.11 2.98 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.881 -1.3 . . . . 0.0 112.477 -0.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.487 ' C ' HD12 ' A' ' 76' ' ' LEU . 84.8 m -144.88 103.0 3.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.719 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 76' ' ' LEU . 4.0 mp -109.67 119.16 38.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.609 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.732 HD11 HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.15 152.41 35.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.054 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.653 ' CD2' HD21 ' A' ' 21' ' ' LEU . 1.9 m-85 -117.87 134.84 54.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.374 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.54 ' CD2' HD22 ' A' ' 15' ' ' LEU . 76.4 m-85 -109.47 147.49 32.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.66 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -145.67 76.91 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.659 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.13 51.62 1.33 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.12 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.76 27.39 59.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.873 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -144.32 147.45 33.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.965 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -102.21 135.01 44.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.673 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.79 -39.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.876 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.812 HG21 ' ND2' ' A' ' 103' ' ' ASN . 83.1 m -101.1 118.94 37.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.849 0.357 . . . . 0.0 110.262 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -118.13 170.66 8.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.017 0.437 . . . . 0.0 111.614 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -155.81 83.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.704 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.3 88.79 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -170.29 -34.52 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.973 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.585 ' HB1' HD13 ' A' ' 37' ' ' ILE . . . 77.53 83.28 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.926 0.393 . . . . 0.0 111.121 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 94' ' ' ALA . 14.3 t-20 -145.41 129.81 8.86 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.625 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.507 ' HD2' ' ND2' ' A' ' 92' ' ' ASN . 30.1 Cg_endo -64.11 -8.64 16.86 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.668 2.245 . . . . 0.0 113.326 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' ' OD1' ' A' ' 92' ' ' ASN . . . -98.1 -34.69 10.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.697 0.285 . . . . 0.0 111.173 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -57.66 -33.87 68.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.128 0.49 . . . . 0.0 110.171 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.977 HD13 HG22 ' A' ' 41' ' ' ILE . 4.2 tp -56.01 -50.41 69.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.297 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 11.0 tmtt? -59.01 -57.35 13.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.718 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -68.71 -11.76 60.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.61 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -81.19 -60.03 2.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.778 0.323 . . . . 0.0 111.38 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 96' ' ' ILE . 2.0 mp -75.66 -57.14 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.068 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 97' ' ' LYS . . . -46.09 -27.05 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.671 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.9 t -77.96 -57.78 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.429 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.812 ' ND2' HG21 ' A' ' 86' ' ' THR . 22.9 p30 -109.97 40.91 1.82 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 111.391 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.45 ' HA ' HD12 ' A' ' 21' ' ' LEU . 11.6 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.992 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.829 0.347 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.632 HG21 ' HG3' ' A' ' 42' ' ' GLU . 61.1 t -53.39 133.61 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 4' ' ' GLN . 4.8 m -107.2 165.02 11.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.08 0.467 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.4 ' N ' HG22 ' A' ' 3' ' ' THR . 14.0 mp0 -96.21 79.07 3.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.48 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.588 HD23 HD21 ' A' ' 56' ' ' LEU . 37.6 tp -89.16 95.75 10.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.495 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -106.02 -36.93 6.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.348 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -105.21 145.43 30.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.622 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.34 75.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.056 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -51.83 -28.95 17.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.72 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -80.8 -30.49 35.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.567 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CE1' HG21 ' A' ' 24' ' ' VAL . 48.2 t80 -78.79 -45.27 21.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.903 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -57.16 -52.24 66.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -62.46 -27.73 69.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.79 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 11' ' ' TYR . . . -61.19 -53.14 60.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 79' ' ' TYR . 83.7 mt -59.47 -30.96 68.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.881 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.22 -67.91 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -90.39 24.9 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.366 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 19' ' ' ASP . . . -58.66 -97.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.628 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 65.4 t0 68.75 -62.16 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.647 0.261 . . . . 0.0 111.167 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -46.62 -82.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.15 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.884 HD21 HG23 ' A' ' 100' ' ' ILE . 34.7 tp -178.47 111.85 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.752 0.31 . . . . 0.0 110.977 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.685 HG13 ' CE2' ' A' ' 54' ' ' TYR . 47.7 t -105.13 141.02 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.616 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.2 t -144.03 111.03 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 111.373 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.536 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 62.1 t -99.96 116.85 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.732 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 27' ' ' PHE . 10.0 t0 -106.07 103.73 13.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.936 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.64 ' CD2' HG21 ' A' ' 70' ' ' VAL . 64.8 m-85 -92.07 108.53 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.986 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CD1' ' OD1' ' A' ' 25' ' ' ASP . 1.7 p90 -153.23 120.37 5.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.888 ' HB2' HG12 ' A' ' 58' ' ' VAL . . . -93.79 27.01 2.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.116 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.2 p 49.72 51.86 15.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.08 0.467 . . . . 0.0 110.999 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.578 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.1 m-90 -66.73 -62.71 1.31 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.009 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.8 t 161.86 144.75 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.758 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.07 -112.43 3.65 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.676 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.884 ' HA ' HD13 ' A' ' 37' ' ' ILE . 91.1 Cg_exo -43.66 -71.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.953 2.435 . . . . 0.0 113.413 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 38' ' ' ALA . 26.8 p -48.78 -24.19 1.33 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -84.15 -73.07 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.784 0.326 . . . . 0.0 111.863 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 83.6 mtp -66.28 -34.07 77.16 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.884 HD13 ' HA ' ' A' ' 33' ' ' PRO . 1.4 mp -90.52 24.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.186 0.517 . . . . 0.0 111.207 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -90.15 -52.35 0.33 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.85 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 34.0 Cg_exo -62.47 -32.18 80.45 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.649 2.233 . . . . 0.0 113.009 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.702 ' CE ' HG23 ' A' ' 37' ' ' ILE . 42.4 mtm -57.56 -77.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.918 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.919 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.6 pp -56.0 -27.41 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.758 0.313 . . . . 0.0 111.044 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.919 ' N ' HD12 ' A' ' 41' ' ' ILE . 89.1 tt0 -75.2 -28.13 59.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.029 0.443 . . . . 0.0 110.512 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' PRO . 22.9 ttpp -83.37 -48.6 10.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.427 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -50.52 -27.12 6.07 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.845 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.59 -28.67 56.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.957 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.92 -14.77 33.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.108 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -85.4 10.08 13.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.571 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.42 153.26 40.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.755 0.312 . . . . 0.0 110.823 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -80.91 -40.34 24.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.968 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -134.52 95.79 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.068 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -143.4 121.75 12.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -100.2 98.39 9.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.371 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 10.6 m-85 -91.64 129.11 37.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.31 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.685 ' CE2' HG13 ' A' ' 22' ' ' VAL . 17.6 m-30 -114.09 107.13 15.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.89 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HB2' HG13 ' A' ' 2' ' ' VAL . 85.6 tttt -89.77 125.43 35.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.437 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.756 HD22 HG11 ' A' ' 61' ' ' VAL . 86.7 mt -130.62 156.74 44.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.067 0.46 . . . . 0.0 111.53 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.54 117.96 15.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.238 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.888 HG12 ' HB2' ' A' ' 28' ' ' ALA . 8.2 p -65.74 74.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.074 0.464 . . . . 0.0 111.2 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 t70 179.89 -69.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.135 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -78.63 -31.03 46.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.886 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.756 HG11 HD22 ' A' ' 56' ' ' LEU . 25.1 t -113.47 30.69 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.878 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.1 p -49.03 -26.89 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.345 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -44.62 -55.36 5.26 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.523 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.725 HG11 ' CD1' ' A' ' 56' ' ' LEU . 48.2 t -59.58 -46.4 93.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.001 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.91 -34.21 58.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.431 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -54.95 -69.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.08 -47.54 85.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -83.5 80.38 9.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.37 111.23 1.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.831 ' CG1' HG21 ' A' ' 75' ' ' THR . 48.7 t -119.08 145.63 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -144.5 70.15 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.031 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.508 ' HB3' HG11 ' A' ' 89' ' ' VAL . 64.4 m -165.46 -175.61 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.697 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.476 ' HB3' ' CH2' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -170.02 106.66 0.44 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.672 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.631 ' O ' HG13 ' A' ' 89' ' ' VAL . 4.9 Cg_exo -74.66 -155.64 1.06 Allowed 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 124.1 -1.208 . . . . 0.0 111.99 -0.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.831 HG21 ' CG1' ' A' ' 70' ' ' VAL . 86.9 m -164.22 108.23 0.96 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.8 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.749 HD12 ' C ' ' A' ' 75' ' ' THR . 3.9 mp -123.56 119.3 29.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.574 HD12 ' CE2' ' A' ' 79' ' ' TYR . 26.3 pt -110.37 152.8 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.017 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -127.03 122.84 35.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.051 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.574 ' CE2' HD12 ' A' ' 77' ' ' ILE . 68.7 m-85 -109.68 136.99 48.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.21 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -118.11 -36.45 3.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.311 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.98 49.57 0.8 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.906 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.54 28.0 66.9 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.777 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' O ' HG13 ' A' ' 85' ' ' VAL . 34.9 mmtp -145.94 114.28 6.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.751 0.31 . . . . 0.0 110.962 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.442 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 11.9 pt-20 -58.08 123.94 17.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.662 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 86' ' ' THR . 35.4 m -136.04 -44.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.494 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 94.3 m -103.33 105.36 15.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 110.619 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -103.49 147.86 26.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.455 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 48.4 t -138.28 82.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.798 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 74' ' ' PRO . 45.4 t -109.54 62.78 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.11 127.05 1.42 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.259 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HB1' HG12 ' A' ' 37' ' ' ILE . . . -55.25 124.68 17.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.774 0.321 . . . . 0.0 111.049 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 51.0 t-20 -176.15 103.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.612 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 11.2 Cg_endo -56.2 -13.98 10.9 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.652 2.235 . . . . 0.0 113.23 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -96.91 -44.56 6.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.69 -31.18 15.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 110.625 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.835 HD13 HG22 ' A' ' 41' ' ' ILE . 4.2 tp -58.03 -44.84 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.05 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -61.32 -75.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.934 0.397 . . . . 0.0 111.2 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -44.66 -32.92 1.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.542 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.98 -41.74 77.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.405 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.884 HG23 HD21 ' A' ' 21' ' ' LEU . 73.7 mt -84.96 -44.34 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.338 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.57 -13.48 59.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.6 p -90.14 -26.32 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.48 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 49.8 m-80 -114.72 -19.43 11.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.658 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.497 ' HA ' HD22 ' A' ' 21' ' ' LEU . 9.1 p . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.614 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.835 0.35 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.711 HG13 ' HB2' ' A' ' 55' ' ' LYS . 59.4 t -48.23 121.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -106.61 170.51 7.89 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.249 0.547 . . . . 0.0 110.974 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 3' ' ' THR . 14.1 mp0 -111.71 98.17 7.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.001 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.679 HD22 HD11 ' A' ' 56' ' ' LEU . 5.4 mp -88.98 119.61 29.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.845 0.355 . . . . 0.0 111.168 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -107.86 -69.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.906 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.6 t -84.56 162.86 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.13 -29.45 60.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.3 p -59.67 -33.39 71.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.05 -31.58 70.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.611 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 45.4 t80 -90.14 -36.37 14.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.61 -54.64 44.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -67.81 -20.12 65.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.279 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.667 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -69.59 -53.27 19.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.215 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.842 HD23 HG11 ' A' ' 22' ' ' VAL . 85.1 mt -58.63 -28.85 66.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.11 -58.87 2.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.356 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -55.96 -72.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.98 129.37 47.36 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.646 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -125.23 22.9 7.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.655 0.264 . . . . 0.0 111.17 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -96.54 -75.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.811 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.86 HD22 ' HB ' ' A' ' 104' ' ' VAL . 20.3 tp -159.09 107.33 1.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.965 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.842 HG11 HD23 ' A' ' 15' ' ' LEU . 52.2 t -103.57 112.91 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.623 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.9 114.68 43.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.584 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.704 ' HB ' HD11 ' A' ' 77' ' ' ILE . 54.8 t -100.28 145.1 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.399 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 38.3 t70 -127.07 92.76 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 0.0 111.595 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.742 ' CE1' HD22 ' A' ' 56' ' ' LEU . 72.6 m-85 -88.84 94.87 10.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.832 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.546 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 5.3 p90 -129.69 122.24 28.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.421 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -93.24 79.45 4.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.363 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 29' ' ' THR . 4.7 t -48.1 94.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.983 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.572 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.8 m-90 -92.06 -48.65 6.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 44.7 t 150.02 58.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.935 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.19 -121.9 0.58 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.655 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.437 ' O ' HG12 ' A' ' 37' ' ' ILE . 32.0 Cg_exo -57.13 -73.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.392 2.061 . . . . 0.0 112.192 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 6.0 p -41.54 -32.06 0.32 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -65.18 -47.36 77.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.039 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.2 mtp -84.81 -23.2 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.395 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 37' ' ' ILE . 49.0 mm -75.53 -7.55 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.425 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.916 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -63.77 -63.98 3.37 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.916 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 72.3 Cg_exo -48.64 -38.49 36.6 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.323 2.015 . . . . 0.0 112.905 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 64.1 mtt -52.5 -82.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.15 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.004 HG22 HD12 ' A' ' 96' ' ' ILE . 2.5 pp -56.38 -26.98 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.16 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.897 ' N ' HD12 ' A' ' 41' ' ' ILE . 89.4 tt0 -72.24 -25.85 61.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.399 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.463 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -85.89 -48.25 8.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.017 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -54.06 -27.46 32.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -56.8 -27.35 59.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.811 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -89.96 -10.78 43.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.095 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -90.08 16.85 7.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.668 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -131.88 158.37 41.54 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.9 m -95.63 -33.78 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -136.39 77.76 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.473 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -130.76 116.63 18.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.85 94.79 9.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.957 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.473 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 9.8 m-85 -90.03 128.55 36.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.638 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.667 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 18.6 m-30 -114.91 96.12 5.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.982 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.789 ' C ' HD12 ' A' ' 56' ' ' LEU . 87.4 tttt -89.79 120.88 31.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.333 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.789 HD12 ' C ' ' A' ' 55' ' ' LYS . 3.6 mp -129.79 -175.94 3.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.471 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.48 ' OD1' HG12 ' A' ' 58' ' ' VAL . 62.5 t0 -137.12 -82.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.953 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.48 HG12 ' OD1' ' A' ' 57' ' ' ASP . 7.7 p 177.83 -37.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.744 0.307 . . . . 0.0 111.025 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -98.22 -31.46 12.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.45 -38.01 82.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.831 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.459 HG21 HD23 ' A' ' 56' ' ' LEU . 45.3 t -103.81 -50.82 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.1 t 68.24 -63.92 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.46 -67.4 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.471 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.4 t -57.41 -61.03 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.029 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.89 -28.9 2.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.387 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -76.02 -62.23 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.739 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.501 ' HD3' ' N ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -60.35 -29.44 68.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.598 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -88.25 80.79 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.895 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -53.75 95.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 68' ' ' ALA . 47.3 t -86.94 157.77 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.273 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.483 ' N ' HG12 ' A' ' 70' ' ' VAL . 80.6 p -149.6 128.52 12.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.73 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.4 m 62.43 82.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.933 0.397 . . . . 0.0 110.553 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.528 ' HE2' ' HA ' ' A' ' 27' ' ' PHE . 38.2 mtp -84.3 152.32 61.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.617 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.07 173.28 53.0 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 123.63 -1.404 . . . . 0.0 112.71 0.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 1.053 HG23 HG12 ' A' ' 89' ' ' VAL . 94.0 m -147.86 132.25 17.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.607 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.886 HD21 HG21 ' A' ' 41' ' ' ILE . 4.1 mp -124.59 142.31 51.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.207 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.744 HD13 ' N ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -139.36 147.47 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.833 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.5 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.6 m-85 -117.87 121.3 40.37 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.051 0.453 . . . . 0.0 111.435 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 61.2 m-85 -109.65 130.4 55.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.002 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.61 53.53 1.83 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.219 0.533 . . . . 0.0 109.924 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.21 41.4 0.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.146 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.34 37.03 86.26 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.078 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -151.09 107.76 3.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.69 0.281 . . . . 0.0 111.242 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 44.4 tt0 -58.77 126.82 29.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.169 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 86' ' ' THR . 22.3 m -138.67 -46.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 71.5 p -113.4 77.88 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.126 0.489 . . . . 0.0 111.045 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -80.7 158.84 25.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.147 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.476 HG21 ' CB ' ' A' ' 99' ' ' ALA . 60.0 t -141.52 85.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.697 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 1.053 HG12 HG23 ' A' ' 75' ' ' THR . 35.1 m -109.26 78.06 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.139 0.495 . . . . 0.0 111.294 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.99 148.05 16.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.325 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.26 76.38 7.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.872 0.367 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -156.48 125.6 3.08 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.58 -6.89 20.1 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.49 2.127 . . . . 0.0 112.79 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.51 -36.32 12.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.0 110.94 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -50.14 -28.08 6.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.159 0.504 . . . . 0.0 110.204 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.004 HD12 HG22 ' A' ' 41' ' ' ILE . 6.1 tt -80.92 -33.03 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.729 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.43 -61.05 2.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -75.69 -5.92 47.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.641 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -89.7 -43.94 10.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.797 0.332 . . . . 0.0 111.244 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.684 HG23 ' CD2' ' A' ' 21' ' ' LEU . 63.0 mt -74.13 -53.81 16.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.782 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.28 -20.94 31.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.652 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.9 p -82.95 -75.52 0.31 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.664 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.541 ' OD1' HD12 ' A' ' 21' ' ' LEU . 20.8 t-20 -52.72 -37.82 59.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.118 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.86 ' HB ' HD22 ' A' ' 21' ' ' LEU . 14.8 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.485 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.861 0.363 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 59.6 t -57.57 145.18 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.48 ' HB ' HD11 ' A' ' 5' ' ' LEU . 2.2 m -107.84 158.62 17.17 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -96.71 92.6 6.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.683 HD22 HD21 ' A' ' 56' ' ' LEU . 4.8 mp -88.9 109.94 20.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.704 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -104.53 -55.65 2.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.34 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.0 t -101.49 151.68 21.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.55 67.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.5 p -55.87 -31.31 62.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -69.23 -36.73 77.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.757 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.519 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 48.3 t80 -60.66 -40.94 93.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.85 -65.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -57.8 -24.6 58.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.019 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HB1' ' CE2' ' A' ' 54' ' ' TYR . . . -57.95 -54.8 42.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.709 HD23 HG21 ' A' ' 22' ' ' VAL . 80.8 mt -82.92 1.39 39.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.332 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.06 -74.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.786 0.327 . . . . 0.0 111.245 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.1 p -71.83 -34.42 69.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.08 119.08 7.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.573 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.78 26.69 5.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.02 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -93.96 -70.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.687 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.568 ' C ' HD23 ' A' ' 21' ' ' LEU . 4.2 tt -174.86 105.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.368 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.709 HG21 HD23 ' A' ' 15' ' ' LEU . 49.3 t -99.82 132.62 44.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 ' CD2' ' A' ' 21' ' ' LEU . 46.1 t -127.82 115.48 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.142 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.505 HG11 ' CE2' ' A' ' 26' ' ' PHE . 47.2 t -99.96 117.79 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.711 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -106.94 99.44 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.505 ' CE2' HG11 ' A' ' 24' ' ' VAL . 53.8 m-85 -90.41 111.24 22.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.999 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.41 ' CE1' ' O ' ' A' ' 56' ' ' LEU . 1.7 p90 -144.56 120.02 10.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.615 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.915 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -85.57 10.33 13.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.538 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.8 p 49.65 51.01 17.29 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.017 0.437 . . . . 0.0 111.204 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.915 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.3 m-90 -67.12 -62.31 1.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.971 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.4 t 160.48 127.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.461 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.25 -118.78 4.08 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.314 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.595 ' CB ' HD12 ' A' ' 37' ' ' ILE . 20.9 Cg_endo -61.33 -43.57 27.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.601 2.201 . . . . 0.0 112.81 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 26.3 p -69.96 63.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 0.0 111.268 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 35' ' ' LYS . 7.2 ttpm? 176.1 -53.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.486 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.0 tpt -84.09 -30.05 26.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.595 HD12 ' CB ' ' A' ' 33' ' ' PRO . 54.6 mt -86.87 -30.43 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.984 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -48.37 -52.63 41.37 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.55 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.698 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 74.0 Cg_exo -49.24 -43.5 37.07 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.039 1.826 . . . . 0.0 111.495 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.822 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 71.0 mtp -60.33 -22.04 62.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.994 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.603 HD13 HD21 ' A' ' 76' ' ' LEU . 13.3 mt -91.62 -55.78 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.151 0.5 . . . . 0.0 110.085 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 3.9 tm-20 -54.94 -57.06 13.18 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.72 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.524 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 5.4 ttpm? -49.62 -47.97 49.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.075 0.464 . . . . 0.0 110.465 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.822 ' CD1' ' O ' ' A' ' 40' ' ' MET . 7.1 m-85 -54.59 -23.93 18.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.192 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -58.46 -28.14 65.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.031 0.444 . . . . 0.0 110.678 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -89.7 -11.25 42.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.068 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.03 15.57 9.86 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.608 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.548 ' CD2' HG21 ' A' ' 100' ' ' ILE . 42.3 m-85 -125.68 145.45 50.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.839 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.8 p -66.54 -47.06 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 104' ' ' VAL . 12.0 p-10 -143.7 99.26 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.988 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.14 122.7 16.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -90.03 97.66 11.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 8.6 m-85 -89.89 126.2 35.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.883 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.63 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 19.3 m-30 -119.37 104.18 10.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.54 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HE3' HG11 ' A' ' 2' ' ' VAL . 40.2 ttmt -89.79 123.5 33.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.091 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.736 HD22 HG11 ' A' ' 61' ' ' VAL . 86.4 mt -128.72 158.93 37.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.855 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -145.69 -176.58 5.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 59' ' ' ASP . 11.1 p -90.54 158.85 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.067 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.489 ' N ' HG22 ' A' ' 58' ' ' VAL . 7.9 t70 67.22 -70.0 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -55.6 -30.37 60.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.98 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.736 HG11 HD22 ' A' ' 56' ' ' LEU . 45.2 t -137.72 53.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.967 0.413 . . . . 0.0 110.936 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.6 t -71.44 -28.68 64.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -58.36 -40.25 81.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.055 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.632 HG11 ' CD1' ' A' ' 56' ' ' LEU . 44.4 t -75.8 -52.85 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.83 -39.41 58.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.21 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -60.87 -31.78 71.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.815 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -81.55 -47.4 13.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.789 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.86 77.66 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.121 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.6 118.12 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.818 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.824 ' CG1' HG21 ' A' ' 75' ' ' THR . 31.5 m -130.73 150.75 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.221 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.7 m -133.78 57.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.98 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 m -141.84 -169.38 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.548 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.1 ptp -166.11 91.59 0.83 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.447 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 83.2 Cg_endo -84.66 -163.79 3.09 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 124.063 -1.224 . . . . 0.0 112.393 -0.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.824 HG21 ' CG1' ' A' ' 70' ' ' VAL . 89.8 m -133.48 118.04 17.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.586 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.753 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -123.74 137.23 54.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.847 0.356 . . . . 0.0 111.278 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.504 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 28.7 pt -133.72 162.72 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.834 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.524 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.0 m-85 -132.41 128.64 37.97 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 111.242 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.504 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 71.2 m-85 -109.89 158.82 17.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.742 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -156.6 73.46 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.794 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.28 -18.65 23.12 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.505 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.01 48.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.26 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -169.96 127.64 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.995 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.66 98.69 5.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.3 m -110.75 -28.32 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.364 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 99.7 m -114.84 103.3 10.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.918 0.389 . . . . 0.0 110.269 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -107.36 157.67 17.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.266 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -155.27 81.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.717 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 89' ' ' VAL . 35.8 m -109.64 106.14 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.333 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.06 -113.43 0.29 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.426 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -178.19 77.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 111.035 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -151.86 129.35 5.74 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.602 ' HB2' ' HE2' ' A' ' 40' ' ' MET . 87.0 Cg_endo -82.39 9.59 3.94 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.635 2.223 . . . . 0.0 113.021 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.91 -50.78 3.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.732 0.301 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.96 -27.93 14.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 110.614 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.45 HG22 ' C ' ' A' ' 93' ' ' PRO . 4.4 tp -54.14 -43.47 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.194 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -71.92 -71.51 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.031 0.443 . . . . 0.0 111.129 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -44.2 -32.19 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.583 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.24 -51.39 15.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.181 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 100' ' ' ILE . 66.4 mt -76.26 -5.14 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.496 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.55 -24.61 21.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 0.0 111.38 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -89.98 -59.38 2.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.31 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.461 HD21 HG21 ' A' ' 86' ' ' THR . 59.6 m-80 -54.62 -43.1 71.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.101 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.511 ' N ' HD12 ' A' ' 21' ' ' LEU . 10.2 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.373 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.858 0.361 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 53' ' ' PHE . 46.8 t -57.63 137.44 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.672 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.5 m -89.94 168.05 12.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 110.871 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.416 ' H ' HG22 ' A' ' 3' ' ' THR . 14.7 mp0 -108.51 94.8 5.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.886 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.84 ' HB2' HD21 ' A' ' 56' ' ' LEU . 4.9 mp -88.96 132.05 34.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.205 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.61 -62.85 0.95 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 t -86.19 152.98 22.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.17 -28.84 64.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.327 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.5 p -57.42 -30.41 64.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.058 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -74.34 -37.64 63.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.47 -52.43 65.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.22 -56.03 27.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.057 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -57.8 -28.72 64.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.028 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.831 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -68.54 -43.42 76.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.135 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 79' ' ' TYR . 78.3 mt -67.96 -40.34 83.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.044 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.0 -46.45 62.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.204 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.5 m -75.78 -53.43 8.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.057 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.06 115.26 7.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.599 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -113.14 -31.89 6.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.71 0.29 . . . . 0.0 111.039 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.91 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.997 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.908 HD13 ' HB2' ' A' ' 103' ' ' ASN . 41.5 tp -159.65 115.98 2.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.569 HG13 ' CE2' ' A' ' 54' ' ' TYR . 54.2 t -111.72 106.34 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.832 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.653 HG21 ' CD1' ' A' ' 100' ' ' ILE . 44.8 t -102.92 144.12 14.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.464 HG11 ' CE2' ' A' ' 26' ' ' PHE . 60.0 t -128.31 146.54 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -135.84 111.8 9.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.944 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.464 ' CE2' HG11 ' A' ' 24' ' ' VAL . 56.5 m-85 -105.44 113.56 27.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.198 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.427 ' HB2' ' CB ' ' A' ' 34' ' ' CYS . 2.1 p90 -147.92 120.72 8.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.721 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.9 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -82.84 9.92 8.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.686 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.2 p 50.57 55.51 9.4 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.059 0.457 . . . . 0.0 111.058 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.9 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.2 m-90 -71.81 -61.88 1.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.014 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 39.6 t 158.85 101.77 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.467 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.84 -126.69 2.51 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.279 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' LYS . 92.4 Cg_exo -42.73 -60.61 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.962 2.441 . . . . 0.0 113.234 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.427 ' CB ' ' HB2' ' A' ' 27' ' ' PHE . 26.9 p -65.85 66.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.357 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' PRO . 56.6 tptt 176.14 -35.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.3 mtt -81.84 -65.89 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.684 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.662 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -88.16 18.69 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.766 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -63.42 -53.37 53.0 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.648 0.261 . . . . 0.0 110.663 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 52.3 Cg_exo -55.58 -33.07 85.58 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.64 2.227 . . . . 0.0 112.21 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.471 ' CE ' ' HB3' ' A' ' 93' ' ' PRO . 67.3 mtp -54.82 -71.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 110.468 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.483 HG22 ' HB ' ' A' ' 96' ' ' ILE . 7.6 pt -52.44 -39.25 28.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.094 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.28 -27.52 65.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.64 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -79.72 -45.84 18.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -53.62 -25.04 15.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.546 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.789 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -55.79 -29.97 60.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.732 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -87.63 -3.12 58.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.877 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -90.27 -35.24 15.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.542 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.796 ' CE2' HG21 ' A' ' 100' ' ' ILE . 45.7 m-85 -76.49 157.29 32.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.798 0.332 . . . . 0.0 111.183 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.4 p -79.98 -38.36 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -155.38 104.07 2.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.133 0.492 . . . . 0.0 111.403 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -150.13 125.69 10.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.104 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.32 107.46 19.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 110.771 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.789 ' CE2' ' HB1' ' A' ' 45' ' ' ALA . 9.3 m-85 -99.96 130.79 46.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.004 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.831 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 20.5 m-30 -113.9 119.73 38.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' HG11 ' A' ' 2' ' ' VAL . 61.4 tttp -104.11 115.02 29.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.883 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.84 HD21 ' HB2' ' A' ' 5' ' ' LEU . 89.7 mt -134.68 170.7 15.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.237 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.28 153.59 46.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.644 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.873 ' HB ' ' HB2' ' A' ' 28' ' ' ALA . 47.3 t -88.09 55.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.986 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -177.46 -65.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.054 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.53 -30.65 61.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.036 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.431 HG21 HD22 ' A' ' 56' ' ' LEU . 51.2 t -102.13 -58.84 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.814 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.9 t 67.35 -64.64 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.393 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -40.6 -68.39 0.18 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.828 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.671 HG11 ' CD1' ' A' ' 56' ' ' LEU . 59.7 t -52.13 -44.21 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.163 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.31 56.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -57.15 -68.24 0.25 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.988 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.94 -25.37 57.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.72 74.49 7.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.311 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.0 mp0 -69.89 105.97 3.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.762 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.626 ' CB ' HG21 ' A' ' 75' ' ' THR . 35.2 m -132.95 -178.58 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.8 p -164.48 72.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.819 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -157.54 -170.17 3.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.609 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.8 ptt? -165.81 98.56 0.76 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.192 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 2.8 Cg_exo -75.76 -155.43 1.06 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.261 -1.141 . . . . 0.0 112.129 0.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.626 HG21 ' CB ' ' A' ' 70' ' ' VAL . 86.7 m -155.65 100.66 2.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.587 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 76' ' ' LEU . 3.9 mp -113.85 162.79 15.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.917 0.389 . . . . 0.0 111.256 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.561 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 17.1 pt -156.89 160.18 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.82 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.634 ' HE2' HD13 ' A' ' 100' ' ' ILE . 1.3 m-85 -128.68 123.05 32.16 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.984 0.421 . . . . 0.0 111.368 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.562 ' CD2' HD22 ' A' ' 15' ' ' LEU . 69.8 m-85 -109.91 101.79 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.831 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.97 -70.53 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 110.732 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.39 27.32 7.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.368 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.08 49.82 1.69 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.364 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' O ' HG13 ' A' ' 85' ' ' VAL . 24.2 ttmm -169.82 114.96 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.334 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -55.62 99.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 83' ' ' LYS . 35.6 m -121.38 -28.99 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.799 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.43 ' O ' ' CD1' ' A' ' 78' ' ' PHE . 89.1 m -122.44 74.99 1.21 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 110.649 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -82.37 159.6 23.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.2 0.524 . . . . 0.0 111.643 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -156.72 86.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.085 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.641 ' O ' HG23 ' A' ' 89' ' ' VAL . 27.8 m -108.61 87.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.37 0.605 . . . . 0.0 111.28 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.36 -152.06 7.09 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.968 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.42 92.75 2.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.795 0.331 . . . . 0.0 110.998 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -144.53 101.21 4.7 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.071 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 96' ' ' ILE . 32.1 Cg_exo -58.52 -15.14 23.76 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.553 2.169 . . . . 0.0 112.431 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.62 -31.49 13.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 110.83 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.86 -31.33 64.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.797 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 93' ' ' PRO . 3.8 tp -53.76 -33.87 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.072 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -68.29 -67.7 0.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.118 0.485 . . . . 0.0 110.832 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -53.72 -49.48 68.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.492 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.562 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -51.25 -65.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.625 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.796 HG21 ' CE2' ' A' ' 48' ' ' TYR . 41.2 mm -52.33 -48.57 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.419 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . . . -55.41 -21.8 17.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.856 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.5 m -57.55 -50.09 74.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.491 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.908 ' HB2' HD13 ' A' ' 21' ' ' LEU . 21.1 m-80 -122.84 5.56 9.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.621 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 101' ' ' ALA . 13.0 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.623 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.811 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 22.9 ptp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.801 0.334 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.66 HG11 ' HE2' ' A' ' 55' ' ' LYS . 43.9 t -55.94 132.27 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.945 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.3 m -107.13 168.71 9.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 110.803 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.445 ' H ' HG22 ' A' ' 3' ' ' THR . 15.0 mp0 -108.41 98.99 8.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.156 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.688 HD12 HD21 ' A' ' 56' ' ' LEU . 63.2 mt -88.81 96.05 10.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.252 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -89.88 -57.06 2.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.882 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.4 t -95.38 158.43 15.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' OD2' ' A' ' 63' ' ' ASP . . . -73.32 -29.33 62.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.083 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.4 p -57.75 -31.34 66.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -71.19 -31.32 67.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -76.21 -42.64 45.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -70.13 -50.17 43.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -58.97 -28.64 66.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.542 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -70.13 -64.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.458 HD22 ' CG ' ' A' ' 79' ' ' TYR . 81.9 mt -57.44 -21.87 39.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.17 -79.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.446 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.7 m -83.43 -29.62 27.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.197 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.1 104.3 0.23 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.673 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -86.99 -27.38 23.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 0.0 110.705 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -53.62 -176.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.973 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 4.8 tt -86.11 115.84 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.698 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.577 HG13 ' CD2' ' A' ' 54' ' ' TYR . 56.5 t -102.99 127.2 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.644 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.42 HG23 HD22 ' A' ' 21' ' ' LEU . 46.3 t -120.12 119.61 60.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.368 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.487 HG13 HD12 ' A' ' 56' ' ' LEU . 51.9 t -104.77 124.84 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.482 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -117.21 103.77 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.919 0.39 . . . . 0.0 111.612 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.429 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 75.1 m-85 -93.88 115.28 27.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.948 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.467 ' CD2' ' CG2' ' A' ' 29' ' ' THR . 1.1 p90 -150.19 117.96 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 111.212 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.36 -9.53 58.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.893 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.467 ' CG2' ' CD2' ' A' ' 27' ' ' PHE . 69.4 p 52.73 74.08 0.31 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.361 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.57 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.0 m-90 -80.92 -62.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 43.6 t 158.86 69.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.459 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.4 -121.11 0.78 Allowed Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.927 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.16 -52.1 6.02 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.702 2.268 . . . . 0.0 112.562 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.5 p -79.77 60.87 3.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.727 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -162.99 -47.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.392 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.2 tpt -83.56 -26.79 29.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.53 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.499 HD11 ' HB1' ' A' ' 91' ' ' ALA . 63.1 mt -79.96 -15.69 13.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.204 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.85 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -52.48 -60.08 7.21 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.403 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.85 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 86.2 Cg_exo -46.93 -36.03 19.44 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.369 2.046 . . . . 0.0 112.605 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.416 ' HB3' ' HB3' ' A' ' 93' ' ' PRO . 55.1 mtt -57.5 -76.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.577 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.904 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -60.23 -24.39 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.908 0.385 . . . . 0.0 110.861 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.904 ' N ' HD12 ' A' ' 41' ' ' ILE . 89.4 tt0 -75.53 -26.58 58.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.489 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 6.6 tmtm? -85.7 -48.3 8.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.177 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.603 ' CD1' HD11 ' A' ' 96' ' ' ILE . 7.4 m-85 -46.33 -29.8 1.81 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.214 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.811 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -52.9 -26.32 14.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -90.06 -30.34 17.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.993 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -62.07 -35.68 79.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.326 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.579 ' CE2' HG21 ' A' ' 100' ' ' ILE . 46.7 m-85 -97.13 155.59 16.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 110.761 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -106.61 -21.77 12.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.309 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.878 ' OD1' HG22 ' A' ' 104' ' ' VAL . 2.9 p30 -125.52 35.32 4.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.764 0.316 . . . . 0.0 111.454 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.8 118.16 36.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.282 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.67 95.84 10.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 13.5 m-85 -89.69 123.34 33.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.607 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.58 ' HB3' HD11 ' A' ' 5' ' ' LEU . 14.7 m-30 -115.82 102.81 10.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.806 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.66 ' HE2' HG11 ' A' ' 2' ' ' VAL . 24.4 ttmm -89.83 124.11 34.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.571 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.688 HD21 HD12 ' A' ' 5' ' ' LEU . 86.2 mt -119.36 146.86 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.293 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -134.39 161.42 35.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.548 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.1 m -77.67 156.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.198 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.1 t0 66.03 -72.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.222 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.44 -30.85 61.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.109 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.574 HG11 HD22 ' A' ' 56' ' ' LEU . 47.4 t -139.95 55.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.4 m -80.48 -22.08 41.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 8' ' ' ALA . 12.2 p-10 -47.21 -29.76 2.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.292 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.634 HG11 ' CD1' ' A' ' 56' ' ' LEU . 47.5 t -79.43 -54.85 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.993 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.43 -35.56 19.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.421 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -58.45 -45.24 88.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.765 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -89.51 -65.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.62 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.66 77.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.822 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -50.86 93.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.18 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.0 t -148.83 136.28 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.814 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.3 p -105.21 150.13 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' A' ' 73' ' ' MET . 60.4 p -61.01 -173.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.904 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.683 ' H ' ' HA ' ' A' ' 74' ' ' PRO . 60.3 ttp 167.52 -38.11 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.683 ' HA ' ' H ' ' A' ' 73' ' ' MET . 94.0 Cg_endo -76.57 175.26 48.97 Favored 'Cis proline' 0 C--N 1.36 1.157 0 CA-C-N 120.67 1.275 . . . . 0.0 113.812 0.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.809 ' C ' HD12 ' A' ' 76' ' ' LEU . 56.3 m -127.89 135.82 50.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.764 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.809 HD12 ' C ' ' A' ' 75' ' ' THR . 4.1 mp -129.93 146.18 51.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.906 0.384 . . . . 0.0 111.231 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.533 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 29.2 pt -143.15 159.86 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.812 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.485 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.3 m-85 -129.57 126.87 39.51 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 111.505 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.533 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 67.5 m-85 -109.69 153.62 24.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.752 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -114.89 -38.78 3.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.975 0.417 . . . . 0.0 110.454 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.77 28.44 0.31 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.067 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.1 42.28 2.1 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.278 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -165.31 109.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.674 0.273 . . . . 0.0 111.13 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.04 115.49 3.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.443 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 m -126.34 -43.2 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 64.5 p -112.31 83.41 1.8 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.151 0.5 . . . . 0.0 110.795 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.527 HH21 HG11 ' A' ' 89' ' ' VAL . 16.5 ptm180 -83.09 166.17 18.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.592 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.8 t -156.72 87.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.967 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.722 HG12 HG23 ' A' ' 75' ' ' THR . 34.3 m -108.76 107.7 23.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.16 0.505 . . . . 0.0 111.337 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -169.77 -118.95 0.47 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.19 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . 177.77 56.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.796 0.331 . . . . 0.0 111.133 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -146.28 134.27 10.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.122 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.553 ' O ' HG12 ' A' ' 96' ' ' ILE . 57.1 Cg_endo -73.67 -19.32 21.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.413 2.075 . . . . 0.0 112.158 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.04 62.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.801 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.11 -39.85 12.62 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.511 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.628 HG21 ' CG2' ' A' ' 41' ' ' ILE . 21.2 pt -59.74 -35.38 59.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.888 0.375 . . . . 0.0 110.822 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -55.23 -70.41 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.948 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -59.94 -29.87 68.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.482 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -64.45 -42.81 95.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.064 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.602 HG23 HD13 ' A' ' 21' ' ' LEU . 75.5 mt -82.34 -31.84 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.63 -27.55 65.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.028 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.7 p -58.28 -58.22 9.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.081 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -128.06 54.54 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.878 HG22 ' OD1' ' A' ' 50' ' ' ASP . 10.0 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.035 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.867 0.365 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.6 t -83.63 136.84 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.8 p -105.01 172.17 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.476 0.655 . . . . 0.0 111.764 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -127.16 107.99 10.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.626 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.657 HD12 HD11 ' A' ' 56' ' ' LEU . 80.6 mt -89.16 88.37 7.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.007 0.432 . . . . 0.0 111.362 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.96 -43.55 10.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.198 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.4 t -105.58 137.41 43.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.783 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.633 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . . . -54.15 -25.86 24.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.416 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -59.17 -28.75 66.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.037 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.627 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 43.5 mt-10 -77.92 -26.28 48.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -78.54 -54.3 6.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.127 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -57.32 -59.86 4.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -57.18 -25.52 59.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.279 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.748 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -67.58 -61.91 1.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.792 0.33 . . . . 0.0 111.373 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -53.64 -24.59 14.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.233 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.07 -68.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.309 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.9 m -60.06 -63.51 1.27 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.42 121.9 24.39 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.732 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -124.01 -1.04 8.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -69.29 -76.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.716 0.293 . . . . 0.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 104' ' ' VAL . 3.7 tt -167.5 110.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.563 HG13 ' CE2' ' A' ' 54' ' ' TYR . 60.2 t -102.34 132.6 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.534 HG23 ' CD2' ' A' ' 21' ' ' LEU . 47.8 t -134.37 118.29 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.277 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.773 HG13 HD13 ' A' ' 56' ' ' LEU . 43.5 t -99.98 123.09 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.452 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -110.86 87.81 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.591 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 24' ' ' VAL . 60.6 m-85 -82.14 112.22 18.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.809 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 3.7 p90 -133.32 117.06 16.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.952 0.406 . . . . 0.0 111.324 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -94.43 107.22 19.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.583 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.416 ' HB ' ' CE ' ' A' ' 35' ' ' LYS . 73.8 p -53.7 114.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.1 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.448 ' CD2' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -179.56 42.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -176.54 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.156 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 152.37 -44.51 0.63 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.219 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 82.7 Cg_exo -45.56 -63.62 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.572 2.181 . . . . 0.0 112.746 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 7.7 p -49.48 -45.53 46.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' CE ' ' HB ' ' A' ' 29' ' ' THR . 99.6 mttt -58.5 -36.99 74.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.123 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.2 tpt -73.36 -26.51 61.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 37' ' ' ILE . 40.9 mm -90.37 27.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.361 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.811 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -86.82 -54.98 0.37 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.084 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 40.9 Cg_exo -57.31 -33.12 95.58 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.423 2.082 . . . . 0.0 112.298 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.416 ' CE ' ' HG3' ' A' ' 93' ' ' PRO . 57.4 mtt -60.56 -75.56 0.06 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 0.0 110.485 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.884 HG22 HD12 ' A' ' 96' ' ' ILE . 12.9 pt -51.57 -30.18 10.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.188 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -78.82 -30.71 45.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.463 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 39' ' ' PRO . 87.9 tttt -84.31 -38.26 20.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -48.24 -25.35 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.773 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 53' ' ' PHE . . . -55.27 -32.35 62.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.15 0.5 . . . . 0.0 110.587 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -85.28 -5.1 59.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -90.14 -51.62 5.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.299 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.451 ' CE2' HG13 ' A' ' 100' ' ' ILE . 50.5 m-85 -79.74 172.41 13.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.174 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.2 p -105.56 -29.68 10.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.241 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -148.72 80.17 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.435 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.742 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.44 124.54 36.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.208 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.45 106.79 18.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.041 0.448 . . . . 0.0 110.688 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 51' ' ' ALA . 21.6 m-85 -99.9 119.44 38.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.232 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.748 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 15.1 m-30 -111.24 96.56 6.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.048 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.636 ' C ' HD12 ' A' ' 56' ' ' LEU . 87.7 tttt -89.83 110.55 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.448 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.786 HD23 HG11 ' A' ' 61' ' ' VAL . 3.8 mp -118.78 157.87 26.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 0.0 111.485 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -129.78 162.31 28.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.353 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 28' ' ' ALA . 54.8 t -64.94 -32.47 58.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.432 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -97.82 -62.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.147 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -52.44 -26.06 11.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.15 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.786 HG11 HD23 ' A' ' 56' ' ' LEU . 42.0 t -133.77 60.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.3 t -81.11 0.66 35.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.415 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.633 ' OD1' ' HB2' ' A' ' 8' ' ' ALA . 7.7 t0 -90.04 -49.1 6.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 111.041 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 68' ' ' ALA . 48.2 t -59.58 -51.53 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.18 -29.52 1.6 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.639 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.95 -71.32 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.001 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -65.48 -42.6 92.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 64' ' ' VAL . . . -90.04 76.78 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -58.42 100.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.88 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 71' ' ' SER . 48.6 t -141.79 157.38 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.151 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 70' ' ' VAL . 50.7 m -86.91 -173.99 4.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.524 ' C ' ' HA ' ' A' ' 74' ' ' PRO . 81.1 p -167.18 79.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.011 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.685 ' N ' ' HA ' ' A' ' 74' ' ' PRO . 23.2 ptp -115.85 8.05 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.685 ' HA ' ' N ' ' A' ' 73' ' ' MET . 73.0 Cg_endo -83.04 -167.33 5.51 Favored 'Cis proline' 0 C--N 1.361 1.225 0 CA-C-N 121.442 1.551 . . . . 0.0 112.62 -0.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.884 HG23 HG12 ' A' ' 89' ' ' VAL . 96.4 m -140.98 133.93 29.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.977 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.761 HD12 ' C ' ' A' ' 75' ' ' THR . 4.1 mp -124.96 115.51 20.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.842 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.4 pt -109.88 158.68 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.762 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -131.15 131.4 44.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.397 . . . . 0.0 111.217 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.487 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 83.9 m-85 -109.36 141.57 41.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.674 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -122.17 68.01 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 0.0 110.77 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.85 26.75 13.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.207 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.6 53.43 2.27 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.364 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.443 ' NZ ' HG11 ' A' ' 85' ' ' VAL . 26.8 ttpp -176.54 122.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 85' ' ' VAL . 52.1 mt-10 -65.76 138.47 57.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.647 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 84' ' ' GLU . 15.5 m -157.19 -39.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.527 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.656 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 88.0 m -105.73 106.93 17.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.951 0.405 . . . . 0.0 110.116 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.455 ' NH2' HG22 ' A' ' 89' ' ' VAL . 8.7 ptm180 -104.23 149.52 25.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.584 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.52 HG11 ' O ' ' A' ' 95' ' ' ALA . 41.6 t -154.55 81.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.534 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.884 HG12 HG23 ' A' ' 75' ' ' THR . 33.2 m -109.64 111.12 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.21 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -117.57 0.42 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.29 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -178.23 71.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 0.0 111.049 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.542 ' ND2' ' HD2' ' A' ' 93' ' ' PRO . 15.7 t-20 -150.93 139.31 12.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.661 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.542 ' HD2' ' ND2' ' A' ' 92' ' ' ASN . 18.9 Cg_exo -65.01 -24.86 59.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.414 2.076 . . . . 0.0 112.275 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.532 ' HB3' ' OD1' ' A' ' 92' ' ' ASN . . . -84.53 -27.19 27.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.925 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.52 ' O ' HG11 ' A' ' 88' ' ' VAL . . . -50.39 -27.61 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.093 0.473 . . . . 0.0 110.213 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.884 HD12 HG22 ' A' ' 41' ' ' ILE . 5.8 tt -90.06 -38.23 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.771 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.436 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -61.81 -57.68 10.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.718 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.44 -13.68 61.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.625 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -84.72 -60.61 2.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.787 0.327 . . . . 0.0 111.535 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.458 HG23 HD13 ' A' ' 21' ' ' LEU . 46.3 mm -47.48 -41.85 7.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.139 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.07 -23.4 46.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.218 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -55.72 -65.43 0.6 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -131.87 65.66 1.57 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.09 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.698 ' HA ' HD12 ' A' ' 21' ' ' LEU . 9.4 p . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.052 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.541 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 8.7 p -63.77 156.92 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.066 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.465 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -118.6 174.29 6.35 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 111.119 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -125.79 105.96 9.34 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.926 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.84 HD11 ' HB3' ' A' ' 54' ' ' TYR . 63.0 mt -88.89 127.47 35.64 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.103 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.712 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 8.8 mmpt? -118.15 -50.42 2.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.759 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.2 t -102.57 159.92 15.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.192 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.73 -29.93 65.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.9 p -56.02 -30.77 62.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.867 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -70.41 -30.62 67.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.766 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.871 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 45.6 t80 -75.37 -46.6 32.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.001 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.26 -50.55 45.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -56.65 -23.26 40.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.488 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.565 ' HB1' ' CE2' ' A' ' 54' ' ' TYR . . . -84.09 -60.24 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.518 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.871 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 86.0 mt -52.06 -25.52 8.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.162 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.64 -55.73 4.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.2 m -90.39 23.3 3.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.396 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.63 149.59 22.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.438 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -156.3 -46.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -58.55 -75.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.852 ' CD2' HG23 ' A' ' 100' ' ' ILE . 28.5 tp -167.47 120.69 0.94 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.808 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.76 HG11 HD23 ' A' ' 15' ' ' LEU . 61.8 t -111.56 124.52 68.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.2 t -128.32 126.22 65.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.584 ' CG2' HD11 ' A' ' 77' ' ' ILE . 57.5 t -112.09 114.0 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.804 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.425 ' OD1' ' HG ' ' A' ' 76' ' ' LEU . 24.3 m-20 -111.42 102.78 11.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.237 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.573 ' CE1' HD12 ' A' ' 56' ' ' LEU . 49.6 m-85 -91.7 107.99 19.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.997 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 2.4 p90 -149.01 121.27 8.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.623 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.713 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -90.26 20.12 4.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.586 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p 49.7 55.84 8.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 111.112 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.713 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.5 m-90 -71.24 -61.74 1.66 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.214 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 43.1 t 164.38 129.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.521 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.81 -122.54 5.38 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.031 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.37 -47.45 5.9 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.56 2.173 . . . . 0.0 112.721 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 26.5 p -52.25 -23.88 6.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.6 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -107.76 -37.56 6.1 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.423 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.3 tpt -76.27 -40.38 51.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 111.351 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 37' ' ' ILE . 59.9 mt -79.0 -1.06 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.661 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.924 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -51.44 -63.3 2.1 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 74.7 Cg_exo -50.28 -35.37 43.5 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.213 1.942 . . . . 0.0 113.237 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' A' ' 93' ' ' PRO . 60.7 mtp -65.49 -69.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.621 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.801 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -56.35 -20.28 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.217 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.801 ' N ' HD12 ' A' ' 41' ' ' ILE . 3.7 mm-40 -86.95 -32.95 19.84 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.1 ttpt -78.27 -44.32 25.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.158 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.19 -32.04 71.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.584 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -54.06 -27.76 34.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.016 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.01 -34.61 16.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.739 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -58.87 -27.83 65.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.073 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CE2' HD12 ' A' ' 100' ' ' ILE . 44.6 m-85 -81.78 155.76 25.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.893 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.5 m -89.24 -32.08 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -151.92 96.87 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.09 112.42 4.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.82 106.93 18.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.172 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 2.1 m-85 -89.91 124.6 34.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.84 ' HB3' HD11 ' A' ' 5' ' ' LEU . 17.8 m-30 -112.43 90.52 3.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.486 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.728 ' NZ ' HD13 ' A' ' 41' ' ' ILE . 68.6 mttm -89.84 156.51 18.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.225 0.536 . . . . 0.0 111.791 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.819 ' CD1' HG11 ' A' ' 64' ' ' VAL . 93.6 mt -151.43 -177.7 6.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.636 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -149.15 133.3 17.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.754 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 58' ' ' VAL . 48.6 t -74.76 60.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.077 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.7 t70 178.82 -63.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.621 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -59.37 -30.13 68.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.426 HG21 HD22 ' A' ' 56' ' ' LEU . 45.0 t -100.78 -58.29 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.048 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 t 68.0 -62.44 0.35 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.423 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -43.71 -61.57 1.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.765 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.819 HG11 ' CD1' ' A' ' 56' ' ' LEU . 58.2 t -57.11 -57.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.808 0.337 . . . . 0.0 111.212 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.99 -31.62 0.95 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.787 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -60.26 -58.64 7.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.876 0.37 . . . . 0.0 110.674 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.549 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.42 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.503 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -65.71 79.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.76 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.25 122.86 9.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.243 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.559 HG13 ' OG1' ' A' ' 75' ' ' THR . 60.7 t -120.08 127.92 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.9 m -134.96 45.14 2.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.6 t -146.36 -163.48 1.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.687 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.9 ptm -171.35 92.67 0.43 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.405 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 69.4 Cg_endo -86.11 -163.52 2.78 Favored 'Cis proline' 0 C--N 1.349 0.6 0 C-N-CA 124.132 -1.195 . . . . 0.0 112.427 0.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.559 ' OG1' HG13 ' A' ' 70' ' ' VAL . 91.9 m -138.98 106.72 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.437 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 76' ' ' LEU . 2.4 mp -118.84 128.58 54.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.302 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 77' ' ' ILE . 2.4 pp -128.57 173.0 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.886 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.658 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 8.2 m-85 -135.0 120.44 19.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.746 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.511 ' CD2' HD13 ' A' ' 77' ' ' ILE . 47.2 m-85 -109.8 137.9 46.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.522 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -106.04 -59.74 1.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 0.0 110.753 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.42 29.52 3.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.141 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.54 35.65 3.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.229 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' NZ ' ' HB3' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -151.88 124.2 8.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 111.142 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.4 tt0 -78.94 98.6 6.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.549 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.75 -37.49 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.684 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.658 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 74.7 m -109.79 110.79 21.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.221 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -122.6 145.07 48.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.593 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.714 ' O ' HG23 ' A' ' 88' ' ' VAL . 30.5 m -139.86 83.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.714 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.568 ' O ' HG23 ' A' ' 89' ' ' VAL . 32.8 m -109.44 66.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.294 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -144.9 17.2 1.97 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.523 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.13 56.45 5.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.349 . . . . 0.0 111.127 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.554 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 67.6 m-20 -106.49 101.19 34.36 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.198 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HB3' ' SD ' ' A' ' 40' ' ' MET . 8.3 Cg_exo -71.28 -17.41 30.98 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.726 2.284 . . . . 0.0 112.195 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.77 -43.44 5.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.554 ' HB3' ' CB ' ' A' ' 92' ' ' ASN . . . -50.51 -28.42 8.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.228 0.537 . . . . 0.0 110.186 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.582 ' CD1' HG22 ' A' ' 41' ' ' ILE . 6.6 tt -60.79 -29.34 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.778 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 5.2 tmtm? -55.69 -58.33 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.434 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -72.61 -36.07 68.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.06 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.84 81.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.221 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.852 HG23 ' CD2' ' A' ' 21' ' ' LEU . 63.5 mt -75.04 -37.68 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.133 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.07 -19.17 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.891 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 64.0 m -90.04 -38.55 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 111.581 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.547 ' HB3' HD11 ' A' ' 21' ' ' LEU . 26.8 t-20 -83.66 -39.42 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.428 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.768 ' N ' HD13 ' A' ' 21' ' ' LEU . 11.9 p . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.339 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 46.8 tpp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.896 0.379 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.535 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.9 t -149.43 110.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.817 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 p -89.72 170.75 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.497 0.665 . . . . 0.0 111.658 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -127.97 120.18 27.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.592 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.788 HD11 ' CD2' ' A' ' 54' ' ' TYR . 72.5 mt -88.96 96.21 10.63 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.194 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -89.93 -47.04 8.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.507 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.5 t -104.04 142.33 34.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.79 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.46 -24.69 21.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.299 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.6 p -59.58 -43.9 93.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 36.5 mt-10 -62.87 -25.68 68.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.873 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.505 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 50.9 t80 -90.05 -46.92 8.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.069 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -60.33 -62.94 1.5 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.034 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -55.41 -26.32 41.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.544 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -65.97 -61.3 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.505 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 85.2 mt -54.03 -24.7 18.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.155 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.66 -74.74 0.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.231 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -64.77 -48.12 75.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.054 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.68 102.52 0.17 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.601 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -112.21 -22.69 10.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.616 0.246 . . . . 0.0 111.188 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -54.2 -72.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.131 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.862 HD22 ' CA ' ' A' ' 104' ' ' VAL . 52.4 tp -171.38 106.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.939 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.598 HG13 ' CE2' ' A' ' 54' ' ' TYR . 59.4 t -105.09 127.97 59.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.045 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 77' ' ' ILE . 43.7 t -129.67 133.8 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.868 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.455 HG13 HD13 ' A' ' 56' ' ' LEU . 47.5 t -114.83 122.17 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.209 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -114.5 121.62 44.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.59 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 69.5 m-85 -107.83 127.88 54.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.247 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.449 ' CZ ' ' HE3' ' A' ' 55' ' ' LYS . 2.2 p90 -146.44 114.77 6.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.548 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.95 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -89.4 16.95 6.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.578 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p 49.97 52.94 13.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.94 0.4 . . . . 0.0 111.471 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.95 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.1 m-90 -73.74 -60.94 2.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.981 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.5 t 154.0 134.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.672 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.93 -105.15 3.16 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.681 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 99.2 Cg_exo -43.12 -62.9 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.883 2.389 . . . . 0.0 113.112 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.4 p -70.9 62.99 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.769 0.318 . . . . 0.0 111.062 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.4 tptt 177.89 -56.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.8 ttt -55.37 -71.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.235 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.905 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -90.26 40.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.237 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -80.6 -57.07 0.63 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.875 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 53.2 Cg_exo -55.13 -26.2 49.57 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.222 1.948 . . . . 0.0 112.053 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 63.6 mtt -60.29 -73.39 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.728 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.928 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -57.42 -26.52 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.989 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.928 ' N ' HD12 ' A' ' 41' ' ' ILE . 4.2 tm-20 -77.32 -30.33 54.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.202 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -82.39 -43.01 17.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.05 -29.34 43.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.197 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.636 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.89 -26.72 26.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.034 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -90.02 -29.31 18.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.797 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -66.05 -14.74 62.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.543 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.686 ' CE2' HD13 ' A' ' 100' ' ' ILE . 43.9 m-85 -92.27 161.96 14.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.772 0.32 . . . . 0.0 111.029 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -78.38 -43.67 26.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -155.69 106.28 2.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.118 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.18 127.56 16.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.856 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.69 102.27 14.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.636 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 7.0 m-85 -92.61 116.13 28.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.037 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.788 ' CD2' HD11 ' A' ' 5' ' ' LEU . 12.3 m-30 -106.55 90.94 3.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.172 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.5 ' C ' HD12 ' A' ' 56' ' ' LEU . 63.5 tttp -89.79 106.69 18.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.161 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.649 HD23 HG11 ' A' ' 61' ' ' VAL . 4.1 mp -110.34 141.03 43.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.803 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -80.7 -80.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 p 178.31 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.962 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -103.77 -33.63 8.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.773 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.11 -30.03 67.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 5' ' ' LEU . 48.9 t -100.82 -65.83 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.03 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.1 t 68.42 -64.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.236 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -46.91 -61.0 2.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.411 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.627 ' HB ' HG11 ' A' ' 61' ' ' VAL . 53.5 t -55.75 -56.29 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.172 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.87 -31.45 28.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.315 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -70.9 -28.74 64.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 44.1 mtmt -86.26 -78.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.402 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.92 81.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.267 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.28 143.72 57.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.809 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 75' ' ' THR . 28.6 m -156.31 144.79 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.4 p -124.24 68.23 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.984 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.4 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 60.7 m -144.23 176.36 9.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.472 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 67.9 mtm -157.18 96.97 2.06 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 33' ' ' PRO . 90.9 Cg_endo -79.89 -161.88 2.81 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.947 -1.272 . . . . 0.0 112.273 -0.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.688 ' C ' HD12 ' A' ' 76' ' ' LEU . 91.3 m -140.32 112.88 7.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.652 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 75' ' ' THR . 4.0 mp -120.09 142.85 48.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.556 ' O ' HG13 ' A' ' 23' ' ' VAL . 26.0 pt -139.24 162.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.442 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.3 m-85 -132.28 127.52 35.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.95 0.405 . . . . 0.0 111.329 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.439 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 60.1 m-85 -109.93 140.03 44.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.696 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -110.5 -31.96 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.837 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.97 27.75 0.35 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.2 33.96 6.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.373 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -154.32 102.04 2.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.328 . . . . 0.0 110.781 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 39.5 tt0 -53.64 97.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.078 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 83' ' ' LYS . 26.9 m -110.77 -31.21 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.322 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 94.6 m -116.29 101.02 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.234 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -108.68 146.91 32.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.057 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.3 t -136.55 80.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.757 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 89' ' ' VAL . 35.0 m -109.95 103.88 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.232 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.02 -109.45 0.22 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.395 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.16 81.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.31 . . . . 0.0 110.904 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 24.8 t-20 -160.09 112.72 1.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.746 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.411 ' O ' HG22 ' A' ' 96' ' ' ILE . 63.9 Cg_exo -52.26 -22.72 16.2 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.629 2.219 . . . . 0.0 112.734 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.438 ' HB3' ' OD1' ' A' ' 92' ' ' ASN . . . -90.56 -30.46 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 92' ' ' ASN . . . -50.98 -27.28 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.019 0.438 . . . . 0.0 110.402 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.813 HG21 HG22 ' A' ' 41' ' ' ILE . 6.1 tt -82.65 -35.13 12.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.832 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -69.43 -62.81 1.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.003 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -59.32 -20.3 53.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.349 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -90.11 -40.68 12.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.57 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.816 HG13 HD21 ' A' ' 21' ' ' LEU . 12.0 tt -75.61 -28.05 19.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.743 0.306 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.05 89.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.384 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.8 m -73.22 -24.05 60.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.289 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.63 ' HB3' HD13 ' A' ' 21' ' ' LEU . 5.6 m120 -92.58 -61.78 1.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.862 ' CA ' HD22 ' A' ' 21' ' ' LEU . 11.2 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.886 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.895 0.378 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.843 HG21 ' OE1' ' A' ' 42' ' ' GLU . 55.4 t -63.86 106.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 p -98.96 177.17 5.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.54 0.686 . . . . 0.0 111.73 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -130.52 107.46 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.674 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.805 HD23 ' HB2' ' A' ' 11' ' ' TYR . 3.6 mp -89.18 101.21 13.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.078 0.466 . . . . 0.0 111.462 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -89.91 -37.6 14.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.871 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.6 t -111.77 141.09 45.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.06 -23.7 14.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.403 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.5 p -59.74 -45.22 92.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.115 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.763 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 72.0 mt-10 -61.67 -26.02 67.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.805 ' HB2' HD23 ' A' ' 5' ' ' LEU . 48.9 t80 -90.07 -49.47 6.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.071 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -57.1 -67.06 0.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 t -56.09 -24.35 39.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.099 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.836 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -63.21 -57.22 11.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.226 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.434 HD22 ' CG ' ' A' ' 79' ' ' TYR . 83.6 mt -56.2 -26.98 52.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.98 -29.94 18.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.252 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -87.36 -60.51 1.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.038 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.99 114.42 4.54 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.653 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -112.32 -30.18 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.738 0.304 . . . . 0.0 110.924 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -59.17 -76.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.942 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.633 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 25.9 tp -156.28 116.66 3.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.983 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 59.2 t -107.93 135.37 46.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.56 143.99 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.006 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.596 ' CG1' HD12 ' A' ' 56' ' ' LEU . 48.9 t -135.03 112.45 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.91 129.82 48.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.479 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 58.2 m-85 -114.64 134.6 54.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.356 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.469 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 1.8 p90 -150.72 113.36 4.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.549 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.767 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -87.97 23.31 2.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.566 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 79.9 p 49.65 49.33 20.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.852 0.358 . . . . 0.0 111.428 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.767 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.5 m-90 -67.96 -60.46 2.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.6 t -163.87 -104.97 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.685 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -101.1 -34.64 4.49 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.619 -0.8 . . . . 0.0 114.69 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 76.1 Cg_exo -41.95 -32.13 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.311 2.007 . . . . 0.0 113.27 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 26.1 p -97.19 -42.15 7.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.389 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -81.67 0.39 38.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 32' ' ' GLY . 16.2 tpt -90.24 -55.34 3.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.858 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.849 HD11 ' HG2' ' A' ' 74' ' ' PRO . 31.9 pt -90.28 36.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.511 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.809 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -75.98 -54.85 2.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.906 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.809 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 41.9 Cg_exo -56.7 -29.46 80.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.328 2.019 . . . . 0.0 111.993 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.586 ' SD ' HG22 ' A' ' 37' ' ' ILE . 59.2 mtt -59.42 -75.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.67 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.958 HG22 HD12 ' A' ' 96' ' ' ILE . 2.4 pp -62.19 -23.42 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.126 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.894 ' N ' HD12 ' A' ' 41' ' ' ILE . 5.4 tp10 -77.95 -27.69 49.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.595 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -87.69 -42.42 12.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -48.03 -27.57 2.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.467 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.36 -30.01 17.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.603 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -89.97 -31.34 17.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.082 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -63.01 -31.5 72.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.805 ' CZ ' HG21 ' A' ' 100' ' ' ILE . 42.7 m-85 -100.58 146.67 26.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.094 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.2 m -85.94 -32.12 21.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.7 p-10 -134.16 85.17 2.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.555 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -134.82 118.43 16.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.749 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.87 105.25 17.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.275 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.555 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 7.4 m-85 -102.25 128.62 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.557 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.836 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 18.0 m-30 -113.37 112.26 23.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.442 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.469 ' HE3' ' CE1' ' A' ' 27' ' ' PHE . 52.9 tptt -89.78 112.1 23.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.471 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.596 HD12 ' CG1' ' A' ' 24' ' ' VAL . 90.4 mt -123.46 150.45 43.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 111.655 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -132.75 150.16 52.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.177 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.68 81.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.574 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -179.97 -92.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.728 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.723 ' HG2' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -57.8 -27.28 62.97 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.784 0.326 . . . . 0.0 110.666 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.723 HG23 ' HG2' ' A' ' 60' ' ' GLU . 32.5 t -112.8 35.04 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 t -51.39 -24.97 5.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -50.87 -55.28 17.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.312 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.579 HG11 HD13 ' A' ' 56' ' ' LEU . 47.2 t -66.77 -59.31 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.07 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.97 -28.25 2.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.514 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -58.44 -55.48 34.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -73.96 -33.64 63.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.52 64.62 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.02 112.68 4.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.634 HG21 HG21 ' A' ' 75' ' ' THR . 35.6 m -134.45 -178.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.6 m -157.41 80.61 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.6 p -173.22 179.0 2.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.462 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 58.9 mtm -152.51 102.29 2.74 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.686 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.849 ' HG2' HD11 ' A' ' 37' ' ' ILE . 1.8 Cg_endo -81.86 -158.38 1.67 Allowed 'Cis proline' 0 C--N 1.348 0.534 0 C-N-CA 124.405 -1.081 . . . . 0.0 112.361 0.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.787 ' HA ' HG12 ' A' ' 89' ' ' VAL . 88.8 m -145.85 96.86 2.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.418 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 76' ' ' LEU . 4.1 mp -109.66 140.57 43.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.004 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.521 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 22.6 pt -133.87 162.08 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.412 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.761 ' HE2' HD13 ' A' ' 100' ' ' ILE . 4.3 m-85 -127.16 125.2 40.74 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.111 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 63.3 m-85 -109.49 164.49 12.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.938 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -168.69 60.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.071 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.72 40.59 0.71 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.026 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.0 34.45 83.49 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.872 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -148.76 117.15 6.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.827 0.346 . . . . 0.0 111.118 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.3 tt0 -73.73 144.67 45.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.679 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 86' ' ' THR . 34.7 m -151.7 -46.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.701 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.678 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 96.5 m -104.4 116.44 32.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.11 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -123.98 127.9 48.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.311 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.704 ' O ' HG23 ' A' ' 88' ' ' VAL . 32.2 m -118.98 84.69 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.163 0.506 . . . . 0.0 110.495 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 75' ' ' THR . 34.8 m -109.14 99.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.394 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -170.1 -109.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.529 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 90' ' ' GLY . . . 178.48 78.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.327 . . . . 0.0 111.176 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -155.02 128.43 4.39 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.71 -13.53 24.52 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.509 2.139 . . . . 0.0 112.753 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.09 -48.59 4.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.181 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.5 -30.29 3.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.234 0.54 . . . . 0.0 110.188 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.958 HD12 HG22 ' A' ' 41' ' ' ILE . 6.0 tt -66.63 -50.58 65.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.177 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.42 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -53.35 -54.16 40.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.369 . . . . 0.0 110.684 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -49.22 -26.53 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.523 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.57 -27.51 22.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.597 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.805 HG21 ' CZ ' ' A' ' 48' ' ' TYR . 48.1 mm -68.23 -59.28 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.373 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . . . -61.86 -14.99 38.82 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.3 m -81.26 -29.5 34.37 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.556 ' C ' HD13 ' A' ' 21' ' ' LEU . 22.4 m120 -122.25 -9.42 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 104' ' ' VAL . 10.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.467 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.453 ' N ' ' HB1' ' A' ' 45' ' ' ALA . 26.5 mmt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.83 0.348 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.638 HG11 ' NZ ' ' A' ' 55' ' ' LYS . 47.2 t -57.69 137.17 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 m -111.28 151.21 28.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.932 0.396 . . . . 0.0 110.955 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -91.55 97.99 11.39 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 5' ' ' LEU . 4.9 mp -88.93 134.89 33.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.0 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -126.1 -64.78 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.5 t -91.44 148.47 22.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.065 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.74 69.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 m -56.88 -33.47 66.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.677 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 50.3 mt-10 -74.73 -25.17 58.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -82.29 -61.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.391 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -55.57 -58.58 7.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.46 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.0 t -56.79 -28.32 61.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.332 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . -66.26 -33.58 76.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 0.0 111.338 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.459 HD22 ' CG ' ' A' ' 79' ' ' TYR . 85.6 mt -62.06 -44.14 97.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.083 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.1 -28.95 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.509 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 t -56.64 -78.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.212 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.96 136.16 13.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.627 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -85.9 -6.8 59.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.675 0.274 . . . . 0.0 111.252 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -54.7 -175.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.807 0.337 . . . . 0.0 110.962 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.441 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 27.1 tp -79.25 107.56 12.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.817 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 49.1 t -99.79 127.97 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.698 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.621 HG22 ' CD2' ' A' ' 78' ' ' PHE . 48.9 t -137.02 133.75 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.552 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.713 HG11 ' CE2' ' A' ' 26' ' ' PHE . 40.6 t -103.24 160.4 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.255 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.504 ' N ' HG12 ' A' ' 24' ' ' VAL . 38.3 t70 -137.53 89.57 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.713 ' CE2' HG11 ' A' ' 24' ' ' VAL . 61.2 m-85 -96.36 111.17 23.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.607 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 0.5 OUTLIER -138.64 -44.99 0.49 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.521 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HB2' ' H ' ' A' ' 58' ' ' VAL . . . 61.87 87.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 110.867 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.406 HG21 ' NZ ' ' A' ' 35' ' ' LYS . 65.9 p -57.69 115.1 2.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.824 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.596 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.1 m-90 -101.61 -59.3 1.72 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 52.4 t 160.3 46.11 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.97 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.59 -118.08 0.42 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.783 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 35' ' ' LYS . 75.4 Cg_exo -49.73 -69.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.495 2.13 . . . . 0.0 112.336 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 10.2 p -61.26 75.85 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.375 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 33' ' ' PRO . 17.3 tppt? 175.72 -42.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.851 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.8 ttm -67.77 -49.01 64.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.224 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.554 HD12 ' C ' ' A' ' 37' ' ' ILE . 2.0 pp -90.22 25.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.001 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.795 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -78.44 -54.18 1.21 Allowed Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.627 0.251 . . . . 0.0 111.036 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 51.7 Cg_exo -55.12 -36.69 93.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.529 2.153 . . . . 0.0 112.226 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.417 ' SD ' HG22 ' A' ' 37' ' ' ILE . 60.6 mtt -54.16 -75.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.545 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.05 HG22 HG21 ' A' ' 96' ' ' ILE . 10.6 pt -51.15 -43.62 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.307 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.549 ' HG3' HG21 ' A' ' 2' ' ' VAL . 39.2 tt0 -64.05 -33.18 75.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.772 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -77.05 -45.91 25.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.572 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.691 ' CG ' HD11 ' A' ' 96' ' ' ILE . 6.9 m-85 -56.03 -32.24 63.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.039 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HB1' ' N ' ' A' ' 1' ' ' MET . . . -50.29 -27.8 6.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.329 0.585 . . . . 0.0 109.723 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -77.93 -38.78 44.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.746 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -58.02 -38.04 75.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.519 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.657 ' CE2' HG21 ' A' ' 100' ' ' ILE . 32.4 m-85 -75.58 170.53 15.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.37 . . . . 0.0 110.925 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.8 m -116.55 -19.77 9.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.495 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -145.24 47.71 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.802 0.334 . . . . 0.0 111.465 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.6 119.16 38.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.553 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.73 96.46 10.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 110.881 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.51 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 6.5 m-85 -90.37 126.15 35.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.882 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.551 ' CG ' HD21 ' A' ' 5' ' ' LEU . 18.8 m-30 -121.78 107.6 12.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.376 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.638 ' NZ ' HG11 ' A' ' 2' ' ' VAL . 4.9 ttmp? -89.78 120.02 30.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.935 0.398 . . . . 0.0 111.173 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.035 HD22 HG11 ' A' ' 61' ' ' VAL . 98.4 mt -138.01 135.68 36.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.812 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -112.64 -178.06 3.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.662 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.85 HG21 ' CE ' ' A' ' 73' ' ' MET . 46.0 t -107.26 65.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 111.099 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -178.35 -60.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.357 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -75.76 -23.6 55.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.035 HG11 HD22 ' A' ' 56' ' ' LEU . 30.5 t -124.81 40.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.791 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 t -53.76 -26.21 22.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.267 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.95 -50.83 72.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.027 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.522 HG11 HD13 ' A' ' 56' ' ' LEU . 43.7 t -72.24 -55.33 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.83 -28.88 2.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.444 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -60.83 -46.73 89.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.846 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -81.77 -47.29 13.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.771 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.11 79.45 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.58 114.86 5.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.934 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.874 ' HB ' HG21 ' A' ' 75' ' ' THR . 35.4 m -135.63 125.26 41.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.113 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.2 t -112.32 92.98 4.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.986 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -177.76 -74.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.705 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.85 ' CE ' HG21 ' A' ' 58' ' ' VAL . 61.7 mtt 57.67 102.45 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.734 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.48 167.77 31.68 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.833 0.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.874 HG21 ' HB ' ' A' ' 70' ' ' VAL . 71.6 m -154.87 132.41 11.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.355 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.825 HD12 ' C ' ' A' ' 75' ' ' THR . 4.1 mp -131.16 136.55 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 111.667 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.472 HD12 ' OH ' ' A' ' 79' ' ' TYR . 28.2 pt -133.13 150.68 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.977 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.621 ' CD2' HG22 ' A' ' 23' ' ' VAL . 1.1 m-85 -125.94 132.47 52.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.093 0.473 . . . . 0.0 111.267 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.472 ' OH ' HD12 ' A' ' 77' ' ' ILE . 84.1 m-85 -109.51 114.35 27.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.151 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -72.18 -75.26 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.799 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.59 33.68 3.87 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.023 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.52 27.42 4.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.176 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -158.24 150.29 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.464 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 91.5 mt-10 -82.39 97.02 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.14 -27.09 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.291 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 97.7 m -117.21 103.4 10.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.942 0.401 . . . . 0.0 110.069 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -103.29 155.24 18.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.363 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t -155.5 80.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.614 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.574 ' O ' HG23 ' A' ' 89' ' ' VAL . 34.1 m -109.55 112.38 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.994 0.426 . . . . 0.0 111.279 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.59 -116.42 0.37 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.36 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -176.51 40.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.81 0.338 . . . . 0.0 111.074 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -130.43 134.08 25.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.528 ' O ' HG12 ' A' ' 96' ' ' ILE . 34.0 Cg_endo -66.62 -56.24 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.361 2.04 . . . . 0.0 112.655 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -40.65 -31.97 0.19 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.21 -22.86 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.591 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.05 HG21 HG22 ' A' ' 41' ' ' ILE . 9.2 pt -76.35 -35.35 27.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.922 0.391 . . . . 0.0 110.929 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -56.1 -68.79 0.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.359 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.49 -34.57 77.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.624 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.98 -43.12 68.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.818 0.342 . . . . 0.0 111.454 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.657 HG21 ' CE2' ' A' ' 48' ' ' TYR . 74.2 mt -84.76 -18.82 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.472 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -90.21 -23.37 21.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.752 0.31 . . . . 0.0 111.569 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.4 m -89.99 -65.75 0.99 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.83 0.348 . . . . 0.0 111.482 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.64 -29.18 16.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.456 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 101' ' ' ALA . 8.6 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.287 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtm . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.775 0.322 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.511 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 13.7 p -54.42 144.1 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -124.14 159.23 30.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.063 0.459 . . . . 0.0 110.933 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -102.0 100.0 10.22 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 5' ' ' LEU . 5.5 mp -88.83 109.36 20.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.806 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -96.25 -66.37 0.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -85.04 150.92 24.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.301 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.74 -28.68 70.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.095 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.1 t -55.88 -35.84 66.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 46.4 mt-10 -65.36 -40.9 94.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.516 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -67.76 -55.76 11.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.929 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.58 -56.3 23.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.9 t -57.03 -29.1 63.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . -64.92 -61.05 2.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.479 HD21 ' CD2' ' A' ' 79' ' ' TYR . 79.6 mt -59.51 -26.72 65.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.004 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.03 -70.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.225 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -74.78 -27.25 60.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.87 169.66 1.66 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.691 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -177.36 -37.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 111.075 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -51.84 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.758 HD13 HG23 ' A' ' 100' ' ' ILE . 4.9 tt -172.73 108.24 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.753 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.657 HG13 ' CE2' ' A' ' 54' ' ' TYR . 60.6 t -100.79 132.06 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.688 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' A' ' 21' ' ' LEU . 46.6 t -125.6 122.24 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.384 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.586 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 49.4 t -105.19 129.92 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.53 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -116.74 106.67 13.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.022 0.439 . . . . 0.0 111.488 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.586 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 77.4 m-85 -99.24 101.29 12.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.226 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.446 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 4.5 p90 -127.22 105.96 8.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.499 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -96.14 73.67 2.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.444 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.452 ' C ' ' O ' ' A' ' 28' ' ' ALA . 68.3 p -23.91 105.72 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.527 ' CZ3' ' HB2' ' A' ' 73' ' ' MET . 3.2 m-90 -113.63 -54.75 2.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.2 m -123.15 -2.15 8.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.109 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.651 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 88.4 23.33 37.41 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.769 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 62.3 Cg_endo -75.53 -50.62 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.87 1.713 . . . . 0.0 111.941 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 27' ' ' PHE . 56.8 m -63.82 -37.37 87.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -64.19 -26.96 68.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.19 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 57.4 ttp -58.47 -62.0 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.0 110.988 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.3 pt -90.35 31.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.707 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.9 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -78.93 -59.38 0.64 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.122 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.9 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 65.0 Cg_exo -52.07 -35.15 60.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.335 2.023 . . . . 0.0 112.298 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.551 ' HE2' ' HB2' ' A' ' 93' ' ' PRO . 66.0 mtp -57.27 -74.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.668 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.841 ' CG2' HG21 ' A' ' 96' ' ' ILE . 6.4 pt -48.52 -42.07 12.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.76 0.314 . . . . 0.0 111.211 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -67.07 -33.75 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.487 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -73.83 -44.75 54.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.111 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 96' ' ' ILE . 7.3 m-85 -55.77 -27.48 51.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.777 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.55 -29.37 50.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.75 -30.46 23.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.589 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -64.69 -25.81 68.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.24 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -79.6 176.28 9.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.861 0.363 . . . . 0.0 110.941 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.8 m -97.89 -36.67 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.788 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -149.84 90.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -134.61 129.31 34.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.837 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -101.53 93.27 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.228 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.511 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 7.4 m-85 -90.08 131.26 36.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.31 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.657 ' CE2' HG13 ' A' ' 22' ' ' VAL . 20.0 m-30 -119.37 129.83 55.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.856 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.483 ' O ' HD23 ' A' ' 56' ' ' LEU . 87.3 tttt -103.5 145.28 30.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.68 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.661 HD11 HG11 ' A' ' 64' ' ' VAL . 88.1 mt -143.73 140.0 29.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.37 -175.72 3.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.94 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.7 t -82.93 151.73 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 7.4 t70 63.36 132.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 39.2 tt0 73.63 -54.77 0.68 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.151 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 61' ' ' VAL . 36.6 t -95.03 2.29 9.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.536 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.1 m -63.81 -30.23 71.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.782 0.325 . . . . 0.0 111.005 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -51.41 -25.85 6.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.4 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.661 HG11 HD11 ' A' ' 56' ' ' LEU . 36.2 t -68.7 -54.61 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.047 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.99 70.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.21 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -56.45 -67.65 0.28 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.986 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -57.59 -37.72 73.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -90.01 78.04 6.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.822 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -53.5 102.2 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.971 HG11 HG21 ' A' ' 75' ' ' THR . 44.5 t -138.94 152.51 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.996 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.3 p -143.82 116.14 8.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.54 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.482 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 41.2 t 179.32 -163.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.222 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.527 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 18.3 ptm 178.41 93.76 0.15 Allowed Pre-proline 0 N--CA 1.463 0.187 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 73.0 Cg_endo -75.85 -161.61 2.61 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.354 -0.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.971 HG21 HG11 ' A' ' 70' ' ' VAL . 19.1 m -146.66 115.82 6.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.05 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.806 HD12 ' C ' ' A' ' 75' ' ' THR . 5.2 mp -126.58 115.7 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.935 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.409 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 28.6 pt -116.03 164.98 11.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.669 ' HE1' HG22 ' A' ' 88' ' ' VAL . 4.0 m-85 -133.86 131.03 38.71 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.038 0.447 . . . . 0.0 111.403 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.479 ' CD2' HD21 ' A' ' 15' ' ' LEU . 75.0 m-85 -109.89 152.33 25.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.625 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -116.15 -38.08 3.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.811 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.71 31.87 0.22 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.282 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.99 37.45 2.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.281 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -161.48 118.7 2.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -73.64 110.57 8.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.312 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.9 -37.46 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.452 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 72.3 m -107.14 111.67 24.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.798 0.332 . . . . 0.0 110.322 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -125.42 152.21 45.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.186 0.517 . . . . 0.0 111.556 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.717 ' O ' HG23 ' A' ' 88' ' ' VAL . 28.5 m -138.67 88.29 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.219 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 89' ' ' VAL . 31.1 m -109.25 94.45 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.333 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.87 -112.77 0.62 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.206 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.09 55.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.861 0.362 . . . . 0.0 111.125 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -144.85 126.37 7.83 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.195 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.551 ' HB2' ' HE2' ' A' ' 40' ' ' MET . 81.4 Cg_endo -79.21 2.62 8.16 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.663 2.242 . . . . 0.0 112.64 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.32 -39.48 10.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.008 0.432 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.14 -30.33 70.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.681 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.841 HG21 ' CG2' ' A' ' 41' ' ' ILE . 2.2 pp -57.43 -32.91 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.827 ' N ' HD12 ' A' ' 96' ' ' ILE . 50.0 tttm -54.27 -69.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.731 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -62.55 -21.64 65.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.623 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -59.66 -54.03 51.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.758 HG23 HD13 ' A' ' 21' ' ' LEU . 2.0 mp -75.51 -35.62 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.576 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.26 68.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.308 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.8 m -57.02 -74.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.12 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.44 ' O ' HD12 ' A' ' 21' ' ' LEU . 16.0 p-10 -105.15 62.03 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.993 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.556 HG13 ' OXT' ' A' ' 104' ' ' VAL . 9.5 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.509 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 10.8 mmt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.8 0.333 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.552 HG13 ' HE2' ' A' ' 55' ' ' LYS . 56.7 t -50.49 111.09 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.926 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.426 ' HB ' HD11 ' A' ' 5' ' ' LEU . 1.1 m -103.47 160.38 14.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 111.241 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -104.65 94.45 5.31 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 5' ' ' LEU . 5.2 mp -88.96 132.32 34.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -130.13 -64.15 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -77.71 143.08 38.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.105 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.75 -29.26 70.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.8 p -55.51 -30.64 61.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 90.9 mt-10 -77.41 -38.26 50.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.606 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 48.7 t80 -72.21 -42.44 65.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.032 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -58.22 -68.17 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.061 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.5 p -55.66 -26.08 42.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HB1' ' HE2' ' A' ' 54' ' ' TYR . . . -59.04 -53.07 62.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.243 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.442 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 84.7 mt -69.35 -30.83 68.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.7 -54.55 15.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.212 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -90.36 24.64 2.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.457 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.12 142.45 16.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.449 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -151.48 -46.6 0.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.635 0.255 . . . . 0.0 110.832 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -57.05 -76.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.803 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.667 HD22 ' N ' ' A' ' 104' ' ' VAL . 41.7 tp -177.23 109.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.136 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' A' ' 54' ' ' TYR . 48.1 t -103.86 117.23 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.744 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.47 122.94 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 61.1 t -109.05 126.24 66.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.402 ' OD1' ' HG ' ' A' ' 76' ' ' LEU . 23.9 m-20 -122.54 107.0 11.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.526 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.513 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 52.6 m-85 -93.34 98.86 11.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.355 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.3 p90 -134.24 121.86 21.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.245 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.16 21.95 3.01 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.7 p 46.88 73.25 0.19 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.856 0.36 . . . . 0.0 110.986 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.538 ' CH2' ' HB2' ' A' ' 73' ' ' MET . 0.0 OUTLIER -146.96 62.26 1.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.153 0.501 . . . . 0.0 112.334 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.1 t 60.29 155.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.508 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.71 178.57 20.12 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.636 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 6.1 Cg_endo -49.63 -22.6 6.85 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.866 2.377 . . . . 0.0 112.548 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.5 p -51.86 -39.99 59.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.877 0.37 . . . . 0.0 111.077 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -87.28 -32.07 19.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.033 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.25 -41.16 70.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.018 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 37' ' ' ILE . 48.8 mt -90.43 21.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.481 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -73.1 -58.21 2.6 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 121.239 -0.184 . . . . 0.0 111.106 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 36.3 Cg_exo -58.28 -35.74 98.4 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.343 2.029 . . . . 0.0 112.002 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.459 ' SD ' HG23 ' A' ' 37' ' ' ILE . 62.5 mtt -54.4 -76.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.4 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.925 HG22 HD12 ' A' ' 96' ' ' ILE . 12.6 pt -49.9 -43.34 19.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.286 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' N ' HG13 ' A' ' 41' ' ' ILE . 39.6 tt0 -63.9 -31.78 73.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.771 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 6.2 ttpm? -84.55 -55.21 4.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.636 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.437 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 11.5 m-85 -49.92 -28.11 6.23 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.851 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.25 -28.15 39.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.037 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -89.7 -33.61 16.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.983 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.27 -27.05 68.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.271 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.736 ' CE2' HG21 ' A' ' 100' ' ' ILE . 44.4 m-85 -82.95 157.05 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 111.014 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -82.12 -37.22 26.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.686 ' O ' HG23 ' A' ' 104' ' ' VAL . 40.8 p-10 -154.5 101.86 2.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.974 0.416 . . . . 0.0 111.149 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.48 124.1 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.973 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.98 106.22 18.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.289 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.429 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 7.1 m-85 -92.52 112.17 24.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.224 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.611 ' HE2' ' HB1' ' A' ' 14' ' ' ALA . 16.7 m-30 -114.73 102.48 10.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.824 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HE2' HG13 ' A' ' 2' ' ' VAL . 68.1 mttm -89.87 130.55 36.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.007 HD13 HG11 ' A' ' 64' ' ' VAL . 90.2 mt -130.63 149.58 52.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.861 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -120.75 159.29 25.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.99 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 59' ' ' ASP . 48.5 t -104.61 160.09 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.502 ' N ' HG12 ' A' ' 58' ' ' VAL . 8.1 t0 69.23 -63.07 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -60.96 -29.7 69.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.626 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 64' ' ' VAL . 47.3 t -98.97 -57.23 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.767 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.4 t 68.18 -62.77 0.35 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.481 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.96 -47.54 8.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.643 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.007 HG11 HD13 ' A' ' 56' ' ' LEU . 40.7 t -78.01 -61.88 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.055 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.32 -30.35 0.81 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.375 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -57.3 -55.27 36.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.725 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -65.86 -63.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.55 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 26' ' ' PHE . . . -75.49 76.79 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -49.65 119.1 3.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.255 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.431 HG13 ' OG1' ' A' ' 75' ' ' THR . 41.7 t -90.33 137.35 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.856 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.0 t -143.16 48.58 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 111.359 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.1 p -179.31 178.2 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.584 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.538 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 20.7 ptt? -150.09 100.25 3.23 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.582 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HD3' ' HG2' ' A' ' 33' ' ' PRO . 95.5 Cg_endo -78.24 -163.58 3.47 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.931 -1.279 . . . . 0.0 112.388 -0.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 32.5 m -143.47 97.17 3.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.988 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 76' ' ' LEU . 2.4 mp -109.87 135.66 50.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.006 0.431 . . . . 0.0 111.656 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.564 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 25.5 pt -132.35 166.18 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.478 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.535 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.3 m-85 -131.52 125.93 33.63 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 111.679 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.564 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 60.8 m-85 -111.56 153.64 25.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.366 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -127.83 -58.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.704 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.75 -14.16 8.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.476 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.97 41.58 0.12 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.261 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.748 ' HG2' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -162.29 127.71 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.965 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 88.7 tt0 -69.63 95.96 0.9 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.746 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.748 HG13 ' HG2' ' A' ' 83' ' ' LYS . 34.7 m -109.88 -32.92 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.156 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.62 HG21 HD22 ' A' ' 103' ' ' ASN . 98.9 m -113.02 103.39 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 110.091 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -106.43 159.66 15.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.574 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.582 ' CG1' ' HB1' ' A' ' 95' ' ' ALA . 44.1 t -155.57 83.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.389 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 89' ' ' VAL . 28.1 m -109.22 77.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.199 0.523 . . . . 0.0 111.264 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -143.73 -112.15 0.83 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.067 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 33' ' ' PRO . . . 171.57 93.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.629 0.252 . . . . 0.0 110.86 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.622 ' OD1' ' HB3' ' A' ' 94' ' ' ALA . 16.6 t-20 -173.5 131.59 0.57 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.968 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HD2' ' ND2' ' A' ' 92' ' ' ASN . 10.8 Cg_endo -54.99 -20.29 22.64 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.634 2.223 . . . . 0.0 112.812 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB3' ' OD1' ' A' ' 92' ' ' ASN . . . -86.55 -35.32 19.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.57 0.224 . . . . 0.0 111.228 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -49.07 -28.86 4.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.157 0.504 . . . . 0.0 110.049 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.925 HD12 HG22 ' A' ' 41' ' ' ILE . 6.3 tt -90.03 -37.97 10.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.427 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.0 -71.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.975 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -56.68 -22.95 38.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.041 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.476 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -77.21 -67.3 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.123 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.736 HG21 ' CE2' ' A' ' 48' ' ' TYR . 37.1 mm -51.99 -35.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.18 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -56.7 -71.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 111.683 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.3 m -61.22 -24.75 66.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.602 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.62 HD22 HG21 ' A' ' 86' ' ' THR . 2.7 m-80 -80.63 -62.47 1.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 50' ' ' ASP . 13.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.763 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.6 mtp . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.794 0.33 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.5 t 60.05 116.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.048 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.4 m -93.81 169.25 10.44 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.146 0.498 . . . . 0.0 110.84 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.464 ' H ' HG22 ' A' ' 3' ' ' THR . 14.3 mp0 -110.12 91.45 3.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.186 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 5' ' ' LEU . 6.6 mp -88.97 136.21 33.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.024 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -130.32 -58.22 1.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.5 t -96.74 142.5 28.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.053 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.83 -27.35 65.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.181 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 t -56.61 -38.07 71.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.31 -36.04 80.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.572 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 49.1 t80 -66.8 -47.68 71.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.972 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -58.45 -60.17 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -57.23 -24.63 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.722 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -70.93 -40.56 72.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.284 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.572 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 83.9 mt -90.17 15.04 11.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.576 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.11 -90.57 0.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.752 -0.203 . . . . 0.0 111.038 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.8 p -90.4 19.14 5.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.625 0.25 . . . . 0.0 111.374 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 19' ' ' ASP . . . -70.2 -74.45 0.67 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.716 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 1.4 m-20 79.77 -41.81 0.24 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.589 0.355 . . . . 0.0 111.365 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -54.03 -174.48 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 21' ' ' LEU . 7.5 tt -77.39 99.06 5.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.979 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' A' ' 54' ' ' TYR . 60.8 t -105.58 111.94 36.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.101 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.826 HG13 ' O ' ' A' ' 77' ' ' ILE . 46.8 t -119.32 139.58 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.808 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.546 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 55.2 t -113.51 128.96 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.497 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 36.5 t70 -112.29 101.51 9.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.962 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.546 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 64.4 m-85 -92.52 107.95 19.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 1.4 p90 -153.01 121.38 6.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.356 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.763 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . . . -85.06 17.41 2.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.663 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.1 p 49.66 55.13 9.85 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.049 0.452 . . . . 0.0 110.945 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.715 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.7 m-90 -69.41 -62.21 1.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.192 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 40.4 t 164.29 140.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.85 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.47 -120.73 6.35 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.537 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.433 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 89.1 Cg_exo -43.07 -70.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.822 2.348 . . . . 0.0 112.863 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.9 p -48.29 -26.64 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 111.423 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 31' ' ' CYS . 67.9 mmtt -85.66 -72.37 0.49 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.791 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.0 mtt -59.51 -22.24 61.34 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 37' ' ' ILE . 55.8 mt -89.97 -11.03 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.952 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -54.1 -65.23 1.33 Allowed Pre-proline 0 C--N 1.331 -0.215 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.32 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.952 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 78.0 Cg_exo -50.29 -36.29 46.67 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.133 1.888 . . . . 0.0 112.616 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.408 ' SD ' ' CB ' ' A' ' 93' ' ' PRO . 56.2 mtt -59.11 -78.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.071 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.94 HG22 HG21 ' A' ' 96' ' ' ILE . 2.4 pp -56.34 -24.76 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.131 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.876 ' N ' HD12 ' A' ' 41' ' ' ILE . 43.3 mt-10 -77.35 -30.5 53.9 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.004 0.431 . . . . 0.0 109.902 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -79.48 -45.21 19.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.145 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -60.32 -29.53 68.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.635 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.36 -31.01 53.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.916 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -84.57 -32.14 23.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.507 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.2 -28.47 69.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.017 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.605 ' CD2' HG21 ' A' ' 100' ' ' ILE . 39.0 m-85 -78.78 148.69 32.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.953 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -80.02 -34.72 38.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -146.27 92.91 2.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.519 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -138.07 123.04 19.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.968 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -96.65 93.98 7.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.164 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.519 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 6.0 m-85 -89.96 127.93 36.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.124 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.722 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 14.9 m-30 -113.5 108.25 16.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.858 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -89.9 120.85 31.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.729 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.896 HD22 HG11 ' A' ' 61' ' ' VAL . 90.3 mt -131.31 145.57 51.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.263 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -106.99 161.21 14.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.57 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.763 ' CG2' ' HB2' ' A' ' 28' ' ' ALA . 50.5 t -82.11 -27.42 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.67 -60.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.168 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.49 -40.12 77.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.185 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.896 HG11 HD22 ' A' ' 56' ' ' LEU . 41.3 t -112.87 48.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.012 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.4 t -62.08 -31.33 71.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -49.15 -45.67 44.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.204 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.617 HG11 HD13 ' A' ' 56' ' ' LEU . 47.2 t -73.51 -56.27 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.966 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.34 -52.87 15.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.721 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -50.25 -59.1 4.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -54.65 -73.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.037 0.446 . . . . 0.0 110.706 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.69 68.16 7.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.522 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -44.27 135.66 4.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.551 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 71' ' ' SER . 46.3 t -117.87 159.28 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.923 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.49 ' N ' HG12 ' A' ' 70' ' ' VAL . 80.7 p -146.21 80.17 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.116 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -178.56 -161.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.613 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 20.3 ptt? -177.28 94.16 0.24 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.404 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 69.3 Cg_endo -88.26 -160.21 1.51 Allowed 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.239 -1.15 . . . . 0.0 112.32 -0.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.821 HG23 ' CG1' ' A' ' 89' ' ' VAL . 51.5 m -139.9 115.73 10.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.834 0.349 . . . . 0.0 110.954 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.707 HD12 ' C ' ' A' ' 75' ' ' THR . 3.9 mp -120.93 115.24 22.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.977 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.826 ' O ' HG13 ' A' ' 23' ' ' VAL . 28.4 pt -109.92 157.52 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.673 ' HE1' HG22 ' A' ' 88' ' ' VAL . 3.0 m-85 -130.83 125.53 33.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 111.774 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.505 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 71.5 m-85 -110.13 150.59 28.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.898 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.04 -22.17 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.136 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.62 31.31 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.27 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.81 44.58 5.11 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.368 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -164.45 107.48 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.382 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -56.93 115.33 2.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.496 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 86' ' ' THR . 11.2 m -128.02 -48.56 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 46.4 p -105.2 82.78 1.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.207 0.527 . . . . 0.0 111.0 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -97.53 142.27 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.633 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.686 ' O ' HG23 ' A' ' 88' ' ' VAL . 32.8 m -139.75 88.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.542 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.821 ' CG1' HG23 ' A' ' 75' ' ' THR . 26.0 m -108.98 109.71 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.524 . . . . 0.0 111.128 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -170.2 -96.2 0.1 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.302 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 90' ' ' GLY . . . 176.44 70.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 110.979 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -137.29 88.14 17.51 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HG3' HG23 ' A' ' 37' ' ' ILE . 24.3 Cg_exo -63.55 -14.44 42.53 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.773 2.315 . . . . 0.0 112.487 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.46 -31.3 14.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 110.96 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.1 -23.82 67.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.206 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.94 HG21 HG22 ' A' ' 41' ' ' ILE . 21.9 pt -56.34 -38.81 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.933 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -49.46 -55.91 11.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.605 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -68.59 -25.9 65.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.812 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.464 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -70.5 -57.41 4.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.144 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.605 HG21 ' CD2' ' A' ' 48' ' ' TYR . 3.1 mp -75.54 -5.7 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.237 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -89.96 -28.75 18.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.702 0.287 . . . . 0.0 111.377 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 m -90.05 -67.0 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 111.408 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -46.86 -32.6 3.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.545 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 101' ' ' ALA . 8.4 p . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.417 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.743 HG22 ' HB2' ' A' ' 53' ' ' PHE . 46.0 t -74.86 129.4 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.965 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 m -120.89 149.74 42.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.994 0.426 . . . . 0.0 110.966 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -89.9 109.72 20.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.872 HD11 ' CD2' ' A' ' 54' ' ' TYR . 70.3 mt -88.83 104.77 17.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 110.868 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 11.1 mmpt? -89.94 -47.46 7.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.028 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.3 t -104.89 147.41 27.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.245 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.44 -27.73 68.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.01 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.3 p -54.86 -31.27 59.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -71.09 -35.1 71.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.58 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CE1' HD21 ' A' ' 15' ' ' LEU . 48.5 t80 -69.4 -43.87 72.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.026 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -53.16 -60.42 3.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.1 p -64.83 -21.17 66.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.212 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.91 71.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.376 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.685 HD21 ' CE1' ' A' ' 11' ' ' TYR . 82.0 mt -57.4 -36.12 70.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.966 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.03 50.72 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.045 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.7 p -81.97 148.44 28.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 19' ' ' ASP . . . -80.3 83.06 1.43 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.615 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 8.8 t70 80.41 -40.6 0.18 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.702 0.401 . . . . 0.0 111.68 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -45.28 129.17 8.06 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.829 0.347 . . . . 0.0 111.231 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.565 ' C ' HD23 ' A' ' 21' ' ' LEU . 4.8 tt -80.33 110.88 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 22' ' ' VAL . 10.6 p -100.84 116.06 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.464 HG23 HD22 ' A' ' 21' ' ' LEU . 47.4 t -104.88 146.76 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.044 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.436 HG21 ' HE1' ' A' ' 11' ' ' TYR . 48.5 t -126.1 113.8 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.806 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -101.48 120.56 40.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.942 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.592 ' CE1' HD12 ' A' ' 56' ' ' LEU . 61.2 m-85 -109.45 106.48 16.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.036 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 5.0 p90 -127.35 121.41 30.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.221 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.793 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -86.16 18.54 3.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p 49.3 78.04 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 111.437 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.793 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 0.7 OUTLIER -100.89 -56.05 2.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.946 179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.614 ' CB ' ' O ' ' A' ' 30' ' ' TRP . 42.0 t 132.73 104.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.562 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.03 -92.85 0.25 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.412 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.474 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 11.4 Cg_endo -55.55 -57.79 1.43 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.835 2.357 . . . . 0.0 112.862 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.1 p -81.12 58.26 3.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 110.975 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -172.19 -46.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.6 ttt -65.68 -54.18 30.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.833 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.0 pt -90.28 21.54 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.52 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.947 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -71.03 -62.74 1.75 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.179 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 74.9 Cg_exo -50.14 -29.62 22.92 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.167 1.911 . . . . 0.0 112.685 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.491 ' CE ' ' HB3' ' A' ' 93' ' ' PRO . 37.7 mtp -62.56 -73.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.098 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.92 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -55.8 -23.46 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.92 ' N ' HD12 ' A' ' 41' ' ' ILE . 39.6 tt0 -81.17 -31.33 34.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.991 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -76.64 -42.06 43.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.377 179.12 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -55.19 -23.45 21.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -55.76 -28.27 55.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.128 0.49 . . . . 0.0 110.513 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.69 -0.49 50.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.807 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -90.15 -60.57 1.89 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.172 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.924 ' CE2' HG21 ' A' ' 100' ' ' ILE . 17.2 m-85 -70.67 165.16 23.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.041 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.6 m -113.69 -18.39 11.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.756 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -134.79 53.7 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.971 0.415 . . . . 0.0 111.398 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -119.28 113.0 20.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.305 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.44 100.5 13.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.127 0.489 . . . . 0.0 110.84 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.743 ' HB2' HG22 ' A' ' 2' ' ' VAL . 12.9 m-85 -92.12 134.22 35.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.186 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.872 ' CD2' HD11 ' A' ' 5' ' ' LEU . 19.0 m-30 -122.91 116.73 24.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.792 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -102.33 91.47 4.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.979 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 5' ' ' LEU . 85.0 mt -95.94 132.62 41.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -80.1 -9.26 59.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.663 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 58' ' ' VAL . 39.1 t 64.74 25.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.111 0.481 . . . . 0.0 110.83 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.1 -47.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.49 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.21 -32.34 73.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.457 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.583 HG21 HD22 ' A' ' 56' ' ' LEU . 44.2 t -96.16 -44.37 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.743 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 61' ' ' VAL . 95.5 p 61.33 -65.85 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.749 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 61' ' ' VAL . 7.5 t70 -36.79 -58.22 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.535 0.334 . . . . 0.0 111.851 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 56' ' ' LEU . 48.1 t -58.0 -54.12 36.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.045 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.63 -46.3 63.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.34 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -58.91 -40.36 84.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -72.1 -62.34 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.738 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.4 85.08 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -58.32 112.35 1.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.091 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 70' ' ' VAL . 35.7 m -155.46 110.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.6 m -105.71 50.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -119.24 -170.73 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.647 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.512 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 18.1 ptp -166.7 98.8 0.68 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.378 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 94.4 Cg_endo -89.32 -165.05 2.67 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 124.262 -1.141 . . . . 0.0 112.451 -0.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.777 ' C ' HD12 ' A' ' 76' ' ' LEU . 87.8 m -144.79 118.44 9.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.777 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -126.37 127.47 45.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.962 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.642 HD12 ' CE2' ' A' ' 79' ' ' TYR . 17.1 pt -122.11 155.95 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.2 m-85 -127.5 118.56 24.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.424 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.667 ' CD2' HD22 ' A' ' 15' ' ' LEU . 61.3 m-85 -109.94 112.43 24.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.698 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.09 -54.26 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.834 0.35 . . . . 0.0 110.791 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.6 28.47 2.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.495 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.1 54.57 0.9 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.325 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -176.9 113.12 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.837 0.351 . . . . 0.0 110.976 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -58.91 96.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 86' ' ' THR . 27.3 m -109.89 -41.59 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 60.0 m -108.68 102.29 11.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.918 0.39 . . . . 0.0 110.151 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -102.6 154.57 19.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.377 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.4 t -154.35 81.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.574 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 89' ' ' VAL . 26.8 m -109.44 72.68 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.59 -136.35 2.36 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.117 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.91 91.71 1.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.282 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -152.08 112.47 2.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.11 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.586 ' O ' HG22 ' A' ' 96' ' ' ILE . 46.2 Cg_exo -57.16 -16.47 21.79 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.71 2.273 . . . . 0.0 112.593 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.82 -30.21 17.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 111.191 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.04 -30.87 16.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 110.841 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 93' ' ' PRO . 4.6 tp -68.58 -22.59 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.22 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -83.82 -53.08 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.197 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -67.34 -47.59 70.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.027 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.472 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -55.5 -59.3 5.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.402 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.924 HG21 ' CE2' ' A' ' 48' ' ' TYR . 32.9 mm -57.43 -40.8 76.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.46 -28.22 66.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.193 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.5 m -57.94 -51.55 69.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.951 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 21' ' ' LEU . 16.0 p-10 -136.35 61.36 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.979 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.99 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.766 0.317 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.9 t 61.03 112.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.661 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -101.96 174.17 6.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.214 0.53 . . . . 0.0 111.061 -179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.502 ' H ' HG22 ' A' ' 3' ' ' THR . 13.9 mp0 -118.42 96.28 5.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.056 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.524 HD11 ' CG ' ' A' ' 54' ' ' TYR . 62.7 mt -88.96 153.85 20.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.294 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -150.03 -66.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.952 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.6 t -82.57 161.94 22.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.128 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . . . -73.71 -31.95 63.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.1 p -56.44 -29.35 61.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.011 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 52.8 mt-10 -75.82 -32.82 59.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.75 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 49.2 t80 -78.3 -46.09 21.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.005 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -57.48 -64.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.084 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 t -57.76 -26.07 61.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.006 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.793 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -63.94 -63.34 1.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.301 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.75 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 84.9 mt -54.16 -25.09 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.123 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.87 -57.13 7.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.073 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.9 t -90.18 18.11 6.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.5 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.22 76.22 2.28 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -88.7 -40.58 13.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.97 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -58.48 -78.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 104' ' ' VAL . 4.5 tt -177.59 113.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.774 0.321 . . . . 0.0 110.412 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.491 ' N ' HD23 ' A' ' 21' ' ' LEU . 62.6 t -104.02 144.15 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.657 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 77' ' ' ILE . 40.0 t -146.18 129.38 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.482 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.773 HG11 ' CE2' ' A' ' 26' ' ' PHE . 52.0 t -100.4 147.75 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.344 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 36.0 t70 -135.6 85.19 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.722 0.296 . . . . 0.0 111.697 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.934 ' CD2' HG21 ' A' ' 70' ' ' VAL . 65.8 m-85 -86.78 77.43 9.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.067 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 12.9 p90 -99.89 -34.59 10.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.629 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . . . 61.37 -162.64 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.584 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 79.2 p -134.11 65.27 1.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.001 0.429 . . . . 0.0 110.975 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.629 ' CE2' ' HB3' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -83.4 -60.1 2.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.916 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 39.1 t 147.44 110.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.458 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 33' ' ' PRO . . . 136.08 -132.42 6.12 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.37 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 10.7 Cg_endo -54.26 -34.09 78.26 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.71 2.274 . . . . 0.0 112.806 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 29.7 p -71.69 56.19 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.19 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 27.9 tptp 172.62 -42.84 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.75 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.541 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 11.1 mmt -58.04 -73.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.408 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.642 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -86.45 8.53 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.68 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -57.91 -52.7 72.51 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.921 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 50.9 Cg_exo -54.69 -31.94 73.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.583 2.189 . . . . 0.0 112.288 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.418 ' CE ' ' HB2' ' A' ' 93' ' ' PRO . 72.2 mtp -54.41 -73.77 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.928 0.394 . . . . 0.0 110.469 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.01 HG22 HG21 ' A' ' 96' ' ' ILE . 8.6 pt -50.56 -44.05 24.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.258 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' N ' HG13 ' A' ' 41' ' ' ILE . 66.1 mm-40 -63.64 -33.15 74.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.79 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.459 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -76.47 -49.35 16.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.939 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.617 ' CD2' HD11 ' A' ' 96' ' ' ILE . 8.0 m-85 -51.79 -27.76 13.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.01 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.653 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.89 -28.89 25.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.055 0.455 . . . . 0.0 110.576 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -82.85 -25.21 32.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.602 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -58.44 -56.74 18.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.034 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.435 ' CE2' HG21 ' A' ' 100' ' ' ILE . 16.3 m-85 -62.28 171.03 2.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.156 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 m -97.14 -31.98 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 1.5 p30 -140.54 99.18 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.183 0.516 . . . . 0.0 111.146 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.471 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -148.83 117.62 6.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.79 107.09 18.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.279 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.653 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 6.6 m-85 -100.01 129.6 46.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.52 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.793 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 17.2 m-30 -115.4 107.26 14.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.444 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -89.85 122.46 32.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.67 HD22 HG11 ' A' ' 61' ' ' VAL . 94.0 mt -136.32 172.19 13.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.644 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -130.54 -102.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.927 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 59' ' ' ASP . 35.6 m -157.54 -45.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 120.709 0.29 . . . . 0.0 111.25 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 58' ' ' VAL . 56.5 m-20 -110.67 -35.96 5.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.01 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.61 -31.45 66.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.756 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.67 HG11 HD22 ' A' ' 56' ' ' LEU . 46.3 t -97.52 -66.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.745 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.0 t 68.31 -63.07 0.35 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.433 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 1.5 m-20 -38.75 -38.62 0.43 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.731 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.02 -54.35 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.096 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.13 -41.12 7.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.811 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -57.33 -47.74 80.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.106 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -82.45 -55.99 4.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.957 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.632 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -70.36 82.16 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -58.49 98.6 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.934 HG21 ' CD2' ' A' ' 26' ' ' PHE . 53.7 t -108.22 151.62 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.2 p -155.79 85.28 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.076 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.2 t -177.9 177.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.435 ' HG2' ' CH2' ' A' ' 30' ' ' TRP . 64.9 mtm -154.64 96.48 2.59 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 3.1 Cg_endo -85.36 -158.75 1.55 Allowed 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.492 -1.045 . . . . 0.0 112.199 0.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.884 HG21 HG13 ' A' ' 70' ' ' VAL . 63.3 m -144.62 114.43 7.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.752 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.773 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -126.89 111.8 14.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.902 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.557 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 26.3 pt -115.75 163.32 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.692 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.3 m-85 -128.11 125.73 39.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.557 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 63.2 m-85 -109.49 165.04 11.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.43 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -168.51 63.79 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.714 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.3 23.83 4.36 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.028 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.73 -4.67 73.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.254 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 13.2 mptt -109.7 110.63 21.72 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.735 0.302 . . . . 0.0 111.088 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 24.4 pt-20 -68.24 125.59 26.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.467 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 86' ' ' THR . 34.8 m -127.92 -42.04 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.612 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 72.2 m -103.96 113.66 27.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.949 0.404 . . . . 0.0 110.093 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -112.14 155.09 24.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.33 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.2 t -155.84 79.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.793 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.642 ' O ' HG23 ' A' ' 89' ' ' VAL . 27.0 m -109.62 91.99 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.313 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -103.38 0.17 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.384 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.5 85.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -151.64 81.88 5.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.859 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' A' ' 37' ' ' ILE . 51.9 Cg_exo -54.55 -20.45 21.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.863 2.375 . . . . 0.0 112.698 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.84 -2.41 58.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.588 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.0 -23.94 21.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.71 0.29 . . . . 0.0 111.267 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.01 HG21 HG22 ' A' ' 41' ' ' ILE . 24.3 pt -54.79 -34.43 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.135 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.47 -60.37 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.032 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -68.17 -27.65 66.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.4 -64.06 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.288 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.435 HG21 ' CE2' ' A' ' 48' ' ' TYR . 66.6 mt -55.78 -35.01 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.216 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.09 -23.79 64.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.327 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.3 m -54.53 -70.13 0.11 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -106.33 56.34 0.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.655 ' HA ' HD12 ' A' ' 21' ' ' LEU . 9.1 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.791 0.329 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 47.7 t -112.12 131.31 63.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.814 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -110.93 159.46 17.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.437 0.637 . . . . 0.0 111.833 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -121.76 116.32 24.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.569 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.567 ' HB2' HD21 ' A' ' 56' ' ' LEU . 67.2 mt -89.05 104.36 16.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.013 0.435 . . . . 0.0 111.306 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -99.52 -35.2 9.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.427 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -117.73 141.09 48.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.944 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.36 -25.98 38.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.427 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -58.63 -40.26 82.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.011 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -63.85 -27.05 68.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.553 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 49.3 t80 -90.0 -46.92 8.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -57.95 -60.74 3.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.072 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.4 p -55.86 -23.09 28.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.294 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -74.84 -28.22 60.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.46 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.553 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 86.1 mt -89.94 -17.96 26.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.364 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.33 -86.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.328 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.1 p -90.47 29.33 1.3 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.08 87.86 1.44 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.77 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -80.07 -37.32 34.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 110.588 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -57.95 -168.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.607 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.849 HD13 HG23 ' A' ' 100' ' ' ILE . 2.7 tt -91.1 119.88 31.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.962 0.411 . . . . 0.0 110.689 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.604 ' N ' HD23 ' A' ' 21' ' ' LEU . 59.6 t -113.05 107.95 24.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.532 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.638 HG23 HD22 ' A' ' 21' ' ' LEU . 43.3 t -99.92 144.81 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.507 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.494 HG11 ' CE2' ' A' ' 26' ' ' PHE . 48.4 t -126.43 147.89 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.447 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 37.7 t70 -137.13 113.16 9.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.961 0.41 . . . . 0.0 111.211 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.539 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 70.4 m-85 -110.34 107.2 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 1.7 p90 -150.69 121.85 7.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.783 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.652 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -88.18 18.17 4.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.638 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.0 p 49.61 62.86 2.42 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.14 0.495 . . . . 0.0 111.119 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.652 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.8 m-90 -77.72 -61.19 2.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.149 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 41.8 t 165.11 109.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.562 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.04 -146.38 18.42 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.027 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . 84.2 Cg_exo -46.28 -36.49 17.32 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.834 2.356 . . . . 0.0 112.88 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 24.4 p -51.76 -26.04 8.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -113.77 -28.7 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.2 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.7 ttm -77.35 -29.85 53.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.292 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 37' ' ' ILE . 54.1 mt -89.94 -6.16 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.706 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.836 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -51.08 -55.35 28.84 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.536 0.208 . . . . 0.0 111.408 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.836 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 37.9 Cg_exo -61.58 -39.04 57.69 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.55 2.167 . . . . 0.0 112.285 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 60.7 mtt -53.08 -75.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.58 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.788 HG22 HG21 ' A' ' 96' ' ' ILE . 11.6 pt -51.69 -43.16 32.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.35 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 41' ' ' ILE . 39.4 tt0 -63.86 -33.65 76.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.753 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.3 ttpt -76.2 -41.25 50.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.288 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.772 ' CG ' HD11 ' A' ' 96' ' ' ILE . 6.1 m-85 -64.26 -23.96 67.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.716 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -54.85 -29.14 54.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.06 0.457 . . . . 0.0 110.473 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -84.54 -1.83 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.944 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -90.17 -46.5 8.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.048 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.528 ' CE2' HD12 ' A' ' 100' ' ' ILE . 17.6 m-85 -73.89 168.05 20.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.186 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -111.6 -22.69 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.269 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.529 ' OD1' HG23 ' A' ' 104' ' ' VAL . 52.7 p-10 -146.0 66.45 1.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.034 0.445 . . . . 0.0 111.199 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HB3' ' HE1' ' A' ' 53' ' ' PHE . . . -124.55 117.64 24.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.018 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.69 104.12 16.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.631 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 3.6 m-85 -89.85 106.89 18.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.928 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.516 ' CE2' HG13 ' A' ' 22' ' ' VAL . 12.8 m-30 -96.86 109.1 21.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 110.953 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -89.89 129.56 36.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.083 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.718 HD22 HG21 ' A' ' 61' ' ' VAL . 96.2 mt -148.35 136.84 21.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.642 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -107.29 -96.73 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.065 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.4 t -156.2 -69.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.849 0.357 . . . . 0.0 111.076 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -79.76 -33.47 40.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.13 -29.41 57.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.041 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.718 HG21 HD22 ' A' ' 56' ' ' LEU . 30.5 t -112.98 -67.13 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.842 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.476 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 33.2 t 75.28 -7.82 1.7 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.14 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.698 ' H ' HG12 ' A' ' 61' ' ' VAL . 35.0 m-20 -90.36 -64.32 1.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.924 0.393 . . . . 0.0 110.865 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.3 t -62.92 -59.98 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.137 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.22 -31.15 2.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.445 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -63.62 -58.59 6.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.738 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -74.31 -55.67 5.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.759 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.4 82.99 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.5 128.02 34.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.109 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.6 t -89.55 132.88 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -136.97 50.85 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.16 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.403 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 36.3 t -170.33 -163.69 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.635 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.486 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.3 ptm -170.1 90.92 0.52 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.431 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.88 -162.53 2.93 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.88 -1.3 . . . . 0.0 112.27 -0.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.589 ' C ' HD12 ' A' ' 76' ' ' LEU . 88.0 m -137.12 105.02 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.602 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 76' ' ' LEU . 3.8 mp -114.05 140.69 48.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.958 0.409 . . . . 0.0 111.217 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.591 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 25.1 pt -138.59 156.79 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.804 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.471 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.4 m-85 -124.1 125.52 44.64 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.959 0.409 . . . . 0.0 111.507 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.591 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 65.4 m-85 -110.93 124.43 52.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.925 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -116.57 -38.26 3.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.44 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.55 45.03 1.22 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.055 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.85 27.03 58.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.908 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.46 ' O ' HG13 ' A' ' 85' ' ' VAL . 60.5 mttp -152.92 124.66 7.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.774 0.321 . . . . 0.0 110.832 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.67 111.05 0.73 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.381 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 86' ' ' THR . 19.0 m -120.91 -46.89 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.485 ' N ' HG23 ' A' ' 85' ' ' VAL . 77.0 p -113.46 77.8 1.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 110.997 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -81.69 160.05 23.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.044 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.1 t -150.95 83.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.854 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 89' ' ' VAL . 32.1 m -109.38 99.38 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.216 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.8 -111.05 0.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.208 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -179.72 91.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 0.0 111.109 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -178.16 123.37 0.26 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.865 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 96' ' ' ILE . 12.3 Cg_endo -57.57 -59.43 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.426 2.084 . . . . 0.0 112.498 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -42.1 -30.44 0.29 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.955 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -20.26 60.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.662 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.788 HG21 HG22 ' A' ' 41' ' ' ILE . 8.9 pt -78.84 -42.96 24.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.872 0.367 . . . . 0.0 111.025 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -62.59 -64.38 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.578 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -54.64 -25.78 28.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.253 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.4 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -83.4 -63.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.047 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.849 HG23 HD13 ' A' ' 21' ' ' LEU . 63.1 mt -59.89 -44.92 95.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.6 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -63.6 -16.43 60.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.747 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.4 t -85.76 -56.71 3.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.796 0.331 . . . . 0.0 111.237 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -70.33 -23.87 62.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.138 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 101' ' ' ALA . 10.8 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.555 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.917 0.389 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 46.7 t 63.72 125.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.685 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.9 m -106.71 166.99 10.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.403 ' H ' HG22 ' A' ' 3' ' ' THR . 13.8 mp0 -106.2 90.28 3.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.064 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.537 HD11 ' CG ' ' A' ' 54' ' ' TYR . 74.6 mt -89.03 132.7 34.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.187 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -133.52 -58.3 0.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.792 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 t -91.88 149.94 21.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.053 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . . . -67.55 -28.25 67.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.208 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -55.67 -30.9 61.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -72.63 -39.26 67.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.95 -71.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.981 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -47.57 -30.08 3.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.532 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 t -66.01 -23.3 66.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.194 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.08 -36.03 15.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.26 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.2 mm? -82.12 -0.3 44.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.446 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.92 -82.12 0.27 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 111.061 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -90.54 30.42 1.15 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.185 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.63 168.04 41.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.645 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -159.57 -45.67 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.644 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -59.43 -170.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.731 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 104' ' ' VAL . 44.4 tp -75.38 107.36 7.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.209 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 58.2 t -109.16 97.63 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.563 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' A' ' 21' ' ' LEU . 43.3 t -105.74 137.97 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.593 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.701 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 48.1 t -116.59 139.08 44.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.329 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -117.93 98.18 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.508 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.701 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 61.3 m-85 -96.02 96.98 9.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.916 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 2.2 p90 -136.54 122.16 19.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.65 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.25 112.16 23.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.479 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.7 p -74.54 105.36 5.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.471 . . . . 0.0 111.629 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.557 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.2 m-90 -105.32 -60.38 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.471 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 44.7 t 159.07 90.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.418 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.3 -82.54 0.21 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.759 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.755 ' O ' ' N ' ' A' ' 35' ' ' LYS . 87.3 Cg_endo -79.79 -155.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.496 2.13 . . . . 0.0 110.852 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 4.6 p 42.04 -68.81 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.755 ' N ' ' O ' ' A' ' 33' ' ' PRO . 86.9 tttt -55.27 -39.84 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.382 . . . . 0.0 111.306 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -62.68 1.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.861 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -90.16 34.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.936 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.878 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -90.06 -59.65 0.24 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.621 0.248 . . . . 0.0 110.914 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.878 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 59.6 Cg_exo -52.54 -41.15 69.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.353 2.035 . . . . 0.0 112.35 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.414 ' CE ' ' CB ' ' A' ' 93' ' ' PRO . 70.0 mtp -50.07 -71.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 110.788 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.781 ' CG2' HG21 ' A' ' 96' ' ' ILE . 9.1 pt -55.38 -45.57 78.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.258 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.62 ' OE2' ' HB1' ' A' ' 38' ' ' ALA . 50.9 mt-10 -59.9 -35.29 74.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.844 0.354 . . . . 0.0 110.727 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 11.6 tmtt? -69.9 -49.28 53.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.417 ' CD2' HD11 ' A' ' 96' ' ' ILE . 6.0 m-85 -47.54 -28.85 2.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.271 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.13 -29.29 57.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.837 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.61 -32.98 25.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.404 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.412 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 84.5 mt-30 -60.52 -26.39 66.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.779 ' CE2' HG21 ' A' ' 100' ' ' ILE . 42.1 m-85 -90.1 176.82 6.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.779 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.3 m -114.05 -27.83 7.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.258 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -138.9 68.96 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 111.424 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.518 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -124.74 115.18 20.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.99 101.3 14.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.394 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.518 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 5.9 m-85 -93.72 132.11 38.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.537 ' CG ' HD11 ' A' ' 5' ' ' LEU . 15.3 m-30 -121.62 106.42 11.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.806 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.91 130.11 36.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.984 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.806 HD22 HG11 ' A' ' 61' ' ' VAL . 97.6 mt -155.47 140.96 17.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.829 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -101.42 -128.38 0.21 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.475 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.3 t -126.58 -70.13 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.084 0 CA-C-O 120.777 0.322 . . . . 0.0 111.015 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -72.61 -39.72 67.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.739 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -58.17 -29.51 65.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.7 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.806 HG11 HD22 ' A' ' 56' ' ' LEU . 43.6 t -140.25 70.53 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.2 t -76.86 -2.03 31.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.541 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 57.1 m-20 -84.83 -38.07 19.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.816 0.341 . . . . 0.0 111.089 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.647 HG11 ' CD1' ' A' ' 56' ' ' LEU . 46.2 t -90.2 -56.31 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.251 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.19 -32.55 16.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.65 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -58.25 -48.28 80.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.89 -51.59 66.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.01 77.33 6.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.091 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.05 115.06 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.481 ' HB ' HG21 ' A' ' 75' ' ' THR . 35.2 m -138.56 143.02 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.188 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -116.77 174.88 5.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.828 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 81.8 p 50.69 95.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.524 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 21.6 mmt -91.24 150.76 42.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.78 -178.98 22.88 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 123.723 -1.366 . . . . 0.0 112.7 0.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.934 HG23 HG12 ' A' ' 89' ' ' VAL . 91.8 m -149.85 130.69 14.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.748 HD12 ' C ' ' A' ' 75' ' ' THR . 4.0 mp -123.98 131.98 53.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.0 111.335 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.466 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 27.8 pt -130.47 139.58 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.502 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.7 m-85 -114.23 125.64 54.15 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.044 0.449 . . . . 0.0 111.572 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.594 ' CD2' HD11 ' A' ' 15' ' ' LEU . 69.7 m-85 -109.61 162.14 14.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.718 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -153.41 67.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.74 20.74 18.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.415 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.77 64.51 1.2 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.565 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -178.18 115.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.954 0.407 . . . . 0.0 111.157 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 44.3 tt0 -79.31 98.43 6.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.575 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.91 -32.43 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.412 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.707 HG21 HD21 ' A' ' 103' ' ' ASN . 92.2 m -113.88 102.8 10.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.889 0.376 . . . . 0.0 110.468 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -110.0 144.31 38.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.003 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.2 t -137.57 82.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.704 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.934 HG12 HG23 ' A' ' 75' ' ' THR . 34.8 m -109.65 106.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.325 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.03 -108.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.371 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -179.93 68.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.991 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 5.7 m120 -142.51 96.4 6.29 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.052 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.45 ' O ' HG13 ' A' ' 96' ' ' ILE . 32.0 Cg_exo -58.6 -17.1 33.32 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.589 2.192 . . . . 0.0 112.503 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.27 -29.73 17.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.853 0.358 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 92' ' ' ASN . . . -71.52 -25.32 62.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.173 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.794 HD12 ' N ' ' A' ' 97' ' ' LYS . 2.1 pp -56.59 -31.9 35.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.794 ' N ' HD12 ' A' ' 96' ' ' ILE . 34.5 ttpt -62.93 -65.11 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.16 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -39.01 -33.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.655 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.47 -46.87 12.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.779 HG21 ' CE2' ' A' ' 48' ' ' TYR . 73.4 mt -74.07 -5.68 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.541 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.22 -32.9 16.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.727 0.299 . . . . 0.0 111.379 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.7 p -89.67 -58.55 2.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 111.387 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.707 HD21 HG21 ' A' ' 86' ' ' THR . 47.2 m-80 -60.08 -17.99 43.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.591 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.614 ' HA ' HD22 ' A' ' 21' ' ' LEU . 11.3 p . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.769 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 23.0 ptp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.889 0.376 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.525 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 45.4 t -147.93 102.19 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.701 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -101.53 152.44 20.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.423 0.63 . . . . 0.0 111.851 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -113.01 118.84 35.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.402 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 11' ' ' TYR . 4.7 mp -89.15 117.68 28.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.977 0.418 . . . . 0.0 111.616 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -107.79 -37.0 6.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.172 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.2 t -115.95 143.81 44.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.831 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.48 -23.79 41.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.302 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 m -60.12 -45.01 94.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -59.9 -27.4 66.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.35 . . . . 0.0 110.895 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.869 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 48.6 t80 -90.03 -48.81 6.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.175 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -57.79 -61.81 2.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.1 p -54.56 -24.33 20.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.349 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.06 -66.06 0.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.362 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.869 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 82.2 mt -54.85 -24.11 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.4 -79.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.205 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -90.2 17.24 7.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.04 105.88 3.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -109.47 -22.0 12.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 111.065 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -54.92 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.092 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.758 HD13 HG23 ' A' ' 100' ' ' ILE . 4.4 tt -177.83 107.99 0.06 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.532 HG13 ' CE2' ' A' ' 54' ' ' TYR . 58.3 t -102.79 124.72 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.723 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 ' CD2' ' A' ' 21' ' ' LEU . 40.8 t -116.19 122.57 69.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.469 HG11 ' CE2' ' A' ' 26' ' ' PHE . 51.8 t -104.0 112.55 37.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.756 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -108.68 98.44 7.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.499 ' CE1' HD12 ' A' ' 56' ' ' LEU . 61.0 m-85 -86.3 115.55 23.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.88 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 2.3 p90 -135.81 117.12 14.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.661 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.882 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -86.79 4.52 40.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.771 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.8 p 49.18 70.83 0.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 111.178 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.882 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 3.0 m-90 -89.12 -57.84 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.148 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.8 t -139.57 -104.35 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.384 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.616 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -136.05 25.76 3.17 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.9 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 85.7 Cg_endo -82.44 -41.32 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 121.982 1.788 . . . . 0.0 112.114 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 22.9 p -98.39 -41.93 7.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.247 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -52.18 -42.12 63.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.382 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.7 ttt -67.72 -25.79 65.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.117 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 37' ' ' ILE . 50.0 mm -86.97 -10.72 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.693 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.901 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -59.91 -63.37 4.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.901 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 82.5 Cg_exo -45.76 -40.68 19.44 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.333 2.022 . . . . 0.0 112.801 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.6 mtt -54.17 -79.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.644 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.934 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -57.55 -29.71 34.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.778 0.323 . . . . 0.0 110.969 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.934 ' N ' HD12 ' A' ' 41' ' ' ILE . 88.4 tt0 -70.35 -26.92 63.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.704 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.431 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 13.4 tmtt? -87.09 -45.92 10.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.241 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -54.82 -27.47 42.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.703 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 1' ' ' MET . . . -51.82 -30.56 23.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.087 0.47 . . . . 0.0 110.495 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -83.15 -26.53 30.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.59 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -72.64 -26.1 61.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.302 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -83.18 167.67 17.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.374 . . . . 0.0 111.039 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -97.28 -33.48 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.821 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -153.01 98.57 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.823 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.63 121.24 10.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.629 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.94 109.28 20.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.525 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 10.4 m-85 -97.96 116.05 29.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.525 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.532 ' CE2' HG13 ' A' ' 22' ' ' VAL . 17.7 m-30 -112.26 99.77 8.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.864 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -90.04 127.63 36.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 5' ' ' LEU . 90.0 mt -130.87 162.77 28.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.216 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.55 ' O ' HG13 ' A' ' 58' ' ' VAL . 38.8 t70 -106.33 -109.5 0.29 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.515 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 57' ' ' ASP . 16.1 m -160.51 -48.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.742 0.306 . . . . 0.0 111.399 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 58' ' ' VAL . 1.3 m-20 -110.75 -33.63 6.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 110.742 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.5 -27.32 56.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.695 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.81 HG12 ' H ' ' A' ' 63' ' ' ASP . 46.8 t -106.74 -68.78 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 61' ' ' VAL . 86.1 p 64.59 5.75 2.86 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.015 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.81 ' H ' HG12 ' A' ' 61' ' ' VAL . 1.4 m-20 -90.49 -38.64 13.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.974 0.416 . . . . 0.0 110.656 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 68' ' ' ALA . 27.0 t -90.05 -47.21 14.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.248 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.0 -30.31 1.0 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.653 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -73.79 -37.03 65.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -88.91 -57.49 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.754 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 64' ' ' VAL . . . -82.06 81.24 8.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.067 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.67 117.81 5.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.613 ' HB ' HG21 ' A' ' 75' ' ' THR . 35.4 m -133.01 174.53 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -175.98 91.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.16 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.405 ' CB ' HG21 ' A' ' 89' ' ' VAL . 39.6 t -178.22 -171.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.474 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 52.8 mtt -156.83 93.73 2.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.02 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.461 ' O ' HG23 ' A' ' 89' ' ' VAL . 95.8 Cg_endo -89.39 -162.66 1.93 Allowed 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.297 -1.126 . . . . 0.0 112.502 0.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.671 ' C ' HD12 ' A' ' 76' ' ' LEU . 95.4 m -141.55 105.65 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.676 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.671 HD12 ' C ' ' A' ' 75' ' ' THR . 3.9 mp -118.91 119.75 35.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.227 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.8 pt -121.31 166.99 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.9 m-85 -130.87 128.55 40.83 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.054 0.454 . . . . 0.0 111.338 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 60.2 m-85 -109.76 131.78 54.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.062 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -132.91 60.05 1.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.085 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.65 38.65 0.65 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.026 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.49 29.12 72.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.006 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -142.72 115.43 8.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 111.06 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.3 tt0 -69.98 104.13 2.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.596 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.42 -37.72 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.462 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.568 HG21 HD21 ' A' ' 103' ' ' ASN . 88.5 m -106.82 107.32 18.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 110.397 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -110.77 152.59 26.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.339 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -149.44 82.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.683 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 89' ' ' VAL . 7.4 p -109.59 98.5 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.199 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -170.1 -107.26 0.2 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.436 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 90' ' ' GLY . . . 173.62 92.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -153.37 116.66 2.74 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.513 ' O ' HG22 ' A' ' 96' ' ' ILE . 21.5 Cg_exo -65.03 -11.99 32.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.507 2.138 . . . . 0.0 112.652 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.57 -38.25 10.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.68 0.276 . . . . 0.0 111.287 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.71 -35.2 21.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 111.021 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.816 HD13 HG22 ' A' ' 41' ' ' ILE . 4.2 tp -53.06 -43.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.524 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.44 -72.2 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.318 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -51.47 -26.24 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.761 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.427 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -72.47 -62.57 1.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.752 0.311 . . . . 0.0 111.071 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.758 HG23 HD13 ' A' ' 21' ' ' LEU . 62.3 mt -73.83 -7.39 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.411 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.04 -27.3 26.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.689 0.28 . . . . 0.0 111.329 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.6 m -90.06 -56.09 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.294 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.568 HD21 HG21 ' A' ' 86' ' ' THR . 60.3 m-80 -55.35 -45.49 76.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.453 -179.524 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.852 0.358 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 53' ' ' PHE . 46.2 t -73.46 123.78 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.568 HG22 ' H ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -96.61 -178.2 4.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 0.0 110.597 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.568 ' H ' HG22 ' A' ' 3' ' ' THR . 21.3 mp0 -124.0 90.13 3.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.19 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.638 HD21 ' CD2' ' A' ' 54' ' ' TYR . 5.0 mp -89.07 141.12 28.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -133.68 -69.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.2 t -79.32 162.18 25.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.056 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . . . -70.27 -30.34 67.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.062 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -59.02 -33.83 71.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 53.1 mt-10 -69.7 -30.72 68.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.826 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.463 ' HH ' HD11 ' A' ' 15' ' ' LEU . 45.8 t80 -75.75 -45.99 33.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.905 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.29 -56.29 19.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -59.1 -28.0 66.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.052 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . -63.66 -66.4 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.136 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.548 ' CD2' HG11 ' A' ' 22' ' ' VAL . 81.4 mt -58.06 -26.72 62.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.037 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.78 -68.0 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -78.21 -28.46 48.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.19 119.07 12.84 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -114.37 -31.08 6.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 0.0 111.195 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.92 -108.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.806 HD12 ' HA ' ' A' ' 104' ' ' VAL . 4.5 tt -139.49 121.65 15.82 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.784 0.326 . . . . 0.0 110.439 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.637 ' N ' HD23 ' A' ' 21' ' ' LEU . 60.3 t -111.92 122.81 66.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.009 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.496 HG23 HD22 ' A' ' 21' ' ' LEU . 42.9 t -118.32 124.7 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.461 HG21 ' HE1' ' A' ' 11' ' ' TYR . 47.0 t -110.67 115.56 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.058 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -102.43 120.24 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.416 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 54.6 m-85 -108.26 119.52 39.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.16 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.424 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 2.5 p90 -155.15 113.3 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.644 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.06 23.2 6.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.403 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p 46.81 70.14 0.42 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.96 0.409 . . . . 0.0 110.769 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 73' ' ' MET . 2.5 m-90 -83.05 -57.86 3.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.868 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.4 t -118.89 -37.1 3.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.894 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 142.14 -38.38 1.48 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.504 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 58.7 Cg_exo -40.7 -46.96 4.71 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.622 2.214 . . . . 0.0 112.927 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.8 p -53.56 -31.75 47.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.004 0.43 . . . . 0.0 110.737 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -83.64 -25.93 30.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.9 ttm -70.18 -33.21 71.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.687 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.605 HG23 ' SD ' ' A' ' 40' ' ' MET . 56.4 mt -90.15 -1.36 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.883 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -59.09 -63.72 3.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 121.206 -0.197 . . . . 0.0 111.279 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.883 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 86.1 Cg_exo -44.07 -34.55 6.69 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.379 2.053 . . . . 0.0 112.512 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.605 ' SD ' HG23 ' A' ' 37' ' ' ILE . 65.7 mtt -56.11 -74.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.855 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -63.8 -25.28 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.199 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.855 ' N ' HD12 ' A' ' 41' ' ' ILE . 93.4 mt-10 -72.41 -30.96 65.11 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.001 0.429 . . . . 0.0 109.997 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -77.23 -44.51 29.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.828 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.437 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.6 m-85 -55.65 -23.05 25.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.647 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -56.94 -28.15 61.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 110.536 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -89.14 -7.78 55.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.872 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -90.06 -51.06 5.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.583 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 100' ' ' ILE . 51.8 m-85 -68.0 143.63 55.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.904 0.383 . . . . 0.0 111.336 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.3 m -76.73 -34.03 58.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 1.5 p30 -150.11 100.32 2.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.297 0.57 . . . . 0.0 111.395 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.71 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -146.54 125.07 12.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.28 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.52 107.39 19.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.71 ' CZ ' ' HB3' ' A' ' 51' ' ' ALA . 14.6 m-85 -101.75 124.95 48.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.915 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.638 ' CD2' HD21 ' A' ' 5' ' ' LEU . 17.6 m-30 -112.36 123.43 50.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' O ' HD23 ' A' ' 56' ' ' LEU . 40.1 ttmt -102.75 119.83 39.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.865 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.034 HD22 HG11 ' A' ' 61' ' ' VAL . 81.2 mt -130.87 155.38 46.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.801 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -120.04 -83.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.119 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 59' ' ' ASP . 8.6 p 178.32 -45.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.33 . . . . 0.0 111.085 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 58' ' ' VAL . 7.5 t0 -85.96 -58.12 2.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.776 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -59.55 -30.47 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.034 HG11 HD22 ' A' ' 56' ' ' LEU . 46.9 t -127.21 54.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.041 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.5 t -70.16 -27.32 64.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 1.5 m-20 -54.63 -40.9 69.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.42 -48.98 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.942 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.52 -45.54 9.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.514 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -59.36 -58.8 7.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.77 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.542 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -60.88 -68.72 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.47 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.94 75.43 2.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.778 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -48.57 137.77 11.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.231 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.649 HG13 HG21 ' A' ' 75' ' ' THR . 56.1 t -124.31 158.64 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.08 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.483 ' N ' HG12 ' A' ' 70' ' ' VAL . 79.9 p -164.56 70.49 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.42 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 41.5 t -177.74 -163.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.646 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.9 ptm -175.03 100.2 0.27 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.426 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.76 -155.35 1.14 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.464 -1.057 . . . . 0.0 112.216 -0.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.75 ' C ' HD12 ' A' ' 76' ' ' LEU . 87.3 m -159.14 111.06 2.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.75 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -123.95 127.3 47.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.259 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.565 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 24.2 pt -117.03 156.32 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.733 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.65 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -127.04 123.46 37.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.01 0.433 . . . . 0.0 111.427 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.565 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 66.7 m-85 -109.83 176.79 4.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.573 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -153.0 -46.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.628 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.0 29.27 1.69 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.191 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.09 44.14 3.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.272 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -162.25 123.57 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.023 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 22.1 pt-20 -82.3 101.72 10.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.45 . . . . 0.0 110.672 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.54 -34.18 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.446 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 63.7 m -107.96 110.36 22.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.417 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -111.56 158.91 18.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.267 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 95' ' ' ALA . 47.6 t -155.22 80.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.773 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 75' ' ' THR . 35.3 m -109.82 63.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.13 0.49 . . . . 0.0 111.27 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -133.57 -158.2 8.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.305 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.03 76.18 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.31 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -154.75 138.32 10.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.555 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.87 -1.03 10.63 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.62 2.213 . . . . 0.0 113.261 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.57 -40.76 9.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.683 0.278 . . . . 0.0 111.241 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' A' ' 88' ' ' VAL . . . -48.3 -31.52 6.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.7 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 41' ' ' ILE . 3.6 tp -69.76 -36.22 68.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.309 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -61.66 -73.33 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.607 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -55.64 -41.74 73.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.986 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.461 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -54.27 -55.85 24.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.317 . . . . 0.0 111.324 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.586 HG21 ' CE2' ' A' ' 48' ' ' TYR . 32.8 mm -62.22 -51.01 77.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.747 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -23.68 66.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.227 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -54.8 -62.91 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.55 . . . . 0.0 110.826 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -127.71 46.54 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.078 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.806 ' HA ' HD12 ' A' ' 21' ' ' LEU . 9.5 p . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.099 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.835 0.35 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.439 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 15.8 m -56.96 154.14 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.034 0.445 . . . . 0.0 111.629 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.513 ' HB ' HD11 ' A' ' 5' ' ' LEU . 6.9 m -101.11 163.9 12.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.867 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.424 ' N ' HG22 ' A' ' 3' ' ' THR . 14.6 mp0 -98.65 90.7 4.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 5' ' ' LEU . 5.2 mp -88.84 127.46 35.63 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.956 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -129.71 -58.21 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.196 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.9 t -90.24 139.82 30.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.13 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.02 66.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.163 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.4 p -55.88 -37.68 69.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.813 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 47.6 mt-10 -67.18 -32.95 74.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.656 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 47.3 t80 -65.09 -62.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.155 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.93 -54.61 42.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.8 p -56.69 -22.55 35.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.22 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.733 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -79.32 -60.55 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.322 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.656 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 78.5 mt -55.7 -23.0 26.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.165 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.89 -61.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 111.249 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -75.16 -48.35 24.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.066 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.79 108.24 0.68 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.773 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -109.85 -25.17 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 0.0 110.916 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -53.49 -79.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.653 HD21 ' CD2' ' A' ' 78' ' ' PHE . 4.3 tt -169.02 116.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 110.554 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.584 HG13 ' CE2' ' A' ' 54' ' ' TYR . 50.1 t -105.76 137.99 33.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.506 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG23 ' CD2' ' A' ' 21' ' ' LEU . 40.6 t -132.31 108.94 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 0.0 111.319 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.732 HG23 HD11 ' A' ' 77' ' ' ILE . 34.7 m -102.38 122.92 55.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.87 103.92 13.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.537 ' HB3' HG21 ' A' ' 70' ' ' VAL . 63.4 m-85 -91.99 101.7 14.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.173 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.435 ' HA ' ' CH2' ' A' ' 30' ' ' TRP . 2.4 p90 -134.53 122.21 22.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.519 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 1.054 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -93.25 23.65 4.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.868 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.2 p 46.52 80.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.985 0.421 . . . . 0.0 111.355 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.45 ' CZ3' ' HG2' ' A' ' 33' ' ' PRO . 3.6 m-90 -86.63 -58.87 2.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.322 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.5 t -143.44 -77.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.502 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.587 ' N ' ' HD3' ' A' ' 33' ' ' PRO . . . -168.69 52.59 0.22 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.923 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 32' ' ' GLY . 37.5 Cg_endo -94.3 -68.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.051 2.501 . . . . 0.0 112.204 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.0 p -68.63 -34.87 76.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.813 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 35' ' ' LYS . 9.4 tmtt? -52.93 -55.5 22.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.66 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.8 ttt -51.22 -42.69 61.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.585 HD13 ' HB1' ' A' ' 91' ' ' ALA . 36.2 pt -90.2 10.7 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.134 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.637 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -62.94 -51.04 74.01 Favored Pre-proline 0 C--N 1.331 -0.203 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.301 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 50.4 Cg_exo -55.53 -32.44 82.72 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.277 1.985 . . . . 0.0 112.09 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 63.3 mtt -55.1 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.977 HG22 HD13 ' A' ' 96' ' ' ILE . 2.5 pp -55.5 -28.78 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 111.132 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.926 ' N ' HD12 ' A' ' 41' ' ' ILE . 8.7 tm-20 -71.38 -27.09 63.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.368 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -86.01 -50.75 6.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.419 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 9.8 m-85 -54.19 -30.25 48.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.406 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -51.91 -27.83 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.239 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -90.1 -33.61 16.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.76 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -61.81 -24.56 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.105 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' CZ ' ' HB ' ' A' ' 100' ' ' ILE . 39.2 m-85 -82.28 159.07 23.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.991 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -81.28 -38.96 26.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 1.6 p30 -150.0 104.75 3.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.118 0.485 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.09 123.23 11.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.092 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -90.0 100.26 13.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 9.4 m-85 -94.87 127.34 40.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.496 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.733 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 18.8 m-30 -118.23 126.44 52.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.004 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -107.32 99.13 8.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.603 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.836 HD22 HG11 ' A' ' 61' ' ' VAL . 98.1 mt -98.77 164.28 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.236 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 38.3 t70 -144.2 162.89 35.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.439 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.054 HG21 ' HB2' ' A' ' 28' ' ' ALA . 45.7 t -86.83 0.53 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.794 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -113.22 -75.93 0.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.644 0.259 . . . . 0.0 111.211 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.813 ' HG3' HG23 ' A' ' 61' ' ' VAL . 12.0 pt-20 -58.57 -23.02 57.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.197 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.836 HG11 HD22 ' A' ' 56' ' ' LEU . 39.8 t -127.98 47.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.5 t -62.69 -26.24 68.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.016 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -60.75 -55.14 36.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.993 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.578 HG11 HD13 ' A' ' 56' ' ' LEU . 55.7 t -58.8 -48.92 84.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.025 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.08 -26.5 6.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.311 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -58.48 -64.54 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.727 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -59.65 -57.95 10.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.801 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.24 83.51 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -56.57 111.77 1.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.027 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 26' ' ' PHE . 45.9 t -92.15 127.36 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.8 t -153.47 39.45 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.177 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.0 m -128.03 -53.87 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.704 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 55.1 mtm 65.16 83.62 0.19 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.303 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 85.9 Cg_endo -89.18 -166.11 2.98 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.881 -1.3 . . . . 0.0 112.477 -0.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.487 ' C ' HD12 ' A' ' 76' ' ' LEU . 84.8 m -144.88 103.0 3.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.719 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 76' ' ' LEU . 4.0 mp -109.67 119.16 38.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.609 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.732 HD11 HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.15 152.41 35.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.054 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.653 ' CD2' HD21 ' A' ' 21' ' ' LEU . 1.9 m-85 -117.87 134.84 54.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.374 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.54 ' CD2' HD22 ' A' ' 15' ' ' LEU . 76.4 m-85 -109.47 147.49 32.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.66 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -145.67 76.91 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.659 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.13 51.62 1.33 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.12 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.76 27.39 59.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.873 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -144.32 147.45 33.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.965 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -102.21 135.01 44.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.673 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.79 -39.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.876 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.812 HG21 ' ND2' ' A' ' 103' ' ' ASN . 83.1 m -101.1 118.94 37.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.849 0.357 . . . . 0.0 110.262 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -118.13 170.66 8.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.017 0.437 . . . . 0.0 111.614 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -155.81 83.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.704 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.3 88.79 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -170.29 -34.52 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.973 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.585 ' HB1' HD13 ' A' ' 37' ' ' ILE . . . 77.53 83.28 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.926 0.393 . . . . 0.0 111.121 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 94' ' ' ALA . 14.3 t-20 -145.41 129.81 8.86 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.625 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.507 ' HD2' ' ND2' ' A' ' 92' ' ' ASN . 30.1 Cg_endo -64.11 -8.64 16.86 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.668 2.245 . . . . 0.0 113.326 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' ' OD1' ' A' ' 92' ' ' ASN . . . -98.1 -34.69 10.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.697 0.285 . . . . 0.0 111.173 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -57.66 -33.87 68.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.128 0.49 . . . . 0.0 110.171 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.977 HD13 HG22 ' A' ' 41' ' ' ILE . 4.2 tp -56.01 -50.41 69.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.297 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 11.0 tmtt? -59.01 -57.35 13.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.718 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -68.71 -11.76 60.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.61 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -81.19 -60.03 2.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.778 0.323 . . . . 0.0 111.38 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 96' ' ' ILE . 2.0 mp -75.66 -57.14 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.068 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 97' ' ' LYS . . . -46.09 -27.05 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.671 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.9 t -77.96 -57.78 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.429 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.812 ' ND2' HG21 ' A' ' 86' ' ' THR . 22.9 p30 -109.97 40.91 1.82 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 111.391 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.45 ' HA ' HD12 ' A' ' 21' ' ' LEU . 11.6 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.992 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.829 0.347 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.632 HG21 ' HG3' ' A' ' 42' ' ' GLU . 61.1 t -53.39 133.61 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 4' ' ' GLN . 4.8 m -107.2 165.02 11.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.08 0.467 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' N ' HG22 ' A' ' 3' ' ' THR . 14.0 mp0 -96.21 79.07 3.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.48 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.588 HD23 HD21 ' A' ' 56' ' ' LEU . 37.6 tp -89.16 95.75 10.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.495 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -106.02 -36.93 6.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.348 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -105.21 145.43 30.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.622 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.34 75.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.056 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -51.83 -28.95 17.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.72 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -80.8 -30.49 35.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.567 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CE1' HG21 ' A' ' 24' ' ' VAL . 48.2 t80 -78.79 -45.27 21.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.903 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -57.16 -52.24 66.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -62.46 -27.73 69.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.79 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 11' ' ' TYR . . . -61.19 -53.14 60.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 79' ' ' TYR . 83.7 mt -59.47 -30.96 68.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.881 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.22 -67.91 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -90.39 24.9 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.366 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 19' ' ' ASP . . . -58.66 -97.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.628 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 65.4 t0 68.75 -62.16 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.647 0.261 . . . . 0.0 111.167 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -46.62 -82.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.15 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.884 HD21 HG23 ' A' ' 100' ' ' ILE . 34.7 tp -178.47 111.85 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.752 0.31 . . . . 0.0 110.977 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.685 HG13 ' CE2' ' A' ' 54' ' ' TYR . 47.7 t -105.13 141.02 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.616 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.2 t -144.03 111.03 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 111.373 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.536 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 62.1 t -99.96 116.85 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.732 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 27' ' ' PHE . 10.0 t0 -106.07 103.73 13.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.936 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.64 ' CD2' HG21 ' A' ' 70' ' ' VAL . 64.8 m-85 -92.07 108.53 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.986 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CD1' ' OD1' ' A' ' 25' ' ' ASP . 1.7 p90 -153.23 120.37 5.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.888 ' HB2' HG12 ' A' ' 58' ' ' VAL . . . -93.79 27.01 2.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.116 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.2 p 49.72 51.86 15.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.08 0.467 . . . . 0.0 110.999 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.578 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.1 m-90 -66.73 -62.71 1.31 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.009 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.8 t 161.86 144.75 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.758 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.07 -112.43 3.65 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.676 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.884 ' HA ' HD13 ' A' ' 37' ' ' ILE . 91.1 Cg_exo -43.66 -71.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.953 2.435 . . . . 0.0 113.413 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 38' ' ' ALA . 26.8 p -48.78 -24.19 1.33 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -84.15 -73.07 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.784 0.326 . . . . 0.0 111.863 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 83.6 mtp -66.28 -34.07 77.16 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.884 HD13 ' HA ' ' A' ' 33' ' ' PRO . 1.4 mp -90.52 24.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.186 0.517 . . . . 0.0 111.207 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -90.15 -52.35 0.33 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.85 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 34.0 Cg_exo -62.47 -32.18 80.45 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.649 2.233 . . . . 0.0 113.009 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.702 ' CE ' HG23 ' A' ' 37' ' ' ILE . 42.4 mtm -57.56 -77.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.918 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.919 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.6 pp -56.0 -27.41 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.758 0.313 . . . . 0.0 111.044 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.919 ' N ' HD12 ' A' ' 41' ' ' ILE . 89.1 tt0 -75.2 -28.13 59.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.029 0.443 . . . . 0.0 110.512 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' PRO . 22.9 ttpp -83.37 -48.6 10.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.427 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -50.52 -27.12 6.07 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.845 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.59 -28.67 56.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.957 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.92 -14.77 33.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.108 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -85.4 10.08 13.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.571 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.42 153.26 40.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.755 0.312 . . . . 0.0 110.823 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -80.91 -40.34 24.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.968 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -134.52 95.79 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.068 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -143.4 121.75 12.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -100.2 98.39 9.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.371 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 10.6 m-85 -91.64 129.11 37.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.31 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.685 ' CE2' HG13 ' A' ' 22' ' ' VAL . 17.6 m-30 -114.09 107.13 15.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.89 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HB2' HG13 ' A' ' 2' ' ' VAL . 85.6 tttt -89.77 125.43 35.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.437 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.756 HD22 HG11 ' A' ' 61' ' ' VAL . 86.7 mt -130.62 156.74 44.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.067 0.46 . . . . 0.0 111.53 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.54 117.96 15.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.238 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.888 HG12 ' HB2' ' A' ' 28' ' ' ALA . 8.2 p -65.74 74.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.074 0.464 . . . . 0.0 111.2 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 t70 179.89 -69.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.135 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -78.63 -31.03 46.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.886 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.756 HG11 HD22 ' A' ' 56' ' ' LEU . 25.1 t -113.47 30.69 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.878 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.1 p -49.03 -26.89 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.345 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -44.62 -55.36 5.26 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.523 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.725 HG11 ' CD1' ' A' ' 56' ' ' LEU . 48.2 t -59.58 -46.4 93.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.001 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.91 -34.21 58.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.431 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -54.95 -69.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.08 -47.54 85.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -83.5 80.38 9.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.37 111.23 1.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.831 ' CG1' HG21 ' A' ' 75' ' ' THR . 48.7 t -119.08 145.63 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -144.5 70.15 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.031 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.508 ' HB3' HG11 ' A' ' 89' ' ' VAL . 64.4 m -165.46 -175.61 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.697 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.476 ' HB3' ' CH2' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -170.02 106.66 0.44 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.672 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.631 ' O ' HG13 ' A' ' 89' ' ' VAL . 4.9 Cg_exo -74.66 -155.64 1.06 Allowed 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 124.1 -1.208 . . . . 0.0 111.99 -0.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.831 HG21 ' CG1' ' A' ' 70' ' ' VAL . 86.9 m -164.22 108.23 0.96 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.8 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.749 HD12 ' C ' ' A' ' 75' ' ' THR . 3.9 mp -123.56 119.3 29.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.574 HD12 ' CE2' ' A' ' 79' ' ' TYR . 26.3 pt -110.37 152.8 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.017 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -127.03 122.84 35.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.051 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.574 ' CE2' HD12 ' A' ' 77' ' ' ILE . 68.7 m-85 -109.68 136.99 48.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.21 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -118.11 -36.45 3.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.311 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.98 49.57 0.8 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.906 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.54 28.0 66.9 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.777 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' O ' HG13 ' A' ' 85' ' ' VAL . 34.9 mmtp -145.94 114.28 6.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.751 0.31 . . . . 0.0 110.962 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.442 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 11.9 pt-20 -58.08 123.94 17.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.662 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 86' ' ' THR . 35.4 m -136.04 -44.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.494 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 94.3 m -103.33 105.36 15.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 110.619 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -103.49 147.86 26.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.455 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 48.4 t -138.28 82.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.798 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 74' ' ' PRO . 45.4 t -109.54 62.78 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.11 127.05 1.42 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.259 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HB1' HG12 ' A' ' 37' ' ' ILE . . . -55.25 124.68 17.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.774 0.321 . . . . 0.0 111.049 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 51.0 t-20 -176.15 103.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.612 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 11.2 Cg_endo -56.2 -13.98 10.9 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.652 2.235 . . . . 0.0 113.23 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -96.91 -44.56 6.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.69 -31.18 15.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 110.625 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.835 HD13 HG22 ' A' ' 41' ' ' ILE . 4.2 tp -58.03 -44.84 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.05 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -61.32 -75.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.934 0.397 . . . . 0.0 111.2 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -44.66 -32.92 1.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.542 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.98 -41.74 77.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.405 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.884 HG23 HD21 ' A' ' 21' ' ' LEU . 73.7 mt -84.96 -44.34 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.338 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.57 -13.48 59.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.6 p -90.14 -26.32 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.48 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 49.8 m-80 -114.72 -19.43 11.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.658 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.497 ' HA ' HD22 ' A' ' 21' ' ' LEU . 9.1 p . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.614 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.835 0.35 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.711 HG13 ' HB2' ' A' ' 55' ' ' LYS . 59.4 t -48.23 121.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -106.61 170.51 7.89 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.249 0.547 . . . . 0.0 110.974 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 3' ' ' THR . 14.1 mp0 -111.71 98.17 7.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.001 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.679 HD22 HD11 ' A' ' 56' ' ' LEU . 5.4 mp -88.98 119.61 29.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.845 0.355 . . . . 0.0 111.168 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -107.86 -69.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.906 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.6 t -84.56 162.86 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.13 -29.45 60.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.3 p -59.67 -33.39 71.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.05 -31.58 70.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.611 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 45.4 t80 -90.14 -36.37 14.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.61 -54.64 44.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -67.81 -20.12 65.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.279 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.667 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -69.59 -53.27 19.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.215 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.842 HD23 HG11 ' A' ' 22' ' ' VAL . 85.1 mt -58.63 -28.85 66.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.11 -58.87 2.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.356 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -55.96 -72.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.98 129.37 47.36 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.646 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -125.23 22.9 7.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.655 0.264 . . . . 0.0 111.17 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -96.54 -75.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.811 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.86 HD22 ' HB ' ' A' ' 104' ' ' VAL . 20.3 tp -159.09 107.33 1.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.965 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.842 HG11 HD23 ' A' ' 15' ' ' LEU . 52.2 t -103.57 112.91 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.623 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.9 114.68 43.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.584 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.704 ' HB ' HD11 ' A' ' 77' ' ' ILE . 54.8 t -100.28 145.1 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.399 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 38.3 t70 -127.07 92.76 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 0.0 111.595 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.742 ' CE1' HD22 ' A' ' 56' ' ' LEU . 72.6 m-85 -88.84 94.87 10.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.832 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.546 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 5.3 p90 -129.69 122.24 28.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.421 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -93.24 79.45 4.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.363 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 29' ' ' THR . 4.7 t -48.1 94.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.983 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.572 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.8 m-90 -92.06 -48.65 6.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 44.7 t 150.02 58.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.935 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.19 -121.9 0.58 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.655 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' O ' HG12 ' A' ' 37' ' ' ILE . 32.0 Cg_exo -57.13 -73.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.392 2.061 . . . . 0.0 112.192 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 6.0 p -41.54 -32.06 0.32 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -65.18 -47.36 77.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.039 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.2 mtp -84.81 -23.2 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.395 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 37' ' ' ILE . 49.0 mm -75.53 -7.55 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.425 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.916 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -63.77 -63.98 3.37 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.916 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 72.3 Cg_exo -48.64 -38.49 36.6 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.323 2.015 . . . . 0.0 112.905 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 64.1 mtt -52.5 -82.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.15 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.004 HG22 HD12 ' A' ' 96' ' ' ILE . 2.5 pp -56.38 -26.98 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.16 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.897 ' N ' HD12 ' A' ' 41' ' ' ILE . 89.4 tt0 -72.24 -25.85 61.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.399 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.463 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -85.89 -48.25 8.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.017 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -54.06 -27.46 32.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -56.8 -27.35 59.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.811 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -89.96 -10.78 43.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.095 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -90.08 16.85 7.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.668 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -131.88 158.37 41.54 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.9 m -95.63 -33.78 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -136.39 77.76 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.473 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -130.76 116.63 18.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.85 94.79 9.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.957 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.473 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 9.8 m-85 -90.03 128.55 36.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.638 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.667 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 18.6 m-30 -114.91 96.12 5.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.982 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.789 ' C ' HD12 ' A' ' 56' ' ' LEU . 87.4 tttt -89.79 120.88 31.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.333 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.789 HD12 ' C ' ' A' ' 55' ' ' LYS . 3.6 mp -129.79 -175.94 3.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.471 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.48 ' OD1' HG12 ' A' ' 58' ' ' VAL . 62.5 t0 -137.12 -82.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.953 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.48 HG12 ' OD1' ' A' ' 57' ' ' ASP . 7.7 p 177.83 -37.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.744 0.307 . . . . 0.0 111.025 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -98.22 -31.46 12.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.45 -38.01 82.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.831 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.459 HG21 HD23 ' A' ' 56' ' ' LEU . 45.3 t -103.81 -50.82 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.1 t 68.24 -63.92 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.46 -67.4 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.471 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.4 t -57.41 -61.03 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.029 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.89 -28.9 2.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.387 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -76.02 -62.23 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.739 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.501 ' HD3' ' N ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -60.35 -29.44 68.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.598 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -88.25 80.79 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.895 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -53.75 95.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 68' ' ' ALA . 47.3 t -86.94 157.77 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.273 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.483 ' N ' HG12 ' A' ' 70' ' ' VAL . 80.6 p -149.6 128.52 12.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.73 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.4 m 62.43 82.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.933 0.397 . . . . 0.0 110.553 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.528 ' HE2' ' HA ' ' A' ' 27' ' ' PHE . 38.2 mtp -84.3 152.32 61.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.617 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.07 173.28 53.0 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 123.63 -1.404 . . . . 0.0 112.71 0.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 1.053 HG23 HG12 ' A' ' 89' ' ' VAL . 94.0 m -147.86 132.25 17.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.607 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.886 HD21 HG21 ' A' ' 41' ' ' ILE . 4.1 mp -124.59 142.31 51.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.207 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.744 HD13 ' N ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -139.36 147.47 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.833 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.5 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.6 m-85 -117.87 121.3 40.37 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.051 0.453 . . . . 0.0 111.435 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 61.2 m-85 -109.65 130.4 55.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.002 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.61 53.53 1.83 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.219 0.533 . . . . 0.0 109.924 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.21 41.4 0.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.146 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.34 37.03 86.26 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.078 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -151.09 107.76 3.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.69 0.281 . . . . 0.0 111.242 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 44.4 tt0 -58.77 126.82 29.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.169 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 86' ' ' THR . 22.3 m -138.67 -46.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 71.5 p -113.4 77.88 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.126 0.489 . . . . 0.0 111.045 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -80.7 158.84 25.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.147 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.476 HG21 ' CB ' ' A' ' 99' ' ' ALA . 60.0 t -141.52 85.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.697 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 1.053 HG12 HG23 ' A' ' 75' ' ' THR . 35.1 m -109.26 78.06 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.139 0.495 . . . . 0.0 111.294 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.99 148.05 16.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.325 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.26 76.38 7.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.872 0.367 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -156.48 125.6 3.08 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.58 -6.89 20.1 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.49 2.127 . . . . 0.0 112.79 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.51 -36.32 12.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.0 110.94 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -50.14 -28.08 6.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.159 0.504 . . . . 0.0 110.204 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.004 HD12 HG22 ' A' ' 41' ' ' ILE . 6.1 tt -80.92 -33.03 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.729 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.43 -61.05 2.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -75.69 -5.92 47.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.641 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -89.7 -43.94 10.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.797 0.332 . . . . 0.0 111.244 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.684 HG23 ' CD2' ' A' ' 21' ' ' LEU . 63.0 mt -74.13 -53.81 16.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.782 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.28 -20.94 31.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.652 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.9 p -82.95 -75.52 0.31 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.664 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.541 ' OD1' HD12 ' A' ' 21' ' ' LEU . 20.8 t-20 -52.72 -37.82 59.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.118 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.86 ' HB ' HD22 ' A' ' 21' ' ' LEU . 14.8 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.485 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.861 0.363 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 59.6 t -57.57 145.18 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.48 ' HB ' HD11 ' A' ' 5' ' ' LEU . 2.2 m -107.84 158.62 17.17 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -96.71 92.6 6.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.683 HD22 HD21 ' A' ' 56' ' ' LEU . 4.8 mp -88.9 109.94 20.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.704 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -104.53 -55.65 2.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.34 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.0 t -101.49 151.68 21.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.55 67.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.5 p -55.87 -31.31 62.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -69.23 -36.73 77.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.757 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.519 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 48.3 t80 -60.66 -40.94 93.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.85 -65.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -57.8 -24.6 58.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.019 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HB1' ' CE2' ' A' ' 54' ' ' TYR . . . -57.95 -54.8 42.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.709 HD23 HG21 ' A' ' 22' ' ' VAL . 80.8 mt -82.92 1.39 39.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.332 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.06 -74.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.786 0.327 . . . . 0.0 111.245 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.1 p -71.83 -34.42 69.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.08 119.08 7.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.573 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.78 26.69 5.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.02 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -93.96 -70.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.687 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.568 ' C ' HD23 ' A' ' 21' ' ' LEU . 4.2 tt -174.86 105.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.368 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.709 HG21 HD23 ' A' ' 15' ' ' LEU . 49.3 t -99.82 132.62 44.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 ' CD2' ' A' ' 21' ' ' LEU . 46.1 t -127.82 115.48 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.142 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.505 HG11 ' CE2' ' A' ' 26' ' ' PHE . 47.2 t -99.96 117.79 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.711 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -106.94 99.44 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.505 ' CE2' HG11 ' A' ' 24' ' ' VAL . 53.8 m-85 -90.41 111.24 22.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.999 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.41 ' CE1' ' O ' ' A' ' 56' ' ' LEU . 1.7 p90 -144.56 120.02 10.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.615 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.915 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -85.57 10.33 13.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.538 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.8 p 49.65 51.01 17.29 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.017 0.437 . . . . 0.0 111.204 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.915 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.3 m-90 -67.12 -62.31 1.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.971 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.4 t 160.48 127.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.461 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.25 -118.78 4.08 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.314 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.595 ' CB ' HD12 ' A' ' 37' ' ' ILE . 20.9 Cg_endo -61.33 -43.57 27.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.601 2.201 . . . . 0.0 112.81 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 26.3 p -69.96 63.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 0.0 111.268 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 35' ' ' LYS . 7.2 ttpm? 176.1 -53.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.486 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.0 tpt -84.09 -30.05 26.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.595 HD12 ' CB ' ' A' ' 33' ' ' PRO . 54.6 mt -86.87 -30.43 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.984 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -48.37 -52.63 41.37 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.55 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.698 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 74.0 Cg_exo -49.24 -43.5 37.07 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.039 1.826 . . . . 0.0 111.495 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.822 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 71.0 mtp -60.33 -22.04 62.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.994 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.603 HD13 HD21 ' A' ' 76' ' ' LEU . 13.3 mt -91.62 -55.78 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.151 0.5 . . . . 0.0 110.085 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 3.9 tm-20 -54.94 -57.06 13.18 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.72 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.524 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 5.4 ttpm? -49.62 -47.97 49.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.075 0.464 . . . . 0.0 110.465 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.822 ' CD1' ' O ' ' A' ' 40' ' ' MET . 7.1 m-85 -54.59 -23.93 18.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.192 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -58.46 -28.14 65.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.031 0.444 . . . . 0.0 110.678 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -89.7 -11.25 42.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.068 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -90.03 15.57 9.86 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.608 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' CD2' HG21 ' A' ' 100' ' ' ILE . 42.3 m-85 -125.68 145.45 50.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.839 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.8 p -66.54 -47.06 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 104' ' ' VAL . 12.0 p-10 -143.7 99.26 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.988 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.14 122.7 16.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -90.03 97.66 11.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 8.6 m-85 -89.89 126.2 35.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.883 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.63 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 19.3 m-30 -119.37 104.18 10.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.54 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HE3' HG11 ' A' ' 2' ' ' VAL . 40.2 ttmt -89.79 123.5 33.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.091 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.736 HD22 HG11 ' A' ' 61' ' ' VAL . 86.4 mt -128.72 158.93 37.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.855 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -145.69 -176.58 5.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 59' ' ' ASP . 11.1 p -90.54 158.85 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.067 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.489 ' N ' HG22 ' A' ' 58' ' ' VAL . 7.9 t70 67.22 -70.0 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -55.6 -30.37 60.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.98 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.736 HG11 HD22 ' A' ' 56' ' ' LEU . 45.2 t -137.72 53.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.967 0.413 . . . . 0.0 110.936 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.6 t -71.44 -28.68 64.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -58.36 -40.25 81.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.055 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.632 HG11 ' CD1' ' A' ' 56' ' ' LEU . 44.4 t -75.8 -52.85 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.83 -39.41 58.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.21 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -60.87 -31.78 71.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.815 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -81.55 -47.4 13.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.789 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.86 77.66 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.121 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.6 118.12 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.818 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.824 ' CG1' HG21 ' A' ' 75' ' ' THR . 31.5 m -130.73 150.75 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.221 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.7 m -133.78 57.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.98 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 m -141.84 -169.38 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.548 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.1 ptp -166.11 91.59 0.83 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.447 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 83.2 Cg_endo -84.66 -163.79 3.09 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 124.063 -1.224 . . . . 0.0 112.393 -0.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.824 HG21 ' CG1' ' A' ' 70' ' ' VAL . 89.8 m -133.48 118.04 17.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.586 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.753 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -123.74 137.23 54.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.847 0.356 . . . . 0.0 111.278 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.504 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 28.7 pt -133.72 162.72 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.834 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.524 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.0 m-85 -132.41 128.64 37.97 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 111.242 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.504 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 71.2 m-85 -109.89 158.82 17.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.742 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -156.6 73.46 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.794 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.28 -18.65 23.12 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.505 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.01 48.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.26 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -169.96 127.64 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.995 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.66 98.69 5.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.3 m -110.75 -28.32 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.364 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 99.7 m -114.84 103.3 10.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.918 0.389 . . . . 0.0 110.269 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -107.36 157.67 17.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.266 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -155.27 81.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.717 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 89' ' ' VAL . 35.8 m -109.64 106.14 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.333 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.06 -113.43 0.29 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.426 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -178.19 77.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 111.035 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -151.86 129.35 5.74 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.602 ' HB2' ' HE2' ' A' ' 40' ' ' MET . 87.0 Cg_endo -82.39 9.59 3.94 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.635 2.223 . . . . 0.0 113.021 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.91 -50.78 3.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.732 0.301 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.96 -27.93 14.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 110.614 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.45 HG22 ' C ' ' A' ' 93' ' ' PRO . 4.4 tp -54.14 -43.47 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.194 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -71.92 -71.51 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.031 0.443 . . . . 0.0 111.129 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -44.2 -32.19 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.583 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.24 -51.39 15.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.181 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 100' ' ' ILE . 66.4 mt -76.26 -5.14 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.496 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.55 -24.61 21.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 0.0 111.38 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -89.98 -59.38 2.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.31 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.461 HD21 HG21 ' A' ' 86' ' ' THR . 59.6 m-80 -54.62 -43.1 71.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.101 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.511 ' N ' HD12 ' A' ' 21' ' ' LEU . 10.2 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.373 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.858 0.361 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 53' ' ' PHE . 46.8 t -57.63 137.44 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.672 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.5 m -89.94 168.05 12.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 110.871 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.416 ' H ' HG22 ' A' ' 3' ' ' THR . 14.7 mp0 -108.51 94.8 5.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.886 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.84 ' HB2' HD21 ' A' ' 56' ' ' LEU . 4.9 mp -88.96 132.05 34.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.205 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.61 -62.85 0.95 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 t -86.19 152.98 22.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.17 -28.84 64.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.327 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.5 p -57.42 -30.41 64.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.058 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -74.34 -37.64 63.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.47 -52.43 65.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.22 -56.03 27.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.057 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -57.8 -28.72 64.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.028 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.831 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -68.54 -43.42 76.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.135 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 79' ' ' TYR . 78.3 mt -67.96 -40.34 83.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.044 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.0 -46.45 62.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.204 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.5 m -75.78 -53.43 8.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.057 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.06 115.26 7.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.599 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -113.14 -31.89 6.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.71 0.29 . . . . 0.0 111.039 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.91 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.997 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.908 HD13 ' HB2' ' A' ' 103' ' ' ASN . 41.5 tp -159.65 115.98 2.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.569 HG13 ' CE2' ' A' ' 54' ' ' TYR . 54.2 t -111.72 106.34 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.832 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.653 HG21 ' CD1' ' A' ' 100' ' ' ILE . 44.8 t -102.92 144.12 14.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.464 HG11 ' CE2' ' A' ' 26' ' ' PHE . 60.0 t -128.31 146.54 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -135.84 111.8 9.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.944 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.464 ' CE2' HG11 ' A' ' 24' ' ' VAL . 56.5 m-85 -105.44 113.56 27.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.198 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.427 ' HB2' ' CB ' ' A' ' 34' ' ' CYS . 2.1 p90 -147.92 120.72 8.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.721 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.9 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -82.84 9.92 8.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.686 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.2 p 50.57 55.51 9.4 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.059 0.457 . . . . 0.0 111.058 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.9 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.2 m-90 -71.81 -61.88 1.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.014 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 39.6 t 158.85 101.77 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.467 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.84 -126.69 2.51 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.279 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' LYS . 92.4 Cg_exo -42.73 -60.61 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.962 2.441 . . . . 0.0 113.234 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.427 ' CB ' ' HB2' ' A' ' 27' ' ' PHE . 26.9 p -65.85 66.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.357 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' PRO . 56.6 tptt 176.14 -35.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.3 mtt -81.84 -65.89 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.684 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.662 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -88.16 18.69 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.766 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -63.42 -53.37 53.0 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.648 0.261 . . . . 0.0 110.663 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 52.3 Cg_exo -55.58 -33.07 85.58 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.64 2.227 . . . . 0.0 112.21 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.471 ' CE ' ' HB3' ' A' ' 93' ' ' PRO . 67.3 mtp -54.82 -71.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 110.468 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.483 HG22 ' HB ' ' A' ' 96' ' ' ILE . 7.6 pt -52.44 -39.25 28.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.094 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.28 -27.52 65.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.64 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -79.72 -45.84 18.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -53.62 -25.04 15.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.546 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.789 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -55.79 -29.97 60.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.732 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -87.63 -3.12 58.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.877 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -90.27 -35.24 15.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.542 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.796 ' CE2' HG21 ' A' ' 100' ' ' ILE . 45.7 m-85 -76.49 157.29 32.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.798 0.332 . . . . 0.0 111.183 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.4 p -79.98 -38.36 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -155.38 104.07 2.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.133 0.492 . . . . 0.0 111.403 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -150.13 125.69 10.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.104 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.32 107.46 19.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 110.771 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.789 ' CE2' ' HB1' ' A' ' 45' ' ' ALA . 9.3 m-85 -99.96 130.79 46.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.004 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.831 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 20.5 m-30 -113.9 119.73 38.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' HG11 ' A' ' 2' ' ' VAL . 61.4 tttp -104.11 115.02 29.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.883 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.84 HD21 ' HB2' ' A' ' 5' ' ' LEU . 89.7 mt -134.68 170.7 15.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.237 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.28 153.59 46.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.644 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.873 ' HB ' ' HB2' ' A' ' 28' ' ' ALA . 47.3 t -88.09 55.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.986 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -177.46 -65.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.054 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.53 -30.65 61.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.036 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.431 HG21 HD22 ' A' ' 56' ' ' LEU . 51.2 t -102.13 -58.84 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.814 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.9 t 67.35 -64.64 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.393 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -40.6 -68.39 0.18 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.828 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.671 HG11 ' CD1' ' A' ' 56' ' ' LEU . 59.7 t -52.13 -44.21 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.163 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.31 56.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -57.15 -68.24 0.25 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.988 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.94 -25.37 57.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.72 74.49 7.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.311 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.0 mp0 -69.89 105.97 3.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.762 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.626 ' CB ' HG21 ' A' ' 75' ' ' THR . 35.2 m -132.95 -178.58 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.8 p -164.48 72.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.819 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -157.54 -170.17 3.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.609 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.8 ptt? -165.81 98.56 0.76 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.192 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 2.8 Cg_exo -75.76 -155.43 1.06 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.261 -1.141 . . . . 0.0 112.129 0.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.626 HG21 ' CB ' ' A' ' 70' ' ' VAL . 86.7 m -155.65 100.66 2.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.587 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 76' ' ' LEU . 3.9 mp -113.85 162.79 15.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.917 0.389 . . . . 0.0 111.256 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.561 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 17.1 pt -156.89 160.18 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.82 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.634 ' HE2' HD13 ' A' ' 100' ' ' ILE . 1.3 m-85 -128.68 123.05 32.16 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.984 0.421 . . . . 0.0 111.368 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.562 ' CD2' HD22 ' A' ' 15' ' ' LEU . 69.8 m-85 -109.91 101.79 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.831 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.97 -70.53 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 110.732 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.39 27.32 7.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.368 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.08 49.82 1.69 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.364 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' O ' HG13 ' A' ' 85' ' ' VAL . 24.2 ttmm -169.82 114.96 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.334 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -55.62 99.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 83' ' ' LYS . 35.6 m -121.38 -28.99 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.799 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.43 ' O ' ' CD1' ' A' ' 78' ' ' PHE . 89.1 m -122.44 74.99 1.21 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 110.649 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -82.37 159.6 23.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.2 0.524 . . . . 0.0 111.643 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -156.72 86.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.085 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.641 ' O ' HG23 ' A' ' 89' ' ' VAL . 27.8 m -108.61 87.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.37 0.605 . . . . 0.0 111.28 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.36 -152.06 7.09 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.968 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.42 92.75 2.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.795 0.331 . . . . 0.0 110.998 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -144.53 101.21 4.7 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.071 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 96' ' ' ILE . 32.1 Cg_exo -58.52 -15.14 23.76 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.553 2.169 . . . . 0.0 112.431 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.62 -31.49 13.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 110.83 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.86 -31.33 64.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.797 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 93' ' ' PRO . 3.8 tp -53.76 -33.87 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.072 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -68.29 -67.7 0.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.118 0.485 . . . . 0.0 110.832 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -53.72 -49.48 68.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.492 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.562 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -51.25 -65.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.625 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.796 HG21 ' CE2' ' A' ' 48' ' ' TYR . 41.2 mm -52.33 -48.57 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.419 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . . . -55.41 -21.8 17.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.856 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.5 m -57.55 -50.09 74.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.491 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.908 ' HB2' HD13 ' A' ' 21' ' ' LEU . 21.1 m-80 -122.84 5.56 9.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.621 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 101' ' ' ALA . 13.0 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.623 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.811 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 22.9 ptp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.801 0.334 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.66 HG11 ' HE2' ' A' ' 55' ' ' LYS . 43.9 t -55.94 132.27 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.945 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.3 m -107.13 168.71 9.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 110.803 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.445 ' H ' HG22 ' A' ' 3' ' ' THR . 15.0 mp0 -108.41 98.99 8.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.156 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.688 HD12 HD21 ' A' ' 56' ' ' LEU . 63.2 mt -88.81 96.05 10.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.252 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -89.88 -57.06 2.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.882 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.4 t -95.38 158.43 15.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' OD2' ' A' ' 63' ' ' ASP . . . -73.32 -29.33 62.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.083 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.4 p -57.75 -31.34 66.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -71.19 -31.32 67.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -76.21 -42.64 45.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -70.13 -50.17 43.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -58.97 -28.64 66.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.542 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -70.13 -64.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.458 HD22 ' CG ' ' A' ' 79' ' ' TYR . 81.9 mt -57.44 -21.87 39.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.17 -79.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.446 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.7 m -83.43 -29.62 27.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.197 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.1 104.3 0.23 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.673 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -86.99 -27.38 23.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 0.0 110.705 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -53.62 -176.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.973 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 4.8 tt -86.11 115.84 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.698 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.577 HG13 ' CD2' ' A' ' 54' ' ' TYR . 56.5 t -102.99 127.2 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.644 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.42 HG23 HD22 ' A' ' 21' ' ' LEU . 46.3 t -120.12 119.61 60.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.368 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.487 HG13 HD12 ' A' ' 56' ' ' LEU . 51.9 t -104.77 124.84 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.482 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -117.21 103.77 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.919 0.39 . . . . 0.0 111.612 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.429 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 75.1 m-85 -93.88 115.28 27.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.948 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.467 ' CD2' ' CG2' ' A' ' 29' ' ' THR . 1.1 p90 -150.19 117.96 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 111.212 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.36 -9.53 58.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.893 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.467 ' CG2' ' CD2' ' A' ' 27' ' ' PHE . 69.4 p 52.73 74.08 0.31 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.361 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.57 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.0 m-90 -80.92 -62.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 43.6 t 158.86 69.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.459 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.4 -121.11 0.78 Allowed Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.927 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.16 -52.1 6.02 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.702 2.268 . . . . 0.0 112.562 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.5 p -79.77 60.87 3.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.727 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -162.99 -47.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.392 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.2 tpt -83.56 -26.79 29.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.53 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.499 HD11 ' HB1' ' A' ' 91' ' ' ALA . 63.1 mt -79.96 -15.69 13.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.204 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.85 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -52.48 -60.08 7.21 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.403 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.85 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 86.2 Cg_exo -46.93 -36.03 19.44 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.369 2.046 . . . . 0.0 112.605 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.416 ' HB3' ' HB3' ' A' ' 93' ' ' PRO . 55.1 mtt -57.5 -76.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.577 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.904 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -60.23 -24.39 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.908 0.385 . . . . 0.0 110.861 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.904 ' N ' HD12 ' A' ' 41' ' ' ILE . 89.4 tt0 -75.53 -26.58 58.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.489 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 6.6 tmtm? -85.7 -48.3 8.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.177 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.603 ' CD1' HD11 ' A' ' 96' ' ' ILE . 7.4 m-85 -46.33 -29.8 1.81 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.214 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.811 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -52.9 -26.32 14.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -90.06 -30.34 17.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.993 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -62.07 -35.68 79.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.326 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.579 ' CE2' HG21 ' A' ' 100' ' ' ILE . 46.7 m-85 -97.13 155.59 16.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 110.761 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -106.61 -21.77 12.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.309 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.878 ' OD1' HG22 ' A' ' 104' ' ' VAL . 2.9 p30 -125.52 35.32 4.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.764 0.316 . . . . 0.0 111.454 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.8 118.16 36.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.282 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.67 95.84 10.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 13.5 m-85 -89.69 123.34 33.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.607 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.58 ' HB3' HD11 ' A' ' 5' ' ' LEU . 14.7 m-30 -115.82 102.81 10.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.806 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.66 ' HE2' HG11 ' A' ' 2' ' ' VAL . 24.4 ttmm -89.83 124.11 34.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.571 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.688 HD21 HD12 ' A' ' 5' ' ' LEU . 86.2 mt -119.36 146.86 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.293 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -134.39 161.42 35.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.548 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.1 m -77.67 156.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.198 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.1 t0 66.03 -72.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.222 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.44 -30.85 61.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.109 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.574 HG11 HD22 ' A' ' 56' ' ' LEU . 47.4 t -139.95 55.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.4 m -80.48 -22.08 41.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 8' ' ' ALA . 12.2 p-10 -47.21 -29.76 2.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.292 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.634 HG11 ' CD1' ' A' ' 56' ' ' LEU . 47.5 t -79.43 -54.85 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.993 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.43 -35.56 19.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.421 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -58.45 -45.24 88.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.765 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -89.51 -65.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.62 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.66 77.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.822 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -50.86 93.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.18 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.0 t -148.83 136.28 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.814 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.3 p -105.21 150.13 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' A' ' 73' ' ' MET . 60.4 p -61.01 -173.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.904 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.683 ' H ' ' HA ' ' A' ' 74' ' ' PRO . 60.3 ttp 167.52 -38.11 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.683 ' HA ' ' H ' ' A' ' 73' ' ' MET . 94.0 Cg_endo -76.57 175.26 48.97 Favored 'Cis proline' 0 C--N 1.36 1.157 0 CA-C-N 120.67 1.275 . . . . 0.0 113.812 0.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.809 ' C ' HD12 ' A' ' 76' ' ' LEU . 56.3 m -127.89 135.82 50.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.764 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.809 HD12 ' C ' ' A' ' 75' ' ' THR . 4.1 mp -129.93 146.18 51.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.906 0.384 . . . . 0.0 111.231 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.533 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 29.2 pt -143.15 159.86 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.812 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.485 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.3 m-85 -129.57 126.87 39.51 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 111.505 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.533 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 67.5 m-85 -109.69 153.62 24.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.752 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -114.89 -38.78 3.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.975 0.417 . . . . 0.0 110.454 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.77 28.44 0.31 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.067 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.1 42.28 2.1 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.278 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -165.31 109.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.674 0.273 . . . . 0.0 111.13 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.04 115.49 3.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.443 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 m -126.34 -43.2 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 64.5 p -112.31 83.41 1.8 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.151 0.5 . . . . 0.0 110.795 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.527 HH21 HG11 ' A' ' 89' ' ' VAL . 16.5 ptm180 -83.09 166.17 18.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.592 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.8 t -156.72 87.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.967 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.722 HG12 HG23 ' A' ' 75' ' ' THR . 34.3 m -108.76 107.7 23.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.16 0.505 . . . . 0.0 111.337 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -169.77 -118.95 0.47 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.19 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . 177.77 56.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.796 0.331 . . . . 0.0 111.133 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -146.28 134.27 10.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.122 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.553 ' O ' HG12 ' A' ' 96' ' ' ILE . 57.1 Cg_endo -73.67 -19.32 21.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.413 2.075 . . . . 0.0 112.158 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.04 62.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.801 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.11 -39.85 12.62 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.511 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.628 HG21 ' CG2' ' A' ' 41' ' ' ILE . 21.2 pt -59.74 -35.38 59.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.888 0.375 . . . . 0.0 110.822 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -55.23 -70.41 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.948 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -59.94 -29.87 68.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.482 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -64.45 -42.81 95.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.064 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.602 HG23 HD13 ' A' ' 21' ' ' LEU . 75.5 mt -82.34 -31.84 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.63 -27.55 65.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.028 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.7 p -58.28 -58.22 9.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.081 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -128.06 54.54 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.878 HG22 ' OD1' ' A' ' 50' ' ' ASP . 10.0 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.035 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.867 0.365 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.6 t -83.63 136.84 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.8 p -105.01 172.17 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.476 0.655 . . . . 0.0 111.764 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -127.16 107.99 10.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.626 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.657 HD12 HD11 ' A' ' 56' ' ' LEU . 80.6 mt -89.16 88.37 7.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.007 0.432 . . . . 0.0 111.362 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.96 -43.55 10.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.198 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.4 t -105.58 137.41 43.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.783 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.633 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . . . -54.15 -25.86 24.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.416 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -59.17 -28.75 66.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.037 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.627 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 43.5 mt-10 -77.92 -26.28 48.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -78.54 -54.3 6.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.127 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -57.32 -59.86 4.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -57.18 -25.52 59.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.279 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.748 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -67.58 -61.91 1.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.792 0.33 . . . . 0.0 111.373 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -53.64 -24.59 14.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.233 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.07 -68.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.309 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.9 m -60.06 -63.51 1.27 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.42 121.9 24.39 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.732 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -124.01 -1.04 8.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -69.29 -76.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.716 0.293 . . . . 0.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 104' ' ' VAL . 3.7 tt -167.5 110.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.563 HG13 ' CE2' ' A' ' 54' ' ' TYR . 60.2 t -102.34 132.6 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.534 HG23 ' CD2' ' A' ' 21' ' ' LEU . 47.8 t -134.37 118.29 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.277 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.773 HG13 HD13 ' A' ' 56' ' ' LEU . 43.5 t -99.98 123.09 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.452 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -110.86 87.81 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.591 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 24' ' ' VAL . 60.6 m-85 -82.14 112.22 18.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.809 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 3.7 p90 -133.32 117.06 16.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.952 0.406 . . . . 0.0 111.324 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -94.43 107.22 19.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.583 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.416 ' HB ' ' CE ' ' A' ' 35' ' ' LYS . 73.8 p -53.7 114.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.1 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.448 ' CD2' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -179.56 42.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -176.54 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.156 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 152.37 -44.51 0.63 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.219 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 82.7 Cg_exo -45.56 -63.62 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.572 2.181 . . . . 0.0 112.746 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 7.7 p -49.48 -45.53 46.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' CE ' ' HB ' ' A' ' 29' ' ' THR . 99.6 mttt -58.5 -36.99 74.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.123 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.2 tpt -73.36 -26.51 61.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 37' ' ' ILE . 40.9 mm -90.37 27.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.361 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.811 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -86.82 -54.98 0.37 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.084 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 40.9 Cg_exo -57.31 -33.12 95.58 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.423 2.082 . . . . 0.0 112.298 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.416 ' CE ' ' HG3' ' A' ' 93' ' ' PRO . 57.4 mtt -60.56 -75.56 0.06 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 0.0 110.485 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.884 HG22 HD12 ' A' ' 96' ' ' ILE . 12.9 pt -51.57 -30.18 10.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.188 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -78.82 -30.71 45.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.463 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 39' ' ' PRO . 87.9 tttt -84.31 -38.26 20.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -48.24 -25.35 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.773 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 53' ' ' PHE . . . -55.27 -32.35 62.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.15 0.5 . . . . 0.0 110.587 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -85.28 -5.1 59.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -90.14 -51.62 5.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.299 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.451 ' CE2' HG13 ' A' ' 100' ' ' ILE . 50.5 m-85 -79.74 172.41 13.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.174 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.2 p -105.56 -29.68 10.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.241 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -148.72 80.17 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.435 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.742 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.44 124.54 36.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.208 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.45 106.79 18.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.041 0.448 . . . . 0.0 110.688 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 51' ' ' ALA . 21.6 m-85 -99.9 119.44 38.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.232 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.748 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 15.1 m-30 -111.24 96.56 6.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.048 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.636 ' C ' HD12 ' A' ' 56' ' ' LEU . 87.7 tttt -89.83 110.55 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.448 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.786 HD23 HG11 ' A' ' 61' ' ' VAL . 3.8 mp -118.78 157.87 26.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 0.0 111.485 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -129.78 162.31 28.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.353 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 28' ' ' ALA . 54.8 t -64.94 -32.47 58.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.432 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -97.82 -62.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.147 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -52.44 -26.06 11.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.15 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.786 HG11 HD23 ' A' ' 56' ' ' LEU . 42.0 t -133.77 60.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.3 t -81.11 0.66 35.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.415 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.633 ' OD1' ' HB2' ' A' ' 8' ' ' ALA . 7.7 t0 -90.04 -49.1 6.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 111.041 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 68' ' ' ALA . 48.2 t -59.58 -51.53 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.18 -29.52 1.6 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.639 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.95 -71.32 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.001 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -65.48 -42.6 92.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 64' ' ' VAL . . . -90.04 76.78 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -58.42 100.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.88 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 71' ' ' SER . 48.6 t -141.79 157.38 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.151 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 70' ' ' VAL . 50.7 m -86.91 -173.99 4.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.524 ' C ' ' HA ' ' A' ' 74' ' ' PRO . 81.1 p -167.18 79.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.011 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.685 ' N ' ' HA ' ' A' ' 74' ' ' PRO . 23.2 ptp -115.85 8.05 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.685 ' HA ' ' N ' ' A' ' 73' ' ' MET . 73.0 Cg_endo -83.04 -167.33 5.51 Favored 'Cis proline' 0 C--N 1.361 1.225 0 CA-C-N 121.442 1.551 . . . . 0.0 112.62 -0.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.884 HG23 HG12 ' A' ' 89' ' ' VAL . 96.4 m -140.98 133.93 29.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.977 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.761 HD12 ' C ' ' A' ' 75' ' ' THR . 4.1 mp -124.96 115.51 20.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.842 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.4 pt -109.88 158.68 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.762 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -131.15 131.4 44.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.397 . . . . 0.0 111.217 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.487 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 83.9 m-85 -109.36 141.57 41.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.674 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -122.17 68.01 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 0.0 110.77 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.85 26.75 13.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.207 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.6 53.43 2.27 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.364 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.443 ' NZ ' HG11 ' A' ' 85' ' ' VAL . 26.8 ttpp -176.54 122.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 85' ' ' VAL . 52.1 mt-10 -65.76 138.47 57.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.647 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 84' ' ' GLU . 15.5 m -157.19 -39.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.527 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.656 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 88.0 m -105.73 106.93 17.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.951 0.405 . . . . 0.0 110.116 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.455 ' NH2' HG22 ' A' ' 89' ' ' VAL . 8.7 ptm180 -104.23 149.52 25.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.584 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.52 HG11 ' O ' ' A' ' 95' ' ' ALA . 41.6 t -154.55 81.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.534 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.884 HG12 HG23 ' A' ' 75' ' ' THR . 33.2 m -109.64 111.12 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.21 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -117.57 0.42 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.29 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -178.23 71.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 0.0 111.049 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.542 ' ND2' ' HD2' ' A' ' 93' ' ' PRO . 15.7 t-20 -150.93 139.31 12.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.661 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.542 ' HD2' ' ND2' ' A' ' 92' ' ' ASN . 18.9 Cg_exo -65.01 -24.86 59.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.414 2.076 . . . . 0.0 112.275 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.532 ' HB3' ' OD1' ' A' ' 92' ' ' ASN . . . -84.53 -27.19 27.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.925 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.52 ' O ' HG11 ' A' ' 88' ' ' VAL . . . -50.39 -27.61 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.093 0.473 . . . . 0.0 110.213 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.884 HD12 HG22 ' A' ' 41' ' ' ILE . 5.8 tt -90.06 -38.23 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.771 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -61.81 -57.68 10.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.718 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.44 -13.68 61.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.625 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -84.72 -60.61 2.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.787 0.327 . . . . 0.0 111.535 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.458 HG23 HD13 ' A' ' 21' ' ' LEU . 46.3 mm -47.48 -41.85 7.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.139 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.07 -23.4 46.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.218 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -55.72 -65.43 0.6 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -131.87 65.66 1.57 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.09 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.698 ' HA ' HD12 ' A' ' 21' ' ' LEU . 9.4 p . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.052 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.541 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 8.7 p -63.77 156.92 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.066 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.465 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -118.6 174.29 6.35 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 111.119 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -125.79 105.96 9.34 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.926 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.84 HD11 ' HB3' ' A' ' 54' ' ' TYR . 63.0 mt -88.89 127.47 35.64 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.103 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.712 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 8.8 mmpt? -118.15 -50.42 2.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.759 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.2 t -102.57 159.92 15.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.192 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.73 -29.93 65.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.9 p -56.02 -30.77 62.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.867 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -70.41 -30.62 67.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.766 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.871 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 45.6 t80 -75.37 -46.6 32.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.001 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.26 -50.55 45.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -56.65 -23.26 40.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.488 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.565 ' HB1' ' CE2' ' A' ' 54' ' ' TYR . . . -84.09 -60.24 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.518 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.871 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 86.0 mt -52.06 -25.52 8.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.162 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.64 -55.73 4.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.2 m -90.39 23.3 3.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.396 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.63 149.59 22.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.438 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -156.3 -46.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -58.55 -75.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.852 ' CD2' HG23 ' A' ' 100' ' ' ILE . 28.5 tp -167.47 120.69 0.94 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.808 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.76 HG11 HD23 ' A' ' 15' ' ' LEU . 61.8 t -111.56 124.52 68.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.2 t -128.32 126.22 65.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.584 ' CG2' HD11 ' A' ' 77' ' ' ILE . 57.5 t -112.09 114.0 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.804 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' OD1' ' HG ' ' A' ' 76' ' ' LEU . 24.3 m-20 -111.42 102.78 11.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.237 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.573 ' CE1' HD12 ' A' ' 56' ' ' LEU . 49.6 m-85 -91.7 107.99 19.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.997 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 2.4 p90 -149.01 121.27 8.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.623 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.713 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -90.26 20.12 4.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.586 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p 49.7 55.84 8.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 111.112 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.713 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.5 m-90 -71.24 -61.74 1.66 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.214 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 43.1 t 164.38 129.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.521 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.81 -122.54 5.38 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.031 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.37 -47.45 5.9 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.56 2.173 . . . . 0.0 112.721 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 26.5 p -52.25 -23.88 6.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.6 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -107.76 -37.56 6.1 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.423 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.3 tpt -76.27 -40.38 51.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 111.351 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 37' ' ' ILE . 59.9 mt -79.0 -1.06 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.661 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.924 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -51.44 -63.3 2.1 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 74.7 Cg_exo -50.28 -35.37 43.5 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.213 1.942 . . . . 0.0 113.237 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' A' ' 93' ' ' PRO . 60.7 mtp -65.49 -69.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.621 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.801 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -56.35 -20.28 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.217 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.801 ' N ' HD12 ' A' ' 41' ' ' ILE . 3.7 mm-40 -86.95 -32.95 19.84 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.1 ttpt -78.27 -44.32 25.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.158 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.19 -32.04 71.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.584 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -54.06 -27.76 34.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.016 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.01 -34.61 16.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.739 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -58.87 -27.83 65.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.073 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CE2' HD12 ' A' ' 100' ' ' ILE . 44.6 m-85 -81.78 155.76 25.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.893 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.5 m -89.24 -32.08 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -151.92 96.87 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.09 112.42 4.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.82 106.93 18.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.172 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 2.1 m-85 -89.91 124.6 34.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.84 ' HB3' HD11 ' A' ' 5' ' ' LEU . 17.8 m-30 -112.43 90.52 3.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.486 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.728 ' NZ ' HD13 ' A' ' 41' ' ' ILE . 68.6 mttm -89.84 156.51 18.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.225 0.536 . . . . 0.0 111.791 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.819 ' CD1' HG11 ' A' ' 64' ' ' VAL . 93.6 mt -151.43 -177.7 6.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.636 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -149.15 133.3 17.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.754 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 58' ' ' VAL . 48.6 t -74.76 60.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.077 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.7 t70 178.82 -63.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.621 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -59.37 -30.13 68.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.426 HG21 HD22 ' A' ' 56' ' ' LEU . 45.0 t -100.78 -58.29 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.048 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 t 68.0 -62.44 0.35 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.423 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -43.71 -61.57 1.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.765 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.819 HG11 ' CD1' ' A' ' 56' ' ' LEU . 58.2 t -57.11 -57.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.808 0.337 . . . . 0.0 111.212 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.99 -31.62 0.95 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.787 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -60.26 -58.64 7.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.876 0.37 . . . . 0.0 110.674 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.549 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.42 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.503 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -65.71 79.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.76 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.25 122.86 9.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.243 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.559 HG13 ' OG1' ' A' ' 75' ' ' THR . 60.7 t -120.08 127.92 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.9 m -134.96 45.14 2.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.6 t -146.36 -163.48 1.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.687 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.9 ptm -171.35 92.67 0.43 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.405 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 69.4 Cg_endo -86.11 -163.52 2.78 Favored 'Cis proline' 0 C--N 1.349 0.6 0 C-N-CA 124.132 -1.195 . . . . 0.0 112.427 0.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.559 ' OG1' HG13 ' A' ' 70' ' ' VAL . 91.9 m -138.98 106.72 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.437 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 76' ' ' LEU . 2.4 mp -118.84 128.58 54.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.302 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 77' ' ' ILE . 2.4 pp -128.57 173.0 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.886 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.658 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 8.2 m-85 -135.0 120.44 19.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.746 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.511 ' CD2' HD13 ' A' ' 77' ' ' ILE . 47.2 m-85 -109.8 137.9 46.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.522 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -106.04 -59.74 1.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 0.0 110.753 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.42 29.52 3.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.141 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.54 35.65 3.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.229 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' NZ ' ' HB3' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -151.88 124.2 8.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 111.142 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.4 tt0 -78.94 98.6 6.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.549 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.75 -37.49 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.684 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.658 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 74.7 m -109.79 110.79 21.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.221 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -122.6 145.07 48.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.593 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.714 ' O ' HG23 ' A' ' 88' ' ' VAL . 30.5 m -139.86 83.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.714 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.568 ' O ' HG23 ' A' ' 89' ' ' VAL . 32.8 m -109.44 66.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.294 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -144.9 17.2 1.97 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.523 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.13 56.45 5.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.349 . . . . 0.0 111.127 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.554 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 67.6 m-20 -106.49 101.19 34.36 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.198 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HB3' ' SD ' ' A' ' 40' ' ' MET . 8.3 Cg_exo -71.28 -17.41 30.98 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.726 2.284 . . . . 0.0 112.195 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.77 -43.44 5.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.554 ' HB3' ' CB ' ' A' ' 92' ' ' ASN . . . -50.51 -28.42 8.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.228 0.537 . . . . 0.0 110.186 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.582 ' CD1' HG22 ' A' ' 41' ' ' ILE . 6.6 tt -60.79 -29.34 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.778 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 5.2 tmtm? -55.69 -58.33 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.434 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -72.61 -36.07 68.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.06 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.84 81.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.221 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.852 HG23 ' CD2' ' A' ' 21' ' ' LEU . 63.5 mt -75.04 -37.68 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.133 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.07 -19.17 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.891 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 64.0 m -90.04 -38.55 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 111.581 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.547 ' HB3' HD11 ' A' ' 21' ' ' LEU . 26.8 t-20 -83.66 -39.42 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.428 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.768 ' N ' HD13 ' A' ' 21' ' ' LEU . 11.9 p . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.339 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 46.8 tpp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.896 0.379 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.535 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.9 t -149.43 110.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.817 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 p -89.72 170.75 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.497 0.665 . . . . 0.0 111.658 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -127.97 120.18 27.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.592 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.788 HD11 ' CD2' ' A' ' 54' ' ' TYR . 72.5 mt -88.96 96.21 10.63 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.194 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -89.93 -47.04 8.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.507 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.5 t -104.04 142.33 34.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.79 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.46 -24.69 21.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.299 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.6 p -59.58 -43.9 93.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 36.5 mt-10 -62.87 -25.68 68.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.873 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.505 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 50.9 t80 -90.05 -46.92 8.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.069 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -60.33 -62.94 1.5 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.034 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -55.41 -26.32 41.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.544 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -65.97 -61.3 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.505 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 85.2 mt -54.03 -24.7 18.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.155 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.66 -74.74 0.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.231 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -64.77 -48.12 75.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.054 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.68 102.52 0.17 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.601 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -112.21 -22.69 10.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.616 0.246 . . . . 0.0 111.188 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -54.2 -72.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.131 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.862 HD22 ' CA ' ' A' ' 104' ' ' VAL . 52.4 tp -171.38 106.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.939 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.598 HG13 ' CE2' ' A' ' 54' ' ' TYR . 59.4 t -105.09 127.97 59.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.045 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 77' ' ' ILE . 43.7 t -129.67 133.8 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.868 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.455 HG13 HD13 ' A' ' 56' ' ' LEU . 47.5 t -114.83 122.17 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.209 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -114.5 121.62 44.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.59 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 69.5 m-85 -107.83 127.88 54.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.247 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.449 ' CZ ' ' HE3' ' A' ' 55' ' ' LYS . 2.2 p90 -146.44 114.77 6.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.548 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.95 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -89.4 16.95 6.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.578 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p 49.97 52.94 13.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.94 0.4 . . . . 0.0 111.471 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.95 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.1 m-90 -73.74 -60.94 2.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.981 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.5 t 154.0 134.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.672 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.93 -105.15 3.16 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.681 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 99.2 Cg_exo -43.12 -62.9 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.883 2.389 . . . . 0.0 113.112 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.4 p -70.9 62.99 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.769 0.318 . . . . 0.0 111.062 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.4 tptt 177.89 -56.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.8 ttt -55.37 -71.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.235 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.905 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -90.26 40.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.237 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -80.6 -57.07 0.63 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.875 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 53.2 Cg_exo -55.13 -26.2 49.57 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.222 1.948 . . . . 0.0 112.053 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 63.6 mtt -60.29 -73.39 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.728 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.928 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -57.42 -26.52 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.989 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.928 ' N ' HD12 ' A' ' 41' ' ' ILE . 4.2 tm-20 -77.32 -30.33 54.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.202 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -82.39 -43.01 17.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.05 -29.34 43.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.197 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.636 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.89 -26.72 26.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.034 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -90.02 -29.31 18.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.797 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -66.05 -14.74 62.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.543 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.686 ' CE2' HD13 ' A' ' 100' ' ' ILE . 43.9 m-85 -92.27 161.96 14.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.772 0.32 . . . . 0.0 111.029 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -78.38 -43.67 26.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -155.69 106.28 2.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.118 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.18 127.56 16.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.856 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.69 102.27 14.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.636 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 7.0 m-85 -92.61 116.13 28.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.037 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.788 ' CD2' HD11 ' A' ' 5' ' ' LEU . 12.3 m-30 -106.55 90.94 3.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.172 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.5 ' C ' HD12 ' A' ' 56' ' ' LEU . 63.5 tttp -89.79 106.69 18.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.161 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.649 HD23 HG11 ' A' ' 61' ' ' VAL . 4.1 mp -110.34 141.03 43.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.803 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -80.7 -80.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 p 178.31 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.962 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -103.77 -33.63 8.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.773 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.11 -30.03 67.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 5' ' ' LEU . 48.9 t -100.82 -65.83 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.03 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.1 t 68.42 -64.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.236 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -46.91 -61.0 2.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.411 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.627 ' HB ' HG11 ' A' ' 61' ' ' VAL . 53.5 t -55.75 -56.29 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.172 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.87 -31.45 28.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.315 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -70.9 -28.74 64.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 44.1 mtmt -86.26 -78.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.402 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.92 81.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.267 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.28 143.72 57.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.809 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 75' ' ' THR . 28.6 m -156.31 144.79 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.4 p -124.24 68.23 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.984 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.4 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 60.7 m -144.23 176.36 9.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.472 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 67.9 mtm -157.18 96.97 2.06 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 33' ' ' PRO . 90.9 Cg_endo -79.89 -161.88 2.81 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.947 -1.272 . . . . 0.0 112.273 -0.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.688 ' C ' HD12 ' A' ' 76' ' ' LEU . 91.3 m -140.32 112.88 7.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.652 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 75' ' ' THR . 4.0 mp -120.09 142.85 48.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.556 ' O ' HG13 ' A' ' 23' ' ' VAL . 26.0 pt -139.24 162.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.442 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.3 m-85 -132.28 127.52 35.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.95 0.405 . . . . 0.0 111.329 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.439 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 60.1 m-85 -109.93 140.03 44.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.696 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -110.5 -31.96 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.837 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.97 27.75 0.35 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.2 33.96 6.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.373 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -154.32 102.04 2.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.328 . . . . 0.0 110.781 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 39.5 tt0 -53.64 97.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.078 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 83' ' ' LYS . 26.9 m -110.77 -31.21 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.322 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 94.6 m -116.29 101.02 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.234 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -108.68 146.91 32.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.057 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.3 t -136.55 80.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.757 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 89' ' ' VAL . 35.0 m -109.95 103.88 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.232 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.02 -109.45 0.22 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.395 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.16 81.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.31 . . . . 0.0 110.904 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 24.8 t-20 -160.09 112.72 1.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.746 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' O ' HG22 ' A' ' 96' ' ' ILE . 63.9 Cg_exo -52.26 -22.72 16.2 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.629 2.219 . . . . 0.0 112.734 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.438 ' HB3' ' OD1' ' A' ' 92' ' ' ASN . . . -90.56 -30.46 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 92' ' ' ASN . . . -50.98 -27.28 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.019 0.438 . . . . 0.0 110.402 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.813 HG21 HG22 ' A' ' 41' ' ' ILE . 6.1 tt -82.65 -35.13 12.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.832 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -69.43 -62.81 1.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.003 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -59.32 -20.3 53.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.349 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -90.11 -40.68 12.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.57 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.816 HG13 HD21 ' A' ' 21' ' ' LEU . 12.0 tt -75.61 -28.05 19.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.743 0.306 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.05 89.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.384 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.8 m -73.22 -24.05 60.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.289 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.63 ' HB3' HD13 ' A' ' 21' ' ' LEU . 5.6 m120 -92.58 -61.78 1.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.862 ' CA ' HD22 ' A' ' 21' ' ' LEU . 11.2 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.886 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.895 0.378 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.843 HG21 ' OE1' ' A' ' 42' ' ' GLU . 55.4 t -63.86 106.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 p -98.96 177.17 5.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.54 0.686 . . . . 0.0 111.73 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -130.52 107.46 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.674 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.805 HD23 ' HB2' ' A' ' 11' ' ' TYR . 3.6 mp -89.18 101.21 13.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.078 0.466 . . . . 0.0 111.462 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -89.91 -37.6 14.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.871 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.6 t -111.77 141.09 45.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.06 -23.7 14.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.403 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.5 p -59.74 -45.22 92.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.115 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.763 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 72.0 mt-10 -61.67 -26.02 67.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.805 ' HB2' HD23 ' A' ' 5' ' ' LEU . 48.9 t80 -90.07 -49.47 6.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.071 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -57.1 -67.06 0.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 t -56.09 -24.35 39.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.099 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.836 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -63.21 -57.22 11.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.226 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.434 HD22 ' CG ' ' A' ' 79' ' ' TYR . 83.6 mt -56.2 -26.98 52.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.98 -29.94 18.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.252 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -87.36 -60.51 1.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.038 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.99 114.42 4.54 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.653 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -112.32 -30.18 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.738 0.304 . . . . 0.0 110.924 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -59.17 -76.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.942 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.633 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 25.9 tp -156.28 116.66 3.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.983 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 59.2 t -107.93 135.37 46.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.56 143.99 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.006 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.596 ' CG1' HD12 ' A' ' 56' ' ' LEU . 48.9 t -135.03 112.45 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.91 129.82 48.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.479 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 58.2 m-85 -114.64 134.6 54.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.356 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.469 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 1.8 p90 -150.72 113.36 4.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.549 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.767 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -87.97 23.31 2.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.566 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 79.9 p 49.65 49.33 20.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.852 0.358 . . . . 0.0 111.428 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.767 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.5 m-90 -67.96 -60.46 2.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.6 t -163.87 -104.97 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.685 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -101.1 -34.64 4.49 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.619 -0.8 . . . . 0.0 114.69 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 76.1 Cg_exo -41.95 -32.13 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.311 2.007 . . . . 0.0 113.27 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 26.1 p -97.19 -42.15 7.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.389 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -81.67 0.39 38.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 32' ' ' GLY . 16.2 tpt -90.24 -55.34 3.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.858 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.849 HD11 ' HG2' ' A' ' 74' ' ' PRO . 31.9 pt -90.28 36.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.511 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.809 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -75.98 -54.85 2.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.906 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.809 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 41.9 Cg_exo -56.7 -29.46 80.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.328 2.019 . . . . 0.0 111.993 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.586 ' SD ' HG22 ' A' ' 37' ' ' ILE . 59.2 mtt -59.42 -75.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.67 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.958 HG22 HD12 ' A' ' 96' ' ' ILE . 2.4 pp -62.19 -23.42 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.126 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.894 ' N ' HD12 ' A' ' 41' ' ' ILE . 5.4 tp10 -77.95 -27.69 49.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.595 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -87.69 -42.42 12.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -48.03 -27.57 2.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.467 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.36 -30.01 17.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.603 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -89.97 -31.34 17.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.082 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -63.01 -31.5 72.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.805 ' CZ ' HG21 ' A' ' 100' ' ' ILE . 42.7 m-85 -100.58 146.67 26.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.094 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.2 m -85.94 -32.12 21.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.7 p-10 -134.16 85.17 2.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.555 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -134.82 118.43 16.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.749 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.87 105.25 17.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.275 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.555 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 7.4 m-85 -102.25 128.62 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.557 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.836 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 18.0 m-30 -113.37 112.26 23.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.442 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.469 ' HE3' ' CE1' ' A' ' 27' ' ' PHE . 52.9 tptt -89.78 112.1 23.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.471 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.596 HD12 ' CG1' ' A' ' 24' ' ' VAL . 90.4 mt -123.46 150.45 43.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 111.655 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -132.75 150.16 52.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.177 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.68 81.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.574 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -179.97 -92.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.728 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.723 ' HG2' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -57.8 -27.28 62.97 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.784 0.326 . . . . 0.0 110.666 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.723 HG23 ' HG2' ' A' ' 60' ' ' GLU . 32.5 t -112.8 35.04 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 t -51.39 -24.97 5.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -50.87 -55.28 17.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.312 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.579 HG11 HD13 ' A' ' 56' ' ' LEU . 47.2 t -66.77 -59.31 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.07 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.97 -28.25 2.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.514 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -58.44 -55.48 34.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -73.96 -33.64 63.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.52 64.62 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.02 112.68 4.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.634 HG21 HG21 ' A' ' 75' ' ' THR . 35.6 m -134.45 -178.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.6 m -157.41 80.61 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.6 p -173.22 179.0 2.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.462 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 58.9 mtm -152.51 102.29 2.74 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.686 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.849 ' HG2' HD11 ' A' ' 37' ' ' ILE . 1.8 Cg_endo -81.86 -158.38 1.67 Allowed 'Cis proline' 0 C--N 1.348 0.534 0 C-N-CA 124.405 -1.081 . . . . 0.0 112.361 0.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.787 ' HA ' HG12 ' A' ' 89' ' ' VAL . 88.8 m -145.85 96.86 2.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.418 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 76' ' ' LEU . 4.1 mp -109.66 140.57 43.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.004 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.521 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 22.6 pt -133.87 162.08 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.412 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.761 ' HE2' HD13 ' A' ' 100' ' ' ILE . 4.3 m-85 -127.16 125.2 40.74 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.111 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 63.3 m-85 -109.49 164.49 12.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.938 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -168.69 60.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.071 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.72 40.59 0.71 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.026 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.0 34.45 83.49 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.872 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -148.76 117.15 6.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.827 0.346 . . . . 0.0 111.118 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.3 tt0 -73.73 144.67 45.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.679 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 86' ' ' THR . 34.7 m -151.7 -46.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.701 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.678 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 96.5 m -104.4 116.44 32.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.11 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -123.98 127.9 48.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.311 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.704 ' O ' HG23 ' A' ' 88' ' ' VAL . 32.2 m -118.98 84.69 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.163 0.506 . . . . 0.0 110.495 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 75' ' ' THR . 34.8 m -109.14 99.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.394 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -170.1 -109.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.529 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 90' ' ' GLY . . . 178.48 78.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.327 . . . . 0.0 111.176 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -155.02 128.43 4.39 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.71 -13.53 24.52 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.509 2.139 . . . . 0.0 112.753 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.09 -48.59 4.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.181 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.5 -30.29 3.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.234 0.54 . . . . 0.0 110.188 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.958 HD12 HG22 ' A' ' 41' ' ' ILE . 6.0 tt -66.63 -50.58 65.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.177 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.42 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -53.35 -54.16 40.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.369 . . . . 0.0 110.684 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -49.22 -26.53 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.523 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.57 -27.51 22.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.597 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.805 HG21 ' CZ ' ' A' ' 48' ' ' TYR . 48.1 mm -68.23 -59.28 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.373 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . . . -61.86 -14.99 38.82 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.3 m -81.26 -29.5 34.37 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.556 ' C ' HD13 ' A' ' 21' ' ' LEU . 22.4 m120 -122.25 -9.42 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 104' ' ' VAL . 10.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.467 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' N ' ' HB1' ' A' ' 45' ' ' ALA . 26.5 mmt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.83 0.348 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.638 HG11 ' NZ ' ' A' ' 55' ' ' LYS . 47.2 t -57.69 137.17 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 m -111.28 151.21 28.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.932 0.396 . . . . 0.0 110.955 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -91.55 97.99 11.39 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 5' ' ' LEU . 4.9 mp -88.93 134.89 33.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.0 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -126.1 -64.78 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.5 t -91.44 148.47 22.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.065 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.74 69.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 m -56.88 -33.47 66.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.677 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 50.3 mt-10 -74.73 -25.17 58.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -82.29 -61.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.391 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -55.57 -58.58 7.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.46 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.0 t -56.79 -28.32 61.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.332 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . -66.26 -33.58 76.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 0.0 111.338 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.459 HD22 ' CG ' ' A' ' 79' ' ' TYR . 85.6 mt -62.06 -44.14 97.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.083 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.1 -28.95 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.509 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 t -56.64 -78.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.212 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.96 136.16 13.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.627 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -85.9 -6.8 59.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.675 0.274 . . . . 0.0 111.252 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -54.7 -175.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.807 0.337 . . . . 0.0 110.962 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.441 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 27.1 tp -79.25 107.56 12.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.817 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 49.1 t -99.79 127.97 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.698 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.621 HG22 ' CD2' ' A' ' 78' ' ' PHE . 48.9 t -137.02 133.75 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.552 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.713 HG11 ' CE2' ' A' ' 26' ' ' PHE . 40.6 t -103.24 160.4 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.255 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.504 ' N ' HG12 ' A' ' 24' ' ' VAL . 38.3 t70 -137.53 89.57 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.713 ' CE2' HG11 ' A' ' 24' ' ' VAL . 61.2 m-85 -96.36 111.17 23.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.607 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 0.5 OUTLIER -138.64 -44.99 0.49 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.521 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HB2' ' H ' ' A' ' 58' ' ' VAL . . . 61.87 87.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 110.867 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.406 HG21 ' NZ ' ' A' ' 35' ' ' LYS . 65.9 p -57.69 115.1 2.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.824 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.596 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.1 m-90 -101.61 -59.3 1.72 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 52.4 t 160.3 46.11 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.97 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.59 -118.08 0.42 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.783 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 35' ' ' LYS . 75.4 Cg_exo -49.73 -69.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.495 2.13 . . . . 0.0 112.336 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 10.2 p -61.26 75.85 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.375 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 33' ' ' PRO . 17.3 tppt? 175.72 -42.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.851 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.8 ttm -67.77 -49.01 64.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.224 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.554 HD12 ' C ' ' A' ' 37' ' ' ILE . 2.0 pp -90.22 25.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.001 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.795 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -78.44 -54.18 1.21 Allowed Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.627 0.251 . . . . 0.0 111.036 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 51.7 Cg_exo -55.12 -36.69 93.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.529 2.153 . . . . 0.0 112.226 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.417 ' SD ' HG22 ' A' ' 37' ' ' ILE . 60.6 mtt -54.16 -75.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.545 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.05 HG22 HG21 ' A' ' 96' ' ' ILE . 10.6 pt -51.15 -43.62 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.307 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.549 ' HG3' HG21 ' A' ' 2' ' ' VAL . 39.2 tt0 -64.05 -33.18 75.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.772 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -77.05 -45.91 25.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.572 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.691 ' CG ' HD11 ' A' ' 96' ' ' ILE . 6.9 m-85 -56.03 -32.24 63.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.039 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HB1' ' N ' ' A' ' 1' ' ' MET . . . -50.29 -27.8 6.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.329 0.585 . . . . 0.0 109.723 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -77.93 -38.78 44.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.746 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -58.02 -38.04 75.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.519 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.657 ' CE2' HG21 ' A' ' 100' ' ' ILE . 32.4 m-85 -75.58 170.53 15.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.37 . . . . 0.0 110.925 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.8 m -116.55 -19.77 9.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.495 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -145.24 47.71 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.802 0.334 . . . . 0.0 111.465 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.6 119.16 38.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.553 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.73 96.46 10.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 110.881 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.51 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 6.5 m-85 -90.37 126.15 35.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.882 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.551 ' CG ' HD21 ' A' ' 5' ' ' LEU . 18.8 m-30 -121.78 107.6 12.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.376 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.638 ' NZ ' HG11 ' A' ' 2' ' ' VAL . 4.9 ttmp? -89.78 120.02 30.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.935 0.398 . . . . 0.0 111.173 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.035 HD22 HG11 ' A' ' 61' ' ' VAL . 98.4 mt -138.01 135.68 36.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.812 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -112.64 -178.06 3.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.662 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.85 HG21 ' CE ' ' A' ' 73' ' ' MET . 46.0 t -107.26 65.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 111.099 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -178.35 -60.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.357 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -75.76 -23.6 55.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.035 HG11 HD22 ' A' ' 56' ' ' LEU . 30.5 t -124.81 40.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.791 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 t -53.76 -26.21 22.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.267 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.95 -50.83 72.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.027 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.522 HG11 HD13 ' A' ' 56' ' ' LEU . 43.7 t -72.24 -55.33 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.83 -28.88 2.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.444 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -60.83 -46.73 89.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.846 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -81.77 -47.29 13.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.771 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.11 79.45 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.58 114.86 5.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.934 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.874 ' HB ' HG21 ' A' ' 75' ' ' THR . 35.4 m -135.63 125.26 41.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.113 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.2 t -112.32 92.98 4.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.986 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -177.76 -74.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.705 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.85 ' CE ' HG21 ' A' ' 58' ' ' VAL . 61.7 mtt 57.67 102.45 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.734 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.48 167.77 31.68 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.833 0.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.874 HG21 ' HB ' ' A' ' 70' ' ' VAL . 71.6 m -154.87 132.41 11.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.355 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.825 HD12 ' C ' ' A' ' 75' ' ' THR . 4.1 mp -131.16 136.55 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 111.667 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.472 HD12 ' OH ' ' A' ' 79' ' ' TYR . 28.2 pt -133.13 150.68 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.977 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.621 ' CD2' HG22 ' A' ' 23' ' ' VAL . 1.1 m-85 -125.94 132.47 52.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.093 0.473 . . . . 0.0 111.267 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.472 ' OH ' HD12 ' A' ' 77' ' ' ILE . 84.1 m-85 -109.51 114.35 27.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.151 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -72.18 -75.26 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.799 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.59 33.68 3.87 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.023 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.52 27.42 4.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.176 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -158.24 150.29 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 91.5 mt-10 -82.39 97.02 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.14 -27.09 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.291 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 97.7 m -117.21 103.4 10.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.942 0.401 . . . . 0.0 110.069 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -103.29 155.24 18.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.363 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t -155.5 80.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.614 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.574 ' O ' HG23 ' A' ' 89' ' ' VAL . 34.1 m -109.55 112.38 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.994 0.426 . . . . 0.0 111.279 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.59 -116.42 0.37 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.36 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -176.51 40.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.81 0.338 . . . . 0.0 111.074 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -130.43 134.08 25.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.528 ' O ' HG12 ' A' ' 96' ' ' ILE . 34.0 Cg_endo -66.62 -56.24 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.361 2.04 . . . . 0.0 112.655 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -40.65 -31.97 0.19 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.21 -22.86 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.591 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.05 HG21 HG22 ' A' ' 41' ' ' ILE . 9.2 pt -76.35 -35.35 27.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.922 0.391 . . . . 0.0 110.929 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -56.1 -68.79 0.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.359 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.49 -34.57 77.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.624 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.98 -43.12 68.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.818 0.342 . . . . 0.0 111.454 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.657 HG21 ' CE2' ' A' ' 48' ' ' TYR . 74.2 mt -84.76 -18.82 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.472 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -90.21 -23.37 21.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.752 0.31 . . . . 0.0 111.569 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.4 m -89.99 -65.75 0.99 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.83 0.348 . . . . 0.0 111.482 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.64 -29.18 16.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.456 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 101' ' ' ALA . 8.6 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.287 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtm . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.775 0.322 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.511 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 13.7 p -54.42 144.1 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -124.14 159.23 30.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.063 0.459 . . . . 0.0 110.933 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -102.0 100.0 10.22 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 5' ' ' LEU . 5.5 mp -88.83 109.36 20.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.806 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -96.25 -66.37 0.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -85.04 150.92 24.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.301 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.74 -28.68 70.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.095 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.1 t -55.88 -35.84 66.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 46.4 mt-10 -65.36 -40.9 94.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.516 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -67.76 -55.76 11.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.929 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.58 -56.3 23.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.9 t -57.03 -29.1 63.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . -64.92 -61.05 2.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.479 HD21 ' CD2' ' A' ' 79' ' ' TYR . 79.6 mt -59.51 -26.72 65.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.004 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.03 -70.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.225 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -74.78 -27.25 60.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.87 169.66 1.66 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.691 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -177.36 -37.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 111.075 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -51.84 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.758 HD13 HG23 ' A' ' 100' ' ' ILE . 4.9 tt -172.73 108.24 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.753 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.657 HG13 ' CE2' ' A' ' 54' ' ' TYR . 60.6 t -100.79 132.06 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.688 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' A' ' 21' ' ' LEU . 46.6 t -125.6 122.24 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.384 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.586 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 49.4 t -105.19 129.92 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.53 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -116.74 106.67 13.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.022 0.439 . . . . 0.0 111.488 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.586 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 77.4 m-85 -99.24 101.29 12.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.226 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.446 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 4.5 p90 -127.22 105.96 8.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.499 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -96.14 73.67 2.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.444 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.452 ' C ' ' O ' ' A' ' 28' ' ' ALA . 68.3 p -23.91 105.72 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.527 ' CZ3' ' HB2' ' A' ' 73' ' ' MET . 3.2 m-90 -113.63 -54.75 2.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.2 m -123.15 -2.15 8.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.109 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.651 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 88.4 23.33 37.41 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.769 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 62.3 Cg_endo -75.53 -50.62 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.87 1.713 . . . . 0.0 111.941 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 27' ' ' PHE . 56.8 m -63.82 -37.37 87.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -64.19 -26.96 68.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.19 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 57.4 ttp -58.47 -62.0 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.0 110.988 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.3 pt -90.35 31.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.707 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.9 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -78.93 -59.38 0.64 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.122 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.9 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 65.0 Cg_exo -52.07 -35.15 60.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.335 2.023 . . . . 0.0 112.298 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.551 ' HE2' ' HB2' ' A' ' 93' ' ' PRO . 66.0 mtp -57.27 -74.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.668 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.841 ' CG2' HG21 ' A' ' 96' ' ' ILE . 6.4 pt -48.52 -42.07 12.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.76 0.314 . . . . 0.0 111.211 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -67.07 -33.75 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.487 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -73.83 -44.75 54.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.111 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 96' ' ' ILE . 7.3 m-85 -55.77 -27.48 51.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.777 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.55 -29.37 50.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.75 -30.46 23.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.589 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -64.69 -25.81 68.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.24 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -79.6 176.28 9.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.861 0.363 . . . . 0.0 110.941 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.8 m -97.89 -36.67 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.788 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -149.84 90.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -134.61 129.31 34.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.837 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -101.53 93.27 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.228 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.511 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 7.4 m-85 -90.08 131.26 36.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.31 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.657 ' CE2' HG13 ' A' ' 22' ' ' VAL . 20.0 m-30 -119.37 129.83 55.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.856 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.483 ' O ' HD23 ' A' ' 56' ' ' LEU . 87.3 tttt -103.5 145.28 30.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.68 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.661 HD11 HG11 ' A' ' 64' ' ' VAL . 88.1 mt -143.73 140.0 29.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.37 -175.72 3.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.94 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.7 t -82.93 151.73 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 7.4 t70 63.36 132.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 39.2 tt0 73.63 -54.77 0.68 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.151 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 61' ' ' VAL . 36.6 t -95.03 2.29 9.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.536 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.1 m -63.81 -30.23 71.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.782 0.325 . . . . 0.0 111.005 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -51.41 -25.85 6.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.4 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.661 HG11 HD11 ' A' ' 56' ' ' LEU . 36.2 t -68.7 -54.61 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.047 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.99 70.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.21 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -56.45 -67.65 0.28 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.986 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -57.59 -37.72 73.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -90.01 78.04 6.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.822 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -53.5 102.2 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.971 HG11 HG21 ' A' ' 75' ' ' THR . 44.5 t -138.94 152.51 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.996 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.3 p -143.82 116.14 8.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.54 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.482 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 41.2 t 179.32 -163.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.222 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.527 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 18.3 ptm 178.41 93.76 0.15 Allowed Pre-proline 0 N--CA 1.463 0.187 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 73.0 Cg_endo -75.85 -161.61 2.61 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.354 -0.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.971 HG21 HG11 ' A' ' 70' ' ' VAL . 19.1 m -146.66 115.82 6.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.05 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.806 HD12 ' C ' ' A' ' 75' ' ' THR . 5.2 mp -126.58 115.7 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.935 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.409 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 28.6 pt -116.03 164.98 11.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.669 ' HE1' HG22 ' A' ' 88' ' ' VAL . 4.0 m-85 -133.86 131.03 38.71 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.038 0.447 . . . . 0.0 111.403 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.479 ' CD2' HD21 ' A' ' 15' ' ' LEU . 75.0 m-85 -109.89 152.33 25.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.625 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -116.15 -38.08 3.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.811 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.71 31.87 0.22 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.282 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.99 37.45 2.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.281 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -161.48 118.7 2.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -73.64 110.57 8.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.312 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.9 -37.46 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.452 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 72.3 m -107.14 111.67 24.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.798 0.332 . . . . 0.0 110.322 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -125.42 152.21 45.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.186 0.517 . . . . 0.0 111.556 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.717 ' O ' HG23 ' A' ' 88' ' ' VAL . 28.5 m -138.67 88.29 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.219 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 89' ' ' VAL . 31.1 m -109.25 94.45 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.333 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.87 -112.77 0.62 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.206 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.09 55.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.861 0.362 . . . . 0.0 111.125 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -144.85 126.37 7.83 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.195 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.551 ' HB2' ' HE2' ' A' ' 40' ' ' MET . 81.4 Cg_endo -79.21 2.62 8.16 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.663 2.242 . . . . 0.0 112.64 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.32 -39.48 10.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.008 0.432 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.14 -30.33 70.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.681 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.841 HG21 ' CG2' ' A' ' 41' ' ' ILE . 2.2 pp -57.43 -32.91 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.827 ' N ' HD12 ' A' ' 96' ' ' ILE . 50.0 tttm -54.27 -69.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.731 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -62.55 -21.64 65.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.623 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -59.66 -54.03 51.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.758 HG23 HD13 ' A' ' 21' ' ' LEU . 2.0 mp -75.51 -35.62 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.576 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.26 68.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.308 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.8 m -57.02 -74.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.12 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.44 ' O ' HD12 ' A' ' 21' ' ' LEU . 16.0 p-10 -105.15 62.03 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.993 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.556 HG13 ' OXT' ' A' ' 104' ' ' VAL . 9.5 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.509 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 10.8 mmt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.8 0.333 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.552 HG13 ' HE2' ' A' ' 55' ' ' LYS . 56.7 t -50.49 111.09 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.926 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.426 ' HB ' HD11 ' A' ' 5' ' ' LEU . 1.1 m -103.47 160.38 14.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 111.241 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -104.65 94.45 5.31 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 5' ' ' LEU . 5.2 mp -88.96 132.32 34.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -130.13 -64.15 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -77.71 143.08 38.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.105 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.75 -29.26 70.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.8 p -55.51 -30.64 61.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 90.9 mt-10 -77.41 -38.26 50.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.606 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 48.7 t80 -72.21 -42.44 65.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.032 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -58.22 -68.17 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.061 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.5 p -55.66 -26.08 42.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HB1' ' HE2' ' A' ' 54' ' ' TYR . . . -59.04 -53.07 62.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.243 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.442 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 84.7 mt -69.35 -30.83 68.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.7 -54.55 15.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.212 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -90.36 24.64 2.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.457 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.12 142.45 16.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.449 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -151.48 -46.6 0.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.635 0.255 . . . . 0.0 110.832 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -57.05 -76.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.803 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.667 HD22 ' N ' ' A' ' 104' ' ' VAL . 41.7 tp -177.23 109.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.136 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' A' ' 54' ' ' TYR . 48.1 t -103.86 117.23 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.744 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.47 122.94 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 61.1 t -109.05 126.24 66.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.402 ' OD1' ' HG ' ' A' ' 76' ' ' LEU . 23.9 m-20 -122.54 107.0 11.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.526 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.513 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 52.6 m-85 -93.34 98.86 11.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.355 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.3 p90 -134.24 121.86 21.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.245 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.16 21.95 3.01 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.7 p 46.88 73.25 0.19 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.856 0.36 . . . . 0.0 110.986 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.538 ' CH2' ' HB2' ' A' ' 73' ' ' MET . 0.0 OUTLIER -146.96 62.26 1.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.153 0.501 . . . . 0.0 112.334 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.1 t 60.29 155.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.508 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.71 178.57 20.12 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.636 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 6.1 Cg_endo -49.63 -22.6 6.85 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.866 2.377 . . . . 0.0 112.548 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.5 p -51.86 -39.99 59.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.877 0.37 . . . . 0.0 111.077 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -87.28 -32.07 19.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.033 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.25 -41.16 70.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.018 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 37' ' ' ILE . 48.8 mt -90.43 21.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.481 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -73.1 -58.21 2.6 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 121.239 -0.184 . . . . 0.0 111.106 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 36.3 Cg_exo -58.28 -35.74 98.4 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.343 2.029 . . . . 0.0 112.002 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.459 ' SD ' HG23 ' A' ' 37' ' ' ILE . 62.5 mtt -54.4 -76.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.4 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.925 HG22 HD12 ' A' ' 96' ' ' ILE . 12.6 pt -49.9 -43.34 19.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.286 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.433 ' N ' HG13 ' A' ' 41' ' ' ILE . 39.6 tt0 -63.9 -31.78 73.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.771 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 6.2 ttpm? -84.55 -55.21 4.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.636 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.437 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 11.5 m-85 -49.92 -28.11 6.23 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.851 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.25 -28.15 39.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.037 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -89.7 -33.61 16.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.983 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.27 -27.05 68.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.271 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.736 ' CE2' HG21 ' A' ' 100' ' ' ILE . 44.4 m-85 -82.95 157.05 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 111.014 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -82.12 -37.22 26.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.686 ' O ' HG23 ' A' ' 104' ' ' VAL . 40.8 p-10 -154.5 101.86 2.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.974 0.416 . . . . 0.0 111.149 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.48 124.1 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.973 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.98 106.22 18.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.289 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.429 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 7.1 m-85 -92.52 112.17 24.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.224 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.611 ' HE2' ' HB1' ' A' ' 14' ' ' ALA . 16.7 m-30 -114.73 102.48 10.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.824 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HE2' HG13 ' A' ' 2' ' ' VAL . 68.1 mttm -89.87 130.55 36.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.007 HD13 HG11 ' A' ' 64' ' ' VAL . 90.2 mt -130.63 149.58 52.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.861 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -120.75 159.29 25.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.99 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 59' ' ' ASP . 48.5 t -104.61 160.09 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.502 ' N ' HG12 ' A' ' 58' ' ' VAL . 8.1 t0 69.23 -63.07 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -60.96 -29.7 69.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.626 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 64' ' ' VAL . 47.3 t -98.97 -57.23 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.767 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.4 t 68.18 -62.77 0.35 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.481 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.96 -47.54 8.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.643 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.007 HG11 HD13 ' A' ' 56' ' ' LEU . 40.7 t -78.01 -61.88 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.055 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.32 -30.35 0.81 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.375 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -57.3 -55.27 36.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.725 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -65.86 -63.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.55 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 26' ' ' PHE . . . -75.49 76.79 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -49.65 119.1 3.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.255 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.431 HG13 ' OG1' ' A' ' 75' ' ' THR . 41.7 t -90.33 137.35 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.856 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.0 t -143.16 48.58 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 111.359 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.1 p -179.31 178.2 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.584 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.538 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 20.7 ptt? -150.09 100.25 3.23 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.582 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HD3' ' HG2' ' A' ' 33' ' ' PRO . 95.5 Cg_endo -78.24 -163.58 3.47 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.931 -1.279 . . . . 0.0 112.388 -0.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 32.5 m -143.47 97.17 3.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.988 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 76' ' ' LEU . 2.4 mp -109.87 135.66 50.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.006 0.431 . . . . 0.0 111.656 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.564 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 25.5 pt -132.35 166.18 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.478 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.535 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.3 m-85 -131.52 125.93 33.63 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 111.679 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.564 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 60.8 m-85 -111.56 153.64 25.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.366 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -127.83 -58.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.704 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.75 -14.16 8.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.476 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.97 41.58 0.12 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.261 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.748 ' HG2' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -162.29 127.71 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.965 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 88.7 tt0 -69.63 95.96 0.9 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.746 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.748 HG13 ' HG2' ' A' ' 83' ' ' LYS . 34.7 m -109.88 -32.92 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.156 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.62 HG21 HD22 ' A' ' 103' ' ' ASN . 98.9 m -113.02 103.39 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 110.091 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -106.43 159.66 15.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.574 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.582 ' CG1' ' HB1' ' A' ' 95' ' ' ALA . 44.1 t -155.57 83.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.389 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 89' ' ' VAL . 28.1 m -109.22 77.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.199 0.523 . . . . 0.0 111.264 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -143.73 -112.15 0.83 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.067 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 33' ' ' PRO . . . 171.57 93.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.629 0.252 . . . . 0.0 110.86 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.622 ' OD1' ' HB3' ' A' ' 94' ' ' ALA . 16.6 t-20 -173.5 131.59 0.57 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.968 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HD2' ' ND2' ' A' ' 92' ' ' ASN . 10.8 Cg_endo -54.99 -20.29 22.64 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.634 2.223 . . . . 0.0 112.812 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB3' ' OD1' ' A' ' 92' ' ' ASN . . . -86.55 -35.32 19.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.57 0.224 . . . . 0.0 111.228 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -49.07 -28.86 4.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.157 0.504 . . . . 0.0 110.049 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.925 HD12 HG22 ' A' ' 41' ' ' ILE . 6.3 tt -90.03 -37.97 10.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.427 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.0 -71.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.975 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -56.68 -22.95 38.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.041 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.476 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -77.21 -67.3 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.123 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.736 HG21 ' CE2' ' A' ' 48' ' ' TYR . 37.1 mm -51.99 -35.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.18 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -56.7 -71.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 111.683 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.3 m -61.22 -24.75 66.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.602 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.62 HD22 HG21 ' A' ' 86' ' ' THR . 2.7 m-80 -80.63 -62.47 1.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 50' ' ' ASP . 13.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.763 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.6 mtp . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.794 0.33 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.5 t 60.05 116.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.048 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.4 m -93.81 169.25 10.44 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.146 0.498 . . . . 0.0 110.84 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.464 ' H ' HG22 ' A' ' 3' ' ' THR . 14.3 mp0 -110.12 91.45 3.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.186 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 5' ' ' LEU . 6.6 mp -88.97 136.21 33.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.024 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -130.32 -58.22 1.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.5 t -96.74 142.5 28.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.053 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.83 -27.35 65.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.181 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 t -56.61 -38.07 71.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.31 -36.04 80.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.572 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 49.1 t80 -66.8 -47.68 71.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.972 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -58.45 -60.17 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -57.23 -24.63 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.722 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -70.93 -40.56 72.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.284 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.572 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 83.9 mt -90.17 15.04 11.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.576 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.11 -90.57 0.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.752 -0.203 . . . . 0.0 111.038 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.8 p -90.4 19.14 5.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.625 0.25 . . . . 0.0 111.374 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 19' ' ' ASP . . . -70.2 -74.45 0.67 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.716 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 1.4 m-20 79.77 -41.81 0.24 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.589 0.355 . . . . 0.0 111.365 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -54.03 -174.48 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 21' ' ' LEU . 7.5 tt -77.39 99.06 5.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.979 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' A' ' 54' ' ' TYR . 60.8 t -105.58 111.94 36.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.101 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.826 HG13 ' O ' ' A' ' 77' ' ' ILE . 46.8 t -119.32 139.58 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.808 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.546 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 55.2 t -113.51 128.96 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.497 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 36.5 t70 -112.29 101.51 9.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.962 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.546 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 64.4 m-85 -92.52 107.95 19.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 1.4 p90 -153.01 121.38 6.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.356 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.763 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . . . -85.06 17.41 2.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.663 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.1 p 49.66 55.13 9.85 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.049 0.452 . . . . 0.0 110.945 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.715 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.7 m-90 -69.41 -62.21 1.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.192 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 40.4 t 164.29 140.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.85 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.47 -120.73 6.35 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.537 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.433 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 89.1 Cg_exo -43.07 -70.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.822 2.348 . . . . 0.0 112.863 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.9 p -48.29 -26.64 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 111.423 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 31' ' ' CYS . 67.9 mmtt -85.66 -72.37 0.49 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.791 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.0 mtt -59.51 -22.24 61.34 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 37' ' ' ILE . 55.8 mt -89.97 -11.03 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.952 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -54.1 -65.23 1.33 Allowed Pre-proline 0 C--N 1.331 -0.215 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.32 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.952 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 78.0 Cg_exo -50.29 -36.29 46.67 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.133 1.888 . . . . 0.0 112.616 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.408 ' SD ' ' CB ' ' A' ' 93' ' ' PRO . 56.2 mtt -59.11 -78.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.071 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.94 HG22 HG21 ' A' ' 96' ' ' ILE . 2.4 pp -56.34 -24.76 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.131 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.876 ' N ' HD12 ' A' ' 41' ' ' ILE . 43.3 mt-10 -77.35 -30.5 53.9 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.004 0.431 . . . . 0.0 109.902 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -79.48 -45.21 19.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.145 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -60.32 -29.53 68.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.635 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.36 -31.01 53.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.916 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -84.57 -32.14 23.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.507 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.2 -28.47 69.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.017 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.605 ' CD2' HG21 ' A' ' 100' ' ' ILE . 39.0 m-85 -78.78 148.69 32.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.953 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -80.02 -34.72 38.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -146.27 92.91 2.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.519 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -138.07 123.04 19.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.968 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -96.65 93.98 7.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.164 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.519 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 6.0 m-85 -89.96 127.93 36.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.124 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.722 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 14.9 m-30 -113.5 108.25 16.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.858 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -89.9 120.85 31.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.729 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.896 HD22 HG11 ' A' ' 61' ' ' VAL . 90.3 mt -131.31 145.57 51.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.263 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -106.99 161.21 14.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.57 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.763 ' CG2' ' HB2' ' A' ' 28' ' ' ALA . 50.5 t -82.11 -27.42 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.67 -60.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.168 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.49 -40.12 77.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.185 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.896 HG11 HD22 ' A' ' 56' ' ' LEU . 41.3 t -112.87 48.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.012 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.4 t -62.08 -31.33 71.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -49.15 -45.67 44.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.204 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.617 HG11 HD13 ' A' ' 56' ' ' LEU . 47.2 t -73.51 -56.27 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.966 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.34 -52.87 15.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.721 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -50.25 -59.1 4.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -54.65 -73.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.037 0.446 . . . . 0.0 110.706 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.69 68.16 7.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.522 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -44.27 135.66 4.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.551 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 71' ' ' SER . 46.3 t -117.87 159.28 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.923 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.49 ' N ' HG12 ' A' ' 70' ' ' VAL . 80.7 p -146.21 80.17 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.116 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -178.56 -161.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.613 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 20.3 ptt? -177.28 94.16 0.24 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.404 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 69.3 Cg_endo -88.26 -160.21 1.51 Allowed 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.239 -1.15 . . . . 0.0 112.32 -0.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.821 HG23 ' CG1' ' A' ' 89' ' ' VAL . 51.5 m -139.9 115.73 10.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.834 0.349 . . . . 0.0 110.954 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.707 HD12 ' C ' ' A' ' 75' ' ' THR . 3.9 mp -120.93 115.24 22.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.977 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.826 ' O ' HG13 ' A' ' 23' ' ' VAL . 28.4 pt -109.92 157.52 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.673 ' HE1' HG22 ' A' ' 88' ' ' VAL . 3.0 m-85 -130.83 125.53 33.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 111.774 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.505 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 71.5 m-85 -110.13 150.59 28.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.898 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.04 -22.17 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.136 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.62 31.31 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.27 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.81 44.58 5.11 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.368 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -164.45 107.48 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.382 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -56.93 115.33 2.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.496 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 86' ' ' THR . 11.2 m -128.02 -48.56 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 46.4 p -105.2 82.78 1.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.207 0.527 . . . . 0.0 111.0 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -97.53 142.27 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.633 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.686 ' O ' HG23 ' A' ' 88' ' ' VAL . 32.8 m -139.75 88.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.542 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.821 ' CG1' HG23 ' A' ' 75' ' ' THR . 26.0 m -108.98 109.71 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.524 . . . . 0.0 111.128 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -170.2 -96.2 0.1 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.302 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 90' ' ' GLY . . . 176.44 70.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 110.979 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -137.29 88.14 17.51 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HG3' HG23 ' A' ' 37' ' ' ILE . 24.3 Cg_exo -63.55 -14.44 42.53 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.773 2.315 . . . . 0.0 112.487 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.46 -31.3 14.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 110.96 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.1 -23.82 67.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.206 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.94 HG21 HG22 ' A' ' 41' ' ' ILE . 21.9 pt -56.34 -38.81 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.933 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -49.46 -55.91 11.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.605 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -68.59 -25.9 65.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.812 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.464 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -70.5 -57.41 4.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.144 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.605 HG21 ' CD2' ' A' ' 48' ' ' TYR . 3.1 mp -75.54 -5.7 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.237 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -89.96 -28.75 18.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.702 0.287 . . . . 0.0 111.377 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 m -90.05 -67.0 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 111.408 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -46.86 -32.6 3.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.545 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 101' ' ' ALA . 8.4 p . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.417 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.743 HG22 ' HB2' ' A' ' 53' ' ' PHE . 46.0 t -74.86 129.4 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.965 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 m -120.89 149.74 42.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.994 0.426 . . . . 0.0 110.966 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -89.9 109.72 20.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.872 HD11 ' CD2' ' A' ' 54' ' ' TYR . 70.3 mt -88.83 104.77 17.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 110.868 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 11.1 mmpt? -89.94 -47.46 7.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.028 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.3 t -104.89 147.41 27.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.245 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.44 -27.73 68.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.01 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.3 p -54.86 -31.27 59.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -71.09 -35.1 71.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.58 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CE1' HD21 ' A' ' 15' ' ' LEU . 48.5 t80 -69.4 -43.87 72.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.026 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -53.16 -60.42 3.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.1 p -64.83 -21.17 66.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.212 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.91 71.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.376 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.685 HD21 ' CE1' ' A' ' 11' ' ' TYR . 82.0 mt -57.4 -36.12 70.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.966 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.03 50.72 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.045 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.7 p -81.97 148.44 28.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 19' ' ' ASP . . . -80.3 83.06 1.43 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.615 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 8.8 t70 80.41 -40.6 0.18 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.702 0.401 . . . . 0.0 111.68 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -45.28 129.17 8.06 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.829 0.347 . . . . 0.0 111.231 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.565 ' C ' HD23 ' A' ' 21' ' ' LEU . 4.8 tt -80.33 110.88 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 22' ' ' VAL . 10.6 p -100.84 116.06 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG23 HD22 ' A' ' 21' ' ' LEU . 47.4 t -104.88 146.76 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.044 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.436 HG21 ' HE1' ' A' ' 11' ' ' TYR . 48.5 t -126.1 113.8 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.806 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -101.48 120.56 40.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.942 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.592 ' CE1' HD12 ' A' ' 56' ' ' LEU . 61.2 m-85 -109.45 106.48 16.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.036 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 5.0 p90 -127.35 121.41 30.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.221 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.793 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -86.16 18.54 3.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p 49.3 78.04 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 111.437 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.793 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 0.7 OUTLIER -100.89 -56.05 2.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.946 179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.614 ' CB ' ' O ' ' A' ' 30' ' ' TRP . 42.0 t 132.73 104.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.562 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.03 -92.85 0.25 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.412 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.474 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 11.4 Cg_endo -55.55 -57.79 1.43 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.835 2.357 . . . . 0.0 112.862 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.1 p -81.12 58.26 3.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 110.975 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -172.19 -46.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.6 ttt -65.68 -54.18 30.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.833 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.0 pt -90.28 21.54 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.52 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.947 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -71.03 -62.74 1.75 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.179 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 74.9 Cg_exo -50.14 -29.62 22.92 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.167 1.911 . . . . 0.0 112.685 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.491 ' CE ' ' HB3' ' A' ' 93' ' ' PRO . 37.7 mtp -62.56 -73.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.098 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.92 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -55.8 -23.46 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.92 ' N ' HD12 ' A' ' 41' ' ' ILE . 39.6 tt0 -81.17 -31.33 34.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.991 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -76.64 -42.06 43.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.377 179.12 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -55.19 -23.45 21.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -55.76 -28.27 55.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.128 0.49 . . . . 0.0 110.513 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.69 -0.49 50.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.807 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -90.15 -60.57 1.89 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.172 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.924 ' CE2' HG21 ' A' ' 100' ' ' ILE . 17.2 m-85 -70.67 165.16 23.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.041 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.6 m -113.69 -18.39 11.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.756 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -134.79 53.7 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.971 0.415 . . . . 0.0 111.398 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -119.28 113.0 20.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.305 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.44 100.5 13.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.127 0.489 . . . . 0.0 110.84 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.743 ' HB2' HG22 ' A' ' 2' ' ' VAL . 12.9 m-85 -92.12 134.22 35.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.186 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.872 ' CD2' HD11 ' A' ' 5' ' ' LEU . 19.0 m-30 -122.91 116.73 24.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.792 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -102.33 91.47 4.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.979 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 5' ' ' LEU . 85.0 mt -95.94 132.62 41.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -80.1 -9.26 59.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.663 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 58' ' ' VAL . 39.1 t 64.74 25.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.111 0.481 . . . . 0.0 110.83 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.1 -47.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.49 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.21 -32.34 73.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.457 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.583 HG21 HD22 ' A' ' 56' ' ' LEU . 44.2 t -96.16 -44.37 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.743 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 61' ' ' VAL . 95.5 p 61.33 -65.85 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.749 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 61' ' ' VAL . 7.5 t70 -36.79 -58.22 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.535 0.334 . . . . 0.0 111.851 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 56' ' ' LEU . 48.1 t -58.0 -54.12 36.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.045 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.63 -46.3 63.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.34 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -58.91 -40.36 84.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -72.1 -62.34 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.738 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.4 85.08 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -58.32 112.35 1.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.091 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 70' ' ' VAL . 35.7 m -155.46 110.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.6 m -105.71 50.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -119.24 -170.73 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.647 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.512 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 18.1 ptp -166.7 98.8 0.68 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.378 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 94.4 Cg_endo -89.32 -165.05 2.67 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 124.262 -1.141 . . . . 0.0 112.451 -0.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.777 ' C ' HD12 ' A' ' 76' ' ' LEU . 87.8 m -144.79 118.44 9.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.777 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -126.37 127.47 45.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.962 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.642 HD12 ' CE2' ' A' ' 79' ' ' TYR . 17.1 pt -122.11 155.95 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.2 m-85 -127.5 118.56 24.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.424 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.667 ' CD2' HD22 ' A' ' 15' ' ' LEU . 61.3 m-85 -109.94 112.43 24.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.698 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.09 -54.26 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.834 0.35 . . . . 0.0 110.791 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.6 28.47 2.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.495 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.1 54.57 0.9 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.325 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -176.9 113.12 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.837 0.351 . . . . 0.0 110.976 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -58.91 96.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 86' ' ' THR . 27.3 m -109.89 -41.59 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 60.0 m -108.68 102.29 11.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.918 0.39 . . . . 0.0 110.151 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -102.6 154.57 19.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.377 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.4 t -154.35 81.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.574 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 89' ' ' VAL . 26.8 m -109.44 72.68 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.59 -136.35 2.36 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.117 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.91 91.71 1.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.282 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -152.08 112.47 2.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.11 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.586 ' O ' HG22 ' A' ' 96' ' ' ILE . 46.2 Cg_exo -57.16 -16.47 21.79 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.71 2.273 . . . . 0.0 112.593 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.82 -30.21 17.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 111.191 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.04 -30.87 16.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 110.841 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 93' ' ' PRO . 4.6 tp -68.58 -22.59 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.22 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -83.82 -53.08 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.197 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -67.34 -47.59 70.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.027 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.472 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -55.5 -59.3 5.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.402 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.924 HG21 ' CE2' ' A' ' 48' ' ' TYR . 32.9 mm -57.43 -40.8 76.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.46 -28.22 66.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.193 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.5 m -57.94 -51.55 69.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.951 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 21' ' ' LEU . 16.0 p-10 -136.35 61.36 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.979 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.99 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.766 0.317 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.9 t 61.03 112.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.661 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -101.96 174.17 6.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.214 0.53 . . . . 0.0 111.061 -179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.502 ' H ' HG22 ' A' ' 3' ' ' THR . 13.9 mp0 -118.42 96.28 5.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.056 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.524 HD11 ' CG ' ' A' ' 54' ' ' TYR . 62.7 mt -88.96 153.85 20.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.294 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -150.03 -66.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.952 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.6 t -82.57 161.94 22.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.128 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . . . -73.71 -31.95 63.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.1 p -56.44 -29.35 61.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.011 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 52.8 mt-10 -75.82 -32.82 59.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.75 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 49.2 t80 -78.3 -46.09 21.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.005 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -57.48 -64.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.084 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 t -57.76 -26.07 61.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.006 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.793 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -63.94 -63.34 1.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.301 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.75 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 84.9 mt -54.16 -25.09 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.123 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.87 -57.13 7.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.073 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.9 t -90.18 18.11 6.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.5 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.22 76.22 2.28 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -88.7 -40.58 13.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.97 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -58.48 -78.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 104' ' ' VAL . 4.5 tt -177.59 113.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.774 0.321 . . . . 0.0 110.412 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.491 ' N ' HD23 ' A' ' 21' ' ' LEU . 62.6 t -104.02 144.15 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.657 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 77' ' ' ILE . 40.0 t -146.18 129.38 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.482 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.773 HG11 ' CE2' ' A' ' 26' ' ' PHE . 52.0 t -100.4 147.75 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.344 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 36.0 t70 -135.6 85.19 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.722 0.296 . . . . 0.0 111.697 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.934 ' CD2' HG21 ' A' ' 70' ' ' VAL . 65.8 m-85 -86.78 77.43 9.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.067 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 12.9 p90 -99.89 -34.59 10.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.629 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . . . 61.37 -162.64 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.584 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 79.2 p -134.11 65.27 1.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.001 0.429 . . . . 0.0 110.975 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.629 ' CE2' ' HB3' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -83.4 -60.1 2.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.916 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 39.1 t 147.44 110.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.458 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 33' ' ' PRO . . . 136.08 -132.42 6.12 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.37 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 10.7 Cg_endo -54.26 -34.09 78.26 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.71 2.274 . . . . 0.0 112.806 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 29.7 p -71.69 56.19 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.19 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 27.9 tptp 172.62 -42.84 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.75 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.541 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 11.1 mmt -58.04 -73.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.408 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.642 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -86.45 8.53 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.68 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -57.91 -52.7 72.51 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.921 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 50.9 Cg_exo -54.69 -31.94 73.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.583 2.189 . . . . 0.0 112.288 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.418 ' CE ' ' HB2' ' A' ' 93' ' ' PRO . 72.2 mtp -54.41 -73.77 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.928 0.394 . . . . 0.0 110.469 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.01 HG22 HG21 ' A' ' 96' ' ' ILE . 8.6 pt -50.56 -44.05 24.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.258 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' N ' HG13 ' A' ' 41' ' ' ILE . 66.1 mm-40 -63.64 -33.15 74.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.79 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.459 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -76.47 -49.35 16.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.939 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.617 ' CD2' HD11 ' A' ' 96' ' ' ILE . 8.0 m-85 -51.79 -27.76 13.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.01 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.653 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.89 -28.89 25.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.055 0.455 . . . . 0.0 110.576 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -82.85 -25.21 32.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.602 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -58.44 -56.74 18.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.034 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.435 ' CE2' HG21 ' A' ' 100' ' ' ILE . 16.3 m-85 -62.28 171.03 2.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.156 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 m -97.14 -31.98 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 1.5 p30 -140.54 99.18 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.183 0.516 . . . . 0.0 111.146 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.471 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -148.83 117.62 6.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.79 107.09 18.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.279 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.653 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 6.6 m-85 -100.01 129.6 46.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.52 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.793 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 17.2 m-30 -115.4 107.26 14.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.444 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -89.85 122.46 32.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.67 HD22 HG11 ' A' ' 61' ' ' VAL . 94.0 mt -136.32 172.19 13.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.644 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -130.54 -102.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.927 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 59' ' ' ASP . 35.6 m -157.54 -45.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 120.709 0.29 . . . . 0.0 111.25 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 58' ' ' VAL . 56.5 m-20 -110.67 -35.96 5.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.01 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.61 -31.45 66.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.756 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.67 HG11 HD22 ' A' ' 56' ' ' LEU . 46.3 t -97.52 -66.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.745 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.0 t 68.31 -63.07 0.35 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.433 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 1.5 m-20 -38.75 -38.62 0.43 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.731 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.02 -54.35 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.096 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.13 -41.12 7.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.811 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -57.33 -47.74 80.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.106 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -82.45 -55.99 4.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.957 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.632 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -70.36 82.16 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -58.49 98.6 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.934 HG21 ' CD2' ' A' ' 26' ' ' PHE . 53.7 t -108.22 151.62 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.2 p -155.79 85.28 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.076 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.2 t -177.9 177.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.435 ' HG2' ' CH2' ' A' ' 30' ' ' TRP . 64.9 mtm -154.64 96.48 2.59 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 3.1 Cg_endo -85.36 -158.75 1.55 Allowed 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.492 -1.045 . . . . 0.0 112.199 0.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.884 HG21 HG13 ' A' ' 70' ' ' VAL . 63.3 m -144.62 114.43 7.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.752 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.773 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -126.89 111.8 14.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.902 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.557 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 26.3 pt -115.75 163.32 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.692 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.3 m-85 -128.11 125.73 39.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.557 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 63.2 m-85 -109.49 165.04 11.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.43 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -168.51 63.79 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.714 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.3 23.83 4.36 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.028 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.73 -4.67 73.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.254 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 13.2 mptt -109.7 110.63 21.72 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.735 0.302 . . . . 0.0 111.088 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 24.4 pt-20 -68.24 125.59 26.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.467 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 86' ' ' THR . 34.8 m -127.92 -42.04 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.612 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 72.2 m -103.96 113.66 27.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.949 0.404 . . . . 0.0 110.093 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -112.14 155.09 24.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.33 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.2 t -155.84 79.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.793 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.642 ' O ' HG23 ' A' ' 89' ' ' VAL . 27.0 m -109.62 91.99 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.313 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -103.38 0.17 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.384 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.5 85.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -151.64 81.88 5.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.859 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' A' ' 37' ' ' ILE . 51.9 Cg_exo -54.55 -20.45 21.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.863 2.375 . . . . 0.0 112.698 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.84 -2.41 58.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.588 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.0 -23.94 21.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.71 0.29 . . . . 0.0 111.267 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.01 HG21 HG22 ' A' ' 41' ' ' ILE . 24.3 pt -54.79 -34.43 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.135 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.47 -60.37 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.032 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -68.17 -27.65 66.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.4 -64.06 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.288 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.435 HG21 ' CE2' ' A' ' 48' ' ' TYR . 66.6 mt -55.78 -35.01 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.216 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.09 -23.79 64.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.327 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.3 m -54.53 -70.13 0.11 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -106.33 56.34 0.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.655 ' HA ' HD12 ' A' ' 21' ' ' LEU . 9.1 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.791 0.329 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 47.7 t -112.12 131.31 63.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.814 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -110.93 159.46 17.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.437 0.637 . . . . 0.0 111.833 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -121.76 116.32 24.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.569 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.567 ' HB2' HD21 ' A' ' 56' ' ' LEU . 67.2 mt -89.05 104.36 16.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.013 0.435 . . . . 0.0 111.306 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -99.52 -35.2 9.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.427 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -117.73 141.09 48.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.944 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.36 -25.98 38.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.427 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -58.63 -40.26 82.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.011 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -63.85 -27.05 68.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.553 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 49.3 t80 -90.0 -46.92 8.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -57.95 -60.74 3.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.072 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.4 p -55.86 -23.09 28.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.294 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.4 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -74.84 -28.22 60.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.46 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.553 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 86.1 mt -89.94 -17.96 26.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.364 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.33 -86.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.328 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.1 p -90.47 29.33 1.3 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.08 87.86 1.44 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.77 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -80.07 -37.32 34.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 110.588 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -57.95 -168.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.607 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.849 HD13 HG23 ' A' ' 100' ' ' ILE . 2.7 tt -91.1 119.88 31.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.962 0.411 . . . . 0.0 110.689 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.604 ' N ' HD23 ' A' ' 21' ' ' LEU . 59.6 t -113.05 107.95 24.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.532 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.638 HG23 HD22 ' A' ' 21' ' ' LEU . 43.3 t -99.92 144.81 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.507 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.494 HG11 ' CE2' ' A' ' 26' ' ' PHE . 48.4 t -126.43 147.89 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.447 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 37.7 t70 -137.13 113.16 9.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.961 0.41 . . . . 0.0 111.211 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.539 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 70.4 m-85 -110.34 107.2 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 1.7 p90 -150.69 121.85 7.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.783 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.652 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -88.18 18.17 4.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.638 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.0 p 49.61 62.86 2.42 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.14 0.495 . . . . 0.0 111.119 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.652 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.8 m-90 -77.72 -61.19 2.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.149 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 41.8 t 165.11 109.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.562 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.04 -146.38 18.42 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.027 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . 84.2 Cg_exo -46.28 -36.49 17.32 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.834 2.356 . . . . 0.0 112.88 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 24.4 p -51.76 -26.04 8.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -113.77 -28.7 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.2 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.7 ttm -77.35 -29.85 53.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.292 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 37' ' ' ILE . 54.1 mt -89.94 -6.16 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.706 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.836 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -51.08 -55.35 28.84 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.536 0.208 . . . . 0.0 111.408 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.836 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 37.9 Cg_exo -61.58 -39.04 57.69 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.55 2.167 . . . . 0.0 112.285 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 60.7 mtt -53.08 -75.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.58 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.788 HG22 HG21 ' A' ' 96' ' ' ILE . 11.6 pt -51.69 -43.16 32.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.35 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 41' ' ' ILE . 39.4 tt0 -63.86 -33.65 76.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.753 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.3 ttpt -76.2 -41.25 50.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.288 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.772 ' CG ' HD11 ' A' ' 96' ' ' ILE . 6.1 m-85 -64.26 -23.96 67.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.716 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -54.85 -29.14 54.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.06 0.457 . . . . 0.0 110.473 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -84.54 -1.83 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.944 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -90.17 -46.5 8.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.048 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.528 ' CE2' HD12 ' A' ' 100' ' ' ILE . 17.6 m-85 -73.89 168.05 20.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.186 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -111.6 -22.69 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.269 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.529 ' OD1' HG23 ' A' ' 104' ' ' VAL . 52.7 p-10 -146.0 66.45 1.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.034 0.445 . . . . 0.0 111.199 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HB3' ' HE1' ' A' ' 53' ' ' PHE . . . -124.55 117.64 24.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.018 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.69 104.12 16.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.631 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 3.6 m-85 -89.85 106.89 18.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.928 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.516 ' CE2' HG13 ' A' ' 22' ' ' VAL . 12.8 m-30 -96.86 109.1 21.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 110.953 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -89.89 129.56 36.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.083 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.718 HD22 HG21 ' A' ' 61' ' ' VAL . 96.2 mt -148.35 136.84 21.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.642 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -107.29 -96.73 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.065 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.4 t -156.2 -69.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.849 0.357 . . . . 0.0 111.076 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -79.76 -33.47 40.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.13 -29.41 57.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.041 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.718 HG21 HD22 ' A' ' 56' ' ' LEU . 30.5 t -112.98 -67.13 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.842 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.476 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 33.2 t 75.28 -7.82 1.7 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.14 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.698 ' H ' HG12 ' A' ' 61' ' ' VAL . 35.0 m-20 -90.36 -64.32 1.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.924 0.393 . . . . 0.0 110.865 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.3 t -62.92 -59.98 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.137 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.22 -31.15 2.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.445 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -63.62 -58.59 6.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.738 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -74.31 -55.67 5.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.759 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.4 82.99 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.5 128.02 34.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.109 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.6 t -89.55 132.88 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -136.97 50.85 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.16 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.403 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 36.3 t -170.33 -163.69 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.635 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.486 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.3 ptm -170.1 90.92 0.52 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.431 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.88 -162.53 2.93 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.88 -1.3 . . . . 0.0 112.27 -0.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.589 ' C ' HD12 ' A' ' 76' ' ' LEU . 88.0 m -137.12 105.02 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.602 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 76' ' ' LEU . 3.8 mp -114.05 140.69 48.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.958 0.409 . . . . 0.0 111.217 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.591 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 25.1 pt -138.59 156.79 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.804 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.471 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.4 m-85 -124.1 125.52 44.64 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.959 0.409 . . . . 0.0 111.507 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.591 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 65.4 m-85 -110.93 124.43 52.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.925 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -116.57 -38.26 3.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.44 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.55 45.03 1.22 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.055 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.85 27.03 58.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.908 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.46 ' O ' HG13 ' A' ' 85' ' ' VAL . 60.5 mttp -152.92 124.66 7.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.774 0.321 . . . . 0.0 110.832 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.67 111.05 0.73 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.381 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 86' ' ' THR . 19.0 m -120.91 -46.89 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.485 ' N ' HG23 ' A' ' 85' ' ' VAL . 77.0 p -113.46 77.8 1.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 110.997 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -81.69 160.05 23.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.044 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.1 t -150.95 83.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.854 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 89' ' ' VAL . 32.1 m -109.38 99.38 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.216 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.8 -111.05 0.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.208 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -179.72 91.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 0.0 111.109 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -178.16 123.37 0.26 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.865 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 96' ' ' ILE . 12.3 Cg_endo -57.57 -59.43 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.426 2.084 . . . . 0.0 112.498 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -42.1 -30.44 0.29 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.955 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -20.26 60.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.662 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.788 HG21 HG22 ' A' ' 41' ' ' ILE . 8.9 pt -78.84 -42.96 24.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.872 0.367 . . . . 0.0 111.025 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -62.59 -64.38 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.578 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -54.64 -25.78 28.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.253 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.4 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -83.4 -63.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.047 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.849 HG23 HD13 ' A' ' 21' ' ' LEU . 63.1 mt -59.89 -44.92 95.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.6 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -63.6 -16.43 60.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.747 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.4 t -85.76 -56.71 3.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.796 0.331 . . . . 0.0 111.237 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -70.33 -23.87 62.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.138 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 101' ' ' ALA . 10.8 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.555 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.917 0.389 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 46.7 t 63.72 125.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.685 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.9 m -106.71 166.99 10.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.403 ' H ' HG22 ' A' ' 3' ' ' THR . 13.8 mp0 -106.2 90.28 3.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.064 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.537 HD11 ' CG ' ' A' ' 54' ' ' TYR . 74.6 mt -89.03 132.7 34.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.187 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -133.52 -58.3 0.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.792 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 t -91.88 149.94 21.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.053 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . . . -67.55 -28.25 67.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.208 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -55.67 -30.9 61.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -72.63 -39.26 67.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.95 -71.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.981 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -47.57 -30.08 3.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.532 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 t -66.01 -23.3 66.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.194 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.08 -36.03 15.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.26 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.2 mm? -82.12 -0.3 44.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.446 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.92 -82.12 0.27 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 111.061 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -90.54 30.42 1.15 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.185 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.63 168.04 41.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.645 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -159.57 -45.67 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.644 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -59.43 -170.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.731 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 104' ' ' VAL . 44.4 tp -75.38 107.36 7.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.209 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 58.2 t -109.16 97.63 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.563 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' A' ' 21' ' ' LEU . 43.3 t -105.74 137.97 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.593 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.701 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 48.1 t -116.59 139.08 44.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.329 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -117.93 98.18 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.508 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.701 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 61.3 m-85 -96.02 96.98 9.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.916 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 2.2 p90 -136.54 122.16 19.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.65 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.25 112.16 23.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.479 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.7 p -74.54 105.36 5.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.471 . . . . 0.0 111.629 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.557 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.2 m-90 -105.32 -60.38 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.471 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 44.7 t 159.07 90.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.418 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.3 -82.54 0.21 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.759 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.755 ' O ' ' N ' ' A' ' 35' ' ' LYS . 87.3 Cg_endo -79.79 -155.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.496 2.13 . . . . 0.0 110.852 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 4.6 p 42.04 -68.81 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.755 ' N ' ' O ' ' A' ' 33' ' ' PRO . 86.9 tttt -55.27 -39.84 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.382 . . . . 0.0 111.306 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -62.68 1.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.861 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -90.16 34.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.936 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.878 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -90.06 -59.65 0.24 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.621 0.248 . . . . 0.0 110.914 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.878 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 59.6 Cg_exo -52.54 -41.15 69.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.353 2.035 . . . . 0.0 112.35 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.414 ' CE ' ' CB ' ' A' ' 93' ' ' PRO . 70.0 mtp -50.07 -71.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 110.788 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.781 ' CG2' HG21 ' A' ' 96' ' ' ILE . 9.1 pt -55.38 -45.57 78.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.258 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.62 ' OE2' ' HB1' ' A' ' 38' ' ' ALA . 50.9 mt-10 -59.9 -35.29 74.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.844 0.354 . . . . 0.0 110.727 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 11.6 tmtt? -69.9 -49.28 53.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.417 ' CD2' HD11 ' A' ' 96' ' ' ILE . 6.0 m-85 -47.54 -28.85 2.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.271 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.13 -29.29 57.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.837 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.61 -32.98 25.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.404 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.412 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 84.5 mt-30 -60.52 -26.39 66.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.779 ' CE2' HG21 ' A' ' 100' ' ' ILE . 42.1 m-85 -90.1 176.82 6.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.779 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.3 m -114.05 -27.83 7.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.258 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -138.9 68.96 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 111.424 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.518 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -124.74 115.18 20.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.99 101.3 14.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.394 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.518 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 5.9 m-85 -93.72 132.11 38.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.537 ' CG ' HD11 ' A' ' 5' ' ' LEU . 15.3 m-30 -121.62 106.42 11.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.806 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.91 130.11 36.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.984 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.806 HD22 HG11 ' A' ' 61' ' ' VAL . 97.6 mt -155.47 140.96 17.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.829 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -101.42 -128.38 0.21 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.475 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.3 t -126.58 -70.13 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.084 0 CA-C-O 120.777 0.322 . . . . 0.0 111.015 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -72.61 -39.72 67.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.739 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -58.17 -29.51 65.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.7 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.806 HG11 HD22 ' A' ' 56' ' ' LEU . 43.6 t -140.25 70.53 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.2 t -76.86 -2.03 31.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.541 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 57.1 m-20 -84.83 -38.07 19.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.816 0.341 . . . . 0.0 111.089 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.647 HG11 ' CD1' ' A' ' 56' ' ' LEU . 46.2 t -90.2 -56.31 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.251 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.19 -32.55 16.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.65 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -58.25 -48.28 80.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.89 -51.59 66.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.01 77.33 6.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.091 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.05 115.06 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.481 ' HB ' HG21 ' A' ' 75' ' ' THR . 35.2 m -138.56 143.02 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.188 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -116.77 174.88 5.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.828 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 81.8 p 50.69 95.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.524 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 21.6 mmt -91.24 150.76 42.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.78 -178.98 22.88 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 123.723 -1.366 . . . . 0.0 112.7 0.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.934 HG23 HG12 ' A' ' 89' ' ' VAL . 91.8 m -149.85 130.69 14.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.748 HD12 ' C ' ' A' ' 75' ' ' THR . 4.0 mp -123.98 131.98 53.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.0 111.335 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.466 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 27.8 pt -130.47 139.58 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.502 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.7 m-85 -114.23 125.64 54.15 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.044 0.449 . . . . 0.0 111.572 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.594 ' CD2' HD11 ' A' ' 15' ' ' LEU . 69.7 m-85 -109.61 162.14 14.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.718 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -153.41 67.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.74 20.74 18.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.415 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.77 64.51 1.2 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.565 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -178.18 115.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.954 0.407 . . . . 0.0 111.157 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 44.3 tt0 -79.31 98.43 6.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.575 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.91 -32.43 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.412 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.707 HG21 HD21 ' A' ' 103' ' ' ASN . 92.2 m -113.88 102.8 10.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.889 0.376 . . . . 0.0 110.468 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -110.0 144.31 38.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.003 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.2 t -137.57 82.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.704 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.934 HG12 HG23 ' A' ' 75' ' ' THR . 34.8 m -109.65 106.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.325 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.03 -108.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.371 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -179.93 68.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.991 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 5.7 m120 -142.51 96.4 6.29 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.052 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.45 ' O ' HG13 ' A' ' 96' ' ' ILE . 32.0 Cg_exo -58.6 -17.1 33.32 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.589 2.192 . . . . 0.0 112.503 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.27 -29.73 17.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.853 0.358 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 92' ' ' ASN . . . -71.52 -25.32 62.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.173 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.794 HD12 ' N ' ' A' ' 97' ' ' LYS . 2.1 pp -56.59 -31.9 35.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.794 ' N ' HD12 ' A' ' 96' ' ' ILE . 34.5 ttpt -62.93 -65.11 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.16 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -39.01 -33.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.655 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.47 -46.87 12.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.779 HG21 ' CE2' ' A' ' 48' ' ' TYR . 73.4 mt -74.07 -5.68 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.541 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.22 -32.9 16.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.727 0.299 . . . . 0.0 111.379 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.7 p -89.67 -58.55 2.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 111.387 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.707 HD21 HG21 ' A' ' 86' ' ' THR . 47.2 m-80 -60.08 -17.99 43.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.591 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.614 ' HA ' HD22 ' A' ' 21' ' ' LEU . 11.3 p . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.769 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 23.0 ptp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.889 0.376 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.525 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 45.4 t -147.93 102.19 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.701 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -101.53 152.44 20.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.423 0.63 . . . . 0.0 111.851 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -113.01 118.84 35.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.402 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 11' ' ' TYR . 4.7 mp -89.15 117.68 28.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.977 0.418 . . . . 0.0 111.616 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -107.79 -37.0 6.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.172 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.2 t -115.95 143.81 44.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.831 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.48 -23.79 41.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.302 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 m -60.12 -45.01 94.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -59.9 -27.4 66.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.35 . . . . 0.0 110.895 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.869 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 48.6 t80 -90.03 -48.81 6.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.175 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -57.79 -61.81 2.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.1 p -54.56 -24.33 20.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.349 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.06 -66.06 0.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.362 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.869 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 82.2 mt -54.85 -24.11 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.4 -79.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.205 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -90.2 17.24 7.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.04 105.88 3.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -109.47 -22.0 12.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 111.065 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -54.92 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.092 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.758 HD13 HG23 ' A' ' 100' ' ' ILE . 4.4 tt -177.83 107.99 0.06 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.532 HG13 ' CE2' ' A' ' 54' ' ' TYR . 58.3 t -102.79 124.72 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.723 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 ' CD2' ' A' ' 21' ' ' LEU . 40.8 t -116.19 122.57 69.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.469 HG11 ' CE2' ' A' ' 26' ' ' PHE . 51.8 t -104.0 112.55 37.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.756 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -108.68 98.44 7.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.499 ' CE1' HD12 ' A' ' 56' ' ' LEU . 61.0 m-85 -86.3 115.55 23.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.88 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 2.3 p90 -135.81 117.12 14.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.661 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.882 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -86.79 4.52 40.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.771 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.8 p 49.18 70.83 0.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 111.178 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.882 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 3.0 m-90 -89.12 -57.84 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.148 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.8 t -139.57 -104.35 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.384 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.616 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -136.05 25.76 3.17 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.9 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 85.7 Cg_endo -82.44 -41.32 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 121.982 1.788 . . . . 0.0 112.114 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 22.9 p -98.39 -41.93 7.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.247 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -52.18 -42.12 63.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.382 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.7 ttt -67.72 -25.79 65.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.117 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 37' ' ' ILE . 50.0 mm -86.97 -10.72 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.693 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.901 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -59.91 -63.37 4.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.901 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 82.5 Cg_exo -45.76 -40.68 19.44 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.333 2.022 . . . . 0.0 112.801 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.6 mtt -54.17 -79.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.644 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.934 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -57.55 -29.71 34.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.778 0.323 . . . . 0.0 110.969 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.934 ' N ' HD12 ' A' ' 41' ' ' ILE . 88.4 tt0 -70.35 -26.92 63.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.704 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.431 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 13.4 tmtt? -87.09 -45.92 10.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.241 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -54.82 -27.47 42.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.703 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 1' ' ' MET . . . -51.82 -30.56 23.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.087 0.47 . . . . 0.0 110.495 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -83.15 -26.53 30.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.59 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -72.64 -26.1 61.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.302 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -83.18 167.67 17.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.374 . . . . 0.0 111.039 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -97.28 -33.48 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.821 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -153.01 98.57 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.823 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.63 121.24 10.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.629 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.94 109.28 20.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.525 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 10.4 m-85 -97.96 116.05 29.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.525 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.532 ' CE2' HG13 ' A' ' 22' ' ' VAL . 17.7 m-30 -112.26 99.77 8.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.864 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -90.04 127.63 36.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 5' ' ' LEU . 90.0 mt -130.87 162.77 28.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.216 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.55 ' O ' HG13 ' A' ' 58' ' ' VAL . 38.8 t70 -106.33 -109.5 0.29 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.515 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 57' ' ' ASP . 16.1 m -160.51 -48.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.742 0.306 . . . . 0.0 111.399 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 58' ' ' VAL . 1.3 m-20 -110.75 -33.63 6.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 110.742 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.5 -27.32 56.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.695 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.81 HG12 ' H ' ' A' ' 63' ' ' ASP . 46.8 t -106.74 -68.78 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 61' ' ' VAL . 86.1 p 64.59 5.75 2.86 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.015 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.81 ' H ' HG12 ' A' ' 61' ' ' VAL . 1.4 m-20 -90.49 -38.64 13.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.974 0.416 . . . . 0.0 110.656 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 68' ' ' ALA . 27.0 t -90.05 -47.21 14.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.248 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.0 -30.31 1.0 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.653 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -73.79 -37.03 65.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -88.91 -57.49 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.754 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 64' ' ' VAL . . . -82.06 81.24 8.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.067 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.67 117.81 5.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.613 ' HB ' HG21 ' A' ' 75' ' ' THR . 35.4 m -133.01 174.53 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -175.98 91.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.16 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.405 ' CB ' HG21 ' A' ' 89' ' ' VAL . 39.6 t -178.22 -171.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.474 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 52.8 mtt -156.83 93.73 2.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.02 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.461 ' O ' HG23 ' A' ' 89' ' ' VAL . 95.8 Cg_endo -89.39 -162.66 1.93 Allowed 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.297 -1.126 . . . . 0.0 112.502 0.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.671 ' C ' HD12 ' A' ' 76' ' ' LEU . 95.4 m -141.55 105.65 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.676 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.671 HD12 ' C ' ' A' ' 75' ' ' THR . 3.9 mp -118.91 119.75 35.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.227 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.8 pt -121.31 166.99 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.9 m-85 -130.87 128.55 40.83 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.054 0.454 . . . . 0.0 111.338 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 60.2 m-85 -109.76 131.78 54.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.062 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -132.91 60.05 1.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.085 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.65 38.65 0.65 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.026 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.49 29.12 72.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.006 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -142.72 115.43 8.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 111.06 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.3 tt0 -69.98 104.13 2.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.596 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.42 -37.72 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.462 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.568 HG21 HD21 ' A' ' 103' ' ' ASN . 88.5 m -106.82 107.32 18.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 110.397 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -110.77 152.59 26.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.339 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -149.44 82.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.683 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 89' ' ' VAL . 7.4 p -109.59 98.5 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.199 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -170.1 -107.26 0.2 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.436 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 90' ' ' GLY . . . 173.62 92.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -153.37 116.66 2.74 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.513 ' O ' HG22 ' A' ' 96' ' ' ILE . 21.5 Cg_exo -65.03 -11.99 32.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.507 2.138 . . . . 0.0 112.652 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.57 -38.25 10.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.68 0.276 . . . . 0.0 111.287 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.71 -35.2 21.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 111.021 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.816 HD13 HG22 ' A' ' 41' ' ' ILE . 4.2 tp -53.06 -43.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.524 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.44 -72.2 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.318 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -51.47 -26.24 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.761 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.427 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -72.47 -62.57 1.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.752 0.311 . . . . 0.0 111.071 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.758 HG23 HD13 ' A' ' 21' ' ' LEU . 62.3 mt -73.83 -7.39 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.411 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.04 -27.3 26.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.689 0.28 . . . . 0.0 111.329 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.6 m -90.06 -56.09 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.294 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.568 HD21 HG21 ' A' ' 86' ' ' THR . 60.3 m-80 -55.35 -45.49 76.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.453 -179.524 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.852 0.358 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 53' ' ' PHE . 46.2 t -73.46 123.78 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.568 HG22 ' H ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -96.61 -178.2 4.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 0.0 110.597 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.568 ' H ' HG22 ' A' ' 3' ' ' THR . 0.2 OUTLIER -124.0 90.13 3.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.19 178.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.638 HD21 ' CD2' ' A' ' 54' ' ' TYR . 5.0 mp -89.07 141.12 28.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -133.68 -69.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.2 t -79.32 162.18 25.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.056 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . . . -70.27 -30.34 67.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.062 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -59.02 -33.83 71.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 53.1 mt-10 -69.7 -30.72 68.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.826 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.463 ' HH ' HD11 ' A' ' 15' ' ' LEU . 45.8 t80 -75.75 -45.99 33.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.905 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.29 -56.29 19.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -59.1 -28.0 66.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.052 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . -63.66 -66.4 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.136 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.548 ' CD2' HG11 ' A' ' 22' ' ' VAL . 81.4 mt -58.06 -26.72 62.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.037 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.78 -68.0 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -78.21 -28.46 48.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.19 119.07 12.84 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -114.37 -31.08 6.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 0.0 111.195 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.92 -108.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.806 HD12 ' HA ' ' A' ' 104' ' ' VAL . 4.5 tt -139.49 121.65 15.82 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.784 0.326 . . . . 0.0 110.439 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.637 ' N ' HD23 ' A' ' 21' ' ' LEU . 60.3 t -111.92 122.81 66.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.009 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.496 HG23 HD22 ' A' ' 21' ' ' LEU . 42.9 t -118.32 124.7 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.461 HG21 ' HE1' ' A' ' 11' ' ' TYR . 47.0 t -110.67 115.56 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.058 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -102.43 120.24 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.416 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 54.6 m-85 -108.26 119.52 39.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.16 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.424 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 2.5 p90 -155.15 113.3 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.644 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.06 23.2 6.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.403 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p 46.81 70.14 0.42 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.96 0.409 . . . . 0.0 110.769 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 73' ' ' MET . 2.5 m-90 -83.05 -57.86 3.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.868 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.4 t -118.89 -37.1 3.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.894 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 142.14 -38.38 1.48 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.504 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 58.7 Cg_exo -40.7 -46.96 4.71 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.622 2.214 . . . . 0.0 112.927 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.8 p -53.56 -31.75 47.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.004 0.43 . . . . 0.0 110.737 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -83.64 -25.93 30.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.9 ttm -70.18 -33.21 71.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.687 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.605 HG23 ' SD ' ' A' ' 40' ' ' MET . 56.4 mt -90.15 -1.36 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.883 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -59.09 -63.72 3.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 121.206 -0.197 . . . . 0.0 111.279 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.883 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 86.1 Cg_exo -44.07 -34.55 6.69 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.379 2.053 . . . . 0.0 112.512 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.605 ' SD ' HG23 ' A' ' 37' ' ' ILE . 65.7 mtt -56.11 -74.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.855 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -63.8 -25.28 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.199 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.855 ' N ' HD12 ' A' ' 41' ' ' ILE . 93.4 mt-10 -72.41 -30.96 65.11 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.001 0.429 . . . . 0.0 109.997 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.451 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -77.23 -44.51 29.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.828 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.437 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.6 m-85 -55.65 -23.05 25.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.647 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -56.94 -28.15 61.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 110.536 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -89.14 -7.78 55.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.872 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -90.06 -51.06 5.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.583 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 100' ' ' ILE . 51.8 m-85 -68.0 143.63 55.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.904 0.383 . . . . 0.0 111.336 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.3 m -76.73 -34.03 58.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 1.5 p30 -150.11 100.32 2.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.297 0.57 . . . . 0.0 111.395 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.71 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -146.54 125.07 12.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.28 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.52 107.39 19.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.71 ' CZ ' ' HB3' ' A' ' 51' ' ' ALA . 14.6 m-85 -101.75 124.95 48.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.915 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.638 ' CD2' HD21 ' A' ' 5' ' ' LEU . 17.6 m-30 -112.36 123.43 50.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' O ' HD23 ' A' ' 56' ' ' LEU . 40.1 ttmt -102.75 119.83 39.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.865 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.034 HD22 HG11 ' A' ' 61' ' ' VAL . 81.2 mt -130.87 155.38 46.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.801 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -120.04 -83.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.119 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 59' ' ' ASP . 8.6 p 178.32 -45.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.33 . . . . 0.0 111.085 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 58' ' ' VAL . 7.5 t0 -85.96 -58.12 2.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.776 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -59.55 -30.47 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.034 HG11 HD22 ' A' ' 56' ' ' LEU . 46.9 t -127.21 54.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.041 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.5 t -70.16 -27.32 64.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 1.5 m-20 -54.63 -40.9 69.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.42 -48.98 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.942 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.52 -45.54 9.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.514 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -59.36 -58.8 7.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.77 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.542 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -60.88 -68.72 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.47 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.94 75.43 2.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.778 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -48.57 137.77 11.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.231 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.649 HG13 HG21 ' A' ' 75' ' ' THR . 56.1 t -124.31 158.64 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.08 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.483 ' N ' HG12 ' A' ' 70' ' ' VAL . 79.9 p -164.56 70.49 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.42 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 41.5 t -177.74 -163.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.646 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.9 ptm -175.03 100.2 0.27 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.426 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.76 -155.35 1.14 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.464 -1.057 . . . . 0.0 112.216 -0.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.75 ' C ' HD12 ' A' ' 76' ' ' LEU . 87.3 m -159.14 111.06 2.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.75 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -123.95 127.3 47.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.259 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.565 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 24.2 pt -117.03 156.32 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.733 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.65 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -127.04 123.46 37.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.01 0.433 . . . . 0.0 111.427 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.565 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 66.7 m-85 -109.83 176.79 4.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.573 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -153.0 -46.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.628 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.0 29.27 1.69 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.191 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.09 44.14 3.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.272 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -162.25 123.57 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.023 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 22.1 pt-20 -82.3 101.72 10.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.45 . . . . 0.0 110.672 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.54 -34.18 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.446 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 63.7 m -107.96 110.36 22.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.417 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -111.56 158.91 18.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.267 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 95' ' ' ALA . 47.6 t -155.22 80.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.773 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 75' ' ' THR . 35.3 m -109.82 63.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.13 0.49 . . . . 0.0 111.27 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -133.57 -158.2 8.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.305 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.03 76.18 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.31 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -154.75 138.32 10.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.555 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.87 -1.03 10.63 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.62 2.213 . . . . 0.0 113.261 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.57 -40.76 9.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.683 0.278 . . . . 0.0 111.241 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' A' ' 88' ' ' VAL . . . -48.3 -31.52 6.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.7 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 41' ' ' ILE . 3.6 tp -69.76 -36.22 68.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.309 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -61.66 -73.33 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.607 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -55.64 -41.74 73.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.986 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.461 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -54.27 -55.85 24.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.317 . . . . 0.0 111.324 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.586 HG21 ' CE2' ' A' ' 48' ' ' TYR . 32.8 mm -62.22 -51.01 77.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.747 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -23.68 66.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.227 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -54.8 -62.91 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.55 . . . . 0.0 110.826 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -127.71 46.54 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.078 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.806 ' HA ' HD12 ' A' ' 21' ' ' LEU . 9.5 p . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.099 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.835 0.35 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.439 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 15.8 m -56.96 154.14 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.034 0.445 . . . . 0.0 111.629 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.513 ' HB ' HD11 ' A' ' 5' ' ' LEU . 6.9 m -101.11 163.9 12.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.867 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.424 ' N ' HG22 ' A' ' 3' ' ' THR . 14.6 mp0 -98.65 90.7 4.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 5' ' ' LEU . 5.2 mp -88.84 127.46 35.63 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.956 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -129.71 -58.21 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.196 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.9 t -90.24 139.82 30.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.13 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.02 66.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.163 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.4 p -55.88 -37.68 69.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.813 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 47.6 mt-10 -67.18 -32.95 74.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.656 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 47.3 t80 -65.09 -62.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.155 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.93 -54.61 42.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.8 p -56.69 -22.55 35.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.22 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.733 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -79.32 -60.55 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.322 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.656 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 78.5 mt -55.7 -23.0 26.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.165 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.89 -61.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 111.249 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -75.16 -48.35 24.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.066 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.79 108.24 0.68 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.773 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -109.85 -25.17 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 0.0 110.916 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -53.49 -79.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.653 HD21 ' CD2' ' A' ' 78' ' ' PHE . 4.3 tt -169.02 116.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 110.554 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.584 HG13 ' CE2' ' A' ' 54' ' ' TYR . 50.1 t -105.76 137.99 33.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.506 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG23 ' CD2' ' A' ' 21' ' ' LEU . 40.6 t -132.31 108.94 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 0.0 111.319 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.732 HG23 HD11 ' A' ' 77' ' ' ILE . 34.7 m -102.38 122.92 55.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.87 103.92 13.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.537 ' HB3' HG21 ' A' ' 70' ' ' VAL . 63.4 m-85 -91.99 101.7 14.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.173 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.435 ' HA ' ' CH2' ' A' ' 30' ' ' TRP . 2.4 p90 -134.53 122.21 22.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.519 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 1.054 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -93.25 23.65 4.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.868 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.2 p 46.52 80.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.985 0.421 . . . . 0.0 111.355 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.45 ' CZ3' ' HG2' ' A' ' 33' ' ' PRO . 3.6 m-90 -86.63 -58.87 2.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.322 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.5 t -143.44 -77.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.502 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.587 ' N ' ' HD3' ' A' ' 33' ' ' PRO . . . -168.69 52.59 0.22 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.923 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 32' ' ' GLY . 37.5 Cg_endo -94.3 -68.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.051 2.501 . . . . 0.0 112.204 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.0 p -68.63 -34.87 76.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.813 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 35' ' ' LYS . 9.4 tmtt? -52.93 -55.5 22.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.66 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.8 ttt -51.22 -42.69 61.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.585 HD13 ' HB1' ' A' ' 91' ' ' ALA . 36.2 pt -90.2 10.7 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.134 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.637 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -62.94 -51.04 74.01 Favored Pre-proline 0 C--N 1.331 -0.203 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.301 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 50.4 Cg_exo -55.53 -32.44 82.72 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.277 1.985 . . . . 0.0 112.09 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 63.3 mtt -55.1 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.977 HG22 HD13 ' A' ' 96' ' ' ILE . 2.5 pp -55.5 -28.78 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 111.132 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.926 ' N ' HD12 ' A' ' 41' ' ' ILE . 8.7 tm-20 -71.38 -27.09 63.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.368 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -86.01 -50.75 6.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.419 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 9.8 m-85 -54.19 -30.25 48.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.406 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -51.91 -27.83 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.239 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -90.1 -33.61 16.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.76 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -61.81 -24.56 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.105 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' CZ ' ' HB ' ' A' ' 100' ' ' ILE . 39.2 m-85 -82.28 159.07 23.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.991 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -81.28 -38.96 26.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 1.6 p30 -150.0 104.75 3.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.118 0.485 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.09 123.23 11.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.092 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -90.0 100.26 13.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 9.4 m-85 -94.87 127.34 40.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.496 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.733 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 18.8 m-30 -118.23 126.44 52.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.004 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -107.32 99.13 8.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.603 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.836 HD22 HG11 ' A' ' 61' ' ' VAL . 98.1 mt -98.77 164.28 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.236 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 38.3 t70 -144.2 162.89 35.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.439 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.054 HG21 ' HB2' ' A' ' 28' ' ' ALA . 45.7 t -86.83 0.53 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.794 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -113.22 -75.93 0.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.644 0.259 . . . . 0.0 111.211 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.813 ' HG3' HG23 ' A' ' 61' ' ' VAL . 12.0 pt-20 -58.57 -23.02 57.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.197 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.836 HG11 HD22 ' A' ' 56' ' ' LEU . 39.8 t -127.98 47.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.5 t -62.69 -26.24 68.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.016 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -60.75 -55.14 36.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.993 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.578 HG11 HD13 ' A' ' 56' ' ' LEU . 55.7 t -58.8 -48.92 84.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.025 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.08 -26.5 6.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.311 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -58.48 -64.54 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.727 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -59.65 -57.95 10.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.801 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.24 83.51 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -56.57 111.77 1.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.027 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 26' ' ' PHE . 45.9 t -92.15 127.36 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.8 t -153.47 39.45 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.177 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.0 m -128.03 -53.87 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.704 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 55.1 mtm 65.16 83.62 0.19 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.303 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 85.9 Cg_endo -89.18 -166.11 2.98 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.881 -1.3 . . . . 0.0 112.477 -0.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.487 ' C ' HD12 ' A' ' 76' ' ' LEU . 84.8 m -144.88 103.0 3.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.719 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 76' ' ' LEU . 4.0 mp -109.67 119.16 38.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.609 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.732 HD11 HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.15 152.41 35.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.054 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.653 ' CD2' HD21 ' A' ' 21' ' ' LEU . 1.9 m-85 -117.87 134.84 54.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.374 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.54 ' CD2' HD22 ' A' ' 15' ' ' LEU . 76.4 m-85 -109.47 147.49 32.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.66 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -145.67 76.91 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.659 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.13 51.62 1.33 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.12 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.76 27.39 59.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.873 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -144.32 147.45 33.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.965 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -102.21 135.01 44.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.673 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.79 -39.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.876 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.812 HG21 ' ND2' ' A' ' 103' ' ' ASN . 83.1 m -101.1 118.94 37.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.849 0.357 . . . . 0.0 110.262 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -118.13 170.66 8.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.017 0.437 . . . . 0.0 111.614 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -155.81 83.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.704 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.3 88.79 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -170.29 -34.52 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.973 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.585 ' HB1' HD13 ' A' ' 37' ' ' ILE . . . 77.53 83.28 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.926 0.393 . . . . 0.0 111.121 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.701 HD21 ' HB3' ' A' ' 94' ' ' ALA . 52.1 t30 -145.41 129.81 8.86 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.625 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' HG22 ' A' ' 96' ' ' ILE . 30.1 Cg_endo -64.11 -8.64 16.86 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.668 2.245 . . . . 0.0 113.326 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.701 ' HB3' HD21 ' A' ' 92' ' ' ASN . . . -98.1 -34.69 10.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.697 0.285 . . . . 0.0 111.173 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -57.66 -33.87 68.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.128 0.49 . . . . 0.0 110.171 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.977 HD13 HG22 ' A' ' 41' ' ' ILE . 4.2 tp -56.01 -50.41 69.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.297 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 11.0 tmtt? -59.01 -57.35 13.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.718 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -68.71 -11.76 60.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.61 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -81.19 -60.03 2.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.778 0.323 . . . . 0.0 111.38 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 96' ' ' ILE . 2.0 mp -75.66 -57.14 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.068 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 97' ' ' LYS . . . -46.09 -27.05 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.671 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.9 t -77.96 -57.78 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.429 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.812 ' ND2' HG21 ' A' ' 86' ' ' THR . 22.9 p30 -109.97 40.91 1.82 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 111.391 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.45 ' HA ' HD12 ' A' ' 21' ' ' LEU . 11.6 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.992 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.829 0.347 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.632 HG21 ' HG3' ' A' ' 42' ' ' GLU . 61.1 t -53.39 133.61 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 4' ' ' GLN . 4.8 m -107.2 165.02 11.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.08 0.467 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.4 ' N ' HG22 ' A' ' 3' ' ' THR . 14.0 mp0 -96.21 79.07 3.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.48 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.588 HD23 HD21 ' A' ' 56' ' ' LEU . 37.6 tp -89.16 95.75 10.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.495 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -106.02 -36.93 6.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.348 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -105.21 145.43 30.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.622 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.34 75.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.056 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -51.83 -28.95 17.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.72 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -80.8 -30.49 35.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.567 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CE1' HG21 ' A' ' 24' ' ' VAL . 48.2 t80 -78.79 -45.27 21.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.903 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -57.16 -52.24 66.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -62.46 -27.73 69.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.79 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 11' ' ' TYR . . . -61.19 -53.14 60.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 79' ' ' TYR . 83.7 mt -59.47 -30.96 68.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.881 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.22 -67.91 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -90.39 24.9 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.366 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 19' ' ' ASP . . . -58.66 -97.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.628 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 65.4 t0 68.75 -62.16 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.647 0.261 . . . . 0.0 111.167 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -46.62 -82.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.15 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.884 HD21 HG23 ' A' ' 100' ' ' ILE . 34.7 tp -178.47 111.85 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.752 0.31 . . . . 0.0 110.977 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.685 HG13 ' CE2' ' A' ' 54' ' ' TYR . 47.7 t -105.13 141.02 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.616 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.2 t -144.03 111.03 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 111.373 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.536 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 62.1 t -99.96 116.85 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.732 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 27' ' ' PHE . 10.0 t0 -106.07 103.73 13.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.936 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.64 ' CD2' HG21 ' A' ' 70' ' ' VAL . 64.8 m-85 -92.07 108.53 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.986 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CD1' ' OD1' ' A' ' 25' ' ' ASP . 1.7 p90 -153.23 120.37 5.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.888 ' HB2' HG12 ' A' ' 58' ' ' VAL . . . -93.79 27.01 2.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.116 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.2 p 49.72 51.86 15.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.08 0.467 . . . . 0.0 110.999 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.578 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.1 m-90 -66.73 -62.71 1.31 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.009 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.8 t 161.86 144.75 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.758 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.07 -112.43 3.65 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.676 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.884 ' HA ' HD13 ' A' ' 37' ' ' ILE . 91.1 Cg_exo -43.66 -71.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.953 2.435 . . . . 0.0 113.413 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 38' ' ' ALA . 26.8 p -48.78 -24.19 1.33 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -84.15 -73.07 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.784 0.326 . . . . 0.0 111.863 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 83.6 mtp -66.28 -34.07 77.16 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.884 HD13 ' HA ' ' A' ' 33' ' ' PRO . 1.4 mp -90.52 24.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.186 0.517 . . . . 0.0 111.207 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -90.15 -52.35 0.33 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.85 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 34.0 Cg_exo -62.47 -32.18 80.45 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.649 2.233 . . . . 0.0 113.009 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.702 ' CE ' HG23 ' A' ' 37' ' ' ILE . 42.4 mtm -57.56 -77.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.918 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.919 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.6 pp -56.0 -27.41 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.758 0.313 . . . . 0.0 111.044 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.919 ' N ' HD12 ' A' ' 41' ' ' ILE . 89.1 tt0 -75.2 -28.13 59.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.029 0.443 . . . . 0.0 110.512 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' PRO . 22.9 ttpp -83.37 -48.6 10.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.427 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -50.52 -27.12 6.07 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.845 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.59 -28.67 56.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.957 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.92 -14.77 33.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.108 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -85.4 10.08 13.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.571 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.42 153.26 40.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.755 0.312 . . . . 0.0 110.823 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -80.91 -40.34 24.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.968 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -134.52 95.79 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.068 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -143.4 121.75 12.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -100.2 98.39 9.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.371 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 10.6 m-85 -91.64 129.11 37.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.31 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.685 ' CE2' HG13 ' A' ' 22' ' ' VAL . 17.6 m-30 -114.09 107.13 15.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.89 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HB2' HG13 ' A' ' 2' ' ' VAL . 85.6 tttt -89.77 125.43 35.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.437 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.756 HD22 HG11 ' A' ' 61' ' ' VAL . 86.7 mt -130.62 156.74 44.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.067 0.46 . . . . 0.0 111.53 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.54 117.96 15.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.238 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.888 HG12 ' HB2' ' A' ' 28' ' ' ALA . 8.2 p -65.74 74.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.074 0.464 . . . . 0.0 111.2 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 t70 179.89 -69.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.135 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -78.63 -31.03 46.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.886 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.756 HG11 HD22 ' A' ' 56' ' ' LEU . 25.1 t -113.47 30.69 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.878 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.1 p -49.03 -26.89 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.345 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -44.62 -55.36 5.26 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.523 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.725 HG11 ' CD1' ' A' ' 56' ' ' LEU . 48.2 t -59.58 -46.4 93.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.001 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.91 -34.21 58.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.431 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -54.95 -69.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.08 -47.54 85.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -83.5 80.38 9.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.37 111.23 1.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.831 ' CG1' HG21 ' A' ' 75' ' ' THR . 48.7 t -119.08 145.63 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -144.5 70.15 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.031 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.508 ' HB3' HG11 ' A' ' 89' ' ' VAL . 64.4 m -165.46 -175.61 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.697 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.476 ' HB3' ' CH2' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -170.02 106.66 0.44 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.672 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.631 ' O ' HG13 ' A' ' 89' ' ' VAL . 4.9 Cg_exo -74.66 -155.64 1.06 Allowed 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 124.1 -1.208 . . . . 0.0 111.99 -0.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.831 HG21 ' CG1' ' A' ' 70' ' ' VAL . 86.9 m -164.22 108.23 0.96 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.8 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.749 HD12 ' C ' ' A' ' 75' ' ' THR . 3.9 mp -123.56 119.3 29.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.574 HD12 ' CE2' ' A' ' 79' ' ' TYR . 26.3 pt -110.37 152.8 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.017 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -127.03 122.84 35.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.051 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.574 ' CE2' HD12 ' A' ' 77' ' ' ILE . 68.7 m-85 -109.68 136.99 48.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.21 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -118.11 -36.45 3.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.311 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.98 49.57 0.8 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.906 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.54 28.0 66.9 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.777 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' O ' HG13 ' A' ' 85' ' ' VAL . 34.9 mmtp -145.94 114.28 6.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.751 0.31 . . . . 0.0 110.962 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.442 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 11.9 pt-20 -58.08 123.94 17.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.662 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 86' ' ' THR . 35.4 m -136.04 -44.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.494 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 94.3 m -103.33 105.36 15.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 110.619 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -103.49 147.86 26.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.455 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 48.4 t -138.28 82.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.798 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 74' ' ' PRO . 45.4 t -109.54 62.78 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.11 127.05 1.42 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.259 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HB1' HG12 ' A' ' 37' ' ' ILE . . . -55.25 124.68 17.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.774 0.321 . . . . 0.0 111.049 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -176.15 103.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.612 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 11.2 Cg_endo -56.2 -13.98 10.9 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.652 2.235 . . . . 0.0 113.23 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -96.91 -44.56 6.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.69 -31.18 15.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 110.625 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.835 HD13 HG22 ' A' ' 41' ' ' ILE . 4.2 tp -58.03 -44.84 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.05 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -61.32 -75.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.934 0.397 . . . . 0.0 111.2 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -44.66 -32.92 1.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.542 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.98 -41.74 77.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.405 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.884 HG23 HD21 ' A' ' 21' ' ' LEU . 73.7 mt -84.96 -44.34 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.338 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.57 -13.48 59.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.6 p -90.14 -26.32 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.48 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 49.8 m-80 -114.72 -19.43 11.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.658 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.497 ' HA ' HD22 ' A' ' 21' ' ' LEU . 9.1 p . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.614 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.835 0.35 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.711 HG13 ' HB2' ' A' ' 55' ' ' LYS . 59.4 t -48.23 121.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -106.61 170.51 7.89 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.249 0.547 . . . . 0.0 110.974 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 3' ' ' THR . 14.1 mp0 -111.71 98.17 7.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.001 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.679 HD22 HD11 ' A' ' 56' ' ' LEU . 5.4 mp -88.98 119.61 29.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.845 0.355 . . . . 0.0 111.168 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -107.86 -69.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.906 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.6 t -84.56 162.86 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.13 -29.45 60.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.3 p -59.67 -33.39 71.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.05 -31.58 70.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.611 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 45.4 t80 -90.14 -36.37 14.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.61 -54.64 44.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -67.81 -20.12 65.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.279 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.667 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -69.59 -53.27 19.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.215 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.842 HD23 HG11 ' A' ' 22' ' ' VAL . 85.1 mt -58.63 -28.85 66.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.11 -58.87 2.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.356 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -55.96 -72.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.98 129.37 47.36 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.646 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -125.23 22.9 7.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.655 0.264 . . . . 0.0 111.17 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -96.54 -75.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.811 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.86 HD22 ' HB ' ' A' ' 104' ' ' VAL . 20.3 tp -159.09 107.33 1.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.965 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.842 HG11 HD23 ' A' ' 15' ' ' LEU . 52.2 t -103.57 112.91 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.623 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.9 114.68 43.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.584 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.704 ' HB ' HD11 ' A' ' 77' ' ' ILE . 54.8 t -100.28 145.1 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.399 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 38.3 t70 -127.07 92.76 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 0.0 111.595 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.742 ' CE1' HD22 ' A' ' 56' ' ' LEU . 72.6 m-85 -88.84 94.87 10.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.832 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.546 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 5.3 p90 -129.69 122.24 28.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.421 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -93.24 79.45 4.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.363 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 29' ' ' THR . 4.7 t -48.1 94.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.983 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.572 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.8 m-90 -92.06 -48.65 6.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 44.7 t 150.02 58.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.935 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.19 -121.9 0.58 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.655 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.437 ' O ' HG12 ' A' ' 37' ' ' ILE . 32.0 Cg_exo -57.13 -73.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.392 2.061 . . . . 0.0 112.192 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 6.0 p -41.54 -32.06 0.32 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -65.18 -47.36 77.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.039 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.2 mtp -84.81 -23.2 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.395 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 37' ' ' ILE . 49.0 mm -75.53 -7.55 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.425 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.916 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -63.77 -63.98 3.37 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.916 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 72.3 Cg_exo -48.64 -38.49 36.6 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.323 2.015 . . . . 0.0 112.905 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 64.1 mtt -52.5 -82.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.15 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.004 HG22 HD12 ' A' ' 96' ' ' ILE . 2.5 pp -56.38 -26.98 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.16 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.897 ' N ' HD12 ' A' ' 41' ' ' ILE . 89.4 tt0 -72.24 -25.85 61.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.399 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.463 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -85.89 -48.25 8.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.017 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -54.06 -27.46 32.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -56.8 -27.35 59.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.811 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -89.96 -10.78 43.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.095 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -90.08 16.85 7.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.668 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -131.88 158.37 41.54 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.9 m -95.63 -33.78 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -136.39 77.76 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.473 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -130.76 116.63 18.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.85 94.79 9.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.957 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.473 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 9.8 m-85 -90.03 128.55 36.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.638 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.667 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 18.6 m-30 -114.91 96.12 5.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.982 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.789 ' C ' HD12 ' A' ' 56' ' ' LEU . 87.4 tttt -89.79 120.88 31.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.333 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.789 HD12 ' C ' ' A' ' 55' ' ' LYS . 3.6 mp -129.79 -175.94 3.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.471 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.48 ' OD1' HG12 ' A' ' 58' ' ' VAL . 62.5 t0 -137.12 -82.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.953 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.48 HG12 ' OD1' ' A' ' 57' ' ' ASP . 7.7 p 177.83 -37.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.744 0.307 . . . . 0.0 111.025 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -98.22 -31.46 12.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.45 -38.01 82.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.831 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.459 HG21 HD23 ' A' ' 56' ' ' LEU . 45.3 t -103.81 -50.82 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.1 t 68.24 -63.92 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.46 -67.4 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.471 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.4 t -57.41 -61.03 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.029 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.89 -28.9 2.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.387 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -76.02 -62.23 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.739 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.501 ' HD3' ' N ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -60.35 -29.44 68.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.598 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -88.25 80.79 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.895 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -53.75 95.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 68' ' ' ALA . 47.3 t -86.94 157.77 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.273 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.483 ' N ' HG12 ' A' ' 70' ' ' VAL . 80.6 p -149.6 128.52 12.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.73 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.4 m 62.43 82.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.933 0.397 . . . . 0.0 110.553 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.528 ' HE2' ' HA ' ' A' ' 27' ' ' PHE . 38.2 mtp -84.3 152.32 61.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.617 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.07 173.28 53.0 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 123.63 -1.404 . . . . 0.0 112.71 0.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 1.053 HG23 HG12 ' A' ' 89' ' ' VAL . 94.0 m -147.86 132.25 17.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.607 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.886 HD21 HG21 ' A' ' 41' ' ' ILE . 4.1 mp -124.59 142.31 51.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.207 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.744 HD13 ' N ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -139.36 147.47 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.833 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.5 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.6 m-85 -117.87 121.3 40.37 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.051 0.453 . . . . 0.0 111.435 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 61.2 m-85 -109.65 130.4 55.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.002 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.61 53.53 1.83 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.219 0.533 . . . . 0.0 109.924 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.21 41.4 0.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.146 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.34 37.03 86.26 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.078 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -151.09 107.76 3.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.69 0.281 . . . . 0.0 111.242 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 44.4 tt0 -58.77 126.82 29.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.169 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 86' ' ' THR . 22.3 m -138.67 -46.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 71.5 p -113.4 77.88 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.126 0.489 . . . . 0.0 111.045 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -80.7 158.84 25.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.147 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.476 HG21 ' CB ' ' A' ' 99' ' ' ALA . 60.0 t -141.52 85.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.697 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 1.053 HG12 HG23 ' A' ' 75' ' ' THR . 35.1 m -109.26 78.06 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.139 0.495 . . . . 0.0 111.294 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.99 148.05 16.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.325 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.26 76.38 7.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.872 0.367 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -156.48 125.6 3.08 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.58 -6.89 20.1 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.49 2.127 . . . . 0.0 112.79 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.51 -36.32 12.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.0 110.94 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -50.14 -28.08 6.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.159 0.504 . . . . 0.0 110.204 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.004 HD12 HG22 ' A' ' 41' ' ' ILE . 6.1 tt -80.92 -33.03 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.729 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.43 -61.05 2.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -75.69 -5.92 47.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.641 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -89.7 -43.94 10.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.797 0.332 . . . . 0.0 111.244 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.684 HG23 ' CD2' ' A' ' 21' ' ' LEU . 63.0 mt -74.13 -53.81 16.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.782 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.28 -20.94 31.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.652 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.9 p -82.95 -75.52 0.31 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.664 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.541 ' OD1' HD12 ' A' ' 21' ' ' LEU . 20.8 t-20 -52.72 -37.82 59.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.118 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.86 ' HB ' HD22 ' A' ' 21' ' ' LEU . 14.8 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.485 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.861 0.363 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 59.6 t -57.57 145.18 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.48 ' HB ' HD11 ' A' ' 5' ' ' LEU . 2.2 m -107.84 158.62 17.17 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -96.71 92.6 6.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.683 HD22 HD21 ' A' ' 56' ' ' LEU . 4.8 mp -88.9 109.94 20.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.704 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -104.53 -55.65 2.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.34 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.0 t -101.49 151.68 21.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.55 67.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.5 p -55.87 -31.31 62.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -69.23 -36.73 77.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.757 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.519 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 48.3 t80 -60.66 -40.94 93.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.85 -65.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -57.8 -24.6 58.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.019 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HB1' ' CE2' ' A' ' 54' ' ' TYR . . . -57.95 -54.8 42.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.709 HD23 HG21 ' A' ' 22' ' ' VAL . 80.8 mt -82.92 1.39 39.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.332 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.06 -74.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.786 0.327 . . . . 0.0 111.245 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.1 p -71.83 -34.42 69.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.08 119.08 7.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.573 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.78 26.69 5.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.02 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -93.96 -70.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.687 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.568 ' C ' HD23 ' A' ' 21' ' ' LEU . 4.2 tt -174.86 105.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.368 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.709 HG21 HD23 ' A' ' 15' ' ' LEU . 49.3 t -99.82 132.62 44.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 ' CD2' ' A' ' 21' ' ' LEU . 46.1 t -127.82 115.48 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.142 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.505 HG11 ' CE2' ' A' ' 26' ' ' PHE . 47.2 t -99.96 117.79 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.711 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -106.94 99.44 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.505 ' CE2' HG11 ' A' ' 24' ' ' VAL . 53.8 m-85 -90.41 111.24 22.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.999 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.41 ' CE1' ' O ' ' A' ' 56' ' ' LEU . 1.7 p90 -144.56 120.02 10.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.615 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.915 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -85.57 10.33 13.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.538 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.8 p 49.65 51.01 17.29 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.017 0.437 . . . . 0.0 111.204 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.915 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.3 m-90 -67.12 -62.31 1.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.971 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.4 t 160.48 127.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.461 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.25 -118.78 4.08 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.314 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.595 ' CB ' HD12 ' A' ' 37' ' ' ILE . 20.9 Cg_endo -61.33 -43.57 27.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.601 2.201 . . . . 0.0 112.81 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 26.3 p -69.96 63.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 0.0 111.268 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 35' ' ' LYS . 7.2 ttpm? 176.1 -53.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.486 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.0 tpt -84.09 -30.05 26.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.595 HD12 ' CB ' ' A' ' 33' ' ' PRO . 54.6 mt -86.87 -30.43 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.984 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -48.37 -52.63 41.37 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.55 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.698 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 74.0 Cg_exo -49.24 -43.5 37.07 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.039 1.826 . . . . 0.0 111.495 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.822 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 71.0 mtp -60.33 -22.04 62.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.994 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.603 HD13 HD21 ' A' ' 76' ' ' LEU . 13.3 mt -91.62 -55.78 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.151 0.5 . . . . 0.0 110.085 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 3.9 tm-20 -54.94 -57.06 13.18 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.72 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.524 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 5.4 ttpm? -49.62 -47.97 49.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.075 0.464 . . . . 0.0 110.465 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.822 ' CD1' ' O ' ' A' ' 40' ' ' MET . 7.1 m-85 -54.59 -23.93 18.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.192 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -58.46 -28.14 65.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.031 0.444 . . . . 0.0 110.678 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -89.7 -11.25 42.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.068 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.03 15.57 9.86 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.608 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.548 ' CD2' HG21 ' A' ' 100' ' ' ILE . 42.3 m-85 -125.68 145.45 50.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.839 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.8 p -66.54 -47.06 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 104' ' ' VAL . 12.0 p-10 -143.7 99.26 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.988 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.14 122.7 16.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -90.03 97.66 11.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 8.6 m-85 -89.89 126.2 35.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.883 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.63 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 19.3 m-30 -119.37 104.18 10.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.54 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HE3' HG11 ' A' ' 2' ' ' VAL . 40.2 ttmt -89.79 123.5 33.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.091 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.736 HD22 HG11 ' A' ' 61' ' ' VAL . 86.4 mt -128.72 158.93 37.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.855 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -145.69 -176.58 5.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 59' ' ' ASP . 11.1 p -90.54 158.85 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.067 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.489 ' N ' HG22 ' A' ' 58' ' ' VAL . 7.9 t70 67.22 -70.0 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -55.6 -30.37 60.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.98 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.736 HG11 HD22 ' A' ' 56' ' ' LEU . 45.2 t -137.72 53.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.967 0.413 . . . . 0.0 110.936 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.6 t -71.44 -28.68 64.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -58.36 -40.25 81.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.055 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.632 HG11 ' CD1' ' A' ' 56' ' ' LEU . 44.4 t -75.8 -52.85 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.83 -39.41 58.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.21 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -60.87 -31.78 71.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.815 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -81.55 -47.4 13.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.789 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.86 77.66 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.121 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.6 118.12 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.818 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.824 ' CG1' HG21 ' A' ' 75' ' ' THR . 31.5 m -130.73 150.75 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.221 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.7 m -133.78 57.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.98 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 m -141.84 -169.38 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.548 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.1 ptp -166.11 91.59 0.83 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.447 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 83.2 Cg_endo -84.66 -163.79 3.09 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 124.063 -1.224 . . . . 0.0 112.393 -0.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.824 HG21 ' CG1' ' A' ' 70' ' ' VAL . 89.8 m -133.48 118.04 17.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.586 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.753 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -123.74 137.23 54.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.847 0.356 . . . . 0.0 111.278 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.504 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 28.7 pt -133.72 162.72 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.834 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.524 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.0 m-85 -132.41 128.64 37.97 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 111.242 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.504 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 71.2 m-85 -109.89 158.82 17.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.742 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -156.6 73.46 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.794 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.28 -18.65 23.12 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.505 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.01 48.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.26 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -169.96 127.64 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.995 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.66 98.69 5.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.3 m -110.75 -28.32 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.364 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 99.7 m -114.84 103.3 10.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.918 0.389 . . . . 0.0 110.269 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -107.36 157.67 17.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.266 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -155.27 81.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.717 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 89' ' ' VAL . 35.8 m -109.64 106.14 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.333 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.06 -113.43 0.29 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.426 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -178.19 77.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 111.035 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -151.86 129.35 5.74 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.602 ' HB2' ' HE2' ' A' ' 40' ' ' MET . 87.0 Cg_endo -82.39 9.59 3.94 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.635 2.223 . . . . 0.0 113.021 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.91 -50.78 3.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.732 0.301 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.96 -27.93 14.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 110.614 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.45 HG22 ' C ' ' A' ' 93' ' ' PRO . 4.4 tp -54.14 -43.47 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.194 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -71.92 -71.51 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.031 0.443 . . . . 0.0 111.129 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -44.2 -32.19 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.583 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.24 -51.39 15.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.181 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 100' ' ' ILE . 66.4 mt -76.26 -5.14 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.496 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.55 -24.61 21.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 0.0 111.38 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -89.98 -59.38 2.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.31 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.461 HD21 HG21 ' A' ' 86' ' ' THR . 59.6 m-80 -54.62 -43.1 71.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.101 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.511 ' N ' HD12 ' A' ' 21' ' ' LEU . 10.2 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.373 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.858 0.361 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 53' ' ' PHE . 46.8 t -57.63 137.44 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.672 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.5 m -89.94 168.05 12.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 110.871 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.416 ' H ' HG22 ' A' ' 3' ' ' THR . 14.7 mp0 -108.51 94.8 5.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.886 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.84 ' HB2' HD21 ' A' ' 56' ' ' LEU . 4.9 mp -88.96 132.05 34.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.205 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.61 -62.85 0.95 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 t -86.19 152.98 22.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.17 -28.84 64.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.327 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.5 p -57.42 -30.41 64.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.058 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -74.34 -37.64 63.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.47 -52.43 65.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.22 -56.03 27.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.057 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -57.8 -28.72 64.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.028 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.831 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -68.54 -43.42 76.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.135 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 79' ' ' TYR . 78.3 mt -67.96 -40.34 83.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.044 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.0 -46.45 62.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.204 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.5 m -75.78 -53.43 8.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.057 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.06 115.26 7.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.599 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -113.14 -31.89 6.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.71 0.29 . . . . 0.0 111.039 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.91 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.997 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.908 HD13 ' HB2' ' A' ' 103' ' ' ASN . 41.5 tp -159.65 115.98 2.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.569 HG13 ' CE2' ' A' ' 54' ' ' TYR . 54.2 t -111.72 106.34 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.832 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.653 HG21 ' CD1' ' A' ' 100' ' ' ILE . 44.8 t -102.92 144.12 14.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.464 HG11 ' CE2' ' A' ' 26' ' ' PHE . 60.0 t -128.31 146.54 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -135.84 111.8 9.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.944 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.464 ' CE2' HG11 ' A' ' 24' ' ' VAL . 56.5 m-85 -105.44 113.56 27.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.198 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.427 ' HB2' ' CB ' ' A' ' 34' ' ' CYS . 2.1 p90 -147.92 120.72 8.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.721 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.9 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -82.84 9.92 8.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.686 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.2 p 50.57 55.51 9.4 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.059 0.457 . . . . 0.0 111.058 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.9 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.2 m-90 -71.81 -61.88 1.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.014 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 39.6 t 158.85 101.77 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.467 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.84 -126.69 2.51 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.279 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' LYS . 92.4 Cg_exo -42.73 -60.61 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.962 2.441 . . . . 0.0 113.234 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.427 ' CB ' ' HB2' ' A' ' 27' ' ' PHE . 26.9 p -65.85 66.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.357 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' PRO . 56.6 tptt 176.14 -35.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.3 mtt -81.84 -65.89 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.684 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.662 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -88.16 18.69 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.766 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -63.42 -53.37 53.0 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.648 0.261 . . . . 0.0 110.663 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 52.3 Cg_exo -55.58 -33.07 85.58 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.64 2.227 . . . . 0.0 112.21 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.471 ' CE ' ' HB3' ' A' ' 93' ' ' PRO . 67.3 mtp -54.82 -71.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 110.468 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.483 HG22 ' HB ' ' A' ' 96' ' ' ILE . 7.6 pt -52.44 -39.25 28.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.094 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.28 -27.52 65.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.64 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -79.72 -45.84 18.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -53.62 -25.04 15.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.546 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.789 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -55.79 -29.97 60.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.732 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -87.63 -3.12 58.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.877 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -90.27 -35.24 15.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.542 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.796 ' CE2' HG21 ' A' ' 100' ' ' ILE . 45.7 m-85 -76.49 157.29 32.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.798 0.332 . . . . 0.0 111.183 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.4 p -79.98 -38.36 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -155.38 104.07 2.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.133 0.492 . . . . 0.0 111.403 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -150.13 125.69 10.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.104 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.32 107.46 19.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 110.771 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.789 ' CE2' ' HB1' ' A' ' 45' ' ' ALA . 9.3 m-85 -99.96 130.79 46.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.004 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.831 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 20.5 m-30 -113.9 119.73 38.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' HG11 ' A' ' 2' ' ' VAL . 61.4 tttp -104.11 115.02 29.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.883 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.84 HD21 ' HB2' ' A' ' 5' ' ' LEU . 89.7 mt -134.68 170.7 15.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.237 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.28 153.59 46.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.644 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.873 ' HB ' ' HB2' ' A' ' 28' ' ' ALA . 47.3 t -88.09 55.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.986 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -177.46 -65.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.054 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.53 -30.65 61.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.036 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.431 HG21 HD22 ' A' ' 56' ' ' LEU . 51.2 t -102.13 -58.84 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.814 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.9 t 67.35 -64.64 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.393 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -40.6 -68.39 0.18 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.828 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.671 HG11 ' CD1' ' A' ' 56' ' ' LEU . 59.7 t -52.13 -44.21 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.163 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.31 56.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -57.15 -68.24 0.25 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.988 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.94 -25.37 57.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.72 74.49 7.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.311 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.0 mp0 -69.89 105.97 3.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.762 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.626 ' CB ' HG21 ' A' ' 75' ' ' THR . 35.2 m -132.95 -178.58 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.8 p -164.48 72.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.819 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -157.54 -170.17 3.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.609 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.8 ptt? -165.81 98.56 0.76 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.192 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 2.8 Cg_exo -75.76 -155.43 1.06 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.261 -1.141 . . . . 0.0 112.129 0.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.626 HG21 ' CB ' ' A' ' 70' ' ' VAL . 86.7 m -155.65 100.66 2.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.587 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 76' ' ' LEU . 3.9 mp -113.85 162.79 15.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.917 0.389 . . . . 0.0 111.256 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.561 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 17.1 pt -156.89 160.18 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.82 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.634 ' HE2' HD13 ' A' ' 100' ' ' ILE . 1.3 m-85 -128.68 123.05 32.16 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.984 0.421 . . . . 0.0 111.368 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.562 ' CD2' HD22 ' A' ' 15' ' ' LEU . 69.8 m-85 -109.91 101.79 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.831 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.97 -70.53 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 110.732 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.39 27.32 7.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.368 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.08 49.82 1.69 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.364 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' O ' HG13 ' A' ' 85' ' ' VAL . 24.2 ttmm -169.82 114.96 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.334 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -55.62 99.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 83' ' ' LYS . 35.6 m -121.38 -28.99 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.799 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.43 ' O ' ' CD1' ' A' ' 78' ' ' PHE . 89.1 m -122.44 74.99 1.21 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 110.649 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -82.37 159.6 23.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.2 0.524 . . . . 0.0 111.643 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -156.72 86.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.085 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.641 ' O ' HG23 ' A' ' 89' ' ' VAL . 27.8 m -108.61 87.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.37 0.605 . . . . 0.0 111.28 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.36 -152.06 7.09 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.968 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.42 92.75 2.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.795 0.331 . . . . 0.0 110.998 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -144.53 101.21 4.7 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.071 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 96' ' ' ILE . 32.1 Cg_exo -58.52 -15.14 23.76 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.553 2.169 . . . . 0.0 112.431 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.62 -31.49 13.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 110.83 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.86 -31.33 64.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.797 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 93' ' ' PRO . 3.8 tp -53.76 -33.87 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.072 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -68.29 -67.7 0.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.118 0.485 . . . . 0.0 110.832 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -53.72 -49.48 68.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.492 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.562 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -51.25 -65.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.625 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.796 HG21 ' CE2' ' A' ' 48' ' ' TYR . 41.2 mm -52.33 -48.57 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.419 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . . . -55.41 -21.8 17.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.856 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.5 m -57.55 -50.09 74.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.491 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.908 ' HB2' HD13 ' A' ' 21' ' ' LEU . 21.1 m-80 -122.84 5.56 9.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.621 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 101' ' ' ALA . 13.0 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.623 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.811 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 22.9 ptp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.801 0.334 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.66 HG11 ' HE2' ' A' ' 55' ' ' LYS . 43.9 t -55.94 132.27 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.945 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.3 m -107.13 168.71 9.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 110.803 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.445 ' H ' HG22 ' A' ' 3' ' ' THR . 15.0 mp0 -108.41 98.99 8.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.156 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.688 HD12 HD21 ' A' ' 56' ' ' LEU . 63.2 mt -88.81 96.05 10.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.252 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -89.88 -57.06 2.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.882 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.4 t -95.38 158.43 15.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' OD2' ' A' ' 63' ' ' ASP . . . -73.32 -29.33 62.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.083 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.4 p -57.75 -31.34 66.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -71.19 -31.32 67.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -76.21 -42.64 45.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -70.13 -50.17 43.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -58.97 -28.64 66.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.542 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -70.13 -64.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.458 HD22 ' CG ' ' A' ' 79' ' ' TYR . 81.9 mt -57.44 -21.87 39.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.17 -79.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.446 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.7 m -83.43 -29.62 27.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.197 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.1 104.3 0.23 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.673 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -86.99 -27.38 23.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 0.0 110.705 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -53.62 -176.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.973 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 4.8 tt -86.11 115.84 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.698 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.577 HG13 ' CD2' ' A' ' 54' ' ' TYR . 56.5 t -102.99 127.2 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.644 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.42 HG23 HD22 ' A' ' 21' ' ' LEU . 46.3 t -120.12 119.61 60.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.368 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.487 HG13 HD12 ' A' ' 56' ' ' LEU . 51.9 t -104.77 124.84 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.482 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -117.21 103.77 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.919 0.39 . . . . 0.0 111.612 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.429 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 75.1 m-85 -93.88 115.28 27.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.948 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.467 ' CD2' ' CG2' ' A' ' 29' ' ' THR . 1.1 p90 -150.19 117.96 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 111.212 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.36 -9.53 58.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.893 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.467 ' CG2' ' CD2' ' A' ' 27' ' ' PHE . 69.4 p 52.73 74.08 0.31 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.361 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.57 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.0 m-90 -80.92 -62.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 43.6 t 158.86 69.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.459 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.4 -121.11 0.78 Allowed Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.927 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.16 -52.1 6.02 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.702 2.268 . . . . 0.0 112.562 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.5 p -79.77 60.87 3.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.727 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -162.99 -47.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.392 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.2 tpt -83.56 -26.79 29.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.53 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.499 HD11 ' HB1' ' A' ' 91' ' ' ALA . 63.1 mt -79.96 -15.69 13.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.204 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.85 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -52.48 -60.08 7.21 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.403 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.85 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 86.2 Cg_exo -46.93 -36.03 19.44 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.369 2.046 . . . . 0.0 112.605 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.416 ' HB3' ' HB3' ' A' ' 93' ' ' PRO . 55.1 mtt -57.5 -76.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.577 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.904 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -60.23 -24.39 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.908 0.385 . . . . 0.0 110.861 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.904 ' N ' HD12 ' A' ' 41' ' ' ILE . 89.4 tt0 -75.53 -26.58 58.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.489 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 6.6 tmtm? -85.7 -48.3 8.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.177 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.603 ' CD1' HD11 ' A' ' 96' ' ' ILE . 7.4 m-85 -46.33 -29.8 1.81 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.214 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.811 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -52.9 -26.32 14.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -90.06 -30.34 17.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.993 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -62.07 -35.68 79.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.326 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.579 ' CE2' HG21 ' A' ' 100' ' ' ILE . 46.7 m-85 -97.13 155.59 16.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 110.761 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -106.61 -21.77 12.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.309 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.878 ' OD1' HG22 ' A' ' 104' ' ' VAL . 2.9 p30 -125.52 35.32 4.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.764 0.316 . . . . 0.0 111.454 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.8 118.16 36.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.282 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.67 95.84 10.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 13.5 m-85 -89.69 123.34 33.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.607 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.58 ' HB3' HD11 ' A' ' 5' ' ' LEU . 14.7 m-30 -115.82 102.81 10.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.806 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.66 ' HE2' HG11 ' A' ' 2' ' ' VAL . 24.4 ttmm -89.83 124.11 34.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.571 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.688 HD21 HD12 ' A' ' 5' ' ' LEU . 86.2 mt -119.36 146.86 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.293 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -134.39 161.42 35.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.548 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.1 m -77.67 156.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.198 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.1 t0 66.03 -72.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.222 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.44 -30.85 61.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.109 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.574 HG11 HD22 ' A' ' 56' ' ' LEU . 47.4 t -139.95 55.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.4 m -80.48 -22.08 41.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 8' ' ' ALA . 12.2 p-10 -47.21 -29.76 2.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.292 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.634 HG11 ' CD1' ' A' ' 56' ' ' LEU . 47.5 t -79.43 -54.85 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.993 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.43 -35.56 19.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.421 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -58.45 -45.24 88.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.765 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -89.51 -65.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.62 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.66 77.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.822 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -50.86 93.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.18 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.0 t -148.83 136.28 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.814 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.3 p -105.21 150.13 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' A' ' 73' ' ' MET . 60.4 p -61.01 -173.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.904 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.683 ' H ' ' HA ' ' A' ' 74' ' ' PRO . 60.3 ttp 167.52 -38.11 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.683 ' HA ' ' H ' ' A' ' 73' ' ' MET . 94.0 Cg_endo -76.57 175.26 48.97 Favored 'Cis proline' 0 C--N 1.36 1.157 0 CA-C-N 120.67 1.275 . . . . 0.0 113.812 0.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.809 ' C ' HD12 ' A' ' 76' ' ' LEU . 56.3 m -127.89 135.82 50.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.764 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.809 HD12 ' C ' ' A' ' 75' ' ' THR . 4.1 mp -129.93 146.18 51.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.906 0.384 . . . . 0.0 111.231 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.533 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 29.2 pt -143.15 159.86 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.812 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.485 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.3 m-85 -129.57 126.87 39.51 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 111.505 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.533 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 67.5 m-85 -109.69 153.62 24.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.752 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -114.89 -38.78 3.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.975 0.417 . . . . 0.0 110.454 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.77 28.44 0.31 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.067 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.1 42.28 2.1 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.278 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -165.31 109.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.674 0.273 . . . . 0.0 111.13 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.04 115.49 3.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.443 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 m -126.34 -43.2 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 64.5 p -112.31 83.41 1.8 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.151 0.5 . . . . 0.0 110.795 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.527 HH21 HG11 ' A' ' 89' ' ' VAL . 16.5 ptm180 -83.09 166.17 18.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.592 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.8 t -156.72 87.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.967 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.722 HG12 HG23 ' A' ' 75' ' ' THR . 34.3 m -108.76 107.7 23.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.16 0.505 . . . . 0.0 111.337 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -169.77 -118.95 0.47 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.19 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . 177.77 56.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.796 0.331 . . . . 0.0 111.133 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -146.28 134.27 10.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.122 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.553 ' O ' HG12 ' A' ' 96' ' ' ILE . 57.1 Cg_endo -73.67 -19.32 21.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.413 2.075 . . . . 0.0 112.158 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.04 62.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.801 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.11 -39.85 12.62 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.511 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.628 HG21 ' CG2' ' A' ' 41' ' ' ILE . 21.2 pt -59.74 -35.38 59.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.888 0.375 . . . . 0.0 110.822 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -55.23 -70.41 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.948 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -59.94 -29.87 68.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.482 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -64.45 -42.81 95.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.064 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.602 HG23 HD13 ' A' ' 21' ' ' LEU . 75.5 mt -82.34 -31.84 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.63 -27.55 65.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.028 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.7 p -58.28 -58.22 9.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.081 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -128.06 54.54 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.878 HG22 ' OD1' ' A' ' 50' ' ' ASP . 10.0 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.035 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.867 0.365 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.6 t -83.63 136.84 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.8 p -105.01 172.17 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.476 0.655 . . . . 0.0 111.764 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -127.16 107.99 10.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.626 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.657 HD12 HD11 ' A' ' 56' ' ' LEU . 80.6 mt -89.16 88.37 7.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.007 0.432 . . . . 0.0 111.362 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.96 -43.55 10.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.198 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.4 t -105.58 137.41 43.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.783 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.633 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . . . -54.15 -25.86 24.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.416 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -59.17 -28.75 66.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.037 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.627 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 43.5 mt-10 -77.92 -26.28 48.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -78.54 -54.3 6.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.127 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -57.32 -59.86 4.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -57.18 -25.52 59.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.279 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.748 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -67.58 -61.91 1.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.792 0.33 . . . . 0.0 111.373 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -53.64 -24.59 14.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.233 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.07 -68.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.309 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.9 m -60.06 -63.51 1.27 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.42 121.9 24.39 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.732 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -124.01 -1.04 8.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -69.29 -76.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.716 0.293 . . . . 0.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 104' ' ' VAL . 3.7 tt -167.5 110.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.563 HG13 ' CE2' ' A' ' 54' ' ' TYR . 60.2 t -102.34 132.6 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.534 HG23 ' CD2' ' A' ' 21' ' ' LEU . 47.8 t -134.37 118.29 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.277 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.773 HG13 HD13 ' A' ' 56' ' ' LEU . 43.5 t -99.98 123.09 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.452 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -110.86 87.81 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.591 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 24' ' ' VAL . 60.6 m-85 -82.14 112.22 18.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.809 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 3.7 p90 -133.32 117.06 16.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.952 0.406 . . . . 0.0 111.324 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -94.43 107.22 19.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.583 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.416 ' HB ' ' CE ' ' A' ' 35' ' ' LYS . 73.8 p -53.7 114.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.1 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.448 ' CD2' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -179.56 42.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -176.54 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.156 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 152.37 -44.51 0.63 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.219 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 82.7 Cg_exo -45.56 -63.62 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.572 2.181 . . . . 0.0 112.746 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 7.7 p -49.48 -45.53 46.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' CE ' ' HB ' ' A' ' 29' ' ' THR . 99.6 mttt -58.5 -36.99 74.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.123 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.2 tpt -73.36 -26.51 61.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 37' ' ' ILE . 40.9 mm -90.37 27.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.361 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.811 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -86.82 -54.98 0.37 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.084 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 40.9 Cg_exo -57.31 -33.12 95.58 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.423 2.082 . . . . 0.0 112.298 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.416 ' CE ' ' HG3' ' A' ' 93' ' ' PRO . 57.4 mtt -60.56 -75.56 0.06 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 0.0 110.485 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.884 HG22 HD12 ' A' ' 96' ' ' ILE . 12.9 pt -51.57 -30.18 10.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.188 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -78.82 -30.71 45.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.463 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 39' ' ' PRO . 87.9 tttt -84.31 -38.26 20.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -48.24 -25.35 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.773 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 53' ' ' PHE . . . -55.27 -32.35 62.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.15 0.5 . . . . 0.0 110.587 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -85.28 -5.1 59.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -90.14 -51.62 5.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.299 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.451 ' CE2' HG13 ' A' ' 100' ' ' ILE . 50.5 m-85 -79.74 172.41 13.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.174 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.2 p -105.56 -29.68 10.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.241 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -148.72 80.17 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.435 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.742 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.44 124.54 36.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.208 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.45 106.79 18.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.041 0.448 . . . . 0.0 110.688 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 51' ' ' ALA . 21.6 m-85 -99.9 119.44 38.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.232 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.748 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 15.1 m-30 -111.24 96.56 6.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.048 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.636 ' C ' HD12 ' A' ' 56' ' ' LEU . 87.7 tttt -89.83 110.55 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.448 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.786 HD23 HG11 ' A' ' 61' ' ' VAL . 3.8 mp -118.78 157.87 26.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 0.0 111.485 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -129.78 162.31 28.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.353 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 28' ' ' ALA . 54.8 t -64.94 -32.47 58.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.432 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -97.82 -62.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.147 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -52.44 -26.06 11.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.15 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.786 HG11 HD23 ' A' ' 56' ' ' LEU . 42.0 t -133.77 60.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.3 t -81.11 0.66 35.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.415 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.633 ' OD1' ' HB2' ' A' ' 8' ' ' ALA . 7.7 t0 -90.04 -49.1 6.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 111.041 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 68' ' ' ALA . 48.2 t -59.58 -51.53 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.18 -29.52 1.6 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.639 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -63.95 -71.32 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.001 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -65.48 -42.6 92.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 64' ' ' VAL . . . -90.04 76.78 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -58.42 100.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.88 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 71' ' ' SER . 48.6 t -141.79 157.38 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.151 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 70' ' ' VAL . 50.7 m -86.91 -173.99 4.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.524 ' C ' ' HA ' ' A' ' 74' ' ' PRO . 81.1 p -167.18 79.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.011 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.685 ' N ' ' HA ' ' A' ' 74' ' ' PRO . 23.2 ptp -115.85 8.05 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.685 ' HA ' ' N ' ' A' ' 73' ' ' MET . 73.0 Cg_endo -83.04 -167.33 5.51 Favored 'Cis proline' 0 C--N 1.361 1.225 0 CA-C-N 121.442 1.551 . . . . 0.0 112.62 -0.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.884 HG23 HG12 ' A' ' 89' ' ' VAL . 96.4 m -140.98 133.93 29.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.977 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.761 HD12 ' C ' ' A' ' 75' ' ' THR . 4.1 mp -124.96 115.51 20.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.842 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.4 pt -109.88 158.68 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.762 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -131.15 131.4 44.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.397 . . . . 0.0 111.217 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.487 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 83.9 m-85 -109.36 141.57 41.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.674 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -122.17 68.01 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 0.0 110.77 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.85 26.75 13.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.207 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.6 53.43 2.27 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.364 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.443 ' NZ ' HG11 ' A' ' 85' ' ' VAL . 26.8 ttpp -176.54 122.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 85' ' ' VAL . 52.1 mt-10 -65.76 138.47 57.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.647 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 84' ' ' GLU . 15.5 m -157.19 -39.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.527 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.656 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 88.0 m -105.73 106.93 17.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.951 0.405 . . . . 0.0 110.116 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.455 ' NH2' HG22 ' A' ' 89' ' ' VAL . 8.7 ptm180 -104.23 149.52 25.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.584 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.52 HG11 ' O ' ' A' ' 95' ' ' ALA . 41.6 t -154.55 81.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.534 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.884 HG12 HG23 ' A' ' 75' ' ' THR . 33.2 m -109.64 111.12 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.21 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -117.57 0.42 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.29 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -178.23 71.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 0.0 111.049 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.682 ' ND2' ' HB3' ' A' ' 94' ' ' ALA . 49.8 t30 -150.93 139.31 12.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.661 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 92' ' ' ASN . 18.9 Cg_exo -65.01 -24.86 59.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.414 2.076 . . . . 0.0 112.275 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.682 ' HB3' ' ND2' ' A' ' 92' ' ' ASN . . . -84.53 -27.19 27.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.925 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.52 ' O ' HG11 ' A' ' 88' ' ' VAL . . . -50.39 -27.61 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.093 0.473 . . . . 0.0 110.213 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.884 HD12 HG22 ' A' ' 41' ' ' ILE . 5.8 tt -90.06 -38.23 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.771 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.436 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -61.81 -57.68 10.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.718 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.44 -13.68 61.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.625 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -84.72 -60.61 2.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.787 0.327 . . . . 0.0 111.535 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.458 HG23 HD13 ' A' ' 21' ' ' LEU . 46.3 mm -47.48 -41.85 7.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.139 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.07 -23.4 46.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.218 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -55.72 -65.43 0.6 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -131.87 65.66 1.57 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.09 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.698 ' HA ' HD12 ' A' ' 21' ' ' LEU . 9.4 p . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.052 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.541 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 8.7 p -63.77 156.92 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.066 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.465 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -118.6 174.29 6.35 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 111.119 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -125.79 105.96 9.34 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.926 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.84 HD11 ' HB3' ' A' ' 54' ' ' TYR . 63.0 mt -88.89 127.47 35.64 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.103 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.712 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 8.8 mmpt? -118.15 -50.42 2.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.759 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.2 t -102.57 159.92 15.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.192 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.73 -29.93 65.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.9 p -56.02 -30.77 62.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.867 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -70.41 -30.62 67.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.766 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.871 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 45.6 t80 -75.37 -46.6 32.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.001 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.26 -50.55 45.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -56.65 -23.26 40.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.488 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.565 ' HB1' ' CE2' ' A' ' 54' ' ' TYR . . . -84.09 -60.24 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.518 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.871 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 86.0 mt -52.06 -25.52 8.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.162 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.64 -55.73 4.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.2 m -90.39 23.3 3.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.396 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.63 149.59 22.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.438 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -156.3 -46.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -58.55 -75.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.852 ' CD2' HG23 ' A' ' 100' ' ' ILE . 28.5 tp -167.47 120.69 0.94 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.808 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.76 HG11 HD23 ' A' ' 15' ' ' LEU . 61.8 t -111.56 124.52 68.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.2 t -128.32 126.22 65.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.584 ' CG2' HD11 ' A' ' 77' ' ' ILE . 57.5 t -112.09 114.0 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.804 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.425 ' OD1' ' HG ' ' A' ' 76' ' ' LEU . 24.3 m-20 -111.42 102.78 11.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.237 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.573 ' CE1' HD12 ' A' ' 56' ' ' LEU . 49.6 m-85 -91.7 107.99 19.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.997 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 2.4 p90 -149.01 121.27 8.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.623 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.713 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -90.26 20.12 4.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.586 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p 49.7 55.84 8.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 111.112 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.713 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.5 m-90 -71.24 -61.74 1.66 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.214 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 43.1 t 164.38 129.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.521 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.81 -122.54 5.38 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.031 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.37 -47.45 5.9 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.56 2.173 . . . . 0.0 112.721 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 26.5 p -52.25 -23.88 6.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.6 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -107.76 -37.56 6.1 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.423 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.3 tpt -76.27 -40.38 51.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 111.351 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 37' ' ' ILE . 59.9 mt -79.0 -1.06 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.661 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.924 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -51.44 -63.3 2.1 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 74.7 Cg_exo -50.28 -35.37 43.5 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.213 1.942 . . . . 0.0 113.237 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' A' ' 93' ' ' PRO . 60.7 mtp -65.49 -69.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.621 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.801 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -56.35 -20.28 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.217 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.801 ' N ' HD12 ' A' ' 41' ' ' ILE . 3.7 mm-40 -86.95 -32.95 19.84 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.1 ttpt -78.27 -44.32 25.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.158 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.19 -32.04 71.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.584 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -54.06 -27.76 34.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.016 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.01 -34.61 16.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.739 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -58.87 -27.83 65.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.073 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CE2' HD12 ' A' ' 100' ' ' ILE . 44.6 m-85 -81.78 155.76 25.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.893 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.5 m -89.24 -32.08 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -151.92 96.87 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.09 112.42 4.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.82 106.93 18.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.172 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 2.1 m-85 -89.91 124.6 34.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.84 ' HB3' HD11 ' A' ' 5' ' ' LEU . 17.8 m-30 -112.43 90.52 3.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.486 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.728 ' NZ ' HD13 ' A' ' 41' ' ' ILE . 68.6 mttm -89.84 156.51 18.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.225 0.536 . . . . 0.0 111.791 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.819 ' CD1' HG11 ' A' ' 64' ' ' VAL . 93.6 mt -151.43 -177.7 6.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.636 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -149.15 133.3 17.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.754 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 58' ' ' VAL . 48.6 t -74.76 60.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.077 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.7 t70 178.82 -63.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.621 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -59.37 -30.13 68.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.426 HG21 HD22 ' A' ' 56' ' ' LEU . 45.0 t -100.78 -58.29 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.048 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 t 68.0 -62.44 0.35 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.423 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -43.71 -61.57 1.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.765 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.819 HG11 ' CD1' ' A' ' 56' ' ' LEU . 58.2 t -57.11 -57.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.808 0.337 . . . . 0.0 111.212 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.99 -31.62 0.95 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.787 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -60.26 -58.64 7.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.876 0.37 . . . . 0.0 110.674 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.549 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.42 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.503 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -65.71 79.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.76 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.25 122.86 9.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.243 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.559 HG13 ' OG1' ' A' ' 75' ' ' THR . 60.7 t -120.08 127.92 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.9 m -134.96 45.14 2.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.6 t -146.36 -163.48 1.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.687 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.9 ptm -171.35 92.67 0.43 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.405 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 69.4 Cg_endo -86.11 -163.52 2.78 Favored 'Cis proline' 0 C--N 1.349 0.6 0 C-N-CA 124.132 -1.195 . . . . 0.0 112.427 0.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.559 ' OG1' HG13 ' A' ' 70' ' ' VAL . 91.9 m -138.98 106.72 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.437 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 76' ' ' LEU . 2.4 mp -118.84 128.58 54.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.302 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 77' ' ' ILE . 2.4 pp -128.57 173.0 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.886 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.658 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 8.2 m-85 -135.0 120.44 19.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.746 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.511 ' CD2' HD13 ' A' ' 77' ' ' ILE . 47.2 m-85 -109.8 137.9 46.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.522 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -106.04 -59.74 1.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 0.0 110.753 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.42 29.52 3.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.141 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.54 35.65 3.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.229 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' NZ ' ' HB3' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -151.88 124.2 8.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 111.142 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.4 tt0 -78.94 98.6 6.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.549 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.75 -37.49 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.684 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.658 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 74.7 m -109.79 110.79 21.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.221 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -122.6 145.07 48.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.593 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.714 ' O ' HG23 ' A' ' 88' ' ' VAL . 30.5 m -139.86 83.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.714 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.568 ' O ' HG23 ' A' ' 89' ' ' VAL . 32.8 m -109.44 66.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.294 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -144.9 17.2 1.97 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.523 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.13 56.45 5.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.349 . . . . 0.0 111.127 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.554 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 5.0 m120 -106.49 101.19 34.36 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.198 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HB3' ' SD ' ' A' ' 40' ' ' MET . 8.3 Cg_exo -71.28 -17.41 30.98 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.726 2.284 . . . . 0.0 112.195 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.77 -43.44 5.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.554 ' HB3' ' CB ' ' A' ' 92' ' ' ASN . . . -50.51 -28.42 8.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.228 0.537 . . . . 0.0 110.186 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.582 ' CD1' HG22 ' A' ' 41' ' ' ILE . 6.6 tt -60.79 -29.34 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.778 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 5.2 tmtm? -55.69 -58.33 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.434 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -72.61 -36.07 68.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.06 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.84 81.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.221 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.852 HG23 ' CD2' ' A' ' 21' ' ' LEU . 63.5 mt -75.04 -37.68 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.133 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.07 -19.17 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.891 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 64.0 m -90.04 -38.55 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 111.581 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.547 ' HB3' HD11 ' A' ' 21' ' ' LEU . 26.8 t-20 -83.66 -39.42 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.428 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.768 ' N ' HD13 ' A' ' 21' ' ' LEU . 11.9 p . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.339 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 46.8 tpp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.896 0.379 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.535 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.9 t -149.43 110.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.817 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 p -89.72 170.75 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.497 0.665 . . . . 0.0 111.658 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.524 ' N ' ' NE2' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -127.97 120.18 27.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.592 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.788 HD11 ' CD2' ' A' ' 54' ' ' TYR . 72.5 mt -88.96 96.21 10.63 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.194 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -89.93 -47.04 8.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.507 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.5 t -104.04 142.33 34.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.79 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.46 -24.69 21.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.299 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.6 p -59.58 -43.9 93.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 36.5 mt-10 -62.87 -25.68 68.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.873 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.505 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 50.9 t80 -90.05 -46.92 8.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.069 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -60.33 -62.94 1.5 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.034 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -55.41 -26.32 41.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.544 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -65.97 -61.3 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.505 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 85.2 mt -54.03 -24.7 18.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.155 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.66 -74.74 0.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.231 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -64.77 -48.12 75.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.054 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.68 102.52 0.17 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.601 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -112.21 -22.69 10.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.616 0.246 . . . . 0.0 111.188 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -54.2 -72.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.131 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.862 HD22 ' CA ' ' A' ' 104' ' ' VAL . 52.4 tp -171.38 106.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.939 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.598 HG13 ' CE2' ' A' ' 54' ' ' TYR . 59.4 t -105.09 127.97 59.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.045 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 77' ' ' ILE . 43.7 t -129.67 133.8 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.868 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.455 HG13 HD13 ' A' ' 56' ' ' LEU . 47.5 t -114.83 122.17 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.209 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -114.5 121.62 44.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.59 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 69.5 m-85 -107.83 127.88 54.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.247 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.449 ' CZ ' ' HE3' ' A' ' 55' ' ' LYS . 2.2 p90 -146.44 114.77 6.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.548 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.95 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -89.4 16.95 6.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.578 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p 49.97 52.94 13.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.94 0.4 . . . . 0.0 111.471 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.95 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.1 m-90 -73.74 -60.94 2.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.981 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.5 t 154.0 134.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.672 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.93 -105.15 3.16 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.681 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 99.2 Cg_exo -43.12 -62.9 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.883 2.389 . . . . 0.0 113.112 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.4 p -70.9 62.99 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.769 0.318 . . . . 0.0 111.062 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.4 tptt 177.89 -56.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.8 ttt -55.37 -71.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.235 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.905 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -90.26 40.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.237 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -80.6 -57.07 0.63 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.875 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 53.2 Cg_exo -55.13 -26.2 49.57 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.222 1.948 . . . . 0.0 112.053 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 63.6 mtt -60.29 -73.39 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.728 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.928 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -57.42 -26.52 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.989 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.928 ' N ' HD12 ' A' ' 41' ' ' ILE . 4.2 tm-20 -77.32 -30.33 54.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.202 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -82.39 -43.01 17.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.05 -29.34 43.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.197 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.636 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.89 -26.72 26.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.034 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -90.02 -29.31 18.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.797 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -66.05 -14.74 62.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.543 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.686 ' CE2' HD13 ' A' ' 100' ' ' ILE . 43.9 m-85 -92.27 161.96 14.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.772 0.32 . . . . 0.0 111.029 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -78.38 -43.67 26.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -155.69 106.28 2.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.118 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.18 127.56 16.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.856 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.69 102.27 14.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.636 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 7.0 m-85 -92.61 116.13 28.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.037 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.788 ' CD2' HD11 ' A' ' 5' ' ' LEU . 12.3 m-30 -106.55 90.94 3.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.172 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.5 ' C ' HD12 ' A' ' 56' ' ' LEU . 63.5 tttp -89.79 106.69 18.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.161 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.649 HD23 HG11 ' A' ' 61' ' ' VAL . 4.1 mp -110.34 141.03 43.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.803 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -80.7 -80.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 p 178.31 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.962 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -103.77 -33.63 8.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.773 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.11 -30.03 67.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 5' ' ' LEU . 48.9 t -100.82 -65.83 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.03 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.1 t 68.42 -64.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.236 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -46.91 -61.0 2.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.411 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.627 ' HB ' HG11 ' A' ' 61' ' ' VAL . 53.5 t -55.75 -56.29 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.172 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.87 -31.45 28.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.315 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -70.9 -28.74 64.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 44.1 mtmt -86.26 -78.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.402 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.92 81.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.267 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.28 143.72 57.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.809 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 75' ' ' THR . 28.6 m -156.31 144.79 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.4 p -124.24 68.23 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.984 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.4 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 60.7 m -144.23 176.36 9.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.472 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 67.9 mtm -157.18 96.97 2.06 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 33' ' ' PRO . 90.9 Cg_endo -79.89 -161.88 2.81 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.947 -1.272 . . . . 0.0 112.273 -0.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.688 ' C ' HD12 ' A' ' 76' ' ' LEU . 91.3 m -140.32 112.88 7.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.652 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 75' ' ' THR . 4.0 mp -120.09 142.85 48.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.556 ' O ' HG13 ' A' ' 23' ' ' VAL . 26.0 pt -139.24 162.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.442 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.3 m-85 -132.28 127.52 35.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.95 0.405 . . . . 0.0 111.329 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.439 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 60.1 m-85 -109.93 140.03 44.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.696 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -110.5 -31.96 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.837 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.97 27.75 0.35 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.2 33.96 6.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.373 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -154.32 102.04 2.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.328 . . . . 0.0 110.781 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 39.5 tt0 -53.64 97.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.078 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 83' ' ' LYS . 26.9 m -110.77 -31.21 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.322 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 94.6 m -116.29 101.02 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.234 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -108.68 146.91 32.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.057 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.3 t -136.55 80.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.757 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 89' ' ' VAL . 35.0 m -109.95 103.88 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.232 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.02 -109.45 0.22 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.395 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.16 81.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.31 . . . . 0.0 110.904 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 24.8 t-20 -160.09 112.72 1.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.746 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.411 ' O ' HG22 ' A' ' 96' ' ' ILE . 63.9 Cg_exo -52.26 -22.72 16.2 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.629 2.219 . . . . 0.0 112.734 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.438 ' HB3' ' OD1' ' A' ' 92' ' ' ASN . . . -90.56 -30.46 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 92' ' ' ASN . . . -50.98 -27.28 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.019 0.438 . . . . 0.0 110.402 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.813 HG21 HG22 ' A' ' 41' ' ' ILE . 6.1 tt -82.65 -35.13 12.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.832 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -69.43 -62.81 1.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.003 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -59.32 -20.3 53.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.349 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -90.11 -40.68 12.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.57 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.816 HG13 HD21 ' A' ' 21' ' ' LEU . 12.0 tt -75.61 -28.05 19.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.743 0.306 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.05 89.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.384 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.8 m -73.22 -24.05 60.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.289 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.63 ' HB3' HD13 ' A' ' 21' ' ' LEU . 5.6 m120 -92.58 -61.78 1.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.862 ' CA ' HD22 ' A' ' 21' ' ' LEU . 11.2 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.886 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.895 0.378 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.843 HG21 ' OE1' ' A' ' 42' ' ' GLU . 55.4 t -63.86 106.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 p -98.96 177.17 5.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.54 0.686 . . . . 0.0 111.73 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -130.52 107.46 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.674 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.805 HD23 ' HB2' ' A' ' 11' ' ' TYR . 3.6 mp -89.18 101.21 13.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.078 0.466 . . . . 0.0 111.462 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -89.91 -37.6 14.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.871 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.6 t -111.77 141.09 45.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.06 -23.7 14.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.403 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.5 p -59.74 -45.22 92.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.115 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.763 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 72.0 mt-10 -61.67 -26.02 67.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.805 ' HB2' HD23 ' A' ' 5' ' ' LEU . 48.9 t80 -90.07 -49.47 6.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.071 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -57.1 -67.06 0.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 t -56.09 -24.35 39.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.099 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.836 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -63.21 -57.22 11.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.226 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.434 HD22 ' CG ' ' A' ' 79' ' ' TYR . 83.6 mt -56.2 -26.98 52.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.98 -29.94 18.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.252 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -87.36 -60.51 1.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.038 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.99 114.42 4.54 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.653 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -112.32 -30.18 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.738 0.304 . . . . 0.0 110.924 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -59.17 -76.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.942 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.633 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 25.9 tp -156.28 116.66 3.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.983 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 59.2 t -107.93 135.37 46.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.56 143.99 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.006 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.596 ' CG1' HD12 ' A' ' 56' ' ' LEU . 48.9 t -135.03 112.45 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.91 129.82 48.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.479 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 58.2 m-85 -114.64 134.6 54.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.356 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.469 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 1.8 p90 -150.72 113.36 4.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.549 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.767 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -87.97 23.31 2.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.566 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 79.9 p 49.65 49.33 20.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.852 0.358 . . . . 0.0 111.428 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.767 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.5 m-90 -67.96 -60.46 2.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.6 t -163.87 -104.97 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.685 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -101.1 -34.64 4.49 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.619 -0.8 . . . . 0.0 114.69 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 76.1 Cg_exo -41.95 -32.13 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.311 2.007 . . . . 0.0 113.27 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 26.1 p -97.19 -42.15 7.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.389 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -81.67 0.39 38.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 32' ' ' GLY . 16.2 tpt -90.24 -55.34 3.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.858 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.849 HD11 ' HG2' ' A' ' 74' ' ' PRO . 31.9 pt -90.28 36.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.511 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.809 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -75.98 -54.85 2.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.906 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.809 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 41.9 Cg_exo -56.7 -29.46 80.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.328 2.019 . . . . 0.0 111.993 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.586 ' SD ' HG22 ' A' ' 37' ' ' ILE . 59.2 mtt -59.42 -75.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.67 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.958 HG22 HD12 ' A' ' 96' ' ' ILE . 2.4 pp -62.19 -23.42 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.126 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.894 ' N ' HD12 ' A' ' 41' ' ' ILE . 5.4 tp10 -77.95 -27.69 49.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.595 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -87.69 -42.42 12.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -48.03 -27.57 2.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.467 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.36 -30.01 17.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.603 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -89.97 -31.34 17.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.082 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -63.01 -31.5 72.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.805 ' CZ ' HG21 ' A' ' 100' ' ' ILE . 42.7 m-85 -100.58 146.67 26.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.094 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.2 m -85.94 -32.12 21.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.7 p-10 -134.16 85.17 2.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.555 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -134.82 118.43 16.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.749 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.87 105.25 17.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.275 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.555 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 7.4 m-85 -102.25 128.62 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.557 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.836 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 18.0 m-30 -113.37 112.26 23.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.442 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.469 ' HE3' ' CE1' ' A' ' 27' ' ' PHE . 52.9 tptt -89.78 112.1 23.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.471 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.596 HD12 ' CG1' ' A' ' 24' ' ' VAL . 90.4 mt -123.46 150.45 43.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 111.655 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -132.75 150.16 52.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.177 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.68 81.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.574 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -179.97 -92.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.728 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.723 ' HG2' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -57.8 -27.28 62.97 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.784 0.326 . . . . 0.0 110.666 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.723 HG23 ' HG2' ' A' ' 60' ' ' GLU . 32.5 t -112.8 35.04 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 t -51.39 -24.97 5.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -50.87 -55.28 17.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.312 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.579 HG11 HD13 ' A' ' 56' ' ' LEU . 47.2 t -66.77 -59.31 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.07 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.97 -28.25 2.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.514 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -58.44 -55.48 34.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -73.96 -33.64 63.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.52 64.62 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.02 112.68 4.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.634 HG21 HG21 ' A' ' 75' ' ' THR . 35.6 m -134.45 -178.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.6 m -157.41 80.61 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.6 p -173.22 179.0 2.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.462 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 58.9 mtm -152.51 102.29 2.74 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.686 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.849 ' HG2' HD11 ' A' ' 37' ' ' ILE . 1.8 Cg_endo -81.86 -158.38 1.67 Allowed 'Cis proline' 0 C--N 1.348 0.534 0 C-N-CA 124.405 -1.081 . . . . 0.0 112.361 0.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.787 ' HA ' HG12 ' A' ' 89' ' ' VAL . 88.8 m -145.85 96.86 2.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.418 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 76' ' ' LEU . 4.1 mp -109.66 140.57 43.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.004 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.521 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 22.6 pt -133.87 162.08 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.412 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.761 ' HE2' HD13 ' A' ' 100' ' ' ILE . 4.3 m-85 -127.16 125.2 40.74 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.111 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 63.3 m-85 -109.49 164.49 12.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.938 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -168.69 60.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.071 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.72 40.59 0.71 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.026 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.0 34.45 83.49 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.872 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -148.76 117.15 6.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.827 0.346 . . . . 0.0 111.118 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.3 tt0 -73.73 144.67 45.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.679 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 86' ' ' THR . 34.7 m -151.7 -46.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.701 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.678 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 96.5 m -104.4 116.44 32.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.11 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -123.98 127.9 48.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.311 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.704 ' O ' HG23 ' A' ' 88' ' ' VAL . 32.2 m -118.98 84.69 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.163 0.506 . . . . 0.0 110.495 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 75' ' ' THR . 34.8 m -109.14 99.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.394 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -170.1 -109.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.529 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 90' ' ' GLY . . . 178.48 78.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.327 . . . . 0.0 111.176 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -155.02 128.43 4.39 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.71 -13.53 24.52 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.509 2.139 . . . . 0.0 112.753 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.09 -48.59 4.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.181 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.5 -30.29 3.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.234 0.54 . . . . 0.0 110.188 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.958 HD12 HG22 ' A' ' 41' ' ' ILE . 6.0 tt -66.63 -50.58 65.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.177 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.42 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -53.35 -54.16 40.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.369 . . . . 0.0 110.684 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.405 ' NE2' ' CE ' ' A' ' 97' ' ' LYS . 99.2 mm-40 -49.22 -26.53 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.523 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.57 -27.51 22.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.597 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.805 HG21 ' CZ ' ' A' ' 48' ' ' TYR . 48.1 mm -68.23 -59.28 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.373 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . . . -61.86 -14.99 38.82 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.3 m -81.26 -29.5 34.37 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.556 ' C ' HD13 ' A' ' 21' ' ' LEU . 36.8 m-80 -122.25 -9.42 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 104' ' ' VAL . 10.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.467 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.453 ' N ' ' HB1' ' A' ' 45' ' ' ALA . 26.5 mmt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.83 0.348 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.638 HG11 ' NZ ' ' A' ' 55' ' ' LYS . 47.2 t -57.69 137.17 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 m -111.28 151.21 28.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.932 0.396 . . . . 0.0 110.955 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -91.55 97.99 11.39 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 5' ' ' LEU . 4.9 mp -88.93 134.89 33.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.0 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -126.1 -64.78 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.5 t -91.44 148.47 22.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.065 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.74 69.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 m -56.88 -33.47 66.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.677 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 50.3 mt-10 -74.73 -25.17 58.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -82.29 -61.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.391 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -55.57 -58.58 7.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.46 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.0 t -56.79 -28.32 61.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.332 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . -66.26 -33.58 76.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 0.0 111.338 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.459 HD22 ' CG ' ' A' ' 79' ' ' TYR . 85.6 mt -62.06 -44.14 97.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.083 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.1 -28.95 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.509 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 t -56.64 -78.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.212 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.96 136.16 13.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.627 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -85.9 -6.8 59.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.675 0.274 . . . . 0.0 111.252 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -54.7 -175.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.807 0.337 . . . . 0.0 110.962 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.441 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 27.1 tp -79.25 107.56 12.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.817 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 49.1 t -99.79 127.97 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.698 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.621 HG22 ' CD2' ' A' ' 78' ' ' PHE . 48.9 t -137.02 133.75 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.552 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.713 HG11 ' CE2' ' A' ' 26' ' ' PHE . 40.6 t -103.24 160.4 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.255 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.504 ' N ' HG12 ' A' ' 24' ' ' VAL . 38.3 t70 -137.53 89.57 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.713 ' CE2' HG11 ' A' ' 24' ' ' VAL . 61.2 m-85 -96.36 111.17 23.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.607 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 0.5 OUTLIER -138.64 -44.99 0.49 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HB2' ' H ' ' A' ' 58' ' ' VAL . . . 61.87 87.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 110.867 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.406 HG21 ' NZ ' ' A' ' 35' ' ' LYS . 65.9 p -57.69 115.1 2.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.824 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.596 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.1 m-90 -101.61 -59.3 1.72 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 52.4 t 160.3 46.11 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.97 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.59 -118.08 0.42 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.783 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 35' ' ' LYS . 75.4 Cg_exo -49.73 -69.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.495 2.13 . . . . 0.0 112.336 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 10.2 p -61.26 75.85 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.375 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 33' ' ' PRO . 17.3 tppt? 175.72 -42.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.851 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.8 ttm -67.77 -49.01 64.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.224 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.554 HD12 ' C ' ' A' ' 37' ' ' ILE . 2.0 pp -90.22 25.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.001 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.795 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -78.44 -54.18 1.21 Allowed Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.627 0.251 . . . . 0.0 111.036 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 51.7 Cg_exo -55.12 -36.69 93.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.529 2.153 . . . . 0.0 112.226 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.417 ' SD ' HG22 ' A' ' 37' ' ' ILE . 60.6 mtt -54.16 -75.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.545 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.05 HG22 HG21 ' A' ' 96' ' ' ILE . 10.6 pt -51.15 -43.62 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.307 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.549 ' HG3' HG21 ' A' ' 2' ' ' VAL . 39.2 tt0 -64.05 -33.18 75.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.772 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -77.05 -45.91 25.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.572 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.691 ' CG ' HD11 ' A' ' 96' ' ' ILE . 6.9 m-85 -56.03 -32.24 63.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.039 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HB1' ' N ' ' A' ' 1' ' ' MET . . . -50.29 -27.8 6.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.329 0.585 . . . . 0.0 109.723 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -77.93 -38.78 44.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.746 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -58.02 -38.04 75.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.519 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.657 ' CE2' HG21 ' A' ' 100' ' ' ILE . 32.4 m-85 -75.58 170.53 15.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.37 . . . . 0.0 110.925 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.8 m -116.55 -19.77 9.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.495 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -145.24 47.71 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.802 0.334 . . . . 0.0 111.465 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.6 119.16 38.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.553 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.73 96.46 10.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 110.881 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.51 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 6.5 m-85 -90.37 126.15 35.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.882 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.551 ' CG ' HD21 ' A' ' 5' ' ' LEU . 18.8 m-30 -121.78 107.6 12.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.376 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.638 ' NZ ' HG11 ' A' ' 2' ' ' VAL . 4.9 ttmp? -89.78 120.02 30.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.935 0.398 . . . . 0.0 111.173 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.035 HD22 HG11 ' A' ' 61' ' ' VAL . 98.4 mt -138.01 135.68 36.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.812 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -112.64 -178.06 3.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.662 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.85 HG21 ' CE ' ' A' ' 73' ' ' MET . 46.0 t -107.26 65.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 111.099 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -178.35 -60.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.357 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -75.76 -23.6 55.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.035 HG11 HD22 ' A' ' 56' ' ' LEU . 30.5 t -124.81 40.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.791 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 t -53.76 -26.21 22.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.267 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.95 -50.83 72.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.027 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.522 HG11 HD13 ' A' ' 56' ' ' LEU . 43.7 t -72.24 -55.33 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.83 -28.88 2.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.444 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -60.83 -46.73 89.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.846 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -81.77 -47.29 13.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.771 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.11 79.45 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.58 114.86 5.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.934 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.874 ' HB ' HG21 ' A' ' 75' ' ' THR . 35.4 m -135.63 125.26 41.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.113 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.2 t -112.32 92.98 4.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.986 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -177.76 -74.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.705 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.85 ' CE ' HG21 ' A' ' 58' ' ' VAL . 61.7 mtt 57.67 102.45 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.734 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.48 167.77 31.68 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.833 0.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.874 HG21 ' HB ' ' A' ' 70' ' ' VAL . 71.6 m -154.87 132.41 11.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.355 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.825 HD12 ' C ' ' A' ' 75' ' ' THR . 4.1 mp -131.16 136.55 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 111.667 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.472 HD12 ' OH ' ' A' ' 79' ' ' TYR . 28.2 pt -133.13 150.68 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.977 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.621 ' CD2' HG22 ' A' ' 23' ' ' VAL . 1.1 m-85 -125.94 132.47 52.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.093 0.473 . . . . 0.0 111.267 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.472 ' OH ' HD12 ' A' ' 77' ' ' ILE . 84.1 m-85 -109.51 114.35 27.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.151 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -72.18 -75.26 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.799 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.59 33.68 3.87 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.023 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.52 27.42 4.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.176 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -158.24 150.29 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.464 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 91.5 mt-10 -82.39 97.02 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.14 -27.09 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.291 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 97.7 m -117.21 103.4 10.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.942 0.401 . . . . 0.0 110.069 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -103.29 155.24 18.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.363 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t -155.5 80.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.614 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.574 ' O ' HG23 ' A' ' 89' ' ' VAL . 34.1 m -109.55 112.38 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.994 0.426 . . . . 0.0 111.279 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.59 -116.42 0.37 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.36 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -176.51 40.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.81 0.338 . . . . 0.0 111.074 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -130.43 134.08 25.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.528 ' O ' HG12 ' A' ' 96' ' ' ILE . 34.0 Cg_endo -66.62 -56.24 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.361 2.04 . . . . 0.0 112.655 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -40.65 -31.97 0.19 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.21 -22.86 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.591 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.05 HG21 HG22 ' A' ' 41' ' ' ILE . 9.2 pt -76.35 -35.35 27.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.922 0.391 . . . . 0.0 110.929 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -56.1 -68.79 0.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.359 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.49 -34.57 77.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.624 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.98 -43.12 68.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.818 0.342 . . . . 0.0 111.454 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.657 HG21 ' CE2' ' A' ' 48' ' ' TYR . 74.2 mt -84.76 -18.82 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.472 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -90.21 -23.37 21.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.752 0.31 . . . . 0.0 111.569 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.4 m -89.99 -65.75 0.99 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.83 0.348 . . . . 0.0 111.482 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.64 -29.18 16.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.456 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 101' ' ' ALA . 8.6 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.287 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtm . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.775 0.322 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.511 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 13.7 p -54.42 144.1 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -124.14 159.23 30.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.063 0.459 . . . . 0.0 110.933 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -102.0 100.0 10.22 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 5' ' ' LEU . 5.5 mp -88.83 109.36 20.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.806 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -96.25 -66.37 0.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -85.04 150.92 24.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.301 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.74 -28.68 70.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.095 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.1 t -55.88 -35.84 66.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 46.4 mt-10 -65.36 -40.9 94.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.516 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -67.76 -55.76 11.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.929 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.58 -56.3 23.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.9 t -57.03 -29.1 63.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . -64.92 -61.05 2.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.479 HD21 ' CD2' ' A' ' 79' ' ' TYR . 79.6 mt -59.51 -26.72 65.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.004 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.03 -70.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.225 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -74.78 -27.25 60.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.87 169.66 1.66 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.691 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -177.36 -37.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 111.075 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -51.84 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.758 HD13 HG23 ' A' ' 100' ' ' ILE . 4.9 tt -172.73 108.24 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.753 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.657 HG13 ' CE2' ' A' ' 54' ' ' TYR . 60.6 t -100.79 132.06 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.688 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' A' ' 21' ' ' LEU . 46.6 t -125.6 122.24 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.384 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.586 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 49.4 t -105.19 129.92 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.53 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -116.74 106.67 13.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.022 0.439 . . . . 0.0 111.488 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.586 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 77.4 m-85 -99.24 101.29 12.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.226 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.446 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 4.5 p90 -127.22 105.96 8.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.499 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -96.14 73.67 2.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.444 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.452 ' C ' ' O ' ' A' ' 28' ' ' ALA . 68.3 p -23.91 105.72 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.527 ' CZ3' ' HB2' ' A' ' 73' ' ' MET . 3.2 m-90 -113.63 -54.75 2.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.2 m -123.15 -2.15 8.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.109 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.651 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 88.4 23.33 37.41 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.769 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 62.3 Cg_endo -75.53 -50.62 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.87 1.713 . . . . 0.0 111.941 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 27' ' ' PHE . 56.8 m -63.82 -37.37 87.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -64.19 -26.96 68.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.19 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 57.4 ttp -58.47 -62.0 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.0 110.988 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.3 pt -90.35 31.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.707 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.9 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -78.93 -59.38 0.64 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.122 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.9 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 65.0 Cg_exo -52.07 -35.15 60.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.335 2.023 . . . . 0.0 112.298 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.551 ' HE2' ' HB2' ' A' ' 93' ' ' PRO . 66.0 mtp -57.27 -74.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.668 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.841 ' CG2' HG21 ' A' ' 96' ' ' ILE . 6.4 pt -48.52 -42.07 12.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.76 0.314 . . . . 0.0 111.211 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -67.07 -33.75 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.487 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -73.83 -44.75 54.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.111 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 96' ' ' ILE . 7.3 m-85 -55.77 -27.48 51.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.777 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.55 -29.37 50.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.75 -30.46 23.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.589 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -64.69 -25.81 68.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.24 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -79.6 176.28 9.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.861 0.363 . . . . 0.0 110.941 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.8 m -97.89 -36.67 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.788 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -149.84 90.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -134.61 129.31 34.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.837 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -101.53 93.27 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.228 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.511 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 7.4 m-85 -90.08 131.26 36.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.31 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.657 ' CE2' HG13 ' A' ' 22' ' ' VAL . 20.0 m-30 -119.37 129.83 55.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.856 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.483 ' O ' HD23 ' A' ' 56' ' ' LEU . 87.3 tttt -103.5 145.28 30.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.68 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.661 HD11 HG11 ' A' ' 64' ' ' VAL . 88.1 mt -143.73 140.0 29.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.37 -175.72 3.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.94 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.7 t -82.93 151.73 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 7.4 t70 63.36 132.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 39.2 tt0 73.63 -54.77 0.68 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.151 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 61' ' ' VAL . 36.6 t -95.03 2.29 9.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.536 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.1 m -63.81 -30.23 71.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.782 0.325 . . . . 0.0 111.005 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -51.41 -25.85 6.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.4 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.661 HG11 HD11 ' A' ' 56' ' ' LEU . 36.2 t -68.7 -54.61 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.047 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.99 70.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.21 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -56.45 -67.65 0.28 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.986 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -57.59 -37.72 73.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -90.01 78.04 6.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.822 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -53.5 102.2 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.971 HG11 HG21 ' A' ' 75' ' ' THR . 44.5 t -138.94 152.51 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.996 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.3 p -143.82 116.14 8.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.54 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.482 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 41.2 t 179.32 -163.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.222 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.527 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 18.3 ptm 178.41 93.76 0.15 Allowed Pre-proline 0 N--CA 1.463 0.187 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 73.0 Cg_endo -75.85 -161.61 2.61 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.354 -0.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.971 HG21 HG11 ' A' ' 70' ' ' VAL . 19.1 m -146.66 115.82 6.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.05 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.806 HD12 ' C ' ' A' ' 75' ' ' THR . 5.2 mp -126.58 115.7 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.935 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.409 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 28.6 pt -116.03 164.98 11.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.669 ' HE1' HG22 ' A' ' 88' ' ' VAL . 4.0 m-85 -133.86 131.03 38.71 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.038 0.447 . . . . 0.0 111.403 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.479 ' CD2' HD21 ' A' ' 15' ' ' LEU . 75.0 m-85 -109.89 152.33 25.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.625 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -116.15 -38.08 3.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.811 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.71 31.87 0.22 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.282 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.99 37.45 2.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.281 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -161.48 118.7 2.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -73.64 110.57 8.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.312 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.9 -37.46 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.452 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 72.3 m -107.14 111.67 24.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.798 0.332 . . . . 0.0 110.322 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -125.42 152.21 45.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.186 0.517 . . . . 0.0 111.556 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.717 ' O ' HG23 ' A' ' 88' ' ' VAL . 28.5 m -138.67 88.29 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.219 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 89' ' ' VAL . 31.1 m -109.25 94.45 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.333 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.87 -112.77 0.62 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.206 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.09 55.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.861 0.362 . . . . 0.0 111.125 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -144.85 126.37 7.83 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.195 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.551 ' HB2' ' HE2' ' A' ' 40' ' ' MET . 81.4 Cg_endo -79.21 2.62 8.16 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.663 2.242 . . . . 0.0 112.64 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.32 -39.48 10.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.008 0.432 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.14 -30.33 70.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.681 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.841 HG21 ' CG2' ' A' ' 41' ' ' ILE . 2.2 pp -57.43 -32.91 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.827 ' N ' HD12 ' A' ' 96' ' ' ILE . 50.0 tttm -54.27 -69.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.731 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -62.55 -21.64 65.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.623 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -59.66 -54.03 51.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.758 HG23 HD13 ' A' ' 21' ' ' LEU . 2.0 mp -75.51 -35.62 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.576 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.26 68.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.308 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.8 m -57.02 -74.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.12 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.44 ' O ' HD12 ' A' ' 21' ' ' LEU . 16.0 p-10 -105.15 62.03 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.993 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.556 HG13 ' OXT' ' A' ' 104' ' ' VAL . 9.5 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.509 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 10.8 mmt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.8 0.333 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.552 HG13 ' HE2' ' A' ' 55' ' ' LYS . 56.7 t -50.49 111.09 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.926 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.426 ' HB ' HD11 ' A' ' 5' ' ' LEU . 1.1 m -103.47 160.38 14.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 111.241 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -104.65 94.45 5.31 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 5' ' ' LEU . 5.2 mp -88.96 132.32 34.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -130.13 -64.15 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -77.71 143.08 38.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.105 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.75 -29.26 70.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.8 p -55.51 -30.64 61.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 90.9 mt-10 -77.41 -38.26 50.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.606 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 48.7 t80 -72.21 -42.44 65.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.032 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -58.22 -68.17 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.061 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.5 p -55.66 -26.08 42.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HB1' ' HE2' ' A' ' 54' ' ' TYR . . . -59.04 -53.07 62.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.243 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.442 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 84.7 mt -69.35 -30.83 68.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.7 -54.55 15.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.212 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -90.36 24.64 2.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.457 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.12 142.45 16.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.449 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -151.48 -46.6 0.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.635 0.255 . . . . 0.0 110.832 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -57.05 -76.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.803 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.667 HD22 ' N ' ' A' ' 104' ' ' VAL . 41.7 tp -177.23 109.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.136 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' A' ' 54' ' ' TYR . 48.1 t -103.86 117.23 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.744 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.47 122.94 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 61.1 t -109.05 126.24 66.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.402 ' OD1' ' HG ' ' A' ' 76' ' ' LEU . 23.9 m-20 -122.54 107.0 11.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.526 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.513 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 52.6 m-85 -93.34 98.86 11.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.355 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.3 p90 -134.24 121.86 21.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.245 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.16 21.95 3.01 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.7 p 46.88 73.25 0.19 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.856 0.36 . . . . 0.0 110.986 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.538 ' CH2' ' HB2' ' A' ' 73' ' ' MET . 0.0 OUTLIER -146.96 62.26 1.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.153 0.501 . . . . 0.0 112.334 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.1 t 60.29 155.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.508 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.71 178.57 20.12 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.636 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 6.1 Cg_endo -49.63 -22.6 6.85 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.866 2.377 . . . . 0.0 112.548 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.5 p -51.86 -39.99 59.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.877 0.37 . . . . 0.0 111.077 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -87.28 -32.07 19.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.033 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.25 -41.16 70.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.018 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 37' ' ' ILE . 48.8 mt -90.43 21.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.481 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -73.1 -58.21 2.6 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 121.239 -0.184 . . . . 0.0 111.106 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 36.3 Cg_exo -58.28 -35.74 98.4 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.343 2.029 . . . . 0.0 112.002 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.459 ' SD ' HG23 ' A' ' 37' ' ' ILE . 62.5 mtt -54.4 -76.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.4 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.925 HG22 HD12 ' A' ' 96' ' ' ILE . 12.6 pt -49.9 -43.34 19.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.286 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' N ' HG13 ' A' ' 41' ' ' ILE . 39.6 tt0 -63.9 -31.78 73.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.771 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 6.2 ttpm? -84.55 -55.21 4.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.636 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.437 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 11.5 m-85 -49.92 -28.11 6.23 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.851 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.25 -28.15 39.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.037 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -89.7 -33.61 16.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.983 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.27 -27.05 68.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.271 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.736 ' CE2' HG21 ' A' ' 100' ' ' ILE . 44.4 m-85 -82.95 157.05 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 111.014 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -82.12 -37.22 26.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.686 ' O ' HG23 ' A' ' 104' ' ' VAL . 40.8 p-10 -154.5 101.86 2.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.974 0.416 . . . . 0.0 111.149 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.48 124.1 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.973 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.98 106.22 18.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.289 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.429 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 7.1 m-85 -92.52 112.17 24.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.224 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.611 ' HE2' ' HB1' ' A' ' 14' ' ' ALA . 16.7 m-30 -114.73 102.48 10.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.824 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HE2' HG13 ' A' ' 2' ' ' VAL . 68.1 mttm -89.87 130.55 36.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.007 HD13 HG11 ' A' ' 64' ' ' VAL . 90.2 mt -130.63 149.58 52.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.861 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -120.75 159.29 25.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.99 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 59' ' ' ASP . 48.5 t -104.61 160.09 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.502 ' N ' HG12 ' A' ' 58' ' ' VAL . 8.1 t0 69.23 -63.07 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -60.96 -29.7 69.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.626 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 64' ' ' VAL . 47.3 t -98.97 -57.23 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.767 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.4 t 68.18 -62.77 0.35 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.481 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.96 -47.54 8.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.643 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.007 HG11 HD13 ' A' ' 56' ' ' LEU . 40.7 t -78.01 -61.88 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.055 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.32 -30.35 0.81 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.375 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -57.3 -55.27 36.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.725 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -65.86 -63.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.55 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 26' ' ' PHE . . . -75.49 76.79 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -49.65 119.1 3.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.255 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.431 HG13 ' OG1' ' A' ' 75' ' ' THR . 41.7 t -90.33 137.35 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.856 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.0 t -143.16 48.58 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 111.359 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.1 p -179.31 178.2 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.584 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.538 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 20.7 ptt? -150.09 100.25 3.23 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.582 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HD3' ' HG2' ' A' ' 33' ' ' PRO . 95.5 Cg_endo -78.24 -163.58 3.47 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.931 -1.279 . . . . 0.0 112.388 -0.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 32.5 m -143.47 97.17 3.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.988 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 76' ' ' LEU . 2.4 mp -109.87 135.66 50.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.006 0.431 . . . . 0.0 111.656 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.564 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 25.5 pt -132.35 166.18 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.478 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.535 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.3 m-85 -131.52 125.93 33.63 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 111.679 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.564 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 60.8 m-85 -111.56 153.64 25.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.366 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -127.83 -58.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.704 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.75 -14.16 8.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.476 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.97 41.58 0.12 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.261 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.748 ' HG2' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -162.29 127.71 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.965 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 88.7 tt0 -69.63 95.96 0.9 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.746 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.748 HG13 ' HG2' ' A' ' 83' ' ' LYS . 34.7 m -109.88 -32.92 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.156 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 98.9 m -113.02 103.39 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 110.091 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -106.43 159.66 15.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.574 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.582 ' CG1' ' HB1' ' A' ' 95' ' ' ALA . 44.1 t -155.57 83.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.389 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 89' ' ' VAL . 28.1 m -109.22 77.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.199 0.523 . . . . 0.0 111.264 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -143.73 -112.15 0.83 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.067 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 33' ' ' PRO . . . 171.57 93.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.629 0.252 . . . . 0.0 110.86 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.762 ' ND2' ' HB3' ' A' ' 94' ' ' ALA . 49.1 t30 -173.5 131.59 0.57 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.968 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.99 -20.29 22.64 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.634 2.223 . . . . 0.0 112.812 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.762 ' HB3' ' ND2' ' A' ' 92' ' ' ASN . . . -86.55 -35.32 19.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.57 0.224 . . . . 0.0 111.228 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -49.07 -28.86 4.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.157 0.504 . . . . 0.0 110.049 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.925 HD12 HG22 ' A' ' 41' ' ' ILE . 6.3 tt -90.03 -37.97 10.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.427 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.0 -71.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.975 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -56.68 -22.95 38.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.041 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -77.21 -67.3 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.123 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.736 HG21 ' CE2' ' A' ' 48' ' ' TYR . 37.1 mm -51.99 -35.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.18 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -56.7 -71.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 111.683 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.3 m -61.22 -24.75 66.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.602 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.551 ' HB3' HD13 ' A' ' 21' ' ' LEU . 5.7 m120 -80.63 -62.47 1.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 50' ' ' ASP . 13.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.763 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.6 mtp . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.794 0.33 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.5 t 60.05 116.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.048 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.4 m -93.81 169.25 10.44 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.146 0.498 . . . . 0.0 110.84 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.464 ' H ' HG22 ' A' ' 3' ' ' THR . 14.3 mp0 -110.12 91.45 3.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.186 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 5' ' ' LEU . 6.6 mp -88.97 136.21 33.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.024 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -130.32 -58.22 1.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.5 t -96.74 142.5 28.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.053 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.83 -27.35 65.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.181 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 t -56.61 -38.07 71.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.31 -36.04 80.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.572 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 49.1 t80 -66.8 -47.68 71.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.972 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -58.45 -60.17 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -57.23 -24.63 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.722 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -70.93 -40.56 72.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.284 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.572 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 83.9 mt -90.17 15.04 11.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.576 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.11 -90.57 0.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.752 -0.203 . . . . 0.0 111.038 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.8 p -90.4 19.14 5.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.625 0.25 . . . . 0.0 111.374 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 19' ' ' ASP . . . -70.2 -74.45 0.67 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.716 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 1.4 m-20 79.77 -41.81 0.24 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.589 0.355 . . . . 0.0 111.365 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -54.03 -174.48 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 21' ' ' LEU . 7.5 tt -77.39 99.06 5.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.979 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' A' ' 54' ' ' TYR . 60.8 t -105.58 111.94 36.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.101 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.826 HG13 ' O ' ' A' ' 77' ' ' ILE . 46.8 t -119.32 139.58 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.808 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.546 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 55.2 t -113.51 128.96 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.497 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 36.5 t70 -112.29 101.51 9.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.962 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.546 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 64.4 m-85 -92.52 107.95 19.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 1.4 p90 -153.01 121.38 6.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.356 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.763 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . . . -85.06 17.41 2.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.663 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.1 p 49.66 55.13 9.85 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.049 0.452 . . . . 0.0 110.945 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.715 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.7 m-90 -69.41 -62.21 1.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.192 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 40.4 t 164.29 140.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.85 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.47 -120.73 6.35 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.537 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.433 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 89.1 Cg_exo -43.07 -70.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.822 2.348 . . . . 0.0 112.863 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.9 p -48.29 -26.64 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 111.423 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 31' ' ' CYS . 67.9 mmtt -85.66 -72.37 0.49 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.791 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.0 mtt -59.51 -22.24 61.34 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 37' ' ' ILE . 55.8 mt -89.97 -11.03 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.952 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -54.1 -65.23 1.33 Allowed Pre-proline 0 C--N 1.331 -0.215 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.32 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.952 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 78.0 Cg_exo -50.29 -36.29 46.67 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.133 1.888 . . . . 0.0 112.616 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.408 ' SD ' ' CB ' ' A' ' 93' ' ' PRO . 56.2 mtt -59.11 -78.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.071 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.94 HG22 HG21 ' A' ' 96' ' ' ILE . 2.4 pp -56.34 -24.76 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.131 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.876 ' N ' HD12 ' A' ' 41' ' ' ILE . 43.3 mt-10 -77.35 -30.5 53.9 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.004 0.431 . . . . 0.0 109.902 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -79.48 -45.21 19.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.145 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -60.32 -29.53 68.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.635 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.36 -31.01 53.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.916 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -84.57 -32.14 23.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.507 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.2 -28.47 69.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.017 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.605 ' CD2' HG21 ' A' ' 100' ' ' ILE . 39.0 m-85 -78.78 148.69 32.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.953 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -80.02 -34.72 38.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -146.27 92.91 2.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.519 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -138.07 123.04 19.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.968 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -96.65 93.98 7.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.164 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.519 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 6.0 m-85 -89.96 127.93 36.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.124 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.722 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 14.9 m-30 -113.5 108.25 16.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.858 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -89.9 120.85 31.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.729 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.896 HD22 HG11 ' A' ' 61' ' ' VAL . 90.3 mt -131.31 145.57 51.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.263 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -106.99 161.21 14.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.57 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.763 ' CG2' ' HB2' ' A' ' 28' ' ' ALA . 50.5 t -82.11 -27.42 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.67 -60.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.168 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.49 -40.12 77.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.185 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.896 HG11 HD22 ' A' ' 56' ' ' LEU . 41.3 t -112.87 48.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.012 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.4 t -62.08 -31.33 71.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -49.15 -45.67 44.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.204 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.617 HG11 HD13 ' A' ' 56' ' ' LEU . 47.2 t -73.51 -56.27 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.966 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.34 -52.87 15.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.721 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -50.25 -59.1 4.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -54.65 -73.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.037 0.446 . . . . 0.0 110.706 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.69 68.16 7.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.522 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -44.27 135.66 4.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.551 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 71' ' ' SER . 46.3 t -117.87 159.28 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.923 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.49 ' N ' HG12 ' A' ' 70' ' ' VAL . 80.7 p -146.21 80.17 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.116 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -178.56 -161.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.613 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 20.3 ptt? -177.28 94.16 0.24 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.404 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 69.3 Cg_endo -88.26 -160.21 1.51 Allowed 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.239 -1.15 . . . . 0.0 112.32 -0.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.821 HG23 ' CG1' ' A' ' 89' ' ' VAL . 51.5 m -139.9 115.73 10.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.834 0.349 . . . . 0.0 110.954 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.707 HD12 ' C ' ' A' ' 75' ' ' THR . 3.9 mp -120.93 115.24 22.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.977 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.826 ' O ' HG13 ' A' ' 23' ' ' VAL . 28.4 pt -109.92 157.52 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.673 ' HE1' HG22 ' A' ' 88' ' ' VAL . 3.0 m-85 -130.83 125.53 33.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 111.774 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.505 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 71.5 m-85 -110.13 150.59 28.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.898 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.04 -22.17 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.136 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.62 31.31 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.27 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.81 44.58 5.11 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.368 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -164.45 107.48 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.382 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -56.93 115.33 2.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.496 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 86' ' ' THR . 11.2 m -128.02 -48.56 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 46.4 p -105.2 82.78 1.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.207 0.527 . . . . 0.0 111.0 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -97.53 142.27 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.633 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.686 ' O ' HG23 ' A' ' 88' ' ' VAL . 32.8 m -139.75 88.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.542 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.821 ' CG1' HG23 ' A' ' 75' ' ' THR . 26.0 m -108.98 109.71 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.524 . . . . 0.0 111.128 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -170.2 -96.2 0.1 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.302 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 90' ' ' GLY . . . 176.44 70.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 110.979 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -137.29 88.14 17.51 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HG3' HG23 ' A' ' 37' ' ' ILE . 24.3 Cg_exo -63.55 -14.44 42.53 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.773 2.315 . . . . 0.0 112.487 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.46 -31.3 14.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 110.96 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.1 -23.82 67.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.206 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.94 HG21 HG22 ' A' ' 41' ' ' ILE . 21.9 pt -56.34 -38.81 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.933 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -49.46 -55.91 11.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.605 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -68.59 -25.9 65.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.812 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.464 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -70.5 -57.41 4.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.144 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.605 HG21 ' CD2' ' A' ' 48' ' ' TYR . 3.1 mp -75.54 -5.7 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.237 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -89.96 -28.75 18.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.702 0.287 . . . . 0.0 111.377 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 m -90.05 -67.0 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 111.408 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -46.86 -32.6 3.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.545 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 101' ' ' ALA . 8.4 p . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.417 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.743 HG22 ' HB2' ' A' ' 53' ' ' PHE . 46.0 t -74.86 129.4 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.965 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 m -120.89 149.74 42.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.994 0.426 . . . . 0.0 110.966 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -89.9 109.72 20.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.872 HD11 ' CD2' ' A' ' 54' ' ' TYR . 70.3 mt -88.83 104.77 17.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 110.868 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 11.1 mmpt? -89.94 -47.46 7.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.028 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.3 t -104.89 147.41 27.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.245 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.44 -27.73 68.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.01 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.3 p -54.86 -31.27 59.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -71.09 -35.1 71.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.58 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CE1' HD21 ' A' ' 15' ' ' LEU . 48.5 t80 -69.4 -43.87 72.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.026 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -53.16 -60.42 3.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.1 p -64.83 -21.17 66.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.212 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.91 71.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.376 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.685 HD21 ' CE1' ' A' ' 11' ' ' TYR . 82.0 mt -57.4 -36.12 70.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.966 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.03 50.72 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.045 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.7 p -81.97 148.44 28.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 19' ' ' ASP . . . -80.3 83.06 1.43 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.615 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 8.8 t70 80.41 -40.6 0.18 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.702 0.401 . . . . 0.0 111.68 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -45.28 129.17 8.06 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.829 0.347 . . . . 0.0 111.231 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.565 ' C ' HD23 ' A' ' 21' ' ' LEU . 4.8 tt -80.33 110.88 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 22' ' ' VAL . 10.6 p -100.84 116.06 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.464 HG23 HD22 ' A' ' 21' ' ' LEU . 47.4 t -104.88 146.76 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.044 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.436 HG21 ' HE1' ' A' ' 11' ' ' TYR . 48.5 t -126.1 113.8 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.806 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -101.48 120.56 40.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.942 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.592 ' CE1' HD12 ' A' ' 56' ' ' LEU . 61.2 m-85 -109.45 106.48 16.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.036 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 5.0 p90 -127.35 121.41 30.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.221 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.793 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -86.16 18.54 3.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p 49.3 78.04 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 111.437 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.793 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 0.7 OUTLIER -100.89 -56.05 2.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.946 179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.614 ' CB ' ' O ' ' A' ' 30' ' ' TRP . 42.0 t 132.73 104.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.562 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.03 -92.85 0.25 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.412 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.474 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 11.4 Cg_endo -55.55 -57.79 1.43 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.835 2.357 . . . . 0.0 112.862 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.1 p -81.12 58.26 3.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 110.975 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -172.19 -46.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.6 ttt -65.68 -54.18 30.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.833 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.0 pt -90.28 21.54 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.52 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.947 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -71.03 -62.74 1.75 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.179 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 74.9 Cg_exo -50.14 -29.62 22.92 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.167 1.911 . . . . 0.0 112.685 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.491 ' CE ' ' HB3' ' A' ' 93' ' ' PRO . 37.7 mtp -62.56 -73.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.098 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.92 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -55.8 -23.46 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.92 ' N ' HD12 ' A' ' 41' ' ' ILE . 39.6 tt0 -81.17 -31.33 34.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.991 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -76.64 -42.06 43.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.377 179.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -55.19 -23.45 21.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -55.76 -28.27 55.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.128 0.49 . . . . 0.0 110.513 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.69 -0.49 50.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.807 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -90.15 -60.57 1.89 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.172 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.924 ' CE2' HG21 ' A' ' 100' ' ' ILE . 17.2 m-85 -70.67 165.16 23.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.041 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.6 m -113.69 -18.39 11.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.756 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -134.79 53.7 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.971 0.415 . . . . 0.0 111.398 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -119.28 113.0 20.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.305 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.44 100.5 13.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.127 0.489 . . . . 0.0 110.84 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.743 ' HB2' HG22 ' A' ' 2' ' ' VAL . 12.9 m-85 -92.12 134.22 35.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.186 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.872 ' CD2' HD11 ' A' ' 5' ' ' LEU . 19.0 m-30 -122.91 116.73 24.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.792 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -102.33 91.47 4.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.979 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 5' ' ' LEU . 85.0 mt -95.94 132.62 41.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -80.1 -9.26 59.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.663 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 58' ' ' VAL . 39.1 t 64.74 25.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.111 0.481 . . . . 0.0 110.83 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.1 -47.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.49 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.21 -32.34 73.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.457 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.583 HG21 HD22 ' A' ' 56' ' ' LEU . 44.2 t -96.16 -44.37 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.743 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 61' ' ' VAL . 95.5 p 61.33 -65.85 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.749 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 61' ' ' VAL . 7.5 t70 -36.79 -58.22 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.535 0.334 . . . . 0.0 111.851 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 56' ' ' LEU . 48.1 t -58.0 -54.12 36.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.045 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.63 -46.3 63.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.34 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -58.91 -40.36 84.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -72.1 -62.34 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.738 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.4 85.08 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -58.32 112.35 1.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.091 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 70' ' ' VAL . 35.7 m -155.46 110.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.6 m -105.71 50.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -119.24 -170.73 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.647 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.512 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 18.1 ptp -166.7 98.8 0.68 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.378 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 94.4 Cg_endo -89.32 -165.05 2.67 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 124.262 -1.141 . . . . 0.0 112.451 -0.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.777 ' C ' HD12 ' A' ' 76' ' ' LEU . 87.8 m -144.79 118.44 9.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.777 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -126.37 127.47 45.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.962 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.642 HD12 ' CE2' ' A' ' 79' ' ' TYR . 17.1 pt -122.11 155.95 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.2 m-85 -127.5 118.56 24.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.424 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.667 ' CD2' HD22 ' A' ' 15' ' ' LEU . 61.3 m-85 -109.94 112.43 24.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.698 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.09 -54.26 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.834 0.35 . . . . 0.0 110.791 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.6 28.47 2.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.495 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.1 54.57 0.9 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.325 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -176.9 113.12 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.837 0.351 . . . . 0.0 110.976 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -58.91 96.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 86' ' ' THR . 27.3 m -109.89 -41.59 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 60.0 m -108.68 102.29 11.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.918 0.39 . . . . 0.0 110.151 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -102.6 154.57 19.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.377 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.4 t -154.35 81.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.574 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 89' ' ' VAL . 26.8 m -109.44 72.68 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.59 -136.35 2.36 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.117 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.91 91.71 1.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.282 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -152.08 112.47 2.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.11 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.586 ' O ' HG22 ' A' ' 96' ' ' ILE . 46.2 Cg_exo -57.16 -16.47 21.79 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.71 2.273 . . . . 0.0 112.593 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.82 -30.21 17.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 111.191 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.04 -30.87 16.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 110.841 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 93' ' ' PRO . 4.6 tp -68.58 -22.59 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.22 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -83.82 -53.08 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.197 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -67.34 -47.59 70.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.027 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.472 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -55.5 -59.3 5.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.402 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.924 HG21 ' CE2' ' A' ' 48' ' ' TYR . 32.9 mm -57.43 -40.8 76.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.46 -28.22 66.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.193 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.5 m -57.94 -51.55 69.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.951 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 21' ' ' LEU . 16.0 p-10 -136.35 61.36 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.979 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.99 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.766 0.317 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.9 t 61.03 112.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.661 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -101.96 174.17 6.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.214 0.53 . . . . 0.0 111.061 -179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.502 ' H ' HG22 ' A' ' 3' ' ' THR . 13.9 mp0 -118.42 96.28 5.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.056 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.524 HD11 ' CG ' ' A' ' 54' ' ' TYR . 62.7 mt -88.96 153.85 20.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.294 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -150.03 -66.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.952 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.6 t -82.57 161.94 22.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.128 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . . . -73.71 -31.95 63.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.1 p -56.44 -29.35 61.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.011 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 52.8 mt-10 -75.82 -32.82 59.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.75 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 49.2 t80 -78.3 -46.09 21.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.005 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -57.48 -64.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.084 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 t -57.76 -26.07 61.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.006 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.793 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -63.94 -63.34 1.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.301 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.75 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 84.9 mt -54.16 -25.09 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.123 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.87 -57.13 7.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.073 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.9 t -90.18 18.11 6.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.5 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.22 76.22 2.28 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -88.7 -40.58 13.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.97 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -58.48 -78.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 104' ' ' VAL . 4.5 tt -177.59 113.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.774 0.321 . . . . 0.0 110.412 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.491 ' N ' HD23 ' A' ' 21' ' ' LEU . 62.6 t -104.02 144.15 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.657 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 77' ' ' ILE . 40.0 t -146.18 129.38 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.482 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.773 HG11 ' CE2' ' A' ' 26' ' ' PHE . 52.0 t -100.4 147.75 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.344 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 36.0 t70 -135.6 85.19 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.722 0.296 . . . . 0.0 111.697 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.934 ' CD2' HG21 ' A' ' 70' ' ' VAL . 65.8 m-85 -86.78 77.43 9.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.067 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 12.9 p90 -99.89 -34.59 10.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.629 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . . . 61.37 -162.64 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.584 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 79.2 p -134.11 65.27 1.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.001 0.429 . . . . 0.0 110.975 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.629 ' CE2' ' HB3' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -83.4 -60.1 2.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.916 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 39.1 t 147.44 110.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.458 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 33' ' ' PRO . . . 136.08 -132.42 6.12 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.37 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 10.7 Cg_endo -54.26 -34.09 78.26 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.71 2.274 . . . . 0.0 112.806 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 29.7 p -71.69 56.19 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.19 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 27.9 tptp 172.62 -42.84 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.75 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.541 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 11.1 mmt -58.04 -73.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.408 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.642 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -86.45 8.53 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.68 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -57.91 -52.7 72.51 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.921 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 50.9 Cg_exo -54.69 -31.94 73.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.583 2.189 . . . . 0.0 112.288 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.418 ' CE ' ' HB2' ' A' ' 93' ' ' PRO . 72.2 mtp -54.41 -73.77 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.928 0.394 . . . . 0.0 110.469 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.01 HG22 HG21 ' A' ' 96' ' ' ILE . 8.6 pt -50.56 -44.05 24.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.258 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' N ' HG13 ' A' ' 41' ' ' ILE . 66.1 mm-40 -63.64 -33.15 74.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.79 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.459 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -76.47 -49.35 16.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.939 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.617 ' CD2' HD11 ' A' ' 96' ' ' ILE . 8.0 m-85 -51.79 -27.76 13.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.01 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.653 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.89 -28.89 25.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.055 0.455 . . . . 0.0 110.576 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -82.85 -25.21 32.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.602 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -58.44 -56.74 18.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.034 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.435 ' CE2' HG21 ' A' ' 100' ' ' ILE . 16.3 m-85 -62.28 171.03 2.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.156 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 m -97.14 -31.98 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 1.5 p30 -140.54 99.18 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.183 0.516 . . . . 0.0 111.146 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.471 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -148.83 117.62 6.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.79 107.09 18.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.279 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.653 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 6.6 m-85 -100.01 129.6 46.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.52 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.793 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 17.2 m-30 -115.4 107.26 14.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.444 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -89.85 122.46 32.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.67 HD22 HG11 ' A' ' 61' ' ' VAL . 94.0 mt -136.32 172.19 13.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.644 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -130.54 -102.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.927 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 59' ' ' ASP . 35.6 m -157.54 -45.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 120.709 0.29 . . . . 0.0 111.25 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 58' ' ' VAL . 56.5 m-20 -110.67 -35.96 5.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.01 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.61 -31.45 66.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.756 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.67 HG11 HD22 ' A' ' 56' ' ' LEU . 46.3 t -97.52 -66.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.745 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.0 t 68.31 -63.07 0.35 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.433 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 1.5 m-20 -38.75 -38.62 0.43 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.731 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.02 -54.35 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.096 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.13 -41.12 7.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.811 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -57.33 -47.74 80.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.106 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -82.45 -55.99 4.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.957 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.632 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -70.36 82.16 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -58.49 98.6 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.934 HG21 ' CD2' ' A' ' 26' ' ' PHE . 53.7 t -108.22 151.62 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.2 p -155.79 85.28 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.076 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.2 t -177.9 177.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.435 ' HG2' ' CH2' ' A' ' 30' ' ' TRP . 64.9 mtm -154.64 96.48 2.59 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 3.1 Cg_endo -85.36 -158.75 1.55 Allowed 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.492 -1.045 . . . . 0.0 112.199 0.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.884 HG21 HG13 ' A' ' 70' ' ' VAL . 63.3 m -144.62 114.43 7.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.752 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.773 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -126.89 111.8 14.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.902 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.557 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 26.3 pt -115.75 163.32 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.692 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.3 m-85 -128.11 125.73 39.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.557 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 63.2 m-85 -109.49 165.04 11.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.43 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -168.51 63.79 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.714 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.3 23.83 4.36 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.028 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.73 -4.67 73.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.254 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 13.2 mptt -109.7 110.63 21.72 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.735 0.302 . . . . 0.0 111.088 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 24.4 pt-20 -68.24 125.59 26.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.467 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 86' ' ' THR . 34.8 m -127.92 -42.04 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.612 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 72.2 m -103.96 113.66 27.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.949 0.404 . . . . 0.0 110.093 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -112.14 155.09 24.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.33 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.2 t -155.84 79.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.793 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.642 ' O ' HG23 ' A' ' 89' ' ' VAL . 27.0 m -109.62 91.99 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.313 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -103.38 0.17 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.384 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.5 85.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -151.64 81.88 5.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.859 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' A' ' 37' ' ' ILE . 51.9 Cg_exo -54.55 -20.45 21.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.863 2.375 . . . . 0.0 112.698 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.84 -2.41 58.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.588 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.0 -23.94 21.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.71 0.29 . . . . 0.0 111.267 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.01 HG21 HG22 ' A' ' 41' ' ' ILE . 24.3 pt -54.79 -34.43 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.135 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.47 -60.37 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.032 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -68.17 -27.65 66.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.4 -64.06 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.288 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.435 HG21 ' CE2' ' A' ' 48' ' ' TYR . 66.6 mt -55.78 -35.01 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.216 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.09 -23.79 64.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.327 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.3 m -54.53 -70.13 0.11 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -106.33 56.34 0.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.655 ' HA ' HD12 ' A' ' 21' ' ' LEU . 9.1 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.791 0.329 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 47.7 t -112.12 131.31 63.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.814 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -110.93 159.46 17.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.437 0.637 . . . . 0.0 111.833 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -121.76 116.32 24.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.569 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.567 ' HB2' HD21 ' A' ' 56' ' ' LEU . 67.2 mt -89.05 104.36 16.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.013 0.435 . . . . 0.0 111.306 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -99.52 -35.2 9.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.427 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -117.73 141.09 48.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.944 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.36 -25.98 38.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.427 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -58.63 -40.26 82.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.011 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -63.85 -27.05 68.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.553 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 49.3 t80 -90.0 -46.92 8.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -57.95 -60.74 3.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.072 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.4 p -55.86 -23.09 28.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.294 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -74.84 -28.22 60.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.46 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.553 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 86.1 mt -89.94 -17.96 26.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.364 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.33 -86.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.328 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.1 p -90.47 29.33 1.3 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.08 87.86 1.44 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.77 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -80.07 -37.32 34.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 110.588 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -57.95 -168.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.607 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.849 HD13 HG23 ' A' ' 100' ' ' ILE . 2.7 tt -91.1 119.88 31.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.962 0.411 . . . . 0.0 110.689 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.604 ' N ' HD23 ' A' ' 21' ' ' LEU . 59.6 t -113.05 107.95 24.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.532 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.638 HG23 HD22 ' A' ' 21' ' ' LEU . 43.3 t -99.92 144.81 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.507 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.494 HG11 ' CE2' ' A' ' 26' ' ' PHE . 48.4 t -126.43 147.89 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.447 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 37.7 t70 -137.13 113.16 9.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.961 0.41 . . . . 0.0 111.211 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.539 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 70.4 m-85 -110.34 107.2 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 1.7 p90 -150.69 121.85 7.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.783 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.652 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -88.18 18.17 4.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.638 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.0 p 49.61 62.86 2.42 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.14 0.495 . . . . 0.0 111.119 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.652 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.8 m-90 -77.72 -61.19 2.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.149 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 41.8 t 165.11 109.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.562 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.04 -146.38 18.42 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.027 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . 84.2 Cg_exo -46.28 -36.49 17.32 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.834 2.356 . . . . 0.0 112.88 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 24.4 p -51.76 -26.04 8.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -113.77 -28.7 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.2 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.7 ttm -77.35 -29.85 53.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.292 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 37' ' ' ILE . 54.1 mt -89.94 -6.16 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.706 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.836 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -51.08 -55.35 28.84 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.536 0.208 . . . . 0.0 111.408 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.836 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 37.9 Cg_exo -61.58 -39.04 57.69 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.55 2.167 . . . . 0.0 112.285 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 60.7 mtt -53.08 -75.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.58 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.788 HG22 HG21 ' A' ' 96' ' ' ILE . 11.6 pt -51.69 -43.16 32.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.35 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 41' ' ' ILE . 39.4 tt0 -63.86 -33.65 76.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.753 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.3 ttpt -76.2 -41.25 50.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.288 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.772 ' CG ' HD11 ' A' ' 96' ' ' ILE . 6.1 m-85 -64.26 -23.96 67.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.716 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -54.85 -29.14 54.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.06 0.457 . . . . 0.0 110.473 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -84.54 -1.83 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.944 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -90.17 -46.5 8.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.048 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.528 ' CE2' HD12 ' A' ' 100' ' ' ILE . 17.6 m-85 -73.89 168.05 20.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.186 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -111.6 -22.69 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.269 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.529 ' OD1' HG23 ' A' ' 104' ' ' VAL . 52.7 p-10 -146.0 66.45 1.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.034 0.445 . . . . 0.0 111.199 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HB3' ' HE1' ' A' ' 53' ' ' PHE . . . -124.55 117.64 24.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.018 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.69 104.12 16.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.631 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 3.6 m-85 -89.85 106.89 18.77 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.928 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.516 ' CE2' HG13 ' A' ' 22' ' ' VAL . 12.8 m-30 -96.86 109.1 21.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 110.953 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -89.89 129.56 36.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.083 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.718 HD22 HG21 ' A' ' 61' ' ' VAL . 96.2 mt -148.35 136.84 21.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.642 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -107.29 -96.73 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.065 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.4 t -156.2 -69.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.849 0.357 . . . . 0.0 111.076 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -79.76 -33.47 40.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.101 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.13 -29.41 57.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.041 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.718 HG21 HD22 ' A' ' 56' ' ' LEU . 30.5 t -112.98 -67.13 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.842 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.476 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 33.2 t 75.28 -7.82 1.7 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.14 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.698 ' H ' HG12 ' A' ' 61' ' ' VAL . 35.0 m-20 -90.36 -64.32 1.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.924 0.393 . . . . 0.0 110.865 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.3 t -62.92 -59.98 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.137 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.22 -31.15 2.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.445 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -63.62 -58.59 6.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.738 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -74.31 -55.67 5.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.759 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.4 82.99 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.5 128.02 34.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.109 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.6 t -89.55 132.88 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -136.97 50.85 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.16 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.403 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 36.3 t -170.33 -163.69 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.635 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.486 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.3 ptm -170.1 90.92 0.52 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.431 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.88 -162.53 2.93 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.88 -1.3 . . . . 0.0 112.27 -0.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.589 ' C ' HD12 ' A' ' 76' ' ' LEU . 88.0 m -137.12 105.02 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.602 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 76' ' ' LEU . 3.8 mp -114.05 140.69 48.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.958 0.409 . . . . 0.0 111.217 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.591 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 25.1 pt -138.59 156.79 29.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.804 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.471 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.4 m-85 -124.1 125.52 44.64 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.959 0.409 . . . . 0.0 111.507 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.591 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 65.4 m-85 -110.93 124.43 52.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.925 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -116.57 -38.26 3.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.44 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.55 45.03 1.22 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.055 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.85 27.03 58.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.908 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.46 ' O ' HG13 ' A' ' 85' ' ' VAL . 60.5 mttp -152.92 124.66 7.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.774 0.321 . . . . 0.0 110.832 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.67 111.05 0.73 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.381 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 86' ' ' THR . 19.0 m -120.91 -46.89 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.485 ' N ' HG23 ' A' ' 85' ' ' VAL . 77.0 p -113.46 77.8 1.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 110.997 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -81.69 160.05 23.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.044 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.1 t -150.95 83.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.854 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 89' ' ' VAL . 32.1 m -109.38 99.38 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.216 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.8 -111.05 0.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.208 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -179.72 91.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 0.0 111.109 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -178.16 123.37 0.26 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.865 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 96' ' ' ILE . 12.3 Cg_endo -57.57 -59.43 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.426 2.084 . . . . 0.0 112.498 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -42.1 -30.44 0.29 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.955 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -20.26 60.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.662 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.788 HG21 HG22 ' A' ' 41' ' ' ILE . 8.9 pt -78.84 -42.96 24.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.872 0.367 . . . . 0.0 111.025 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -62.59 -64.38 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.578 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -54.64 -25.78 28.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.253 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.4 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -83.4 -63.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.047 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.849 HG23 HD13 ' A' ' 21' ' ' LEU . 63.1 mt -59.89 -44.92 95.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.6 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -63.6 -16.43 60.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.747 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.4 t -85.76 -56.71 3.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.796 0.331 . . . . 0.0 111.237 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -70.33 -23.87 62.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.138 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 101' ' ' ALA . 10.8 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.555 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.917 0.389 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 46.7 t 63.72 125.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.685 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.9 m -106.71 166.99 10.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.403 ' H ' HG22 ' A' ' 3' ' ' THR . 13.8 mp0 -106.2 90.28 3.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.064 178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.537 HD11 ' CG ' ' A' ' 54' ' ' TYR . 74.6 mt -89.03 132.7 34.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.187 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -133.52 -58.3 0.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.792 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 t -91.88 149.94 21.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.053 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . . . -67.55 -28.25 67.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.208 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -55.67 -30.9 61.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -72.63 -39.26 67.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.95 -71.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.981 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -47.57 -30.08 3.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.532 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 t -66.01 -23.3 66.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.194 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.08 -36.03 15.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.26 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 15' ' ' LEU . 2.2 mm? -82.12 -0.3 44.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.446 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.92 -82.12 0.27 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 0.0 111.061 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -90.54 30.42 1.15 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.185 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.63 168.04 41.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.645 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -159.57 -45.67 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.644 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -59.43 -170.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.731 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.614 HD22 ' HA ' ' A' ' 104' ' ' VAL . 44.4 tp -75.38 107.36 7.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.209 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 58.2 t -109.16 97.63 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.563 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.405 HG23 ' HG ' ' A' ' 21' ' ' LEU . 43.3 t -105.74 137.97 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.593 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.701 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 48.1 t -116.59 139.08 44.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.329 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -117.93 98.18 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.508 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.701 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 61.3 m-85 -96.02 96.98 9.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.916 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 2.2 p90 -136.54 122.16 19.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.65 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.25 112.16 23.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.479 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.7 p -74.54 105.36 5.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.471 . . . . 0.0 111.629 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.557 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.2 m-90 -105.32 -60.38 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.471 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 44.7 t 159.07 90.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.418 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.3 -82.54 0.21 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.759 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.755 ' O ' ' N ' ' A' ' 35' ' ' LYS . 87.3 Cg_endo -79.79 -155.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.496 2.13 . . . . 0.0 110.852 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 4.6 p 42.04 -68.81 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.755 ' N ' ' O ' ' A' ' 33' ' ' PRO . 86.9 tttt -55.27 -39.84 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.382 . . . . 0.0 111.306 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -62.68 1.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.991 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.861 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -90.16 34.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.936 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.878 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -90.06 -59.65 0.24 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.621 0.248 . . . . 0.0 110.914 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.878 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 59.6 Cg_exo -52.54 -41.15 69.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.353 2.035 . . . . 0.0 112.35 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.414 ' CE ' ' CB ' ' A' ' 93' ' ' PRO . 70.0 mtp -50.07 -71.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 110.788 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.781 ' CG2' HG21 ' A' ' 96' ' ' ILE . 9.1 pt -55.38 -45.57 78.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.258 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.62 ' OE2' ' HB1' ' A' ' 38' ' ' ALA . 50.9 mt-10 -59.9 -35.29 74.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.844 0.354 . . . . 0.0 110.727 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 11.6 tmtt? -69.9 -49.28 53.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.417 ' CD2' HD11 ' A' ' 96' ' ' ILE . 6.0 m-85 -47.54 -28.85 2.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.271 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.13 -29.29 57.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.837 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.61 -32.98 25.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.404 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.412 ' OE1' ' CG ' ' A' ' 44' ' ' PHE . 84.5 mt-30 -60.52 -26.39 66.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.779 ' CE2' HG21 ' A' ' 100' ' ' ILE . 42.1 m-85 -90.1 176.82 6.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.779 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.3 m -114.05 -27.83 7.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.258 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -138.9 68.96 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 111.424 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.518 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -124.74 115.18 20.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.99 101.3 14.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.394 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.518 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 5.9 m-85 -93.72 132.11 38.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.356 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.537 ' CG ' HD11 ' A' ' 5' ' ' LEU . 15.3 m-30 -121.62 106.42 11.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.806 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -89.91 130.11 36.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.984 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.806 HD22 HG11 ' A' ' 61' ' ' VAL . 97.6 mt -155.47 140.96 17.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.829 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -101.42 -128.38 0.21 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.475 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.3 t -126.58 -70.13 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.084 0 CA-C-O 120.777 0.322 . . . . 0.0 111.015 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -72.61 -39.72 67.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.739 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -58.17 -29.51 65.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.7 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.806 HG11 HD22 ' A' ' 56' ' ' LEU . 43.6 t -140.25 70.53 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.863 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.2 t -76.86 -2.03 31.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.541 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 57.1 m-20 -84.83 -38.07 19.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.816 0.341 . . . . 0.0 111.089 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.647 HG11 ' CD1' ' A' ' 56' ' ' LEU . 46.2 t -90.2 -56.31 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.251 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.19 -32.55 16.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.65 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -58.25 -48.28 80.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.89 -51.59 66.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.01 77.33 6.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.091 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.05 115.06 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.481 ' HB ' HG21 ' A' ' 75' ' ' THR . 35.2 m -138.56 143.02 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.188 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -116.77 174.88 5.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.828 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 81.8 p 50.69 95.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.524 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 21.6 mmt -91.24 150.76 42.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.78 -178.98 22.88 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 123.723 -1.366 . . . . 0.0 112.7 0.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.934 HG23 HG12 ' A' ' 89' ' ' VAL . 91.8 m -149.85 130.69 14.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.748 HD12 ' C ' ' A' ' 75' ' ' THR . 4.0 mp -123.98 131.98 53.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.0 111.335 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.466 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 27.8 pt -130.47 139.58 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.502 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.7 m-85 -114.23 125.64 54.15 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.044 0.449 . . . . 0.0 111.572 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.594 ' CD2' HD11 ' A' ' 15' ' ' LEU . 69.7 m-85 -109.61 162.14 14.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.718 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -153.41 67.73 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.74 20.74 18.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.415 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.77 64.51 1.2 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.565 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -178.18 115.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.954 0.407 . . . . 0.0 111.157 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 44.3 tt0 -79.31 98.43 6.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.575 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -112.91 -32.43 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.412 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.707 HG21 HD21 ' A' ' 103' ' ' ASN . 92.2 m -113.88 102.8 10.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.889 0.376 . . . . 0.0 110.468 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -110.0 144.31 38.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.003 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.2 t -137.57 82.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.704 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.934 HG12 HG23 ' A' ' 75' ' ' THR . 34.8 m -109.65 106.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.325 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.03 -108.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.371 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -179.93 68.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.991 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 5.7 m120 -142.51 96.4 6.29 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.052 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.45 ' O ' HG13 ' A' ' 96' ' ' ILE . 32.0 Cg_exo -58.6 -17.1 33.32 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.589 2.192 . . . . 0.0 112.503 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.27 -29.73 17.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.853 0.358 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 92' ' ' ASN . . . -71.52 -25.32 62.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.173 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.794 HD12 ' N ' ' A' ' 97' ' ' LYS . 2.1 pp -56.59 -31.9 35.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.794 ' N ' HD12 ' A' ' 96' ' ' ILE . 34.5 ttpt -62.93 -65.11 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.16 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -39.01 -33.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.655 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.47 -46.87 12.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.779 HG21 ' CE2' ' A' ' 48' ' ' TYR . 73.4 mt -74.07 -5.68 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.541 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.22 -32.9 16.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.727 0.299 . . . . 0.0 111.379 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.7 p -89.67 -58.55 2.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 111.387 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.707 HD21 HG21 ' A' ' 86' ' ' THR . 47.2 m-80 -60.08 -17.99 43.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.591 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.614 ' HA ' HD22 ' A' ' 21' ' ' LEU . 11.3 p . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.769 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 23.0 ptp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.889 0.376 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.525 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 45.4 t -147.93 102.19 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.701 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -101.53 152.44 20.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.423 0.63 . . . . 0.0 111.851 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -113.01 118.84 35.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.402 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 11' ' ' TYR . 4.7 mp -89.15 117.68 28.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.977 0.418 . . . . 0.0 111.616 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -107.79 -37.0 6.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.172 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.2 t -115.95 143.81 44.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.831 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.48 -23.79 41.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.302 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 m -60.12 -45.01 94.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -59.9 -27.4 66.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.35 . . . . 0.0 110.895 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.869 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 48.6 t80 -90.03 -48.81 6.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.175 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -57.79 -61.81 2.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.1 p -54.56 -24.33 20.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.349 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.06 -66.06 0.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.362 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.869 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 82.2 mt -54.85 -24.11 21.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.4 -79.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.205 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -90.2 17.24 7.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.413 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.04 105.88 3.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -109.47 -22.0 12.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 111.065 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -54.92 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.092 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.758 HD13 HG23 ' A' ' 100' ' ' ILE . 4.4 tt -177.83 107.99 0.06 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.8 0.333 . . . . 0.0 110.635 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.532 HG13 ' CE2' ' A' ' 54' ' ' TYR . 58.3 t -102.79 124.72 57.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.723 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 ' CD2' ' A' ' 21' ' ' LEU . 40.8 t -116.19 122.57 69.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.269 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.469 HG11 ' CE2' ' A' ' 26' ' ' PHE . 51.8 t -104.0 112.55 37.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.756 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -108.68 98.44 7.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.499 ' CE1' HD12 ' A' ' 56' ' ' LEU . 61.0 m-85 -86.3 115.55 23.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.88 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 2.3 p90 -135.81 117.12 14.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.661 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.882 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -86.79 4.52 40.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.771 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.8 p 49.18 70.83 0.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 111.178 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.882 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 3.0 m-90 -89.12 -57.84 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.148 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.8 t -139.57 -104.35 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.384 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.616 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -136.05 25.76 3.17 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.9 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 85.7 Cg_endo -82.44 -41.32 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 121.982 1.788 . . . . 0.0 112.114 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 22.9 p -98.39 -41.93 7.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.247 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -52.18 -42.12 63.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.382 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.7 ttt -67.72 -25.79 65.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.117 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 37' ' ' ILE . 50.0 mm -86.97 -10.72 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.693 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.901 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -59.91 -63.37 4.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.901 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 82.5 Cg_exo -45.76 -40.68 19.44 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.333 2.022 . . . . 0.0 112.801 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.6 mtt -54.17 -79.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.644 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.934 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -57.55 -29.71 34.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.778 0.323 . . . . 0.0 110.969 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.934 ' N ' HD12 ' A' ' 41' ' ' ILE . 88.4 tt0 -70.35 -26.92 63.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.704 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.431 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 13.4 tmtt? -87.09 -45.92 10.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.241 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -54.82 -27.47 42.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.703 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 1' ' ' MET . . . -51.82 -30.56 23.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.087 0.47 . . . . 0.0 110.495 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -83.15 -26.53 30.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.59 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -72.64 -26.1 61.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.302 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -83.18 167.67 17.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.374 . . . . 0.0 111.039 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -97.28 -33.48 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.821 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -153.01 98.57 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.823 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.63 121.24 10.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.629 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.94 109.28 20.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.525 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 10.4 m-85 -97.96 116.05 29.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.525 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.532 ' CE2' HG13 ' A' ' 22' ' ' VAL . 17.7 m-30 -112.26 99.77 8.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.864 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -90.04 127.63 36.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 5' ' ' LEU . 90.0 mt -130.87 162.77 28.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.216 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.55 ' O ' HG13 ' A' ' 58' ' ' VAL . 38.8 t70 -106.33 -109.5 0.29 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.515 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 57' ' ' ASP . 16.1 m -160.51 -48.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.742 0.306 . . . . 0.0 111.399 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 58' ' ' VAL . 1.3 m-20 -110.75 -33.63 6.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 110.742 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -56.5 -27.32 56.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.695 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.81 HG12 ' H ' ' A' ' 63' ' ' ASP . 46.8 t -106.74 -68.78 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 61' ' ' VAL . 86.1 p 64.59 5.75 2.86 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.015 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.81 ' H ' HG12 ' A' ' 61' ' ' VAL . 1.4 m-20 -90.49 -38.64 13.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.974 0.416 . . . . 0.0 110.656 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 68' ' ' ALA . 27.0 t -90.05 -47.21 14.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.248 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.0 -30.31 1.0 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.653 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -73.79 -37.03 65.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.861 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -88.91 -57.49 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.754 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 64' ' ' VAL . . . -82.06 81.24 8.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.067 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.67 117.81 5.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.995 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.613 ' HB ' HG21 ' A' ' 75' ' ' THR . 35.4 m -133.01 174.53 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -175.98 91.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.16 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.405 ' CB ' HG21 ' A' ' 89' ' ' VAL . 39.6 t -178.22 -171.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.474 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 52.8 mtt -156.83 93.73 2.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.02 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.461 ' O ' HG23 ' A' ' 89' ' ' VAL . 95.8 Cg_endo -89.39 -162.66 1.93 Allowed 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.297 -1.126 . . . . 0.0 112.502 0.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.671 ' C ' HD12 ' A' ' 76' ' ' LEU . 95.4 m -141.55 105.65 4.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.676 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.671 HD12 ' C ' ' A' ' 75' ' ' THR . 3.9 mp -118.91 119.75 35.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.227 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.8 pt -121.31 166.99 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.559 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.9 m-85 -130.87 128.55 40.83 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.054 0.454 . . . . 0.0 111.338 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 60.2 m-85 -109.76 131.78 54.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.062 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -132.91 60.05 1.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.085 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.65 38.65 0.65 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.026 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.49 29.12 72.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.006 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -142.72 115.43 8.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 111.06 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.3 tt0 -69.98 104.13 2.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.596 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.42 -37.72 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.462 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.568 HG21 HD21 ' A' ' 103' ' ' ASN . 88.5 m -106.82 107.32 18.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 110.397 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -110.77 152.59 26.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.339 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -149.44 82.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.683 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 89' ' ' VAL . 7.4 p -109.59 98.5 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.199 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -170.1 -107.26 0.2 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.436 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 90' ' ' GLY . . . 173.62 92.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -153.37 116.66 2.74 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.513 ' O ' HG22 ' A' ' 96' ' ' ILE . 21.5 Cg_exo -65.03 -11.99 32.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.507 2.138 . . . . 0.0 112.652 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.57 -38.25 10.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.68 0.276 . . . . 0.0 111.287 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.71 -35.2 21.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 111.021 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.816 HD13 HG22 ' A' ' 41' ' ' ILE . 4.2 tp -53.06 -43.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.524 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.44 -72.2 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.318 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -51.47 -26.24 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.761 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.427 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -72.47 -62.57 1.4 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.752 0.311 . . . . 0.0 111.071 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.758 HG23 HD13 ' A' ' 21' ' ' LEU . 62.3 mt -73.83 -7.39 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.411 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.04 -27.3 26.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.689 0.28 . . . . 0.0 111.329 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.6 m -90.06 -56.09 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.294 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.568 HD21 HG21 ' A' ' 86' ' ' THR . 60.3 m-80 -55.35 -45.49 76.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.453 -179.524 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.852 0.358 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 53' ' ' PHE . 46.2 t -73.46 123.78 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.568 HG22 ' H ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -96.61 -178.2 4.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 0.0 110.597 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.568 ' H ' HG22 ' A' ' 3' ' ' THR . 0.2 OUTLIER -124.0 90.13 3.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.19 178.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.638 HD21 ' CD2' ' A' ' 54' ' ' TYR . 5.0 mp -89.07 141.12 28.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -133.68 -69.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.2 t -79.32 162.18 25.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.056 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . . . -70.27 -30.34 67.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.062 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -59.02 -33.83 71.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 53.1 mt-10 -69.7 -30.72 68.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.826 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.463 ' HH ' HD11 ' A' ' 15' ' ' LEU . 45.8 t80 -75.75 -45.99 33.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.905 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.29 -56.29 19.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -59.1 -28.0 66.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.052 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . -63.66 -66.4 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.136 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.548 ' CD2' HG11 ' A' ' 22' ' ' VAL . 81.4 mt -58.06 -26.72 62.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.037 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.78 -68.0 0.31 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -78.21 -28.46 48.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.19 119.07 12.84 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -114.37 -31.08 6.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 0.0 111.195 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -60.92 -108.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.806 HD12 ' HA ' ' A' ' 104' ' ' VAL . 4.5 tt -139.49 121.65 15.82 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.784 0.326 . . . . 0.0 110.439 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.637 ' N ' HD23 ' A' ' 21' ' ' LEU . 60.3 t -111.92 122.81 66.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.009 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.496 HG23 HD22 ' A' ' 21' ' ' LEU . 42.9 t -118.32 124.7 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.461 HG21 ' HE1' ' A' ' 11' ' ' TYR . 47.0 t -110.67 115.56 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.058 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -102.43 120.24 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.416 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 54.6 m-85 -108.26 119.52 39.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.16 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.424 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 2.5 p90 -155.15 113.3 3.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.644 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.06 23.2 6.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.403 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p 46.81 70.14 0.42 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.96 0.409 . . . . 0.0 110.769 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 73' ' ' MET . 2.5 m-90 -83.05 -57.86 3.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.868 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.4 t -118.89 -37.1 3.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.894 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 142.14 -38.38 1.48 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.504 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 58.7 Cg_exo -40.7 -46.96 4.71 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.622 2.214 . . . . 0.0 112.927 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.8 p -53.56 -31.75 47.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.004 0.43 . . . . 0.0 110.737 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -83.64 -25.93 30.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.9 ttm -70.18 -33.21 71.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.824 0.345 . . . . 0.0 110.687 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.605 HG23 ' SD ' ' A' ' 40' ' ' MET . 56.4 mt -90.15 -1.36 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.599 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.883 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -59.09 -63.72 3.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 121.206 -0.197 . . . . 0.0 111.279 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.883 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 86.1 Cg_exo -44.07 -34.55 6.69 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.379 2.053 . . . . 0.0 112.512 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.605 ' SD ' HG23 ' A' ' 37' ' ' ILE . 65.7 mtt -56.11 -74.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.855 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -63.8 -25.28 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.199 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.855 ' N ' HD12 ' A' ' 41' ' ' ILE . 93.4 mt-10 -72.41 -30.96 65.11 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.001 0.429 . . . . 0.0 109.997 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -77.23 -44.51 29.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.828 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.437 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.6 m-85 -55.65 -23.05 25.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.647 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -56.94 -28.15 61.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 110.536 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -89.14 -7.78 55.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.872 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -90.06 -51.06 5.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.583 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 100' ' ' ILE . 51.8 m-85 -68.0 143.63 55.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.904 0.383 . . . . 0.0 111.336 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.3 m -76.73 -34.03 58.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 1.5 p30 -150.11 100.32 2.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.297 0.57 . . . . 0.0 111.395 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.71 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -146.54 125.07 12.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.28 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.52 107.39 19.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.71 ' CZ ' ' HB3' ' A' ' 51' ' ' ALA . 14.6 m-85 -101.75 124.95 48.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.915 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.638 ' CD2' HD21 ' A' ' 5' ' ' LEU . 17.6 m-30 -112.36 123.43 50.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' O ' HD23 ' A' ' 56' ' ' LEU . 40.1 ttmt -102.75 119.83 39.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.865 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.034 HD22 HG11 ' A' ' 61' ' ' VAL . 81.2 mt -130.87 155.38 46.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.801 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -120.04 -83.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.119 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 59' ' ' ASP . 8.6 p 178.32 -45.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.33 . . . . 0.0 111.085 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 58' ' ' VAL . 7.5 t0 -85.96 -58.12 2.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.776 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -59.55 -30.47 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.034 HG11 HD22 ' A' ' 56' ' ' LEU . 46.9 t -127.21 54.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.041 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.5 t -70.16 -27.32 64.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 1.5 m-20 -54.63 -40.9 69.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.42 -48.98 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.942 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.52 -45.54 9.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.514 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -59.36 -58.8 7.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.77 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.542 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -60.88 -68.72 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.47 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.94 75.43 2.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.778 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -48.57 137.77 11.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.231 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.649 HG13 HG21 ' A' ' 75' ' ' THR . 56.1 t -124.31 158.64 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.08 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.483 ' N ' HG12 ' A' ' 70' ' ' VAL . 79.9 p -164.56 70.49 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.42 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 41.5 t -177.74 -163.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.646 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.9 ptm -175.03 100.2 0.27 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.426 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.76 -155.35 1.14 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.464 -1.057 . . . . 0.0 112.216 -0.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.75 ' C ' HD12 ' A' ' 76' ' ' LEU . 87.3 m -159.14 111.06 2.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.75 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -123.95 127.3 47.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.259 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.565 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 24.2 pt -117.03 156.32 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.733 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.65 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -127.04 123.46 37.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.01 0.433 . . . . 0.0 111.427 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.565 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 66.7 m-85 -109.83 176.79 4.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.573 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -153.0 -46.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.628 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.0 29.27 1.69 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.191 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.09 44.14 3.36 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.272 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -162.25 123.57 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.023 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 22.1 pt-20 -82.3 101.72 10.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.45 . . . . 0.0 110.672 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.54 -34.18 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.446 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 63.7 m -107.96 110.36 22.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.417 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -111.56 158.91 18.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.267 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 95' ' ' ALA . 47.6 t -155.22 80.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.773 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 75' ' ' THR . 35.3 m -109.82 63.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.13 0.49 . . . . 0.0 111.27 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -133.57 -158.2 8.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.305 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.03 76.18 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.31 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -154.75 138.32 10.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.555 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.87 -1.03 10.63 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.62 2.213 . . . . 0.0 113.261 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.57 -40.76 9.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.683 0.278 . . . . 0.0 111.241 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' A' ' 88' ' ' VAL . . . -48.3 -31.52 6.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.7 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 41' ' ' ILE . 3.6 tp -69.76 -36.22 68.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.309 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -61.66 -73.33 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.607 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -55.64 -41.74 73.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.986 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.461 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -54.27 -55.85 24.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.317 . . . . 0.0 111.324 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.586 HG21 ' CE2' ' A' ' 48' ' ' TYR . 32.8 mm -62.22 -51.01 77.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.747 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -23.68 66.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.227 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.3 t -54.8 -62.91 1.35 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.55 . . . . 0.0 110.826 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -127.71 46.54 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.078 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.806 ' HA ' HD12 ' A' ' 21' ' ' LEU . 9.5 p . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.099 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.835 0.35 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.439 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 15.8 m -56.96 154.14 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.034 0.445 . . . . 0.0 111.629 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.513 ' HB ' HD11 ' A' ' 5' ' ' LEU . 6.9 m -101.11 163.9 12.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.867 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.424 ' N ' HG22 ' A' ' 3' ' ' THR . 14.6 mp0 -98.65 90.7 4.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 5' ' ' LEU . 5.2 mp -88.84 127.46 35.63 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.956 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -129.71 -58.21 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.196 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.9 t -90.24 139.82 30.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.13 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.02 66.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.163 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.4 p -55.88 -37.68 69.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.813 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 47.6 mt-10 -67.18 -32.95 74.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.78 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.656 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 47.3 t80 -65.09 -62.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.155 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.93 -54.61 42.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.8 p -56.69 -22.55 35.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.22 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.733 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -79.32 -60.55 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.322 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.656 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 78.5 mt -55.7 -23.0 26.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.165 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.89 -61.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 111.249 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -75.16 -48.35 24.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.066 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.79 108.24 0.68 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.773 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -109.85 -25.17 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 0.0 110.916 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -53.49 -79.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.653 HD21 ' CD2' ' A' ' 78' ' ' PHE . 4.3 tt -169.02 116.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 110.554 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.584 HG13 ' CE2' ' A' ' 54' ' ' TYR . 50.1 t -105.76 137.99 33.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.506 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG23 ' CD2' ' A' ' 21' ' ' LEU . 40.6 t -132.31 108.94 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 0.0 111.319 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.732 HG23 HD11 ' A' ' 77' ' ' ILE . 34.7 m -102.38 122.92 55.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.87 103.92 13.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.537 ' HB3' HG21 ' A' ' 70' ' ' VAL . 63.4 m-85 -91.99 101.7 14.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.173 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.435 ' HA ' ' CH2' ' A' ' 30' ' ' TRP . 2.4 p90 -134.53 122.21 22.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.519 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 1.054 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -93.25 23.65 4.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.868 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.2 p 46.52 80.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.985 0.421 . . . . 0.0 111.355 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.45 ' CZ3' ' HG2' ' A' ' 33' ' ' PRO . 3.6 m-90 -86.63 -58.87 2.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.322 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.5 t -143.44 -77.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.502 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.587 ' N ' ' HD3' ' A' ' 33' ' ' PRO . . . -168.69 52.59 0.22 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.923 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 32' ' ' GLY . 37.5 Cg_endo -94.3 -68.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.051 2.501 . . . . 0.0 112.204 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.0 p -68.63 -34.87 76.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.813 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 35' ' ' LYS . 9.4 tmtt? -52.93 -55.5 22.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.66 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.8 ttt -51.22 -42.69 61.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.052 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.585 HD13 ' HB1' ' A' ' 91' ' ' ALA . 36.2 pt -90.2 10.7 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.134 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.637 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -62.94 -51.04 74.01 Favored Pre-proline 0 C--N 1.331 -0.203 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.301 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 50.4 Cg_exo -55.53 -32.44 82.72 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.277 1.985 . . . . 0.0 112.09 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 63.3 mtt -55.1 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.977 HG22 HD13 ' A' ' 96' ' ' ILE . 2.5 pp -55.5 -28.78 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 111.132 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.926 ' N ' HD12 ' A' ' 41' ' ' ILE . 8.7 tm-20 -71.38 -27.09 63.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.368 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -86.01 -50.75 6.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.419 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 9.8 m-85 -54.19 -30.25 48.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.406 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -51.91 -27.83 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.239 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -90.1 -33.61 16.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.76 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -61.81 -24.56 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.105 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' CZ ' ' HB ' ' A' ' 100' ' ' ILE . 39.2 m-85 -82.28 159.07 23.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.991 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -81.28 -38.96 26.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 1.6 p30 -150.0 104.75 3.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.118 0.485 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.09 123.23 11.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.092 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -90.0 100.26 13.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 9.4 m-85 -94.87 127.34 40.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.496 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.733 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 18.8 m-30 -118.23 126.44 52.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.004 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -107.32 99.13 8.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.603 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.836 HD22 HG11 ' A' ' 61' ' ' VAL . 98.1 mt -98.77 164.28 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.236 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 38.3 t70 -144.2 162.89 35.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.439 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.054 HG21 ' HB2' ' A' ' 28' ' ' ALA . 45.7 t -86.83 0.53 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.794 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -113.22 -75.93 0.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.644 0.259 . . . . 0.0 111.211 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.813 ' HG3' HG23 ' A' ' 61' ' ' VAL . 12.0 pt-20 -58.57 -23.02 57.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.197 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.836 HG11 HD22 ' A' ' 56' ' ' LEU . 39.8 t -127.98 47.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.875 0.369 . . . . 0.0 111.08 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.5 t -62.69 -26.24 68.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.016 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -60.75 -55.14 36.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.993 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.578 HG11 HD13 ' A' ' 56' ' ' LEU . 55.7 t -58.8 -48.92 84.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.025 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.08 -26.5 6.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.311 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -58.48 -64.54 0.89 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.727 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -59.65 -57.95 10.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.801 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.24 83.51 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -56.57 111.77 1.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.027 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 26' ' ' PHE . 45.9 t -92.15 127.36 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.8 t -153.47 39.45 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.177 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.0 m -128.03 -53.87 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.704 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 55.1 mtm 65.16 83.62 0.19 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.303 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 85.9 Cg_endo -89.18 -166.11 2.98 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.881 -1.3 . . . . 0.0 112.477 -0.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.487 ' C ' HD12 ' A' ' 76' ' ' LEU . 84.8 m -144.88 103.0 3.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.719 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 76' ' ' LEU . 4.0 mp -109.67 119.16 38.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.609 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.732 HD11 HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.15 152.41 35.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.054 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.653 ' CD2' HD21 ' A' ' 21' ' ' LEU . 1.9 m-85 -117.87 134.84 54.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.374 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.54 ' CD2' HD22 ' A' ' 15' ' ' LEU . 76.4 m-85 -109.47 147.49 32.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.66 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -145.67 76.91 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.659 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.13 51.62 1.33 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.12 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 57.76 27.39 59.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.873 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -144.32 147.45 33.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.965 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -102.21 135.01 44.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.673 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.79 -39.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.876 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.812 HG21 ' ND2' ' A' ' 103' ' ' ASN . 83.1 m -101.1 118.94 37.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.849 0.357 . . . . 0.0 110.262 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -118.13 170.66 8.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.017 0.437 . . . . 0.0 111.614 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.3 t -155.81 83.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.704 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.3 88.79 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -170.29 -34.52 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.396 -0.906 . . . . 0.0 112.973 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.585 ' HB1' HD13 ' A' ' 37' ' ' ILE . . . 77.53 83.28 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.926 0.393 . . . . 0.0 111.121 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.701 HD21 ' HB3' ' A' ' 94' ' ' ALA . 52.1 t30 -145.41 129.81 8.86 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.625 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' HG22 ' A' ' 96' ' ' ILE . 30.1 Cg_endo -64.11 -8.64 16.86 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.668 2.245 . . . . 0.0 113.326 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.701 ' HB3' HD21 ' A' ' 92' ' ' ASN . . . -98.1 -34.69 10.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.697 0.285 . . . . 0.0 111.173 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -57.66 -33.87 68.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.128 0.49 . . . . 0.0 110.171 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.977 HD13 HG22 ' A' ' 41' ' ' ILE . 4.2 tp -56.01 -50.41 69.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.297 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 11.0 tmtt? -59.01 -57.35 13.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.718 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -68.71 -11.76 60.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.61 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -81.19 -60.03 2.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.778 0.323 . . . . 0.0 111.38 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 96' ' ' ILE . 2.0 mp -75.66 -57.14 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.068 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 97' ' ' LYS . . . -46.09 -27.05 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.671 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.9 t -77.96 -57.78 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.429 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.812 ' ND2' HG21 ' A' ' 86' ' ' THR . 22.9 p30 -109.97 40.91 1.82 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 0.0 111.391 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.45 ' HA ' HD12 ' A' ' 21' ' ' LEU . 11.6 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.992 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.829 0.347 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.632 HG21 ' HG3' ' A' ' 42' ' ' GLU . 61.1 t -53.39 133.61 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 4' ' ' GLN . 4.8 m -107.2 165.02 11.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.08 0.467 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' N ' HG22 ' A' ' 3' ' ' THR . 14.0 mp0 -96.21 79.07 3.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.48 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.588 HD23 HD21 ' A' ' 56' ' ' LEU . 37.6 tp -89.16 95.75 10.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.495 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -106.02 -36.93 6.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.348 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -105.21 145.43 30.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.622 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.34 75.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.056 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -51.83 -28.95 17.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.72 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -80.8 -30.49 35.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.567 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CE1' HG21 ' A' ' 24' ' ' VAL . 48.2 t80 -78.79 -45.27 21.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.903 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -57.16 -52.24 66.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -62.46 -27.73 69.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.79 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 11' ' ' TYR . . . -61.19 -53.14 60.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 79' ' ' TYR . 83.7 mt -59.47 -30.96 68.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.881 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.22 -67.91 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -90.39 24.9 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.366 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 19' ' ' ASP . . . -58.66 -97.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.628 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 65.4 t0 68.75 -62.16 0.4 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.647 0.261 . . . . 0.0 111.167 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -46.62 -82.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.15 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.884 HD21 HG23 ' A' ' 100' ' ' ILE . 34.7 tp -178.47 111.85 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.752 0.31 . . . . 0.0 110.977 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.685 HG13 ' CE2' ' A' ' 54' ' ' TYR . 47.7 t -105.13 141.02 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.616 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.2 t -144.03 111.03 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 111.373 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.536 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 62.1 t -99.96 116.85 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.732 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 27' ' ' PHE . 10.0 t0 -106.07 103.73 13.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.936 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.64 ' CD2' HG21 ' A' ' 70' ' ' VAL . 64.8 m-85 -92.07 108.53 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.986 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CD1' ' OD1' ' A' ' 25' ' ' ASP . 1.7 p90 -153.23 120.37 5.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.888 ' HB2' HG12 ' A' ' 58' ' ' VAL . . . -93.79 27.01 2.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.116 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.2 p 49.72 51.86 15.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.08 0.467 . . . . 0.0 110.999 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.578 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.1 m-90 -66.73 -62.71 1.31 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.009 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.8 t 161.86 144.75 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.758 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.07 -112.43 3.65 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.676 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.884 ' HA ' HD13 ' A' ' 37' ' ' ILE . 91.1 Cg_exo -43.66 -71.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.953 2.435 . . . . 0.0 113.413 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 38' ' ' ALA . 26.8 p -48.78 -24.19 1.33 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -84.15 -73.07 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.784 0.326 . . . . 0.0 111.863 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 83.6 mtp -66.28 -34.07 77.16 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.884 HD13 ' HA ' ' A' ' 33' ' ' PRO . 1.4 mp -90.52 24.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.186 0.517 . . . . 0.0 111.207 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -90.15 -52.35 0.33 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.85 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 34.0 Cg_exo -62.47 -32.18 80.45 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.649 2.233 . . . . 0.0 113.009 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.702 ' CE ' HG23 ' A' ' 37' ' ' ILE . 42.4 mtm -57.56 -77.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.918 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.919 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.6 pp -56.0 -27.41 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.758 0.313 . . . . 0.0 111.044 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.919 ' N ' HD12 ' A' ' 41' ' ' ILE . 89.1 tt0 -75.2 -28.13 59.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.029 0.443 . . . . 0.0 110.512 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' PRO . 22.9 ttpp -83.37 -48.6 10.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.427 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -50.52 -27.12 6.07 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.845 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.59 -28.67 56.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.957 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -89.92 -14.77 33.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.108 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -85.4 10.08 13.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.571 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.42 153.26 40.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.755 0.312 . . . . 0.0 110.823 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -80.91 -40.34 24.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.968 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -134.52 95.79 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.068 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -143.4 121.75 12.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -100.2 98.39 9.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.371 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 10.6 m-85 -91.64 129.11 37.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.31 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.685 ' CE2' HG13 ' A' ' 22' ' ' VAL . 17.6 m-30 -114.09 107.13 15.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.89 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HB2' HG13 ' A' ' 2' ' ' VAL . 85.6 tttt -89.77 125.43 35.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.437 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.756 HD22 HG11 ' A' ' 61' ' ' VAL . 86.7 mt -130.62 156.74 44.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.067 0.46 . . . . 0.0 111.53 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.54 117.96 15.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.238 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.888 HG12 ' HB2' ' A' ' 28' ' ' ALA . 8.2 p -65.74 74.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.074 0.464 . . . . 0.0 111.2 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 t70 179.89 -69.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.135 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -78.63 -31.03 46.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.886 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.756 HG11 HD22 ' A' ' 56' ' ' LEU . 25.1 t -113.47 30.69 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.878 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.1 p -49.03 -26.89 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.345 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -44.62 -55.36 5.26 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.523 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.725 HG11 ' CD1' ' A' ' 56' ' ' LEU . 48.2 t -59.58 -46.4 93.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.001 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.91 -34.21 58.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.431 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -54.95 -69.91 0.12 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.08 -47.54 85.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -83.5 80.38 9.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.37 111.23 1.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.831 ' CG1' HG21 ' A' ' 75' ' ' THR . 48.7 t -119.08 145.63 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -144.5 70.15 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.031 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.508 ' HB3' HG11 ' A' ' 89' ' ' VAL . 64.4 m -165.46 -175.61 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.697 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.476 ' HB3' ' CH2' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -170.02 106.66 0.44 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.672 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.631 ' O ' HG13 ' A' ' 89' ' ' VAL . 4.9 Cg_exo -74.66 -155.64 1.06 Allowed 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 124.1 -1.208 . . . . 0.0 111.99 -0.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.831 HG21 ' CG1' ' A' ' 70' ' ' VAL . 86.9 m -164.22 108.23 0.96 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.8 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.749 HD12 ' C ' ' A' ' 75' ' ' THR . 3.9 mp -123.56 119.3 29.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.574 HD12 ' CE2' ' A' ' 79' ' ' TYR . 26.3 pt -110.37 152.8 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.017 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -127.03 122.84 35.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.051 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.574 ' CE2' HD12 ' A' ' 77' ' ' ILE . 68.7 m-85 -109.68 136.99 48.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.21 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -118.11 -36.45 3.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.311 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.98 49.57 0.8 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.906 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.54 28.0 66.9 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.777 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' O ' HG13 ' A' ' 85' ' ' VAL . 34.9 mmtp -145.94 114.28 6.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.751 0.31 . . . . 0.0 110.962 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.442 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 11.9 pt-20 -58.08 123.94 17.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.662 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 86' ' ' THR . 35.4 m -136.04 -44.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.494 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 94.3 m -103.33 105.36 15.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 110.619 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -103.49 147.86 26.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.455 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 48.4 t -138.28 82.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.798 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 74' ' ' PRO . 45.4 t -109.54 62.78 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.11 127.05 1.42 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.259 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HB1' HG12 ' A' ' 37' ' ' ILE . . . -55.25 124.68 17.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.774 0.321 . . . . 0.0 111.049 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -176.15 103.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.612 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 11.2 Cg_endo -56.2 -13.98 10.9 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.652 2.235 . . . . 0.0 113.23 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -96.91 -44.56 6.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 0.0 111.102 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.69 -31.18 15.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 110.625 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.835 HD13 HG22 ' A' ' 41' ' ' ILE . 4.2 tp -58.03 -44.84 87.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.05 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -61.32 -75.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.934 0.397 . . . . 0.0 111.2 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -44.66 -32.92 1.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.542 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.98 -41.74 77.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.405 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.884 HG23 HD21 ' A' ' 21' ' ' LEU . 73.7 mt -84.96 -44.34 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.338 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.57 -13.48 59.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.6 p -90.14 -26.32 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.48 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 49.8 m-80 -114.72 -19.43 11.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.658 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.497 ' HA ' HD22 ' A' ' 21' ' ' LEU . 9.1 p . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.614 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.835 0.35 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.711 HG13 ' HB2' ' A' ' 55' ' ' LYS . 59.4 t -48.23 121.72 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -106.61 170.51 7.89 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.249 0.547 . . . . 0.0 110.974 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 3' ' ' THR . 14.1 mp0 -111.71 98.17 7.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.001 178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.679 HD22 HD11 ' A' ' 56' ' ' LEU . 5.4 mp -88.98 119.61 29.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.845 0.355 . . . . 0.0 111.168 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -107.86 -69.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.906 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.6 t -84.56 162.86 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.13 -29.45 60.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.3 p -59.67 -33.39 71.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.05 -31.58 70.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.611 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 45.4 t80 -90.14 -36.37 14.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -58.61 -54.64 44.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -67.81 -20.12 65.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.279 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.667 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -69.59 -53.27 19.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.215 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.842 HD23 HG11 ' A' ' 22' ' ' VAL . 85.1 mt -58.63 -28.85 66.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.11 -58.87 2.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.356 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -55.96 -72.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.98 129.37 47.36 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.646 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -125.23 22.9 7.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.655 0.264 . . . . 0.0 111.17 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -96.54 -75.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.811 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.86 HD22 ' HB ' ' A' ' 104' ' ' VAL . 20.3 tp -159.09 107.33 1.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.965 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.842 HG11 HD23 ' A' ' 15' ' ' LEU . 52.2 t -103.57 112.91 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.623 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.9 114.68 43.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.584 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.704 ' HB ' HD11 ' A' ' 77' ' ' ILE . 54.8 t -100.28 145.1 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.399 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 38.3 t70 -127.07 92.76 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 0.0 111.595 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.742 ' CE1' HD22 ' A' ' 56' ' ' LEU . 72.6 m-85 -88.84 94.87 10.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.832 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.546 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 5.3 p90 -129.69 122.24 28.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.421 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -93.24 79.45 4.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.363 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 29' ' ' THR . 4.7 t -48.1 94.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.983 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.572 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.8 m-90 -92.06 -48.65 6.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 44.7 t 150.02 58.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.935 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.19 -121.9 0.58 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.655 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' O ' HG12 ' A' ' 37' ' ' ILE . 32.0 Cg_exo -57.13 -73.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.392 2.061 . . . . 0.0 112.192 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 6.0 p -41.54 -32.06 0.32 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -65.18 -47.36 77.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.039 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 84.2 mtp -84.81 -23.2 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.395 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 37' ' ' ILE . 49.0 mm -75.53 -7.55 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.425 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.916 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -63.77 -63.98 3.37 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.916 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 72.3 Cg_exo -48.64 -38.49 36.6 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.323 2.015 . . . . 0.0 112.905 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 64.1 mtt -52.5 -82.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.15 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.004 HG22 HD12 ' A' ' 96' ' ' ILE . 2.5 pp -56.38 -26.98 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.16 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.897 ' N ' HD12 ' A' ' 41' ' ' ILE . 89.4 tt0 -72.24 -25.85 61.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.399 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.463 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -85.89 -48.25 8.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.017 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -54.06 -27.46 32.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -56.8 -27.35 59.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.811 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -89.96 -10.78 43.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.095 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -90.08 16.85 7.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.668 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -131.88 158.37 41.54 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.9 m -95.63 -33.78 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -136.39 77.76 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.835 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.473 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -130.76 116.63 18.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.103 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.85 94.79 9.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.957 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.473 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 9.8 m-85 -90.03 128.55 36.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.638 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.667 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 18.6 m-30 -114.91 96.12 5.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.982 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.789 ' C ' HD12 ' A' ' 56' ' ' LEU . 87.4 tttt -89.79 120.88 31.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.333 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.789 HD12 ' C ' ' A' ' 55' ' ' LYS . 3.6 mp -129.79 -175.94 3.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.471 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.48 ' OD1' HG12 ' A' ' 58' ' ' VAL . 62.5 t0 -137.12 -82.44 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.953 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.48 HG12 ' OD1' ' A' ' 57' ' ' ASP . 7.7 p 177.83 -37.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.744 0.307 . . . . 0.0 111.025 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -98.22 -31.46 12.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -60.45 -38.01 82.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.831 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.459 HG21 HD23 ' A' ' 56' ' ' LEU . 45.3 t -103.81 -50.82 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.1 t 68.24 -63.92 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.254 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.46 -67.4 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.471 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.4 t -57.41 -61.03 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.029 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.89 -28.9 2.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.387 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -76.02 -62.23 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.739 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.501 ' HD3' ' N ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -60.35 -29.44 68.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.598 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -88.25 80.79 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.895 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -53.75 95.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 68' ' ' ALA . 47.3 t -86.94 157.77 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.273 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.483 ' N ' HG12 ' A' ' 70' ' ' VAL . 80.6 p -149.6 128.52 12.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.73 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.4 m 62.43 82.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.933 0.397 . . . . 0.0 110.553 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.528 ' HE2' ' HA ' ' A' ' 27' ' ' PHE . 38.2 mtp -84.3 152.32 61.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.617 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.07 173.28 53.0 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 123.63 -1.404 . . . . 0.0 112.71 0.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 1.053 HG23 HG12 ' A' ' 89' ' ' VAL . 94.0 m -147.86 132.25 17.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.607 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.886 HD21 HG21 ' A' ' 41' ' ' ILE . 4.1 mp -124.59 142.31 51.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.207 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.744 HD13 ' N ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -139.36 147.47 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.833 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.5 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.6 m-85 -117.87 121.3 40.37 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.051 0.453 . . . . 0.0 111.435 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 61.2 m-85 -109.65 130.4 55.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.002 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -128.61 53.53 1.83 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.219 0.533 . . . . 0.0 109.924 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.21 41.4 0.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.146 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.34 37.03 86.26 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.078 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -151.09 107.76 3.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.69 0.281 . . . . 0.0 111.242 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 44.4 tt0 -58.77 126.82 29.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.169 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 86' ' ' THR . 22.3 m -138.67 -46.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 71.5 p -113.4 77.88 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.126 0.489 . . . . 0.0 111.045 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -80.7 158.84 25.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.147 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.476 HG21 ' CB ' ' A' ' 99' ' ' ALA . 60.0 t -141.52 85.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.697 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 1.053 HG12 HG23 ' A' ' 75' ' ' THR . 35.1 m -109.26 78.06 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.139 0.495 . . . . 0.0 111.294 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.99 148.05 16.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.325 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.26 76.38 7.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.872 0.367 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -156.48 125.6 3.08 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.848 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.58 -6.89 20.1 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.49 2.127 . . . . 0.0 112.79 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.51 -36.32 12.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.0 110.94 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 99' ' ' ALA . . . -50.14 -28.08 6.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.159 0.504 . . . . 0.0 110.204 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.004 HD12 HG22 ' A' ' 41' ' ' ILE . 6.1 tt -80.92 -33.03 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.729 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.43 -61.05 2.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -75.69 -5.92 47.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.641 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -89.7 -43.94 10.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.797 0.332 . . . . 0.0 111.244 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.684 HG23 ' CD2' ' A' ' 21' ' ' LEU . 63.0 mt -74.13 -53.81 16.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.782 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.28 -20.94 31.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.652 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.9 p -82.95 -75.52 0.31 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.664 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.541 ' OD1' HD12 ' A' ' 21' ' ' LEU . 20.8 t-20 -52.72 -37.82 59.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.118 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.86 ' HB ' HD22 ' A' ' 21' ' ' LEU . 14.8 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.485 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.861 0.363 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.512 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 59.6 t -57.57 145.18 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.48 ' HB ' HD11 ' A' ' 5' ' ' LEU . 2.2 m -107.84 158.62 17.17 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -96.71 92.6 6.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.683 HD22 HD21 ' A' ' 56' ' ' LEU . 4.8 mp -88.9 109.94 20.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.704 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -104.53 -55.65 2.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.34 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.0 t -101.49 151.68 21.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.55 67.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.5 p -55.87 -31.31 62.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.909 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -69.23 -36.73 77.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.757 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.519 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 48.3 t80 -60.66 -40.94 93.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.85 -65.87 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -57.8 -24.6 58.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.019 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HB1' ' CE2' ' A' ' 54' ' ' TYR . . . -57.95 -54.8 42.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.709 HD23 HG21 ' A' ' 22' ' ' VAL . 80.8 mt -82.92 1.39 39.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.332 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.06 -74.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.786 0.327 . . . . 0.0 111.245 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.1 p -71.83 -34.42 69.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.08 119.08 7.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.573 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.78 26.69 5.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.02 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -93.96 -70.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.687 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.568 ' C ' HD23 ' A' ' 21' ' ' LEU . 4.2 tt -174.86 105.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.368 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.709 HG21 HD23 ' A' ' 15' ' ' LEU . 49.3 t -99.82 132.62 44.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 ' CD2' ' A' ' 21' ' ' LEU . 46.1 t -127.82 115.48 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.142 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.505 HG11 ' CE2' ' A' ' 26' ' ' PHE . 47.2 t -99.96 117.79 45.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.711 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -106.94 99.44 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.505 ' CE2' HG11 ' A' ' 24' ' ' VAL . 53.8 m-85 -90.41 111.24 22.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.999 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.41 ' CE1' ' O ' ' A' ' 56' ' ' LEU . 1.7 p90 -144.56 120.02 10.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.615 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.915 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -85.57 10.33 13.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.538 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.8 p 49.65 51.01 17.29 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.017 0.437 . . . . 0.0 111.204 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.915 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.3 m-90 -67.12 -62.31 1.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.971 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.4 t 160.48 127.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.461 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.25 -118.78 4.08 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.314 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.595 ' CB ' HD12 ' A' ' 37' ' ' ILE . 20.9 Cg_endo -61.33 -43.57 27.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.601 2.201 . . . . 0.0 112.81 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 26.3 p -69.96 63.39 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 0.0 111.268 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 35' ' ' LYS . 7.2 ttpm? 176.1 -53.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.486 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.0 tpt -84.09 -30.05 26.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.595 HD12 ' CB ' ' A' ' 33' ' ' PRO . 54.6 mt -86.87 -30.43 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.984 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -48.37 -52.63 41.37 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.55 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.698 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 74.0 Cg_exo -49.24 -43.5 37.07 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.039 1.826 . . . . 0.0 111.495 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.822 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 71.0 mtp -60.33 -22.04 62.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.994 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.603 HD13 HD21 ' A' ' 76' ' ' LEU . 13.3 mt -91.62 -55.78 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.151 0.5 . . . . 0.0 110.085 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 3.9 tm-20 -54.94 -57.06 13.18 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.72 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.524 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 5.4 ttpm? -49.62 -47.97 49.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.075 0.464 . . . . 0.0 110.465 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.822 ' CD1' ' O ' ' A' ' 40' ' ' MET . 7.1 m-85 -54.59 -23.93 18.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.192 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -58.46 -28.14 65.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.031 0.444 . . . . 0.0 110.678 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -89.7 -11.25 42.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.068 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.03 15.57 9.86 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.608 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' CD2' HG21 ' A' ' 100' ' ' ILE . 42.3 m-85 -125.68 145.45 50.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.839 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.8 p -66.54 -47.06 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 104' ' ' VAL . 12.0 p-10 -143.7 99.26 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.988 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.14 122.7 16.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -90.03 97.66 11.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 45' ' ' ALA . 8.6 m-85 -89.89 126.2 35.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.883 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.63 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 19.3 m-30 -119.37 104.18 10.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.54 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HE3' HG11 ' A' ' 2' ' ' VAL . 40.2 ttmt -89.79 123.5 33.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.091 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.736 HD22 HG11 ' A' ' 61' ' ' VAL . 86.4 mt -128.72 158.93 37.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.855 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -145.69 -176.58 5.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 59' ' ' ASP . 11.1 p -90.54 158.85 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.067 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.489 ' N ' HG22 ' A' ' 58' ' ' VAL . 7.9 t70 67.22 -70.0 0.12 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -55.6 -30.37 60.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.98 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.736 HG11 HD22 ' A' ' 56' ' ' LEU . 45.2 t -137.72 53.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.967 0.413 . . . . 0.0 110.936 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.6 t -71.44 -28.68 64.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -58.36 -40.25 81.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.055 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.632 HG11 ' CD1' ' A' ' 56' ' ' LEU . 44.4 t -75.8 -52.85 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.83 -39.41 58.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.21 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -60.87 -31.78 71.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.815 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -81.55 -47.4 13.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.789 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.86 77.66 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.121 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.6 118.12 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.818 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.824 ' CG1' HG21 ' A' ' 75' ' ' THR . 31.5 m -130.73 150.75 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.221 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.7 m -133.78 57.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.98 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.7 m -141.84 -169.38 2.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.548 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.1 ptp -166.11 91.59 0.83 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.447 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 83.2 Cg_endo -84.66 -163.79 3.09 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 124.063 -1.224 . . . . 0.0 112.393 -0.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.824 HG21 ' CG1' ' A' ' 70' ' ' VAL . 89.8 m -133.48 118.04 17.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.586 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.753 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -123.74 137.23 54.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.847 0.356 . . . . 0.0 111.278 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.504 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 28.7 pt -133.72 162.72 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.834 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.524 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.0 m-85 -132.41 128.64 37.97 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 111.242 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.504 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 71.2 m-85 -109.89 158.82 17.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.742 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -156.6 73.46 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.794 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.28 -18.65 23.12 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.505 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.01 48.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.26 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -169.96 127.64 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.995 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.66 98.69 5.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.3 m -110.75 -28.32 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.364 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 99.7 m -114.84 103.3 10.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.918 0.389 . . . . 0.0 110.269 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -107.36 157.67 17.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.266 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -155.27 81.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.717 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 89' ' ' VAL . 35.8 m -109.64 106.14 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.333 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.06 -113.43 0.29 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.426 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -178.19 77.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 111.035 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -151.86 129.35 5.74 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.602 ' HB2' ' HE2' ' A' ' 40' ' ' MET . 87.0 Cg_endo -82.39 9.59 3.94 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.635 2.223 . . . . 0.0 113.021 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.91 -50.78 3.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.732 0.301 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.96 -27.93 14.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 110.614 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.45 HG22 ' C ' ' A' ' 93' ' ' PRO . 4.4 tp -54.14 -43.47 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.194 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -71.92 -71.51 0.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.031 0.443 . . . . 0.0 111.129 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -44.2 -32.19 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.583 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.24 -51.39 15.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.181 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 100' ' ' ILE . 66.4 mt -76.26 -5.14 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.496 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.55 -24.61 21.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 0.0 111.38 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -89.98 -59.38 2.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.31 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.461 HD21 HG21 ' A' ' 86' ' ' THR . 59.6 m-80 -54.62 -43.1 71.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.101 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.511 ' N ' HD12 ' A' ' 21' ' ' LEU . 10.2 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.373 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.858 0.361 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 53' ' ' PHE . 46.8 t -57.63 137.44 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.672 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.5 m -89.94 168.05 12.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 110.871 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.416 ' H ' HG22 ' A' ' 3' ' ' THR . 14.7 mp0 -108.51 94.8 5.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.886 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.84 ' HB2' HD21 ' A' ' 56' ' ' LEU . 4.9 mp -88.96 132.05 34.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.205 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.61 -62.85 0.95 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.669 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 t -86.19 152.98 22.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.17 -28.84 64.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.327 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.5 p -57.42 -30.41 64.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.058 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -74.34 -37.64 63.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.47 -52.43 65.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.22 -56.03 27.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.057 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -57.8 -28.72 64.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.028 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.831 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -68.54 -43.42 76.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.135 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 79' ' ' TYR . 78.3 mt -67.96 -40.34 83.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.044 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.0 -46.45 62.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.204 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.5 m -75.78 -53.43 8.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.057 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.06 115.26 7.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.599 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -113.14 -31.89 6.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.71 0.29 . . . . 0.0 111.039 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -55.91 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.997 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.908 HD13 ' HB2' ' A' ' 103' ' ' ASN . 41.5 tp -159.65 115.98 2.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.569 HG13 ' CE2' ' A' ' 54' ' ' TYR . 54.2 t -111.72 106.34 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.832 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.653 HG21 ' CD1' ' A' ' 100' ' ' ILE . 44.8 t -102.92 144.12 14.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.464 HG11 ' CE2' ' A' ' 26' ' ' PHE . 60.0 t -128.31 146.54 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -135.84 111.8 9.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.944 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.464 ' CE2' HG11 ' A' ' 24' ' ' VAL . 56.5 m-85 -105.44 113.56 27.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.198 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.427 ' HB2' ' CB ' ' A' ' 34' ' ' CYS . 2.1 p90 -147.92 120.72 8.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.721 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.9 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -82.84 9.92 8.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.686 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.2 p 50.57 55.51 9.4 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.059 0.457 . . . . 0.0 111.058 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.9 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.2 m-90 -71.81 -61.88 1.62 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.014 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 39.6 t 158.85 101.77 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.467 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 146.84 -126.69 2.51 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.279 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' LYS . 92.4 Cg_exo -42.73 -60.61 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.962 2.441 . . . . 0.0 113.234 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.427 ' CB ' ' HB2' ' A' ' 27' ' ' PHE . 26.9 p -65.85 66.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.357 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' PRO . 56.6 tptt 176.14 -35.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.3 mtt -81.84 -65.89 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.684 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.662 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -88.16 18.69 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.766 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -63.42 -53.37 53.0 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.648 0.261 . . . . 0.0 110.663 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 52.3 Cg_exo -55.58 -33.07 85.58 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.64 2.227 . . . . 0.0 112.21 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.471 ' CE ' ' HB3' ' A' ' 93' ' ' PRO . 67.3 mtp -54.82 -71.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 110.468 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.483 HG22 ' HB ' ' A' ' 96' ' ' ILE . 7.6 pt -52.44 -39.25 28.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.094 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.28 -27.52 65.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.64 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -79.72 -45.84 18.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -53.62 -25.04 15.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.546 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.789 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -55.79 -29.97 60.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.732 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -87.63 -3.12 58.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.877 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -90.27 -35.24 15.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.542 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.796 ' CE2' HG21 ' A' ' 100' ' ' ILE . 45.7 m-85 -76.49 157.29 32.28 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.798 0.332 . . . . 0.0 111.183 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.4 p -79.98 -38.36 32.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -155.38 104.07 2.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.133 0.492 . . . . 0.0 111.403 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -150.13 125.69 10.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.104 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.32 107.46 19.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 110.771 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.789 ' CE2' ' HB1' ' A' ' 45' ' ' ALA . 9.3 m-85 -99.96 130.79 46.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.004 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.831 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 20.5 m-30 -113.9 119.73 38.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' HG11 ' A' ' 2' ' ' VAL . 61.4 tttp -104.11 115.02 29.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.883 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.84 HD21 ' HB2' ' A' ' 5' ' ' LEU . 89.7 mt -134.68 170.7 15.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.237 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.28 153.59 46.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.644 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.873 ' HB ' ' HB2' ' A' ' 28' ' ' ALA . 47.3 t -88.09 55.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.986 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -177.46 -65.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.054 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.53 -30.65 61.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.036 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.431 HG21 HD22 ' A' ' 56' ' ' LEU . 51.2 t -102.13 -58.84 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.814 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.9 t 67.35 -64.64 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.393 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -40.6 -68.39 0.18 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.828 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.671 HG11 ' CD1' ' A' ' 56' ' ' LEU . 59.7 t -52.13 -44.21 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.163 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.31 56.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -57.15 -68.24 0.25 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.988 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.94 -25.37 57.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.72 74.49 7.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.311 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.0 mp0 -69.89 105.97 3.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.762 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.626 ' CB ' HG21 ' A' ' 75' ' ' THR . 35.2 m -132.95 -178.58 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.8 p -164.48 72.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.819 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -157.54 -170.17 3.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.609 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.517 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.8 ptt? -165.81 98.56 0.76 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.192 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 2.8 Cg_exo -75.76 -155.43 1.06 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.261 -1.141 . . . . 0.0 112.129 0.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.626 HG21 ' CB ' ' A' ' 70' ' ' VAL . 86.7 m -155.65 100.66 2.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.587 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 76' ' ' LEU . 3.9 mp -113.85 162.79 15.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.917 0.389 . . . . 0.0 111.256 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.561 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 17.1 pt -156.89 160.18 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.82 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.634 ' HE2' HD13 ' A' ' 100' ' ' ILE . 1.3 m-85 -128.68 123.05 32.16 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.984 0.421 . . . . 0.0 111.368 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.562 ' CD2' HD22 ' A' ' 15' ' ' LEU . 69.8 m-85 -109.91 101.79 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.831 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -62.97 -70.53 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 110.732 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.39 27.32 7.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.368 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.08 49.82 1.69 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.364 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' O ' HG13 ' A' ' 85' ' ' VAL . 24.2 ttmm -169.82 114.96 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.334 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -55.62 99.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 83' ' ' LYS . 35.6 m -121.38 -28.99 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.799 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.43 ' O ' ' CD1' ' A' ' 78' ' ' PHE . 89.1 m -122.44 74.99 1.21 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.818 0.342 . . . . 0.0 110.649 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -82.37 159.6 23.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.2 0.524 . . . . 0.0 111.643 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -156.72 86.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.085 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.641 ' O ' HG23 ' A' ' 89' ' ' VAL . 27.8 m -108.61 87.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.37 0.605 . . . . 0.0 111.28 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.36 -152.06 7.09 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.968 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.42 92.75 2.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.795 0.331 . . . . 0.0 110.998 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -144.53 101.21 4.7 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.071 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 96' ' ' ILE . 32.1 Cg_exo -58.52 -15.14 23.76 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.553 2.169 . . . . 0.0 112.431 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.62 -31.49 13.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 110.83 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.86 -31.33 64.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.797 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 93' ' ' PRO . 3.8 tp -53.76 -33.87 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.072 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -68.29 -67.7 0.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.118 0.485 . . . . 0.0 110.832 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -53.72 -49.48 68.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.492 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.562 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -51.25 -65.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.625 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.796 HG21 ' CE2' ' A' ' 48' ' ' TYR . 41.2 mm -52.33 -48.57 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.419 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . . . -55.41 -21.8 17.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.856 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.5 m -57.55 -50.09 74.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.491 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.908 ' HB2' HD13 ' A' ' 21' ' ' LEU . 21.1 m-80 -122.84 5.56 9.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.621 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 101' ' ' ALA . 13.0 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.623 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.811 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 22.9 ptp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.801 0.334 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.66 HG11 ' HE2' ' A' ' 55' ' ' LYS . 43.9 t -55.94 132.27 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.945 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.3 m -107.13 168.71 9.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 110.803 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.445 ' H ' HG22 ' A' ' 3' ' ' THR . 15.0 mp0 -108.41 98.99 8.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.156 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.688 HD12 HD21 ' A' ' 56' ' ' LEU . 63.2 mt -88.81 96.05 10.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.252 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -89.88 -57.06 2.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.882 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.4 t -95.38 158.43 15.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' OD2' ' A' ' 63' ' ' ASP . . . -73.32 -29.33 62.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.083 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.4 p -57.75 -31.34 66.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -71.19 -31.32 67.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -76.21 -42.64 45.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -70.13 -50.17 43.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -58.97 -28.64 66.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.542 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -70.13 -64.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.458 HD22 ' CG ' ' A' ' 79' ' ' TYR . 81.9 mt -57.44 -21.87 39.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.17 -79.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.446 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.7 m -83.43 -29.62 27.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.197 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.1 104.3 0.23 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.673 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -86.99 -27.38 23.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 0.0 110.705 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -53.62 -176.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.973 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 4.8 tt -86.11 115.84 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.698 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.577 HG13 ' CD2' ' A' ' 54' ' ' TYR . 56.5 t -102.99 127.2 57.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.644 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.42 HG23 HD22 ' A' ' 21' ' ' LEU . 46.3 t -120.12 119.61 60.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 111.368 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.487 HG13 HD12 ' A' ' 56' ' ' LEU . 51.9 t -104.77 124.84 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.482 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -117.21 103.77 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.919 0.39 . . . . 0.0 111.612 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.429 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 75.1 m-85 -93.88 115.28 27.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.948 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.467 ' CD2' ' CG2' ' A' ' 29' ' ' THR . 1.1 p90 -150.19 117.96 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 111.212 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.36 -9.53 58.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.893 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.467 ' CG2' ' CD2' ' A' ' 27' ' ' PHE . 69.4 p 52.73 74.08 0.31 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.361 . . . . 0.0 111.626 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.57 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 2.0 m-90 -80.92 -62.58 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 43.6 t 158.86 69.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.459 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.4 -121.11 0.78 Allowed Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.927 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.16 -52.1 6.02 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.702 2.268 . . . . 0.0 112.562 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.5 p -79.77 60.87 3.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.727 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -162.99 -47.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.392 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.2 tpt -83.56 -26.79 29.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.53 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.499 HD11 ' HB1' ' A' ' 91' ' ' ALA . 63.1 mt -79.96 -15.69 13.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.204 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.85 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -52.48 -60.08 7.21 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.403 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.85 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 86.2 Cg_exo -46.93 -36.03 19.44 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.369 2.046 . . . . 0.0 112.605 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.416 ' HB3' ' HB3' ' A' ' 93' ' ' PRO . 55.1 mtt -57.5 -76.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.577 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.904 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -60.23 -24.39 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.908 0.385 . . . . 0.0 110.861 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.904 ' N ' HD12 ' A' ' 41' ' ' ILE . 89.4 tt0 -75.53 -26.58 58.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.489 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 6.6 tmtm? -85.7 -48.3 8.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.177 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.603 ' CD1' HD11 ' A' ' 96' ' ' ILE . 7.4 m-85 -46.33 -29.8 1.81 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.214 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.811 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -52.9 -26.32 14.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -90.06 -30.34 17.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.993 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -62.07 -35.68 79.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.326 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.579 ' CE2' HG21 ' A' ' 100' ' ' ILE . 46.7 m-85 -97.13 155.59 16.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 110.761 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -106.61 -21.77 12.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.309 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.878 ' OD1' HG22 ' A' ' 104' ' ' VAL . 2.9 p30 -125.52 35.32 4.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.764 0.316 . . . . 0.0 111.454 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.8 118.16 36.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.282 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.67 95.84 10.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 13.5 m-85 -89.69 123.34 33.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.607 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.58 ' HB3' HD11 ' A' ' 5' ' ' LEU . 14.7 m-30 -115.82 102.81 10.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.806 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.66 ' HE2' HG11 ' A' ' 2' ' ' VAL . 24.4 ttmm -89.83 124.11 34.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.571 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.688 HD21 HD12 ' A' ' 5' ' ' LEU . 86.2 mt -119.36 146.86 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.293 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -134.39 161.42 35.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.548 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.1 m -77.67 156.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.198 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.1 t0 66.03 -72.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.222 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.44 -30.85 61.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.109 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.574 HG11 HD22 ' A' ' 56' ' ' LEU . 47.4 t -139.95 55.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 55.4 m -80.48 -22.08 41.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 8' ' ' ALA . 12.2 p-10 -47.21 -29.76 2.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.292 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.634 HG11 ' CD1' ' A' ' 56' ' ' LEU . 47.5 t -79.43 -54.85 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.993 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.43 -35.56 19.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.421 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -58.45 -45.24 88.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.765 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -89.51 -65.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.62 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.66 77.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.822 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -50.86 93.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.18 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.0 t -148.83 136.28 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.814 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.3 p -105.21 150.13 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' A' ' 73' ' ' MET . 60.4 p -61.01 -173.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.904 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.683 ' H ' ' HA ' ' A' ' 74' ' ' PRO . 60.3 ttp 167.52 -38.11 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.683 ' HA ' ' H ' ' A' ' 73' ' ' MET . 94.0 Cg_endo -76.57 175.26 48.97 Favored 'Cis proline' 0 C--N 1.36 1.157 0 CA-C-N 120.67 1.275 . . . . 0.0 113.812 0.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.809 ' C ' HD12 ' A' ' 76' ' ' LEU . 56.3 m -127.89 135.82 50.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.764 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.809 HD12 ' C ' ' A' ' 75' ' ' THR . 4.1 mp -129.93 146.18 51.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.906 0.384 . . . . 0.0 111.231 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.533 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 29.2 pt -143.15 159.86 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.812 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.485 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 1.3 m-85 -129.57 126.87 39.51 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 111.505 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.533 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 67.5 m-85 -109.69 153.62 24.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.752 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -114.89 -38.78 3.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.975 0.417 . . . . 0.0 110.454 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.77 28.44 0.31 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.067 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.1 42.28 2.1 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.278 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -165.31 109.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.674 0.273 . . . . 0.0 111.13 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.04 115.49 3.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.443 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 m -126.34 -43.2 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 64.5 p -112.31 83.41 1.8 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.151 0.5 . . . . 0.0 110.795 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.527 HH21 HG11 ' A' ' 89' ' ' VAL . 16.5 ptm180 -83.09 166.17 18.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.592 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.8 t -156.72 87.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.967 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.722 HG12 HG23 ' A' ' 75' ' ' THR . 34.3 m -108.76 107.7 23.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.16 0.505 . . . . 0.0 111.337 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -169.77 -118.95 0.47 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.19 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 37' ' ' ILE . . . 177.77 56.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.796 0.331 . . . . 0.0 111.133 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -146.28 134.27 10.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.122 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.553 ' O ' HG12 ' A' ' 96' ' ' ILE . 57.1 Cg_endo -73.67 -19.32 21.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.413 2.075 . . . . 0.0 112.158 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.04 62.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.801 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.11 -39.85 12.62 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.511 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.628 HG21 ' CG2' ' A' ' 41' ' ' ILE . 21.2 pt -59.74 -35.38 59.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.888 0.375 . . . . 0.0 110.822 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -55.23 -70.41 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.948 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -59.94 -29.87 68.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.855 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.482 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -64.45 -42.81 95.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.064 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.602 HG23 HD13 ' A' ' 21' ' ' LEU . 75.5 mt -82.34 -31.84 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.63 -27.55 65.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.028 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.7 p -58.28 -58.22 9.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.081 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -128.06 54.54 1.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.878 HG22 ' OD1' ' A' ' 50' ' ' ASP . 10.0 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.035 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.867 0.365 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.6 t -83.63 136.84 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.8 p -105.01 172.17 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.476 0.655 . . . . 0.0 111.764 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -127.16 107.99 10.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.626 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.657 HD12 HD11 ' A' ' 56' ' ' LEU . 80.6 mt -89.16 88.37 7.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.007 0.432 . . . . 0.0 111.362 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.96 -43.55 10.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.198 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.4 t -105.58 137.41 43.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.783 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.633 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . . . -54.15 -25.86 24.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.416 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -59.17 -28.75 66.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.037 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.627 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 43.5 mt-10 -77.92 -26.28 48.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.029 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -78.54 -54.3 6.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.127 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -57.32 -59.86 4.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -57.18 -25.52 59.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.279 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.748 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -67.58 -61.91 1.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.792 0.33 . . . . 0.0 111.373 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -53.64 -24.59 14.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.233 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.07 -68.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.309 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.9 m -60.06 -63.51 1.27 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.42 121.9 24.39 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.732 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -124.01 -1.04 8.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -69.29 -76.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.716 0.293 . . . . 0.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 104' ' ' VAL . 3.7 tt -167.5 110.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.563 HG13 ' CE2' ' A' ' 54' ' ' TYR . 60.2 t -102.34 132.6 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.534 HG23 ' CD2' ' A' ' 21' ' ' LEU . 47.8 t -134.37 118.29 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.277 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.773 HG13 HD13 ' A' ' 56' ' ' LEU . 43.5 t -99.98 123.09 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.452 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -110.86 87.81 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.591 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 24' ' ' VAL . 60.6 m-85 -82.14 112.22 18.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.809 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 3.7 p90 -133.32 117.06 16.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.952 0.406 . . . . 0.0 111.324 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 58' ' ' VAL . . . -94.43 107.22 19.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.583 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.416 ' HB ' ' CE ' ' A' ' 35' ' ' LYS . 73.8 p -53.7 114.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.1 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.448 ' CD2' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -179.56 42.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -176.54 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.156 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 152.37 -44.51 0.63 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.219 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 82.7 Cg_exo -45.56 -63.62 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.572 2.181 . . . . 0.0 112.746 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 7.7 p -49.48 -45.53 46.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' CE ' ' HB ' ' A' ' 29' ' ' THR . 99.6 mttt -58.5 -36.99 74.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.123 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.2 tpt -73.36 -26.51 61.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.019 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 37' ' ' ILE . 40.9 mm -90.37 27.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.361 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.811 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -86.82 -54.98 0.37 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.084 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 40.9 Cg_exo -57.31 -33.12 95.58 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.423 2.082 . . . . 0.0 112.298 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.416 ' CE ' ' HG3' ' A' ' 93' ' ' PRO . 57.4 mtt -60.56 -75.56 0.06 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 0.0 110.485 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.884 HG22 HD12 ' A' ' 96' ' ' ILE . 12.9 pt -51.57 -30.18 10.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.188 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -78.82 -30.71 45.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.463 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 39' ' ' PRO . 87.9 tttt -84.31 -38.26 20.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -48.24 -25.35 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.773 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 53' ' ' PHE . . . -55.27 -32.35 62.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.15 0.5 . . . . 0.0 110.587 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -85.28 -5.1 59.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -90.14 -51.62 5.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.299 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.451 ' CE2' HG13 ' A' ' 100' ' ' ILE . 50.5 m-85 -79.74 172.41 13.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.174 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.2 p -105.56 -29.68 10.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.241 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -148.72 80.17 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.435 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.742 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -128.44 124.54 36.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.208 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.45 106.79 18.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.041 0.448 . . . . 0.0 110.688 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 51' ' ' ALA . 21.6 m-85 -99.9 119.44 38.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.232 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.748 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 15.1 m-30 -111.24 96.56 6.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.048 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.636 ' C ' HD12 ' A' ' 56' ' ' LEU . 87.7 tttt -89.83 110.55 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.448 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.786 HD23 HG11 ' A' ' 61' ' ' VAL . 3.8 mp -118.78 157.87 26.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 0.0 111.485 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -129.78 162.31 28.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.353 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 28' ' ' ALA . 54.8 t -64.94 -32.47 58.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.432 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -97.82 -62.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.147 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -52.44 -26.06 11.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.15 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.786 HG11 HD23 ' A' ' 56' ' ' LEU . 42.0 t -133.77 60.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.3 t -81.11 0.66 35.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.415 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.633 ' OD1' ' HB2' ' A' ' 8' ' ' ALA . 7.7 t0 -90.04 -49.1 6.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 111.041 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 68' ' ' ALA . 48.2 t -59.58 -51.53 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.18 -29.52 1.6 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.639 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -63.95 -71.32 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.001 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -65.48 -42.6 92.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 64' ' ' VAL . . . -90.04 76.78 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -58.42 100.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.88 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 71' ' ' SER . 48.6 t -141.79 157.38 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.151 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 70' ' ' VAL . 50.7 m -86.91 -173.99 4.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.524 ' C ' ' HA ' ' A' ' 74' ' ' PRO . 81.1 p -167.18 79.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.011 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.685 ' N ' ' HA ' ' A' ' 74' ' ' PRO . 23.2 ptp -115.85 8.05 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.685 ' HA ' ' N ' ' A' ' 73' ' ' MET . 73.0 Cg_endo -83.04 -167.33 5.51 Favored 'Cis proline' 0 C--N 1.361 1.225 0 CA-C-N 121.442 1.551 . . . . 0.0 112.62 -0.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.884 HG23 HG12 ' A' ' 89' ' ' VAL . 96.4 m -140.98 133.93 29.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.977 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.761 HD12 ' C ' ' A' ' 75' ' ' THR . 4.1 mp -124.96 115.51 20.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.842 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.4 pt -109.88 158.68 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.762 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.656 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.1 m-85 -131.15 131.4 44.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.397 . . . . 0.0 111.217 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.487 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 83.9 m-85 -109.36 141.57 41.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.674 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -122.17 68.01 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 0.0 110.77 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.85 26.75 13.96 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.207 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.6 53.43 2.27 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.364 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.443 ' NZ ' HG11 ' A' ' 85' ' ' VAL . 26.8 ttpp -176.54 122.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 85' ' ' VAL . 52.1 mt-10 -65.76 138.47 57.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.647 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 84' ' ' GLU . 15.5 m -157.19 -39.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.527 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.656 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 88.0 m -105.73 106.93 17.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.951 0.405 . . . . 0.0 110.116 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.455 ' NH2' HG22 ' A' ' 89' ' ' VAL . 8.7 ptm180 -104.23 149.52 25.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.584 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.52 HG11 ' O ' ' A' ' 95' ' ' ALA . 41.6 t -154.55 81.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.534 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.884 HG12 HG23 ' A' ' 75' ' ' THR . 33.2 m -109.64 111.12 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.21 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -117.57 0.42 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.29 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -178.23 71.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 0.0 111.049 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.682 ' ND2' ' HB3' ' A' ' 94' ' ' ALA . 49.8 t30 -150.93 139.31 12.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.661 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 92' ' ' ASN . 18.9 Cg_exo -65.01 -24.86 59.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.414 2.076 . . . . 0.0 112.275 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.682 ' HB3' ' ND2' ' A' ' 92' ' ' ASN . . . -84.53 -27.19 27.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.925 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.52 ' O ' HG11 ' A' ' 88' ' ' VAL . . . -50.39 -27.61 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.093 0.473 . . . . 0.0 110.213 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.884 HD12 HG22 ' A' ' 41' ' ' ILE . 5.8 tt -90.06 -38.23 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.771 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -61.81 -57.68 10.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.718 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.44 -13.68 61.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.625 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -84.72 -60.61 2.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.787 0.327 . . . . 0.0 111.535 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.458 HG23 HD13 ' A' ' 21' ' ' LEU . 46.3 mm -47.48 -41.85 7.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.139 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.07 -23.4 46.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.218 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -55.72 -65.43 0.6 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -131.87 65.66 1.57 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.09 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.698 ' HA ' HD12 ' A' ' 21' ' ' LEU . 9.4 p . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.052 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.541 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 8.7 p -63.77 156.92 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.066 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.465 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -118.6 174.29 6.35 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 111.119 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -125.79 105.96 9.34 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.926 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.84 HD11 ' HB3' ' A' ' 54' ' ' TYR . 63.0 mt -88.89 127.47 35.64 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.103 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.712 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 8.8 mmpt? -118.15 -50.42 2.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.759 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.2 t -102.57 159.92 15.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.192 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.73 -29.93 65.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.9 p -56.02 -30.77 62.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.867 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -70.41 -30.62 67.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.766 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.871 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 45.6 t80 -75.37 -46.6 32.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.001 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.26 -50.55 45.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -56.65 -23.26 40.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.488 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.565 ' HB1' ' CE2' ' A' ' 54' ' ' TYR . . . -84.09 -60.24 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.518 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.871 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 86.0 mt -52.06 -25.52 8.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.162 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.64 -55.73 4.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.2 m -90.39 23.3 3.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.396 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.63 149.59 22.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.438 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -156.3 -46.53 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -58.55 -75.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.852 ' CD2' HG23 ' A' ' 100' ' ' ILE . 28.5 tp -167.47 120.69 0.94 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.808 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.76 HG11 HD23 ' A' ' 15' ' ' LEU . 61.8 t -111.56 124.52 68.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.2 t -128.32 126.22 65.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.584 ' CG2' HD11 ' A' ' 77' ' ' ILE . 57.5 t -112.09 114.0 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.804 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' OD1' ' HG ' ' A' ' 76' ' ' LEU . 24.3 m-20 -111.42 102.78 11.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.237 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.573 ' CE1' HD12 ' A' ' 56' ' ' LEU . 49.6 m-85 -91.7 107.99 19.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.997 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 2.4 p90 -149.01 121.27 8.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.623 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.713 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -90.26 20.12 4.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.586 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p 49.7 55.84 8.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.976 0.417 . . . . 0.0 111.112 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.713 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.5 m-90 -71.24 -61.74 1.66 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.214 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 43.1 t 164.38 129.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.521 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.81 -122.54 5.38 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.031 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.37 -47.45 5.9 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.56 2.173 . . . . 0.0 112.721 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 26.5 p -52.25 -23.88 6.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.6 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -107.76 -37.56 6.1 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.423 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.3 tpt -76.27 -40.38 51.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 111.351 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 37' ' ' ILE . 59.9 mt -79.0 -1.06 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.661 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.924 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -51.44 -63.3 2.1 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 74.7 Cg_exo -50.28 -35.37 43.5 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.213 1.942 . . . . 0.0 113.237 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' A' ' 93' ' ' PRO . 60.7 mtp -65.49 -69.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.621 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.801 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -56.35 -20.28 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.217 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.801 ' N ' HD12 ' A' ' 41' ' ' ILE . 3.7 mm-40 -86.95 -32.95 19.84 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.1 ttpt -78.27 -44.32 25.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.158 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.19 -32.04 71.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.584 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -54.06 -27.76 34.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.016 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.01 -34.61 16.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.739 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -58.87 -27.83 65.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.073 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CE2' HD12 ' A' ' 100' ' ' ILE . 44.6 m-85 -81.78 155.76 25.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.893 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.5 m -89.24 -32.08 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -151.92 96.87 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.09 112.42 4.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.82 106.93 18.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.172 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 2.1 m-85 -89.91 124.6 34.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.744 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.84 ' HB3' HD11 ' A' ' 5' ' ' LEU . 17.8 m-30 -112.43 90.52 3.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.486 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.728 ' NZ ' HD13 ' A' ' 41' ' ' ILE . 68.6 mttm -89.84 156.51 18.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.225 0.536 . . . . 0.0 111.791 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.819 ' CD1' HG11 ' A' ' 64' ' ' VAL . 93.6 mt -151.43 -177.7 6.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.636 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -149.15 133.3 17.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.754 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 58' ' ' VAL . 48.6 t -74.76 60.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.077 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.7 t70 178.82 -63.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.621 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -59.37 -30.13 68.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.426 HG21 HD22 ' A' ' 56' ' ' LEU . 45.0 t -100.78 -58.29 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.048 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 t 68.0 -62.44 0.35 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.423 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -43.71 -61.57 1.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.765 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.819 HG11 ' CD1' ' A' ' 56' ' ' LEU . 58.2 t -57.11 -57.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.808 0.337 . . . . 0.0 111.212 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.99 -31.62 0.95 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.787 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -60.26 -58.64 7.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.876 0.37 . . . . 0.0 110.674 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.549 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.42 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.503 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -65.71 79.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.76 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.25 122.86 9.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.243 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.559 HG13 ' OG1' ' A' ' 75' ' ' THR . 60.7 t -120.08 127.92 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.9 m -134.96 45.14 2.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.6 t -146.36 -163.48 1.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.687 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 19.9 ptm -171.35 92.67 0.43 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.405 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 69.4 Cg_endo -86.11 -163.52 2.78 Favored 'Cis proline' 0 C--N 1.349 0.6 0 C-N-CA 124.132 -1.195 . . . . 0.0 112.427 0.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.559 ' OG1' HG13 ' A' ' 70' ' ' VAL . 91.9 m -138.98 106.72 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.437 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 76' ' ' LEU . 2.4 mp -118.84 128.58 54.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.302 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 77' ' ' ILE . 2.4 pp -128.57 173.0 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.886 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.658 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 8.2 m-85 -135.0 120.44 19.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.959 0.409 . . . . 0.0 111.746 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.511 ' CD2' HD13 ' A' ' 77' ' ' ILE . 47.2 m-85 -109.8 137.9 46.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.522 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -106.04 -59.74 1.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 0.0 110.753 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.42 29.52 3.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.141 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.54 35.65 3.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.229 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' NZ ' ' HB3' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -151.88 124.2 8.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 111.142 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.4 tt0 -78.94 98.6 6.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.549 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.75 -37.49 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.684 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.658 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 74.7 m -109.79 110.79 21.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.221 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -122.6 145.07 48.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.593 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.714 ' O ' HG23 ' A' ' 88' ' ' VAL . 30.5 m -139.86 83.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.714 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.568 ' O ' HG23 ' A' ' 89' ' ' VAL . 32.8 m -109.44 66.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.294 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -144.9 17.2 1.97 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.523 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.13 56.45 5.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.349 . . . . 0.0 111.127 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.554 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 5.0 m120 -106.49 101.19 34.36 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.198 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HB3' ' SD ' ' A' ' 40' ' ' MET . 8.3 Cg_exo -71.28 -17.41 30.98 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.726 2.284 . . . . 0.0 112.195 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.77 -43.44 5.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.554 ' HB3' ' CB ' ' A' ' 92' ' ' ASN . . . -50.51 -28.42 8.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.228 0.537 . . . . 0.0 110.186 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.582 ' CD1' HG22 ' A' ' 41' ' ' ILE . 6.6 tt -60.79 -29.34 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.778 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 5.2 tmtm? -55.69 -58.33 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.434 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -72.61 -36.07 68.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.06 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.84 81.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.221 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.852 HG23 ' CD2' ' A' ' 21' ' ' LEU . 63.5 mt -75.04 -37.68 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.133 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.07 -19.17 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.891 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 64.0 m -90.04 -38.55 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 111.581 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.547 ' HB3' HD11 ' A' ' 21' ' ' LEU . 26.8 t-20 -83.66 -39.42 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.428 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.768 ' N ' HD13 ' A' ' 21' ' ' LEU . 11.9 p . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.339 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 46.8 tpp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.896 0.379 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.535 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.9 t -149.43 110.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.817 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 p -89.72 170.75 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.497 0.665 . . . . 0.0 111.658 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.524 ' N ' ' NE2' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -127.97 120.18 27.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.592 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.788 HD11 ' CD2' ' A' ' 54' ' ' TYR . 72.5 mt -88.96 96.21 10.63 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.194 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -89.93 -47.04 8.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.507 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.5 t -104.04 142.33 34.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.79 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.46 -24.69 21.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.299 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.6 p -59.58 -43.9 93.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 36.5 mt-10 -62.87 -25.68 68.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.873 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.505 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 50.9 t80 -90.05 -46.92 8.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.069 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -60.33 -62.94 1.5 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.034 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -55.41 -26.32 41.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.544 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -65.97 -61.3 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.505 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 85.2 mt -54.03 -24.7 18.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.155 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.66 -74.74 0.4 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.231 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -64.77 -48.12 75.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.054 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.68 102.52 0.17 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.601 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -112.21 -22.69 10.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.616 0.246 . . . . 0.0 111.188 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -54.2 -72.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.131 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.862 HD22 ' CA ' ' A' ' 104' ' ' VAL . 52.4 tp -171.38 106.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.939 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.598 HG13 ' CE2' ' A' ' 54' ' ' TYR . 59.4 t -105.09 127.97 59.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.045 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 77' ' ' ILE . 43.7 t -129.67 133.8 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.868 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.455 HG13 HD13 ' A' ' 56' ' ' LEU . 47.5 t -114.83 122.17 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.209 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -114.5 121.62 44.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.59 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 69.5 m-85 -107.83 127.88 54.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.247 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.449 ' CZ ' ' HE3' ' A' ' 55' ' ' LYS . 2.2 p90 -146.44 114.77 6.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.548 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.95 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -89.4 16.95 6.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.578 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p 49.97 52.94 13.68 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.94 0.4 . . . . 0.0 111.471 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.95 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.1 m-90 -73.74 -60.94 2.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.981 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 37.5 t 154.0 134.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.672 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.93 -105.15 3.16 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.681 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . 99.2 Cg_exo -43.12 -62.9 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.883 2.389 . . . . 0.0 113.112 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.4 p -70.9 62.99 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.769 0.318 . . . . 0.0 111.062 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.4 tptt 177.89 -56.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.8 ttt -55.37 -71.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.235 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.905 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -90.26 40.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.237 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -80.6 -57.07 0.63 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.875 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 53.2 Cg_exo -55.13 -26.2 49.57 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.222 1.948 . . . . 0.0 112.053 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 63.6 mtt -60.29 -73.39 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.728 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.928 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.5 pp -57.42 -26.52 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.989 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.928 ' N ' HD12 ' A' ' 41' ' ' ILE . 4.2 tm-20 -77.32 -30.33 54.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.202 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -82.39 -43.01 17.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.05 -29.34 43.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.197 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.636 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.89 -26.72 26.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.034 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -90.02 -29.31 18.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.797 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -66.05 -14.74 62.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.543 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.686 ' CE2' HD13 ' A' ' 100' ' ' ILE . 43.9 m-85 -92.27 161.96 14.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.772 0.32 . . . . 0.0 111.029 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -78.38 -43.67 26.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -155.69 106.28 2.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.118 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.18 127.56 16.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.856 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.69 102.27 14.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.636 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 7.0 m-85 -92.61 116.13 28.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.037 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.788 ' CD2' HD11 ' A' ' 5' ' ' LEU . 12.3 m-30 -106.55 90.94 3.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.172 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.5 ' C ' HD12 ' A' ' 56' ' ' LEU . 63.5 tttp -89.79 106.69 18.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.161 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.649 HD23 HG11 ' A' ' 61' ' ' VAL . 4.1 mp -110.34 141.03 43.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.803 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -80.7 -80.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 p 178.31 -38.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.962 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -103.77 -33.63 8.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.773 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.11 -30.03 67.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 5' ' ' LEU . 48.9 t -100.82 -65.83 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.03 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.1 t 68.42 -64.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.236 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -46.91 -61.0 2.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.411 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.627 ' HB ' HG11 ' A' ' 61' ' ' VAL . 53.5 t -55.75 -56.29 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.172 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.87 -31.45 28.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.315 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -70.9 -28.74 64.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 44.1 mtmt -86.26 -78.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.402 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.92 81.81 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.267 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.28 143.72 57.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.809 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 75' ' ' THR . 28.6 m -156.31 144.79 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.4 p -124.24 68.23 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.984 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.4 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 60.7 m -144.23 176.36 9.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.472 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 67.9 mtm -157.18 96.97 2.06 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 33' ' ' PRO . 90.9 Cg_endo -79.89 -161.88 2.81 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.947 -1.272 . . . . 0.0 112.273 -0.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.688 ' C ' HD12 ' A' ' 76' ' ' LEU . 91.3 m -140.32 112.88 7.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.652 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 75' ' ' THR . 4.0 mp -120.09 142.85 48.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.556 ' O ' HG13 ' A' ' 23' ' ' VAL . 26.0 pt -139.24 162.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.442 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.3 m-85 -132.28 127.52 35.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.95 0.405 . . . . 0.0 111.329 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.439 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 60.1 m-85 -109.93 140.03 44.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.696 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -110.5 -31.96 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.837 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.97 27.75 0.35 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.2 33.96 6.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.373 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -154.32 102.04 2.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.328 . . . . 0.0 110.781 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 39.5 tt0 -53.64 97.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.078 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 83' ' ' LYS . 26.9 m -110.77 -31.21 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.322 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 94.6 m -116.29 101.02 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.234 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -108.68 146.91 32.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.057 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.3 t -136.55 80.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.757 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 89' ' ' VAL . 35.0 m -109.95 103.88 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.232 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.02 -109.45 0.22 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.395 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.16 81.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.31 . . . . 0.0 110.904 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 24.8 t-20 -160.09 112.72 1.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.746 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' O ' HG22 ' A' ' 96' ' ' ILE . 63.9 Cg_exo -52.26 -22.72 16.2 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.629 2.219 . . . . 0.0 112.734 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.438 ' HB3' ' OD1' ' A' ' 92' ' ' ASN . . . -90.56 -30.46 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 92' ' ' ASN . . . -50.98 -27.28 7.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.019 0.438 . . . . 0.0 110.402 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.813 HG21 HG22 ' A' ' 41' ' ' ILE . 6.1 tt -82.65 -35.13 12.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.832 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -69.43 -62.81 1.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.003 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -59.32 -20.3 53.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.349 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -90.11 -40.68 12.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.57 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.816 HG13 HD21 ' A' ' 21' ' ' LEU . 12.0 tt -75.61 -28.05 19.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.743 0.306 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.05 89.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.384 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.8 m -73.22 -24.05 60.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.289 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.63 ' HB3' HD13 ' A' ' 21' ' ' LEU . 5.6 m120 -92.58 -61.78 1.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.862 ' CA ' HD22 ' A' ' 21' ' ' LEU . 11.2 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.886 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.895 0.378 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.843 HG21 ' OE1' ' A' ' 42' ' ' GLU . 55.4 t -63.86 106.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 p -98.96 177.17 5.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.54 0.686 . . . . 0.0 111.73 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -130.52 107.46 9.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.674 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.805 HD23 ' HB2' ' A' ' 11' ' ' TYR . 3.6 mp -89.18 101.21 13.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.078 0.466 . . . . 0.0 111.462 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -89.91 -37.6 14.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.871 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.6 t -111.77 141.09 45.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.06 -23.7 14.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.403 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.5 p -59.74 -45.22 92.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.115 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.763 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 72.0 mt-10 -61.67 -26.02 67.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.805 ' HB2' HD23 ' A' ' 5' ' ' LEU . 48.9 t80 -90.07 -49.47 6.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.071 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -57.1 -67.06 0.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 t -56.09 -24.35 39.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.099 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.836 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -63.21 -57.22 11.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.226 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.434 HD22 ' CG ' ' A' ' 79' ' ' TYR . 83.6 mt -56.2 -26.98 52.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.98 -29.94 18.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.252 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -87.36 -60.51 1.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.038 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.99 114.42 4.54 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.653 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -112.32 -30.18 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.738 0.304 . . . . 0.0 110.924 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -59.17 -76.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.942 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.633 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 25.9 tp -156.28 116.66 3.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.983 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 79' ' ' TYR . 59.2 t -107.93 135.37 46.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.56 143.99 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.006 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.596 ' CG1' HD12 ' A' ' 56' ' ' LEU . 48.9 t -135.03 112.45 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.91 129.82 48.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.479 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 58.2 m-85 -114.64 134.6 54.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.356 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.469 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 1.8 p90 -150.72 113.36 4.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.549 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.767 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -87.97 23.31 2.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.566 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 79.9 p 49.65 49.33 20.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.852 0.358 . . . . 0.0 111.428 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.767 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.5 m-90 -67.96 -60.46 2.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.6 t -163.87 -104.97 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.685 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -101.1 -34.64 4.49 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.619 -0.8 . . . . 0.0 114.69 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 76.1 Cg_exo -41.95 -32.13 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.311 2.007 . . . . 0.0 113.27 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.413 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 26.1 p -97.19 -42.15 7.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.389 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -81.67 0.39 38.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 32' ' ' GLY . 16.2 tpt -90.24 -55.34 3.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.858 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.849 HD11 ' HG2' ' A' ' 74' ' ' PRO . 31.9 pt -90.28 36.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.511 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.809 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -75.98 -54.85 2.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.906 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.809 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 41.9 Cg_exo -56.7 -29.46 80.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.328 2.019 . . . . 0.0 111.993 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.586 ' SD ' HG22 ' A' ' 37' ' ' ILE . 59.2 mtt -59.42 -75.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.67 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.958 HG22 HD12 ' A' ' 96' ' ' ILE . 2.4 pp -62.19 -23.42 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.126 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.894 ' N ' HD12 ' A' ' 41' ' ' ILE . 5.4 tp10 -77.95 -27.69 49.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.595 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -87.69 -42.42 12.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.844 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -48.03 -27.57 2.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.467 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.36 -30.01 17.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.603 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -89.97 -31.34 17.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.082 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -63.01 -31.5 72.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.805 ' CZ ' HG21 ' A' ' 100' ' ' ILE . 42.7 m-85 -100.58 146.67 26.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.094 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.2 m -85.94 -32.12 21.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.866 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.7 p-10 -134.16 85.17 2.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.555 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -134.82 118.43 16.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.749 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.87 105.25 17.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.275 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.555 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 7.4 m-85 -102.25 128.62 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.557 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.836 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 18.0 m-30 -113.37 112.26 23.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.442 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.469 ' HE3' ' CE1' ' A' ' 27' ' ' PHE . 52.9 tptt -89.78 112.1 23.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.471 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.596 HD12 ' CG1' ' A' ' 24' ' ' VAL . 90.4 mt -123.46 150.45 43.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.123 0.487 . . . . 0.0 111.655 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -132.75 150.16 52.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.177 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.68 81.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.574 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -179.97 -92.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.728 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.723 ' HG2' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -57.8 -27.28 62.97 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.784 0.326 . . . . 0.0 110.666 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.723 HG23 ' HG2' ' A' ' 60' ' ' GLU . 32.5 t -112.8 35.04 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 t -51.39 -24.97 5.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -50.87 -55.28 17.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.312 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.579 HG11 HD13 ' A' ' 56' ' ' LEU . 47.2 t -66.77 -59.31 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.07 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.97 -28.25 2.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.514 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -58.44 -55.48 34.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -73.96 -33.64 63.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.52 64.62 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.02 112.68 4.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.634 HG21 HG21 ' A' ' 75' ' ' THR . 35.6 m -134.45 -178.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.6 m -157.41 80.61 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.6 p -173.22 179.0 2.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.961 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.462 ' HG2' ' CZ2' ' A' ' 30' ' ' TRP . 58.9 mtm -152.51 102.29 2.74 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.686 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.849 ' HG2' HD11 ' A' ' 37' ' ' ILE . 1.8 Cg_endo -81.86 -158.38 1.67 Allowed 'Cis proline' 0 C--N 1.348 0.534 0 C-N-CA 124.405 -1.081 . . . . 0.0 112.361 0.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.787 ' HA ' HG12 ' A' ' 89' ' ' VAL . 88.8 m -145.85 96.86 2.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.418 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 76' ' ' LEU . 4.1 mp -109.66 140.57 43.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.004 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.521 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 22.6 pt -133.87 162.08 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.412 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.761 ' HE2' HD13 ' A' ' 100' ' ' ILE . 4.3 m-85 -127.16 125.2 40.74 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.111 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.521 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 63.3 m-85 -109.49 164.49 12.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.938 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -168.69 60.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.071 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.72 40.59 0.71 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.026 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.0 34.45 83.49 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.872 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -148.76 117.15 6.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.827 0.346 . . . . 0.0 111.118 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 89.3 tt0 -73.73 144.67 45.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.679 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 86' ' ' THR . 34.7 m -151.7 -46.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.701 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.678 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 96.5 m -104.4 116.44 32.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.11 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -123.98 127.9 48.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.311 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.704 ' O ' HG23 ' A' ' 88' ' ' VAL . 32.2 m -118.98 84.69 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.163 0.506 . . . . 0.0 110.495 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 75' ' ' THR . 34.8 m -109.14 99.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.394 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -170.1 -109.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.529 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 90' ' ' GLY . . . 178.48 78.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.788 0.327 . . . . 0.0 111.176 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -155.02 128.43 4.39 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.71 -13.53 24.52 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.509 2.139 . . . . 0.0 112.753 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.09 -48.59 4.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.181 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.5 -30.29 3.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.234 0.54 . . . . 0.0 110.188 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.958 HD12 HG22 ' A' ' 41' ' ' ILE . 6.0 tt -66.63 -50.58 65.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.177 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.42 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -53.35 -54.16 40.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.369 . . . . 0.0 110.684 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.405 ' NE2' ' CE ' ' A' ' 97' ' ' LYS . 99.2 mm-40 -49.22 -26.53 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.523 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.57 -27.51 22.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.597 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.805 HG21 ' CZ ' ' A' ' 48' ' ' TYR . 48.1 mm -68.23 -59.28 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.373 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . . . -61.86 -14.99 38.82 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.3 m -81.26 -29.5 34.37 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.556 ' C ' HD13 ' A' ' 21' ' ' LEU . 36.8 m-80 -122.25 -9.42 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 104' ' ' VAL . 10.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.467 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' N ' ' HB1' ' A' ' 45' ' ' ALA . 26.5 mmt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.83 0.348 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.638 HG11 ' NZ ' ' A' ' 55' ' ' LYS . 47.2 t -57.69 137.17 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.124 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 m -111.28 151.21 28.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.932 0.396 . . . . 0.0 110.955 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -91.55 97.99 11.39 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 5' ' ' LEU . 4.9 mp -88.93 134.89 33.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.0 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -126.1 -64.78 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.5 t -91.44 148.47 22.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.065 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.74 69.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 m -56.88 -33.47 66.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.677 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 50.3 mt-10 -74.73 -25.17 58.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -82.29 -61.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.391 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -55.57 -58.58 7.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.46 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.0 t -56.79 -28.32 61.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.332 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . -66.26 -33.58 76.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 0.0 111.338 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.459 HD22 ' CG ' ' A' ' 79' ' ' TYR . 85.6 mt -62.06 -44.14 97.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.083 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.1 -28.95 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.509 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 t -56.64 -78.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.212 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.96 136.16 13.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.627 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -85.9 -6.8 59.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.675 0.274 . . . . 0.0 111.252 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -54.7 -175.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.807 0.337 . . . . 0.0 110.962 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.441 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 27.1 tp -79.25 107.56 12.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.817 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.628 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 49.1 t -99.79 127.97 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.698 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.621 HG22 ' CD2' ' A' ' 78' ' ' PHE . 48.9 t -137.02 133.75 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.552 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.713 HG11 ' CE2' ' A' ' 26' ' ' PHE . 40.6 t -103.24 160.4 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.255 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.504 ' N ' HG12 ' A' ' 24' ' ' VAL . 38.3 t70 -137.53 89.57 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.849 0.357 . . . . 0.0 111.772 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.713 ' CE2' HG11 ' A' ' 24' ' ' VAL . 61.2 m-85 -96.36 111.17 23.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.607 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 0.5 OUTLIER -138.64 -44.99 0.49 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HB2' ' H ' ' A' ' 58' ' ' VAL . . . 61.87 87.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 110.867 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.406 HG21 ' NZ ' ' A' ' 35' ' ' LYS . 65.9 p -57.69 115.1 2.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.824 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.596 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.1 m-90 -101.61 -59.3 1.72 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 52.4 t 160.3 46.11 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.97 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.59 -118.08 0.42 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.783 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 35' ' ' LYS . 75.4 Cg_exo -49.73 -69.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.495 2.13 . . . . 0.0 112.336 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 10.2 p -61.26 75.85 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.375 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 33' ' ' PRO . 17.3 tppt? 175.72 -42.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.851 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 49.8 ttm -67.77 -49.01 64.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.224 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.554 HD12 ' C ' ' A' ' 37' ' ' ILE . 2.0 pp -90.22 25.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.001 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.795 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -78.44 -54.18 1.21 Allowed Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.627 0.251 . . . . 0.0 111.036 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 51.7 Cg_exo -55.12 -36.69 93.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.529 2.153 . . . . 0.0 112.226 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.417 ' SD ' HG22 ' A' ' 37' ' ' ILE . 60.6 mtt -54.16 -75.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.545 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.05 HG22 HG21 ' A' ' 96' ' ' ILE . 10.6 pt -51.15 -43.62 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.307 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.549 ' HG3' HG21 ' A' ' 2' ' ' VAL . 39.2 tt0 -64.05 -33.18 75.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.772 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -77.05 -45.91 25.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.572 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.691 ' CG ' HD11 ' A' ' 96' ' ' ILE . 6.9 m-85 -56.03 -32.24 63.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.039 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HB1' ' N ' ' A' ' 1' ' ' MET . . . -50.29 -27.8 6.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.329 0.585 . . . . 0.0 109.723 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -77.93 -38.78 44.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.746 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -58.02 -38.04 75.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.519 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.657 ' CE2' HG21 ' A' ' 100' ' ' ILE . 32.4 m-85 -75.58 170.53 15.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.37 . . . . 0.0 110.925 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.8 m -116.55 -19.77 9.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.495 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -145.24 47.71 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.802 0.334 . . . . 0.0 111.465 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.6 119.16 38.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.553 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.73 96.46 10.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 110.881 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.51 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 6.5 m-85 -90.37 126.15 35.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.882 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.551 ' CG ' HD21 ' A' ' 5' ' ' LEU . 18.8 m-30 -121.78 107.6 12.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.376 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.638 ' NZ ' HG11 ' A' ' 2' ' ' VAL . 4.9 ttmp? -89.78 120.02 30.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.935 0.398 . . . . 0.0 111.173 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.035 HD22 HG11 ' A' ' 61' ' ' VAL . 98.4 mt -138.01 135.68 36.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.812 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -112.64 -178.06 3.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.662 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.85 HG21 ' CE ' ' A' ' 73' ' ' MET . 46.0 t -107.26 65.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 111.099 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -178.35 -60.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.357 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -75.76 -23.6 55.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.644 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.035 HG11 HD22 ' A' ' 56' ' ' LEU . 30.5 t -124.81 40.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.791 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 t -53.76 -26.21 22.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.267 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.95 -50.83 72.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.027 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.522 HG11 HD13 ' A' ' 56' ' ' LEU . 43.7 t -72.24 -55.33 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.83 -28.88 2.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.444 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -60.83 -46.73 89.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.846 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -81.77 -47.29 13.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.771 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.11 79.45 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.58 114.86 5.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.934 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.874 ' HB ' HG21 ' A' ' 75' ' ' THR . 35.4 m -135.63 125.26 41.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.113 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.2 t -112.32 92.98 4.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.986 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -177.76 -74.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.705 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.85 ' CE ' HG21 ' A' ' 58' ' ' VAL . 61.7 mtt 57.67 102.45 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.734 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.48 167.77 31.68 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.833 0.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.874 HG21 ' HB ' ' A' ' 70' ' ' VAL . 71.6 m -154.87 132.41 11.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.355 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.825 HD12 ' C ' ' A' ' 75' ' ' THR . 4.1 mp -131.16 136.55 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 111.667 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.472 HD12 ' OH ' ' A' ' 79' ' ' TYR . 28.2 pt -133.13 150.68 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.977 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.621 ' CD2' HG22 ' A' ' 23' ' ' VAL . 1.1 m-85 -125.94 132.47 52.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.093 0.473 . . . . 0.0 111.267 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.472 ' OH ' HD12 ' A' ' 77' ' ' ILE . 84.1 m-85 -109.51 114.35 27.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.151 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -72.18 -75.26 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.799 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.59 33.68 3.87 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.023 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.52 27.42 4.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.176 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -158.24 150.29 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 91.5 mt-10 -82.39 97.02 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.14 -27.09 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.291 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 97.7 m -117.21 103.4 10.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.942 0.401 . . . . 0.0 110.069 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -103.29 155.24 18.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.363 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.9 t -155.5 80.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.614 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.574 ' O ' HG23 ' A' ' 89' ' ' VAL . 34.1 m -109.55 112.38 40.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.994 0.426 . . . . 0.0 111.279 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.59 -116.42 0.37 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.36 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -176.51 40.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.81 0.338 . . . . 0.0 111.074 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -130.43 134.08 25.64 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.528 ' O ' HG12 ' A' ' 96' ' ' ILE . 34.0 Cg_endo -66.62 -56.24 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.361 2.04 . . . . 0.0 112.655 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -40.65 -31.97 0.19 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.21 -22.86 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.591 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.05 HG21 HG22 ' A' ' 41' ' ' ILE . 9.2 pt -76.35 -35.35 27.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.922 0.391 . . . . 0.0 110.929 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -56.1 -68.79 0.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.359 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.49 -34.57 77.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.624 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.98 -43.12 68.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.818 0.342 . . . . 0.0 111.454 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.657 HG21 ' CE2' ' A' ' 48' ' ' TYR . 74.2 mt -84.76 -18.82 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.472 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -90.21 -23.37 21.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.752 0.31 . . . . 0.0 111.569 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.4 m -89.99 -65.75 0.99 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.83 0.348 . . . . 0.0 111.482 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.64 -29.18 16.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.456 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 101' ' ' ALA . 8.6 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.287 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtm . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.775 0.322 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.511 ' HA ' ' CB ' ' A' ' 53' ' ' PHE . 13.7 p -54.42 144.1 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -124.14 159.23 30.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.063 0.459 . . . . 0.0 110.933 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -102.0 100.0 10.22 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 5' ' ' LEU . 5.5 mp -88.83 109.36 20.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.806 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -96.25 -66.37 0.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.401 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -85.04 150.92 24.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.301 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.74 -28.68 70.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.095 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.1 t -55.88 -35.84 66.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 46.4 mt-10 -65.36 -40.9 94.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.516 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -67.76 -55.76 11.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.929 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.58 -56.3 23.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.9 t -57.03 -29.1 63.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . -64.92 -61.05 2.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.215 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.479 HD21 ' CD2' ' A' ' 79' ' ' TYR . 79.6 mt -59.51 -26.72 65.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.004 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.03 -70.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.225 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -74.78 -27.25 60.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.87 169.66 1.66 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.691 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -177.36 -37.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 111.075 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -51.84 -73.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.758 HD13 HG23 ' A' ' 100' ' ' ILE . 4.9 tt -172.73 108.24 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.753 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.657 HG13 ' CE2' ' A' ' 54' ' ' TYR . 60.6 t -100.79 132.06 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.688 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' A' ' 21' ' ' LEU . 46.6 t -125.6 122.24 61.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.384 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.586 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 49.4 t -105.19 129.92 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.53 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -116.74 106.67 13.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.022 0.439 . . . . 0.0 111.488 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.586 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 77.4 m-85 -99.24 101.29 12.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.226 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.446 ' O ' ' CG ' ' A' ' 27' ' ' PHE . 4.5 p90 -127.22 105.96 8.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.499 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -96.14 73.67 2.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.444 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.452 ' C ' ' O ' ' A' ' 28' ' ' ALA . 68.3 p -23.91 105.72 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.527 ' CZ3' ' HB2' ' A' ' 73' ' ' MET . 3.2 m-90 -113.63 -54.75 2.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.2 m -123.15 -2.15 8.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.109 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.651 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . 88.4 23.33 37.41 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.769 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 32' ' ' GLY . 62.3 Cg_endo -75.53 -50.62 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.87 1.713 . . . . 0.0 111.941 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 27' ' ' PHE . 56.8 m -63.82 -37.37 87.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -64.19 -26.96 68.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.19 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 57.4 ttp -58.47 -62.0 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.0 110.988 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.3 pt -90.35 31.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.707 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.9 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -78.93 -59.38 0.64 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.122 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.9 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 65.0 Cg_exo -52.07 -35.15 60.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.335 2.023 . . . . 0.0 112.298 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.551 ' HE2' ' HB2' ' A' ' 93' ' ' PRO . 66.0 mtp -57.27 -74.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.668 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.841 ' CG2' HG21 ' A' ' 96' ' ' ILE . 6.4 pt -48.52 -42.07 12.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.76 0.314 . . . . 0.0 111.211 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -67.07 -33.75 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.487 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -73.83 -44.75 54.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.111 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 96' ' ' ILE . 7.3 m-85 -55.77 -27.48 51.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.777 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.55 -29.37 50.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.75 -30.46 23.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.589 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -64.69 -25.81 68.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.24 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -79.6 176.28 9.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.861 0.363 . . . . 0.0 110.941 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.8 m -97.89 -36.67 10.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.788 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -149.84 90.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -134.61 129.31 34.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.837 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -101.53 93.27 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.228 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.511 ' CB ' ' HA ' ' A' ' 2' ' ' VAL . 7.4 m-85 -90.08 131.26 36.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.31 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.657 ' CE2' HG13 ' A' ' 22' ' ' VAL . 20.0 m-30 -119.37 129.83 55.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.856 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.483 ' O ' HD23 ' A' ' 56' ' ' LEU . 87.3 tttt -103.5 145.28 30.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.68 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.661 HD11 HG11 ' A' ' 64' ' ' VAL . 88.1 mt -143.73 140.0 29.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.028 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.37 -175.72 3.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.94 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.7 t -82.93 151.73 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 7.4 t70 63.36 132.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 39.2 tt0 73.63 -54.77 0.68 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.151 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 61' ' ' VAL . 36.6 t -95.03 2.29 9.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.536 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.1 m -63.81 -30.23 71.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.782 0.325 . . . . 0.0 111.005 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -51.41 -25.85 6.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.4 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.661 HG11 HD11 ' A' ' 56' ' ' LEU . 36.2 t -68.7 -54.61 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.047 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.99 70.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.21 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -56.45 -67.65 0.28 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.986 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -57.59 -37.72 73.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -90.01 78.04 6.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.822 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -53.5 102.2 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.971 HG11 HG21 ' A' ' 75' ' ' THR . 44.5 t -138.94 152.51 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.996 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.3 p -143.82 116.14 8.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.54 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.482 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 41.2 t 179.32 -163.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.222 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.527 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 18.3 ptm 178.41 93.76 0.15 Allowed Pre-proline 0 N--CA 1.463 0.187 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 73.0 Cg_endo -75.85 -161.61 2.61 Favored 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.354 -0.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.971 HG21 HG11 ' A' ' 70' ' ' VAL . 19.1 m -146.66 115.82 6.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.05 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.806 HD12 ' C ' ' A' ' 75' ' ' THR . 5.2 mp -126.58 115.7 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.935 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.409 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 28.6 pt -116.03 164.98 11.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.669 ' HE1' HG22 ' A' ' 88' ' ' VAL . 4.0 m-85 -133.86 131.03 38.71 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.038 0.447 . . . . 0.0 111.403 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.479 ' CD2' HD21 ' A' ' 15' ' ' LEU . 75.0 m-85 -109.89 152.33 25.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.625 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -116.15 -38.08 3.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.811 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.71 31.87 0.22 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.282 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.99 37.45 2.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.281 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -161.48 118.7 2.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -73.64 110.57 8.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.312 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.9 -37.46 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.452 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 72.3 m -107.14 111.67 24.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.798 0.332 . . . . 0.0 110.322 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -125.42 152.21 45.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.186 0.517 . . . . 0.0 111.556 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.717 ' O ' HG23 ' A' ' 88' ' ' VAL . 28.5 m -138.67 88.29 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.219 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 89' ' ' VAL . 31.1 m -109.25 94.45 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.333 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.87 -112.77 0.62 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.206 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.09 55.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.861 0.362 . . . . 0.0 111.125 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -144.85 126.37 7.83 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.195 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.551 ' HB2' ' HE2' ' A' ' 40' ' ' MET . 81.4 Cg_endo -79.21 2.62 8.16 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.663 2.242 . . . . 0.0 112.64 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.32 -39.48 10.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.008 0.432 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.14 -30.33 70.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.681 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.841 HG21 ' CG2' ' A' ' 41' ' ' ILE . 2.2 pp -57.43 -32.91 42.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.827 ' N ' HD12 ' A' ' 96' ' ' ILE . 50.0 tttm -54.27 -69.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.731 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -62.55 -21.64 65.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.952 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.623 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -59.66 -54.03 51.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.758 HG23 HD13 ' A' ' 21' ' ' LEU . 2.0 mp -75.51 -35.62 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.576 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.26 68.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.308 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.8 m -57.02 -74.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.12 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.44 ' O ' HD12 ' A' ' 21' ' ' LEU . 16.0 p-10 -105.15 62.03 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.993 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.556 HG13 ' OXT' ' A' ' 104' ' ' VAL . 9.5 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.126 -0.94 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.509 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 10.8 mmt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.8 0.333 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.552 HG13 ' HE2' ' A' ' 55' ' ' LYS . 56.7 t -50.49 111.09 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.926 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.426 ' HB ' HD11 ' A' ' 5' ' ' LEU . 1.1 m -103.47 160.38 14.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 111.241 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -104.65 94.45 5.31 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 5' ' ' LEU . 5.2 mp -88.96 132.32 34.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -130.13 -64.15 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 t -77.71 143.08 38.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.105 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.75 -29.26 70.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.8 p -55.51 -30.64 61.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 90.9 mt-10 -77.41 -38.26 50.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.606 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 48.7 t80 -72.21 -42.44 65.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.032 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -58.22 -68.17 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.061 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.5 p -55.66 -26.08 42.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HB1' ' HE2' ' A' ' 54' ' ' TYR . . . -59.04 -53.07 62.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.243 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.442 ' CD2' ' CD2' ' A' ' 79' ' ' TYR . 84.7 mt -69.35 -30.83 68.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.7 -54.55 15.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.212 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -90.36 24.64 2.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.457 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.12 142.45 16.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.449 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -151.48 -46.6 0.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.635 0.255 . . . . 0.0 110.832 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -57.05 -76.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.803 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.667 HD22 ' N ' ' A' ' 104' ' ' VAL . 41.7 tp -177.23 109.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.136 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' A' ' 54' ' ' TYR . 48.1 t -103.86 117.23 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.744 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.47 122.94 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 61.1 t -109.05 126.24 66.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.402 ' OD1' ' HG ' ' A' ' 76' ' ' LEU . 23.9 m-20 -122.54 107.0 11.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.526 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.513 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 52.6 m-85 -93.34 98.86 11.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.355 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.3 p90 -134.24 121.86 21.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.245 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.16 21.95 3.01 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.7 p 46.88 73.25 0.19 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.856 0.36 . . . . 0.0 110.986 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.538 ' CH2' ' HB2' ' A' ' 73' ' ' MET . 0.0 OUTLIER -146.96 62.26 1.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.153 0.501 . . . . 0.0 112.334 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.1 t 60.29 155.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.508 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.71 178.57 20.12 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.636 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 6.1 Cg_endo -49.63 -22.6 6.85 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.866 2.377 . . . . 0.0 112.548 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.5 p -51.86 -39.99 59.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.877 0.37 . . . . 0.0 111.077 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -87.28 -32.07 19.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.033 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.25 -41.16 70.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.018 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 37' ' ' ILE . 48.8 mt -90.43 21.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.481 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -73.1 -58.21 2.6 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 121.239 -0.184 . . . . 0.0 111.106 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 36.3 Cg_exo -58.28 -35.74 98.4 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.343 2.029 . . . . 0.0 112.002 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.459 ' SD ' HG23 ' A' ' 37' ' ' ILE . 62.5 mtt -54.4 -76.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.4 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.925 HG22 HD12 ' A' ' 96' ' ' ILE . 12.6 pt -49.9 -43.34 19.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.286 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.433 ' N ' HG13 ' A' ' 41' ' ' ILE . 39.6 tt0 -63.9 -31.78 73.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.771 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 6.2 ttpm? -84.55 -55.21 4.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.636 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.437 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 11.5 m-85 -49.92 -28.11 6.23 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.851 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.25 -28.15 39.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.037 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -89.7 -33.61 16.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.983 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.27 -27.05 68.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.271 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.736 ' CE2' HG21 ' A' ' 100' ' ' ILE . 44.4 m-85 -82.95 157.05 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 111.014 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.0 m -82.12 -37.22 26.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.686 ' O ' HG23 ' A' ' 104' ' ' VAL . 40.8 p-10 -154.5 101.86 2.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.974 0.416 . . . . 0.0 111.149 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.48 124.1 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.973 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.98 106.22 18.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.289 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.429 ' HB2' ' HA ' ' A' ' 2' ' ' VAL . 7.1 m-85 -92.52 112.17 24.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.224 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.611 ' HE2' ' HB1' ' A' ' 14' ' ' ALA . 16.7 m-30 -114.73 102.48 10.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.824 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.552 ' HE2' HG13 ' A' ' 2' ' ' VAL . 68.1 mttm -89.87 130.55 36.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.007 HD13 HG11 ' A' ' 64' ' ' VAL . 90.2 mt -130.63 149.58 52.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.861 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -120.75 159.29 25.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.99 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 59' ' ' ASP . 48.5 t -104.61 160.09 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.502 ' N ' HG12 ' A' ' 58' ' ' VAL . 8.1 t0 69.23 -63.07 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -60.96 -29.7 69.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.626 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 64' ' ' VAL . 47.3 t -98.97 -57.23 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.767 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.4 t 68.18 -62.77 0.35 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.481 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.96 -47.54 8.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.643 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.007 HG11 HD13 ' A' ' 56' ' ' LEU . 40.7 t -78.01 -61.88 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.055 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.32 -30.35 0.81 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.375 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -57.3 -55.27 36.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.725 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -65.86 -63.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.55 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 26' ' ' PHE . . . -75.49 76.79 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -49.65 119.1 3.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.255 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.431 HG13 ' OG1' ' A' ' 75' ' ' THR . 41.7 t -90.33 137.35 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.856 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.0 t -143.16 48.58 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 111.359 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.1 p -179.31 178.2 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.584 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.538 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 20.7 ptt? -150.09 100.25 3.23 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.582 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HD3' ' HG2' ' A' ' 33' ' ' PRO . 95.5 Cg_endo -78.24 -163.58 3.47 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.931 -1.279 . . . . 0.0 112.388 -0.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 32.5 m -143.47 97.17 3.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.988 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 76' ' ' LEU . 2.4 mp -109.87 135.66 50.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.006 0.431 . . . . 0.0 111.656 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.564 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 25.5 pt -132.35 166.18 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.478 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.535 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 2.3 m-85 -131.52 125.93 33.63 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 111.679 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.564 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 60.8 m-85 -111.56 153.64 25.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.366 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -127.83 -58.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.704 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.75 -14.16 8.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.476 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 135.97 41.58 0.12 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.261 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.748 ' HG2' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -162.29 127.71 3.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.965 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 88.7 tt0 -69.63 95.96 0.9 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.746 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.748 HG13 ' HG2' ' A' ' 83' ' ' LYS . 34.7 m -109.88 -32.92 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.156 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 98.9 m -113.02 103.39 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 110.091 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -106.43 159.66 15.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.574 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.582 ' CG1' ' HB1' ' A' ' 95' ' ' ALA . 44.1 t -155.57 83.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.389 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 89' ' ' VAL . 28.1 m -109.22 77.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.199 0.523 . . . . 0.0 111.264 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -143.73 -112.15 0.83 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.067 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 33' ' ' PRO . . . 171.57 93.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.629 0.252 . . . . 0.0 110.86 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.762 ' ND2' ' HB3' ' A' ' 94' ' ' ALA . 49.1 t30 -173.5 131.59 0.57 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.968 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.99 -20.29 22.64 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.634 2.223 . . . . 0.0 112.812 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.762 ' HB3' ' ND2' ' A' ' 92' ' ' ASN . . . -86.55 -35.32 19.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.57 0.224 . . . . 0.0 111.228 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.582 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -49.07 -28.86 4.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.157 0.504 . . . . 0.0 110.049 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.925 HD12 HG22 ' A' ' 41' ' ' ILE . 6.3 tt -90.03 -37.97 10.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.427 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.0 -71.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.975 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -56.68 -22.95 38.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.041 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 95' ' ' ALA . . . -77.21 -67.3 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.123 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.736 HG21 ' CE2' ' A' ' 48' ' ' TYR . 37.1 mm -51.99 -35.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.18 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -56.7 -71.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 111.683 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.3 m -61.22 -24.75 66.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.602 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.551 ' HB3' HD13 ' A' ' 21' ' ' LEU . 5.7 m120 -80.63 -62.47 1.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 50' ' ' ASP . 13.2 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.763 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.6 mtp . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.794 0.33 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.5 t 60.05 116.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.048 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 4' ' ' GLN . 1.4 m -93.81 169.25 10.44 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.146 0.498 . . . . 0.0 110.84 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.464 ' H ' HG22 ' A' ' 3' ' ' THR . 14.3 mp0 -110.12 91.45 3.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.186 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 5' ' ' LEU . 6.6 mp -88.97 136.21 33.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.024 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -130.32 -58.22 1.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.5 t -96.74 142.5 28.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.053 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.83 -27.35 65.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.181 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 t -56.61 -38.07 71.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.31 -36.04 80.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.572 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 49.1 t80 -66.8 -47.68 71.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.972 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -58.45 -60.17 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -57.23 -24.63 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.722 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -70.93 -40.56 72.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.284 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.572 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 83.9 mt -90.17 15.04 11.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.576 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.11 -90.57 0.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.752 -0.203 . . . . 0.0 111.038 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.8 p -90.4 19.14 5.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.625 0.25 . . . . 0.0 111.374 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 19' ' ' ASP . . . -70.2 -74.45 0.67 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.716 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 1.4 m-20 79.77 -41.81 0.24 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.589 0.355 . . . . 0.0 111.365 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -54.03 -174.48 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 21' ' ' LEU . 7.5 tt -77.39 99.06 5.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.979 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' A' ' 54' ' ' TYR . 60.8 t -105.58 111.94 36.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.101 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.826 HG13 ' O ' ' A' ' 77' ' ' ILE . 46.8 t -119.32 139.58 46.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.808 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.546 HG11 ' CZ ' ' A' ' 26' ' ' PHE . 55.2 t -113.51 128.96 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.497 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 36.5 t70 -112.29 101.51 9.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.962 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.546 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 64.4 m-85 -92.52 107.95 19.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.99 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.436 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 1.4 p90 -153.01 121.38 6.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.356 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.763 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . . . -85.06 17.41 2.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.663 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.1 p 49.66 55.13 9.85 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.049 0.452 . . . . 0.0 110.945 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.715 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 2.7 m-90 -69.41 -62.21 1.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.192 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 40.4 t 164.29 140.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.85 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.47 -120.73 6.35 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.537 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.433 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 89.1 Cg_exo -43.07 -70.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.822 2.348 . . . . 0.0 112.863 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.9 p -48.29 -26.64 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 111.423 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 31' ' ' CYS . 67.9 mmtt -85.66 -72.37 0.49 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.791 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.0 mtt -59.51 -22.24 61.34 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 37' ' ' ILE . 55.8 mt -89.97 -11.03 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.952 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -54.1 -65.23 1.33 Allowed Pre-proline 0 C--N 1.331 -0.215 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.32 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.952 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 78.0 Cg_exo -50.29 -36.29 46.67 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.133 1.888 . . . . 0.0 112.616 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.408 ' SD ' ' CB ' ' A' ' 93' ' ' PRO . 56.2 mtt -59.11 -78.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.071 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.94 HG22 HG21 ' A' ' 96' ' ' ILE . 2.4 pp -56.34 -24.76 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.131 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.876 ' N ' HD12 ' A' ' 41' ' ' ILE . 43.3 mt-10 -77.35 -30.5 53.9 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.004 0.431 . . . . 0.0 109.902 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 39' ' ' PRO . 38.2 ttpt -79.48 -45.21 19.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.145 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -60.32 -29.53 68.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.635 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.36 -31.01 53.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.916 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -84.57 -32.14 23.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.507 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.2 -28.47 69.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.017 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.605 ' CD2' HG21 ' A' ' 100' ' ' ILE . 39.0 m-85 -78.78 148.69 32.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.953 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -80.02 -34.72 38.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -146.27 92.91 2.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.519 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -138.07 123.04 19.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.968 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -96.65 93.98 7.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.164 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.519 ' HE1' ' HB1' ' A' ' 51' ' ' ALA . 6.0 m-85 -89.96 127.93 36.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.124 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.722 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 14.9 m-30 -113.5 108.25 16.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.858 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -89.9 120.85 31.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.729 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.896 HD22 HG11 ' A' ' 61' ' ' VAL . 90.3 mt -131.31 145.57 51.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.97 0.414 . . . . 0.0 111.263 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -106.99 161.21 14.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.57 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.763 ' CG2' ' HB2' ' A' ' 28' ' ' ALA . 50.5 t -82.11 -27.42 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.67 -60.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.168 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.49 -40.12 77.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.185 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.896 HG11 HD22 ' A' ' 56' ' ' LEU . 41.3 t -112.87 48.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.012 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.4 t -62.08 -31.33 71.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.832 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -49.15 -45.67 44.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.204 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.617 HG11 HD13 ' A' ' 56' ' ' LEU . 47.2 t -73.51 -56.27 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.966 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.34 -52.87 15.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.721 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -50.25 -59.1 4.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -54.65 -73.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.037 0.446 . . . . 0.0 110.706 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.69 68.16 7.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.522 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -44.27 135.66 4.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.551 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 71' ' ' SER . 46.3 t -117.87 159.28 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.923 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.49 ' N ' HG12 ' A' ' 70' ' ' VAL . 80.7 p -146.21 80.17 1.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.116 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -178.56 -161.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.613 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 20.3 ptt? -177.28 94.16 0.24 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.404 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 69.3 Cg_endo -88.26 -160.21 1.51 Allowed 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.239 -1.15 . . . . 0.0 112.32 -0.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.821 HG23 ' CG1' ' A' ' 89' ' ' VAL . 51.5 m -139.9 115.73 10.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.834 0.349 . . . . 0.0 110.954 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.707 HD12 ' C ' ' A' ' 75' ' ' THR . 3.9 mp -120.93 115.24 22.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.977 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.826 ' O ' HG13 ' A' ' 23' ' ' VAL . 28.4 pt -109.92 157.52 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.673 ' HE1' HG22 ' A' ' 88' ' ' VAL . 3.0 m-85 -130.83 125.53 33.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 111.774 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.505 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 71.5 m-85 -110.13 150.59 28.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.898 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.04 -22.17 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.136 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.62 31.31 0.19 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.27 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.81 44.58 5.11 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.368 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -164.45 107.48 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.382 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -56.93 115.33 2.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.496 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 86' ' ' THR . 11.2 m -128.02 -48.56 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' A' ' 78' ' ' PHE . 46.4 p -105.2 82.78 1.88 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.207 0.527 . . . . 0.0 111.0 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -97.53 142.27 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.633 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.686 ' O ' HG23 ' A' ' 88' ' ' VAL . 32.8 m -139.75 88.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.542 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.821 ' CG1' HG23 ' A' ' 75' ' ' THR . 26.0 m -108.98 109.71 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.201 0.524 . . . . 0.0 111.128 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 91' ' ' ALA . . . -170.2 -96.2 0.1 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.302 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 90' ' ' GLY . . . 176.44 70.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 110.979 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -137.29 88.14 17.51 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HG3' HG23 ' A' ' 37' ' ' ILE . 24.3 Cg_exo -63.55 -14.44 42.53 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.773 2.315 . . . . 0.0 112.487 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.46 -31.3 14.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.811 0.339 . . . . 0.0 110.96 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.1 -23.82 67.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.206 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.94 HG21 HG22 ' A' ' 41' ' ' ILE . 21.9 pt -56.34 -38.81 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.933 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -49.46 -55.91 11.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.605 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -68.59 -25.9 65.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.812 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.464 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -70.5 -57.41 4.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.144 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.605 HG21 ' CD2' ' A' ' 48' ' ' TYR . 3.1 mp -75.54 -5.7 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.237 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.473 ' O ' HG12 ' A' ' 104' ' ' VAL . . . -89.96 -28.75 18.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.702 0.287 . . . . 0.0 111.377 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.6 m -90.05 -67.0 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 111.408 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -46.86 -32.6 3.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.545 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 101' ' ' ALA . 8.4 p . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.417 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.743 HG22 ' HB2' ' A' ' 53' ' ' PHE . 46.0 t -74.86 129.4 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.965 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 m -120.89 149.74 42.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.994 0.426 . . . . 0.0 110.966 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -89.9 109.72 20.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.872 HD11 ' CD2' ' A' ' 54' ' ' TYR . 70.3 mt -88.83 104.77 17.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 110.868 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 11.1 mmpt? -89.94 -47.46 7.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.028 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.3 t -104.89 147.41 27.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.245 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.44 -27.73 68.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.01 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.3 p -54.86 -31.27 59.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.858 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -71.09 -35.1 71.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.58 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.685 ' CE1' HD21 ' A' ' 15' ' ' LEU . 48.5 t80 -69.4 -43.87 72.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.026 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -53.16 -60.42 3.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.1 p -64.83 -21.17 66.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.212 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.91 71.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.376 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.685 HD21 ' CE1' ' A' ' 11' ' ' TYR . 82.0 mt -57.4 -36.12 70.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.966 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.03 50.72 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.045 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.7 p -81.97 148.44 28.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 19' ' ' ASP . . . -80.3 83.06 1.43 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.615 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 8.8 t70 80.41 -40.6 0.18 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.702 0.401 . . . . 0.0 111.68 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -45.28 129.17 8.06 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.829 0.347 . . . . 0.0 111.231 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.565 ' C ' HD23 ' A' ' 21' ' ' LEU . 4.8 tt -80.33 110.88 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 22' ' ' VAL . 10.6 p -100.84 116.06 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG23 HD22 ' A' ' 21' ' ' LEU . 47.4 t -104.88 146.76 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.044 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.436 HG21 ' HE1' ' A' ' 11' ' ' TYR . 48.5 t -126.1 113.8 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.806 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -101.48 120.56 40.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.942 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.592 ' CE1' HD12 ' A' ' 56' ' ' LEU . 61.2 m-85 -109.45 106.48 16.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.036 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 5.0 p90 -127.35 121.41 30.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.221 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.793 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . . . -86.16 18.54 3.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.8 p 49.3 78.04 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 111.437 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.793 ' NE1' ' HB3' ' A' ' 28' ' ' ALA . 0.7 OUTLIER -100.89 -56.05 2.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.946 179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.614 ' CB ' ' O ' ' A' ' 30' ' ' TRP . 42.0 t 132.73 104.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.562 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.03 -92.85 0.25 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.412 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.474 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 11.4 Cg_endo -55.55 -57.79 1.43 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.835 2.357 . . . . 0.0 112.862 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.1 p -81.12 58.26 3.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 110.975 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -172.19 -46.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.6 ttt -65.68 -54.18 30.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.833 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.0 pt -90.28 21.54 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.52 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.947 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -71.03 -62.74 1.75 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.179 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 74.9 Cg_exo -50.14 -29.62 22.92 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.167 1.911 . . . . 0.0 112.685 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.491 ' CE ' ' HB3' ' A' ' 93' ' ' PRO . 37.7 mtp -62.56 -73.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.098 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.92 HD12 ' N ' ' A' ' 42' ' ' GLU . 2.4 pp -55.8 -23.46 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.92 ' N ' HD12 ' A' ' 41' ' ' ILE . 39.6 tt0 -81.17 -31.33 34.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.991 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -76.64 -42.06 43.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.377 179.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -55.19 -23.45 21.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 53' ' ' PHE . . . -55.76 -28.27 55.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.128 0.49 . . . . 0.0 110.513 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.69 -0.49 50.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.807 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -90.15 -60.57 1.89 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.172 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.924 ' CE2' HG21 ' A' ' 100' ' ' ILE . 17.2 m-85 -70.67 165.16 23.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.041 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.6 m -113.69 -18.39 11.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.756 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -134.79 53.7 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.971 0.415 . . . . 0.0 111.398 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -119.28 113.0 20.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.305 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 22' ' ' VAL . . . -89.44 100.5 13.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.127 0.489 . . . . 0.0 110.84 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.743 ' HB2' HG22 ' A' ' 2' ' ' VAL . 12.9 m-85 -92.12 134.22 35.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.186 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.872 ' CD2' HD11 ' A' ' 5' ' ' LEU . 19.0 m-30 -122.91 116.73 24.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.792 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -102.33 91.47 4.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.979 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 5' ' ' LEU . 85.0 mt -95.94 132.62 41.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -80.1 -9.26 59.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.663 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 58' ' ' VAL . 39.1 t 64.74 25.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.111 0.481 . . . . 0.0 110.83 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.1 -47.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.49 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.21 -32.34 73.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.457 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.583 HG21 HD22 ' A' ' 56' ' ' LEU . 44.2 t -96.16 -44.37 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.743 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 61' ' ' VAL . 95.5 p 61.33 -65.85 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.749 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 61' ' ' VAL . 7.5 t70 -36.79 -58.22 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.535 0.334 . . . . 0.0 111.851 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 56' ' ' LEU . 48.1 t -58.0 -54.12 36.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.045 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -51.63 -46.3 63.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.34 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -58.91 -40.36 84.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -72.1 -62.34 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.738 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.4 85.08 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -58.32 112.35 1.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.091 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 70' ' ' VAL . 35.7 m -155.46 110.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.6 m -105.71 50.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -119.24 -170.73 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.647 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.512 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 18.1 ptp -166.7 98.8 0.68 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.378 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 94.4 Cg_endo -89.32 -165.05 2.67 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 124.262 -1.141 . . . . 0.0 112.451 -0.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.777 ' C ' HD12 ' A' ' 76' ' ' LEU . 87.8 m -144.79 118.44 9.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.777 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -126.37 127.47 45.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.962 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.642 HD12 ' CE2' ' A' ' 79' ' ' TYR . 17.1 pt -122.11 155.95 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.2 m-85 -127.5 118.56 24.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.424 -179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.667 ' CD2' HD22 ' A' ' 15' ' ' LEU . 61.3 m-85 -109.94 112.43 24.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.698 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -75.09 -54.26 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.834 0.35 . . . . 0.0 110.791 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.6 28.47 2.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.495 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.1 54.57 0.9 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.325 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -176.9 113.12 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.837 0.351 . . . . 0.0 110.976 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -58.91 96.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 86' ' ' THR . 27.3 m -109.89 -41.59 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.541 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 60.0 m -108.68 102.29 11.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.918 0.39 . . . . 0.0 110.151 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -102.6 154.57 19.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.377 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.4 t -154.35 81.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.574 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 89' ' ' VAL . 26.8 m -109.44 72.68 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.168 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.59 -136.35 2.36 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.117 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.91 91.71 1.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.282 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -152.08 112.47 2.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.11 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.586 ' O ' HG22 ' A' ' 96' ' ' ILE . 46.2 Cg_exo -57.16 -16.47 21.79 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.71 2.273 . . . . 0.0 112.593 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.82 -30.21 17.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 111.191 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.04 -30.87 16.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 110.841 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 93' ' ' PRO . 4.6 tp -68.58 -22.59 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.22 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -83.82 -53.08 5.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.197 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -67.34 -47.59 70.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.027 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.472 ' HB1' ' CZ ' ' A' ' 78' ' ' PHE . . . -55.5 -59.3 5.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.402 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.924 HG21 ' CE2' ' A' ' 48' ' ' TYR . 32.9 mm -57.43 -40.8 76.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.46 -28.22 66.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.193 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.5 m -57.94 -51.55 69.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.951 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 21' ' ' LEU . 16.0 p-10 -136.35 61.36 1.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.979 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.99 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.766 0.317 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 53' ' ' PHE . 48.9 t 61.03 112.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.661 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -101.96 174.17 6.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.214 0.53 . . . . 0.0 111.061 -179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.502 ' H ' HG22 ' A' ' 3' ' ' THR . 13.9 mp0 -118.42 96.28 5.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.056 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.524 HD11 ' CG ' ' A' ' 54' ' ' TYR . 62.7 mt -88.96 153.85 20.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.294 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -150.03 -66.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.952 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.6 t -82.57 161.94 22.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.128 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . . . -73.71 -31.95 63.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.1 p -56.44 -29.35 61.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.011 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 52.8 mt-10 -75.82 -32.82 59.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.75 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 49.2 t80 -78.3 -46.09 21.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.005 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -57.48 -64.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.084 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 t -57.76 -26.07 61.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.006 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.793 ' HB1' ' OH ' ' A' ' 54' ' ' TYR . . . -63.94 -63.34 1.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.301 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.75 HD11 ' CZ ' ' A' ' 11' ' ' TYR . 84.9 mt -54.16 -25.09 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.123 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.87 -57.13 7.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.073 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.9 t -90.18 18.11 6.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.5 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.22 76.22 2.28 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.519 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -88.7 -40.58 13.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.97 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -58.48 -78.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 104' ' ' VAL . 4.5 tt -177.59 113.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.774 0.321 . . . . 0.0 110.412 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.491 ' N ' HD23 ' A' ' 21' ' ' LEU . 62.6 t -104.02 144.15 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.657 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 77' ' ' ILE . 40.0 t -146.18 129.38 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.482 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.773 HG11 ' CE2' ' A' ' 26' ' ' PHE . 52.0 t -100.4 147.75 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.344 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' OD2' ' CD1' ' A' ' 27' ' ' PHE . 36.0 t70 -135.6 85.19 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.722 0.296 . . . . 0.0 111.697 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.934 ' CD2' HG21 ' A' ' 70' ' ' VAL . 65.8 m-85 -86.78 77.43 9.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.067 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 12.9 p90 -99.89 -34.59 10.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.629 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . . . 61.37 -162.64 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.584 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 79.2 p -134.11 65.27 1.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.001 0.429 . . . . 0.0 110.975 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.629 ' CE2' ' HB3' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -83.4 -60.1 2.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.916 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 39.1 t 147.44 110.34 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.458 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 33' ' ' PRO . . . 136.08 -132.42 6.12 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.37 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 10.7 Cg_endo -54.26 -34.09 78.26 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.71 2.274 . . . . 0.0 112.806 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 29.7 p -71.69 56.19 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.19 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 27.9 tptp 172.62 -42.84 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.75 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.541 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 11.1 mmt -58.04 -73.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.408 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.642 HD13 ' H ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -86.45 8.53 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.68 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -57.91 -52.7 72.51 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.921 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 50.9 Cg_exo -54.69 -31.94 73.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.583 2.189 . . . . 0.0 112.288 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.418 ' CE ' ' HB2' ' A' ' 93' ' ' PRO . 72.2 mtp -54.41 -73.77 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.928 0.394 . . . . 0.0 110.469 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.01 HG22 HG21 ' A' ' 96' ' ' ILE . 8.6 pt -50.56 -44.05 24.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.258 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' N ' HG13 ' A' ' 41' ' ' ILE . 66.1 mm-40 -63.64 -33.15 74.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.79 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.459 ' C ' ' HD3' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -76.47 -49.35 16.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.939 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.617 ' CD2' HD11 ' A' ' 96' ' ' ILE . 8.0 m-85 -51.79 -27.76 13.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.01 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.653 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.89 -28.89 25.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.055 0.455 . . . . 0.0 110.576 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -82.85 -25.21 32.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.602 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -58.44 -56.74 18.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.034 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.435 ' CE2' HG21 ' A' ' 100' ' ' ILE . 16.3 m-85 -62.28 171.03 2.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.156 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.9 m -97.14 -31.98 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 1.5 p30 -140.54 99.18 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.183 0.516 . . . . 0.0 111.146 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.471 ' HB1' ' HE1' ' A' ' 53' ' ' PHE . . . -148.83 117.62 6.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -89.79 107.09 18.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.279 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.653 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 6.6 m-85 -100.01 129.6 46.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.52 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.793 ' OH ' ' HB1' ' A' ' 14' ' ' ALA . 17.2 m-30 -115.4 107.26 14.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.444 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -89.85 122.46 32.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.67 HD22 HG11 ' A' ' 61' ' ' VAL . 94.0 mt -136.32 172.19 13.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.644 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -130.54 -102.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.927 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 59' ' ' ASP . 35.6 m -157.54 -45.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 120.709 0.29 . . . . 0.0 111.25 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 58' ' ' VAL . 56.5 m-20 -110.67 -35.96 5.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.01 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.61 -31.45 66.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.756 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.67 HG11 HD22 ' A' ' 56' ' ' LEU . 46.3 t -97.52 -66.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.745 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.0 t 68.31 -63.07 0.35 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.433 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 8' ' ' ALA . 1.5 m-20 -38.75 -38.62 0.43 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.731 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.02 -54.35 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.096 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.13 -41.12 7.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.811 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -57.33 -47.74 80.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.106 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -82.45 -55.99 4.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.957 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.632 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -70.36 82.16 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -58.49 98.6 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.934 HG21 ' CD2' ' A' ' 26' ' ' PHE . 53.7 t -108.22 151.62 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.2 p -155.79 85.28 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.076 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.2 t -177.9 177.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.435 ' HG2' ' CH2' ' A' ' 30' ' ' TRP . 64.9 mtm -154.64 96.48 2.59 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 73' ' ' MET . 3.1 Cg_endo -85.36 -158.75 1.55 Allowed 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.492 -1.045 . . . . 0.0 112.199 0.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.884 HG21 HG13 ' A' ' 70' ' ' VAL . 63.3 m -144.62 114.43 7.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.752 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.773 HD12 ' C ' ' A' ' 75' ' ' THR . 4.2 mp -126.89 111.8 14.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.902 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.557 HD12 ' CZ ' ' A' ' 79' ' ' TYR . 26.3 pt -115.75 163.32 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.692 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 1.3 m-85 -128.11 125.73 39.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.557 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 63.2 m-85 -109.49 165.04 11.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.43 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -168.51 63.79 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.714 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.3 23.83 4.36 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.028 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.73 -4.67 73.15 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.254 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 13.2 mptt -109.7 110.63 21.72 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.735 0.302 . . . . 0.0 111.088 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . 24.4 pt-20 -68.24 125.59 26.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.467 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 86' ' ' THR . 34.8 m -127.92 -42.04 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.612 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 78' ' ' PHE . 72.2 m -103.96 113.66 27.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.949 0.404 . . . . 0.0 110.093 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -112.14 155.09 24.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.33 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.2 t -155.84 79.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.793 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.642 ' O ' HG23 ' A' ' 89' ' ' VAL . 27.0 m -109.62 91.99 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.313 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -103.38 0.17 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.384 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 179.5 85.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 111.144 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -151.64 81.88 5.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.859 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' A' ' 37' ' ' ILE . 51.9 Cg_exo -54.55 -20.45 21.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.863 2.375 . . . . 0.0 112.698 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.84 -2.41 58.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.588 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.0 -23.94 21.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.71 0.29 . . . . 0.0 111.267 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.01 HG21 HG22 ' A' ' 41' ' ' ILE . 24.3 pt -54.79 -34.43 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.135 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.47 -60.37 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.032 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -68.17 -27.65 66.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.124 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.4 -64.06 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.288 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.435 HG21 ' CE2' ' A' ' 48' ' ' TYR . 66.6 mt -55.78 -35.01 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.216 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.09 -23.79 64.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.327 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.3 m -54.53 -70.13 0.11 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -106.33 56.34 0.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.655 ' HA ' HD12 ' A' ' 21' ' ' LEU . 9.1 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 stop_ save_